|
|
|
Scientific Literature, 2006
-
Aarsetoy H, Brugger-Andersen T, Hetland O, Grundt H, Nilsen DW. Long term influence of regular intake of high dose n-3 fatty acids on CD40-ligand, pregnancy-associated plasma protein A and matrix metalloproteinase-9 following acute myocardial infarction.
Thromb. Haemost. 95: 329-336 (2006).
-
Aas V, Rokling-Andersen MH, Kase ET, Thoresen GH, Rustan AC. Eicosapentaenoic acid (20:5 n-3) increases fatty acid and glucose uptake in cultured human skeletal muscle cells.
J. Lipid Res. 47: 366-374 (2006).
*
-
Abad C, Gomariz RP, Waschek JA. Neuropeptide mimetics and antagonists in the treatment of inflammatory disease: focus on VIP and PACAP.
Curr. Top. Med. Chem. 6: 151-163 (2006).
-
Abadia-Molina AC, Ji H, Faubion WA, Julien A, Latchman Y, Yagita H, Sharpe A, Bhan AK, Terhorst C. CD48 controls T cell and antigen-presenting cell functions in experimental colitis.
Gastroenterology 130: 424-434 (2006).
*
-
Abanmi A, Harthi FA, Baqami RA, Assaf SA, Zouman A, Arfin M, Tariq M. Association of HLA loci alleles and antigens in Saudi patients with vitiligo.
Arch. Dermatol. Res. 298: 347-352 (2006).
*
-
Abate N, Chandalia M, Di Paola R, Foster DW, Grundy SM, Trischitta V. Mechanisms of disease: ectonucleotide pyrophosphatase phosphodiesterase 1 as a 'gatekeeper' of insulin receptors.
Nat. Clin. Pract. Endocrinol. Metab. 2: 694-701 (2006).
*
-
Abbasciano V, Trevisani L, Di Todaro F, Guglielmini C, Marzola A, Sartori S, Salemi A. Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome. An early case.
Recenti Prog. Med. 97: 28-31 (2006).
-
Abbott CA, Yazbeck R, Geier MS, Demuth HU, Howarth GS. Dipeptidyl peptidases and inflammatory bowel disease.
Adv. Exp. Med. Biol. 575: 155-162 (2006).
-
Abd El-Ghaffar HA, Aladle DA, Farahat SE, Abd El-Hady N. P-Glycoprotein (P-170) expression in acute leukemias.
Hematology 11: 35-41 (2006).
-
Abdalian R, Heathcote EJ. Sclerosing cholangitis: a focus on secondary causes.
Hepatology 44: 1063-1074 (2006).
*
-
Abdallah AM, Renzoni EA, Anevlavis S, Lagan AL, Munkonge FM, Fonseca C, Black CM, Briggs D, Wells AU, Marshall SE, McHugh N, du Bois RM, Welsh KI. A polymorphism in the promoter region of the CD86 (B7.2) gene is associated with systemic sclerosis.
Int. J. Immunogenet. 33: 155-161 (2006).
*
-
Abdeen H, Heggarty S, Hawkins SA, Hutchinson M, McDonnell GV, Graham CA. Mapping candidate non-MHC susceptibility regions to multiple sclerosis.
Genes Immun. 7: 494-502 (2006).
*
-
Abdel Rahman H, Abdul Wahab A, Abdel Rahman MO, Mostafa OA. Faecal elastase-1 concentration in cystic fibrosis patients with CFTR I1234V mutation.
Acta Paediatr. 95: 1066-1069 (2006).
*
-
Abdel-Naser MB, Wollina U, El Hefnawi MA, Habib MA, El Okby M. Non-sarcoidal, non-tuberculoid granuloma in common variable immunodeficiency.
J. Drugs Dermatol. 5: 370-372 (2006).
-
Abdelbaqi M, Chidlow JH, Matthews KM, Pavlick KP, Barlow SC, Linscott AJ, Grisham MB, Fowler MR, Kevil CG. Regulation of dextran sodium sulfate induced colitis by leukocyte beta 2 integrins.
Lab. Invest. 86: 380-390 (2006).
*
-
Abdelmalek MF, Liu C, Shuster J, Nelson DR, Asal NR. Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease.
Clin. Gastroenterol. Hepatol. 4: 1162-1169 (2006).
-
Abdgawad M, Hellmark T, Gunnarsson L, Westman KW, Segelmark M. Increased neutrophil membrane expression and plasma level of proteinase 3 in systemic vasculitis are not a consequence of the - 564 A/G promotor polymorphism.
Clin. Exp. Immunol. 145: 63-70 (2006).
*
-
Abdo AA. Clinical presentation, response to therapy, and predictors of fibrosis in patients with autoimmune hepatitis in Saudi Arabia.
Saudi J. Gastroenterol. 12: 73-76 (2006).
*
-
Abdo AA. Mycophenolate mofetil (CellCept) in patients with autoimmune hepatitis.
Saudi J. Gastroenterol. 12: 38 (2006).
*
-
Abdulahad WH, van der Geld YM, Stegeman CA, Kallenberg CG. Persistent expansion of CD4(+) effector memory T cells in Wegener's granulomatosis.
Kidney Int. 70: 938-947 (2006).
*
-
Abdulla D, Goralski KB, Renton KW. The regulation of cytochrome P450 2E1 during LPS-induced inflammation in the rat.
Toxicol. Appl. Pharmacol. 216: 1-10 (2006).
*
-
Abdullaev IF, Rudkouskaya A, Schools GP, Kimelberg HK, Mongin AA. Pharmacological comparison of swelling-activated excitatory amino acid release and Cl- currents in rat cultured astrocytes.
J. Physiol. 572: 677-689 (2006).
*
-
Abdullah HI, Pedraza PL, Hao S, Rodland KD, McGiff JC, Ferreri NR. NFAT regulates calcium sensing receptor-mediated TNF production.
Am. J. Physiol. Renal Physiol. 290: F1110-F1117 (2006).
*
-
Abe M. Complement activation and inflammation.
Rinsho Byori 54: 744-756 (2006).
-
Abe M, Thomson AW. Dexamethasone preferentially suppresses plasmacytoid dendritic cell differentiation and enhances their apoptotic death.
Clin. Immunol. 118: 300-306 (2006).
*
-
Abe T, Takeuchi T, Miyasaka N, Hashimoto H, Kondo H, Ichikawa Y, Nagaya I. A multicenter, double-blind, randomized, placebo controlled trial of infliximab combined with low dose methotrexate in Japanese patients with rheumatoid arthritis.
J. Rheumatol. 33: 37-44 (2006).
-
Abe-Dohmae S, Ueda K, Yokoyama S. ABCA7, a molecule with unknown function.
FEBS Lett. 580: 1178-1182 (2006).
*
-
Abebe F, Mustafa T, Nerland AH, Bjune GA. Cytokine profile during latent and slowly progressive primary tuberculosis: a possible role for interleukin-15 in mediating clinical disease.
Clin. Exp. Immunol. 143: 180-192 (2006).
*
-
Abedin M, Lim J, Tang TB, Park D, Demer LL, Tintut Y. n-3 Fatty acids inhibit vascular calcification via the p38-MAPK and peroxisome proliferator-activated receptor-gamma pathways.
Circ. Res. 98: 727-729 (2006).
*
-
Abedin M, Scheurich D, Reimold SC, Reimold AM. Acute coronary syndrome after infliximab infusion.
Cardiol. Rev. 14: 50-52 (2006).
-
Abedin SA, Banwell CM, Colston KW, Carlberg C, Campbell MJ. Epigenetic corruption of VDR signalling in malignancy.
Anticancer Res. 26: 2557-2566 (2006).
-
Abel B, Kurrer M, Shamshiev A, Marty RR, Eriksson U, Gunthert U, Kopf M. The osteopontin - CD44 pathway is superfluous for the development of autoimmune myocarditis.
Eur. J. Immunol. 36: 494-499 (2006).
*
-
Abel M, Cellier C, Kumar N, Cerf-Bensussan N, Schmitz J, Caillat-Zucman S. Adulthood-onset celiac disease is associated with intercellular adhesion molecule-1 (ICAM-1) gene polymorphism.
Hum. Immunol. 67: 612-617 (2006).
-
Abel S, Yang Y, Waring JF. Development of an in vitro gene expression assay for predicting hepatotoxicity.
ALTEX 23: S326-S331 (2006).
-
Abele R, Tampe R. Modulation of the antigen transport machinery TAP by friends and enemies.
FEBS Lett. 580: 1156-1163 (2006).
*
-
Abeles AM, Pillinger MH. The role of the synovial fibroblast in rheumatoid arthritis - cartilage destruction and the regulation of matrix metalloproteinases.
Bull. Hosp. Jt. Dis. 64: 20-24 (2006).
-
Abenavoli L, Proietti I, Leggio L, Ferrulli A, Vonghia L, Capizzi R, Rotoli M, Amerio PL, Gasbarrini G, Addolorato G. Cutaneous manifestations in celiac disease.
World J. Gastroenterol. 12: 843-852 (2006).
*
-
Aberle J, Hopfer I, Beil FU, Seedorf U. Association of peroxisome proliferator-activated receptor delta +294T/C with body mass index and interaction with peroxisome proliferator-activated receptor alpha L162V.
Int. J. Obes. (Lond.) 30: 1709-1713 (2006).
-
Aberra FN. To be or not to be: infliximab during pregnancy?
Inflamm. Bowel Dis. 12: 76-78 (2006).
*
-
Aberra FN, Lichtenstein GR. Infliximab in ulcerative colitis.
Gastroenterol. Clin. North Am. 35: 821-836 (2006).
-
Abildayeva K, Jansen PJ, Hirsch-Reinshagen V, Bloks VW, Bakker AH, Ramaekers FC, De Vente J, Groen AK, Wellington CL, Kuipers F, Mulder M. 24(S)-Hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux.
J. Biol. Chem. 281: 12799-12808 (2006).
*
-
Ablin JN, Boguslavski V, Aloush V, Elkayam O, Paran D, Caspi D, George J. Effect of anti-TNFalpha treatment on circulating endothelial progenitor cells (EPCs) in rheumatoid arthritis.
Life Sci. 79: 2364-2369 (2006).
*
-
Ablin JN, Cohen H, Buskila D. Mechanisms of disease: genetics of fibromyalgia.
Nat. Clin. Pract. Rheumatol. 2: 671-678 (2006).
*
-
Aboian E, Winter DC, Metcalf DR, Wolff BG. Perineal hernia after proctectomy: prevalence, risks, and management.
Dis. Colon Rectum 49: 1564-1568 (2006).
*
-
Abou-Raya A, Abou-Raya S. Inflammation: a pivotal link between autoimmune diseases and atherosclerosis.
Autoimmun. Rev. 5: 331-337 (2006).
-
Aboul-Enein F, Weiser P, Hoftberger R, Lassmann H, Bradl M. Transient axonal injury in the absence of demyelination: a correlate of clinical disease in acute experimental autoimmune encephalomyelitis.
Acta Neuropathol. (Berl.) 111: 539-547 (2006).
-
Abraham C, Cho JH. Functional consequences of NOD2 (CARD15) mutations.
Inflamm. Bowel Dis. 12: 641-650 (2006).
*
-
Abraham J, Earl HM, Pharoah PD, Caldas C. Pharmacogenetics of cancer chemotherapy.
Biochim. Biophys. Acta 1766: 168-183 (2006).
*
-
Abraham SC, Kamath PS, Eghtesad B, Demetris AJ, Krasinskas AM. Liver transplantation in precirrhotic biliary tract disease: portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.
Am. J. Surg. Pathol. 30: 1454-1461 (2006).
-
Abraldes JG, Pasarin M, Garcia-Pagan JC. Animal models of portal hypertension.
World J. Gastroenterol. 12: 6577-6584 (2006).
*
-
Abramovits W, Losornio M. Failure of two TNF-alpha blockers to influence the course of alopecia areata.
Skinmed. 5: 177-181 (2006).
-
Abrams JA, Brar P, Diamond B, Rotterdam H, Green PH. Utility in clinical practice of immunoglobulin A anti-tissue transglutaminase antibody for the diagnosis of celiac disease.
Clin. Gastroenterol. Hepatol. 4: 726-730 (2006).
-
Abramson SB, Attur M, Yazici Y. Prospects for disease modification in osteoarthritis.
Nat. Clin. Pract. Rheumatol. 2: 304-312 (2006).
*
-
Abramson SB, Yazici Y. Biologics in development for rheumatoid arthritis: relevance to osteoarthritis.
Adv. Drug Deliv. Rev. 58: 212-225 (2006).
*
-
Abreu MT. Serologies in Crohn's disease: can we change the gray zone to black and white?
Gastroenterology 131: 664-667 (2006).
*
-
Abreu MT, Geller JL, Vasiliauskas EA, Kam LY, Vora P, Martyak LA, Yang H, Hu B, Lin YC, Keenan G, Price J, Landers CJ, Adams JS, Targan SR. Treatment with infliximab is associated with increased markers of bone formation in patients with Crohn's disease.
J. Clin. Gastroenterol. 40: 55-63 (2006).
-
Abreu MT, Sparrow MP. Translational research in inflammatory bowel disease.
Mt. Sinai J. Med. 73: 1067-1073 (2006).
*
-
Abroms L, Maibach E, Lyon-Daniel K, Feldman SR. What is the best approach to reducing birth defects associated with isotretinoin?
PLoS Med. 3: e483 (2006).
*
-
Absar S, Mason J, Anjum K, Haboubi N. A new combined form significantly improves accuracy of pathological diagnosis in inflammatory bowel disease in absence of the clinicopathological conference.
Tech. Coloproctol. 10: 227-232 (2006).
*
-
Abu-Elmagd KM. Intestinal transplantation for short bowel syndrome and gastrointestinal failure: current consensus, rewarding outcomes, and practical guidelines.
Gastroenterology 130: S132-S137 (2006).
*
-
AbuGhazaleh AA, Holmes LD, Jacobson BN, Kalscheur KF. Short communication: eicosatrienoic acid and docosatrienoic acid do not promote vaccenic acid accumulation in mixed ruminal cultures.
J. Dairy Sci. 89: 4336-4339 (2006).
*
-
Abuzaytoun R, Shahidi F. Oxidative stability of algal oils as affected by their minor components.
J. Agric. Food Chem. 54: 8253-8260 (2006).
*
-
Acar N, Bonhomme B, Joffre C, Bron AM, Creuzot-Garcher C, Bretillon L, Doly M, Chardigny JM. The retina is more susceptible than the brain and the liver to the incorporation of trans isomers of DHA in rats consuming trans isomers of alpha-linolenic acid.
Reprod. Nutr. Dev. 46: 515-525 (2006).
*
-
Achard-Joris M, Bourdineaud JP. Heterologous expression of bacterial and human multidrug resistance proteins protect Escherichia coli against mercury and zinc contamination.
Biometals 19: 695-704 (2006).
*
-
Achila D, Banci L, Bertini I, Bunce J, Ciofi-Baffoni S, Huffman DL. Structure of human Wilson protein domains 5 and 6 and their interplay with domain 4 and the copper chaperone HAH1 in copper uptake.
Proc. Natl. Acad. Sci. U.S.A. 103: 5729-5734 (2006).
*
-
Achiron A. Measuring disability progression in multiple sclerosis.
J. Neurol. 253: vi31-vi36 (2006).
*
-
Achkar JP, Dassopoulos T, Silverberg MS, Tuvlin JA, Duerr RH, Brant SR, Siminovitch K, Reddy D, Datta LW, Bayless TM, Zhang L, Barmada MM, Rioux JD, Steinhart AH, McLeod RS, Griffiths AM, Cohen Z, Yang H, Bromfield GP, Schumm P, Hanauer SB, Cho JH, et al. Phenotype-stratified genetic linkage study demonstrates that IBD2 is an extensive ulcerative colitis locus.
Am. J. Gastroenterol. 101: 572-580 (2006).
*
-
Ackerman LS. Sex hormones and the genesis of autoimmunity.
Arch. Dermatol. 142: 371-376 (2006).
*
-
Ackert-Bicknell C, Rosen C. The genetics of PPARG and the skeleton.
PPAR Res. 2006: 93258 (2006).
*
-
Adachi M, Inoko A, Hata M, Furuse K, Umeda K, Itoh M, Tsukita S. Normal establishment of epithelial tight junctions in mice and cultured cells lacking expression of ZO-3, a tight-junction MAGUK protein.
Mol. Cell. Biol. 26: 9003-9015 (2006).
*
-
Adachi M, Kurotani R, Morimura K, Shah Y, Sanford M, Madison BB, Gumucio DL, Marin HE, Peters JM, Young HA, Gonzalez FJ. PPARgamma in colonic epithelial cells protects against experimental inflammatory bowel disease.
Gut 55: 1104-1113 (2006).
*
-
Adachi T, Matsushita T, Ichihashi R, Hirashima K, Ito M, Inukai A, Yokozawa T, Nishida T, Murata M, Hayashi M, Katsumi A, Kojima T, Saito H, Naoe T. High titer of ADAMTS13 inhibitor associated with thrombotic microangiopathy of the gut and skeletal muscle after allogeneic hematopoietic stem cell transplantation.
Int. J. Hematol. 83: 415-419 (2006).
-
Adachi T, Toishi T, Takashima E, Hara H. Infliximab neutralizes the suppressive effect of TNF-alpha on expression of extracellular-superoxide dismutase in vitro.
Biol. Pharm. Bull. 29: 2095-2098 (2006).
*
-
Adak M, Gupta JK. Evaluation of anti-inflammatory activity of Calotropis gigantea (AKANDA) in various biological system.
Nepal. Med. Coll. J. 8: 156-161 (2006).
-
Adam B, Liebregts T, Holtmann G. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.
Z. Gastroenterol. 44: 267-269 (2006).
-
Adam R, Sturrock RD, Gracie JA. TLR4 mutations (Asp299Gly and Thr399Ile) are not associated with ankylosing spondylitis.
Ann. Rheum. Dis. 65: 1099-1101 (2006).
*
-
Adamopoulos AB. Inflammatory bowel disease (IBD) and the liver.
Annals of Gastroenterology 19: 146-151 (2006). *
-
Adams DH, Eksteen B. Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease.
Nat. Rev. Immunol. 6: 244-251 (2006).
*
-
Adams DR, Buckel T, Sceppa JA. Infliximab associated new-onset psoriasis.
J. Drugs Dermatol. 5: 178-179 (2006).
-
Adams LS, Seeram NP, Aggarwal BB, Takada Y, Sand D, Heber D. Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells.
J. Agric. Food Chem. 54: 980-985 (2006).
-
Adams MA, Roughley PJ. What is intervertebral disc degeneration, and what causes it?
Spine 31: 2151-2161 (2006).
*
-
Adamsen S, Olsen M, Jendresen MB, Holck S, Glenthoj A. Endobiliary brush biopsy: intra- and interobserver variation in cytological evaluation of brushings from bile duct strictures.
Scand. J. Gastroenterol. 41: 597-603 (2006).
*
-
Adamson AW, Dreesen TD, Tekle M, Tang C, Cho HP, Clarke SD, Gettys TW. A newly discovered member of the fatty acid desaturase gene family: a non-coding, antisense RNA gene to Delta5-desaturase.
Prostaglandins Leukot. Essent. Fatty Acids 75: 97-106 (2006).
*
-
Adamson AW, Suchankova G, Rufo C, Nakamura MT, Teran-Garcia M, Clarke SD, Gettys TW. Hepatocyte nuclear factor-4alpha contributes to carbohydrate-induced transcriptional activation of hepatic fatty acid synthase.
Biochem. J. 399: 285-295 (2006).
*
-
Adarichev VA, Glant TT. Experimental spondyloarthropathies: animal models of ankylosing spondylitis.
Curr. Rheumatol. Rep. 8: 267-274 (2006).
-
Adarichev VA, Vermes C, Hanyecz A, Ludanyi K, Tunyogi-Csapo M, Finnegan A, Mikecz K, Glant TT. Antigen-induced differential gene expression in lymphocytes and gene expression profile in synovium prior to the onset of arthritis.
Autoimmunity 39: 663-673 (2006).
-
Adegbola O, Yang H, Zhuang H. Hepatobiliary scintigraphy monitoring patency of partial external biliary diversion in a patient with progressive familial intrahepatic cholestasis.
Clin. Nucl. Med. 31: 622-623 (2006).
-
Ader F, Chatellier D, Le Berre R, Morand P, Fourrier F. Fulminant Epstein-Barr virus (EBV) hepatitis in a young immunocompetent subject.
Med. Mal. Infect. 36: 396-398 (2006).
-
Adib-Conquy M, Adrie C, Fitting C, Gattolliat O, Beyaert R, Cavaillon JM. Up-regulation of MyD88s and SIGIRR, molecules inhibiting Toll-like receptor signaling, in monocytes from septic patients.
Crit. Care Med. 34: 2377-2385 (2006).
-
Adida A, Spener F. Adipocyte-type fatty acid-binding protein as inter-compartmental shuttle for peroxisome proliferator activated receptor gamma agonists in cultured cell.
Biochim. Biophys. Acta 1761: 172-181 (2006).
*
-
Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J, Vehkavaara S, Hakkinen A, Olofsson SO, Yki-Jarvinen H, Boren J. Overproduction of large VLDL particles is driven by increased liver fat content in man.
Diabetologia 49: 755-765 (2006).
*
-
Adighibe O, Arepalli S, Duckworth J, Hardy J, Wavrant-De Vrieze F. Genetic variability at the LXR gene (NR1H2) may contribute to the risk of Alzheimer's disease.
Neurobiol. Aging 27: 1431-1434 (2006).
-
Adisen E, Gulekon A, Erdem O, Dursun A, Gurer M. The effects of calcipotriol and methylprednisolone aseponate on bcl-2, p53 and ki-67 expression in psoriasis.
J. Eur. Acad. Dermatol. Venereol. 20: 527-533 (2006).
*
-
Adorini L, Daniel KC, Penna G. Vitamin D receptor agonists, cancer and the immune system: an intricate relationship.
Curr. Top. Med. Chem. 6: 1297-1301 (2006).
-
Adriaansen J, Kuhlman RR, Holten JV, Kaynor C, Vervoordeldonk MJ, Tak PP. Intraarticular interferon-beta gene therapy ameliorates adjuvant arthritis in rats.
Hum. Gene Ther. 17: 985-996 (2006).
-
Adriaansen J, Vervoordeldonk MJ, Tak PP. Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: innovative vectors and therapeutic genes.
Rheumatology (Oxford) 45: 656-668 (2006).
*
-
Adrych KJ, Marek IE, Kryszewski AJ. Adults celiac disease - the tip of the iceberg.
Wiad. Lek. 59: 359-363 (2006).
-
Adsay NV. Role of MUC genes and mucins in pancreatic neoplasia.
Am. J. Gastroenterol. 101: 2330-2332 (2006).
*
-
Aeberli D, Leech M, Morand EF. Macrophage migration inhibitory factor and glucocorticoid sensitivity.
Rheumatology (Oxford) 45: 937-943 (2006).
*
-
Affolter VK, Moore PF. Feline progressive histiocytosis.
Vet. Pathol. 43: 646-655 (2006).
*
-
Afman L, Muller M. Nutrigenomics: from molecular nutrition to prevention of disease.
J. Am. Diet. Assoc. 106: 569-576 (2006).
-
Aftab MN, Dee A, Helm TN. Erythema elevatum diutinum arising in the setting of dermatitis herpetiformis.
Cutis 78: 129-132 (2006).
-
AGA Clinical Practice and Economics Committee. Position of the American Gastroenterological Association (AGA) Institute on computed tomographic colonography.
Gastroenterology 131: 1627-1628 (2006).
*
-
Agaba AE, Berry N, Agaba PO, Charaklias N, Wong LS. One stop rectal bleeding clinic: the Coventry experience.
Int. Surg. 91: 288-290 (2006).
-
Agace WW. Tissue-tropic effector T cells: generation and targeting opportunities.
Nat. Rev. Immunol. 6: 682-692 (2006).
*
-
Agapov M. Balantidiasis in a patient with suspected Crohn's disease.
Endoscopy 38: 655 (2006).
*
-
Agardh D, Lynch K, Brundin C, Ivarsson SA, Lernmark A, Cilio CM. Reduction of tissue transglutaminase autoantibody levels by gluten-free diet is associated with changes in subsets of peripheral blood lymphocytes in children with newly diagnosed coeliac disease.
Clin. Exp. Immunol. 144: 67-75 (2006).
*
-
Agarwal N, Sharma BC, Sarin SK. Endoscopic management of acute cholangitis in elderly patients.
World J. Gastroenterol. 12: 6551-6555 (2006).
*
-
Agarwal R, Agarwal C, Ichikawa H, Singh RP, Aggarwal BB. Anticancer potential of silymarin: from bench to bed side.
Anticancer Res. 26: 4457-4498 (2006).
-
Agarwal SK, Brenner MB. Role of adhesion molecules in synovial inflammation.
Curr. Opin. Rheumatol. 18: 268-276 (2006).
-
Agerberth B, Gudmundsson GH. Host antimicrobial defence peptides in human disease.
Curr. Top. Microbiol. Immunol. 306: 67-90 (2006).
-
Aggarwal BB, Sethi G, Nair A, Ichikawa H. Nuclear factor-kB: a holy grail in cancer prevention and therapy.
Current Signal Transduction Therapy 1: 25-52 (2006). *
-
Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G. Inflammation and cancer: how hot is the link?
Biochem. Pharmacol. 72: 1605-1621 (2006).
*
-
Aggarwal BB, Shishodia S, Takada Y, Jackson-Bernitsas D, Ahn KS, Sethi G, Ichikawa H. TNF blockade: an inflammatory issue.
Ernst Schering Res. Found. Workshop 56: 161-186 (2006).
-
Aggarwal P, Aggarwal A, Gupta S, Misra R. Osteopenia is common in adult male patients with active juvenile idiopathic arthritis.
J. Rheumatol. 33: 1642-1645 (2006).
-
Aggarwal S, Kim SW, Cheon K, Tabassam FH, Yoon JH, Koo JS. Nonclassical action of retinoic acid on the activation of the cAMP response element-binding protein in normal human bronchial epithelial cells.
Mol. Biol. Cell. 17: 566-575 (2006).
*
-
Aggelidou E, Iordanidou P, Demetriades C, Piltsi O, Hadzopoulou-Cladaras M. Functional characterization of hepatocyte nuclear factor-4alpha dimerization interface mutants.
FEBS J. 273: 1948-1958 (2006).
*
-
Aghai ZH, Mudduluru M, Nakhla TA, Amendolia B, Longo D, Kemble N, Kaki S, Sutsko R, Saslow JG, Stahl GE. Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis.
J. Perinatol. 26: 550-555 (2006).
-
Agirbasli M, Inanc N, Baykan OA, Direskeneli H. The effects of TNF alpha inhibition on plasma fibrinolytic balance in patients with chronic inflammatory rheumatical disorders.
Clin. Exp. Rheumatol. 24: 580-583 (2006).
-
Agoston ES, Hatcher MA, Kensler TW, Posner GH. Vitamin D analogs as anti-carcinogenic agents.
Anticancer Agents Med. Chem. 6: 53-71 (2006).
-
Agoumi S, Himdi B, Abidi K, Zeggwagh A, Abouqal R. Acute pancreatitis revealing a systemic lupus erythematous.
Rev. Med. Interne. 27: 799-802 (2006).
-
Agrawal AA, Kapley A, Yeltiwar RK, Purohit HJ. Assessment of single nucleotide polymorphism at IL-1A+4845 and IL-1B+3954 as genetic susceptibility test for chronic periodontitis in Maharashtrian ethnicity.
J. Periodontol. 77: 1515-1521 (2006).
-
Agrawal N, Chiang LK, Rifkin IR. Lupus nephritis.
Semin. Nephrol. 26: 95-104 (2006).
-
Aguilera-Montilla N, Perez-Blas M, Paola Valeri A, Lopez-Santalla M, Rodriguez-Juan C, Mencia A, Castellano G, Luisa Manzano M, Casis B, Sanchez F, Manuel Martin-Villa J. Herpesvirus saimiri (HVS)-transformed T-cell lines: a method to study mucosal T cells in inflammatory bowel disease.
Scand. J. Gastroenterol. 41: 1361-1363 (2006).
*
-
Aguillon JC, Cruzat A, Aravena O, Salazar L, Llanos C, Cuchacovich M. Could single-nucleotide polymorphisms (SNPs) affecting the tumour necrosis factor promoter be considered as part of rheumatoid arthritis evolution?
Immunobiology 211: 75-84 (2006).
-
Aguirre S, Silber AM, Brito ME, Ribone ME, Lagier CM, Marcipar IS. Design, construction, and evaluation of a specific chimeric antigen to diagnose chagasic infection.
J. Clin. Microbiol. 44: 3768-3774 (2006).
*
-
Aharoni R, Kayhan B, Brenner O, Domev H, Labunskay G, Arnon R. Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease.
J. Pharmacol. Exp. Ther. 318: 68-78 (2006).
*
-
Ahdoot A, Kotler DP, Suh JS, Kutler C, Flamholz R. Lymphogranuloma venereum in human immunodeficiency virus-infected individuals in New York city.
J. Clin. Gastroenterol. 40: 385-390 (2006).
-
Ahima RS. Obesity epidemic in need of answers.
Gastroenterology 131: 991 (2006).
*
-
Ahlemann M, Schmitt B, Stieber P, Gires O, Lang S, Zeidler R. Evaluation of CK8-specific autoantibodies in carcinomas of distinct localisations.
Anticancer Res. 26: 783-789 (2006).
-
Ahluwalia M, Gotlieb V, Damerla V, Saif MW. Aggressive Burkitt-like lymphoma of colon in a patient with prior celiac disease.
Yale J. Biol. Med. 79: 173-175 (2006).
*
-
Ahmad A, Frank BB. Introduction: women's issues in gastroenterology and hepatology.
Am. J. Gastroenterol. 101 Suppl. 3: S601 (2006).
*
-
Ahmad K, Rogers S. Three years' experience with infliximab in recalcitrant psoriasis.
Clin. Exp. Dermatol. 31: 630-633 (2006).
*
-
Ahmad S, Tester RF, Corbett A, Karkalas J. Dextran and 5-aminosalicylic acid (5-ASA) conjugates: synthesis, characterisation and enzymic hydrolysis.
Carbohydr. Res. 341: 2694-2701 (2006).
*
-
Ahmad T, Marshall SE, Jewell D. Genetics of inflammatory bowel disease: the role of the HLA complex.
World J. Gastroenterol. 12: 3628-3635 (2006).
*
-
Ahmed FE. Gene-gene, gene-environment and multiple interactions in colorectal cancer.
J. Environ. Sci. Health C. Environ. Carcinog. Ecotoxicol. Rev. 24: 1-101 (2006).
*
-
Ahmed FE. Role of genes, the environment and their interactions in the etiology of inflammatory bowel diseases.
Expert Rev. Mol. Diagn. 6: 345-363 (2006).
-
Ahmed I, Boulter MK, Lobo DN. The SLAPPA (significance of lower abdominal/periumbilical piercing as a predictor of acute appendicitis) audit.
Sex Health 3: 195-196 (2006).
-
Ahmed I, Harshad SR. Subcutaneous sarcoidosis: is it a specific subset of cutaneous sarcoidosis frequently associated with systemic disease?
J. Am. Acad. Dermatol. 54: 55-60 (2006).
-
Ahmed M, Davies IH, Hood K, Jenkins HR. Incidence of paediatric inflammatory bowel disease in South Wales.
Arch. Dis. Child. 91: 344-345 (2006).
-
Ahmed MH. Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): the need for biochemical markers.
Scand. J. Gastroenterol. 41: 372 (2006).
*
-
Ahmed MM, Berney SM, Wolf RE, Hearth-Holmes M, Hayat S, Mubashir E, Vanderheyde H, Chang WL, King JW. Prevalence of active hepatitis C virus infection in patients with systemic lupus erythematosus.
Am. J. Med. Sci. 331: 252-256 (2006).
-
Ahmed MM, Mubashir E, Wolf RE, Hayat S, Hall V, Shi R, Berney SM. Impact of treatment with infliximab on anticyclic citrullinated peptide antibody and rheumatoid factor in patients with rheumatoid arthritis.
South. Med. J. 99: 1209-1215 (2006).
-
Ahmed W, Orasanu G, Nehra V, Asatryan L, Rader DJ, Ziouzenkova O, Plutzky J. High-density lipoprotein hydrolysis by endothelial lipase activates PPARalpha. A candidate mechanism for high-density lipoprotein-mediated repression of leukocyte adhesion.
Circ. Res. 98: 490-498 (2006).
*
-
Ahmetov II, Mozhayskaya IA, Flavell DM, Astratenkova IV, Komkova AI, Lyubaeva EV, Tarakin PP, Shenkman BS, Vdovina AB, Netreba AI, Popov DV, Vinogradova OL, Montgomery HE, Rogozkin VA. PPARalpha gene variation and physical performance in Russian athletes.
Eur. J. Appl. Physiol. 97: 103-108 (2006).
-
Ahn HS, Lee SK, Kim HJ, Jang JY, Joo KR, Dong SH, Kim BH, Lee JI, Chang YW, Chang R. Risk of postoperative infection in patients with inflammatory bowel disease.
Korean J. Gastroenterol. 48: 306-312 (2006).
-
Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, Terry MB, Neugut AI, Eng SM, Zhang Y, Garza C, Ambrosone CB. Effects of glutathione S-transferase A1 (GSTA1) genotype and potential modifiers on breast cancer risk.
Carcinogenesis 27: 1876-1882 (2006).
*
-
Ahn JH, Shin MS, Jung SH, Kang SK, Kim KR, Rhee SD, Jung WH, Yang SD, Kim SJ, Woo JR, Lee JH, Cheon HG, Kim SS. Indenone derivatives: a novel template for peroxisome proliferator-activated receptor gamma (PPARgamma) agonists.
J. Med. Chem. 49: 4781-4784 (2006).
*
-
Ahn LB, Schroy PC 3rd. Statins and colorectal cancer risk: a new panacea?
Gastroenterology 130: 278-280 (2006).
*
-
Ahn SH, Kim DY, Chang HY, Hong SP, Shin JS, Kim YS, Kim H, Kim JK, Paik YH, Lee KS, Chon CY, Moon YM, Han KH. Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea.
J. Med. Virol. 78: 1564-1571 (2006).
*
-
Ahn T, Houki N, Ohkura Y, Masui K, Fukui H, Shimada K, Yamasaki H, Nakamura-Uchiyama F, Yoshikawa M. Serologically diagnosed toxocariasis with hemophagocytic syndrome in a patient with primary biliary cirrhosis.
Intern. Med. 45: 31-32 (2006).
*
-
Aho TL, Sandholm J, Peltola KJ, Ito Y, Koskinen PJ. Pim-1 kinase phosphorylates RUNX family transcription factors and enhances their activity.
BMC Cell Biol. 7: 21 (2006).
*
-
Ahuja J, Kampani K, Datta S, Wigdahl B, Flaig KE, Jain P. Use of human antigen presenting cell gene array profiling to examine the effect of human T-cell leukemia virus type 1 Tax on primary human dendritic cells.
J. Neurovirol. 12: 47-59 (2006).
-
Ahuja V, Dieckgraefe B, Anant S. Molecular biology of the small intestine.
Curr. Opin. Gastroenterol. 22: 90-94 (2006).
-
Ahya SN, Jose Soler M, Levitsky J, Batlle D. Acid-base and potassium disorders in liver disease.
Semin. Nephrol. 26: 466-470 (2006).
-
Aichele D, Schnare M, Saake M, Rollinghoff M, Gessner A. Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients.
Infect. Immun. 74: 4708-4714 (2006).
*
-
Aida Y, Maeno M, Suzuki N, Namba A, Motohashi M, Matsumoto M, Makimura M, Matsumura H. The effect of IL-1beta on the expression of inflammatory cytokines and their receptors in human chondrocytes.
Life Sci. 79: 764-771 (2006).
*
-
Aiello A, Pandini G, Frasca F, Conte E, Murabito A, Sacco A, Genua M, Vigneri R, Belfiore A. Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells.
Endocrinology 147: 4463-4475 (2006).
*
-
Aihara K, Azuma H, Matsumoto T. Vitamin D-vitamin D receptor system regulates antithrombogenicity in vivo.
Clin. Calcium 16: 1173-1179 (2006).
-
Aimbire F, Albertini R, Pacheco MT, Castro-Faria-Neto HC, Leonardo PS, Iversen VV, Lopes-Martins RA, Bjordal JM. Low-level laser therapy induces dose-dependent reduction of TNFalpha levels in acute inflammation.
Photomed. Laser Surg. 24: 33-37 (2006).
-
Ainsworth DM, Wagner B, Franchini M, Grunig G, Erb HN, Tan JY. Time-dependent alterations in gene expression of interleukin-8 in the bronchial epithelium of horses with recurrent airway obstruction.
Am. J. Vet. Res. 67: 669-677 (2006).
-
Airaghi L, Tedeschi A. Negative association between occurrence of type 1 diabetes and tuberculosis incidence at population level.
Acta Diabetol. 43: 43-45 (2006).
*
-
Airas L, Mikkola J, Vainio JM, Elovaara I, Smith DJ. Elevated serum soluble vascular adhesion protein-1 (VAP-1) in patients with active relapsing remitting multiple sclerosis.
J. Neuroimmunol. 177: 132-135 (2006).
-
Aishima S, Kuroda Y, Nishihara Y, Taguchi K, Yoshizumi T, Taketomi A, Maehara Y, Tsuneyoshi M. Characteristic differences according to the cirrhotic pattern of advanced primary biliary cirrhosis: macronodular cirrhosis indicates slow progression.
Hepatol. Res. 36: 188-194 (2006).
-
Ait-Belgnaoui A, Han W, Lamine F, Eutamene H, Fioramonti J, Bueno L, Theodorou V. Lactobacillus farciminis treatment suppresses stress-induced visceral hypersensitivity: a possible action through interaction with epithelial cells cytoskeleton contraction.
Gut 55: 1090-1094 (2006).
*
-
Ait-Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, Zoll J, Merval R, Esposito B, Cohen JL, Fisson S, Flavell RA, Hansson GK, Klatzmann D, Tedgui A, Mallat Z. Natural regulatory T cells control the development of atherosclerosis in mice.
Nat. Med. 12: 178-180 (2006).
*
-
Aitken AE, Richardson TA, Morgan ET. Regulation of drug-metabolizing enzymes and transporters in inflammation.
Annu. Rev. Pharmacol. Toxicol. 46: 123-149 (2006).
*
-
Aitken RJ, Wingate JK, DE Iuliis GN, Koppers AJ, McLaughlin EA. Cis-unsaturated fatty acids stimulate reactive oxygen species generation and lipid peroxidation in human spermatozoa.
J. Clin. Endocrinol. Metab. 91: 4154-4163 (2006).
*
-
Aitman TJ, Dong R, Vyse TJ, Norsworthy PJ, Johnson MD, Smith J, Mangion J, Roberton-Lowe C, Marshall AJ, Petretto E, Hodges MD, Bhangal G, Patel SG, Sheehan-Rooney K, Duda M, Cook PR, Evans DJ, Domin J, Flint J, Boyle JJ, Pusey CD, Cook HT. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans.
Nature 439: 851-855 (2006).
*
-
Ajaj W, Goyen M, Langhorst J, Ruehm SG, Gerken G, Lauenstein TC. MR colonography for the assessment of colonic anastomoses.
J. Magn. Reson. Imaging 24: 101-107 (2006).
-
Ajiro J, Narita I, Sato F, Saga D, Hasegawa H, Kuroda T, Nakano M, Gejyo F. SAA1 gene polymorphisms and the risk of AA amyloidosis in Japanese patients with rheumatoid arthritis.
Mod. Rheumatol. 16: 294-299 (2006).
*
-
Ajith C, Gupta S, Kanwar AJ. Efficacy and safety of the topical sensitizer squaric acid dibutyl ester in alopecia areata and factors influencing the outcome.
J. Drugs Dermatol. 5: 262-266 (2006).
-
Ajuebor MN, Carey JA, Swain MG. CCR5 in T cell-mediated liver diseases: what's going on?
J. Immunol. 177: 2039-2045 (2006).
*
-
Akabas SR, Deckelbaum RJ. Summary of a workshop on n-3 fatty acids: current status of recommendations and future directions.
Am. J. Clin. Nutr. 83: 1536S-1538S (2006).
*
-
Akagawa M, Ito S, Toyoda K, Ishii Y, Tatsuda E, Shibata T, Yamaguchi S, Kawai Y, Ishino K, Kishi Y, Adachi T, Tsubata T, Takasaki Y, Hattori N, Matsuda T, Uchida K. Bispecific Abs against modified protein and DNA with oxidized lipids.
Proc. Natl. Acad. Sci. U.S.A. 103: 6160-6165 (2006).
*
-
Akahoshi M, Nakashima H, Shirakawa T. Roles of genetic variations in signalling/immunoregulatory molecules in susceptibility to systemic lupus erythematosus.
Semin. Immunol. 18: 224-229 (2006).
*
-
Akaogi J, Barker T, Kuroda Y, Nacionales DC, Yamasaki Y, Stevens BR, Reeves WH, Satoh M. Role of non-protein amino acid L-canavanine in autoimmunity.
Autoimmun. Rev. 5: 429-435 (2006).
-
Akaogi J, Nozaki T, Satoh M, Yamada H. Role of PGE2 and EP receptors in the pathogenesis of rheumatoid arthritis and as a novel therapeutic strategy.
Endocr. Metab. Immune Disord. Drug Targets 6: 383-394 (2006).
-
Akar N, Hasipek M, Ozturk A, Akar E, Tekin M. Serum amyloid A1 -13 T/C alleles in Turkish familial Mediterranean fever patients with and without amyloidosis.
J. Nephrol. 19: 318-321 (2006).
-
Akar N, Ozturk A, Ozel D, Akar E, Ekim M. Is MEFV P706 polymorphism important in familial Mediterranean fever patients?
J. Nephrol. 19: 119-120 (2006).
-
Akare S, Jean-Louis S, Chen W, Wood DJ, Powell AA, Martinez JD. Ursodeoxycholic acid modulates histone acetylation and induces differentiation and senescence.
Int. J. Cancer 119: 2958-2969 (2006).
*
-
Akashi M, Tanaka A, Takikawa H. Effect of cyclosporin A on the biliary excretion of cholephilic compounds in rats.
Hepatol. Res. 34: 193-198 (2006).
-
Akashi-Takamura S, Miyake K. Toll-like receptors (TLRs) and immune disorders.
J. Infect. Chemother. 12: 233-240 (2006).
*
-
Akay N, Boyvat A, Heper AO, Soykan I, Arica IE, Bektas M, Ensari A, Cokca F. Behcet's disease-like presentation of bullous pyoderma gangrenosum associated with Crohn's disease.
Clin. Exp. Dermatol. 31: 384-386 (2006).
*
-
Akaza T, El-Awar N, Nguyen A, Kitawaki J, Terasaki P. HLA class I epitopes: C-locus.
Clin. Transpl. 2006: 95-102 (2006).
-
Akbari O. The role of iNKT cells in development of bronchial asthma: a translational approach from animal models to human.
Allergy 61: 962-968 (2006).
*
-
Akbari O, Faul JL, Hoyte EG, Berry GJ, Wahlstrom J, Kronenberg M, DeKruyff RH, Umetsu DT. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma.
N. Engl. J. Med. 354: 1117-1129 (2006).
*
-
Akbas SH, Bilgen T, Keser I, Tuncer M, Yucetin L, Tosun O, Gultekin M, Luleci G. The effect of MDR1 (ABCB1) polymorphism on the pharmacokinetic of tacrolimus in Turkish renal transplant recipients.
Transplant. Proc. 38: 1290-1292 (2006).
*
-
Akcakaya A, Sahin M, Coskun A, Demiray S. Comparison of mechanical bowel obstruction cases of intra-abdominal tumor and non-tumoral origin.
World J. Surg. 30: 1295-1299 (2006).
*
-
Akcam M, Yildiz M, Yilmaz A, Artan R. Bone mineral density in response to two different regimes in rickets.
Indian Pediatr. 43: 423-427 (2006).
*
-
Akdogan M, Camci C, Gurakar A, Gilcher R, Alamian S, Wright H, Nour B, Sebastian A. The effect of total plasma exchange on fulminant hepatic failure.
J. Clin. Apher. 21: 96-99 (2006).
-
Akerman L, Mimouni D, Trattner A, David M. Pemphigus vulgaris - an alternative for steroid treatment?
Harefuah. 145: 493-494, 551 (2006).
-
Akgul B, Curten M, Haigis H, Rogosz I, Pfister H. Interferon regulatory factor 5.2 acts as a transcription repressor of epidermodysplasia verruciformis-associated human papillomaviruses.
Arch. Virol. 151: 2461-2473 (2006).
*
-
Akgul S, Erbil Y, Giris M, Alis H, Yanik BT, Olgac V, Toker GA. The effect of octreotide on pancreatic damage in TNBS-induced colitis.
Surg. Innov. 13: 102-108 (2006).
-
Akiba Y, Ghayouri S, Takeuchi T, Mizumori M, Guth PH, Engel E, Swenson ER, Kaunitz JD. Carbonic anhydrases and mucosal vanilloid receptors help mediate the hyperemic response to luminal CO(2) in rat duodenum.
Gastroenterology 131: 142-152 (2006).
*
-
Akinbami FO, Venugopalan P, Elnour IB, Nirmala V, Abiodun P, Azubuike JC. Pattern of chronic diarrhoea in children: a prospective analysis of causes, clinical features and outcome.
Niger Postgrad. Med. J. 13: 53-56 (2006).
-
Akira S. TLR signaling.
Curr. Top. Microbiol. Immunol. 311: 1-16 (2006).
-
Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity.
Cell 124: 783-801 (2006).
*
-
Akiyama M. Pathomechanisms of harlequin ichthyosis and ABCA transporters in human diseases.
Arch. Dermatol. 142: 914-918 (2006).
*
-
Akiyama M, Sakai K, Sugiyama-Nakagiri Y, Yamanaka Y, McMillan JR, Sawamura D, Niizeki H, Miyagawa S, Shimizu H. Compound heterozygous mutations including a de novo missense mutation in ABCA12 led to a case of harlequin ichthyosis with moderate clinical severity.
J. Invest. Dermatol. 126: 1518-1523 (2006).
*
-
Akkad DA, Godde R, Epplen JT. No association between synapsin III gene promoter polymorphisms and multiple sclerosis in German patients.
J. Neurol. 253: 1365-1366 (2006).
*
-
Akkad DA, Jagiello P, Szyld P, Goedde R, Wieczorek S, Gross WL, Epplen JT. Promoter polymorphism rs3087456 in the MHC class II transactivator gene is not associated with susceptibility for selected autoimmune diseases in German patient groups.
Int. J. Immunogenet. 33: 59-61 (2006).
*
-
Akkari R, Burbiel JC, Hockemeyer J, Muller CE. Recent progress in the development of adenosine receptor ligands as antiinflammatory drugs.
Curr. Top. Med. Chem. 6: 1375-1399 (2006).
-
Akkoc N, van der Linden S, Khan MA. Ankylosing spondylitis and symptom-modifying vs disease-modifying therapy.
Best Pract. Res. Clin. Rheumatol. 20: 539-557 (2006).
-
Akman A, Sallakci N, Coskun M, Bacanli A, Yavuzer U, Alpsoy E, Yegin O. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behcet's disease.
Br. J. Dermatol. 155: 350-356 (2006).
*
-
Akman SA, Arikan C, Sozen G, Ozturk C, Yagci RV. Infliximab treatment of pediatric refractory Crohn's disease: a case report.
Turk. J. Gastroenterol. 17: 133-136 (2006).
*
-
Akman-Demir G, Gul A, Gurol E, Ozdogan H, Bahar S, Oge AE, Gurvit H, Saruhan-Direskeneli G, Yazici H, Eraksoy M. Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association?
J. Neurol. 253: 928-934 (2006).
*
-
Akobeng AK. Infliximab for induction and maintenance theraphy for ulcerative colitis.
J. Pediatr. Gastroenterol. Nutr. 42: 589-590 (2006).
*
-
Akobeng AK, Ramanan AV, Buchan I, Heller RF. Effect of breast-feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies.
Arch. Dis. Child. 91: 39-43 (2006).
-
Akomolafe A, Lunetta K, Erlich P, Cupples L, Baldwin C, Huyck M, Green R, Farrer L; MIRAGE Study Group. Genetic association between endothelial nitric oxide synthase and Alzheimer disease.
Clin. Genet. 70: 49-56 (2006).
*
-
Akritidis N, Papadopoulos A, Pappas G. Long-term follow-up of patients with adult-onset Still's disease.
Scand. J. Rheumatol. 35: 395-397 (2006).
*
-
Aksamit AJ. Review of progressive multifocal leukoencephalopathy and natalizumab.
Neurologist 12: 293-298 (2006).
-
Aksoy Y, Aksoy H, Altinkaynak K, Aydin HR, Ozkan A. Sperm fatty acid composition in subfertile men.
Prostaglandins Leukot. Essent. Fatty Acids 75: 75-79 (2006).
*
-
Aktas O, Prozorovski T, Zipp F. Death ligands and autoimmune demyelination.
Neuroscientist 12: 305-316 (2006).
*
-
Al Hamoudi W, Lee SS. Cirrhotic cardiomyopathy.
Ann. Hepatol. 5: 132-139 (2006).
*
-
Al Khalidi H, Kandel G, Streutker CJ. Enteropathy with loss of enteroendocrine and Paneth cells in a patient with immune dysregulation: a case of adult autoimmune enteropathy.
Hum. Pathol. 37: 373-376 (2006).
-
Al Maini M, Carette S. Diagnosis of Wegener's granulomatosis in the ANCA era.
J. Rheumatol. 33: 1923-1925 (2006).
-
Al Saieg N, Luzar MJ. Etanercept induced multiple sclerosis and transverse myelitis.
J. Rheumatol. 33: 1202-1204 (2006).
-
Al-Akeely MH. The impact of elective diagnostic laparoscopy in chronic abominal disorders.
Saudi J. Gastroenterol. 12: 27-30 (2006).
*
-
Al-Ashy R, Chakroun I, El-Sabban ME, Homaidan FR. The role of NF-kappaB in mediating the anti-inflammatory effects of IL-10 in intestinal epithelial cells.
Cytokine 36: 1-8 (2006).
-
Al-Chalabi T, Boccato S, Portmann BC, McFarlane IG, Heneghan MA. Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre.
J. Hepatol. 45: 575-583 (2006).
*
-
Al-Dosari MS, Knapp JE, Liu D. Activation of human CYP2C9 promoter and regulation by CAR and PXR in mouse liver.
Mol. Pharm. 3: 322-328 (2006).
*
-
Al-Hathlol K, Al-Madani A, Al-Saif S, Abulaimoun B, Al-Tawil K, El-Demerdash A. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants.
Singapore Med. J. 47: 147-151 (2006).
*
-
Al-Hwiesh AK. Pyoderma gangrenosum in a renal transplant recipient: a case report.
Saudi J. Kidney Dis. Transpl. 17: 559-563 (2006).
-
Al-Khalili L, Bouzakri K, Glund S, Lonnqvist F, Koistinen HA, Krook A. Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle.
Mol. Endocrinol. 20: 3364-3375 (2006).
*
-
Al-Masri AN, Flemming P, Rodeck B, Melter M, Leonhardt J, Petersen C. Expression of the interferon-induced Mx proteins in biliary atresia.
J. Pediatr. Surg. 41: 1139-1143 (2006).
-
Al-Mayouf SM, Al-Sonbul A, Al Jumaah S, Al-Hemidan A. Sarcoidosis: a delayed or missed diagnosis in children.
Ann. Saudi Med. 26: 220-223 (2006).
-
Al-Moundhri MS, Al-Nabhani M, Al-Bahrani B, Burney IA, Al-Madhani A, Ganguly SS, Al-Yahyaee SA, Grant CS. Interleukin-1beta gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms and gastric cancer risk in an Omani Arab population.
Gastric Cancer 9: 284-290 (2006).
*
-
Al-Moundhri MS, Al-Thahli K, Al-Kindy S, Salam J, Rao L. Metastatic gastrointestinal stromal tumor and hypercalcemia in a patient with ulcerative colitis.
Saudi Med. J. 27: 1585-1587 (2006).
-
Al-Nakkash L, Clarke LL, Rottinghaus GE, Chen YJ, Cooper K, Rubin LJ. Dietary genistein stimulates anion secretion across female murine intestine.
J. Nutr. 136: 2785-2790 (2006).
*
-
Al-Saleh J, el-Eissawy S. The role of T helper cell subsets in pathogenesis of systemic lupus erythematosus and their relation to disease activity.
Egypt. J. Immunol. 13: 41-48 (2006).
-
Al-Shukaili AK, Al-Jabri AA. Rheumatoid arthritis, cytokines and hypoxia. What is the link?
Saudi Med. J. 27: 1642-1649 (2006).
-
Al-Swailem R, Al-Rayes H, Sobki S, Arfin M, Tariq M. HLA-DRB1 association in Saudi rheumatoid arthritis patients.
Rheumatol. Int. 26: 1019-1024 (2006).
*
-
Al-Toma A, Goerres MS, Meijer JW, Pena AS, Crusius JB, Mulder CJ. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma.
Clin. Gastroenterol. Hepatol. 4: 315-319 (2006).
-
Al-Toma A, Goerres MS, Meijer JW, von Blomberg BM, Wahab PJ, Kerckhaert JA, Mulder CJ. Cladribine therapy in refractory celiac disease with aberrant T cells.
Clin. Gastroenterol. Hepatol. 4: 1322-1327 (2006).
-
Al-Wahadneh AM, Dahabreh MM. Familial mediterranean fever in children: a single centre experience in Jordan.
East. Mediterr. Health J. 12: 818-823 (2006).
-
Ala A, Stanca CM, Bu-Ghanim M, Ahmado I, Branch AD, Schiano TD, Odin JO, Bach N. Increased prevalence of primary biliary cirrhosis near superfund toxic waste sites.
Hepatology 43: 525-531 (2006).
*
-
Ala-Laurila P, Kolesnikov AV, Crouch RK, Tsina E, Shukolyukov SA, Govardovskii VI, Koutalos Y, Wiggert B, Estevez ME, Cornwall MC. Visual cycle: dependence of retinol production and removal on photoproduct decay and cell morphology.
J. Gen. Physiol. 128: 153-169 (2006).
*
-
Alachkar H, Taubenheim N, Haeney MR, Durandy A, Arkwright PD. Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency.
Clin. Immunol. 120: 310-318 (2006).
*
-
Alaedini A, Latov N. Transglutaminase-independent binding of gliadin to intestinal brush border membrane and GM1 ganglioside.
J. Neuroimmunol. 177: 167-172 (2006).
-
Alaez C, Loyola M, Murguia A, Flores H, Rodriguez A, Ovilla R, Ignacio G, Amador R, Salinas V, Perez F, Rodriguez D, Morales Z, Llinguin G, Vazquez A, Altamirano A, Gorodezky C. Hematopoietic stem cell transplantation (HSCT): an approach to autoimmunity.
Autoimmun. Rev. 5: 167-179 (2006).
-
Alaibac M, Berti E, Chizzolini C, Fineschi S, Marzano AV, Pigozzi B, Riboldi E, Sozzani S, Kuhn A. Role of cellular immunity in the pathogenesis of autoimmune skin diseases.
Clin. Exp. Rheumatol. 24: S14-S19 (2006).
-
Alam S, Khanna R, Sherwani R, Siraj I. Celiac disease: anti-endomysial antibody versus villous atrophy.
Indian J. Gastroenterol. 25: 317-318 (2006).
*
-
Alamanos Y, Tsifetaki N, Voulgari PV, Venetsanopoulou AI, Siozos C, Drosos AA. Epidemiology of primary Sjogren's syndrome in north-west Greece, 1982-2003.
Rheumatology (Oxford) 45: 187-191 (2006).
*
-
Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review.
Semin. Arthritis Rheum. 36: 182-188 (2006).
*
-
Alamo JM, Gomez MA, Pareja F, Martinez A, Lopez F, Romero E, Barrera L, Serrano J, Garcia I, Bernardos A. Morbidity and mortality in liver retransplantation.
Transplant. Proc. 38: 2475-2477 (2006).
*
-
Alamoudi OS. Sleep-disordered breathing in patients with acquired retrognathia secondary to rheumatoid arthritis.
Med. Sci. Monit. 12: CR530-CR534 (2006).
*
-
Alarcon GS, Calvo-Alen J, McGwin G, Uribe AG, Toloza SM, Roseman J, Fernandez M, Fessler BJ, Vila L, Ahn C, Tan FK, Reveille JD. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time.
Ann. Rheum. Dis. 65: 1168-1174 (2006).
*
-
Alarcon-Riquelme ME. Nucleic acid by-products and chronic inflammation.
Nat. Genet. 38: 866-867 (2006).
*
-
Alarcon-Riquelme ME. The genetics of systemic lupus erythematosus: understanding how SNPs confer disease susceptibility.
Springer Semin. Immunopathol. 28: 109-117 (2006).
*
-
Alard P, Manirarora JN, Parnell SA, Hudkins JL, Clark SL, Kosiewicz MM. Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.
Diabetes 55: 2098-2105 (2006).
*
-
Alavi A, Axford JS. The pivotal nature of sugars in normal physiology and disease.
Wien. Med. Wochenschr. 156: 19-33 (2006).
-
Alazmi W, Bustamante M, O'loughlin C, Gonzalez J, Raskin JB. The association of Streptococcus bovis bacteremia and gastrointestinal diseases: a retrospective analysis.
Dig. Dis. Sci. 51: 732-736 (2006).
*
-
Alazmi WM, Fogel EL, Schmidt S, Watkins JL, McHenry L, Sherman S, Lehman GA. ERCP findings in idiopathic pancreatitis: patients who are cystic fibrosis gene positive and negative.
Gastrointest. Endosc. 63: 234-239 (2006).
-
Alazmi WM, Fogel EL, Watkins JL, McHenry L, Tector JA, Fridell J, Mosler P, Sherman S, Lehman GA. Recurrence rate of anastomotic biliary strictures in patients who have had previous successful endoscopic therapy for anastomotic narrowing after orthotopic liver transplantation.
Endoscopy 38: 571-574 (2006).
-
Alazmi WM, McHenry L, Watkins JL, Fogel EL, Schmidt S, Sherman S, Lehman GL. Chemotherapy-induced sclerosing cholangitis: long-term response to endoscopic therapy.
J. Clin. Gastroenterol. 40: 353-357 (2006).
-
Albala BC, Jimenez RB, Perez B F, Liberman GC. Fatty acid binding protein 2 (FABP-2) polymorphism, obesity and insulin resistance.
Rev. Med. Chil. 134: 372-379 (2006).
-
Alber G, Al-Robaiy S, Kleinschek M, Knauer J, Krumbholz P, Richter J, Schoeneberger S, Schuetze N, Schulz S, Toepfer K, Voigtlaender R, Lehmann J, Mueller U. Induction of immunity and inflammation by interleukin-12 family members.
Ernst Schering Res. Found. Workshop 56: 107-127 (2006).
-
Albers M, Blume B, Schlueter T, Wright MB, Kober I, Kremoser C, Deuschle U, Koegl M. A novel principle for partial agonism of liver X receptor ligands. Competitive recruitment of activators and repressors.
J. Biol. Chem. 281: 4920-4930 (2006).
*
-
Albert KM. Open access: implications for scholarly publishing and medical libraries.
J. Med. Libr. Assoc. 94: 253-262 (2006).
*
-
Albert S, Blons H, Jonard L, Feldmann D, Chauvin P, Loundon N, Sergent-Allaoui A, Houang M, Joannard A, Schmerber S, Delobel B, Leman J, Journel H, Catros H, Dollfus H, Eliot MM, David A, Calais C, Drouin-Garraud V, Obstoy MF, Tran Ba Huy P, et al. SLC26A4 gene is frequently involved in nonsyndromic hearing impairment with enlarged vestibular aqueduct in Caucasian populations.
Eur. J. Hum. Genet. 14: 773-779 (2006).
*
-
Albillos A, Munoz L, Nieto M, Ubeda M, de-la-Hera A, Alvarez-Mon M. Systemic effects of TNF-alpha secreted by circulating monocytes and fatigue in cirrhosis.
Hepatology 43: 1399 (2006).
*
-
Albrecht J, Atzeni F, Baldini C, Bombardieri S, Dalakas MC, Demirkesen C, Yazici H, Mat C, Werth VP, Sarzi-Puttini P. Skin involvement and outcome measures in systemic autoimmune diseases.
Clin. Exp. Rheumatol. 24: S52-S59 (2006).
-
Albrecht J, Norenberg MD. Glutamine: a Trojan horse in ammonia neurotoxicity.
Hepatology 44: 788-794 (2006).
*
-
Alcaro MC, Papini AM. Contribution of peptides to multiple sclerosis research.
Biopolymers 84: 349-367 (2006).
*
-
Aldamiz-Echevarria L, Sanjurjo P, Elorz J, Prieto JA, Perez C, Andrade F, Rodriguez-Soriano J. Effect of docosahexaenoic acid administration on plasma lipid profile and metabolic parameters of children with methylmalonic acidaemia.
J. Inherit. Metab. Dis. 29: 58-63 (2006).
*
-
Alden KJ, Marosy B, Nzegwu N, Justice CM, Wilson AF, Miller NH. Idiopathic scoliosis: identification of candidate regions on chromosome 19p13.
Spine 31: 1815-1819 (2006).
-
Alderson MR, McGowan P, Baldridge JR, Probst P. TLR4 agonists as immunomodulatory agents.
J. Endotoxin Res. 12: 313-319 (2006).
*
-
Aleem A, Al-Sugair S. Thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus.
Acta Haematol. 115: 68-73 (2006).
-
Alegre ML, Fallarino F. Mechanisms of CTLA-4-Ig in tolerance induction.
Curr. Pharm. Des. 12: 149-160 (2006).
-
Aleksunes LM, Goedken M, Manautou JE. Up-regulation of NAD(P)H quinone oxidoreductase 1 during human liver injury.
World J. Gastroenterol. 12: 1937-1940 (2006).
*
-
Aleksunes LM, Slitt AL, Maher JM, Dieter MZ, Knight TR, Goedken M, Cherrington NJ, Chan JY, Klaassen CD, Manautou JE. Nuclear factor-E2-related factor 2 expression in liver is critical for induction of NAD(P)H:quinone oxidoreductase 1 during cholestasis.
Cell Stress Chaperones 11: 356-363 (2006).
-
Alenghat T, Yu J, Lazar MA. The N-CoR complex enables chromatin remodeler SNF2H to enhance repression by thyroid hormone receptor.
EMBO J. 25: 3966-3974 (2006).
*
-
Alessandri C, Bombardieri M, Valesini G. Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prevalence and clinical relevance.
Adv. Clin. Chem. 42: 297-326 (2006).
-
Alessandri C, Sorice M, Bombardieri M, Conigliaro P, Longo A, Garofalo T, Manganelli V, Conti F, Esposti ED, Valesini G. Anti-phospholipid reactivity against cardiolipin metabolites occurring during endothelial cell apoptosis.
Arthritis Res. Ther. 8: R180 (2006).
*
-
Alestas T, Ganceviciene R, Fimmel S, Muller-Decker K, Zouboulis CC. Enzymes involved in the biosynthesis of leukotriene B(4) and prostaglandin E(2) are active in sebaceous glands.
J. Mol. Med. 84: 75-87 (2006).
*
-
Aletaha D, Smolen JS. The definition and measurement of disease modification in inflammatory rheumatic diseases.
Rheum. Dis. Clin. North Am. 32: 9-44 (2006).
-
Aletaha D, Smolen JS. Remission of rheumatoid arthritis: should we care about definitions?
Clin. Exp. Rheumatol. 24: S045-S051 (2006).
*
-
Alexander D, Friedrich B, Abruzzese T, Gondolph-Zink B, Wulker N, Aicher WK. The active form of leflunomide, HMR1726, facilitates TNF-alpha and IL-17 induced MMP-1 and MMP-3 expression.
Cell. Physiol. Biochem. 17: 69-78 (2006).
*
-
Alexopoulou L, Kranidioti K, Xanthoulea S, Denis M, Kotanidou A, Douni E, Blackshear PJ, Kontoyiannis DL, Kollias G. Transmembrane TNF protects mutant mice against intracellular bacterial infections, chronic inflammation and autoimmunity.
Eur. J. Immunol. 36: 2768-2780 (2006).
*
-
Alfaro C, Murillo O, Tirapu I, Azpilicueta A, Huarte E, Arina A, Arribillaga L, Perez-Gracia J, Bendandi M, Prieto J, Lasarte J, Melero I. The immunotherapy potential of agonistic anti-CD137 (4-1BB) monoclonal antibodies for malignancies and chronic viral diseases.
An. Sist. Sanit. Navar. 29: 77-96 (2006).
-
Alfirevic A, Jorgensen AL, Williamson PR, Chadwick DW, Park BK, Pirmohamed M. HLA-B locus in Caucasian patients with carbamazepine hypersensitivity.
Pharmacogenomics 7: 813-818 (2006).
-
Alfirevic A, Mills T, Harrington P, Pinel T, Sherwood J, Jawaid A, Smith JC, March RE, Barratt BJ, Chadwick DW, Kevin Park B, Pirmohamed M. Serious carbamazepine-induced hypersensitivity reactions associated with the HSP70 gene cluster.
Pharmacogenet. Genomics 16: 287-296 (2006).
-
Alhan E, Turkyilmaz S, Ercin C, Kaklikkaya N, Kural BV. Effects of omega-3 fatty acids on acute necrotizing pancreatitis in rats.
Eur. Surg. Res. 38: 314-321 (2006).
-
Ali AA, Moatter T, Baig JA, Iqbal A, Hussain A, Iqbal MP. Polymorphism of HLA-DR and HLA-DQ in rheumatoid arthritis patients and clinical response to methotrexate - a hospital-based study.
J. Pak. Med. Assoc. 56: 452-456 (2006).
-
Ali FY, Davidson SJ, Moraes LA, Traves SL, Paul-Clark M, Bishop-Bailey D, Warner TD, Mitchell JA. Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARbeta.
FASEB J. 20: 326-328 (2006).
*
-
Ali S, Roberts PR. Nutrients with immune-modulating effects: what role should they play in the intensive care unit?
Curr. Opin. Anaesthesiol. 19: 132-139 (2006).
-
Ali-Khan SE, Hales BF. Retinoid receptor antagonists alter the pattern of apoptosis in organogenesis stage mouse limbs.
Toxicol. Sci. 90: 208-220 (2006).
*
-
Alibakhshi R, Zamani M. Mutation analysis of CFTR gene in 70 Iranian cystic fibrosis patients.
Iran. J. Allergy Asthma Immunol. 5: 3-8 (2006).
-
Aliev SA, Aliev ES. Complications of the terminal colostomy and their treatment.
Vestn. Khir. Im. I I Grek. 165: 71-75 (2006).
-
Alifirova VM, Orlova IuIu, Babenko SA, Rudko AA, Puzyrev VP. The 1188 A/C ILI2B gene polymorphism in patients with multiple sclerosis and in healthy subjects of Tomsk region.
Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova 2006 Spec. No 3: 130-135 (2006).
-
Alique M, Lucio FJ, Herrero JF. Vitamin A active metabolite, all-trans retinoic acid, induces spinal cord sensitization. II. Effects after intrathecal administration.
Br. J. Pharmacol. 149: 65-72 (2006).
*
-
Alique M, Lucio-Cazana FJ, Moreno V, Xu Q, Konta T, Nakayama K, Furusu A, Sepulveda JC, Kitamura M. Upregulation of cyclooxygenases by retinoic acid in rat mesangial cells.
Pharmacology 79: 57-64 (2006).
-
Alkemade A, Friesema EC, Kuiper GG, Wiersinga WM, Swaab DF, Visser TJ, Fliers E. Novel neuroanatomical pathways for thyroid hormone action in the human anterior pituitary.
Eur. J. Endocrinol. 154: 491-500 (2006).
*
-
Alkofer B, Samstein B, Guarrera JV, Kin C, Jan D, Bellemare S, Kinkhabwala M, Brown R Jr, Emond JC, Renz JF. Extended-donor criteria liver allografts.
Semin. Liver Dis. 26: 221-233 (2006).
-
Alla V, Abraham J, Siddiqui J, Raina D, Wu GY, Chalasani NP, Bonkovsky HL. Autoimmune hepatitis triggered by statins.
J. Clin. Gastroenterol. 40: 757-776 (2006)..
-
Allard JB, Poynter ME, Marr KA, Cohn L, Rincon M, Whittaker LA. Aspergillus fumigatus generates an enhanced Th2-biased immune response in mice with defective cystic fibrosis transmembrane conductance regulator.
J. Immunol. 177: 5186-5194 (2006).
*
-
Allcock R, Dolecki KJ, Boodhoo A, Abdul Khalil A, Wong AM, Price P. Genomic sequence and expression profile of murine Bat1a and Nfkbil1.
DNA Seq. 17: 292-299 (2006).
-
Allen ML, Hoschtitzky JA, Peters MJ, Elliott M, Goldman A, James I, Klein NJ. Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery.
Crit. Care Med. 34: 2658-2665 (2006).
-
Allen T, Zhang F, Moodie SA, Clemens LE, Smith A, Gregoire F, Bell A, Muscat GE, Gustafson TA. Halofenate is a selective peroxisome proliferator-activated receptor gamma modulator with antidiabetic activity.
Diabetes 55: 2523-2533 (2006).
*
-
Allenspach K, Bergman PJ, Sauter S, Grone A, Doherr MG, Gaschen F. P-glycoprotein expression in lamina propria lymphocytes of duodenal biopsy samples in dogs with chronic idiopathic enteropathies.
J. Comp. Pathol. 134: 1-7 (2006).
*
-
Allenspach K, Rufenacht S, Sauter S, Grone A, Steffan J, Strehlau G, Gaschen F. Pharmacokinetics and clinical efficacy of cyclosporine treatment of dogs with steroid-refractory inflammatory bowel disease.
J. Vet. Intern. Med. 20: 239-244 (2006).
-
Allenspach K, Steiner JM, Shah BN, Berghoff N, Ruaux C, Williams DA, Blum JW, Gaschen F. Evaluation of gastrointestinal permeability and mucosal absorptive capacity in dogs with chronic enteropathy.
Am. J. Vet. Res. 67: 479-483 (2006).
-
Allgayer H, Kruis W. Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine.
Clin. Gastroenterol. Hepatol. 4: 521 (2006).
-
Allina J, Hu B, Sullivan DM, Fiel MI, Thung SN, Bronk SF, Huebert RC, van de Water J, LaRusso NF, Gershwin ME, Gores GJ, Odin JA. T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis.
J. Autoimmun. 27: 232-241 (2006).
-
Allocca M, Crosignani A, Gritti A, Ghilardi G, Gobatti D, Caruso D, Zuin M, Podda M, Battezzati PM. Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis.
Gut 55: 1795-1800 (2006).
*
-
Almasi S, Erfani N, Mojtahedi Z, Rajaee A, Ghaderi A. Association of CTLA-4 gene promoter polymorphisms with systemic sclerosis in Iranian population.
Genes Immun. 7: 401-406 (2006).
*
-
Almeida AR, Zaragoza B, Freitas AA. Indexation as a novel mechanism of lymphocyte homeostasis: the number of CD4+CD25+ regulatory T cells is indexed to the number of IL-2-producing cells.
J. Immunol. 177: 192-200 (2006).
*
-
Almeida J, Galhenage S, Yu J, Kurtovic J, Riordan SM. Gut flora and bacterial translocation in chronic liver disease.
World J. Gastroenterol. 12: 1493-1502 (2006).
*
-
Almroth G, Axelsson T, Mussener E, Grodzinsky E, Midhagen G, Olcen P. Increased prevalence of anti-gliadin IgA-antibodies with aberrant duodenal histopathological findings in patients with IgA-nephropathy and related disorders.
Ups. J. Med. Sci. 111: 339-352 (2006).
*
-
Alnajjar A, Chabane Sari D, Abuharfeil N, Hudaib M, Aburjai T. Effect of n-3 and n-6 polyunsaturated fatty acids on lymphocyte proliferation, interleukin production and phospholipid fatty acids composition in type 2 diabetic and healthy subjects in Jordan people.
Prostaglandins Leukot. Essent. Fatty Acids 74: 347-356 (2006).
*
-
Alnounou M, Munoz SJ. Nutrition Issues In Gastroenterology, Series #37. Nutrition concerns of the patient with primary biliary cirrhosis or primary sclerosing cholangitis. [http://www.healthsystem.virginia.edu/internet/digestive-health/nutritionarticles/April2006.pdf]
Practical Gastroenterology April 2006: 92-100 (2006). *
-
Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases.
Nat. Rev. Immunol. 6: 205-217 (2006).
*
-
Alonso A, Bignone ML, Brunzini M, Brunzini R. Ocular autoimmune pemphigoid and cyclosporin A.
Allergol. Immunopathol. (Madr.) 34: 113-115 (2006).
-
Alonso A, Egues Olazabal N, Ayo Martin O. Infection by Epstein-Barr virus and multiple sclerosis.
Neurologia 21: 249-255 (2006).
-
Alonso A, Jick SS, Hernan MA. Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis.
Neurology 66: 572-575 (2006).
-
Alonso A, Jick SS, Jick H, Hernan MA. Antibiotic use and risk of multiple sclerosis.
Am. J. Epidemiol. 163: 997-1002 (2006).
*
-
Alonso L AG. Effect of pregnancy on pre-existing liver disease physiological changes during pregnancy.
Ann. Hepatol. 5: 184-186 (2006).
*
-
Alonso-Navarro H, Jimenez-Jimenez FJ, Garcia-Agundez JA. The role of CYP2C19 polymorphism in the development of adverse effects to drugs and the risk for diseases.
Med. Clin. (Barc.) 126: 697-706 (2006).
-
Alonso-Navarro H, Martin R, Arenas JA, Jimenez-Jimenez FJ. Limbic encephalitis associated with primary biliary cirrhosis.
Eur. Neurol. 55: 174-176 (2006).
-
Aloush V, Litinsky I, Caspi D, Elkayam O. Propylthiouracil-induced autoimmune syndromes: two distinct clinical presentations with different course and management.
Semin. Arthritis Rheum. 36: 4-9 (2006).
*
-
Aloysius MM, Kaye PV, Lobo DN. Non-steroidal anti-inflammatory drug (NSAID)-induced colonic strictures and perforation: a case report.
Dig. Liver Dis. 38: 276-278 (2006).
-
Alper CA, Husain Z, Larsen CE, Dubey DP, Stein R, Day C, Baker A, Beyan H, Hawa M, Ola TO, Leslie RD. Incomplete penetrance of susceptibility genes for MHC-determined immunoglobulin deficiencies in monozygotic twins discordant for type 1 diabetes.
J. Autoimmun. 27: 89-95 (2006).
*
-
Alper CA, Larsen CE, Dubey DP, Awdeh ZL, Fici DA, Yunis EJ. The haplotype structure of the human major histocompatibility complex.
Hum. Immunol. 67: 73-84 (2006).
*
-
Alper SL. Molecular physiology of SLC4 anion exchangers.
Exp. Physiol. 91: 153-161 (2006).
*
-
Alper SL, Stewart AK, Chernova MN, Zolotarev AS, Clark JS, Vandorpe DH. Anion exchangers in flux: functional differences between human and mouse SLC26A6 polypeptides.
Novartis Found. Symp. 273: 107-119 (2006).
-
Alpers DH. Glutamine: do the data support the cause for glutamine supplementation in humans?
Gastroenterology 130: S106-S116 (2006).
*
-
Alsaeid K, Alawadhi A, Al-Saeed O, Haider MZ. Human leukocyte antigen DRB1*04 is associated with rheumatoid arthritis in Kuwaiti patients.
Joint Bone Spine 73: 62-65 (2006).
*
-
Alsaeid K, Haider MZ, Sharma PN, Ayoub EM. The prevalence of human leukocyte antigen (HLA) DR/DQ/DP alleles in Kuwaiti children with oligoarticular juvenile idiopathic arthritis.
Rheumatol. Int. 26: 224-228 (2006).
*
-
Alsarra IA, Brockmann WG, Cunningham ML, Badr MZ. Hepatocellular proliferation in response to agonists of peroxisome proliferator-activated receptor alpha: a role for Kupffer cells?
J. Carcinog. 5: 26 (2006).
*
-
Alsasua Del Valle A. Implication of cannabinoids in neurological diseases.
Cell. Mol. Neurobiol. 26: 577-589 (2006).
*
-
Alter H. Hepatology highlights.
Hepatology 43: 643-645 (2006).
*
-
Alter H. Viral hepatitis.
Hepatology 43: S230-S234 (2006).
*
-
Alter M, Kahana E, Zilber N, Miller A. Multiple sclerosis frequency in Israel's diverse populations.
Neurology 66: 1061-1066 (2006).
-
Althoff CE, Hermann KG, Braun J, Sieper J. Ankylosing spondylitis - current state of imaging including scoring methods.
Z. Rheumatol. 65: 688-699 (2006).
-
Altiparmak F, Akalin A, Ferhatosmanoglu H. Predicting the binding affinity of MHC class II peptides.
Comput. Syst. Bioinformatics Conf. 2006: 331-334 (2006).
*
-
Aluvihare VR, Betz AG. The role of regulatory T cells in alloantigen tolerance.
Immunol. Rev. 212: 330-343 (2006).
*
-
Alvarado-Sanchez B, Hernandez-Castro B, Portales-Perez D, Baranda L, Layseca-Espinosa E, Abud-Mendoza C, Cubillas-Tejeda AC, Gonzalez-Amaro R. Regulatory T cells in patients with systemic lupus erythematosus.
J. Autoimmun. 27: 110-118 (2006).
-
Alvarez F. Autoimmune hepatitis and primary sclerosing cholangitis.
Clin. Liver Dis. 10: 89-107 (2006).
-
Alvarez-Lafuente R, De Las Heras V, Bartolome M, Garcia-Montojo M, Arroyo R. Human herpesvirus 6 and multiple sclerosis: a one-year follow-up study.
Brain Pathol. 16: 20-27 (2006).
-
Alvarez-Lafuente R, Garcia-Montojo M, De Las Heras V, Bartolome M, Arroyo R. Clinical parameters and HHV-6 active replication in relapsing-remitting multiple sclerosis patients.
J. Clin. Virol. 37 Suppl. 1: S24-S26 (2006).
-
Alvaro D, Barbaro B, Franchitto A, Onori P, Glaser SS, Alpini G, Francis H, Marucci L, Sterpetti P, Ginanni-Corradini S, Onetti Muda A, Dostal DE, De Santis A, Attili AF, Benedetti A, Gaudio E. Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma.
Am. J. Pathol. 169: 877-888 (2006).
*
-
Alvaro D, Mancino MG, Onori P, Franchitto A, Alpini G, Francis H, Glaser S, Gaudio E. Estrogens and the pathophysiology of the biliary tree.
World J. Gastroenterol. 12: 3537-3545 (2006).
*
-
Alves A, Penna C. Surgical treatment of ulcerative colitis in a young woman.
Ann. Chir. 131: 39-41 (2006).
-
Alves C, Meyer I, Toralles MB, Marback RL. Association of human histocompatibility antigens with ophthalmological disorders.
Arq. Bras. Oftalmol. 69: 273-278 (2006).
-
Alves C, Vieira N, Toralles MB, Lyra A. Human histocompatibility system association with gastrointestinal diseases.
Acta Gastroenterol. Latinoam. 36: 86-93 (2006).
-
Alves-Filho JC, Cunha FQ. Modulation of Toll-like receptor expression: a further effect of statins?
Arterioscler. Thromb. Vasc. Biol. 26: e128 (2006).
-
Alves-Filho JC, de Freitas A, Russo M, Cunha FQ. Toll-like receptor 4 signaling leads to neutrophil migration impairment in polymicrobial sepsis.
Crit. Care Med. 34: 461-470 (2006).
-
Alves-Filho JC, Tavares-Murta BM, Barja-Fidalgo C, Benjamim CF, Basile-Filho A, Arraes SM, Cunha FQ. Neutrophil function in severe sepsis.
Endocr. Metab. Immune Disord. Drug Targets 6: 151-158 (2006).
-
Alwayn IP, Andersson C, Lee S, Arsenault DA, Bistrian B, Gura KM, Nose V, Zauscher B, Moses MA, Puder M. Inhibition of matrix metalloproteinases increases PPAR-alpha and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model.
Am. J. Physiol. Gastrointest. Liver Physiol. 291: G1011-G1019 (2006).
*
-
Aly TA, Eller E, Ide A, Gowan K, Babu SR, Erlich HA, Rewers MJ, Eisenbarth GS, Fain PR. Multi-SNP analysis of MHC region: remarkable conservation of HLA-A1-B8-DR3 haplotype.
Diabetes 55: 1265-1269 (2006).
*
-
Aly TA, Ide A, Jahromi MM, Barker JM, Fernando MS, Babu SR, Yu L, Miao D, Erlich HA, Fain PR, Barriga KJ, Norris JM, Rewers MJ, Eisenbarth GS. Extreme genetic risk for type 1A diabetes.
Proc. Natl. Acad. Sci. U.S.A. 103: 14074-14079 (2006).
*
-
Amagai M. Desmoglein, the target molecule in autoimmunity and infection.
Nihon Rinsho Meneki Gakkai Kaishi 29: 325-333 (2006).
-
Amagai M, Ahmed AR, Kitajima Y, Bystryn JC, Milner Y, Gniadecki R, Hertl M, Pincelli C, Fridkis-Hareli M, Aoyama Y, Frusic-Zlotkin M, Muller E, David M, Mimouni D, Vind-Kezunovic D, Michel B, Mahoney M, Grando S. Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just 'witnesses of disease'?
Exp. Dermatol. 15: 815 (2006).
*
-
Amann-Zalcenstein D, Avidan N, Kanyas K, Ebstein RP, Kohn Y, Hamdan A, Ben-Asher E, Karni O, Mujaheed M, Segman RH, Maier W, Macciardi F, Beckmann JS, Lancet D, Lerer B. AHI1, a pivotal neurodevelopmental gene, and C6orf217 are associated with susceptibility to schizophrenia.
Eur. J. Hum. Genet. 14: 1111-1119 (2006).
*
-
Amano K. Pulmonary infections in patients with rheumatoid arthritis who have received anti-TNF therapy.
Intern. Med. 45: 991-992 (2006).
*
-
Amantea G, Cammarano M, Zefferino L, Martin A, Romito G, Piccirillo M, Gentile V. Molecular mechanisms responsible for the involvement of tissue transglutaminase in human diseases: celiac disease.
Front. Biosci. 11: 249-255 (2006).
-
Amarapurka DN, Amarapurkar AD, Patel ND, Agal S, Baigal R, Gupte P, Pramanik S. Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis.
Ann. Hepatol. 5: 30-33 (2006).
*
-
Amarapurkar DN, Punamiya S, Patel ND. An experience with covered transjugular intrahepatic portosystemic shunt for refractory ascites from western India.
Ann. Hepatol. 5: 103-108 (2006).
*
-
Amat M, Benjamim CF, Williams LM, Prats N, Terricabras E, Beleta J, Kunkel SL, Godessart N. Pharmacological blockade of CCR1 ameliorates murine arthritis and alters cytokine networks in vivo.
Br. J. Pharmacol. 149: 666-575 (2006).
*
-
Amati L, Passeri ME, Resta F, Triggiani V, Jirillo E, Sabba C. Ablation of T-helper 1 cell derived cytokines and of monocyte-derived tumor necrosis factor-alpha in hereditary hemorrhagic telangiectasia: immunological consequences and clinical considerations.
Curr. Pharm. Des. 12: 1201-1208 (2006).
-
Amati L, Passeri ME, Selicato F, Mastronardi ML, Penna A, Jirillo E, Covelli V. New insights into the biological and clinical significance of fecal calprotectin in inflammatory bowel disease.
Immunopharmacol. Immunotoxicol. 28: 665-681 (2006).
-
Amati L, Pepe M, Passeri ME, Mastronardi ML, Jirillo E, Covelli V. Toll-like receptor signaling mechanisms involved in dendritic cell activation: potential therapeutic control of T cell polarization.
Curr. Pharm. Des. 12: 4247-4254 (2006).
-
Amato MP, Zipoli V, Goretti B, Portaccio E, De Caro MF, Ricchiuti L, Siracusa G, Masini M, Sorbi S, Trojano M. Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort.
J. Neurol. 253: 1054-1059 (2006).
*
-
Amcheslavsky A, Bar-Shavit Z. Interleukin (IL)-12 mediates the anti-osteoclastogenic activity of CpG-oligodeoxynucleotides.
J. Cell. Physiol. 207: 244-250 (2006).
*
-
Amemori S, Iwakiri R, Endo H, Ootani A, Ogata S, Noda T, Tsunada S, Sakata H, Matsunaga H, Mizuguchi M, Ikeda Y, Fujimoto K. Oral dimethyl sulfoxide for systemic amyloid A amyloidosis complication in chronic inflammatory disease: a retrospective patient chart review.
J. Gastroenterol. 41: 444-449 (2006).
*
-
Amend B, Doster H, Lange C, Dubois E, Kalbacher H, Melms A, Bischof F. Induction of autoimmunity by expansion of autoreactive CD4+CD62Llow cells in vivo.
J. Immunol. 177: 4384-4390 (2006).
*
-
American Academy of Family Physicians. Information from your family doctor. Psoriasis: what you should know.
Am. Fam. Physician 73: 646 (2006).
-
American Academy of Family Physicians. Information from your family doctor. Celiac disease: what you should know.
Am. Fam. Physician 74: 1921-1922 (2006).
-
American Gastroenterological Association Institute. American Gastroenterological Association Institute medical position statement on the management of gastric subepithelial masses.
Gastroenterology 130: 2215-2216 (2006).
*
-
Amerine E. Celiac disease goes against the grain.
Nursing 36: 46-48 (2006).
-
Amerio P, Tracanna M, De Remigis P, Betterle C, Vianale L, Marra ME, Di Rollo D, Capizzi R, Feliciani C, Tulli A. Vitiligo associated with other autoimmune diseases: polyglandular autoimmune syndrome types 3B+C and 4.
Clin. Exp. Dermatol. 31: 746-749 (2006).
*
-
Amezcua-Guerra LM, Hernandez-Martinez B, Pineda C, Bojalil R. Ulcerative colitis during CTLA-4Ig therapy in a patient with rheumatoid arthritis.
Gut 55: 1059-1060 (2006).
*
-
Amezcua-Guerra LM, Prieto P, Bojalil R, Pineda C, Amigo MC. Microscopic polyangiitis associated with primary biliary cirrhosis: a causal or casual association?
J. Rheumatol. 33: 2351-2353 (2006).
-
Amezcua-Guerra LM, Springall R, Marquez-Velasco R, Gomez-Garcia L, Vargas A, Bojalil R. Presence of antibodies against cyclic citrullinated peptides (anti-CCP) in patients with rhupus: a cross-sectional study.
Arthritis Res. Ther. 8: R144 (2006).
*
-
Amicosante M, Fontenot AP. T cell recognition in chronic beryllium disease.
Clin. Immunol. 121: 134-143 (2006).
*
-
Amigo L, Castro J, Miquel JF, Zanlungo S, Young SG, Nervi F. Inactivation of hepatic microsomal triglyceride transfer protein protects mice from diet-induced gallstones.
Gastroenterology 131: 1870-1878 (2006).
*
-
Amin EA, Welsh WJ. A preliminary in silico lead series of 2-phthalimidinoglutaric acid analogues designed as MMP-3 inhibitors.
J. Chem. Inf. Model. 46: 2104-2109 (2006).
*
-
Amin MR, Malakooti J, Sandoval R, Dudeja PK, Ramaswamy K. IFN-gamma and TNF-alpha regulate the human NHE3 gene expression by modulating the Sp family transcription factors in human intestinal epithelial cell line, C2BBe1.
Am. J. Physiol. Cell Physiol. 291: C887-C896 (2006).
*
-
Amit-Romach E, Reifen R, Uni Z. Mucosal function in rat jejunum and ileum is altered by induction of colitis.
Int. J. Mol. Med. 18: 721-727 (2006).
*
-
Amital H, Gershwin EM, Shoenfeld Y. Reshaping the mosaic of autoimmunity.
Semin. Arthritis Rheum. 35: 341-343 (2006).
*
-
Amlong CA, Nardelli DT, Peterson SH, Warner TF, Callister SM, Schell RF. Anti-interleukin-15 prevents arthritis in Borrelia-vaccinated and -infected mice.
Clin. Vaccine Immunol. 13: 289-296 (2006).
*
-
Ammann R. Diagnosis and management of chronic pancreatitis: current knowledge.
Swiss Med. Wkly. 136: 166-174 (2006).
*
-
Ammon HP. Boswellic acids in chronic inflammatory diseases.
Planta Med. 72: 1100-1116 (2006).
-
Amos CI, Chen WV, Lee A, Li W, Kern M, Lundsten R, Batliwalla F, Wener M, Remmers E, Kastner DA, Criswell LA, Seldin MF, Gregersen PK. High-density SNP analysis of 642 Caucasian families with rheumatoid arthritis identifies two new linkage regions on 11p12 and 2q33.
Genes Immun. 7: 277-286 (2006).
*
-
Amos JA, Bridge-Cook P, Ponek V, Jarvis MR. A universal array-based multiplexed test for cystic fibrosis carrier screening.
Expert Rev. Mol. Diagn. 6: 15-22 (2006).
-
Amoudruz P, Minang JT, Sundstrom Y, Nilsson C, Lilja G, Troye-Blomberg M, Sverremark-Ekstrom E. Pregnancy, but not the allergic status, influences spontaneous and induced interleukin-1beta (IL-1beta), IL-6, IL-10 and IL-12 responses.
Immunology 119: 18-26 (2006).
*
-
Amoura Z, Piette JC. New therapeutic approaches to autoimmune diseases.
Presse. Med. 35: 709-713 (2006).
-
Amoura Z, Piette JC. New therapies for autoimmune diseases.
Rev. Neurol. (Paris) 162 Spec. No. 1: 7-11 (2006).
-
Amre DK, Lambrette P, Law L, Krupoves A, Chotard V, Costea F, Grimard G, Israel D, Mack D, Seidman EG. Investigating the hygiene hypothesis as a risk factor in pediatric onset Crohn's disease: a case-control study.
Am. J. Gastroenterol. 101: 1005-1011 (2006).
*
-
Amre DK, Lu SE, Costea F, Seidman EG. Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn's disease patients.
Am. J. Gastroenterol. 101: 645-652 (2006).
*
-
Amundsen SS, Monsuur AJ, Wapenaar MC, Lie BA, Ek J, Gudjonsdottir AH, Ascher H, Wijmenga C, Sollid LM. Association analysis of MYO9B gene polymorphisms with celiac disease in a Swedish/Norwegian cohort.
Hum. Immunol. 67: 341-345 (2006).
-
Amundsen SS, Vatn M; the IBSEN study group; Wijmenga C, Sollid LM, Lie BA. Association analysis of MYO9B gene polymorphisms and inflammatory bowel disease in a Norwegian cohort.
Tissue Antigens 68: 249-252 (2006).
*
-
An H, Zhao W, Hou J, Zhang Y, Xie Y, Zheng Y, Xu H, Qian C, Zhou J, Yu Y, Liu S, Feng G, Cao X. SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production.
Immunity 25: 919-928 (2006).
*
-
An MM, Fan KX, Cao YB, Shen H, Zhang JD, Lu L, Gao PH, Jiang YY. Lymphtoxin beta receptor-Ig protects from T-cell-mediated liver injury in mice through blocking LIGHT/HVEM signaling.
Biol. Pharm. Bull. 29: 2025-2030 (2006).
*
-
Anagnostopoulos GK, Margantinis G, Tsiakos S, Kostopoulos P, Grigoriadis K, Arvanitidis D. Postinfantile giant-cell hepatitis associated with ulcerative colitis and autoimmune hepatitis.
J. Gastroenterol. Hepatol. 21: 1863-1864 (2006).
*
-
Anagnostopoulos GK, Shonde T, Kaye P, Ragunath K. A case of a "fragile" oesophagus.
Gut 55: 1495 (2006).
*
-
Anan A, Baskin-Bey ES, Bronk SF, Werneburg NW, Shah VH, Gores GJ. Proteasome inhibition induces hepatic stellate cell apoptosis.
Hepatology 43: 335-344 (2006).
*
-
Anandarajah AP, Schwarz EM. Anti-RANKL therapy for inflammatory bone disorders: mechanisms and potential clinical applications.
J. Cell. Biochem. 97: 226-232 (2006).
*
-
Anapolsky A, Teng S, Dixit S, Piquette-Miller M. The role of pregnane X receptor in 2-acetylaminofluorene-mediated induction of drug transport and metabolizing enzymes in mice.
Drug Metab. Dispos. 34: 405-409 (2006).
*
-
Anaya JM. Autoimmunity and autoimmune disease: a Colombian construction beyond deconstructions.
Autoimmun. Rev. 5: 165-166 (2006).
-
Anaya JM, Castiblanco J, Tobon GJ, Garcia J, Abad V, Cuervo H, Velasquez A, Angel ID, Vega P, Arango A. Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus.
J. Autoimmun. 26: 208-214 (2006).
-
Anaya JM, Delgado-Vega AM, Castiblanco J. Genetic basis of Sjogren's syndrome. How strong is the evidence?
Clin. Dev. Immunol. 13: 209-222 (2006).
*
-
Anaya JM, Gomez L, Castiblanco J. Is there a common genetic basis for autoimmune diseases?
Clin. Dev. Immunol. 13: 185-195 (2006).
*
-
Anaya JM, Tobon GJ, Vega P, Castiblanco J. Autoimmune disease aggregation in families with primary Sjogren's syndrome.
J. Rheumatol. 33: 2227-2234 (2006).
-
Andersen G, Overgaard J, Albrechtsen A, Glumer C, Borch-Johnsen K, Jorgensen T, Hansen T, Pedersen O. Studies of the association of the GNB3 825C>T polymorphism with components of the metabolic syndrome in white Danes.
Diabetologia 49: 75-82 (2006).
*
-
Andersen HU, Lanng S, Pressler T, Laugesen CS, Mathiesen ER. Cystic fibrosis-related diabetes: the presence of microvascular diabetes complications.
Diabetes Care 29: 2660-2663 (2006).
*
-
Andersen JM, Al-Khairy D, Ingalls RR. Innate immunity at the mucosal surface: role of Toll-like receptor 3 and Toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
Biol. Reprod. 74: 824-831 (2006).
*
-
Andersen K, Vogt C, Blondin D, Beck A, Heinen W, Aurich V, Haussinger D, Modder U, Cohnen M. Multi-detector CT-colonography in inflammatory bowel disease: prospective analysis of CT-findings to high-resolution video colonoscopy.
Eur. J. Radiol. 58: 140-146 (2006).
-
Andersen MH, Schrama D, Thor Straten P, Becker JC. Cytotoxic T cells.
J. Invest. Dermatol. 126: 32-41 (2006).
*
-
Andersen S, Okkels H, Krarup H, Laurberg P. Geographical clustering and maintained health in individuals harbouring the mutation for Greenland familial cholestasis: a population-based study.
Scand. J. Gastroenterol. 41: 445-450 (2006).
*
-
Anderson AC, Anderson DE. TIM-3 in autoimmunity.
Curr. Opin. Immunol. 18: 665-669 (2006).
-
Anderson CL, Chaudhury C, Kim J, Bronson CL, Wani MA, Mohanty S. Perspective - FcRn transports albumin: relevance to immunology and medicine.
Trends Immunol. 27: 343-348 (2006).
*
-
Anderson EJ, McGrath MA, Thalhamer T, McInnes IB. Interleukin-12 to interleukin 'infinity': the rationale for future therapeutic cytokine targeting.
Springer Semin. Immunopathol. 27: 425-442 (2006).
*
-
Anderson JE, Hansen LL, Mooren FC, Post M, Hug H, Zuse A, Los M. Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: towards personalized medicine.
Drug Resist. Updat. 9: 198-210 (2006).
-
Anderson K, Fitzgerald M, Dupont M, Wang T, Paz N, Dorsch M, Healy A, Xu Y, Ocain T, Schopf L, Jaffee B, Picarella D. Mice deficient in PKC theta demonstrate impaired in vivo T cell activation and protection from T cell-mediated inflammatory diseases.
Autoimmunity 39: 469-478 (2006).
-
Anderson KK, Ballok DA, Prasad N, Szechtman H, Sakic B. Impaired response to amphetamine and neuronal degeneration in the nucleus accumbens of autoimmune MRL-lpr mice.
Behav. Brain Res. 166: 32-38 (2006).
*
-
Anderson KM, Czinn SJ, Redline RW, Blanchard TG. Induction of CTLA-4-mediated anergy contributes to persistent colonization in the murine model of gastric Helicobacter pylori infection.
J. Immunol. 176: 5306-5313 (2006).
*
-
Anderson MK. At the crossroads: diverse roles of early thymocyte transcriptional regulators.
Immunol. Rev. 209: 191-211 (2006).
-
Anderson N, Borlak J. Drug-induced phospholipidosis.
FEBS Lett. 580: 5533-5540 (2006).
*
-
Anderson RP, van Heel DA, Tye-Din JA, Jewell DP, Hill AV. Antagonists and non-toxic variants of the dominant wheat gliadin T cell epitope in coeliac disease.
Gut 55: 485-491 (2006).
*
-
Andersson M, Svenungsson E, Khademi M, Lampa J, Brundin L, Wallstrom E. No signs of immunoactivation in the cerebrospinal fluid during treatment with infliximab.
Ann. Rheum. Dis. 65: 1237-1240 (2006).
*
-
Andersson ML, Petersson IF, Karlsson K, Jonsson NE, Mansson B, Heinegard D, Saxne T. Diurnal variation in serum levels of cartilage oligomeric matrix protein (COMP) in individuals with knee osteoarthritis or rheumatoid arthritis.
Ann. Rheum. Dis. 65: 1490-1494 (2006).
*
-
Andersson P, Varenhorst E, Soderkvist P. Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk.
Eur. J. Cancer 42: 2833-2837 (2006).
*
-
Anderton SM. Avoiding autoimmune disease - T cells know their limits.
Trends Immunol. 27: 208-214 (2006).
*
-
Ando T, El-Omar EM, Goto Y, Nobata K, Watanabe O, Maeda O, Ishiguro K, Minami M, Hamajima N, Goto H. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy.
Gut 55: 158-164 (2006).
*
-
Andoh A, Deguchi Y, Inatomi O, Yagi Y, Bamba S, Tsujikawa T, Fujiyama Y. Immunohistochemical study of chymase-positive mast cells in inflammatory bowel disease.
Oncol. Rep. 16: 103-107 (2006).
*
-
Andoh A, Endo Y, Kushima R, Hata K, Tsujikawa T, Sasaki M, Mekata E, Tani T, Fujiyama Y. A case of Crohn's disease involving the gallbladder.
World J. Gastroenterol. 12: 977-978 (2006).
*
-
Andoh A, Fujiyama Y. Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease.
World J. Gastroenterol. 12: 4452-4460 (2006).
*
-
Andoh A, Yoshida T, Yagi Y, Bamba S, Hata K, Tsujikawa T, Kitoh K, Sasaki M, Fujiyama Y. Increased aggregation response of platelets in patients with inflammatory bowel disease.
J. Gastroenterol. 41: 47-54 (2006).
*
-
Andrade MC, Menezes JS, Cassali GD, Martins-Filho OA, Cara DC, Faria AM. Alcohol-induced gastritis prevents oral tolerance induction in mice.
Clin. Exp. Immunol. 146: 312-322 (2006).
*
-
Andrade RJ, Lucena MI, Kaplowitz N, Garcia-Munoz B, Borraz Y, Pachkoria K, Garcia-Cortes M, Fernandez MC, Pelaez G, Rodrigo L, Duran JA, Costa J, Planas R, Barriocanal A, Guarner C, Romero-Gomez M, Munoz-Yague T, Salmeron J, Hidalgo R. Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry.
Hepatology 44: 1581-1588 (2006).
*
-
Andrassy M, Igwe J, Autschbach F, Volz C, Remppis A, Neurath MF, Schleicher E, Humpert PM, Wendt T, Liliensiek B, Morcos M, Schiekofer S, Thiele K, Chen J, Kientsch-Engel R, Schmidt AM, Stremmel W, Stern DM, Katus HA, Nawroth PP, Bierhaus A. Posttranslationally modified proteins as mediators of sustained intestinal inflammation.
Am. J. Pathol. 169: 1223-1237 (2006).
*
-
Andreani SM, Dang HH, Edwards DP, Baig MK, Khan M, Payne JG. Ovarian Crohn's disease: contiguous or metastatic?
Inflamm. Bowel Dis. 12: 1091-1092 (2006).
*
-
Andresen H, Zarse K, Grotzinger C, Hollidt JM, Ehrentreich-Forster E, Bier FF, Kreuzer OJ. Development of peptide microarrays for epitope mapping of antibodies against the human TSH receptor.
J. Immunol. Methods 315: 11-18 (2006).
*
-
Andresen M. Accutane registry compulsory in US, but not Canada.
CMAJ 174: 1701 (2006).
*
-
Andress DL. Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation.
Kidney Int. 69: 33-43 (2006).
*
-
Andrews AL, Holloway JW, Holgate ST, Davies DE. IL-4 receptor alpha is an important modulator of IL-4 and IL-13 receptor binding: implications for the development of therapeutic targets.
J. Immunol. 176: 7456-7461 (2006).
*
-
Andrulionyte L, Laukkanen O, Chiasson JL, Laakso M; STOP-NIDDM Study Group. Single nucleotide polymorphisms of the HNF4alpha gene are associated with the conversion to type 2 diabetes mellitus: the STOP-NIDDM trial.
J. Mol. Med. 84: 701-708 (2006).
*
-
Andrulionyte L, Peltola P, Chiasson JL, Laakso M. Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
Diabetes 55: 2148-2152 (2006).
*
-
Andryushkova AA, Kuznetsova IA, Orlovskaya IA, Buneva VN, Nevinsky GA. Antibodies with amylase activity from the sera of autoimmune-prone MRL/MpJ-lpr mice.
FEBS Lett. 580: 5089-5095 (2006).
*
-
Anfossi N, Andre P, Guia S, Falk CS, Roetynck S, Stewart CA, Breso V, Frassati C, Reviron D, Middleton D, Romagne F, Ugolini S, Vivier E. Human NK cell education by inhibitory receptors for MHC class I.
Immunity 25: 331-342 (2006).
*
-
Ang YS, Farrell RJ. Risk of lymphoma: inflammatory bowel disease and immunomodulators.
Gut 55: 580-581 (2006).
*
-
Angel Mercado M, Chan C, Orozco H, Barajas Olivas A, Villalta JM, Dominguez I, Erana J, Poucel F. Bile duct injuries related to misplacement of "T tubes".
Ann. Hepatol. 5: 44-48 (2006).
*
-
Angelberger S, Reinisch W, Dejaco C. Prevention of abortion by ciclosporin treatment of fulminant ulcerative colitis during pregnancy.
Gut 55: 1364-1365 (2006).
*
-
Angeli P, Wong F, Watson H, Gines P. Hyponatremia in cirrhosis: results of a patient population survey.
Hepatology 44: 1535-1542 (2006).
*
-
Angelone DF, Wessels MR, Coughlin M, Suter EE, Valentini P, Kalish LA, Levy O. Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo.
Pediatr. Res. 60: 205-209 (2006).
*
-
Anger T, Ekici AB, Daniel WG, Garlichs CD. Gene polymorphisms leading to calcified and stenotic aortic valves.
Herz. 31: 635-643 (2006).
-
Angers I, Sancho-Shimizu V, Descoteaux A, Gewirtz AT, Malo D. Tlr5 is not primarily associated with susceptibility to Salmonella typhimurium infection in MOLF/Ei mice.
Mamm. Genome 17: 385-397 (2006).
*
-
Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramirez C, Cavallari U, Trabetti E, Sabate M, Hernandez R, Moreno R, Escaned J, Alfonso F, Banuelos C, Costa MA, Bass TA, Pignatti PF, Macaya C. Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel.
Arterioscler. Thromb. Vasc. Biol. 26: 1895-1900 (2006).
-
Angulo S, Llopis M, Antolin M, Gironella M, Sans M, Malagelada JR, Pique JM, Guarner F, Panes J. Lactobacillus casei prevents the upregulation of ICAM-1 expression and leukocyte recruitment in experimental colitis.
Am. J. Physiol. Gastrointest. Liver Physiol. 291: G1155-G1162 (2006).
*
-
Angus PW. Role of endothelin in systemic and portal resistance in cirrhosis.
Gut 55: 1230-1232 (2006).
*
-
Anheim M, Degos B, Echaniz-Laguna A, Fleury M, Grucker M, Tranchant C. Ataxia associated with gluten sensitivity, myth or reality?
Rev. Neurol. (Paris) 162: 214-221 (2006).
-
Anijeet DR, Graham C, Khooshabeh R. Giant cell arteritis-part of a spectrum of autoimmune disease?
Eye 20: 1434-1435 (2006).
-
Annese V, Latiano A, Palmieri O, Lombardi G, Andriulli A; Italian Group of Inflammatory Bowel Disease. NOD2/CARD15 in healthy relatives of IBD patients.
Eur. Rev. Med. Pharmacol. Sci. 10: 33-36 (2006).
-
Annese V, Latiano A, Rossi L, Bossa F, Damonte G, Dallapiccola B, Serafini S, Pierige F, Andriulli A, Magnani M. The polymorphism of multi-drug resistance 1 gene (MDR1) does not influence the pharmacokinetics of dexamethasone loaded into autologous erythrocytes of patients with inflammatory bowel disease.
Eur. Rev. Med. Pharmacol. Sci. 10: 27-31 (2006).
-
Annese V, Valvano MR, Palmieri O, Latiano A, Bossa F, Andriulli A. Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis.
World J. Gastroenterol. 12: 3636-3644 (2006).
*
-
Annibali V, Ristori G, Cannoni S, Romano S, Visconti A, Ghazaryan A, Figa Talamanca L, Salvetti M, Mechelli R. Multiple sclerosis: pharmacogenomics and personalised drug treatment.
Neurol. Sci. 27 Suppl. 5: s347-s349 (2006).
*
-
Annilo T, Chen ZQ, Shulenin S, Costantino J, Thomas L, Lou H, Stefanov S, Dean M. Evolution of the vertebrate ABC gene family: analysis of gene birth and death.
Genomics 88: 1-11 (2006).
*
-
Anokhina SV. Effect of diet enriched with essential nutrients and S-adenosylmethionine on the structural and functional state of erythrocytes in patients with metabolic syndrome.
Lik. Sprava. 2006: 16-23 (2006).
-
Ansari MJ, Sayegh MH. Costimulation couture: a designer approach to regulating autoimmunity.
J. Clin. Invest. 116: 2080-2083 (2006).
*
-
Ansari N, Abdulla J, Zayyani N, Brahmi U, Taha S, Abdel Satir A. Comparison of RANTES expression in Crohn's disease and ulcerative colitis: an aid in the differential diagnosis?
J. Clin. Pathol. 59: 1066-1072 (2006).
*
-
Ansel KM, Djuretic I, Tanasa B, Rao A. Regulation of Th2 differentiation and Il4 locus accessibility.
Annu. Rev. Immunol. 24: 607-656 (2006).
*
-
Anselmi M, Acuna JC, Del Valle A, Gemmato AM. Endoscopic biliary stents for the temporary management of choledocholithiasis.
Rev. Med. Chil. 134: 721-725 (2006).
-
Anson DS, Smith GJ, Parsons DW. Gene therapy for cystic fibrosis airway disease- is clinical success imminent?
Curr. Gene Ther. 6: 161-179 (2006).
-
Antel J, Bar-Or A. Roles of immunoglobulins and B cells in multiple sclerosis: from pathogenesis to treatment.
J. Neuroimmunol. 180: 3-8 (2006).
-
Anthoni C, Laukoetter MG, Rijcken E, Vowinkel T, Mennigen R, Muller S, Senninger N, Russell J, Jauch J, Bergmann J, Granger DN, Krieglstein CF. Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis.
Am. J. Physiol. Gastrointest. Liver Physiol. 290: G1131-G1137 (2006).
*
-
Anthoni C, Mennigen RB, Rijcken EJ, Laukotter MG, Spiegel HU, Senninger N, Schurmann G, Krieglstein CF. Bosentan, an endothelin receptor antagonist, reduces leucocyte adhesion and inflammation in a murine model of inflammatory bowel disease.
Int. J. Colorectal Dis. 21: 409-418 (2006).
*
-
Antinozzi PA, Garcia-Diaz A, Hu C, Rothman JE. Functional mapping of disease susceptibility loci using cell biology.
Proc. Natl. Acad. Sci. U.S.A. 103: 3698-3703 (2006).
*
-
Antoine JC. Coeliac disease and peripheral neuropathy of unknown cause.
Rev. Neurol. (Paris) 162: 1290-1291 (2006).
-
Antolic B, Gersak K, Verdenik I, Novak-Antolic Z. Adverse effects of thyroid dysfunction on pregnancy and pregnancy outcome: epidemiologic study in Slovenia.
J. Matern. Fetal Neonatal Med. 19: 651-654 (2006).
-
Anton DT, Moraru D, Cirdei E, Bozomitu L. Malnutrition and complex nutritional therapy in cystic fibrosis.
Rev. Med. Chir. Soc. Med. Nat. Iasi. 110: 801-806 (2006).
-
Antonelli A, Sedie AD, Fallahi P, Ferrari SM, Maccheroni M, Ferrannini E, Bombardieri S, Riente L. High prevalence of thyroid autoimmunity and hypothyroidism in patients with psoriatic arthritis.
J. Rheumatol. 33: 2026-2028 (2006).
-
Antonenkov VD, Hiltunen JK. Peroxisomal membrane permeability and solute transfer.
Biochim. Biophys. Acta 1763: 1697-1706 (2006).
*
-
Antoniades CG, Berry PA, Davies ET, Hussain M, Bernal W, Vergani D, Wendon J. Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure.
Hepatology 44: 34-43 (2006).
*
-
Antonioli L, Fornai M, Colucci R, Ghisu N, Blandizzi C, Del Tacca M. A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis.
Inflamm. Bowel Dis. 12: 117-122 (2006).
*
-
Antoniu SA. Infliximab for chronic obstructive pulmonary disease: towards a more specific inflammation targeting?
Expert Opin. Investig. Drugs 15: 181-184 (2006).
-
Antoniv TT, Ivashkiv LB. Dysregulation of interleukin-10-dependent gene expression in rheumatoid arthritis synovial macrophages.
Arthritis Rheum. 54: 2711-2721 (2006).
*
-
Antony JM, Izad M, Bar-Or A, Warren KG, Vodjgani M, Mallet F, Power C. Quantitative analysis of human endogenous retrovirus-W env in neuroinflammatory diseases.
AIDS Res. Hum. Retroviruses 22: 1253-1259 (2006).
-
Antonyak MA, Jansen JM, Miller AM, Ly TK, Endo M, Cerione RA. Two isoforms of tissue transglutaminase mediate opposing cellular fates.
Proc. Natl. Acad. Sci. U.S.A. 103: 18609-18614 (2006).
*
-
Antoun J, Amet Y, Simon B, Dreano Y, Corlu A, Corcos L, Salaun JP, Plee-Gautier E. CYP4A11 is repressed by retinoic acid in human liver cells.
FEBS Lett. 580: 3361-3367 (2006).
*
-
Antoun S, Merad M, Raynard B, Ruffie P. Malnutrition in cancer patients.
Rev. Prat. 56: 2025-2029 (2006).
-
Antunes H, Abreu I, Nogueiras A, Sa C, Goncalves C, Cleto P, Garcia F, Alves A, Lemos D. First prevalence of celiac disease in a Portuguese population.
Acta Med. Port. 19: 115-120 (2006).
-
Anuchapreeda S, Thanarattanakorn P, Sittipreechacharn S, Tima S, Chanarat P, Limtrakul P. Inhibitory effect of curcumin on MDR1 gene expression in patient leukemic cells.
Arch. Pharm. Res. 29: 866-873 (2006).
-
Anwer MS, Ananthanarayanan M, Suchy FJ. Role of Ntcp phosphorylation in cAMP-mediated stimulation of hepatic bile acid uptake.
Falk Symposium 155. XIII FALK LIVER WEEK (Part I) XIX International Bile Acid Meeting. Bile Acids: Biological Actions and Clinical Relevance, October 6 - 7, 2006 Freiburg (Germany), p. 29 (2006). *
-
Anzai N, Kanai Y, Endou H. Organic anion transporter family: current knowledge.
J. Pharmacol. Sci. 100: 411-426 (2006).
*
-
Anzilotti C, Merlini G, Pratesi F, Tommasi C, Chimenti D, Migliorini P. Antibodies to viral citrullinated peptide in rheumatoid arthritis.
J. Rheumatol. 33: 647-651 (2006).
-
Aoki CA, Dawson K, Kenny TP, Gershwin ME, Bowlus CL. Gene expression by PBMC in primary sclerosing cholangitis: evidence for dysregulation of immune mediated genes.
Clin. Dev. Immunol. 13: 265-271 (2006).
*
-
Aoki CA, Roifman CM, Lian ZX, Bowlus CL, Norman GL, Shoenfeld Y, Mackay IR, Gershwin ME. IL-2 receptor alpha deficiency and features of primary biliary cirrhosis.
J. Autoimmun. 27: 50-53 (2006).
-
Aoki K, Taniyama M, Nagayama C, Oikawa Y, Shimada A. T cell immunity to glutamic acid decarboxylase in fulminant type 1 diabetes without significant elevation of serum amylase.
Ann. N. Y. Acad. Sci. 1079: 181-185 (2006).
*
-
Aoki T, Hirota T, Tamari M, Ichikawa K, Takeda K, Arinami T, Shibasaki M, Noguchi E. An association between asthma and TNF-308G/A polymorphism: meta-analysis.
J. Hum. Genet. 51: 677-685 (2006).
*
-
Aoki-Ota M, Kinoshita M, Ota T, Tsunoda K, Iwasaki T, Tanaka S, Koyasu S, Nishikawa T, Amagai M. Tolerance induction by the blockade of CD40/CD154 interaction in pemphigus vulgaris mouse model.
J. Invest. Dermatol. 126: 105-113 (2006).
*
-
Aosai F, Rodriguez Pena MS, Mun HS, Fang H, Mitsunaga T, Norose K, Kang HK, Bae YS, Yano A. Toxoplasma gondii-derived heat shock protein 70 stimulates maturation of murine bone marrow-derived dendritic cells via Toll-like receptor 4.
Cell Stress Chaperones 11: 13-22 (2006).
*
-
Aouabdi S, Gibson GG, Plant N. Transcriptional regulation of the PXR gene: identification and characterization of a functional PPARalpha-binding site within the proximal promoter of the PXR gene.
Drug Metab. Dispos. 34: 138-144 (2006).
*
-
Aoyama N, Takahashi N, Kitaichi K, Ishihara R, Saito S, Maeno N, Ji X, Takagi K, Sekine Y, Iyo M, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Iwata N, Inada T, Ozaki N. Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder.
Alcohol Clin. Exp. Res. 30: 1644-1649 (2006).
*
-
Apan TZ, Kaygusuz S. Echinococcosis: a possible etiology in psoriatic disease.
Dermatology 213: 334-336 (2006).
-
APDW2004 Chinese IBD Working Group. Retrospective analysis of 515 cases of Crohn's disease hospitalization in China: nationwide study from 1990 to 2003.
J. Gastroenterol. Hepatol. 21: 1009-1015 (2006).
*
-
Apenteng T, Kaplan B, Meyers K. Renal outcomes in children with lupus and a family history of autoimmune disease.
Lupus 15: 65-70 (2006).
-
Apiratpracha W, Ho JK, Powell JJ, Yoshida EM. Acute lower gastrointestinal bleeding from a dieulafoy lesion proximal to the anorectal junction post-orthotopic liver transplant.
World J. Gastroenterol. 12: 7547-7548 (2006).
*
-
Apostolopoulos J, Ooi JD, Odobasic D, Holdsworth SR, Kitching AR. The isolation and purification of biologically active recombinant and native autoantigens for the study of autoimmune disease.
J. Immunol. Methods 308: 167-178 (2006).
*
-
Appel GB, Waldman M. The IgA nephropathy treatment dilemma.
Kidney Int. 69: 1939-1944 (2006).
*
-
Aprahamian T, Bonegio R, Rizzo J, Perlman H, Lefer DJ, Rifkin IR, Walsh K. Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model.
J. Immunol. 177: 3028-3034 (2006).
*
-
Apte RN, Dotan S, Elkabets M, White MR, Reich E, Carmi Y, Song X, Dvozkin T, Krelin Y, Voronov E. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions.
Cancer Metastasis Rev. 25: 387-408 (2006).
*
-
Apte U, Zeng G, Muller P, Tan X, Micsenyi A, Cieply B, Dai C, Liu Y, Kaestner KH, Monga SP. Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice.
Hepatology 44: 992-1002 (2006).
*
-
Ara C, Esrefoglu M, Polat A, Isik B, Aladag M, Gul M, Ay S, Tekerleklioglu MS, Yilmaz S. The effect of caffeic acid phenethyl ester on bacterial translocation and intestinal damage in cholestatic rats.
Dig. Dis. Sci. 51: 1754-1760 (2006).
*
-
Arabi A, Khoury N, Birbari A, Zahed L, El-Hajj Fuleihan G. Regression of skeletal manifestations of hyperparathyroidism with oral vitamin D.
J. Clin. Endocrinol. Metab. 91: 2480-2483 (2006).
*
-
Aracena C R, Nogales-Gaete J. Coexistence of myasthenia gravis and systemic lupus erythematosus: is it more frequent than we thought?
Rev. Med. Chil. 134: 1203-1205 (2006).
-
Arachchige PG, Takahashi Y, Ide T. Dietary sesamin and docosahexaenoic and eicosapentaenoic acids synergistically increase the gene expression of enzymes involved in hepatic peroxisomal fatty acid oxidation in rats.
Metabolism 55: 381-390 (2006).
*
-
Arafat HA, Lada E, Katakam AK, Amin N. Osteopontin deficiency impacts the pancreatic TH1/TH2 cytokine profile following multiple low dose streptozotocin-induced diabetes.
Exp. Clin. Endocrinol. Diabetes 114: 555-562 (2006).
-
Arakawa S, Hatano Y, Katagiri K, Terashi H, Fujiwara S. Effects of ultraviolet B irradiation on the production of regulated upon activation normal T-cell expressed and secreted protein in cultured human epidermal keratinocytes.
Arch. Dermatol. Res. 297: 377-380 (2006).
*
-
Araki T, Parc Y, Lefevre J, Dehni N, Tiret E, Parc R. The effect on morbidity of mesentery lengthening techniques and the use of a covering stoma after ileoanal pouch surgery.
Dis. Colon Rectum 49: 621-628 (2006).
*
-
Araki Y, Sugihara H, Hattori T. The free radical scavengers edaravone and tempol suppress experimental dextran sulfate sodium-induced colitis in mice.
Int. J. Mol. Med. 17: 331-334 (2006).
*
-
Araki Y, Sugihara H, Hattori T. In vitro effects of dextran sulfate sodium on a Caco-2 cell line and plausible mechanisms for dextran sulfate sodium-induced colitis.
Oncol. Rep. 16: 1357-1362 (2006).
*
-
Aral M, Arican O, Gul M, Sasmaz S, Kocturk SA, Kastal U, Ekerbicer HC. The relationship between serum levels of total IgE, IL-18, IL-12, IFN-gamma and disease severity in children with atopic dermatitis.
Mediators Inflamm. 2006: 73098 (2006).
*
-
Aranami T, Miyake S, Yamamura T. Differential expression of CD11c by peripheral blood NK cells reflects temporal activity of multiple sclerosis.
J. Immunol. 177: 5659-5667 (2006).
*
-
Aratari A, Caprilli R. Seasonality in onset of symptoms in Crohn's disease.
Dig. Liver Dis. 38: 356 (2006).
-
Aratari A, Papi C, Galletti B, Angelucci E, Viscido A, D'Ovidio V, Ciaco A, Abdullahi M, Caprilli R. Seasonal variations in onset of symptoms in Crohn's disease.
Dig. Liver Dis. 38: 319-323 (2006).
-
Araujo J, da Silva GA, de Melo FM. Serum prevalence of celiac disease in children and adolescents with type 1 diabetes mellitus.
J. Pediatr. (Rio J.) 82: 210-214 (2006).
*
-
Araujo J, Silva GA, Melo FM. Prevalence of celiac disease in children and adolescents with type 1 diabetes - authors' reply.
J. Pediatr. (Rio J.) 82: 401 (2006).
-
Aravindhan K, Webb CL, Jaye M, Ghosh A, Willette RN, Dinardo NJ, Jucker BM. Assessing the effects of LXR agonists on cellular cholesterol handling: a stable isotope tracer study.
J. Lipid Res. 47: 1250-1260 (2006).
*
-
Araya QM. Improving the management of celiac disease: an urgent challenge.
Rev. Med. Chil. 134: 361-364 (2006).
-
Arbour N, Lapointe R, Saikali P, McCrea E, Regen T, Antel JP. A new clinically relevant approach to expand myelin specific T cells.
J. Immunol. Methods 310: 53-61 (2006).
*
-
Arcavi M, Orfus G. Prevalence of antinuclear envelope antibodies and their isotypes in sera positive for antinuclear antibodies.
Medicina (B. Aires) 66: 327-331 (2006).
-
Archer H, Jura N, Keller J, Jacobson M, Bar-Sagi D. A mouse model of hereditary pancreatitis generated by transgenic expression of R122H trypsinogen.
Gastroenterology 131: 1844-1855 (2006).
*
-
Archer KA, Roy CR. MyD88-dependent responses involving Toll-like receptor 2 are important for protection and clearance of Legionella pneumophila in a mouse model of Legionnaires' disease.
Infect. Immun. 74: 3325-3333 (2006).
*
-
Arck P, Paus R. From the brain-skin connection: the neuroendocrine-immune misalliance of stress and itch.
Neuroimmunomodulation 13: 347-356 (2006).
-
Arcus VL, Lott JS, Johnston JM, Baker EN. The potential impact of structural genomics on tuberculosis drug discovery.
Drug Discov. Today 11: 28-34 (2006).
-
Ardizzone S, Maconi G, Russo A, Imbesi V, Colombo E, Bianchi Porro G. Randomised, controlled trial, of azathioprine and 5-aminosalicylic acid for treatment of steroid-dependent ulcerative colitis.
Gut 55: 47-53 (2006).
*
-
Arends J, Bodoky G, Bozzetti F, Fearon K, Muscaritoli M, Selga G, van Bokhorst-de van der Schueren MA, von Meyenfeldt M. ESPEN guidelines on enteral nutrition: non-surgical oncology.
Clin. Nutr. 25: 245-259 (2006).
-
Arends J, Wu J, Borillo J, Troung L, Zhou C, Vigneswaran N, Lou YH. T cell epitope mimicry in antiglomerular basement membrane disease.
J. Immunol. 176: 1252-1258 (2006).
*
-
Arepally GM, Ortel TL. Clinical practice. Heparin-induced thrombocytopenia.
N. Engl. J. Med. 355: 809-817 (2006).
*
-
Argueta JG, Shiota S, Yamaguchi N, Masuhiro Y, Hanazawa S. Induction of Porphyromonas gingivalis GroEL signaling via binding to Toll-like receptors 2 and 4.
Oral. Microbiol. Immunol. 21: 245-251 (2006).
*
-
Arias IM. Reflections on the first five years of Hepatology, 1981-1986.
Hepatology 43: S3-S4 (2006).
*
-
Ariel A, Fredman G, Sun YP, Kantarci A, Van Dyke TE, Luster AD, Serhan CN. Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression.
Nat. Immunol. 7: 1209-1216 (2006).
*
-
Aries PM, Hellmich B, Gross WL. Diagnosis und therapy of ANCA-associated vasculitis.
Dtsch. Med. Wochenschr. 131: 443-446 (2006).
-
Arikan C, Berdeli A, Ozgenc F, Tumgor G, Yagci RV, Aydogdu S. Positive association of macrophage migration inhibitory factor gene-173G/C polymorphism with biliary atresia.
J. Pediatr. Gastroenterol. Nutr. 42: 77-82 (2006).
*
-
Arimura Y. ANCA associated glomerulonephritis: pathogenesis, pathophysiology, and therapy.
Nippon Rinsho 64 Suppl. 2: 454-459 (2006).
-
Arimura Y, Goto A, Yamashita K, Endo T, Ikeda H, Tanaka K, Tsutsumi H, Shinomura Y, Imai K. Intractable colitis associated with chronic granulomatous disease.
J. Med. Microbiol. 55: 1587-1590 (2006).
*
-
Arish N, Eldor R, Fellig Y, Bogot N, Laxer U, Izhar U, Rokach A. Lymphocytic interstitial pneumonia associated with common variable immunodeficiency resolved with intravenous immunoglobulins.
Thorax 61: 1096-1097 (2006).
*
-
Aristodemou P, Stanford M. Therapy insight: the recognition and treatment of retinal manifestations of systemic vasculitis.
Nat. Clin. Pract. Rheumatol. 2: 443-451 (2006).
*
-
Arita K, Shimizu T, Hashimoto H, Hidaka Y, Yamada M, Sato M. Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4.
Proc. Natl. Acad. Sci. U.S.A. 103: 5291-5396 (2006).
*
-
Arita M, Oh S, Chonan T, Hong S, Elangovan S, Sun YP, Uddin J, Petasis NA, Serhan CN. Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions.
J. Biol. Chem. 281: 22847-22854 (2006).
*
-
Arkkila PE. Thromboangiitis obliterans (Buerger's disease).
Orphanet J. Rare Dis. 1: 14 (2006).
*
-
Arman A, Yilmaz B, Coker A, Inanc N, Direskeneli H. Interleukin-1 receptor antagonist (IL-1RN) and interleukin-1B gene polymorphisms in Turkish patients with rheumatoid arthritis.
Clin. Exp. Rheumatol. 24: 643-648 (2006).
-
Armentano F, Knight T, Makker S, Tramontano A. Induction of covalent binding antibodies.
Immunol. Lett. 103: 51-57 (2006).
-
Armstrong D, Wright S, McVeigh C, Finch M. Infective endocarditis complicating rituximab (anti-CD20 monoclonal antibody) treatment in an SLE patient with a past history of Libman-Sacks endocarditis: a case for antibiotic prophylaxis?
Clin. Rheumatol. 25: 583-584 (2006).
*
-
Arndt T, Meier U, Nauck M, Gressner AM. Primary biliary cirrhosis is not a clinical condition for increased carbohydrate-deficient transferrin: experience with four independent CDT analysis methods.
Clin. Chim. Acta 372: 184-187 (2006).
*
-
Arnold HL, Harrison SA. H. pylori and platelet counts.
Hepatology 44: 1685-1687 (2006).
*
-
Arnold JN, Dwek RA, Rudd PM, Sim RB. Mannan binding lectin and its interaction with immunoglobulins in health and in disease.
Immunol. Lett. 106: 103-110 (2006).
-
Arnold JN, Wallis R, Willis AC, Harvey DJ, Royle L, Dwek RA, Rudd PM, Sim RB. Interaction of mannan binding lectin with alpha-2 macroglobulin via exposed oligomannose glycans: a conserved feature of the thiol-ester protein family?
J. Biol. Chem. 281: 6955-6963 (2006).
*
-
Aroeira LS. TCR vaccination in aluminum adjuvant protects against autoimmune encephalomyelitis.
Clin. Immunol. 119: 252-260 (2006).
*
-
Aronson PS. Role of SLC26-mediated Cl-/base exchange in proximal tubule NaCl transport.
Novartis Found. Symp. 273: 148-158 (2006).
-
Aronson PS. Ion exchangers mediating Na+, HCO3 - and Cl- transport in the renal proximal tubule.
J. Nephrol. 19 Suppl. 9: S3-S10 (2006).
-
Aronson PS. Essential roles of CFEX-mediated Cl(-)-oxalate exchange in proximal tubule NaCl transport and prevention of urolithiasis.
Kidney Int. 70: 1207-1213 (2006).
*
-
Arranz A, Abad C, Juarranz Y, Torroba M, Rosignoli F, Leceta J, Gomariz RP, Martinez C. Effect of VIP on TLR2 and TLR4 expression in lymph node immune cells during TNBS-induced colitis.
Ann. N. Y. Acad. Sci. 1070: 129-134 (2006).
*
-
Arredondo J, Chernyavsky AI, Jolkovsky DL, Webber RJ, Grando SA. SLURP-2: a novel cholinergic signaling peptide in human mucocutaneous epithelium.
J. Cell. Physiol. 208: 238-245 (2006).
*
-
Arrese M. Cholestasis during pregnancy: rare hepatic diseases unmasked by pregnancy.
Ann. Hepatol. 5: 216-218 (2006).
*
-
Arrese M, Miquel JF, Ananthanarayanan M. BetaKlotho: a new kid on the bile acid biosynthesis block.
Hepatology 43: 191-193 (2006).
*
-
Arrese M, Reyes H. Intrahepatic cholestasis of pregnancy: a past and present riddle.
Ann. Hepatol. 5: 202-205 (2006).
*
-
Arriba-Mendez S, Sanz C, Isidoro-Garcia M, Davild I, Laffond E, Horeno E, Avila C, Lorente F. 927T>C polymorphism of the cysteinyl-leukotriene type-1 receptor (CYSLTR1) gene in children with asthma and atopic dermatitis.
Pediatr. Allergy Immunol. 17: 323-328 (2006).
*
-
Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability.
Gut 55: 1512-1520 (2006).
*
-
Arrieta-Aguirre I, Garcia-Etxebarria K, Jugo BM. Optimization of the MhcOvar-DRB1 gene typing.
Tissue Antigens 67: 222-228 (2006).
*
-
Arrizabalaga P, Sole M, Iglesias C, Escaramís G, Ascaso C. Renal expression of ICAM-1 and VCAM-1 in ANCA-associated glomerulonephritis - are there differences among serologic subgroups?
Clin. Nephrol. 65: 79-86 (2006).
-
Arron JR, Winslow MM, Polleri A, Chang CP, Wu H, Gao X, Neilson JR, Chen L, Heit JJ, Kim SK, Yamasaki N, Miyakawa T, Francke U, Graef IA, Crabtree GR. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21.
Nature 441: 595-600 (2006).
*
-
Arroyo M, Crawford JM. Hepatitic inherited metabolic disorders.
Semin. Diagn. Pathol. 23: 182-189 (2006).
-
Arroyo V, Terra C, Gines P. New treatments of hepatorenal syndrome.
Semin. Liver Dis. 26: 254-264 (2006).
-
Arseneau KO, Sultan S, Provenzale DT, Onken J, Bickston SJ, Foley E, Connors AF Jr, Cominelli F. Do patient preferences influence decisions on treatment for patients with steroid-refractory ulcerative colitis?
Clin. Gastroenterol. Hepatol. 4: 1135-1142 (2006).
-
Arslan N, Mavi A, Kalkan S, Aydin A, Ortac R, Buyukgebiz B, Durak H. Findings of hepatobiliary scintigraphy and liver biopsy in Maroteaux-Lamy syndrome presenting as neonatal cholestasis.
Pediatr. Int. 48: 498-500 (2006).
*
-
Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans.
Am. J. Clin. Nutr. 83: 1467S-1476S (2006).
*
-
Arthur JS, Darragh J. Signaling downstream of p38 in psoriasis.
J. Invest. Dermatol. 126: 1689-1691 (2006).
*
-
Artigas P, Al'aref SJ, Hobart EA, Diaz LF, Sakaguchi M, Straw S, Andersen OS. 2,3 Butanedione monoxime affects CFTR channel function through phosphorylation-dependent and phosphorylation-independent mechanisms. The role of bilayer material properties.
Mol. Pharmacol. 70: 2015-2026 (2006).
*
-
Arulampalam V, Greicius G, Pettersson S. The long and winding road to gut homeostasis.
Curr. Opin. Gastroenterol. 22: 349-353 (2006).
-
Arulmozhi DK, Dwyer DS, Bodhankar SL. Antipsychotic induced metabolic abnormalities: an interaction study with various PPAR modulators in mice.
Life Sci. 79: 1865-1872 (2006).
*
-
Arulventhan R, Larcos G, Gruenewald S, Farrell G. Primary sclerosing cholangitis: correlation of hepatobiliary scintigraphy with clinical and laboratory status.
Australas. Radiol. 50: 330-334 (2006).
-
Aruna BV, Ben-David H, Sela M, Mozes E. A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosis.
Immunology 118: 413-424 (2006).
*
-
Arvanitakis M, Deviere J. Primary sclerosing cholangitis and recognition of bile duct cancer: problem solved?
Endoscopy 38: 743-744 (2006).
-
Arya S, Rana SS, Sinha SK, Nagi B, Bhasin DK. Celiac disease and chronic calcific pancreatitis with pancreas divisum.
Gastrointest. Endosc. 63: 1080-1081 (2006).
-
Asada Y, Isomoto H, Shikuwa S, Wen CY, Fukuda E, Miyazato M, Okamoto K, Nakamura T, Nishiyama H, Mizuta Y, Migita K, Ito M, Kohno S. Development of ulcerative colitis during the course of rheumatoid arthritis: association with selective IgA deficiency.
World J. Gastroenterol. 12: 5240-5243 (2006).
*
-
Asahina A, Tamaki K. Role of Langerhans cells in cutaneous protective immunity: is the reappraisal necessary?
J. Dermatol. Sci. 44: 1-9 (2006).
-
Asahina K, Teramoto K, Teraoka H. Embryonic stem cells: hepatic differentiation and regenerative medicine for the treatment of liver disease.
Curr. Stem Cell Res. Ther. 1: 139-156 (2006).
-
Asai M, Yoshida M, Miura Y. Immunologic tolerance to intravenously injected insulin.
N. Engl. J. Med. 354: 307-309 (2006).
-
Asai T, Okumura K, Takahashi R, Matsui H, Numaguchi Y, Murakami H, Murakami R, Murohara T. Combined therapy with PPARalpha agonist and L-carnitine rescues lipotoxic cardiomyopathy due to systemic carnitine deficiency.
Cardiovasc. Res. 70: 566-577 (2006).
*
-
Asaka JI, Terada T, Okuda M, Katsura T, Inui KI. Androgen receptor is responsible for rat organic cation transporter 2 gene regulation but not for rOCT1 and rOCT3.
Pharm. Res. 23: 697-704 (2006).
*
-
Asano K, Ikegami H, Fujisawa T, Kawabata Y, Noso S, Hiromine Y, Ogihara T. The gene for human IL-21 and genetic susceptibility to type 1 diabetes in the Japanese.
Ann. N. Y. Acad. Sci. 1079: 47-50 (2006).
*
-
Asano Y, Ihn H, Jinnin M, Mimura Y, Tamaki K. Involvement of alphavbeta5 integrin in the establishment of autocrine TGF-beta signaling in dermal fibroblasts derived from localized scleroderma.
J. Invest. Dermatol. 126: 1761-1769 (2006).
*
-
Asanuma M, Miyazaki I. Nonsteroidal anti-inflammatory drugs in Parkinson's disease: possible involvement of quinone formation.
Expert Rev. Neurother. 6: 1313-1325 (2006).
-
Asashima N, Fujimoto M, Watanabe R, Nakashima H, Yazawa N, Okochi H, Tamaki K. Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris.
Br. J. Dermatol. 155: 330-336 (2006).
*
-
Asatiani G, Tokhadze L, Gopodze L. Oxidative homeostasis of organism during mechanical jaundice.
Georgian Med. News 134: 115-118 (2006).
-
Aschoff AJ. MDCT of the abdomen.
Eur. Radiol. 16 Suppl. 7: M54-M57 (2006).
-
Ashcroft DM, Seston E, Griffiths CE. Trade-offs between the benefits and risks of drug treatment for psoriasis: a discrete choice experiment with U.K. dermatologists.
Br. J. Dermatol. 155: 1236-1241 (2006).
*
-
Asheim P, Uggen PE, Aasarod K, Aadahl P. Intraperitoneal fluid therapy: an alternative to intravenous treatment in a patient with limited vascular access.
Anaesthesia 61: 502-504 (2006).
*
-
Asherson RA. The catastrophic antiphospholipid (Asherson's) syndrome.
Autoimmun. Rev. 6: 64-67 (2006).
-
Asherson RA, Bosman C, Tikly M, Spiro F, Pope FM. Ehlers-Danlos syndrome type IV in a young man.
J. Rheumatol. 33: 2091-2096 (2006).
-
Asherson RA, Frances C, Iaccarino L, Khamashta MA, Malacarne F, Piette JC, Tincani A, Doria A. The antiphospholipid antibody syndrome: diagnosis, skin.
Clin. Exp. Rheumatol. 24: S46-S51 (2006).
-
Ashfield R, Jakobsen BK. Making high-affinity T-cell receptors: a new class of targeted therapeutics.
IDrugs 9: 554-559 (2006).
-
Ashizawa T, Matsuno N, Yokoyama T, Kihara Y, Kuzuoka K, Taira S, Konno O, Jyojima Y, Akashi I, Nakamura Y, Hama K, Iwamoto H, Iwahori T, Nagao T, Kasahara M, Tanaka K. The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation.
Transplant. Proc. 38: 3629-3632 (2006).
*
-
Ashizuka S, Nishiura R, Ishikawa N, Yamaga J, Inatsu H, Fujimoto S, Eto T. Leukocytapheresis for ulcerative colitis: a comparative study of anticoagulant (nafamostat mesilate vs. dalteparin sodium) for reducing clinical complications.
Ther. Apher. Dial. 10: 54-58 (2006).
-
Ashour HM, Niederkorn JY. Peripheral tolerance via the anterior chamber of the eye: role of B cells in MHC class I and II antigen presentation.
J. Immunol. 176: 5950-5957 (2006).
*
-
Ashraf VV, Taly AB, Veerendrakumar M, Rao S. Myasthenia gravis in children: a longitudinal study.
Acta Neurol. Scand. 114: 119-123 (2006).
*
-
Ashwell JD. The many paths to p38 mitogen-activated protein kinase activation in the immune system.
Nat. Rev. Immunol. 6: 532-540 (2006).
*
-
Ashwood P, Wakefield AJ. Immune activation of peripheral blood and mucosal CD3(+) lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms.
J. Neuroimmunol. 173: 126-134 (2006).
-
Asif AR, Ljubojevic M, Sabolic I, Shnitsar V, Metten M, Anzai N, Mueller GA, Burckhardt G, Hagos Y. Regulation of steroid hormone biosynthesis enzymes and organic anion transporters by forskolin and DHEAS treatment in adrenocortical cells.
Am. J. Physiol. Endocrinol. Metab. 291: E1351-E1359 (2006).
*
-
Asimuakopoulos G. Pregnancy and liver disease.
Rev. Med. Chir. Soc. Med. Nat. Iasi. 110: 326-333 (2006).
-
Aslam R, Speck ER, Kim M, Crow AR, Bang KA, Nestel FP, Ni H, Lazarus AH, Freedman J, Semple JW. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo.
Blood 107: 637-641 (2006).
*
-
Aslamkhan AG, Thompson DM, Perry JL, Bleasby K, Wolff NA, Barros S, Miller DS, Pritchard JB. The flounder organic anion transporter fOat has sequence, function and substrate specificity similarity to both mammalian Oat1 and Oat3.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 291: R1773-R1780 (2006).
*
-
Aslanian FM, Marques MT, Matos HJ, Pontes LF, Porto LC, Azevedo LM, Filgueira AL. HLA markers in familial lichen sclerosus.
J. Dtsch. Dermatol. Ges. 4: 842-847 (2006).
*
-
Aslanidis S, Pyrpasopoulou A, Leontsini M, Zamboulis C. Anti-TNF-alpha-induced psoriasis: case report of an unusual adverse event.
Int. J. Dermatol. 45: 982-983 (2006).
*
-
Asleh R, Miller-Lotan R, Aviram M, Hayek T, Yulish M, Levy JE, Miller B, Blum S, Milman U, Shapira C, Levy AP. Haptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in vitro and in vivo.
Circ. Res. 99: 1419-1425 (2006).
*
-
Asma SD, Soumaya Y, Kahena J, Raouf DM, Nejib D. Perianal Crohn disease.
Dermatol. Online J. 12: 18 (2006).
-
Aso Y, Matsuura H, Momobayashi A, Inukai Y, Sugawara N, Nakano T, Yamamoto R, Wakabayashi S, Takebayashi K, Inukai T. Profound reduction in T-helper (Th) 1 lymphocytes in peripheral blood from patients with concurrent type 1 diabetes and Graves' disease.
Endocr. J. 53: 377-385 (2006).
*
-
Asokan R, Hua J, Young KA, Gould HJ, Hannan JP, Kraus DM, Szakonyi G, Grundy GJ, Chen XS, Crow MK, Holers VM. Characterization of human complement receptor type 2 (CR2/CD21) as a receptor for IFN-alpha: a potential role in systemic lupus erythematosus.
J. Immunol. 177: 383-394 (2006).
*
-
Aspberg S, Dahlquist G, Kahan T, Kallen B. Fetal and perinatal risk factors for inflammatory bowel disease.
Acta Paediatr. 95: 1001-1004 (2006).
*
-
Aspinall AI, Adams DH. Sickness behaviors in chronic cholestasis: an immune-mediated process?
Hepatology 43: 20-23 (2006).
*
-
Aspinall R. T cell development, ageing and interleukin-7.
Mech. Ageing Dev. 127: 572-578 (2006).
-
Asriri A, Mahmal A. Bronchectasia revealing ulcerative colitis.
Rev. Pneumol. Clin. 62: 403-406 (2006).
-
Assaraf YG. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.
Drug Resist. Updat. 9: 227-246 (2006).
-
Assi K, Pillai R, Gomez-Munoz A, Owen D, Salh B. The specific JNK inhibitor SP600125 targets tumour necrosis factor-alpha production and epithelial cell apoptosis in acute murine colitis.
Immunology 118: 112-121 (2006).
*
-
Assimakopoulos SF, Thomopoulos KC, Patsoukis N, Georgiou CD, Scopa CD, Nikolopoulou VN, Vagianos CE. Evidence for intestinal oxidative stress in patients with obstructive jaundice.
Eur. J. Clin. Invest. 36: 181-187 (2006).
*
-
Assisi A, Banzi R, Buonocore C, Capasso F, Muzio VD, Michelacci F, Renzo D, Tafuri G, Trotta F, Vitocolonna M, Garattini S. Fish oil and mental health: the role of n-3 long-chain polyunsaturated fatty acids in cognitive development and neurological disorders.
Int. Clin. Psychopharmacol. 21: 319-336 (2006).
-
Asteria CR, Ficari F, Bagnoli S, Milla M, Tonelli F. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
Scand. J. Gastroenterol. 41: 1064-1072 (2006).
*
-
Astermark J, Oldenburg J, Pavlova A, Berntorp E, Lefvert AK. Polymorphisms in the IL-10 but not in the IL-1beta and IL-4 genes are associated with inhibitor development in patients with hemophilia A.
Blood 107: 3167-3172 (2006).
*
-
Astier AL, Meiffren G, Freeman S, Hafler DA. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis.
J. Clin. Invest. 116: 3252-3257 (2006).
*
-
Astolfi CM, Shinohara AL, da Silva RA, Santos MC, Line SR, de Souza AP. Genetic polymorphisms in the MMP-1 and MMP-3 gene may contribute to chronic periodontitis in a Brazilian population.
J. Clin. Periodontol. 33: 699-703 (2006).
*
-
Atalay C, Deliloglu Gurhan I, Irkkan C, Gunduz U. Multidrug resistance in locally advanced breast cancer.
Tumour Biol. 27: 309-318 (2006).
-
Atchia II, Kidd CE, Bell RW. Rheumatoid arthritis-associated necrotizing scleritis and peripheral ulcerative keratitis treated successfully with infliximab.
J. Clin. Rheumatol. 12: 291-293 (2006).
-
Atherton HJ, Bailey NJ, Zhang W, Taylor J, Major H, Shockcor J, Clarke K, Griffin JL. A combined 1H NMR spectroscopy and mass spectrometry-based metabolomic study of the PPAR-alpha null mutant mouse defines profound systemic changes in metabolism linked to the metabolic syndrome.
Physiol. Genomics 27: 178-186 (2006).
*
-
Atkins EJ, Biousse V, Newman NJ. The natural history of optic neuritis.
Rev. Neurol. Dis. 3: 45-56 (2006).
-
Atkinson W, Lockhart S, Whorwell PJ, Keevil B, Houghton LA. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome.
Gastroenterology 130: 34-43 (2006).
*
-
Atochina O, Harn D. Prevention of psoriasis-like lesions development in fsn/fsn mice by helminth glycans.
Exp. Dermatol. 15: 461-468 (2006).
*
-
Atreya R, Atreya I, Neurath MF. Novel signal transduction pathways: analysis of STAT-3 and Rac-1 signaling in inflammatory bowel disease.
Ann. N. Y. Acad. Sci. 1072: 98-113 (2006).
*
-
Attene-Ramos MS, Wagner ED, Plewa MJ, Gaskins HR. Evidence that hydrogen sulfide is a genotoxic agent.
Mol. Cancer Res. 4: 9-14 (2006).
*
-
Attvall E, Frigyesi A, Sternby B. What is the impact of resistance to activated protein C (Leiden mutation to factor V) in inflammatory bowel disease?
Int. J. Colorectal Dis. 21: 705-710 (2006).
*
-
Auada MP, Puzzi MB, Cintra ML, Steiner CE, Alexandrino F, Sartorato EL, Aguiar TS, Azulay RD, Carney G, Rizzo WB. Sjogren-Larsson syndrome in Brazil is caused by a common c.1108-1G-->C splice-site mutation in the ALDH3A2 gene.
Br. J. Dermatol. 154: 770-773 (2006).
*
-
Aubareda A, Mulero MC, Perez-Riba M. Functional characterization of the calcipressin 1 motif that suppresses calcineurin-mediated NFAT-dependent cytokine gene expression in human T cells.
Cell. Signal. 18: 1430-1438 (2006).
*
-
Aubart FC, Ouayoun M, Brauner M, Attali P, Kambouchner M, Valeyre D, Nunes H. Sinonasal involvement in sarcoidosis: a case-control study of 20 patients.
Medicine (Baltimore) 85: 365-371 (2006).
-
Aubin CN, Linsdell P. Positive charges at the intracellular mouth of the pore regulate anion conduction in the CFTR chloride channel.
J. Gen. Physiol. 128: 535-545 (2006).
*
-
Aucejo F, Rofaiel G, Miller C. Who is at risk for post-transplant lymphoproliferative disorders (PTLD) after liver transplantation?
J. Hepatol. 44: 19-23 (2006).
*
-
Aud D, Peng SL. Mechanisms of disease: transcription factors in inflammatory arthritis.
Nat. Clin. Pract. Rheumatol. 2: 434-442 (2006).
*
-
Augereau P, Badia E, Carascossa S, Castet A, Fritsch S, Harmand PO, Jalaguier S, Cavailles V. The nuclear receptor transcriptional coregulator RIP140.
Nucl. Recept. Signal. 4: e024 (2006).
*
-
August A, Mueller C, Weaver V, Polanco TA, Walsh ER, Cantorna MT. Nutrients, nuclear receptors, inflammation, immunity lipids, PPAR, and allergic asthma.
J. Nutr. 136: 695-699 (2006).
*
-
Aulock SV, Deininger S, Draing C, Gueinzius K, Dehus O, Hermann C. Gender difference in cytokine secretion on immune stimulation with LPS and LTA.
J. Interferon Cytokine Res. 26: 887-892 (2006).
-
Aung CS, Faddy HM, Lister EJ, Monteith GR, Roberts-Thomson SJ. Isoform specific changes in PPARalpha and beta in colon and breast cancer with differentiation.
Biochem. Biophys. Res. Commun. 340: 656-660 (2006).
*
-
Ausch C, Madoff RD, Gnant M, Rosen HR, Garcia-Aguilar J, Holbling N, Herbst F, Buxhofer V, Holzer B, Rothenberger DA, Schiessel R. Aetiology and surgical management of toxic megacolon.
Colorectal Dis. 8: 195-201 (2006).
*
-
Ausiello CM, Fedele G, Palazzo R, Spensieri F, Ciervo A, Cassone A. 60-kDa heat shock protein of Chlamydia pneumoniae promotes a T helper type 1 immune response through IL-12/IL-23 production in monocyte-derived dendritic cells.
Microbes Infect. 8: 714-720 (2006).
*
-
Ausman JI. Why omega-3 fatty acids are important to neurosurgeons.
Surg. Neurol. 65: 325 (2006).
-
Aust S, Brucker B, Graf J, Klimpfinger M, Thalhammer T. Melatonin modulates acid/base transport in human pancreatic carcinoma cells.
Cell. Physiol. Biochem. 18: 91-102 (2006).
*
-
Austin GL, Shaheen NJ, Sandler RS. Positive and negative predictive values: use of inflammatory bowel disease serologic markers.
Am. J. Gastroenterol. 101: 413-416 (2006).
*
-
Autret-Leca E, Bensouda-Grimaldi L, Jonville-Bera AP, Beau-Salinas F. Pharmacovigilance of vaccines.
Arch. Pediatr. 13: 175-180 (2006).
-
Avallone R, Demers A, Rodrigue-Way A, Bujold K, Harb D, Anghel S, Wahli W, Marleau S, Ong H, Tremblay A. A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor upregulates ABC sterol transporters and cholesterol efflux in macrophages through a PPARgamma-dependent pathway.
Mol. Endocrinol. 20: 3165-3178 (2006).
*
-
Avital S, Hermon H, Greenberg R, Karin E, Skornick Y. Learning curve in laparoscopic colorectal surgery: our first 100 patients.
Isr. Med. Assoc. J. 8: 683-686 (2006).
*
-
Avouac J, Gossec L, Dougados M. Diagnostic and predictive value of anti-CCP (cyclic citrullinated protein) antibodies in rheumatoid arthritis: a systematic literature review.
Ann. Rheum. Dis. 65: 845-851 (2006).
*
-
Avril T, Attrill H, Zhang J, Raper A, Crocker PR. Negative regulation of leucocyte functions by CD33-related siglecs.
Biochem. Soc. Trans. 34: 1024-1027 (2006).
*
-
Awad J, Farah R, Reshef R, Cohen H, Horn I. Pyloric stenosis as a presenting symptom of Crohn's disease.
J. Gastrointestin. Liver Dis. 15: 175-177 (2006).
*
-
Awadallah NS, Chen YK, Piraka C, Antillon MR, Shah RJ. Is there a role for cholangioscopy in patients with primary sclerosing cholangitis?
Am. J. Gastroenterol. 101: 284-291 (2006).
*
-
Awakura Y, Ito N, Nakamura E, Takahashi T, Kotani H, Mikami Y, Manabe T, Kamoto T, Habuchi T, Ogawa O. Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population.
Cancer Lett. 241: 59-63 (2006).
*
-
Awomoyi A, Sirugo G, Newport MJ, Tishkoff S. Global distribution of a novel trinucleotide microsatellite polymorphism (ATA) in intron 8 of the SLC11A1 gene and susceptibility to pulmonary tuberculosis.
Int. J. Immunogenet. 33: 11-15 (2006).
*
-
Axtell RC, Xu L, Barnum SR, Raman C. CD5-CK2 binding/activation-deficient mice are resistant to experimental autoimmune encephalomyelitis: protection is associated with diminished populations of IL-17-expressing T cells in the central nervous system.
J. Immunol. 177: 8542-8549 (2006).
*
-
Ayadi-Kaddour A, Saiji E, Ben Slama S, Chelly-Ennaiffer I, Lahmar-Boufaroua A, Goutallier-Ben Fadhel C, Ben Sassi L, Khalfallah MT, Mzabi-Regaya S. Hepatic mesenchymal hamartoma in adulthood: a case report with literature review.
Tunis. Med. 84: 263-265 (2006).
-
Ayala YM, Pagani F, Baralle FE. TDP43 depletion rescues aberrant CFTR exon 9 skipping.
FEBS Lett. 580: 1339-1344 (2006).
*
-
Ayaori M, Sawada S, Yonemura A, Iwamoto N, Ogura M, Tanaka N, Nakaya K, Kusuhara M, Nakamura H, Ohsuzu F. Glucocorticoid receptor regulates ATP-binding cassette transporter-A1 expression and apolipoprotein-mediated cholesterol efflux from macrophages.
Arterioscler. Thromb. Vasc. Biol. 26: 163-168 (2006).
*
-
Aybek H, Aybek Z, Sinik Z, Demir S, Sancak B, Tuncay L. Elevation of serum and urinary carbohydrate antigen 19-9 in benign hydronephrosis.
Int. J. Urol. 13: 1380-1384 (2006).
*
-
Aydinli B, Ozturk G, Balik AA, Aslan S, Erdogan F. Spontaneous rupture of the spleen in secondary amyloidosis: a patient with rheumatoid arthritis.
Amyloid 13: 160-163 (2006).
-
Aydog E, Yesilli O, Sever A, Usan H. Dermatitis herpetiformis and rheumatoid arthritis.
Saudi Med. J. 27: 881-884 (2006).
-
Aydogan K, Karadogan SK, Adim SB, Tunali S. Hypocomplementemic urticarial vasculitis: a rare presentation of systemic lupus erythematosus.
Int. J. Dermatol. 45: 1057-1061 (2006).
*
-
Aydogan K, Karadogan SK, Akdag I, Tunali S. HLA class I and class II antigens in Turkish patients with chronic ordinary urticaria.
Clin. Exp. Dermatol. 31: 424-429 (2006).
*
-
Ayed K, Ayed-Jendoubi S, Ben Abdallah T, Bardi R, Gorgi Y, Sfar I, Dhrif B, Abderrahim E, Kheder A. Polymorphism of the renin-angiotensin-aldosterone system in patients with chronic allograft dysfunction.
Transpl. Immunol. 15: 303-309 (2006).
-
Ayensu WK, Tchounwou PB. Microarray analysis of mercury-induced changes in gene expression in human liver carcinoma (HepG2) cells: importance in immune responses.
Int. J. Environ. Res. Public Health 3: 141-173 (2006).
-
Aylett P. Digestive Disease Week 2006. Therapies for Crohn's disease and ulcerative colitis.
IDrugs 9: 452-454 (2006).
-
Ayse Selimoglu M, Ertekin V, Gursan N, Orbak Z, Esrefoglu M. Brunner's gland hyperplasia in a child with diabetes mellitus and coeliac disease.
Acta Paediatr. 95: 508-510 (2006).
*
-
Aytac S, Kargili A, Turkay C. A prolonged gestational intrahepatic cholestasis: a case report.
Turk. J. Gastroenterol. 17: 206-208 (2006).
*
-
Ayyildiz O, Altintas A, Isikdogan A, Tuzcu A. Aggressive natural killer cell leukemia in a patient with common variable immunodeficiency syndrome.
Gynecol. Endocrinol. 22: 286-287 (2006).
-
Azarpira N, Aghdaie MH, Behzad-Behbahanie A, Geramizadeh B, Behzadi S, Malekhoseinie SA, Raisjalal GH, Rahsaz M, Pourgholami A, Sagheb F. Association between cyclosporine concentration and genetic polymorphisms of CYP3A5 and MDR1 during the early stage after renal transplantation.
Exp. Clin. Transplant. 4: 416-419 (2006).
-
Azevedo TD, Feijo GC, Bezerra AC. Presence of developmental defects of enamel in cystic fibrosis patients.
J. Dent. Child. (Chic.) 73: 159-163 (2006).
-
Azkargorta M, Arizmendi JM, Elortza F, Alkorta N, Zubiaga AM, Fullaondo A. Differential proteome profiles in E2F2-deficient T lymphocytes.
Proteomics 6 Suppl. 1: S42-S50 (2006).
*
-
Azoulay L, Oraichi D, Berard A. Patterns and utilization of isotretinoin for acne from 1984 to 2003: is there need for concern?
Eur. J. Clin. Pharmacol. 62: 667-674 (2006).
*
-
Azulay JP. The extent of the clinical manifestations of chronic polyradiculoneuropathy.
Rev. Neurol. (Paris) 162: 518-521 (2006).
-
Azulay JP. The diagnosis of chronic axonal polyneuropathy: the poorly understood chronic polyradiculoneuritides.
Rev. Neurol. (Paris) 162: 1292-1295 (2006).
-
Azzam N, Al Ashgar H, Dababo M, Al Kahtani N, Shahid M. Mesentric vein thrombosis as a presentation of subclinical celiac disease.
Ann. Saudi Med. 26: 471-473 (2006).
-
B'chir Hamzaoui S, Harmel A, Bouslama K, Abdallah M, Ennafaa M, M'rad S, Ben Dridi M; le groupe tunisien d'etude sur la maladie de Behcet. Behcet's disease in Tunisia. Clinical study of 519 cases.
Rev. Med. Interne. 27: 742-750 (2006).
-
Baba MI, Kaul D, Grover A. Importance of blood cellular genomic profile in coronary heart disease.
J. Biomed. Sci. 13: 17-26 (2006).
*
-
Baba N, Kobashi H, Yamamoto K, Terada R, Suzuki T, Hakoda T, Okano N, Shimada N, Fujioka S, Iwasaki Y, Shiratori Y. Gene expression profiling in biliary epithelial cells of primary biliary cirrhosis using laser capture microdissection and cDNA microarray.
Transl. Res. 148: 103-113 (2006).
*
-
Baba T, Ishizu A, Iwasaki S, Suzuki A, Tomaru U, Ikeda H, Yoshiki T, Kasahara M. CD4/CD8 double-positive macrophages infiltrating at inflammatory sites: a population of monocytes/macrophages with a cytotoxic phenotype.
Blood 107: 2004-2012 (2006).
*
-
Babatin MA, Sanai FM, Swain MG. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
Aliment. Pharmacol. Ther. 24: 813-820 (2006).
*
-
Babbin BA, Crawford K, Sitaraman SV. Malabsorption work-up: utility of small bowel biopsy.
Clin. Gastroenterol. Hepatol. 4: 1193-1198 (2006).
-
Babcock AA, Wirenfeldt M, Holm T, Nielsen HH, Dissing-Olesen L, Toft-Hansen H, Millward JM, Landmann R, Rivest S, Finsen B, Owens T. Toll-like receptor 2 signaling in response to brain injury: an innate bridge to neuroinflammation.
J. Neurosci. 26: 12826-12837 (2006).
-
Babu S, Blauvelt CP, Kumaraswami V, Nutman TB. Regulatory networks induced by live parasites impair both Th1 and Th2 pathways in patent lymphatic filariasis: implications for parasite persistence.
J. Immunol. 176: 3248-3256 (2006).
*
-
Babusukumar U, Wang T, McGuire E, Broeckel U, Kugathasan S. Contribution of OCTN variants within the IBD5 locus to pediatric onset Crohn's disease.
Am. J. Gastroenterol. 101: 1354-1361 (2006).
*
-
Baca V, Velazquez-Cruz R, Salas-Martinez G, Espinosa-Rosales F, Saldana-Alvarez Y, Orozco L. Association analysis of the PTPN22 gene in childhood-onset systemic lupus erythematosus in Mexican population.
Genes Immun. 7: 693-695 (2006).
*
-
Bacanli A, Sallakci N, Yavuzer U, Alpsoy E, Yegin O. Toll-like receptor 2 Arg753Gln gene polymorphism in Turkish patients with Behcet's disease.
Clin. Exp. Dermatol. 31: 699-701 (2006).
*
-
Bacchetta R, Passerini L, Gambineri E, Dai M, Allan SE, Perroni L, Dagna-Bricarelli F, Sartirana C, Matthes-Martin S, Lawitschka A, Azzari C, Ziegler SF, Levings MK, Roncarolo MG. Defective regulatory and effector T cell functions in patients with FOXP3 mutations.
J. Clin. Invest. 116: 1713-1722 (2006).
*
-
Baccini F, Aloe Spiriti MA, Vannella L, Monarca B, Delle Fave G, Annibale B. Unawareness of gastrointestinal symptomatology in adult coeliac patients with unexplained iron-deficiency anaemia presentation.
Aliment. Pharmacol. Ther. 23: 915-921 (2006).
*
-
Bach JF. Induction of immunological tolerance using monoclonal antibodies: applications to organ transplantation and autoimmune disease.
C. R. Biol. 329: 260-262 (2006).
*
-
Bach JF. Therapeutic monoclonal antibodics.
Ann. Pharm. Fr. 64: 308-311 (2006).
-
Bach SP, Mortensen NJ. Revolution and evolution: 30 years of ileoanal pouch surgery.
Inflamm. Bowel Dis. 12: 131-145 (2006).
*
-
Bachar O, Adner M, Cardell LO. Toll-like receptor activation in airway smooth muscle - dual actions, via separate MAPK pathways.
Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L322-L323 (2006).
*
-
Bachmann C, Klibanov AL, Olson TS, Sonnenschein JR, Rivera-Nieves J, Cominelli F, Ley KF, Lindner JR, Pizarro TT. Targeting mucosal addressin cellular adhesion molecule (MAdCAM)-1 to noninvasively image experimental Crohn's disease.
Gastroenterology 130: 8-16 (2006).
*
-
Bachmann MF, Kopf M, Marsland BJ. Chemokines: more than just road signs.
Nat. Rev. Immunol. 6: 159-164 (2006).
*
-
Bachmann MP, Bartsch H, Gross JK, Maier SM, Gross TF, Workman JL, James JA, Farris AD, Jung B, Franke C, Conrad K, Schmitz M, Buttner C, Buyon JP, Semsei I, Harley JB, Rieber EP. Autoimmunity as a result of escape from RNA surveillance.
J. Immunol. 177: 1698-1707 (2006).
*
-
Bachmeyer C. Cutaneous infections in a patient with idiopathic thrombocytopenic purpura.
J. Am. Acad. Dermatol. 55: 364-365 (2006).
-
Bachmeyer C, Barrier A, Frazier A, Fulgencio JP, Lecomte I, Grateau G, Callard P. Diffuse large and small bowel necrosis in catastrophic antiphospholipid syndrome.
Eur. J. Gastroenterol. Hepatol. 18: 1011-1014 (2006).
-
Bachmeyer C, Rohaut B. Sarcoidosis mimicking rheumatoid arthritis.
Presse. Med. 35: 623-624 (2006).
-
Bacon BR. Hepatology: where do we go from here?
Gastroenterology 131: 1373-1374 (2006).
*
-
Badagnani I, Castro RA, Taylor TR, Brett CM, Huang CC, Stryke D, Kawamoto M, Johns SJ, Ferrin TE, Carlson EJ, Burchard EG, Giacomini KM. Interaction of methotrexate with OATP1A2 and its genetic variants.
J. Pharmacol. Exp. Ther. 318: 521-529 (2006).
*
-
Badn W, Kalliomaki S, Widegren B, Sjogren HO. Low-dose combretastatin a4 phosphate enhances the immune response of tumor hosts to experimental colon carcinoma.
Clin. Cancer Res. 12: 4714-4719 (2006).
*
-
Badriashvili N, Topuridze M, Chakhunachvili G, Tabutsadze D, Khvtisiashvili N. Interferon system in children with cystic fibrosis.
Georgian Med. News 136: 74-77 (2006).
-
Bae SC, Lee YH. Phosphorylation, acetylation and ubiquitination: the molecular basis of RUNX regulation.
Gene 366: 58-66 (2006).
*
-
Bae SH, Kim JS, Kim DH. Deflazacort for type-1 autoimmune hepatitis in a Korean girl.
J. Korean Med. Sci. 21: 758-760 (2006).
*
-
Bae SY, Choi SK, Kim KR, Park CS, Lee SK, Roh HK, Shin DW, Pie JE, Woo ZH, Kang JH. Effects of genetic polymorphisms of MDR1, FMO3 and CYP1A2 on susceptibility to colorectal cancer in Koreans.
Cancer Sci. 97: 774-779 (2006).
*
-
Baecher-Allan C, Hafler DA. Human regulatory T cells and their role in autoimmune disease.
Immunol. Rev. 212: 203-216 (2006).
*
-
Baecher-Allan C, Wolf E, Hafler DA. MHC class II expression identifies functionally distinct human regulatory T cells.
J. Immunol. 176: 4622-4631 (2006).
*
-
Baechler EC, Batliwalla FM, Reed AM, Peterson EJ, Gaffney PM, Moser KL, Gregersen PK, Behrens TW. Gene expression profiling in human autoimmunity.
Immunol. Rev. 210: 120-137 (2006).
*
-
Baecklund E, Backlin C, Iliadou A, Granath F, Ekbom A, Amini RM, Feltelius N, Enblad G, Sundstrom C, Klareskog L, Askling J, Rosenquist R. Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis.
Arthritis Rheum. 54: 3774-3781 (2006).
*
-
Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, Catrina AI, Rosenquist R, Feltelius N, Sundstrom C, Klareskog L. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis.
Arthritis Rheum. 54: 692-701 (2006).
*
-
Baek SJ, Okazaki R, Lee SH, Martinez J, Kim JS, Yamaguchi K, Mishina Y, Martin DW, Shoieb A, McEntee MF, Eling TE. Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia.
Gastroenterology 131: 1553-1560 (2006).
*
-
Bafna V, Bansal V. Inference about recombination from haplotype data: lower bounds and recombination hotspots.
J. Comput. Biol. 13: 501-521 (2006).
-
Bagaeva LV, Rao P, Powers JM, Segal BM. CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis.
J. Immunol. 176: 7676-7685 (2006).
*
-
Bagci S, Ercin CN, Yesilova Z, Ozcan A, Degertekin B, Dagalp K. Levels of serologic markers of celiac disease in patients with reflux esophagitis.
World J. Gastroenterol. 12: 6707-6710 (2006).
*
-
Bager P, Nielsen NM, Bihrmann K, Frisch M, Wohlfart J, Koch-Henriksen N, Melbye M, Westergaard T. Sibship characteristics and risk of multiple sclerosis: a nationwide cohort study in Denmark.
Am. J. Epidemiol. 163: 1112-1117 (2006).
*
-
Bagi Z, Hamar P, Kardos M, Koller A. Lack of flow mediated dilation and enhanced angiotensin II-induced constriction in skeletal muscle arterioles of lupus-prone autoimmune mice.
Lupus 15: 326-334 (2006).
-
Bagnato F, Ohayon JM, Ehrmantraut M, Chiu AW, Riva M, Ikonomidou VN. Clinical and imaging metrics for monitoring disease progression in patients with multiple sclerosis.
Expert Rev. Neurother. 6: 599-612 (2006).
-
Bagnato G, De Filippis LG, Caliri A, Bruno A, Gambardella N, Muscatello MR, Cambria R, Zoccali R. Comparation of levels of anxiety and depression in patients with autommune and chronic-degenerative rheumatic: preliminary data.
Reumatismo 58: 206-211 (2006).
-
Bagos PG, Nikolopoulos G, Ioannidis A. Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis.
Mult. Scler. 12: 397-411 (2006).
*
-
Bahr MJ, Ockenga J, Boker KH, Manns MP, Tietge UJ. Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance.
Am. J. Physiol. Endocrinol. Metab. 291: E199-E206 (2006).
*
-
Bai AP, Ouyang Q. Probiotics and inflammatory bowel diseases.
Postgrad. Med. J. 82: 376-382 (2006).
*
-
Bai AP, Ouyang Q, Xiao XR, Li SF. Probiotics modulate inflammatory cytokine secretion from inflamed mucosa in active ulcerative colitis.
Int. J. Clin. Pract. 60: 284-288 (2006).
*
-
Bai L, Kao JY, Law DJ, Merchant JL. Recruitment of ataxia-telangiectasia mutated to the p21(waf1) promoter by ZBP-89 plays a role in mucosal protection.
Gastroenterology 131: 841-852 (2006).
*
-
Bai M, Katsanos KH, Economou M, Kamina S, Balli C, Briasoulis E, Kappas AM, Agnantis N, Tsianos EV. Rectal Epstein-Barr virus-positive Hodgkin's lymphoma in a patient with Crohn's disease: case report and review of the literature.
Scand. J. Gastroenterol. 41: 866-869 (2006).
*
-
Baichi MM, Arifuddin RM, Mantry PS. What we have learned from 5 cases of permanent capsule retention.
Gastrointest. Endosc. 64: 283-287 (2006).
-
Baici A, Muntener K, Willimann A, Zwicky R. Regulation of human cathepsin B by alternative mRNA splicing: homeostasis, fatal errors and cell death.
Biol. Chem. 387: 1017-1021 (2006).
-
Baier G, Asadullah K, Zugel U. The immunological synapse: kinases in T cell signalling as potential drug targets.
Immunol. Lett. 105: 3-5 (2006).
-
Baier PK, Arampatzis G, Imdahl A, Hopt UT. The iliopsoas abscess: aetiology, therapy, and outcome.
Langenbecks Arch. Surg. 391: 411-417 (2006).
*
-
Baier PK, Hempel S, Waldvogel B, Baumgartner U. Zonation of hepatic bile salt transporters.
Dig. Dis. Sci. 51: 587-593 (2006).
*
-
Baig MK, Weiss EG, Nogueras JJ, Wexner SD. Lengthening of small bowel mesentery: stepladder incision technique.
Am. J. Surg. 191: 715-717 (2006).
*
-
Bailey DP, Kashyap M, Bouton LA, Murray PJ, Ryan JJ. Interleukin-10 induces apoptosis in developing mast cells and macrophages.
J. Leukoc. Biol. 80: 581-589 (2006).
*
-
Bailey JR, Williams TM, Siliciano RF, Blankson JN. Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations.
J. Exp. Med. 203: 1357-1369 (2006).
*
-
Bailey SD, Loredo-Osti JC, Lepage P, Faith J, Fontaine J, Desbiens KM, Hudson TJ, Bouchard C, Gaudet D, Perusse L, Vohl MC, Engert JC. Common polymorphisms in the promoter of the visfatin gene (PBEF1) influence plasma insulin levels in a French-Canadian population.
Diabetes 55: 2896-2902 (2006).
*
-
Baillat D, Leprivier G, Regnier D, Vintonenko N, Begue A, Stehelin D, Aumercier M. Stromelysin-1 expression is activated in vivo by Ets-1 through palindromic head-to-head Ets binding sites present in the promoter.
Oncogene 25: 5764-5776 (2006).
*
-
Bailly-Maitre B, Fondevila C, Kaldas F, Droin N, Luciano F, Ricci JE, Croxton R, Krajewska M, Zapata JM, Kupiec-Weglinski JW, Farmer D, Reed JC. Cytoprotective gene bi-1 is required for intrinsic protection from endoplasmic reticulum stress and ischemia-reperfusion injury.
Proc. Natl. Acad. Sci. U.S.A. 103: 2809-2814 (2006).
*
-
Baishanbo A, Gargala G, Duclos C, Francois A, Rossignol JF, Ballet JJ, Favennec L. Efficacy of nitazoxanide and paromomycin in biliary tract cryptosporidiosis in an immunosuppressed gerbil model.
J. Antimicrob. Chemother. 57: 353-355 (2006).
*
-
Bajaj JS, Bajaj S, Dua KS, Jaradeh S, Rittmann T, Hofmann C, Shaker R. Influence of sleep stages on esophago-upper esophageal sphincter contractile reflex and secondary esophageal peristalsis.
Gastroenterology 130: 17-25 (2006).
*
-
Bajenoff M, Egen JG, Koo LY, Laugier JP, Brau F, Glaichenhaus N, Germain RN. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes.
Immunity 25: 989-1001 (2006).
*
-
Bajor A, Kilander A, Galman C, Rudling M, Ung KA. Budesonide treatment is associated with increased bile acid absorption in collagenous colitis.
Aliment. Pharmacol. Ther. 24: 1643-1649 (2006).
*
-
Bajtay Z, Csomor E, Sandor N, Erdei A. Expression and role of Fc- and complement-receptors on human dendritic cells.
Immunol. Lett. 104: 46-52 (2006).
-
Bak H, Lee JW, Ahn HJ, Hwang SM, Choi EH, Lee SH, Ahn SK. An unusual case with membranous lipodystrophy in a hypertensive patient with transepidermal elimination.
Yonsei. Med. J. 47: 428-431 (2006).
*
-
Bak-Romaniszyn L, Cedzynski M, Szemraj J, St Swierzko A, Zeman K, Kaluzynski A, Planeta-Malecka I. Mannan-binding lectin in children with chronic gastritis.
Scand. J. Immunol. 63: 131-135 (2006).
*
-
Bakema JE, de Haij S, den Hartog-Jager CF, Bakker J, Vidarsson G, van Egmond M, van de Winkel JG, Leusen JH. Signaling through mutants of the IgA receptor CD89 and consequences for Fc receptor gamma-chain interaction.
J. Immunol. 176: 3603-3610 (2006).
*
-
Baken KA, Ezendam J, Gremmer ER, de Klerk A, Pennings JL, Matthee B, Peijnenburg AA, van Loveren H. Evaluation of immunomodulation by Lactobacillus casei Shirota: immune function, autoimmunity and gene expression.
Int. J. Food Microbiol. 112: 8-18 (2006).
*
-
Baker BS, Powles A, Fry L. Peptidoglycan: a major aetiological factor for psoriasis?
Trends Immunol. 27: 545-551 (2006).
*
-
Baker DE. MMX Mesalamine.
Rev. Gastroenterol. Disord. 6: 146-152 (2006).
-
Bakker-Jonges LE, ter Borg PC, van Buuren HR, Hooijkaas H. A retrospective study on the role of antibodies against soluble liver antigen (anti-SLA antibodies) and other autoantibodies in the diagnostics of autoimmune hepatitis.
Ned. Tijdschr. Geneeskd. 150: 490-494 (2006).
-
Bako W, Marek A, Sikorska-Wisniewska G, Liberek A, Raczkowska-Kozak J, Gora-Gebka M, Szlagatys-Sidorkiewicz A, Zagierski M, Jankowska A. Short bowel syndrome in children - own experience.
Med. Wieku. Rozwoj. X: 563-572 (2006).
-
Bakrac M, Bonaci B, Krstic M, Simic S, Colovic M. A rare case of enteropathy-associated T-cell lymphoma presenting as acute renal failure.
World J. Gastroenterol. 12: 2301-2304 (2006).
*
-
Baksh MF, Balding DJ, Vyse TJ, Whittaker JC. A likelihood ratio approach to family-based association studies with covariates.
Ann. Hum. Genet. 70: 131-139 (2006).
*
-
Bala G, Swincow G, Rytarowska A, Czerwionka-Szaflarska M. Non-specific inflammatory bowel disease or allergic colitis in small children - what is the final diagnosis?
Med. Wieku. Rozwoj. X: 475-482 (2006).
-
Balaban YH, Sumer H, Simsek H, Us D, Tatar G. Metabolic syndrome, non-alcoholic steatohepatitis (NASH), and hepatocyte growth factor (HGF).
Ann. Hepatol. 5: 109-114 (2006).
*
-
Balabanov R, Strand K, Kemper A, Lee JY, Popko B. Suppressor of cytokine signaling 1 expression protects oligodendrocytes from the deleterious effects of interferon-gamma.
J. Neurosci. 26: 5143-5152 (2006).
-
Balachandran P, Pugh ND, Ma G, Pasco DS. Toll-like receptor 2-dependent activation of monocytes by Spirulina polysaccharide and its immune enhancing action in mice.
Int. Immunopharmacol. 6: 1808-1814 (2006).
-
Balada E, Simeon-Aznar CP, Serrano-Acedo S, Martinez-Lostao L, Selva-O' Callaghan A, Fonollosa-Pla V, Vilardell-Tarres M. Lack of association of the PTPN22 gene polymorphism R620W with systemic sclerosis.
Clin. Exp. Rheumatol. 24: 321-324 (2006).
-
Balada E, Villarreal-Tolchinsky J, Ordi-Ros J, Labrador M, Serrano-Acedo S, Martinez-Lostao L, Vilardell-Tarres M. Multiplex family-based study in systemic lupus erythematosus: association between the R620W polymorphism of PTPN22 and the FcgammaRIIa (CD32A) R131 allele.
Tissue Antigens 68: 432-438 (2006).
*
-
Balakrishnan A, Polli JE. Apical sodium dependent bile acid transporter (ASBT, SLC10A2): a potential prodrug target.
Mol. Pharm. 3: 223-230 (2006).
*
-
Balakrishnan A, Wring SA, Coop A, Polli JE. Influence of charge and steric bulk in the C-24 region on the interaction of bile acids with human apical sodium-dependent bile acid transporter.
Mol. Pharm. 3: 282-292 (2006).
*
-
Balakrishnan A, Wring SA, Polli JE. Interaction of native bile acids with human apical sodium-dependent bile acid transporter (hASBT): influence of steroidal hydroxylation pattern and C-24 conjugation.
Pharm. Res. 23: 1451-1459 (2006).
*
-
Balas A, Garcia-Sanchez F, Vicario JL. Sequencing of a new HLA-C allele, HLA-Cw*0742, with a novel HLA polymorphism at exon 3.
Tissue Antigens 68: 530-531 (2006).
*
-
Balboni I, Chan SM, Kattah M, Tenenbaum JD, Butte AJ, Utz PJ. Multiplexed protein array platforms for analysis of autoimmune diseases.
Annu. Rev. Immunol. 24: 391-418 (2006).
*
-
Baldan A, Tarr P, Lee R, Edwards PA. ATP-binding cassette transporter G1 and lipid homeostasis.
Curr. Opin. Lipidol. 17: 227-232 (2006).
-
Baldwin CL, Goenka R. Host immune responses to the intracellular bacteria Brucella: does the bacteria instruct the host to facilitate chronic infection?
Crit. Rev. Immunol. 26: 407-442 (2006).
-
Baldwin HE. Coping with the isotretinoin registry.
Dermatol. Ther. 19: 241-250 (2006).
*
-
Baldys-Waligorska A, Kusnierz-Cabala B, Huszno B. A special case of thyroid associated ophthalmopathy in the course of Graves-Basedow disease.
Endokrynol. Pol. 57: 536-540 (2006).
-
Balga R, Wetterwald A, Portenier J, Dolder S, Mueller C, Hofstetter W. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro.
Bone 39: 325-335 (2006).
*
-
Balic A, Harcus YM, Taylor MD, Brombacher F, Maizels RM. IL-4R signaling is required to induce IL-10 for the establishment of T(h)2 dominance.
Int. Immunol. 18: 1421-1431 (2006).
*
-
Balint BL, Nagy L. Selective modulators of PPAR activity as new therapeutic tools in metabolic diseases.
Endocr. Metab. Immune Disord. Drug Targets 6: 33-43 (2006).
-
Balistreri CR, Grimaldi MP, Vasto S, Listi F, Chiappelli M, Licastro F, Lio D, Caruso C, Candore G. Association between the polymorphism of CCR5 and Alzheimer's disease: results of a study performed on male and female patients from northern Italy.
Ann. N. Y. Acad. Sci. 1089: 454-461 (2006).
*
-
Balistreri WF, Bezerra JA. Whatever happened to “neonatal hepatitis”?
Clin. Liver Dis. 10: 27-53 (2006).
-
Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review.
Atherosclerosis 189: 19-30 (2006).
-
Ballanger F, Allix ML, Rimbert M, Audrain M, Muller JY, Dreno B. Auto-immunity induced by low doses of interferon in melanoma stage I.
Ann. Dermatol. Venereol. 133: 543-548 (2006).
-
Ballatori N, Henson JH, Seward DJ, Cai SY, Runnegar M, Fricker G, Miller DS, Boyer JL. Retention of structural and functional polarity in cultured skate hepatocytes undergoing in vitro morphogenesis.
Comp. Biochem. Physiol. B. Biochem. Mol. Biol. 144: 167-179 (2006).
*
-
Ballestero MR, Monte MJ, Briz O, Jimenez F, Gonzalez-San Martin F, Marin JJ. Expression of transporters potentially involved in the targeting of cytostatic bile acid derivatives to colon cancer and polyps.
Biochem. Pharmacol. 72: 729-738 (2006).
*
-
Ballestero Y, Hernandez MI, Rojo P, Manzanares J, Nebreda V, Carbajosa H, Infante E, Baro M. Hyponatremic dehydration as a presentation of cystic fibrosis.
Pediatr. Emerg. Care 22: 725-727 (2006).
-
Ballotti S, Chiarelli F, de Martino M. Autoimmunity: basic mechanisms and implications in endocrine diseases. Part II.
Horm. Res. 66: 142-152 (2006).
-
Ballow M. Biologic immune modifiers: trials and tribulations - are we there yet?
J. Allergy Clin. Immunol. 118: 1209-1215 (2006).
*
-
Bamba S, Lee CY, Brittan M, Preston S, Direkze N, Poulsom R, Alison M, Wright N, Otto W. Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice.
J. Pathol. 209: 265-273 (2006).
*
-
Bamias G, Cominelli F. Novel strategies to attenuate immune activation in Crohn's disease.
Curr. Opin. Pharmacol. 6: 401-407 (2006).
-
Bamias G, Mishina M, Nyce M, Ross WG, Kollias G, Rivera-Nieves J, Pizarro TT, Cominelli F. Role of TL1A and its receptor DR3 in two models of chronic murine ileitis.
Proc. Natl. Acad. Sci. U.S.A. 103: 8441-8446 (2006).
*
-
Bamoulid J, Courivaud C, Deschamps M, Mercier P, Ferrand C, Penfornis A, Tiberghien P, Chalopin JM, Saas P, Ducloux D. IL-6 promoter polymorphism -174 is associated with new-onset diabetes after transplantation.
J. Am. Soc. Nephrol. 17: 2333-2340 (2006).
*
-
Banach-Petrosky W, Ouyang X, Gao H, Nader K, Ji Y, Suh N, Dipaola RS, Abate-Shen C. Vitamin D inhibits the formation of prostatic intraepithelial neoplasia in Nkx3.1; Pten mutant mice.
Clin. Cancer Res. 12: 5895-5901 (2006).
*
-
Banales JM, Arenas F, Rodriguez-Ortigosa CM, Saez E, Uriarte I, Doctor RB, Prieto J, Medina JF. Bicarbonate-rich choleresis induced by secretin in normal rat is taurocholate-dependent and involves AE2 anion exchanger.
Hepatology 43: 266-275 (2006).
*
-
Banales JM, Prieto J, Medina JF. Cholangiocyte anion exchange and biliary bicarbonate excretion.
World J. Gastroenterol. 12: 3496-3511 (2006).
*
-
Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases.
Immunity 25: 383-392 (2006).
*
-
Banda NK, Thurman JM, Kraus D, Wood A, Carroll MC, Arend WP, Holers VM. Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis.
J. Immunol. 177: 1904-1912 (2006).
*
-
Bandyopadhyay SK, Bandyopadhyay R, Dutta A. Primary amyloidosis presenting as intrahepatic cholestasis.
Indian J. Pathol. Microbiol. 49: 557-559 (2006).
-
Bandyopadhyay SK, Moulick A, Dutta A. Retinal vasculitis - an initial presentation of systemic lupus erythematosus.
J. Indian Med. Assoc. 104: 526-527 (2006).
-
Banerjee A, Gugasyan R, McMahon M, Gerondakis S. Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells.
Proc. Natl. Acad. Sci. U.S.A. 103: 3274-3279 (2006).
*
-
Banerjee S, Bishop WP. Evolution of thiopurine use in pediatric inflammatory bowel disease in an academic center: role of thiopurine methyltransferase and 6-mercaptopurine metabolite measurements.
J. Pediatr. Gastroenterol. Nutr. 43: 324-330 (2006).
*
-
Banerjee S, Rahhal R, Bishop WP. Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis.
J. Pediatr. Gastroenterol. Nutr. 43: 353-356 (2006).
*
-
Bang B, Gniadecki R. Severe exacerbation of psoriatic arthritis during treatment with efalizumab. A case report.
Acta Derm. Venereol. 86: 456-457 (2006).
-
Bangs SC, McMichael AJ, Xu XN. Bystander T cell activation - implications for HIV infection and other diseases.
Trends Immunol. 27: 518-524 (2006).
*
-
Banham AH. Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells.
Trends Immunol. 27: 541-544 (2006).
*
-
Banham AH, Powrie FM, Suri-Payer E. FOXP3+ regulatory T cells: current controversies and future perspectives.
Eur. J. Immunol. 36: 2832-2836 (2006).
*
-
Bania J, Dabrowska A, Rozalska B, Sadowska B, Wieckowska-Szakiel M, Korzekwa K, Zarczynska A, Bystron J, Chrzanowska J, Molenda J. Superantigen types in Staphylococcus aureus isolated from patients with cystic fibrosis.
Folia. Microbiol. (Praha.) 51: 614-618 (2006).
-
Baniasadi V, Narain N, Goswami R, Das SN. Promoter region -318 C/ T and -1661 A/G CTLA-4 single nucleotide polymorphisms and type 1 diabetes in North Indians.
Tissue Antigens 67: 383-389 (2006).
*
-
Bank U, Heimburg A, Helmuth M, Stefin S, Lendeckel U, Reinhold D, Faust J, Fuchs P, Sens B, Neubert K, Tager M, Ansorge S. Triggering endogenous immunosuppressive mechanisms by combined targeting of dipeptidyl peptidase IV (DPIV/CD26) and aminopeptidase N (APN/ CD13) - a novel approach for the treatment of inflammatory bowel disease.
Int. Immunopharmacol. 6: 1925-1934 (2006).
-
Banka NH, Dhavan P, Chevale BP. Coeliac sprue - new frontiers in diagnosis and role of capsule endoscopy.
J. Assoc. Physicians India 54: 959-961 (2006).
-
Bankar RN, Dafe CO, Kohnke A, Babu PS. Ulcerative colitis probably associated with isotretinoin.
Indian J. Gastroenterol. 25: 171-172 (2006).
*
-
Banks PA, Freeman ML; Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines in acute pancreatitis.
Am. J. Gastroenterol. 101: 2379-2400 (2006).
*
-
Bano S, Bombardieri S, Doria A, Iaccarino L, Lehmann P, Mosca M. Lupus erythematosus and the skin.
Clin. Exp. Rheumatol. 24: S26-S35 (2006).
-
Bansback N, Young A, Brennan A, Dixey J. A prognostic model for functional outcome in early rheumatoid arthritis.
J. Rheumatol. 33: 1503-1510 (2006).
-
Bantis C, Heering PJ, Aker S, Siekierka M, Kuhr N, Grabensee B, Ivens K. Tumor necrosis factor-alpha gene G-308A polymorphism is a risk factor for the development of membranous glomerulonephritis.
Am. J. Nephrol. 26: 12-15 (2006).
-
Banus HA, Vandebriel RJ, de Ruiter H, Dormans JA, Nagelkerke NJ, Mooi FR, Hoebee B, van Kranen HJ, Kimman TG. Host genetics of Bordetella pertussis infection in mice: significance of Toll-like receptor 4 in genetic susceptibility and pathobiology.
Infect. Immun. 74: 2596-2605 (2006).
*
-
Banville N, Broderick A, Fitzgerald R, Drumm B, McDermott M. Giant inflammatory polyposis coli as a manifestation of Crohn's disease in patients with coexistent cystic fibrosis.
Pediatr. Dev. Pathol. 9: 25-30 (2006).
-
Banwell B, Reder AT, Krupp L, Tenembaum S, Eraksoy M, Alexey B, Pohl D, Freedman M, Schelensky L, Antonijevic I. Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis.
Neurology 66: 472-476 (2006).
-
Banwell CM, Maccartney DP, Guy M, Miles AE, Uskokovic MR, Mansi J, Stewart PM, O'neill LP, Turner BM, Colston KW, Campbell MJ. Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells.
Clin. Cancer Res. 12: 2004-2013 (2006).
*
-
Bar-Meir S. Review article: capsule endoscopy - are all small intestinal lesions Crohn's disease?
Aliment. Pharmacol. Ther. 24 Suppl. 3: 19-21 (2006).
*
-
Bar-Meir S, Wallace MB. Diagnostic colonoscopy: the end is coming.
Gastroenterology 131: 992-994 (2006).
*
-
Barahmani N, de Andrade M, Slusser JP, Zhang Q, Duvic M. Major histocompatibility complex class I chain-related gene a polymorphisms and extended haplotypes are associated with familial alopecia areata.
J. Invest. Dermatol. 126: 74-78 (2006).
*
-
Baran W, Szepietowski JC, Mazur G, Baran E. A - 308 promoter polymorphism of tumor necrosis factor alpha gene does not associate with the susceptibility to psoriasis vulgaris. No difference either between psoriasis type I and type II patients.
Acta Dermatovenerol. Alp. Panonica Adriat. 15: 113-118 (2006).
*
-
Barancik M, Bohacova V, Sedlak J, Sulova Z, Breier A. LY294,002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance.
Eur. J. Pharm. Sci. 29: 426-434 (2006).
*
-
Baranzini SE. Systems-based medicine approaches to understand and treat complex diseases. The example of multiple sclerosis.
Autoimmunity 39: 651-662 (2006).
-
Barao I, Hanash AM, Hallett W, Welniak LA, Sun K, Redelman D, Blazar BR, Levy RB, Murphy WJ. Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells.
Proc. Natl. Acad. Sci. U.S.A. 103: 5460-5465 (2006).
*
-
Barath S, Sipka S, Aleksza M, Szegedi A, Szodoray P, Vegh J, Szegedi G, Bodolay E. Regulatory T cells in peripheral blood of patients with mixed connective tissue disease.
Scand. J. Rheumatol. 35: 300-304 (2006).
*
-
Baratti C, De Simone A, Grassi C, Righi I, Massara PP, Pizzi M, Ferla F, Sposato J, Ardizzone S, Trabucchi E. Inflammatory colitis: classification and surgical treatment.
Ann. Ital. Chir. 77: 313-317 (2006).
-
Barbato M, Curione M, Viola F, Versacci P, Parisi F, Amato S, Cucchiara S. Cardiac involvement in children with IBD during infliximab therapy.
Inflamm. Bowel Dis. 12: 828-829 (2006).
*
-
Barbe-Tuana FM, Klein D, Ichii H, Berman DM, Coffey L, Kenyon NS, Ricordi C, Pastori RL. CD40-CD40 ligand interaction activates proinflammatory pathways in pancreatic islets.
Diabetes 55: 2437-2445 (2006).
*
-
Barber CE, Geldenhuys L, Hanly JG. Sustained remission of lupus nephritis.
Lupus 15: 94-101 (2006).
-
Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, Freeman GJ, Ahmed R. Restoring function in exhausted CD8 T cells during chronic viral infection.
Nature 439: 682-687 (2006).
*
-
Barber RC, Chang LY, Arnoldo BD, Purdue GF, Hunt JL, Horton JW, Aragaki CC. Innate immunity SNPs are associated with risk for severe sepsis after burn injury.
Clin. Med. Res. 4: 250-255 (2006).
*
-
Barbosa FA, de Labio RW, de Oliveira S Rigolin V, Minett T, Bertolucci PH, de Arruda Cardoso Smith M, Payao SL. Apolipoprotein A-V gene polymorphism -1131T>C and Alzheimer's disease.
J. Alzheimers Dis. 10: 365-369 (2006).
-
Barcellos LF, Kamdar BB, Ramsay PP, Deloa C, Lincoln RR, Caillier S, Schmidt S, Haines JL, Pericak-Vance MA, Oksenberg JR, Hauser SL. Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study.
Lancet Neurol. 5: 924-931 (2006).
-
Barcellos LF, Sawcer S, Ramsay PP, Baranzini SE, Thomson G, Briggs F, Cree BC, Begovich AB, Villoslada P, Montalban X, Ucelli A, Savettieri G, Lincoln RL, Deloa C, Haines JL, Pericak-Vance MA, Compston A, Hauser SL, Oksenberg JR. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
Hum. Mol. Genet. 15: 2813-2824 (2006).
*
-
Barcena R, Moreno A, Foruny JR, Moreno A, Sanchez J, Gil-Grande L, Blazquez J, Nuno J, Fortun J, Rodriguez-Gandia MA, Oton E. Improved graft function in liver-transplanted patients after partial splenic embolization: reversal of splenic artery steal syndrome?
Clin. Transplant. 20: 517-523 (2006).
*
-
Barclay AN, Brown MH. The SIRP family of receptors and immune regulation.
Nat. Rev. Immunol. 6: 457-464 (2006).
*
-
Bardet V, Junior AP, Coste J, Lecoq-Lafon C, Chouzenoux S, Bernard D, Soubrane O, Lacombe C, Calmus Y, Conti F. Impaired erythropoietin production in liver transplant recipients: the role of calcineurin inhibitors.
Liver Transpl. 12: 1649-1654 (2006).
*
-
Bardin N, Reumaux D, Geboes K, Colombel JF, Blot-Chabaud M, Sampol J, Duthilleul P, Dignat-George F. Increased expression of CD146, a new marker of the endothelial junction in active inflammatory bowel disease.
Inflamm. Bowel Dis. 12: 16-21 (2006).
*
-
Baricevic I, Jones DR, Nikolic JA, Nedic O. Gastrointestinal inflammation and the circulating IGF system in humans.
Horm. Metab. Res. 38: 22-27 (2006).
-
Barile S, Medda E, Nistico L, Bordignon V, Cordiali-Fei P, Carducci M, Rainaldi A, Marinelli R, Bonifati C. Vascular endothelial growth factor gene polymorphisms increase the risk to develop psoriasis.
Exp. Dermatol. 15: 368-376 (2006).
*
-
Baris N, Akdeniz B, Ozerkan F, Onder RM, Akarca U, Guneri S. The relationship between hypertensive retinopathy and angiotensin converting enzyme gene polymorphism.
Cardiovasc. Hematol. Disord. Drug Targets 6: 57-61 (2006).
-
Barisani D, Ceroni S, Meneveri R, Cesana BM, Bardella MT. IL-10 polymorphisms are associated with early-onset celiac disease and severe mucosal damage in patients of Caucasian origin.
Genet. Med. 8: 169-174 (2006).
-
Barish GD. Peroxisome proliferator-activated receptors and liver X receptors in atherosclerosis and immunity.
J. Nutr. 136: 690-694 (2006).
*
-
Barish GD, Narkar VA, Evans RM. PPARdelta: a dagger in the heart of the metabolic syndrome.
J. Clin. Invest. 116: 590-597 (2006).
*
-
Barisic GI, Krivokapic ZV, Adzic TN, Pavlovic AR, Popovic MA, Gojnic M. Fecopneumothorax and colopleural fistula - uncommon complications of Crohn's disease.
BMC Gastroenterol. 6: 17 (2006).
*
-
Barker DF, Husain A, Neale JR, Martini BD, Zhang X, Doll MA, Christopher States J, Hein DW. Functional properties of an alternative, tissue-specific promoter for human arylamine N-acetyltransferase 1.
Pharmacogenet. Genomics 16: 515-525 (2006).
*
-
Barker JM. Type 1 diabetes associated autoimmunity: natural history, genetic associations and screening.
J. Clin. Endocrinol. Metab. 91: 1210-1217 (2006).
*
-
Barker RH Jr, Dagher R, Davidson DM, Marquis JK. Review article: tolevamer, a novel toxin-binding polymer: overview of preclinical pharmacology and physicochemical properties.
Aliment. Pharmacol. Ther. 24: 1525-1534 (2006).
*
-
Barksby HE, Milner JM, Patterson AM, Peake NJ, Hui W, Robson T, Lakey R, Middleton J, Cawston TE, Richards CD, Rowan AD. Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: implications for cartilage degradation in arthritis.
Arthritis Rheum. 54: 3244-3253 (2006).
*
-
Barlan I, Bahceciler NN, Akdis M, Akdis CA. Bacillus Calmette-Guerin, Mycobacterium bovis, as an immunomodulator in atopic diseases.
Immunol. Allergy Clin. North Am. 26: 365-377 (2006).
-
Barlic J, Zhang Y, Foley JF, Murphy PM. Oxidized lipid-driven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferator-activated receptor gamma-dependent pathway.
Circulation 114: 807-819 (2006).
-
Barlow C. Ulcerative colitis, pregnancy, prenatal expression and breastfeeding.
Breastfeed. Rev. 14: 17-19 (2006).
-
Barnacle AM, Aylwin AC, Jackson JE. Angiographic diagnosis of inflammatory bowel disease in patients presenting with gastrointestinal bleeding.
AJR Am. J. Roentgenol. 187: 976-985 (2006).
*
-
Barnes KC, Grant A, Gao P, Baltadjieva D, Berg T, Chi P, Zhang S, Zambelli-Weiner A, Ehrlich E, Zardkoohi O, Brummet ME, Stockton M, Watkins T, Gao L, Gittens M, Wills-Karp M, Cheadle C, Beck LA, Beaty TH, Becker KG, Garcia JG, Mathias RA. Polymorphisms in the novel gene acyloxyacyl hydroxylase (AOAH) are associated with asthma and associated phenotypes.
J. Allergy Clin. Immunol. 118: 70-77 (2006).
*
-
Barnes KC, Grant AV, Baltadzhieva D, Zhang S, Berg T, Shao L, Zambelli-Weiner A, Anderson W, Nelsen A, Pillai S, Yarnall DP, Dienger K, Ingersoll RG, Scott AF, Fallin MD, Mathias RA, Beaty TH, Garcia JG, Wills-Karp M. Variants in the gene encoding C3 are associated with asthma and related phenotypes among African Caribbean families.
Genes Immun. 7: 27-35 (2006).
*
-
Barnes MP. Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain.
Expert Opin. Pharmacother. 7: 607-615 (2006).
-
Barnes PJ. How corticosteroids control inflammation: Quintiles Prize Lecture 2005.
Br. J. Pharmacol. 148: 245-254 (2006).
*
-
Barnes PJ. Corticosteroid effects on cell signalling.
Eur. Respir. J. 27: 413-426 (2006).
*
-
Barnes PJ. Receptor heterodimerization: a new level of cross-talk.
J. Clin. Invest. 116: 1210-1212 (2006).
*
-
Barnetche T, Constantin A, Gourraud PA, Abbal M, Garnier JG, Cantagrel A, Cambon-Thomsen A. Microsatellite typing of the human leucocyte antigen region: analytical approach and contribution to rheumatoid arthritis immunogenetic studies.
Tissue Antigens 68: 390-398 (2006).
*
-
Barnetson RA, Tenesa A, Farrington SM, Nicholl ID, Cetnarskyj R, Porteous ME, Campbell H, Dunlop MG. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer.
N. Engl. J. Med. 354: 2751-2763 (2006).
*
-
Barnett MH, Sutton I. The pathology of multiple sclerosis: a paradigm shift.
Curr. Opin. Neurol. 19: 242-247 (2006).
-
Barnstein BO, Li G, Wang Z, Kennedy S, Chalfant C, Nakajima H, Bunting KD, Ryan JJ. Stat5 expression is required for IgE-mediated mast cell function.
J. Immunol. 177: 3421-3426 (2006).
*
-
Baron JA, Sandler RS, Bresalier RS, Quan H, Riddell R, Lanas A, Bolognese JA, Oxenius B, Horgan K, Loftus S, Morton DG. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.
Gastroenterology 131: 1674-1682 (2006).
*
-
Baron TH, Petersen BT, Mergener K, Chak A, Cohen J, Deal SE, Hoffinan B, Jacobson BC, Petrini JL, Safdi MA, Faigel DO, Pike IM; ASGE/ACG Taskforce on Quality in Endoscopy. Quality indicators for endoscopic retrograde cholangiopancreatography.
Am. J. Gastroenterol. 101: 892-897 (2006).
*
-
Baroni A, Orlando M, Donnarumma G, Farro P, Iovene MR, Tufano MA, Buommino E. Toll-like receptor 2 (TLR2) mediates intracellular signalling in human keratinocytes in response to Malassezia furfur.
Arch. Dermatol. Res. 297: 280-288 (2006).
*
-
Baroni SS, Santillo M, Bevilacqua F, Luchetti M, Spadoni T, Mancini M, Fraticelli P, Sambo P, Funaro A, Kazlauskas A, Avvedimento EV, Gabrielli A. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis.
N. Engl. J. Med. 354: 2667-2676 (2006).
*
-
Barquero-Romero J, Rodriguez Vazquez C. Carotenodermia in a patient with ulcerative colitis.
Gastroenterol. Hepatol. 29: 431 (2006).
-
Barr M, Mackenzie SM, Wilkinson DM, Holloway CD, Friel EC, Miller S, Macdonald T, Fraser R, Connell JM, Davies E. Functional effects of genetic variants in the 11beta-hydroxylase (CYP11B1) gene.
Clin. Endocrinol. (Oxf.) 65: 816-825 (2006).
*
-
Barr ML, Belghiti J, Villamil FG, Pomfret EA, Sutherland DS, Gruessner RW, Langnas AN, Delmonico FL. A report of the Vancouver forum on the care of the live organ donor: lung, liver, pancreas, and intestine data and medical guidelines.
Transplantation 81: 1373-1385 (2006).
-
Barral AM, Thomas HE, Ling EM, Darwiche R, Rodrigo E, Christen U, Ejrnaes M, Wolfe T, Kay TW, von Herrath MG. SOCS-1 protects from virally-induced CD8 T cell mediated type 1 diabetes.
J. Autoimmun. 27: 166-173 (2006).
-
Barreales M, Perez-Carreras M, Meizoso T, Garrido M, Masedo A, Colina F, Solis JA. Epstein-Barr virus infection and cholestatic hepatitis.
An. Med. Interna. 23: 483-486 (2006).
-
Barrie A, Plevy S. Treatment of immune-mediated extraintestinal manifestations of inflammatory bowel disease with infliximab.
Gastroenterol. Clin. North Am. 35: 883-893 (2006).
-
Barrier M, Lacroix-Lamande S, Mancassola R, Auray G, Bernardet N, Chausse AM, Uematsu S, Akira S, Laurent F. Oral and intraperitoneal administration of phosphorothioate oligodeoxynucleotides leads to control of Cryptosporidium parvum infection in neonatal mice.
J. Infect. Dis. 193: 1400-1407 (2006).
*
-
Barros SS, Soares MP, Gimeno EJ. Macrophages and giant cell proliferation associated with bone protein synthesis and calcification in the trachea and bronchi of rabbits intoxicated with Solanum glaucophyllum.
Vet. Pathol. 43: 494-499 (2006).
*
-
Barroso I, Luan J, Sandhu MS, Franks PW, Crowley V, Schafer AJ, O'Rahilly S, Wareham NJ. Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes.
Diabetologia 49: 501-505 (2006).
*
-
Barroso S, Rieubland C, Josealvarez A, Lopez-Trascasa M, Bart PA, Nunez-Roldan A, Sanchez B. Molecular defects of the C7 gene in two patients with complement C7 deficiency.
Immunology 118: 257-260 (2006).
*
-
Barrows BR, Parks EJ. Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states.
J. Clin. Endocrinol. Metab. 91: 1446-1452 (2006).
*
-
Barshes NR, Lee TR, Goss JA, Goodpastor SE, Huls MH, Rooney CM, Karpen SJ, Wyllie S. Slc11a1 (formerly Nramp1) polymorphisms and susceptibility to post-transplant lymphoproliferative disease following pediatric liver transplantation.
Transpl. Infect. Dis. 8: 108-112 (2006).
*
-
Barta SK, Yahalom J, Shia J, Hamlin PA. Idiopathic cholestasis as a paraneoplastic phenomenon in Hodgkin's lymphoma.
Clin. Lymphoma Myeloma 7: 77-82 (2006).
-
Barta Z, Toth L, Zeher M. Pulse cyclophosphamide therapy for inflammatory bowel disease.
World J. Gastroenterol. 12: 1278-1280 (2006).
*
-
Bartee E, McCormack A, Fruh K. Quantitative membrane proteomics reveals new cellular targets of viral immune modulators.
PLoS Pathog. 2: e107 (2006).
*
-
Bartek J, Lukas J. The stress of finding NEMO.
Science 311: 1110-1111 (2006).
*
-
Barter P. Managing diabetic dyslipidaemia-beyond LDL-C:HDL-C and triglycerides.
Atheroscler. Suppl. 7: 17-21 (2006).
-
Barter PJ, Rye KA. Cardioprotective properties of fibrates: which fibrate, which patients, what mechanism?
Circulation 113: 1553-1555 (2006).
*
-
Barth A, Braun J, Muller D. Influence of verapamil and cyclosporin A on bile acid metabolism and transport in rat liver slices.
Exp. Toxicol. Pathol. 58: 31-37 (2006).
*
-
Barth A, Braun J, Muller D. Bile acid transport and metabolism in rat liver slices.
Exp. Toxicol. Pathol. 57: 313-319 (2006).
-
Barthet M, Lesavre N, Desplats S, Panuel M, Gasmi M, Bernard JP, Dagorn JC, Grimaud JC. Frequency and characteristics of pancreatitis in patients with inflammatory bowel disease.
Pancreatology 6: 464-471 (2006).
-
Bartholin L, Powers SE, Melhuish TA, Lasse S, Weinstein M, Wotton D. TGIF inhibits retinoid signaling.
Mol. Cell. Biol. 26: 990-1001 (2006).
*
-
Bartolini G, Orlandi M, Papi A, Ammar K, Guerra F, Ferreri AM, Rocchi P. A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells.
In Vivo 20: 729-733 (2006).
-
Barton BE. STAT3: a potential therapeutic target in dendritic cells for the induction of transplant tolerance.
Expert Opin. Ther. Targets 10: 459-470 (2006).
-
Barton GM, Kagan JC, Medzhitov R. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA.
Nat. Immunol. 7: 49-56 (2006).
*
-
Bartosik-Psujek H, Stelmasiak Z. Multiple sclerosis - difficult answers to easy questions.
Neurol. Neurochir. Pol. 40: 441-445 (2006).
-
Bartram SA, Peaston RT, Rawlings DJ, Walshaw D, Francis RM, Thompson NP. Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn's disease.
World J. Gastroenterol. 12: 5680-5686 (2006).
*
-
Bartsch H, Nair J. Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair.
Langenbecks Arch. Surg. 391: 499-510 (2006).
*
-
Bartsch O, Rasi S, Delicado A, Dyack S, Neumann LM, Seemanova E, Volleth M, Haaf T, Kalscheuer VM. Evidence for a new contiguous gene syndrome, the chromosome 16p13.3 deletion syndrome alias severe Rubinstein-Taybi syndrome.
Hum. Genet. 120: 179-186 (2006).
*
-
Bartsocas CS, Gerasimidi-Vazeou A. Genetics of type 1 diabetes mellitus.
Pediatr. Endocrinol. Rev. 3 Suppl. 3: 508-513 (2006).
-
Bartt RE. Multiple sclerosis, natalizumab therapy, and progressive multifocal leukoencephalopathy.
Curr. Opin. Neurol. 19: 341-349 (2006).
-
Bartynski WS, Boardman JF, Zeigler ZR, Shadduck RK, Lister J. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock.
AJNR Am. J. Neuroradiol. 27: 2179-2190 (2006).
*
-
Bartz H, Avalos NM, Baetz A, Heeg K, Dalpke AH. Involvement of suppressors of cytokine signaling in Toll-like receptor-mediated block of dendritic cell differentiation.
Blood 108: 4102-4108 (2006).
*
-
Baruah P, Dumitriu IE, Peri G, Russo V, Mantovani A, Manfredi AA, Rovere-Querini P. The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells.
J. Leukoc. Biol. 80: 87-95 (2006).
*
-
Barve S, Joshi-Barve S, Song Z, Hill D, Hote P, Deaciuc I, McClain C. Interactions of cytokines, S-adenosylmethionine, and S-adenosylhomocysteine in alcohol-induced liver disease and immune suppression.
J. Gastroenterol. Hepatol. 21 Suppl. 3: S38-S42 (2006).
*
-
Basaranoglu M. Symptom date is better than the endoscopic diagnosis date in seasonal variation studies in IBD.
Am. J. Gastroenterol. 101: 2668-2669 (2006).
*
-
Basavaraju KP, Hale RJ, Ahluwalia NK. An unusual cause of rectal bleeding.
Gut 55: 1402 (2006).
*
-
Bascones-Ilundain C, Gonzalez-Moles MA, Esparza-Gomez G, Gil-Montoya JA, Bascones-Martinez A. Importance of apoptotic mechanisms in inflammatory infiltrate of oral lichen planus lesions.
Anticancer Res. 26: 357-362 (2006).
-
Baselga J. Targeting tyrosine kinases in cancer: the second wave.
Science 312: 1175-1178 (2006).
*
-
Bashirova AA, Martin MP, McVicar DW, Carrington M. The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense.
Annu. Rev. Genomics Hum. Genet. 7: 277-300 (2006).
*
-
Basic S, Hajnsek S, Poljakovic Z, Basic M. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.
Epilepsia 47: 449 (2006).
*
-
Basile G, Chiarenza S, Di Mari P, Leanza S, Boscarelli G, Buffone A. Crohn's disease in the elderly.
Ann. Ital. Chir. 77: 247-251 (2006).
-
Basile LA, Taylor SN, Wagner CL, Horst RL, Hollis BW. The effect of high-dose vitamin D supplementation on serum vitamin D levels and milk calcium concentration in lactating women and their infants.
Breastfeed. Med. 1: 27-35 (2006).
-
Basili G, Lorenzetti L, Celona G, Biondi G, Preziuso E, Angrisano C, Goletti O, Belcari C, Venturini G. Gallstone ileus in patient with Crohn's disease: report of a clinical observation.
Surg. Endosc. 20: 703-704 (2006).
-
Basiratnia M, Vasei M, Bahador A, Ebrahimi E, Derakhshan A. Acute acalculous cholecystitis in a child with systemic lupus erythematosus.
Pediatr. Nephrol. 21: 873-876 (2006).
*
-
Baskin-Bey ES, Huang W, Ishimura N, Isomoto H, Bronk SF, Braley K, Craig RW, Moore DD, Gores GJ. Constitutive androstane receptor (CAR) ligand, TCPOBOP, attenuates Fas-induced murine liver injury by altering Bcl-2 proteins.
Hepatology 44: 252-262 (2006).
*
-
Baskin-Bey ES, Moreno Luna LE, Gores GJ. Diagnosis of cholangiocarcinoma in patients with PSC: a sight on cytology.
J. Hepatol. 45: 476-479 (2006).
*
-
Basler T, Jeckstadt S, Valentin-Weigand P, Goethe R. Mycobacterium paratuberculosis, Mycobacterium smegmatis, and lipopolysaccharide induce different transcriptional and post-transcriptional regulation of the IRG1 gene in murine macrophages.
J. Leukoc. Biol. 79: 628-638 (2006).
*
-
Bassaganya-Riera J, Hontecillas R. CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD.
Clin. Nutr. 25: 454-465 (2006).
-
Basso D, Guariso G, Fasolo M, Pittoni M, Schiavon S, Fogar P, Greco E, Navaglia F, Zambon CF, Plebani M. A new indirect chemiluminescent immunoassay to measure anti-tissue transglutaminase antibodies.
J. Pediatr. Gastroenterol. Nutr. 43: 613-618 (2006).
*
-
Basso D, Guariso G, Fogar P, Navaglia F, Zambon CF, Plebani M. Insights in the laboratory diagnosis of celiac disease.
Lupus 15: 462-465 (2006).
*
-
Bassotti G, Villanacci V, Mazzocchi A, Castellani D, Giuliano V, Corsi S, Morelli A. Colonic propulsive and postprandial motor activity in patients with ulcerative colitis in remission.
Eur. J. Gastroenterol. Hepatol. 18: 507-510 (2006).
-
Basu A, Devaraj S, Jialal I. Dietary factors that promote or retard inflammation.
Arterioscler. Thromb. Vasc. Biol. 26: 995-1001 (2006).
*
-
Basu A, Yang K, Wang M, Liu S, Chintala R, Palm T, Zhao H, Peng P, Wu D, Zhang Z, Hua J, Hsieh MC, Zhou J, Petti G, Li X, Janjua A, Mendez M, Liu J, Longley C, Zhang Z, Mehlig M, Borowski V, Viswanathan M, Filpula D. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
Bioconjug. Chem. 17: 618-630 (2006).
*
-
Bataller R. Time to ban smoking in patients with chronic liver diseases.
Hepatology 44: 1394-1396 (2006).
*
-
Bates IR, Hebert B, Luo Y, Liao J, Bachir AI, Kolin DL, Wiseman PW, Hanrahan JW. Membrane lateral diffusion and capture of CFTR within transient confinement zones.
Biophys. J. 91: 1046-1058 (2006).
*
-
Bates JM, Mittge E, Kuhlman J, Baden KN, Cheesman SE, Guillemin K. Distinct signals from the microbiota promote different aspects of zebrafish gut differentiation.
Dev. Biol. 297: 374-386 (2006).
*
-
Bathon JM, Fleischmann RM, Van der Heijde D, Tesser JR, Peloso PM, Chon Y, White B. Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis.
J. Rheumatol. 33: 234-243 (2006).
-
Bathum L, Hansen H, Teisner B, Koch C, Garred P, Rasmussen K, Wang P. Association between combined properdin and mannose-binding lectin deficiency and infection with Neisseria meningitidis.
Mol. Immunol. 43: 473-479 (2006).
*
-
Batrakova EV, Kelly DL, Li S, Li Y, Yang Z, Xiao L, Alakhova DY, Sherman S, Alakhov VY, Kabanov AV. Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: pluronic P85.
Mol. Pharm. 3: 113-123 (2006).
*
-
Battaglia M, Stabilini A, Migliavacca B, Horejs-Hoeck J, Kaupper T, Roncarolo MG. Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients.
J. Immunol. 177: 8338-8347 (2006).
*
-
Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, Lucas S, Lee J, de Sauvage FJ, Ghilardi N. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells.
Nat. Immunol. 7: 929-936 (2006).
*
-
Battista N, Fezza F, Finazzi-Agro A, Maccarrone M. The endocannabinoid system in neurodegeneration.
Ital. J. Biochem. 55: 283-289 (2006).
-
Battistelli S, Vittoria A, Stefanoni M, Bing C, Roviello F. Total plasma homocysteine and methylenetetrahydrofolate reductase C677T polymorphism in patients with colorectal carcinoma.
World J. Gastroenterol. 12: 6128-6132 (2006).
*
-
Battle MA, Konopka G, Parviz F, Gaggl AL, Yang C, Sladek FM, Duncan SA. Hepatocyte nuclear factor 4alpha orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver.
Proc. Natl. Acad. Sci. U.S.A. 103: 8419-8424 (2006).
*
-
Bauch A, Superti-Furga G. Charting protein complexes, signaling pathways, and networks in the immune system.
Immunol. Rev. 210: 187-207 (2006).
*
-
Baudino L, Azeredo da Silveira S, Nakata M, Izui S. Molecular and cellular basis for pathogenicity of autoantibodies: lessons from murine monoclonal autoantibodies.
Springer Semin. Immunopathol. 28: 175-184 (2006).
*
-
Bauer AW. Possibilities and limits of retrospective diagnoses. Pathobiografical notes on Wolfgang Amadeus Mozart's diseases (1756-1791).
Wurzbg. Medizinhist. Mitt. 25: 153-173 (2006).
-
Bauer B, Yang X, Hartz AM, Olson ER, Zhao R, Kalvass JC, Pollack GM, Miller DS. In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein upregulation.
Mol. Pharmacol. 70: 1212-1219 (2006).
*
-
Bauer E, Williams BA, Smidt H, Verstegen MW, Mosenthin R. Influence of the gastrointestinal microbiota on development of the immune system in young animals.
Curr. Issues Intest. Microbiol. 7: 35-51 (2006).
-
Bauer JW, Baechler EC, Petri M, Batliwalla FM, Crawford D, Ortmann WA, Espe KJ, Li W, Patel DD, Gregersen PK, Behrens TW. Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus.
PLoS Med. 3: e491 (2006).
*
-
Bauer S, Jendro MC, Wadle A, Kleber S, Stenner F, Dinser R, Reich A, Faccin E, Goedde S, Dinges H, Mueller-Ladner U, Renner C. Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes.
Arthritis Res. Ther. 8: R171 (2006).
*
-
Bauerfeind P, Beglinger C, Beltinger J, Braegger C, Eigenmann F, Fried M, Guyot J, Hurlimann R, Michetti P, Seibold F, Straumann A. Infliximab - practical guidelines for the treatment of Crohn's disease.
Rev. Med. Suisse. 2: 1807-1815 (2006).
-
Bauerova K, Ponist S, Ondrejickova O, Komendova D, Mihalova D. Association between tissue gamma-glutamyl-transferase and clinical markers of adjuvant arthritis in Lewis rats.
Neuro. Endocrinol. Lett. 27: S172-S175 (2006).
-
Baughman RP, Drent M, Kavuru M, Judson MA, Costabel U, du Bois R, Albera C, Brutsche M, Davis G, Donohue JF, Muller-Quernheim J, Schlenker-Herceg R, Flavin S, Lo KH, Oemar B, Barnathan ES. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.
Am. J. Respir. Crit. Care Med. 174: 795-802 (2006).
*
-
Baumgart DC, Pintoffl JP, Sturm A, Wiedenmann B, Dignass AU. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease - a long-term follow-up.
Am. J. Gastroenterol. 101: 1048-1056 (2006).
*
-
Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, et al. Resveratrol improves health and survival of mice on a high-calorie diet.
Nature 444: 337-342 (2006).
*
-
Baussano I, Tardivo I, Bellezza-Fontana R, Forneris MP, Lezo A, Anfossi L, Castello M, Aleksandar V, Bignamini E. Neonatal screening for cystic fibrosis does not affect time to first infection with Pseudomonas aeruginosa.
Pediatrics 118: 888-895 (2006).
*
-
Baxter JD, Webb P. Metabolism: bile acids heat things up.
Nature 439: 402-403 (2006).
*
-
Bayary J, Dasgupta S, Misra N, Ephrem A, Duong Van Huyen JP, Delignat S, Hassan G, Caligiuri G, Nicoletti A, Lacroix-Desmazes S, Kazatchkine MD, Kaveri S. Intravenous immunoglobulin in autoimmune disorders: an insight into the immunoregulatory mechanisms.
Int. Immunopharmacol. 6: 528-534 (2006).
-
Bayazit YA. Genetics of headache and catechol-O-methyltransferase gene polymorphism.
J. Headache Pain 7: 60 (2006).
*
-
Bayazit YA, Yilmaz M. An overview of hereditary hearing loss.
ORL J. Otorhinolaryngol. Relat. Spec. 68: 57-63 (2006).
-
Bayoumi RA, Simsek M, Yahya TM, Bendict S, Al-Hinai A, Al-Barwani H, Hassan MO. Insertion-deletion polymorphism in the angiotensin-converting enzyme (ACE) gene among Sudanese, Somalis, Emiratis, and Omanis.
Hum. Biol. 78: 103-108 (2006).
-
Bays H. Clinical overview of omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids.
Am. J. Cardiol. 98: S71-S76 (2006).
*
-
Bazan NG. Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors.
Trends Neurosci. 29: 263-271 (2006).
*
-
Bazarah SM, Ritenour R, Patel ST, Hirsch G, Peltekian KM, Cruess AF. Choroidal neovascularization with interferon associated retinopathy: case report and review of literature.
Ann. Hepatol. 5: 172-176 (2006).
*
-
Bazin R, Lemieux R, Tremblay T. Reversal of immune thrombocytopenia in mice by cross-linking human immunoglobulin G with a high-affinity monoclonal antibody.
Br. J. Haematol. 135: 97-100 (2006).
*
-
Bazzigaluppi E, Roggero P, Parma B, Brambillasca MF, Meroni F, Mora S, Bosi E, Barera G. Antibodies to recombinant human tissue-transglutaminase in coeliac disease: diagnostic effectiveness and decline pattern after gluten-free diet.
Dig. Liver Dis. 38: 98-102 (2006).
-
Bdioui F, Sakly N, Hassine M, Saffar H. Prevalence of celiac disease in Tunisian blood donors.
Gastroenterol. Clin. Biol. 30: 33-36 (2006).
*
-
Beadling C, Slifka MK. Regulation of innate and adaptive immune responses by the related cytokines IL-12, IL-23, and IL-27.
Arch. Immunol. Ther. Exp. (Warsz.) 54: 15-24 (2006).
-
Beasley RP. Diabetes and hepatocellular carcinoma.
Hepatology 44: 1408-1410 (2006).
*
-
Beattie RM. The changing face of coeliac disease.
Arch. Dis. Child. 91: 955-956 (2006).
*
-
Beattie RM, Croft NM, Fell JM, Afzal NA, Heuschkel RB. Inflammatory bowel disease.
Arch. Dis. Child. 91: 426-432 (2006).
*
-
Beaudette-Zlatanova BC, Ling T, Shlomchik MJ, Marshak-Rothstein A, Rifkin IR. B cells and dendritic cells from Vkappa8 light chain transgenic mice activate MRL-lpr/gld CD4+ T cells.
J. Immunol. 177: 45-52 (2006).
*
-
Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J. Predictors of disabling Crohn’s disease.
Gastroenterology 130: 650-656 (2006).
*
-
Beaven SW, Tontonoz P. Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia.
Annu. Rev. Med. 57: 313-329 (2006).
*
-
Bebb JR, Lawson A, Knight T, Long RG. Long-term follow-up of coeliac disease - what do coeliac patients want?
Aliment. Pharmacol. Ther. 23: 827-831 (2006).
*
-
Becanovic K, Jagodic M, Sheng JR, Dahlman I, Aboul-Enein F, Wallstrom E, Olofsson P, Holmdahl R, Lassmann H, Olsson T. Advanced intercross line mapping of Eae5 reveals Ncf-1 and CLDN4 as candidate genes for experimental autoimmune encephalomyelitis.
J. Immunol. 176: 6055-6064 (2006).
*
-
Bechade D, Desrame J, Sallansonnet-Froment M, Taillia H, Algayres JP. Cerebral venous thrombosis and ulcerative colitis.
Rev. Med. Interne. 27: 958-961 (2006).
-
Becher B, Bechmann I, Greter M. Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain.
J. Mol. Med. 84: 532-543 (2006).
*
-
Beck KE, Blansfield JA, Tran KQ, Feldman AL, Hughes MS, Royal RE, Kammula US, Topalian SL, Sherry RM, Kleiner D, Quezado M, Lowy I, Yellin M, Rosenberg SA, Yang JC. Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4.
J. Clin. Oncol. 24: 2283-2289 (2006).
*
-
Becker C, Dornhoff H, Neufert C, Fantini MC, Wirtz S, Huebner S, Nikolaev A, Lehr HA, Murphy AJ, Valenzuela DM, Yancopoulos GD, Galle PR, Karow M, Neurath MF. Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis.
J. Immunol. 177: 2760-2764 (2006).
*
-
Becker H, Gaubitz M, Domschke W, Kucharzik T. Joint involvement in chronic inflammatory bowel disease - current diagnostics and treatment options.
Z. Gastroenterol. 44: 497-502 (2006).
-
Becker H, Maaser C, Mickholz E, Dyong A, Domschke W, Gaubitz M. Relationship between serum levels of macrophage migration inhibitory factor and the activity of antineutrophil cytoplasmic antibody-associated vasculitides.
Clin. Rheumatol. 25: 368-372 (2006).
*
-
Becker J, Delayre-Orthez C, Frossard N, Pons F. Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?
Fundam. Clin. Pharmacol. 20: 429-447 (2006).
*
-
Becker JM, Prushik SG, Stucchi AF. Infliximab for ulcerative colitis.
N. Engl. J. Med. 354: 1424-1426 (2006).
*
-
Becker M, Cotena A, Gordon S, Platt N. Expression of the class A macrophage scavenger receptor on specific subpopulations of murine dendritic cells limits their endotoxin response.
Eur. J. Immunol. 36: 950-960 (2006).
*
-
Becker Y. Molecular immunological approaches to biotherapy of human cancers - a review, hypothesis and implications.
Anticancer Res. 26: 1113-1134 (2006).
-
Becker-Merok A, Kalaaji M, Haugbro K, Nikolaisen C, Nilsen K, Rekvig OP, Nossent JC. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
Arthritis Res. Ther. 8: R162 (2006).
*
-
Becker-Merok A, Nikolaisen C, Nossent HC. B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time.
Lupus 15: 570-576 (2006).
-
Becker-Merok A, Nossent HC. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality.
J. Rheumatol. 33: 1570-1577 (2006).
-
Becq F. On the discovery and development of CFTR chloride channel activators.
Curr. Pharm. Des. 12: 471-484 (2006).
-
Becquemont L, Glaeser H, Drescher S, Hitzl M, Simon N, Murdter TE, Heinkele G, Hofmann U, Schaefer C, Burk O, Verstuyft C, Eichelbaum M, Fromm MF. Effects of ursodeoxycholic acid on P-glycoprotein and cytochrome P450 3A4-dependent pharmacokinetics in humans.
Clin. Pharmacol. Ther. 79: 449-460 (2006).
*
-
Becvar R, Stork J, Jansa P. New trends in diagnosis and treatment of systemic sclerosis.
Vnitr. Lek. 52: 712-717 (2006).
-
Beddy D, Mulsow J, Watson RW, Fitzpatrick JM, O'Connell PR. Expression and regulation of connective tissue growth factor by transforming growth factor beta and tumour necrosis factor alpha in fibroblasts isolated from strictures in patients with Crohn's disease.
Br. J. Surg. 93: 1290-1296 (2006).
*
-
Bedeir A, Jukic DM, Wang L, Mullady DK, Regueiro M, Krasinskas AM. Systemic mastocytosis mimicking inflammatory bowel disease: a case report and discussion of gastrointestinal pathology in systemic mastocytosis.
Am. J. Surg. Pathol. 30: 1478-1482 (2006).
-
Bedford PA, Todorovic V, Westcott ED, Windsor AC, English NR, Al-Hassi HO, Raju KS, Mills S, Knight SC. Adipose tissue of human omentum is a major source of dendritic cells, which lose MHC class II and stimulatory function in Crohn's disease.
J. Leukoc. Biol. 80: 546-554 (2006).
*
-
Bedir A, Aliyazicioglu Y, Kahraman H, Yurdakul Z, Uysal M, Suvaci DE, Okuyucu A, Hokelek M, Alvur M. Genotoxicity in rats treated with the antidiabetic agent, rosiglitazone.
Environ. Mol. Mutagen. 47: 718-724 (2006).
*
-
Beech JT, Andreakos E, Ciesielski CJ, Green P, Foxwell BM, Brennan FM. T cell contact-dependent regulation of CC and CXC chemokine production in monocytes through differential involvement of NF-kappaB: implications for rheumatoid arthritis.
Arthritis Res. Ther. 8: R168 (2006).
*
-
Beer TM, Myrthue A. Calcitriol in the treatment of prostate cancer.
Anticancer Res. 26: 2647-2651 (2006).
-
Beer TM, Venner PM, Ryan CW, Petrylak DP, Chatta G, Dean Ruether J, Chi KN, Curd JG, Deloughery TG. High dose calcitriol may reduce thrombosis in cancer patients.
Br. J. Haematol. 135: 392-394 (2006).
*
-
Beeton C, Wulff H, Standifer NE, Azam P, Mullen KM, Pennington MW, Kolski-Andreaco A, Wei E, Grino A, Counts DR, Wang PH, Leehealey CJ, S Andrews B, Sankaranarayanan A, Homerick D, Roeck WW, Tehranzadeh J, Stanhope KL, Zimin P, Havel PJ, Griffey S, et al. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases.
Proc. Natl. Acad. Sci. U.S.A. 103: 17414-17419 (2006).
*
-
Begg GE, Holman SR, Stokes PH, Matthews JM, Graham RM, Iismaa SE. Mutation of a critical GTP-binding arginine in transglutaminase 2 disinhibits intracellular crosslinking activity.
J. Biol. Chem. 281: 12603-12609 (2006).
*
-
Begleiter A, Hewitt D, Maksymiuk AW, Ross DA, Bird RP. A NAD(P)H:quinone oxidoreductase 1 polymorphism is a risk factor for human colon cancer.
Cancer Epidemiol. Biomarkers Prev. 15: 2422-2426 (2006).
*
-
Begue B, Dumant C, Bambou JC, Beaulieu JF, Chamaillard M, Hugot JP, Goulet O, Schmitz J, Philpott DJ, Cerf-Bensussan N, Ruemmele FM. Microbial induction of CARD15 expression in intestinal epithelial cells via Toll-like receptor 5 triggers an antibacterial response loop.
J. Cell. Physiol. 209: 241-252 (2006).
*
-
Begue B, Wajant H, Bambou JC, Dubuquoy L, Siegmund D, Beaulieu JF, Canioni D, Berrebi D, Brousse N, Desreumaux P, Schmitz J, Lentze MJ, Goulet O, Cerf-Bensussan N, Ruemmele FM. Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions.
Gastroenterology 130: 1962-1974 (2006).
*
-
Behar J, Corazziari E, Guelrud M, Hogan W, Sherman S, Toouli J. Functional disorders of gallbladder and sphincter of oddi.
Gastroenterology 130: 1498-1509 (2006).
*
-
Behera AK, Hildebrand E, Szafranski J, Hung HH, Grodzinsky AJ, Lafyatis R, Koch AE, Kalish R, Perides G, Steere AC, Hu LT. Role of aggrecanase 1 in Lyme arthritis.
Arthritis Rheum. 54: 3319-3329 (2006).
*
-
Behr MA, Schurr E. Mycobacteria in Crohn's disease: a persistent hypothesis.
Inflamm. Bowel Dis. 12: 1000-1004 (2006).
*
-
Beissert S, Cavazzana I, Mascia F, Meroni P, Pastore S, Tessari G, Girolomoni G. Mechanisms of immune-mediated skin diseases: an overview.
Clin. Exp. Rheumatol. 24: S1-S6 (2006).
-
Beissert S, Schwarz A, Schwarz T. Regulatory T cells.
J. Invest. Dermatol. 126: 15-24 (2006).
*
-
Beitz E, Wu B, Holm LM, Schultz JE, Zeuthen T. Point mutations in the aromatic/arginine region in aquaporin 1 allow passage of urea, glycerol, ammonia, and protons.
Proc. Natl. Acad. Sci. U.S.A. 103: 269-274 (2006).
*
-
Bel Hadj Jrad B, Mahfouth W, Bouaouina N, Gabbouj S, Ahmed SB, Ltaief M, Jalbout M, Chouchane L. A polymorphism in FAS gene promoter associated with increased risk of nasopharyngeal carcinoma and correlated with anti-nuclear autoantibodies induction.
Cancer Lett. 233: 21-27 (2006).
*
-
Belaiche J, Louis E. Diagnosis of small bowel malabsorption syndromes in adults.
Acta Gastroenterol. Belg. 69: 31-37 (2006).
-
Belakavadi M, Fondell JD. Role of the mediator complex in nuclear hormone receptor signaling.
Rev. Physiol. Biochem. Pharmacol. 156: 23-43 (2006).
-
Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, Balas B, Gastaldelli A, Tio F, Pulcini J, Berria R, Ma JZ, Dwivedi S, Havranek R, Fincke C, DeFronzo R, Bannayan GA, Schenker S, Cusi K. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.
N. Engl. J. Med. 355: 2297-2307 (2006).
*
-
Belhocine K, Chaoui F. Menetrier disease and ulcerative colitis: an unusual association.
Gastroenterol. Clin. Biol. 30: 1105-1107 (2006).
-
Belizon A, Sardinha CT, Sher ME. Converted laparoscopic colectomy: what are the consequences?
Surg. Endosc. 20: 947-951 (2006).
*
-
Belkaid Y, Blank RB, Suffia I. Natural regulatory T cells and parasites: a common quest for host homeostasis.
Immunol. Rev. 212: 287-300 (2006).
*
-
Bell AJ, Price AB, Forbes A, Ciclitira PJ, Groves C, Nicholls RJ. Pre-pouch ileitis: a disease of the ileum in ulcerative colitis after restorative proctocolectomy.
Colorectal Dis. 8: 402-410 (2006).
*
-
Bell AW, Michalopoulos GK. Phenobarbital regulates nuclear expression of HNF-4alpha in mouse and rat hepatocytes independent of CAR and PXR.
Hepatology 44: 186-194 (2006).
*
-
Bell CW, Jiang W, Reich CF 3rd, Pisetsky DS. The extracellular release of HMGB1 during apoptotic cell death.
Am. J. Physiol. Cell Physiol. 291: C1318-C1325 (2006).
*
-
Bell DA. Can we rely on anti-citrulline antibody determination for the diagnosis of early rheumatoid arthritis?
J. Rheumatol. 33: 2369-2371 (2006).
-
Bell JK, Askins J, Hall PR, Davies DR, Segal DM. The dsRNA binding site of human Toll-like receptor 3.
Proc. Natl. Acad. Sci. U.S.A. 103: 8792-8797 (2006).
*
-
Bell JK, Botos I, Hall PR, Askins J, Shiloach J, Davies DR, Segal DM. The molecular structure of the TLR3 extracellular domain.
J. Endotoxin Res. 12: 375-378 (2006).
*
-
Bellinghausen I, Konig B, Bottcher I, Knop J, Saloga J. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
Clin. Exp. Allergy 36: 1546-1555 (2006).
*
-
Bellomo-Brandao MA, Costa-Pinto EA, Tommaso AM, Hessel G. Clinical and biochemical features of autoimmune hepatitis in 36 pediatric patients.
Arq. Gastroenterol. 43: 45-49 (2006).
*
-
Belmont HM. Treatment of ANCA-associated systemic vasculitis.
Bull. Hosp. Jt. Dis. 64: 60-66 (2006).
*
-
Belo A, Marchbank T, Fitzgerald A, Ghosh S, Playford RJ. Gastroprotective effects of oral nucleotide administration.
Gut 55: 165-171 (2006).
*
-
Belousova E. Epidemiology of inflammatory bowel disease in Russia.
Falk Symposium 154: INFLAMMATORY BOWEL DISEASE - DIAGNOSTIC AND THERAPEUTIC STRATEGIES, Moscow (Russia), June 9 - 10, 2006, p. 31 (2006). *
-
Belov K, Deakin JE, Papenfuss AT, Baker ML, Melman SD, Siddle HV, Gouin N, Goode DL, Sargeant TJ, Robinson MD, Wakefield MJ, Mahony S, Cross JG, Benos PV, Samollow PB, Speed TP, Graves JA, Miller RD. Reconstructing an ancestral mammalian immune supercomplex from a marsupial major histocompatibility complex.
PLoS Biol. 4: e46 (2006).
*
-
Belpoggi F, Soffritti M, Tibaldi E, Falcioni L, Bua L, Trabucco F. Results of long-term carcinogenicity bioassays on Coca-Cola administered to Sprague-Dawley rats.
Ann. N. Y. Acad. Sci. 1076: 736-752 (2006).
*
-
Beltran B, Nos P, Bastida G, Iborra M, Hoyos M, Ponce J. Safe and effective application of anti-TNF-alpha in a patient infected with HIV and concomitant Crohn's disease.
Gut 55: 1670-1671 (2006).
*
-
Beltran S, Lescure FX, El Esper I, Schmit JL, Desailloud R. Subclinical hypothyroidism in HIV-infected patients is not an autoimmune disease.
Horm. Res. 66: 21-26 (2006).
-
Belvederesi L, Bianchi F, Loretelli C, Gagliardini D, Galizia E, Bracci R, Rosati S, Bearzi I, Viel A, Cellerino R, Porfiri E. Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features.
Eur. J. Hum. Genet. 14: 853-859 (2006).
*
-
Belvisi MG, Hele DJ, Birrell MA. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation.
Eur. J. Pharmacol. 533: 101-109 (2006).
*
-
Ben Amar M. Cannabinoids in medicine: a review of their therapeutic potential.
J. Ethnopharmacol. 105: 1-25 (2006).
*
-
Ben-Baruch A. Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators.
Semin. Cancer Biol. 16: 38-52 (2006).
*
-
Ben-David H, Aruna BV, Seger R, Sela M, Mozes E. A 50-kDa ERK-like protein is up-regulated by a dual altered peptide ligand that suppresses myasthenia gravis-associated responses.
Proc. Natl. Acad. Sci. U.S.A. 103: 18232-18237 (2006).
*
-
Ben-Horin S, Green PH, Bank I, Chess L, Goldstein I. Characterizing the circulating, gliadin-specific CD4+ memory T cells in patients with celiac disease: linkage among memory function, gut homing, and Th1 polarization.
J. Leukoc. Biol. 79: 676-685 (2006).
*
-
Ben-Hur T, van Heeswijk RB, Einstein O, Aharonowiz M, Xue R, Frost EE, Mori S, Reubinoff BE, Bulte JW. Serial in vivo MR tracking of magnetically labeled neural spheres transplanted in chronic EAE mice.
Magn. Reson. Med. 57: 164-171 (2006).
-
Ben-Nun A, de Rosbo NK, Kaushansky N, Eisenstein M, Cohen L, Kaye JF, Mendel I. Anatomy of T cell autoimmunity to myelin oligodendrocyte glycoprotein (MOG): prime role of MOG44F in selection and control of MOG-reactive T cells in H-2(b) mice.
Eur. J. Immunol. 36: 478-493 (2006).
*
-
Benais-Pont G, Dupertuis YM, Kossovsky MP, Nouet P, Allal AS, Buchegger F, Pichard C. omega-3 Polyunsaturated fatty acids and ionizing radiation: combined cytotoxicity on human colorectal adenocarcinoma cells.
Nutrition 22: 931-939 (2006).
*
-
Bendayan D, Shitrit D, Kramer MR. Pulmonary arterial hypertension associated with autoimmune disease: a single medical center experience.
Isr. Med. Assoc. J. 8: 252-254 (2006).
*
-
Bendtzen K, Geborek P, Svenson M, Larsson L, Kapetanovic MC, Saxne T. Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab.
Arthritis Rheum. 54: 3782-3789 (2006).
*
-
Bene J, Komlosi K, Havasi V, Talian G, Gasztonyi B, Horvath K, Mozsik G, Hunyad y B, Melegh B, Figler M. Changes of plasma fasting carnitine ester profile in patients with ulcerative colitis.
World J. Gastroenterol. 12: 110-113 (2006).
*
-
Bene J, Magyari L, Talian G, Komlosi K, Gasztonyi B, Tari B, Varkonyi A, Mozsik G, Melegh B. Prevalence of SLC22A4, SLC22A5 and CARD15 gene mutations in Hungarian pediatric patients with Crohn's disease.
World J. Gastroenterol. 12: 5550-5553 (2006).
*
-
Benedek TG. The history of bacteriologic concepts of rheumatic fever and rheumatoid arthritis.
Semin. Arthritis Rheum. 36: 109-123 (2006).
*
-
Benelli R, Lorusso G, Albini A, Noonan DM. Cytokines and chemokines as regulators of angiogenesis in health and disease.
Curr. Pharm. Des. 12: 3101-3115 (2006).
-
Benes Z, Koten J, Kabelkova M, Benes J. Imported cryptococcal infection mimicking primary sclerosing cholangitis.
Klin. Mikrobiol. Infekc. Lek. 12: 240-243 (2006).
-
Bengmark S. Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases.
JPEN J. Parenter. Enteral Nutr. 30: 45-51 (2006).
*
-
Bengmark S, Gil A. Bioecological and nutritional control of disease: prebiotics, probiotics and synbiotics.
Nutr. Hosp. 21 Suppl. 2: 72-84, 73-86 (2006).
-
Bengtson MB, Ronning T, Vatn M, Harris J. Irritable bowel syndrome in twins: genes and environment.
Gut 55: 1754-1759 (2006).
*
-
Benigni A, Zoja C, Tomasoni S, Campana M, Corna D, Zanchi C, Gagliardini E, Garofano E, Rottoli D, Ito T, Remuzzi G. Transcriptional regulation of nephrin gene by peroxisome proliferator-activated receptor-gamma agonist: molecular mechanism of the antiproteinuric effect of pioglitazone.
J. Am. Soc. Nephrol. 17: 1624-1632 (2006).
*
-
Benito Conejero S, Diaz Espejo C, Lopez Dominguez JM, Pujol de la Llave E. Cerebral calcifications: a clue for a diagnostic process in a inespecific clinical case.
An. Med. Interna. 23: 127-129 (2006).
-
Benito P, Caballero J, Moreno J, Gutierrez-Alcantara C, Munoz C, Rojo G, Garcia S, Soriguer FC. Effects of milk enriched with omega-3 fatty acid, oleic acid and folic acid in patients with metabolic syndrome.
Clin. Nutr. 25: 581-587 (2006).
-
Bennett DJ, Cooke AJ, Edwards AS. Non-steroidal LXR agonists; an emerging therapeutic strategy for the treatment of atherosclerosis.
Recent Patents Cardiovasc. Drug Discov. 1: 21-46 (2006).
-
Bennett JL. Natalizumab and progressive multifocal leukoencephalopathy: migrating towards safe adhesion molecule therapy in multiple sclerosis.
Neurol. Res. 28: 291-298 (2006).
-
Bennouna S, Sukhumavasi W, Denkers EY. Toxoplasma gondii inhibits Toll-like receptor 4 ligand-induced mobilization of intracellular tumor necrosis factor alpha to the surface of mouse peritoneal neutrophils.
Infect. Immun. 74: 4274-4281 (2006).
*
-
Benoist C, Germain RN, Mathis D. A plaidoyer for 'systems immunology'.
Immunol. Rev. 210: 229-234 (2006).
*
-
Benoit G, Cooney A, Giguere V, Ingraham H, Lazar M, Muscat G, Perlmann T, Renaud JP, Schwabe J, Sladek F, Tsai MJ, Laudet V. International Union of Pharmacology. LXVI. Orphan nuclear receptors.
Pharmacol. Rev. 58: 798-836 (2006).
*
-
Benson JD, Chen YN, Cornell-Kennon SA, Dorsch M, Kim S, Leszczyniecka M, Sellers WR, Lengauer C. Validating cancer drug targets.
Nature 441: 451-456 (2006).
*
-
Benson M, Carlsson L, Guillot G, Jernas M, Langston MA, Rudemo M, Andersson B. A network-based analysis of allergen-challenged CD4+ T cells from patients with allergic rhinitis.
Genes Immun. 7: 514-521 (2006).
*
-
Bensoussan M, Jovenin N, Garcia B, Vandromme L, Jolly D, Bouche O, Thiefin G, Cadiot G. Complementary and alternative medicine use by patients with inflammatory bowel disease.
Gastroenterol. Clin. Biol. 30: 14-23 (2006).
*
-
Benucci M, Turchini S, Parrochi P, Boccaccini P, Manetti R, Cammelli E, Manfredi M. Correlation between different clinical activity and anti CC-P (anti-cyclic citrullinated peptide antibodies) titres in rheumatoid arthritis treated with three different tumor necrosis factors TNF-alpha blockers.
Recenti Prog. Med. 97: 134-139 (2006).
-
Benvenga S, Santarpia L, Trimarchi F, Guarneri F. Human thyroid autoantigens and proteins of Yersinia and Borrelia share amino acid sequence homology that includes binding motifs to HLA-DR molecules and T-cell receptor.
Thyroid 16: 225-236 (2006).
-
Berahovich RD, Lai NL, Wei Z, Lanier LL, Schall TJ. Evidence for NK cell subsets based on chemokine receptor expression.
J. Immunol. 177: 7833-7840 (2006).
*
-
Bercion R, Demartin M, Recio C, Massamba PM, Frank T, Escriba JM, Grimont F, Grimont PA, Weill FX. Molecular epidemiology of multidrug-resistant Shigella dysenteriae type 1 causing dysentery outbreaks in Central African Republic, 2003-2004.
Trans. R. Soc. Trop. Med. Hyg. 100: 1151-1158 (2006).
-
Berdeli A, Gurkan A, Emingil G, Atilla G, Kose T. Endothelial nitric oxide synthase Glu298Asp gene polymorphism in periodontal diseases.
J. Periodontol. 77: 1348-1354 (2006).
-
Berdeli A, Ozyurek AR, Ulger Z, Gurses D, Levent E, Salar K, Gurpinar AR. Association of macrophage migration inhibitory factor gene -173 G/C polymorphism with prognosis in Turkish children with juvenile rheumatoid arthritis.
Rheumatol. Int. 26: 726-731 (2006).
*
-
Berdeli A, Tabel Y, Celik HA, Ozyurek R, Dogrusoz B, Aydin HH. Lack of association between TNFalpha gene polymorphism at position -308 and risk of acute rheumatic fever in Turkish patients.
Scand. J. Rheumatol. 35: 44-47 (2006).
*
-
Berdiev BK, Benos DJ. Epithelial sodium channel in planar lipid bilayers.
Methods Mol. Biol. 337: 89-99 (2006).
-
Bereket A. Vitamin D receptor polymorphism in nutritional rickets.
Pediatr. Endocrinol. Rev. 3 Suppl. 3: 476-479 (2006).
-
Berends MA, Snoek J, DE Jong EM, VAN DE Kerkhof PC, VAN Oijen MG, VAN Krieken JH, Drenth JP. Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent.
Aliment. Pharmacol. Ther. 24: 805-811 (2006).
*
-
Berentsen S, Ulvestad E, Langholm R, Beiske K, Hjorth-Hansen H, Ghanima W, Sorbo JH, Tjonnfjord GE. Primary chronic cold agglutinin disease: a population based clinical study of 86 patients.
Haematologica 91: 460-466 (2006).
*
-
Beresford MW, Davidson JE. Adolescent development and SLE.
Best Pract. Res. Clin. Rheumatol. 20: 353-368 (2006).
-
Berg CP, Stein GM, Klein R, Pascu M, Berg T, Kammer W, Priemer M, Nordheim A, Schulze-Osthoff K, Gregor M, Wesselborg S, Berg PA. Demonstration of PDC-E1 subunits as major antigens in the complement-fixing fraction M4 and re-evaluation of PDC-E1-specific antibodies in PBC patients.
Liver Int. 26: 846-855 (2006).
*
-
Berg DT, Gerlitz B, Sharma GR, Richardson MA, Stephens EJ, Grubbs RL, Holmes KC, Fynboe K, Montani D, Cramer MS, Engle SD, Jakubowski JA, Heuer JG, Grinnell BW. FoxA2 involvement in suppression of protein C, an outcome predictor in experimental sepsis.
Clin. Vaccine Immunol. 13: 426-432 (2006).
*
-
Bergamaschi R, Montomoli C, Candeloro E, Monti MC, Cioccale R, Bernardinelli L, Fratino P, Cosi V; the PREMS (Pavia REgister of Multiple Sclerosis) Group. Bayesian mapping of multiple sclerosis prevalence in the province of Pavia, northern Italy.
J. Neurol. Sci. 244: 127-131 (2006).
*
-
Bergamo P, Luongo D, Maurano F, Mazzarella G, Stefanile R, Rossi M. Conjugated linoleic acid enhances glutathione synthesis and attenuates pathological signs in MRL/lpr mice.
J. Lipid Res. 47: 2382-2391 (2006).
*
-
Bergasa NV, McGee M, Ginsburg IH, Engler D. Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial.
Hepatology 44: 1317-1323 (2006).
*
-
Berger A, Roberts MA, Hoff B. How dietary arachidonic- and docosahexaenoic- acid rich oils differentially affect the murine hepatic transcriptome.
Lipids Health Dis. 5: 10 (2006).
*
-
Berger BM, Schroy PC 3rd, Rosenberg JL, Lai-Goldman M, Eisenberg M, Brown T, Rochelle RB, Billings PR. Colorectal cancer screening using stool DNA analysis in clinical practice: early clinical experience with respect to patient acceptance and colonoscopic follow-up of abnormal tests.
Clin. Colorectal Cancer 5: 338-343 (2006).
-
Berger CL, Vasquez JG, Shofner J, Mariwalla K, Edelson RL. Langerhans cells: mediators of immunity and tolerance.
Int. J. Biochem. Cell Biol. 38: 1632-1636 (2006).
*
-
Berger JR. Natalizumab.
Drugs Today (Barc.) 42: 639-655 (2006).
-
Berger S, Hinz D, Bannantine JP, Griffin JF. Isolation of high-affinity single-chain antibodies against Mycobacterium avium subsp. paratuberculosis surface proteins from sheep with Johne's disease.
Clin. Vaccine Immunol. 13: 1022-1029 (2006).
*
-
Berger T, Reindl M. Biomarkers in multiple sclerosis: role of antibodies.
Dis. Markers 22: 207-212 (2006).
-
Bergeron R, Yao J, Woods JW, Zycband EI, Liu C, Li Z, Adams A, Berger JP, Zhang BB, Moller DE, Doebber TW. Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in ZDF rats: a comparison to PPARgamma agonism.
Endocrinology 147: 4252-4262 (2006).
*
-
Bergheim I, Guo L, Davis MA, Duveau I, Arteel GE. Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis.
J. Pharmacol. Exp. Ther. 316: 592-600 (2006).
*
-
Bergheim I, Harsch S, Mueller O, Schimmel S, Fritz P, Stange EF. Apical sodium bile acid transporter and ileal lipid binding protein in gallstone carriers.
J. Lipid Res. 47: 42-50 (2006).
*
-
Berghofer B, Frommer T, Haley G, Fink L, Bein G, Hackstein H. TLR7 ligands induce higher IFN-alpha production in females.
J. Immunol. 177: 2088-2096 (2006).
*
-
Berglund LJ, Jones GJ, Murali R, Fulcher DA. TACI mutation with invasive polyclonal CD8+ T-cell lymphoproliferation in a patient with common variable immunodeficiency.
J. Allergy Clin. Immunol. 117: 870-877 (2006).
*
-
Bergman E, Forsell P, Tevell A, Persson EM, Hedeland M, Bondesson U, Knutson L, Lennernas H. Biliary secretion of rosuvastatin and bile acids in humans during the absorption phase.
Eur. J. Pharm. Sci. 29: 205-214 (2006).
*
-
Bergman R, Parkes M. Systematic review: the use of mesalazine in inflammatory bowel disease.
Aliment. Pharmacol. Ther. 23: 841-855 (2006).
*
-
Bergquist A, Glaumann H, Lindberg B, Broome U. Primary sclerosing cholangitis can present with acute liver failure: report of two cases.
J. Hepatol. 44: 1005-1008 (2006).
*
-
Bergquist A, Montgomery SM, Lund U, Ekbom A, Olsson R, Lindgren S, Prytz H, Hultcrantz R, Broome U. Perinatal events and the risk of developing primary sclerosing cholangitis.
World J. Gastroenterol. 12: 6037-6040 (2006).
*
-
Bergqvist D. Venous thromboembolism: a review of risk and prevention in colorectal surgery patients.
Dis. Colon Rectum 49: 1620-1628 (2006).
*
-
Bergtold A, Gavhane A, D'Agati V, Madaio M, Clynes R. FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis.
J. Immunol. 177: 7287-7295 (2006).
*
-
Berin MC, Li H, Sperber K. Antibody-mediated antigen sampling across intestinal epithelial barriers.
Ann. N. Y. Acad. Sci. 1072: 253-261 (2006).
*
-
Berin MC, Zheng Y, Domaradzki M, Li XM, Sampson HA. Role of TLR4 in allergic sensitization to food proteins in mice.
Allergy 61: 64-71 (2006).
-
Berkhout M, Friederich P, van Krieken JH, Peters WH, Nagengast FM. Low detoxification capacity in the ileal pouch mucosa of patients with ulcerative colitis.
Inflamm. Bowel Dis. 12: 112-116 (2006).
*
-
Berkovic M, Cacev T, Zjacic-Rotkvic V, Kapitanovic S. TNF-alpha promoter single nucleotide polymorphisms in gastroenteropancreatic neuroendocrine tumors.
Neuroendocrinology 84: 346-352 (2006).
-
Berkson BM, Rubin DM, Berkson AJ. The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alpha-lipoic acid/low-dose naltrexone protocol.
Integr. Cancer Ther. 5: 83-89 (2006).
-
Berkun Y, Padeh S, Barash J, Uziel Y, Harel L, Mukamel M, Revel-Vilk S, Kenet G. Antiphospholipid syndrome and recurrent thrombosis in children.
Arthritis Rheum. 55: 850-855 (2006).
*
-
Berlo SE, Guichelaar T, Ten Brink CB, van Kooten PJ, Hauet-Broeren F, Ludanyi K, van Eden W, Broeren CP, Glant TT. Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice.
Arthritis Rheum. 54: 2423-2433 (2006).
*
-
Bermejo Velasco PE, Burgos Garcia A. Neurological complications of celiac disease.
Med. Clin. (Barc.) 127: 500-507 (2006).
-
Bernal I, Domenech E, Garcia-Planella E, Marin L, Manosa M, Navarro M, Cabre E, Gassull MA. Medication-taking behavior in a cohort of patients with inflammatory bowel disease.
Dig. Dis. Sci. 51: 2165-2169 (2006).
*
-
Bernal I, Manosa M, Domenech E, Garcia-Planella E, Navarro M, Lorenzo-Zuniga V, Cabre E, Gassull MA. Predictors of clinical response to systemic steroids in active ulcerative colitis.
Dig. Dis. Sci. 51: 1434-1438 (2006).
*
-
Bernal NP, Stehr W, Coyle R, Erwin CR, Warner BW. Epidermal growth factor receptor signaling regulates Bax and Bcl-w expression and apoptotic responses during intestinal adaptation in mice.
Gastroenterology 130: 412-423 (2006).
*
-
Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, Urowitz M, Fortin PR, Petri M, Barr S, Gordon C, Bae SC, Isenberg D, Zoma A, Aranow C, Dooley MA, Nived O, Sturfelt G, Steinsson K, Alarcon G, Senecal JL, Zummer M, Hanly J, et al. Mortality in systemic lupus erythematosus.
Arthritis Rheum. 54: 2550-2557 (2006).
*
-
Bernatsky S, Clarke A, Gladman DD, Urowitz M, Fortin PR, Barr SG, Senecal JL, Zummer M, Edworthy S, Sibley J, Pope J, Ensworth S, Ramsey-Goldman R, Hanly JG. Mortality related to cerebrovascular disease in systemic lupus erythematosus.
Lupus 15: 835-839 (2006).
-
Bernatsky S, Clarke A, Pope J, Hanly JG, Smith CD, Peschken C, Rich E, Boire G, Fortin PR. Malignancy prevalence in the first-degree relatives of persons with systemic lupus erythematous: a pilot study.
Lupus 15: 695-696 (2006).
-
Bernatsky S, Pineau CA, Lee JL, Clarke AE. Headache, Raynaud's syndrome and serotonin receptor agonists in systemic lupus erythematosus.
Lupus 15: 671-674 (2006).
-
Bernatsky S, Ramsey-Goldman R, Clarke A. Malignancy and autoimmunity.
Curr. Opin. Rheumatol. 18: 129-134 (2006).
-
Bernatsky S, Ramsey-Goldman R, Lachance S, Pineau CA, Clarke AE. Lymphoma in a patient with systemic lupus erythematosus.
Nat. Clin. Pract. Rheumatol. 2: 570-574 (2006).
*
-
Bernbom N, Norrung B, Saadbye P, Molbak L, Vogensen FK, Licht TR. Comparison of methods and animal models commonly used for investigation of fecal microbiota: effects of time, host and gender.
J. Microbiol. Methods 66: 87-95 (2006).
*
-
Berndt SI, Dodson JL, Huang WY, Nicodemus KK. A systematic review of vitamin D receptor gene polymorphisms and prostate cancer risk.
J. Urol. 175: 1613-1623 (2006).
-
Berner IC, Dudler J. Viral arthritis.
Rev. Med. Suisse. 2: 732-734, 737 (2006).
-
Bernhardt WM, Schefold JC, Weichert W, Rudolph B, Frei U, Groneberg DA, Schindler R. Amelioration of anemia after kidney transplantation in severe secondary oxalosis.
Clin. Nephrol. 65: 216-221 (2006).
-
Berni Canani R, Terrin G, Borrelli O, Romano MT, Manguso F, Coruzzo A, D'Armiento F, Romeo EF, Cucchiara S. Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn's disease.
Dig. Liver Dis. 38: 381-387 (2006).
-
Bernig T, Chanock SJ. Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer.
Expert Rev. Mol. Diagn. 6: 319-331 (2006).
-
Bernklev T, Jahnsen J, Henriksen M, Lygren I, Aadland E, Sauar J, Schulz T, Stray N, Vatn M, Moum B. Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease.
Inflamm. Bowel Dis. 12: 402-412 (2006).
*
-
Bernotiene E, Palmer G, Gabay C. The role of leptin in innate and adaptive immune responses.
Arthritis Res. Ther. 8: 217 (2006).
*
-
Bernstein CN. Biomarkers, surveillance strategies, chromoendoscopy medication-induced malignancies and chemoprevention (past).
Inflamm. Bowel Dis. 12 Suppl. 3: S10-S11 (2006).
-
Bernstein CN. Inflammatory bowel diseases as secondary causes of osteoporosis.
Curr. Osteoporos. Rep. 4: 116-123 (2006).
-
Bernstein CN. Natural history and management of flat and polypoid dysplasia in inflammatory bowel disease.
Gastroenterol. Clin. North Am. 35: 573-579 (2006).
-
Bernstein CN. Osteoporosis in patients with inflammatory bowel disease.
Clin. Gastroenterol. Hepatol. 4: 152-156 (2006).
-
Bernstein CN. Neoplasia in inflammatory bowel disease: surveillance and management strategies.
Curr. Gastroenterol. Rep. 8: 513-518 (2006).
-
Bernstein CN, Nabalamba A. Hospitalization, surgery, and readmission rates of IBD in Canada: a population-based study.
Am. J. Gastroenterol. 101: 110-118 (2006).
*
-
Bernstein CN, Rawsthorne P, Cheang M, Blanchard JF. A population-based case control study of potential risk factors for IBD.
Am. J. Gastroenterol. 101: 993-1002 (2006).
*
-
Bernstein CN, Wajda A, Svenson LW, MacKenzie A, Koehoorn M, Jackson M, Fedorak R, Israel D, Blanchard JF. The epidemiology of inflammatory bowel disease in Canada: a population-based study.
Am. J. Gastroenterol. 101: 1559-1568 (2006).
*
-
Bernstein CN, Walker JR, Graff LA. On studying the connection between stress and IBD.
Am. J. Gastroenterol. 101: 782-785 (2006).
*
-
Bernstein H, Holubec H, Bernstein C, Ignatenko N, Gerner E, Dvorak K, Besselsen D, Ramsey L, Dall'Agnol M, Blohm-Mangone KA, Padilla-Torres J, Cui H, Garewal H, Payne CM. Unique dietary-related mouse model of colitis.
Inflamm. Bowel Dis. 12: 278-293 (2006).
*
-
Bernstein LR. Does nucleolin bind the NF kappa B DNA binding motif?
Hepatology 43: 376 (2006).
*
-
Bernstein-Hanley I, Balsara ZR, Ulmer W, Coers J, Starnbach MN, Dietrich WF. Genetic analysis of susceptibility to Chlamydia trachomatis in mouse.
Genes Immun. 7: 122-129 (2006).
*
-
Bernt C, Vennegeerts T, Beuers U, Rust C. The human transcription factor AP-1 is a mediator of bile acid-induced liver cell apoptosis.
Biochem. Biophys. Res. Commun. 340: 800-806 (2006).
*
-
Berruyer C, Pouyet L, Millet V, Martin FM, Legoffic A, Canonici A, Garcia S, Bagnis C, Naquet P, Galland F. Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity.
J. Exp. Med. 203: 2817-2827 (2006).
*
-
Berry MA, Hargadon B, Shelley M, Parker D, Shaw DE, Green RH, Bradding P, Brightling CE, Wardlaw AJ, Pavord ID. Evidence of a role of tumor necrosis factor alpha in refractory asthma.
N. Engl. J. Med. 354: 697-708 (2006).
*
-
Bersot T, Haffner S, Harris WS, Kellick KA, Morris CM. Hypertriglyceridemia: management of atherogenic dyslipidemia.
J. Fam. Pract. 55: S1-S8 (2006).
-
Berstad AE, Aabakken L, Smith HJ, Aasen S, Boberg KM, Schrumpf E. Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis.
Clin. Gastroenterol. Hepatol. 4: 514-520 (2006).
-
Berthelot C, Cather J, Jones D, Duvic M. Atypical CD8+ cutaneous T-cell lymphoma after immunomodulatory therapy.
Clin. Lymphoma Myeloma 6: 329-332 (2006).
-
Berthelot P, Carricajo A, Aubert G, Akhavan H, Gazielly D, Lucht F. Outbreak of postoperative shoulder arthritis due to Propionibacterium acnes infection in nondebilitated patients.
Infect. Control Hosp. Epidemiol. 27: 987-990 (2006).
*
-
Berti I, Della Vedova R, Paduano R, Devetta M, Caradonna M, Villanacci V, Not T, Martelossi S, Tamburlini G, Ventura A. Coeliac disease in primary care: evaluation of a case-finding strategy.
Dig. Liver Dis. 38: 461-467 (2006).
-
Bertinetto FE, Dall'omo AM, Mazzola GA, Rendine S, Berrino M, Bertola L, Magistroni P, Caropreso P, Falda M, Locatelli F, Busca A, Amoroso A. Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantation.
Int. J. Immunogenet. 33: 375-384 (2006).
*
-
Bertolaccini ML, Khamashta MA. Laboratory diagnosis and management challenges in the antiphospholipid syndrome.
Lupus 15: 172-178 (2006).
-
Bertoli AM, Alarcon GS, Calvo-Alen J, Fernandez M, Vila LM, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort: clinical features, course, and outcome in patients with late-onset disease.
Arthritis Rheum. 54: 1580-1587 (2006).
*
-
Bertoli AM, Fernandez M, McGwin G Jr, Alarcon GS, Tan FK, Reveille JD, Vila LM. Systemic lupus erythematosus in a multiethnic US cohort: XXXVI. Influence of mannose-binding lectin exon 1 polymorphisms in disease manifestations, course, and outcome.
Arthritis Rheum. 54: 1703-1704 (2006).
*
-
Bertolotti M, Gabbi C, Anzivino C, Mitro N, Godio C, De Fabiani E, Crestani M, Del Puppo M, Ricchi M, Carulli L, Rossi A, Loria P, Carulli N. Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis.
Eur. J. Clin. Invest. 36: 170-175 (2006).
-
Bertrand PP. Real-time measurement of serotonin release and motility in guinea pig ileum.
J. Physiol. 577: 689-704 (2006).
*
-
Bertuzzo CS, Pinto W. Molecular screening of CFTR gene in Brazilian men with bilateral agenesis of the vas deferens.
Hum. Fertil. (Camb.) 9: 53-56 (2006).
-
Berven FS, Flikka K, Berle M, Vedeler C, Ulvik RJ. Proteomic-based biomarker discovery with emphasis on cerebrospinal fluid and multiple sclerosis.
Curr. Pharm. Biotechnol. 7: 147-158 (2006).
-
Berzigotti A, Magalotti D, Zappoli P, Rossi C, Callea F, Zoli M. Peliosis hepatis as an early histological finding in idiopathic portal hypertension: a case report.
World J. Gastroenterol. 12: 3612-3615 (2006).
*
-
Bessant R, Duncan R, Ambler G, Swanton J, Isenberg DA, Gordon C, Rahman A. Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: a case-control study.
Arthritis Rheum. 55: 892-899 (2006).
*
-
Bessard A, Coutant A, Rescan C, Ezan F, Fremin C, Courselaud B, Ilyin G, Baffet G. An MLCK-dependent window in late G1 controls S phase entry of proliferating rodent hepatocytes via ERK-p70S6K pathway.
Hepatology 44: 152-163 (2006).
*
-
Bessis N, Boissier MC. Gene therapy for patients with rheumatoid arthritis.
Joint Bone Spine 73: 169-176 (2006).
*
-
Best WR. Predicting the Crohn's disease activity index from the Harvey-Bradshaw index.
Inflamm. Bowel Dis. 12: 304-310 (2006).
*
-
Beswick EJ, Suarez G, Reyes VE. H. pylori and host interactions that influence pathogenesis.
World J. Gastroenterol. 12: 5599-5605 (2006).
*
-
Bethoux F. Fatigue and multiple sclerosis.
Ann. Readapt. Med. Phys. 49: 355-360 (2006).
-
Betser-Cohen G, Katz G, Gonen-Gross T, Stern N, Arnon TI, Achdout H, Gazit R, Mandelboim O. Reduced KIR2DL1 recognition of MHC class I molecules presenting phosphorylated peptides.
J. Immunol. 176: 6762-6769 (2006).
*
-
Bettelli E, Baeten D, Jager A, Sobel RA, Kuchroo VK. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice.
J. Clin. Invest. 116: 2393-2402 (2006).
*
-
Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.
Nature 441: 235-238 (2006).
*
-
Bettendorf M, Doerr HG, Hauffa BP, Lindberg A, Mehls O, Partsch CJ, Schwarz HP, Stahnke N, Ranke MB. Prevalence of autoantibodies associated with thyroid and celiac disease in Ullrich-Turner syndrome in relation to adult height after growth hormone treatment.
J. Pediatr. Endocrinol. Metab. 19: 149-154 (2006).
-
Betterle C. Parathyroid and autoimmunity.
Ann. Endocrinol. (Paris) 67: 147-154 (2006).
-
Betterle C, Lazzarotto F, Spadaccino AC, Basso D, Plebani M, Pedini B, Chiarelli S, Albergoni M. Celiac disease in North Italian patients with autoimmune Addison's disease.
Eur. J. Endocrinol. 154: 275-279 (2006).
*
-
Beuers U. Mechanisms of action of ursodeoxycholic acid for treatment of primary sclerosing cholangitis.
Falk Workshop "Primary Sclerosing Cholangitis: Complications and Consequences", Moscow (Russia), June 11, 2006, p. 12 (2006). *
-
Beuers U. Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis.
Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 318-328 (2006).
*
-
Beuers U, Gerken G, Pusl T. Biliary drainage transiently relieves intractable pruritus in primary biliary cirrhosis.
Hepatology 44: 280-281 (2006).
*
-
Beuers U, Hohenester S, Pusl T, Rust C, Wimmer R. Tauroursodeoxycholic acid antagonizes taurolithocholic acid induced cholestasis via a cooperative protein kinase C- and protein kinase A-dependent signaling pathway in the perfused rat liver.
Falk Symposium 155. XIII FALK LIVER WEEK (Part I) XIX International Bile Acid Meeting. Bile Acids: Biological Actions and Clinical Relevance, October 6 - 7, 2006 Freiburg (Germany), p. 81 (2006). *
-
Beuers U, Pusl T. Intrahepatic cholestasis of pregnancy - a heterogeneous group of pregnancy-related disorders?
Hepatology 43: 647-649 (2006).
*
-
Beutler B, Jiang Z, Georgel P, Crozat K, Croker B, Rutschmann S, Du X, Hoebe K. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large.
Annu. Rev. Immunol. 24: 353-389 (2006).
*
-
Bevelacqua V, Libra M, Mazzarino MC, Gangemi P, Nicotra G, Curatolo S, Massimino D, Plumari A, Merito P, Valente G, Stivala F, La Greca S, Malaponte G. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
Int. J. Mol. Med. 18: 415-423 (2006).
*
-
Bevins CL. Host factors that shape the enteric flora: what changes in IBD?
Inflamm. Bowel Dis. 12 Suppl. 3: S3 (2006).
-
Bevins CL. Paneth cell defensins: key effector molecules of innate immunity.
Biochem. Soc. Trans. 34: 263-266 (2006).
*
-
Bewley MS, Pena JT, Plesch FN, Decker SE, Weber GJ, Forrest Jr JN. Shark rectal gland vasoactive intestinal peptide receptor: cloning, functional expression, and regulation of CFTR chloride channels.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 291: R1157-R1164 (2006).
*
-
Beyan H, Ola T, David R, Leslie G. Progression of autoimmune diabetes: slowly progressive insulin-dependent diabetes mellitus or latent autoimmune diabetes of adult.
Ann. N. Y. Acad. Sci. 1079: 81-89 (2006).
*
-
Beyer M, Schultze JL. Regulatory T cells in cancer.
Blood 108: 804-811 (2006).
*
-
Beyersdorf N, Balbach K, Hunig T, Kerkau T. Large-scale expansion of rat CD4 CD25 T cells in the absence of T-cell receptor stimulation.
Immunology 119: 441-450 (2006).
*
-
Beyersdorf N, Hanke T, Kerkau T, Hunig T. CD28 superagonists put a break on autoimmunity by preferentially activating CD4(+)CD25(+) regulatory T cells.
Autoimmun. Rev. 5: 40-45 (2006).
-
Bezerra JA. The next challenge in pediatric cholestasis: deciphering the pathogenesis of biliary atresia.
J. Pediatr. Gastroenterol. Nutr. 43 Suppl. 1: S23-S29 (2006).
*
-
Bezerra JA, Balistreri WF. Pediatric hepatology: progress in deciphering mechanisms and advancing therapy.
Clin. Liver Dis. 10: ix-xii (2006).
*
-
Bhaduri N, Mukhopadhyay K. Lack of significant association between -1021C-->T polymorphism in the dopamine beta hydroxylase gene and attention deficit hyperactivity disorder.
Neurosci. Lett. 402: 12-16 (2006).
*
-
Bhandoola A, Sambandam A. From stem cell to T cell: one route or many?
Nat. Rev. Immunol. 6: 117-126 (2006).
*
-
Bharat A, Fields RC, Trulock EP, Patterson GA, Mohanakumar T. Induction of IL-10 suppressors in lung transplant patients by CD4+25+ regulatory T cells through CTLA-4 signaling.
J. Immunol. 177: 5631-5638 (2006).
*
-
Bharhani MS, Borojevic R, Basak S, Ho E, Zhou P, Croitoru K. IL-10 protects mouse intestinal epithelial cells from Fas-induced apoptosis via modulating Fas expression and altering caspase-8 and FLIP expression.
Am. J. Physiol. Gastrointest. Liver Physiol. 291: G820-829 (2006).
*
-
Bharucha AE. Pro: Anorectal testing is useful in fecal incontinence.
Am. J. Gastroenterol. 101: 2679-2681 (2006).
*
-
Bhaskar S, Reddy DN, Mahurkar S, Rao GV, Singh L, Chandak GR. Lack of significant association of an insertion/deletion polymorphism in the angiotensin converting enzyme (ACE) gene with tropical calcific pancreatitis.
BMC Gastroenterol. 6: 42 (2006).
*
-
Bhat R, Eissmann P, Endt J, Hoffmann S, Watzl C. Fine-tuning of immune responses by SLAM-related receptors.
J. Leukoc. Biol. 79: 417-424 (2006).
*
-
Bhatia AS, Mihas AA. Cholestatic liver disease. Recognizing the clinical signs.
Postgrad. Med. 119: 67-75, 82 (2006).
-
Bhatia J, Bratcher J, Korelitz B, Vakher K, Mannor S, Shevchuk M, Panagopoulos G, Ofer A, Tamas E, Kotsali P, Vele O. Abnormalities of uterine cervix in women with inflammatory bowel disease.
World J. Gastroenterol. 12: 6167-6171 (2006).
*
-
Bhatia V, Viswanathan P. Insulin resistance and PPAR insulin sensitizers.
Curr. Opin. Investig. Drugs 7: 891-897 (2006).
-
Bhatnagar S, Phillips AD, Bhan MK. Celiac disease in India.
J. Pediatr. Gastroenterol. Nutr. 43: 263-264 (2006).
*
-
Bhatnagar S, Tandon N. Diagnosis of celiac disease.
Indian J. Pediatr. 73: 703-709 (2006).
*
-
Bhatnagar V, Xu G, Hamilton BA, Truong DM, Eraly SA, Wu W, Nigam SK. Analyses of 5' regulatory region polymorphisms in human SLC22A6 (OAT1) and SLC22A8 (OAT3).
J. Hum. Genet. 51: 575-580 (2006).
*
-
Bhatt SP, Handa R, Gulati GS, Sharma S, Pandey RM, Aggarwal P, Ramakrishnan L, Shankar S. Atherosclerosis in Asian Indians with systemic lupus erythematosus.
Scand. J. Rheumatol. 35: 128-132 (2006).
*
-
Bhattacharjee RN, Akira S. Modifying Toll-like receptor 9 signaling for therapeutic use.
Mini. Rev. Med. Chem. 6: 287-291 (2006).
-
Bhattacharjee RN, Park KS, Kumagai Y, Okada K, Yamamoto M, Uematsu S, Matsui K, Kumar H, Kawai T, Iida T, Honda T, Takeuchi O, Akira S. VP1686, a Vibrio type III secretion protein, induces Toll-like receptor independent apoptosis in macrophage through NF-kappa B inhibition.
J. Biol. Chem. 281: 36897-36904 (2006).
*
-
Bhattacharya A, Ghosal S, Bhattacharya SK. Effect of fish oil on offensive and defensive factors in gastric ulceration in rats.
Prostaglandins Leukot. Essent. Fatty Acids 74: 109-116 (2006).
*
-
Bhojani MS, Hamstra DA, Chang DC, Coppola JM, Khan AP, Reddy GR, Ross BD, Rehemtulla A. Imaging of proteolytic activity using a conditional cell surface receptor.
Mol. Imaging 5: 129-137 (2006).
-
Bhosle MJ, Feldman SR, Camacho FT, Timothy Whitmire J, Nahata MC, Balkrishnan R. Medication adherence and health care costs associated with biologics in Medicaid-enrolled patients with psoriasis.
J. Dermatolog. Treat. 17: 294-301 (2006).
-
Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R. Quality of life in patients with psoriasis.
Health Qual. Life Outcomes 4: 35 (2006).
-
Bi EG, Shi W, Zou J, Hao ZH, Li ZH, Cai D, Zhang HQ, Sun B. IL-12p40 is not required for islet allograft rejection.
Acta Pharmacol. Sin. 27: 1065-1070 (2006).
*
-
Bi YA, Kazolias DC, Duignan DB. Use of cryopreserved human hepatocytes in sandwich-culture to measure hepatobiliary transport.
Drug Metab. Dispos. 34: 1658-1665 (2006).
*
-
Biagi F, Campanella J, Laforenza U, Gastaldi G, Tritto S, Grazioli M, Villanacci V, Corazza GR. Transglutaminase 2 in the enterocytes is coeliac specific and gluten dependent.
Dig. Liver Dis. 38: 652-658 (2006).
-
Biagi F, Campanella J, Soriani A, Vailati A, Corazza GR. Prevalence of coeliac disease in Italian patients affected by Addison's disease.
Scand. J. Gastroenterol. 41: 302-305 (2006).
*
-
Biagi F, Rondonotti E, Campanella J, Villa F, Bianchi PI, Klersy C, De Franchis R, Corazza GR. Video capsule endoscopy and histology for small-bowel mucosa evaluation: a comparison performed by blinded observers.
Clin. Gastroenterol. Hepatol. 4: 998-1003 (2006).
-
Biagini MR, Tozzi A, Grippo A, Galli A, Milani S, Amantini A. Muscle fatigue in women with primary biliary cirrhosis: spectral analysis of surface electromyography.
World J. Gastroenterol. 12: 5186-5190 (2006).
*
-
Biagini MR, Tozzi A, Marcucci R, Paniccia R, Fedi S, Milani S, Galli A, Ceni E, Capanni M, Manta R, Abbate R, Surrenti C. Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis.
World J. Gastroenterol. 12: 1607-1612 (2006).
*
-
Biagioni C, Favilli F, Catarzi S, Marcucci T, Fazi M, Tonelli F, Vincenzini MT, Iantomasi T. Redox state and O2*- production in neutrophils of Crohn's disease patients.
Exp. Biol. Med. (Maywood) 231: 186-195 (2006).
*
-
Bianchi A. From the cradle to enteral autonomy: the role of autologous gastrointestinal reconstruction.
Gastroenterology 130: S138-S146 (2006).
*
-
Bianco AC, Kim BW. Deiodinases: implications of the local control of thyroid hormone action.
J. Clin. Invest. 116: 2571-2579 (2006).
*
-
Biancone L, Cretella M, Tosti C, Palmieri G, Petruzziello C, Geremia A, Calabrese E, Pallone F. Local injection of infliximab in the postoperative recurrence of Crohn's disease.
Gastrointest. Endosc. 63: 486-492 (2006).
-
Biancone L, Orlando A, Kohn A, Colombo E, Sostegni R, Angelucci E, Rizzello F, Castiglione F, Benezzato L, Papi C, Meucci G, Riegler G, Mocciaro F, Geremia A, Calabrese E, Cottone M, Pallone F. Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched-pair study.
Gut 55: 228-233 (2006).
*
-
Biank VF, Kugathasan S. What are the risk factors for surgery and their implications for management of children with Crohn's disease?
Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 660-661 (2006).
*
-
Bibiloni R, Mangold M, Madsen KL, Fedorak RN, Tannock GW. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients.
J. Med. Microbiol. 55: 1141-1149 (2006).
*
-
Bidot CJ, Jy W, Horstman LL, Ahn ER, Yaniz M, Ahn YS. Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS).
Am. J. Hematol. 81: 391-396 (2006).
*
-
Biecker E, Sauerbruch T. Control of infection in gastrointestinal endoscopy.
Dtsch. Med. Wochenschr. 131: 2726-2732 (2006).
-
Biedermann T. Dissecting the role of infections in atopic dermatitis.
Acta Derm. Venereol. 86: 99-109 (2006).
*
-
Bielekova B, Catalfamo M, Reichert-Scrivner S, Packer A, Cerna M, Waldmann TA, McFarland H, Henkart PA, Martin R. Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.
Proc. Natl. Acad. Sci. U.S.A. 103: 5941-5946 (2006).
*
-
Bielicki D, Wasilewicz MP. Acute lower gastrointestinal tract bleeding caused by Dieulafoy lesion in rectum - case report.
Pol. Merkuriusz. Lek. 20: 708-709 (2006).
-
Bienvenu F. Will serologic tests allow to diagnose coeliac disease in children?
Arch. Pediatr. 13: 574-575 (2006).
-
Bierbaum S, Nickel R, Zitnik S, Ahlert I, Lau S, Deichmann KA, Wahn U, Heinzmann A. Confirmation of association of IL-15 with pediatric asthma and comparison of different controls.
Allergy 61: 576-580 (2006).
*
-
Bierbaum S, Sengler C, Gerhold K, Berner R, Heinzmann A. Polymorphisms within interleukin 15 are associated with juvenile idiopathic arthritis.
Clin. Exp. Rheumatol. 24: 219 (2006).
-
Bierhaus A, Humpert PM, Nawroth PP. Linking stress to inflammation.
Anesthesiol. Clin. 24: 325-340 (2006).
-
Biggins SW, Bambha K. MELD-based liver allocation: who is underserved?
Semin. Liver Dis. 26: 211-220 (2006).
-
Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, Therneau T, Kremers W, Wiesner R, Kamath P, Klintmalm G. Evidence-based incorporation of serum sodium concentration into MELD.
Gastroenterology 130: 1652-1660 (2006).
*
-
Bihl F, Emmenegger U, Reichen J, Neftel KA, Zimmermann A, Cerny A. Macrophage activating syndrome is associated with lobular hepatitis and severe bile duct injury with cholestasis.
J. Hepatol. 44: 1208-1212 (2006).
*
-
Bijl M, Kallenberg CG. Ultraviolet light and cutaneous lupus.
Lupus 15: 724-727 (2006).
-
Bijl M, Reefman E, Horst G, Limburg PC, Kallenberg CG. Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus (SLE): correlates with decreased serum levels of complement.
Ann. Rheum. Dis. 65: 57-63 (2006).
*
-
Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F, Perez-Perez G, Blaser MJ, Relman DA. Molecular analysis of the bacterial microbiota in the human stomach.
Proc. Natl. Acad. Sci. U.S.A. 103: 732-737 (2006).
*
-
Bikle DD, Elalieh H, Chang S, Xie Z, Sundberg JP. Development and progression of alopecia in the vitamin D receptor null mouse.
J. Cell. Physiol. 207: 340-353 (2006).
*
-
Bilavsky E, Yarden-Bilavsky H, Zevit N, Amir J. Primary meningococcal arthritis in a child: case report and literature review.
Scand. J. Infect. Dis. 38: 396-399 (2006).
*
-
Bilbao JR, Calvo B, Aransay AM, Martin-Pagola A, Perez de Nanclares G, Aly TA, Rica I, Vitoria JC, Gaztambide S, Noble J, Fain PR, Awdeh ZL, Alper CA, Castano L. Conserved extended haplotypes discriminate HLA-DR3-homozygous Basque patients with type 1 diabetes mellitus and celiac disease.
Genes Immun. 7: 550-554 (2006).
*
-
Bilinska M, Frydecka I, Kosmaczewska A, Ciszak L, Koszewicz M, Pokryszko-Dragan A. CD40L expression on T CD4+ lymphocytes from peripheral blood in patients with relapsing-remitting and secondary progressive multiple sclerosis.
Pol. Merkuriusz. Lek. 20: 41-45 (2006).
-
Billack B. Macrophage activation: role of Toll-like receptors, nitric oxide, and nuclear factor kappa B.
Am. J. Pharm. Educ. 70: 102 (2006).
-
Billaut-Laden I, Allorge D, Crunelle-Thibaut A, Rat E, Cauffiez C, Chevalier D, Houdret N, Lo-Guidice JM, Broly F. Evidence for a functional genetic polymorphism of the human thiosulfate sulfurtransferase (Rhodanese), a cyanide and H(2)S detoxification enzyme.
Toxicology 225: 1-11 (2006).
*
-
Billaut-Laden I, Rat E, Allorge D, Crunelle-Thibaut A, Cauffiez C, Chevalier D, Lo-Guidice JM, Broly F. Evidence for a functional genetic polymorphism of the human mercaptopyruvate sulfurtransferase (MPST), a cyanide detoxification enzyme.
Toxicol. Lett. 165: 101-111 (2006).
-
Biller H, Zissel G, Ruprecht B, Nauck M, Busse Grawitz A, Muller-Quernheim J. Genotype-corrected reference values for serum angiotensin-converting enzyme.
Eur. Respir. J. 28: 1085-1091 (2006).
-
Billiau A. Anti-inflammatory properties of type I interferons.
Antiviral Res. 71: 108-116 (2006).
*
-
Bilodeau M. Central fatigue in continuous and intermittent contractions of triceps brachii.
Muscle Nerve 34: 205-213 (2006).
-
Bilu Martin D, Deng A, Gaspari A, Pearson F. Perinuclear antineutrophil cytoplasmic antibody-associated vasculitis in a patient with Graves' disease treated with methimazole.
Skinmed. 5: 302-305 (2006).
*
-
Bilz S, Samuel V, Morino K, Savage D, Choi CS, Shulman GI. Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters.
Am. J. Physiol. Endocrinol. Metab. 290: E716-E722 (2006).
*
-
Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells in host defense and liver disease.
Liver Int. 26: 1175-1186 (2006).
*
-
Binder A. Identification of genes for a complex trait: examples from hypertension.
Curr. Pharm. Biotechnol. 7: 1-13 (2006).
-
Binder B, Ahlgrimm-Siess V, Hofmann-Wellenhof R. Eruptive melanocytic nevi of the palms and soles in a patient with Crohn disease.
J. Dtsch. Dermatol. Ges. 4: 486-488 (2006).
-
Binder HJ. Causes of chronic diarrhea.
N. Engl. J. Med. 355: 236-239 (2006).
*
-
Binder SR. Autoantibody detection using multiplex technologies.
Lupus 15: 412-421 (2006).
-
Binder SR, Hixson C, Glossenger J. Protein arrays and pattern recognition: new tools to assist in the identification and management of autoimmune disease.
Autoimmun. Rev. 5: 234-241 (2006).
-
Binder T, Salaj P, Zima T, Vitek L. Ursodeoxycholic acid, S-adenosyl-L-methionine and their combinations in the treatment of gestational intrahepatic cholestasis (ICP).
Ceska. Gynekol. 71: 92-98 (2006).
-
Binder T, Salaj P, Zima T, Vitek L. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy.
J. Perinat. Med. 34: 383-391 (2006).
-
Bingham S. The fibre-folate debate in colo-rectal cancer.
Proc. Nutr. Soc. 65: 19-23 (2006).
*
-
Binion DG, Kugathasan S, Dwinell MB. Molecular stratification of Crohn's disease by chemokine receptors: fractalkine receptor polymorphisms define a fibrostenosing ileal subgroup.
Am. J. Gastroenterol. 101: 107-109 (2006).
*
-
Binkley N, Drezner MK, Hollis BW. Laboratory reporting of 25-hydroxyvitamin D results: potential for clinical misinterpretation.
Clin. Chem. 52: 2124-2125 (2006).
*
-
Binstadt BA, Patel PR, Alencar H, Nigrovic PA, Lee DM, Mahmood U, Weissleder R, Mathis D, Benoist C. Particularities of the vasculature can promote the organ specificity of autoimmune attack.
Nat. Immunol. 7: 284-292 (2006).
*
-
Biondo M, Field J, Toh BH, Alderuccio F. Prednisolone promotes remission and gastric mucosal regeneration in experimental autoimmune gastritis.
J. Pathol. 209: 384-391 (2006).
*
-
Biral AC, Magalhaes RF, Wastowski IJ, Simoes R, Donadi EA, Simoes AL, Mendes-Junior CT, Tanaka AM, Kraemer MH. Association of HLA-A, -B, -C genes and TNF microsatellite polymorphism with psoriasis vulgaris: a study of genetic risk in Brazilian patients.
Eur. J. Dermatol. 16: 523-529 (2006).
-
Birand B, Cabre P, Bonnan M, Olindo S, Smadja D. A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative.
Rev. Med. Interne. 27: 616-619 (2006).
-
Bird NC, Ooi RC, Luo XY, Chin SB, Johnson AG. Investigation of the functional three-dimensional anatomy of the human cystic duct: a single helix?
Clin. Anat. 19: 528-534 (2006).
-
Birinci A, Bilgici A, Kuru O, Durupinar B. HLA-B27 polymorphism in Turkish patients with ankylosing spondylitis.
Rheumatol. Int. 26: 285-287 (2006).
*
-
Birlea S, Birlea M, Cimponeriu D, Apostol P, Cosgarea R, Gavrila L, Tigan S, Costin G, Das PK. Autoimmune diseases and vitamin D receptor Apa-I polymorphism are associated with vitiligo in a small inbred Romanian community.
Acta Derm. Venereol. 86: 209-214 (2006).
*
-
Birmingham DJ, Nagaraja HN, Rovin BH, Spetie L, Zhao Y, Li X, Hackshaw KV, Yu CY, Malarkey WB, Hebert LA. Fluctuation in self-perceived stress and increased risk of flare in patients with lupus nephritis carrying the serotonin receptor 1A -1019 G allele.
Arthritis Rheum. 54: 3291-3299 (2006).
*
-
Biro A. Clarifying omega-3 fatty acid recommendations.
Can. Fam. Physician. 52: 1060-1061 (2006).
*
-
Biro E, Szekanecz Z, Czirjak L, Danko K, Kiss E, Szabo NA, Szucs G, Zeher M, Bodolay E, Szegedi G, Bako G. Association of systemic and thyroid autoimmune diseases.
Clin. Rheumatol. 25: 240-245 (2006).
*
-
Biros DJ, Taylor AW, Kitaichi N. Melanocortin 5 receptor and ocular immunity.
Cell. Mol. Biol. (Noisy-le-grand) 52: 53-59 (2006).
-
Birring SS, Pavord ID, Mund E, Larsson K. Idiopathic chronic cough and organ-specific autoimmune disease.
Chest 129: 213-214 (2006).
*
-
Bischoff SC, Gebhardt T. Role of mast cells and eosinophils in neuroimmune interactions regulating mucosal inflammation in inflammatory bowel disease.
Adv. Exp. Med. Biol. 579: 177-208 (2006).
-
Bishnupuri KS, Luo Q, Murmu N, Houchen CW, Anant S, Dieckgraefe BK. Reg IV activates the epidermal growth factor receptor/Akt/AP-1 signaling pathway in colon adenocarcinomas.
Gastroenterology 130: 137-149 (2006).
*
-
Bisi A, Gobbi S, Rampa A, Belluti F, Piazzi L, Valenti P, Gyemant N, Molnar J. New potent P-glycoprotein inhibitors carrying a polycyclic scaffold.
J. Med. Chem. 49: 3049-3051 (2006).
*
-
Bisschops R, Rutgeerts P. Magnification imaging in inflammatory bowel disease: a useful aid for the prediction of disease relapse?
Endoscopy 38: 1268-1270 (2006).
-
Bissett DL. Glucosamine: an ingredient with skin and other benefits.
J. Cosmet. Dermatol. 5: 309-315 (2006).
-
Bissonnette R. Etanercept for the treatment of psoriasis.
Skin Therapy Lett. 11: 1-4 (2006).
-
Bissonnette R, Papp K, Poulin Y, Lauzon G, Aspeslet L, Huizinga R, Mayo P, Foster RT, Yatscoff RW, Maksymowych WP; on behalf of the ISA247 Psoriasis Study Group. A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasis.
J. Am. Acad. Dermatol. 54: 472-478 (2006).
-
Biswas-Fiss EE. Interaction of the nucleotide binding domains and regulation of the ATPase activity of the human retina specific ABC transporter, ABCR.
Biochemistry 45: 3813-3823 (2006).
*
-
Bittencourt VC, da Figueiredo RT, Silva RB, Mourao-Sa DS, Fernandez PL, Sassaki GL, Mulloy B, Bozza MT, Barreto-Bergter E. An alpha-glucan of Pseudallescheria boydii is involved in fungal phagocytosis and TLR activation.
J. Biol. Chem. 281: 22614-22623 (2006).
*
-
Bizzaro N, Tampoia M, Villalta D, Platzgummer S, Liguori M, Tozzoli R, Tonutti E. Low specificity of anti-tissue transglutaminase antibodies in patients with primary biliary cirrhosis.
J. Clin. Lab. Anal. 20: 184-189 (2006).
-
Bizzarri C, Beccari AR, Bertini R, Cavicchia MR, Giorgini S, Allegretti M. ELR(+) CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets.
Pharmacol. Ther. 112: 139-149 (2006).
*
-
Bjorkbacka H. Multiple roles of Toll-like receptor signaling in atherosclerosis.
Curr. Opin. Lipidol. 17: 527-533 (2006).
-
Bjorkhem I, Meaney S, Heverin M, Andersson U, Axelsson M, Panzenboek U, Sattler W. Role of oxysterols and cholestenoic acids in a crosstalk between the brain and the liver.
Falk Symposium 155. XIII FALK LIVER WEEK (Part I) XIX International Bile Acid Meeting. Bile Acids: Biological Actions and Clinical Relevance, October 6 - 7, 2006 Freiburg (Germany), p. 23 (2006). *
-
Bjorkkjaer T, Brun JG, Valen M, Arslan G, Lind R, Brunborg LA, Berstad A, Froyland L. Short-term duodenal seal oil administration normalised n-6 to n-3 fatty acid ratio in rectal mucosa and ameliorated bodily pain in patients with inflammatory bowel disease.
Lipids Health Dis. 5: 6 (2006).
*
-
Bjorkman DJ, Popp JW Jr. Measuring the quality of endoscopy.
Am. J. Gastroenterol. 101: 864-865 (2006).
*
-
Bjorksten B. The gut microbiota: a complex ecosystem.
Clin. Exp. Allergy 36: 1215-1217 (2006).
*
-
Bjornsson E, Nordlinder H, Olsson R. Clinical characteristics and prognostic markers in disulfiram-induced liver injury.
J. Hepatol. 44: 791-797 (2006).
*
-
Bjornvold M, Amundsen SS, Stene LC, Joner G, Dahl-Jorgensen K, Njolstad PR, Ek J, Ascher H, Gudjonsdottir AH, Lie BA, Skinningsrud B, Akselsen HE, Ronningen KS, Sollid LM, Undlien DE. FOXP3 polymorphisms in type 1 diabetes and coeliac disease.
J. Autoimmun. 27: 140-144 (2006).
-
Bjoro K, Brandsaeter B, Foss A, Schrumpf E. Liver transplantation in primary sclerosing cholangitis.
Semin. Liver Dis. 26: 69-79 (2006).
*
-
Black A. Antiphospholipid syndrome: an overview.
Clin. Lab. Sci. 19: 144-147 (2006).
-
Black PH. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
Med. Hypotheses 67: 879-891 (2006).
-
Blackman SM, Deering-Brose R, McWilliams R, Naughton K, Coleman B, Lai T, Algire M, Beck S, Hoover-Fong J, Hamosh A, Fallin MD, West K, Arking DE, Chakravarti A, Cutler DJ, Cutting GR, Cutting G. Relative contribution of genetic and non-genetic modifiers to intestinal obstruction in cystic fibrosis.
Gastroenterology 131: 1030-1039 (2006).
*
-
Blagosklonny MV. Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition.
Cell Cycle 5: 2087-2102 (2006).
*
-
Blair HC, Carrington JL. Bone cell precursors and the pathophysiology of bone loss.
Ann. N. Y. Acad. Sci. 1068: 244-249 (2006).
*
-
Blair SA, Kane SV, Clayburgh DR, Turner JR. Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease.
Lab. Invest. 86: 191-201 (2006).
*
-
Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP, Jameson SC, Kirby C, Konikoff MR, Collins MH, Cohen MB, Akers R, Hogan SP, Assa'ad AH, Putnam PE, Aronow BJ, Rothenberg ME. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis.
J. Clin. Invest. 116: 536-547 (2006).
*
-
Blanchard DS. Omega-3 fatty acid supplementation in perinatal settings.
MCN Am. J. Matern. Child. Nurs. 31: 250-256 (2006).
-
Blanco Y, Gomez-Choco M, Arostegui JL, Casanova B, Martinez-Rodriguez JE, Bosca I, Munteis E, Yague J, Graus F, Saiz A. No association of the Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) to multiple sclerosis.
Neurosci. Lett. 396: 217-219 (2006).
*
-
Blanco-Barca O, Gomez-Lado C, Rodrigo-Saez E, Curros-Novos C, Briones-Godino P, Eiris-Punal J, Castro-Gago M. Pyruvate dehydrogenase deficit associated to the C515T mutation in exon 6 of the E1alpha gene.
Rev. Neurol. 43: 341-345 (2006).
-
Blanco-Quiros A, Solis-Sanchez P, Garrote-Adrados JA, Arranz-Sanz E. Common variable immunodeficiency. Old questions are getting clearer.
Allergol. Immunopathol. (Madr.) 34: 263-275 (2006).
-
Blander JM, Medzhitov R. On regulation of phagosome maturation and antigen presentation.
Nat. Immunol. 7: 1029-1035 (2006).
*
-
Blander JM, Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells.
Nature 440: 808-812 (2006).
*
-
Blanes A, Diaz-Cano SJ. Complementary analysis of microsatellite tumor profile and mismatch repair defects in colorectal carcinomas.
World J. Gastroenterol. 12: 5932-5940 (2006).
*
-
Blank C. The use of questionnaires in pediatric inflammatory bowel disease.
Curr. Gastroenterol. Rep. 8: 242-245 (2006).
-
Blank M, Gisondi P, Mimouni D, Peserico A, Piaserico S, Shoenfeld Y. New insights into the autoantibody-mediated mechanisms of autoimmune bullous diseases and urticaria.
Clin. Exp. Rheumatol. 24: S20-S25 (2006).
-
Blank M, Krause I, Magrini L, Spina G, Kalil J, Jacobsen S, Thiesen HJ, Cunningham MW, Guilherme L, Shoenfeld Y. Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome.
Rheumatology (Oxford) 45: 833-841 (2006).
*
-
Blank RB, Lamb EW, Tocheva AS, Crow ET, Lim KC, McKerrow JH, Davies SJ. The common gamma chain cytokines interleukin (IL)-2 and IL-7 indirectly modulate blood fluke development via effects on CD4+ T cells.
J. Infect. Dis. 194: 1609-1616 (2006).
*
-
Blaschke F, Caglayan E, Hsueh WA. Peroxisome proliferator-activated receptor gamma agonists: their role as vasoprotective agents in diabetes.
Endocrinol. Metab. Clin. North Am. 35: 561-574 (2006).
-
Blaschke F, Spanheimer R, Khan M, Law RE. Vascular effects of TZDs: new implications.
Vascul. Pharmacol. 45: 3-18 (2006).
-
Blaschke F, Takata Y, Caglayan E, Collins A, Tontonoz P, Hsueh WA, Tangirala RK. A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor.
Circ. Res. 99: e88-e99 (2006).
*
-
Blaschke F, Takata Y, Caglayan E, Law RE, Hsueh WA. Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes.
Arterioscler. Thromb. Vasc. Biol. 26: 28-40 (2006).
*
-
Blaszyk H, Hyman NH, Cooper K. Herpes simplex virus colitis in ulcerative colitis, simulating malignancy.
Histopathology 49: 316-318 (2006).
*
-
Blattman JN, Greenberg PD. PD-1 blockade: rescue from a near-death experience.
Nat. Immunol. 7: 227-228 (2006).
*
-
Blaumeiser B, van der Goot I, Fimmers R, Hanneken S, Ritzmann S, Seymons K, Betz RC, Ruzicka T, Wienker TF, De Weert J, Lambert J, Kruse R, Nothen MM. Familial aggregation of alopecia areata.
J. Am. Acad. Dermatol. 54: 627-632 (2006).
-
Bleakman D, Alt A, Nisenbaum ES. Glutamate receptors and pain.
Semin. Cell. Dev. Biol. 17: 592-604 (2006).
*
-
Blechacz B, Splinter PL, Greiner S, Myers R, Peng KW, Federspiel MJ, Russell SJ, LaRusso NF. Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma.
Hepatology 44: 1465-1477 (2006).
*
-
Blei AT. Innovations in hepatology.
Hepatology 44: 1373 (2006).
*
-
Blei DA. 25 years of Hepatology.
Hepatology 43: S1 (2006).
*
-
Blendis L. Child, MELD, hyponatremia, and now portal pressure.
Gastroenterology 130: 1920-1921 (2006).
*
-
Blendis L. Budd-Chiari syndrome: a clinical model of the hepatorenal reflex?
Gastroenterology 131: 671-672 (2006).
*
-
Blendis L. Percutaneous ethanol ablation of small hepatocellular carcinomas: twenty years on.
Gastroenterology 130: 280-282 (2006).
*
-
Blenman KR, Duan B, Xu Z, Wan S, Atkinson MA, Flotte TR, Croker BP, Morel L. IL-10 regulation of lupus in the NZM2410 murine model.
Lab. Invest. 86: 1136-1148 (2006).
*
-
Bliddal H, Terslev L, Qvistgaard E, Konig M, Holm CC, Rogind H, Boesen M, Danneskiold-Samsoe B, Torp-Pedersen S. A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis.
Scand. J. Rheumatol. 35: 341-345 (2006).
*
-
Bloch DB, Gulick T, Bloch KD, Yang WH. Processing body autoantibodies reconsidered.
RNA 12: 707-709 (2006).
*
-
Blomhoff A, Olsson M, Johansson S, Akselsen HE, Pociot F, Nerup J, Kockum I, Cambon-Thomsen A, Thorsby E, Undlien DE, Lie BA. Linkage disequilibrium and haplotype blocks in the MHC vary in an HLA haplotype specific manner assessed mainly by DRB1(*)03 and DRB1(*)04 haplotypes.
Genes Immun. 7: 130-140 (2006).
*
-
Blomhoff R, Blomhoff HK. Overview of retinoid metabolism and function.
J. Neurobiol. 66: 606-630 (2006).
-
Blonski W, Lichtenstein GR. Safety of biologics in inflammatory bowel disease.
Curr. Treat. Options Gastroenterol. 9: 221-233 (2006).
-
Blonski W, Lichtenstein GR. Complications of biological therapy for inflammatory bowel diseases.
Curr. Opin. Gastroenterol. 22: 30-43 (2006).
-
Blonski W, Lichtenstein GR. Infliximab treatment of postoperative ulcers in Crohn's disease: to inject or not to inject-that is the question.
Gastrointest. Endosc. 63: 493-496 (2006).
-
Bloomfeld RS. Are COX-2 inhibitors safe for anyone.
Inflamm. Bowel Dis. 12: 922-923 (2006).
*
-
Bloomfield SF, Stanwell-Smith R, Crevel RW, Pickup J. Too clean, or not too clean: the hygiene hypothesis and home hygiene.
Clin. Exp. Allergy 36: 402-425 (2006).
*
-
Blossom SJ, Doss JC, Gilbert KM. Ability of trichloroethylene metabolite to promote immune pathology is strain-specific.
J. Immunotoxicol. 3: 179-187 (2006).
-
Blossom SJ, Gilbert KM. Exposure to a metabolite of the environmental toxicant, trichloroethylene, attenuates CD4+ T cell activation-induced cell death by metalloproteinase-dependent FasL shedding.
Toxicol. Sci. 92: 103-114 (2006).
*
-
Bloudickova S, Rajnoch J, Lodererova A, Honsova E, Viklicky O. Mycophenolate mofetil ameliorates accelerated progressive nephropathy in rat.
Kidney Blood Press. Res. 29: 60-66 (2006).
-
Blouquit S, Regnier A, Dannhoffer L, Fermanian C, Naline E, Boucher R, Chinet T. Ion and fluid transport properties of small airways in cystic fibrosis.
Am. J. Respir. Crit. Care Med. 174: 299-305 (2006).
*
-
Bluestone JA, Boehmer H. Regulatory T cells.
Semin. Immunol. 18: 77 (2006).
*
-
Bluestone JA, St Clair EW, Turka LA. CTLA4Ig: bridging the basic immunology with clinical application.
Immunity 24: 233-238 (2006).
*
-
Blum HE. Gene therapy for liver diseases: experimental strategies.
Falk Symposium 156. XIII Falk Liver Week (Part II). GENETICS IN LIVER DISEASES, Freiburg (Germany), October 8-9, 2006, p. 44-45 (2006). *
-
Blum KS, Pabst R. Keystones in lymph node development.
J. Anat. 209: 585-595 (2006).
*
-
Blumberg JM, Tzameli I, Astapova I, Lam FS, Flier JS, Hollenberg AN. Complex role of the vitamin D receptor and its ligand in adipogenesis in 3T3-L1 cells.
J. Biol. Chem. 281: 11205-11213 (2006).
*
-
Blumenberg M. DNA microarrays in dermatology and skin biology.
OMICS 10: 243-260 (2006).
-
Blumenthal S. Multiple sclerosis.
Radiol. Technol. 77: 309-321 (2006).
-
Blyth K, Vaillant F, Hanlon L, Mackay N, Bell M, Jenkins A, Neil JC, Cameron ER. Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo.
Cancer Res. 66: 2195-2201 (2006).
*
-
Boadu E, Choi HY, Lee DW, Waddington EI, Chan T, Asztalos B, Vance JE, Chan A, Castro G, Francis GA. Correction of apolipoprotein A-I-mediated lipid efflux and HDL particle formation in human Niemann-Pick type C disease fibroblasts.
J. Biol. Chem. 281: 37081-37090 (2006).
*
-
Bobe P, Bonardelle D, Benihoud K, Opolon P, Chelbi-Alix MK. Arsenic trioxide: a novel promising therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice.
Blood 108: 3967-3975 (2006).
*
-
Bober A. Passing it on: should health care professionals be permitted to disclose patients' genetic information to their reproductive partners?
J. Law Med. 14: 262-281 (2006).
-
Boberg KM, Jebsen P, Clausen OP, Foss A, Aabakken L, Schrumpf E. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
J. Hepatol. 45: 568-574 (2006).
*
-
Bobota AC, Megalakaki C, Repousis P, Chalkiopoulou I, Lalaki I, Trafalis DT, Athanassiou AE, Mentzikof CM. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
J. BUON 11: 485-489 (2006).
-
Boccardo J, Khandelwal A, Ye D, Duke BE. Common bile duct MALT lymphoma: case report and review of the literature.
Am. Surg. 72: 85-88 (2006).
-
Boccia S, Cadoni G, La Torre G, Arzani D, Volante M, Cattel C, Gianfagna F, Paludetti G, Almadori G, Ricciardi G. A case-control study investigating the role of sulfotransferase 1A1 polymorphism in head and neck cancer.
J. Cancer Res. Clin. Oncol. 132: 466-472 (2006).
*
-
Bochenski J, Placha G, Wanic K, Malecki M, Sieradzki J, Warram JH, Krolewski AS. New polymorphism of ENPP1 (PC-1) is associated with increased risk of type 2 diabetes among obese individuals.
Diabetes 55: 2626-2630 (2006).
*
-
Bockelmann R, Gollnick H, Bonnekoh B. Anti-cyclic citrullinated peptide antibodies in psoriasis patients without arthritis.
Arthritis Rheum. 54: 1701-1702 (2006).
*
-
Bockenstedt LK, Liu N, Schwartz I, Fish D. MyD88 deficiency enhances acquisition and transmission of Borrelia burgdorferi by Ixodes scapularis ticks.
Infect. Immun. 74: 2154-2160 (2006).
*
-
Bocker U. Infliximab in ulcerative colitis.
Scand. J. Gastroenterol. 41: 997-1000 (2006).
*
-
Bodamer OA, Mitterer G, Maurer W, Pollak A, Mueller MW, Schmidt WM. Evidence for an association between mannose-binding lectin 2 (MBL2) gene polymorphisms and pre-term birth.
Genet. Med. 8: 518-524 (2006).
-
Bodano A, Gonzalez A, Ferreiros-Vidal I, Balada E, Ordi J, Carreira P, Gomez-Reino JJ, Conde C. Association of a non-synonymous single-nucleotide polymorphism of DNASEI with SLE susceptibility.
Rheumatology (Oxford) 45: 819-823 (2006).
*
-
Bode L, Freeze HH. Applied glycoproteomics-approaches to study genetic-environmental collisions causing protein-losing enteropathy.
Biochim. Biophys. Acta 1760: 547-559 (2006).
*
-
Boden G, Zhang M. Recent findings concerning thiazolidinediones in the treatment of diabetes.
Expert Opin. Investig. Drugs 15: 243-250 (2006).
-
Bodger K, Halfvarson J, Dodson A, Campbell F, Wilson S, Lee R, Lindberg E, Jarnerot G, Tysk C, Rhodes J. Altered colonic glycoprotein expression in unaffected monozygotic twins of inflammatory bowel disease patients.
Gut 55: 973-977 (2006).
*
-
Bodily KD, Fletcher JG, Solem CA, Johnson CD, Fidler JL, Barlow JM, Bruesewitz MR, McCollough CH, Sandborn WJ, Loftus EV Jr, Harmsen WS, Crownhart BS. Crohn disease: mural attenuation and thickness at contrast-enhanced CT enterography - correlation with endoscopic and histologic findings of inflammation.
Radiology 238: 505-516 (2006).
*
-
Boehm I. Apoptosis in physiological and pathological skin: implications for therapy.
Curr. Mol. Med. 6: 375-394 (2006).
-
Boehm T. Co-evolution of a primordial peptide-presentation system and cellular immunity.
Nat. Rev. Immunol. 6: 79-84 (2006).
*
-
Boehm T, Zufall F. MHC peptides and the sensory evaluation of genotype.
Trends Neurosci. 29: 100-107 (2006).
*
-
Boehncke WH, Prinz J, Gottlieb AB. Biologic therapies for psoriasis. A systematic review.
J. Rheumatol. 33: 1447-1451 (2006).
-
Boers M. Abatacept in rheumatoid arthritis: a new branch on the "biologics" tree.
Ann. Intern. Med. 144: 933-935 (2006).
*
-
Boeshans KM, Wolf R, Voscopoulos C, Gillette W, Esposito D, Mueser TC, Yuspa SH, Ahvazi B. Purification, crystallization and preliminary X-ray diffraction of human S100A15.
Acta Crystallograph. Sect. F. Struct. Biol. Cryst. Commun. 62: 467-470 (2006).
-
Boettler T, Panther E, Bengsch B, Nazarova N, Spangenberg HC, Blum HE, Thimme R. Expression of the interleukin-7 receptor alpha chain (CD127) on virus-specific CD8+ T cells identifies functionally and phenotypically defined memory T cells during acute resolving hepatitis B virus infection.
J. Virol. 80: 3532-3540 (2006).
*
-
Bogardus ST Jr. What do we know about diverticular disease?: a brief overview.
J. Clin. Gastroenterol. 40 Suppl. 3: S108-111 (2006).
-
Bogas M, Afonso Mdo C, Araujo D. Erosive enteropathy in a patient with a polyarthritis.
Acta Reumatol. Port. 31: 349-354 (2006).
-
Bogdan C, Schleicher U. Production of interferon-gamma by myeloid cells - fact or fancy?
Trends Immunol. 27: 282-290 (2006).
*
-
Bogdanos DP, Koutsoumpas A, Baum H, Vergani D. Borrelia burgdorferi: a new self-mimicking trigger in primary biliary cirrhosis.
Dig. Liver Dis. 38: 781-782 (2006).
-
Bogdanos DP, Liaskos C, Rigopoulou EI, Dalekos GN. Anti-mitochondrial antibodies in patients with systemic lupus erythematosus: revealing the unforeseen.
Clin. Chim. Acta 373: 183-184 (2006).
*
-
Bogdanos DP, Vergani D. Origin of cross-reactive autoimmunity in primary biliary cirrhosis.
Liver Int. 26: 633-635 (2006).
*
-
Boggild M. Rationale and experience with combination therapies in multiple sclerosis.
J. Neurol. 253: vi45-vi51 (2006).
*
-
Bogoevska V, Horst A, Klampe B, Lucka L, Wagener C, Nollau P. CEACAM1, an adhesion molecule of human granulocytes, is fucosylated by fucosyltransferase IX and interacts with DC-SIGN of dendritic cells via LewisX residues.
Glycobiology 16: 197-209 (2006).
*
-
Bogoyevitch MA. The isoform-specific functions of the c-Jun N-terminal kinases (JNKs): differences revealed by gene targeting.
Bioessays 28: 923-934 (2006).
*
-
Bogunia-Kubik K, Koscinska K, Suchnicki K, Lange A. HSP70-hom gene single nucleotide (+2763 G/A and +2437 C/T) polymorphisms in sarcoidosis.
Int. J. Immunogenet. 33: 135-140 (2006).
*
-
Bogunia-Kubik K, Uklejewska A, Dickinson A, Jarvis M, Lange A. HSP70-hom gene polymorphism as a prognostic marker of graft-versus-host disease.
Transplantation 82: 1116-1117 (2006).
-
Bohm I. Quantification of absolute peripheral white blood cells and their subsets in patients with lupus erythematosus: comparison with other inflammatory diseases with and without autoimmune background.
Biomed. Pharmacother. 60: 92-95 (2006).
-
Bohm I. The apoptosis marker enzyme poly-(ADP-ribose) polymerase (PARP) in systemic lupus erythematosus.
Z. Rheumatol. 65: 541-544 (2006).
-
Bohm M, Luger TA, Schneider M, Schwarz T, Kuhn A. New insight into immunosuppression and treatment of autoimmune diseases.
Clin. Exp. Rheumatol. 24: S67-S71 (2006).
-
Bohm S, Kruis W. Probiotics in chronic inflammatory bowel disease.
MMW Fortschr. Med. 148: 30-34 (2006).
-
Bohm SK, Kruis W. Probiotics: do they help to control intestinal inflammation?
Ann. N. Y. Acad. Sci. 1072: 339-350 (2006).
*
-
Bohn E, Bechtold O, Zahir N, Frick JS, Reimann J, Jilge B, Autenrieth IB. Host gene expression in the colon of gnotobiotic interleukin-2-deficient mice colonized with commensal colitogenic or noncolitogenic bacterial strains: common patterns and bacteria strain specific signatures.
Inflamm. Bowel Dis. 12: 853-862 (2006).
*
-
Bohnhorst J, Rasmussen T, Moen SH, Flottum M, Knudsen L, Borset M, Espevik T, Sundan A. Toll-like receptors mediate proliferation and survival of multiple myeloma cells.
Leukemia 20: 1138-1144 (2006).
-
Bohr UR, Selgrad M, Ochmann C, Backert S, Konig W, Fenske A, Wex T, Malfertheiner P. Prevalence and spread of enterohepatic Helicobacter species in mice reared in a specific-pathogen-free animal facility.
J. Clin. Microbiol. 44: 738-742 (2006).
*
-
Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Cantini F, Macchioni P, Bajocchi G, Catanoso MG, Pulsatelli L, Consonni D, Salvarani C. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
J. Rheumatol. 33: 703-708 (2006).
-
Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Macchioni P, Cimino L, Bajocchi G, Grazia Catanoso M, Pattacini L, Salvarani C. Interleukin-10 promoter polymorphisms in giant cell arteritis.
Arthritis Rheum. 54: 4011-4017 (2006).
*
-
Boirivant M, Pallone F, Di Giacinto C, Fina D, Monteleone I, Marinaro M, Caruso R, Colantoni A, Palmieri G, Sanchez M, Strober W, Macdonald TT, Monteleone G. Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-beta1-mediated suppression of colitis.
Gastroenterology 131: 1786-1798 (2006).
*
-
Bolander FF. Vitamins: not just for enzymes.
Curr. Opin. Investig. Drugs 7: 912-915 (2006).
-
Bolder U, Jeschke MG, Landmann L, Wolf F, de Sousa C, Schlitt HJ, Przkora R. Heat stress enhances recovery of hepatocyte bile acid and organic anion transporters in endotoxemic rats by multiple mechanisms.
Cell Stress Chaperones 11: 89-100 (2006).
*
-
Boldt AB, Culpi L, Tsuneto LT, de Souza IR, Kun JF, Petzl-Erler ML. Diversity of the MBL2 gene in various Brazilian populations and the case of selection at the mannose-binding lectin locus.
Hum. Immunol. 67: 722-734 (2006).
-
Boldt AB, Luty A, Grobusch MP, Dietz K, Dzeing A, Kombila M, Kremsner PG, Kun JF. Association of a new mannose-binding lectin variant with severe malaria in Gabonese children.
Genes Immun. 7: 393-400 (2006).
*
-
Bolek T, Baker ME, Walsh RM. Imaging's roles in acute pancreatitis.
Cleve. Clin. J. Med. 73: 857-862 (2006).
*
-
Bolton C, Paul C. Glutamate receptors in neuroinflammatory demyelinating disease.
Mediators Inflamm. 2006: 93684 (2006).
*
-
Bommareddy A, Arasada BL, Mathees DP, Dwivedi C. Chemopreventive effects of dietary flaxseed on colon tumor development.
Nutr. Cancer 54: 216-222 (2006).
*
-
Bommireddy R, Pathak LJ, Martin J, Ormsby I, Engle SJ, Boivin GP, Babcock GF, Eriksson AU, Singh RR, Doetschman T. Self-antigen recognition by TGFbeta1-deficient T cells causes their activation and systemic inflammation.
Lab. Invest. 86: 1008-1019 (2006).
*
-
Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K; NORVIT Trial Investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction.
N. Engl. J. Med. 354: 1578-1588 (2006).
*
-
Bonaci-Nikolic B, Andrejevic S, Bukilica M, Urosevic I, Nikolic M. Autoantibodies to mitotic apparatus: association with other autoantibodies and their clinical significance.
J. Clin. Immunol. 26: 438-446 (2006).
*
-
Bonamico M, Ferri M, Mariani P, Nenna R, Thanasi E, Luparia RP, Picarelli A, Magliocca FM, Mora B, Bardella MT, Verrienti A, Fiore B, Uccini S, Megiorni F, Mazzilli MC, Tiberti C. Serologic and genetic markers of celiac disease: a sequential study in the screening of first degree relatives.
J. Pediatr. Gastroenterol. Nutr. 42: 150-154 (2006).
*
-
Bonarius HP, Baas F, Remmerswaal EB, van Lier RA, Berge IJ, Tak PP, de Vries N. Monitoring the T-cell receptor repertoire at single-clone resolution.
PLoS ONE 1: e55 (2006).
*
-
Bonavita S, Dinacci D, Lavorgna L, Savettieri G, Quattrone A, Livrea P, Bresciamorra V, Orefice G, Paciello M, Coniglio G, Di Costanzo A, Valentino P, Patti F, Salemi G, Simone I, Tedeschi G. Treatment of multiple sclerosis with interferon beta in clinical practice: 2-year follow-up data from the South Italy Mobile MRI Project.
Neurol. Sci. 27 Suppl. 5: s365-s368 (2006).
-
Bond JH. The case for direct colonoscopy screening for colorectal cancer.
Am. J. Gastroenterol. 101: 263-265 (2006).
*
-
Bondeson J, Wainwright SD, Lauder S, Amos N, Hughes CE. The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases and other destructive and inflammatory responses in osteoarthritis.
Arthritis Res. Ther. 8: R187 (2006).
*
-
Bonfield TL, Barna BP, John N, Malur A, Culver DA, Kavuru MS, Thomassen MJ. Suppression of activin A in autoimmune lung disease associated with anti-GM-CSF.
J. Autoimmun. 26: 37-41 (2006).
-
Bonfield TL, Swaisgood CM, Barna BP, Farver CF, Kavuru MS, Thomassen MJ. Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor.
J. Leukoc. Biol. 79: 133-139 (2006).
*
-
Bongiovanni M, Ranieri R, Ferrero S, Casanova F, Monforte AD. Crohn's disease onset in an HIV/hepatitis C virus co-infected woman taking pegylated interferon alpha-2b plus ribavirin.
AIDS 20: 1989-1990 (2006).
-
Bonif M, Meuwis MA, Close P, Benoit V, Heyninck K, Chapelle JP, Bours V, Merville MP, Piette J, Beyaert R, Chariot A. TNFalpha- and IKKbeta-mediated TANK/I-TRAF phosphorylation: implications for interaction with NEMO/IKKgamma and NF-kappaB activation.
Biochem. J. 394: 593-603 (2006).
*
-
Bonifati V. Parkinson's disease: the LRRK2-G2019S mutation: opening a novel era in Parkinson's disease genetics.
Eur. J. Hum. Genet. 14: 1061-1062 (2006).
*
-
Bonilla FA, Geha RS. 2. Update on primary immunodeficiency diseases.
J. Allergy Clin. Immunol. 117: S435-S441 (2006).
*
-
Bonini S, Bresciani M, Gramiccioni C. Global environmental changes and immune diseases.
Inflamm. Bowel Dis. 12 Suppl. 3: S1 (2006).
-
Boniotto M, Berti I, Santon D, Ventura A, Crovella S. Absence of maternal microchimerism in very early onset inflammatory bowel disease R1.
J. Gastroenterol. Hepatol. 21: 1082-1084 (2006).
*
-
Bonis PA, Kaplan M. Methotrexate for treatment of primary biliary cirrhosis.
Hepatology 43: 632 (2006).
*
-
Bonnard A, Fouquet V, Berrebi D, Hugot JP, Belarbi N, Bruneau B, Aigrain Y, de Lagausie P. Crohn's disease in children. Preliminary experience with a laparoscopic approach.
Eur. J. Pediatr. Surg. 16: 90-93 (2006).
-
Bonnekoh B, Bockelmann R, Pommer AJ, Malykh Y, Philipsen L, Gollnick H. The CD11a binding site of efalizumab in psoriatic skin tissue as analyzed by multi-epitope ligand cartography robot technology. Introduction of a novel biological drug-binding biochip assay.
Skin Pharmacol. Physiol. 20: 96-111 (2006).
-
Bonnel AS, Quinque K, Le Roux P, Le Luyer B. Semi-invasive necrotic aspergillosis in a child with cystic fibrosis.
Rev. Mal. Respir. 23: 343-347 (2006).
-
Bonnycastle LL, Willer CJ, Conneely KN, Jackson AU, Burrill CP, Watanabe RM, Chines PS, Narisu N, Scott LJ, Enloe ST, Swift AJ, Duren WL, Stringham HM, Erdos MR, Riebow NL, Buchanan TA, Valle TT, Tuomilehto J, Bergman RN, Mohlke KL, Boehnke M, Collins FS. Common variants in maturity-onset diabetes of the young genes contribute to risk of type 2 diabetes in Finns.
Diabetes 55: 2534-2540 (2006).
*
-
Bontrop RE. Comparative genetics of MHC polymorphisms in different primate species: duplications and deletions.
Hum. Immunol. 67: 388-397 (2006).
-
Bookman EB, Langehorne AA, Eckfeldt JH, Glass KC, Jarvik GP, Klag M, Koski G, Motulsky A, Wilfond B, Manolio TA, Fabsitz RR, Luepker RV; NHLBI Working Group. Reporting genetic results in research studies: summary and recommendations of an NHLBI working group.
Am. J. Med. Genet. A. 140: 1033-1040 (2006).
-
Bookman ID, Pham J, Guindi M, Heathcote EJ. Distinguishing nonalcoholic steatohepatitis from fatty liver: serum-free fatty acids, insulin resistance, and serum lipoproteins.
Liver Int. 26: 566-571 (2006).
*
-
Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network.
Cell 126: 789-799 (2006).
*
-
Boon AC, de Mutsert G, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. The hypervariable immunodominant NP418-426 epitope from the influenza A virus nucleoprotein is recognized by cytotoxic T lymphocytes with high functional avidity.
J. Virol. 80: 6024-6032 (2006).
*
-
Boone RH, Cheung AM, Girlan LM, Heathcote EJ. Osteoporosis in primary biliary cirrhosis: a randomized trial of the efficacy and feasibility of estrogen/progestin.
Dig. Dis. Sci. 51: 1103-1112 (2006).
*
-
Boonen A, van der Linden SM. The burden of ankylosing spondylitis.
J. Rheumatol. Suppl. 78: 4-11 (2006).
*
-
Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder?
Eur. Heart J. 27: 136-149 (2006).
*
-
Booya F, Fletcher JG, Huprich JE, Barlow JM, Johnson CD, Fidler JL, Solem CA, Sandborn WJ, Loftus EV Jr, Harmsen WS. Active Crohn disease: CT findings and interobserver agreement for enteric phase CT enterography.
Radiology 241: 787-795 (2006).
*
-
Boraschi D, Dinarello CA. IL-18 in autoimmunity: review.
Eur. Cytokine Netw. 17: 224-252 (2006).
-
Boraschi D, Tagliabue A. The interleukin-1 receptor family.
Vitam. Horm. 74C: 229-254 (2006).
-
Boraska Jelavic T, Barisic M, Drmic Hofman I, Boraska V, Vrdoljak E, Peruzovic M, Hozo I, Puljiz Z, Terzic J. Microsatelite GT polymorphism in the Toll-like receptor 2 is associated with colorectal cancer.
Clin. Genet. 70: 156-160 (2006).
*
-
Boraska V, Terzic J, Skrabic V, Cacev T, Bucevic-Popovic V, Peruzovic M, Markotic A, Zemunik T. NeuroD1 gene and interleukin-18 gene polymorphisms in type 1 diabetes in Dalmatian population of Southern Croatia.
Croat. Med. J. 47: 571-578 (2006).
*
-
Borba EF, Carvalho JF, Bonfa E. Mechanisms of dyslipoproteinemias in systemic lupus erythematosus.
Clin. Dev. Immunol. 13: 203-208 (2006).
*
-
Borchers AT, Chang C, Keen CL, Gershwin ME. Airborne environmental injuries and human health.
Clin. Rev. Allergy Immunol. 31: 1-101 (2006).
*
-
Borchers AT, Selmi C, Cheema G, Keen CL, Shoenfeld Y, Gershwin ME. Juvenile idiopathic arthritis.
Autoimmun. Rev. 5: 279-298 (2006).
-
Bordet R, Ouk T, Petrault O, Gele P, Gautier S, Laprais M, Deplanque D, Duriez P, Staels B, Fruchart JC, Bastide M. PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases.
Biochem. Soc. Trans. 34: 1341-1346 (2006).
*
-
Bordoni A, Di Nunzio M, Danesi F, Biagi PL. Polyunsaturated fatty acids: from diet to binding to PPARs and other nuclear receptors.
Genes Nutr. 1: 95-106 (2006).
*
-
Borer JS. Cyclooxygenase inhibition: what should we do to resolve the confusion? An American perspective.
J. Cardiovasc. Pharmacol. 47 Suppl. 1: S87-S91 (2006).
-
Borg M. Symptomatic myoclonus.
Neurophysiol. Clin. 36: 309-318 (2006).
-
Borgaonkar MR, Duggan PR, Adams G. Differing clinical manifestations of celiac disease transmitted by bone marrow transplantation.
Dig. Dis. Sci. 51: 210-212 (2006).
*
-
Borhani-Haghighi A, Samangooie S, Ashjazadeh N, Nikseresht A, Shariat A, Yousefipour G, Safari A. Neurological manifestations of Behcet s disease.
Saudi Med. J. 27: 1542-1546 (2006).
-
Borjesson L, Lundstam U, Oresland T, Brevinge H, Hulten L. The place for colectomy and ileorectal anastomosis: a valid surgical option for ulcerative colitis?
Tech. Coloproctol. 10: 237-241 (2006).
*
-
Bornstein SR, Ziegler CG, Krug AW, Kanczkowski W, Rettori V, McCann SM, Wirth M, Zacharowski K. The role of Toll-like receptors in the immune-adrenal crosstalk.
Ann. N. Y. Acad. Sci. 1088: 307-318 (2006).
*
-
Borody TJ, Heifets LB. Severe recurrent Crohn's disease of ileocolonic anastomosis and antimicrobial (anti-mycobacterial) therapy.
Gut 55: 1211 (2006).
*
-
Boross P, Verbeek JS. The complex role of Fcgamma receptors in the pathology of arthritis.
Springer Semin. Immunopathol. 28: 339-350 (2006).
*
-
Borrelli F, Capasso F, Capasso R, Ascione V, Aviello G, Longo R, Izzo AA. Effect of Boswellia serrata on intestinal motility in rodents: inhibition of diarrhoea without constipation.
Br. J. Pharmacol. 148: 553-560 (2006).
*
-
Borrelli O, Cordischi L, Cirulli M, Paganelli M, Labalestra V, Uccini S, Russo PM, Cucchiara S. Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial.
Clin. Gastroenterol. Hepatol. 4: 744-753 (2006).
-
Borska L, Fiala Z, Krejsek J, Andrys C, Vokurkova D, Hamakova K, Kremlacek J, Ettler K. Selected immunological changes in patients with Goeckerman's therapy TNF-alpha, sE-selectin, sP-selectin, sICAM-1 and IL-8.
Physiol. Res. 55: 699-706 (2006).
*
-
Borst P, Zelcer N, van de Wetering K, Poolman B. On the putative co-transport of drugs by multidrug resistance proteins.
FEBS Lett. 580: 1085-1093 (2006).
*
-
Borthne AS, Abdelnoor M, Rugtveit J, Perminow G, Reiseter T, Klow NE. Bowel magnetic resonance imaging of pediatric patients with oral mannitol MRI compared to endoscopy and intestinal ultrasound.
Eur. Radiol. 16: 207-214 (2006).
-
Borum ML, Liu E. Crohn's disease mimicking bulimia nervosa.
Prim. Care Companion J. Clin. Psychiatry 8: 311-312 (2006).
*
-
Borutinskaite VV, Navakauskiene R, Magnusson KE. Retinoic acid and histone deacetylase inhibitor BML-210 inhibit proliferation of human cervical cancer HeLa cells.
Ann. N. Y. Acad. Sci. 1091: 346-355 (2006).
*
-
Bos CL, Diks SH, Hardwick JC, Walburg KV, Peppelenbosch MP, Richel DJ. Protein phosphatase 2A is required for mesalazine-dependent inhibition of Wnt/beta-catenin pathway activity.
Carcinogenesis 27: 2371-2382 (2006).
*
-
Bos JD, de Korte J. Effects of etanercept on quality of life, fatigue, and depression in psoriasis.
Lancet 367: 6-7 (2006).
*
-
Bos WE, Thio HB, Neumann HA, van der Fits L, Prens EP. The pathogenesis of inflammatory dermatoses, especially psoriasis.
Ned. Tijdschr. Geneeskd. 150: 179-183 (2006).
-
Bosca MM, Perez-Baylach CM, Solis MA, Anton R, Mayordomo E, Pons S, Minguez M, Benages A. Secondary amyloidosis in Crohn's disease: treatment with tumour necrosis factor inhibitor.
Gut 55: 294-295 (2006).
*
-
Bosch J, Garcia-Pagan JC, Berzigotti A, Abraldes JG. Measurement of portal pressure and its role in the management of chronic liver disease.
Semin. Liver Dis. 26: 348-362 (2006).
-
Bosch TM, Deenen M, Pruntel R, Smits PH, Schellens JH, Beijnen JH, Meijerman I. Screening for polymorphisms in the PXR gene in a Dutch population.
Eur. J. Clin. Pharmacol. 62: 395-399 (2006).
*
-
Bosch TM, Huitema AD, Doodeman VD, Jansen R, Witteveen E, Smit WM, Jansen RL, van Herpen CM, Soesan M, Beijnen JH, Schellens JH. Pharmacogenetic screening of CYP3A and ABCB1 in relation to population pharmacokinetics of docetaxel.
Clin. Cancer Res. 12: 5786-5793 (2006).
*
-
Bosch X, Guilabert A. Kikuchi-Fujimoto disease.
Orphanet J. Rare Dis. 1: 18 (2006).
*
-
Bosch X, Guilabert A, Font J. Antineutrophil cytoplasmic antibodies.
Lancet 368: 404-418 (2006).
*
-
Bosco P, Gueant-Rodriguez RM, Anello G, Spada R, Romano A, Fajardo A, Caraci F, Ferri R, Gueant JL. Association of homocysteine (but not of MTHFR 677 C>T, MTR 2756 A>G, MTRR 66 A>G and TCN2 776 C>G) with ischaemic cerebrovascular disease in Sicily.
Thromb. Haemost. 96: 154-159 (2006).
-
Bosi E, Molteni L, Radaelli MG, Folini L, Fermo I, Bazzigaluppi E, Piemonti L, Pastore MR, Paroni R. Increased intestinal permeability precedes clinical onset of type 1 diabetes.
Diabetologia 49: 2824-2827 (2006).
*
-
Bosse T, Piaseckyj CM, Burghard E, Fialkovich JJ, Rajagopal S, Pu WT, Krasinski SD. Gata4 is essential for the maintenance of jejunal-ileal identities in the adult mouse small intestine.
Mol. Cell. Biol. 26: 9060-9070 (2006).
*
-
Bossen C, Ingold K, Tardivel A, Bodmer JL, Gaide O, Hertig S, Ambrose C, Tschopp J, Schneider P. Interactions of TNF and TNF receptor family members in the mouse and human.
J. Biol. Chem. 281: 13964-13971 (2006).
*
-
Bosso JA, Mauldin PD, Steed LL. Consequences of combining cystic fibrosis- and non-cystic fibrosis-derived Pseudomonas aeruginosa antibiotic susceptibility results in hospital antibiograms.
Ann. Pharmacother. 40: 1946-1949 (2006).
-
Bossuyt X. Serologic markers in inflammatory bowel disease.
Clin. Chem. 52: 171-181 (2006).
*
-
Bosworth BP, Sanders A, Maltz C. Common variable immunodeficiency masquerading as Crohn's ileocolitis.
Inflamm. Bowel Dis. 12: 151-152 (2006).
*
-
Botchkarev VA, Yaar M, Peters EM, Raychaudhuri SP, Botchkareva NV, Marconi A, Raychaudhuri SK, Paus R, Pincelli C. Neurotrophins in skin biology and pathology.
J. Invest. Dermatol. 126: 1719-1727 (2006).
*
-
Botella C, Marin L, Moya-Quiles R, Miras M, Sanchez-Bueno F, Minguela A, Bermejo J, Parrilla P, Alvarez-Lopez R, Muro M. Lack of association between the -403G/A promoter polymorphism in the human CCL5/RANTES chemokine gene in liver transplant outcome.
Transpl. Int. 19: 98-104 (2006).
*
-
Botolin D, Wang Y, Christian B, Jump DB. Docosahexaneoic acid [22:6,n-3] regulates rat hepatocyte sterol regulatory element binding protein-1 (SREBP-1) nuclear abundance by Erk- and 26S proteasome-dependent pathways.
J. Lipid Res. 47: 181-192 (2006).
*
-
Bottazzi B, Garlanda C, Salvatori G, Jeannin P, Manfredi A, Mantovani A. Pentraxins as a key component of innate immunity.
Curr. Opin. Immunol. 18: 10-15 (2006).
-
Bottcher A, Gaipl US, Furnrohr BG, Herrmann M, Girkontaite I, Kalden JR, Voll RE. Involvement of phosphatidylserine, alphavbeta3, CD14, CD36, and complement C1q in the phagocytosis of primary necrotic lymphocytes by macrophages.
Arthritis Rheum. 54: 927-938 (2006).
*
-
Botti J, Djavaheri-Mergny M, Pilatte Y, Codogno P. Autophagy signaling and the cogwheels of cancer.
Autophagy 2: 67-73 (2006).
*
-
Bottini N, Vang T, Cucca F, Mustelin T. Role of PTPN22 in type 1 diabetes and other autoimmune diseases.
Semin. Immunol. 18: 207-213 (2006).
*
-
Boughan PK, Argent RH, Body-Malapel M, Park JH, Ewings KE, Bowie AG, Ong SJ, Cook SJ, Sorensen OE, Manzo BA, Inohara N, Klein NJ, Nunez G, Atherton JC, Bajaj-Elliott M. Nucleotide-binding oligomerization domain-1 and epidermal growth factor receptor: critical regulators of beta-defensins during Helicobacter pylori infection.
J. Biol. Chem. 281: 11637-11648 (2006).
*
-
Bougnoux ME, Diogo D, Francois N, Sendid B, Veirmeire S, Colombel JF, Bouchier C, Van Kruiningen H, d'Enfert C, Poulain D. Multilocus sequence typing reveals intrafamilial transmission and microevolutions of Candida albicans isolates from the human digestive tract.
J. Clin. Microbiol. 44: 1810-1820 (2006).
*
-
Bougnoux P, Giraudeau B, Couet C. Diet, cancer, and the lipidome.
Cancer Epidemiol. Biomarkers Prev. 15: 416-421 (2006).
*
-
Bouillon R, Eelen G, Verlinden L, Mathieu C, Carmeliet G, Verstuyf A. Vitamin D and cancer.
J. Steroid Biochem. Mol. Biol. 102: 156-162 (2006).
-
Bouillon R, Verstuyf A, Mathieu C, Van Cromphaut S, Masuyama R, Dehaes P, Carmeliet G. Vitamin D resistance.
Best Pract. Res. Clin. Endocrinol. Metab. 20: 627-645 (2006).
-
Bouis D, Kusumanto Y, Meijer C, Mulder NH, Hospers GA. A review on pro- and anti-angiogenic factors as targets of clinical intervention.
Pharmacol. Res. 53: 89-103 (2006).
*
-
Boulanger H, Mansouri R, Gautier JF, Glotz D. Are peroxisome proliferator-activated receptors new therapeutic targets in diabetic and non-diabetic nephropathies?
Nephrol. Dial. Transplant. 21: 2696-2702 (2006).
*
-
Boumendjel A, Tawk L, Malefijt Rde W, Boulay V, Yssel H, Pene J. IL-27 induces the production of IgG1 by human B cells.
Eur. Cytokine Netw. 17: 281-289 (2006).
-
Bour-Jordan H, Bluestone JA. Sensory neurons link the nervous system and autoimmune diabetes.
Cell 127: 1097-1099 (2006).
*
-
Bourbon JR, Benachi A. CFTR gene therapy, a method to rescue lung hypoplasia in congenital diaphragmatic hernia?
Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L1-L3 (2006).
*
-
Bourikas LA, Sidiropoulos PI, Goulielmos GN, Boumpas DT, Kritikos HD. Concomitant onset of Graves disease and rheumatoid arthritis after a serious life event.
J. Clin. Rheumatol. 12: 326-327 (2006).
-
Bourre JM. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients.
J. Nutr. Health Aging 10: 377-385 (2006).
-
Bourre JM. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2: macronutrients.
J. Nutr. Health Aging 10: 386-399 (2006).
-
Bourre JM, Galea F. An important source of omega-3 fatty acids, vitamins D and E, carotenoids, iodine and selenium: a new natural multi-enriched egg.
J. Nutr. Health Aging 10: 371-376 (2006).
-
Bourreille A, Jarry M, D'Halluin PN, Ben-Soussan E, Maunoury V, Bulois P, Sacher-Huvelin S, Vahedy K, Lerebours E, Heresbach D, Bretagne JF, Colombel JF, Galmiche JP. Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of post-operative recurrence of Crohn's disease: a prospective study.
Gut 55: 978-983 (2006).
*
-
Bousvaros A, Sylvester F, Kugathasan S, Szigethy E, Fiocchi C, Colletti R, Otley A, Amre D, Ferry G, Czinn SJ, Splawski JB, Oliva-Hemker M, Hyams JS, Faubion WA, Kirschner BS, Dubinsky MC; and the Members of the Challenges in Pediatric IBD Study Groups. Challenges in pediatric inflammatory bowel disease.
Inflamm. Bowel Dis. 12: 885-913 (2006).
*
-
Boutlis CS, Yeo TW, Anstey NM. Malaria tolerance - for whom the cell tolls?
Trends Parasitol. 22: 371-377 (2006).
*
-
Bouwman LH, Roep BO, Roos A. Mannose-binding lectin: clinical implications for infection, transplantation, and autoimmunity.
Hum. Immunol. 67: 247-256 (2006).
-
Bovenschen HJ, Tjioe M, Vermaat H, Hoop D, Witteman BM, Janssens RW, Stoof TJ, Kerkhof PC. Induction of eruptive benign melanocytic naevi by immune suppressive agents, including biologicals.
Br. J. Dermatol. 154: 880-884 (2006).
*
-
Bovenschen HJ, van Vlijmen-Willems IM, van de Kerkhof PC, van Erp PE. Identification of lesional CD4+ CD25+ Foxp3+ regulatory T cells in psoriasis.
Dermatology 213: 111-117 (2006).
-
Bovo R, Aimoni C, Martini A. Immune-mediated inner ear disease.
Acta Otolaryngol. 126: 1012-1021 (2006).
*
-
Bowden DW, Rudock M, Ziegler J, Lehtinen AB, Xu J, Wagenknecht LE, Herrington D, Rich SS, Freedman BI, Carr JJ, Langefeld CD. Coincident linkage of type 2 diabetes, metabolic syndrome, and measures of cardiovascular disease in a genome scan of the diabetes heart study.
Diabetes 55: 1985-1994 (2006).
*
-
Bowles J, Knight D, Smith C, Wilhelm D, Richman J, Mamiya S, Yashiro K, Chawengsaksophak K, Wilson MJ, Rossant J, Hamada H, Koopman P. Retinoid signaling determines germ cell fate in mice.
Science 312: 596-600 (2006).
*
-
Bowlus CL, Karlsen TH, Broome U, Thorsby E, Vatn M; the IBSEN study group; Schrumpf E, Lie BA, Boberg KM. Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis.
J. Hepatol. 45: 704-710 (2006).
*
-
Bowman EP, Chackerian AA, Cua DJ. Rationale and safety of anti-interleukin-23 and anti-interleukin-17A therapy.
Curr. Opin. Infect. Dis. 19: 245-252 (2006).
-
Boyce BF, Schwarz EM, Xing L. Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease.
Curr. Opin. Rheumatol. 18: 427-432 (2006).
-
Boyd AS. Localized chronic cutaneous lupus erythematosus masquerading as pigmented lesions: a new clinical subset?
Lupus 15: 292-295 (2006).
-
Boyd JH, Divangahi M, Yahiaoui L, Gvozdic D, Qureshi S, Petrof BJ. Toll-like receptors differentially regulate CC and CXC chemokines in skeletal muscle via NF-kappaB and calcineurin.
Infect. Immun. 74: 6829-6838 (2006).
*
-
Boyer JL, Trauner M, Mennone A, Soroka CJ, Cai SY, Moustafa T, Zollner G, Lee JY, Ballatori N. Up-regulation of a basolateral FXR-dependent bile acid efflux transporter, OSTalpha-OSTbeta, in cholestasis in humans and rodents.
Am. J. Physiol. Gastrointest. Liver Physiol. 290: G1124-G1130 (2006).
*
-
Boyle DL, Jones TL, Hammaker D, Svensson CI, Rosengren S, Albani S, Sorkin L, Firestein GS. Regulation of peripheral inflammation by spinal p38 MAP kinase in rats.
PLoS Med. 3: e338 (2006).
*
-
Boyle LH, Gillingham AK, Munro S, Trowsdale J. Selective export of HLA-F by its cytoplasmic tail.
J. Immunol. 176: 6464-6472 (2006).
*
-
Boyles AL, Billups AV, Deak KL, Siegel DG, Mehltretter L, Slifer SH, Bassuk AG, Kessler JA, Reed MC, Nijhout HF, George TM, Enterline DS, Gilbert JR, Speer MC. Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions.
Environ. Health Perspect. 114: 1547-1552 (2006).
*
-
Boyman O, Cho JH, Tan JT, Surh CD, Sprent J. A major histocompatibility complex class I-dependent subset of memory phenotype CD8+ cells.
J. Exp. Med. 203: 1817-1825 (2006).
*
-
Boyman O, Kovar M, Rubinstein MP, Surh CD, Sprent J. Selective stimulation of T cell subsets with antibody-cytokine immune complexes.
Science 311: 1924-1927 (2006).
*
-
Boyman O, Surh CD, Sprent J. Potential use of IL-2/anti-IL-2 antibody immune complexes for the treatment of cancer and autoimmune disease.
Expert Opin. Biol. Ther. 6: 1323-1331 (2006).
-
Boyton RJ, Reynolds C, Wahid FN, Jones MG, Ozerovitch L, Ahmad T, Chaudhry A, Jewell DP, Kon OM, Smith J, Rose M, Newman-Taylor AJ, Cole P, Wilson R, Altmann DM. IFNgamma and CXCR-1 gene polymorphisms in idiopathic bronchiectasis.
Tissue Antigens 68: 325-330 (2006).
*
-
Bozzi A, Pereira PP, Reis BS, Goulart MI, Pereira MC, Pedroso EP, Leite MF, Goes AM. Interleukin-10 and tumor necrosis factor-alpha single nucleotide gene polymorphism frequency in paracoccidioidomycosis.
Hum. Immunol. 67: 931-939 (2006).
-
Bozzolo E, Scotti R, Franchini S, Baldissera E, Angeli E, Sabbadini MG. Celiac disease in a young woman with Takayasu arteritis.
J. Clin. Rheumatol. 12: 213-214 (2006).
-
Braat H, Peppelenbosch MP, Hommes DW. Immunology of Crohn's disease.
Ann. N. Y. Acad. Sci. 1072: 135-154 (2006).
*
-
Braat H, Rottiers P, Hommes DW, Huyghebaert N, Remaut E, Remon JP, van Deventer SJ, Neirynck S, Peppelenbosch MP, Steidler L. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease.
Clin. Gastroenterol. Hepatol. 4: 754-759 (2006).
-
Braaten DC, McClellan JS, Messaoudi I, Tibbetts SA, McClellan KB, Nikolich-Zugich J, Virgin HW. Effective control of chronic gamma-herpesvirus infection by unconventional MHC class Ia-independent CD8 T cells.
PLoS Pathog. 2: e37 (2006).
*
-
Bracke KR, D'hulst AI, Maes T, Moerloose KB, Demedts IK, Lebecque S, Joos GF, Brusselle GG. Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice.
J. Immunol. 177: 4350-4359 (2006).
*
-
Bracken SC, Kilmartin C, Wieser H, Jackson J, Feighery C. Barley and rye prolamins induce an mRNA interferon-gamma response in coeliac mucosa.
Aliment. Pharmacol. Ther. 23: 1307-1314 (2006).
*
-
Braddock M, Murray C. 10th Anniversary Inflammation and Immune Diseases Drug Discovery and Development Summit 20 - 21 March 2006, New Brunswick, USA.
Expert Opin. Investig. Drugs 15: 721-727 (2006).
-
Bradna P. Gout and diabetes.
Vnitr. Lek. 52: 488-492 (2006).
-
Bradstock KF, Hertzberg MS, Kerridge IH, Svennilson J, McGurgan M, Huang G, Antonenas V, Gottlieb DJ. Unrelated umbilical cord blood transplantation for adults with haematological malignancies: results from a single Australian centre.
Intern. Med. J. 36: 355-361 (2006).
*
-
Braga-Neto UM, Marques ET. From functional genomics to functional immunomics: new challenges, old problems, big rewards.
PLoS Comput. Biol. 2: e81 (2006).
*
-
Bramstedt KA. Living liver donor mortality: where do we stand?
Am. J. Gastroenterol. 101: 755-759 (2006).
*
-
Branagan G, Thompson MR, Senapati A. Cleft closure for the treatment of unhealed perineal sinus.
Colorectal Dis. 8: 314-317 (2006).
*
-
Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, Otte JM, Diepolder H, Marquardt A, Jagla W, Popp A, Leclair S, Herrmann K, Seiderer J, Ochsenkuhn T, Goke B, Auernhammer CJ, Dambacher J. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration.
Am. J. Physiol. Gastrointest. Liver Physiol. 290: G827-G838 (2006).
*
-
Brand S, Hofbauer K, Dambacher J, Schnitzler F, Staudinger T, Pfennig S, Seiderer J, Tillack C, Konrad A, Goke B, Ochsenkuhn T, Lohse P. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease phenotype.
Am. J. Gastroenterol. 101: 99-106 (2006).
*
-
Brand S, Olszak T, Beigel F, Diebold J, Otte JM, Eichhorst ST, Goke B, Dambacher J. Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells.
J. Cell. Biochem. 97: 709-723 (2006).
*
-
Brand W, Schutte ME, Williamson G, van Zanden JJ, Cnubben NH, Groten JP, van Bladeren PJ, Rietjens IM. Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients.
Biomed. Pharmacother. 60: 508-519 (2006).
-
Brandacher G, Perathoner A, Ladurner R, Schneeberger S, Obrist P, Winkler C, Werner ER, Werner-Felmayer G, Weiss HG, Gobel G, Margreiter R, Konigsrainer A, Fuchs D, Amberger A. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.
Clin. Cancer Res. 12: 1144-1151 (2006).
*
-
Brandoni A, Anzai N, Kanai Y, Endou H, Torres AM. Renal elimination of p-aminohippurate (PAH) in response to three days of biliary obstruction in the rat. The role of OAT1 and OAT3.
Biochim. Biophys. Acta 1762: 673-682 (2006).
*
-
Brandoni A, Villar SR, Picena JC, Anzai N, Endou H, Torres AM. Expression of rat renal cortical OAT1 and OAT3 in response to acute biliary obstruction.
Hepatology 43: 1092-1100 (2006).
*
-
Brandsch M. Transport of L-proline, L-proline-containing peptides and related drugs at mammalian epithelial cell membranes.
Amino Acids 31: 119-136 (2006).
*
-
Brandt D, Bernstein JA. Questionnaire evaluation and risk factor identification for nonallergic vasomotor rhinitis.
Ann. Allergy Asthma Immunol. 96: 526-532 (2006).
-
Brandt D, Gershwin ME. Common variable immune deficiency and autoimmunity.
Autoimmun. Rev. 5: 465-470 (2006).
-
Brandt J, Braun J. Anti-TNF-alpha agents in the treatment of psoriatic arthritis.
Expert Opin. Biol. Ther. 6: 99-107 (2006).
-
Brandtzaeg P. The changing immunological paradigm in coeliac disease.
Immunol. Lett. 105: 127-139 (2006).
-
Brandtzaeg P, Carlsen HS, Halstensen TS. The B-cell system in inflammatory bowel disease.
Adv. Exp. Med. Biol. 579: 149-167 (2006).
-
Brannagan TH 3rd, Alaedini A, Gladstone DE. High-dose cyclophosphamide without stem cell rescue for refractory multifocal motor neuropathy.
Muscle Nerve 34: 246-250 (2006).
-
Brannstrom J, Hassler S, Peltonen L, Herrmann B, Winqvist O. Defect internalization and tyrosine kinase activation in Aire deficient antigen presenting cells exposed to Candida albicans antigens.
Clin. Immunol. 121: 265-273 (2006).
*
-
Branski D, Fasano A, Troncone R. Latest developments in the pathogenesis and treatment of celiac disease.
J. Pediatr. 149: 295-300 (2006).
*
-
Brar P, Kwon GY, Holleran S, Bai D, Tall AR, Ramakrishnan R, Green PH. Change in lipid profile in celiac disease: beneficial effect of gluten-free diet.
Am. J. Med. 119: 786-790 (2006).
*
-
Brar P, Lee AR, Lewis SK, Bhagat G, Green PH. Celiac disease in African-Americans.
Dig. Dis. Sci. 51: 1012-1015 (2006).
*
-
Brasaemle DL. Cell biology. A metabolic push to proliferate.
Science 313: 1581-1582 (2006).
*
-
Braselmann S, Taylor V, Zhao H, Wang S, Sylvain C, Balloum M, Qu K, Herlaar E, Lau A, Young C, Wong BR, Lovell S, Sun T, Park G, Argade A, Jurcevic S, Pine P, Singh R, Grossbard EB, Payan DG, Masuda ES. R406, an orally svailable Syk kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation.
J. Pharmacol. Exp. Ther. 319: 998-1008 (2006).
*
-
Brass SD, Chen NK, Mulkern RV, Bakshi R. Magnetic resonance imaging of iron deposition in neurological disorders.
Top. Magn. Reson. Imaging 17: 31-40 (2006).
-
Brassat D, Motsinger AA, Caillier SJ, Erlich HA, Walker K, Steiner LL, Cree BA, Barcellos LF, Pericak-Vance MA, Schmidt S, Gregory S, Hauser SL, Haines JL, Oksenberg JR, Ritchie MD. Multifactor dimensionality reduction reveals gene-gene interactions associated with multiple sclerosis susceptibility in African Americans.
Genes Immun. 7: 310-315 (2006).
*
-
Bratcher JM, Korelitz BI. Toxicity of infliximab in the course of treatment of Crohn's disease.
Expert Opin. Drug Saf. 5: 9-16 (2006).
-
Brauer DJ. A method for pattern recognition.
Res. Theory Nurs. Pract. 20: 277-289 (2006).
-
Braun AT, Farrell PM, Ferec C, Audrezet MP, Laxova A, Li Z, Kosorok MR, Rosenberg MA, Gershan WM. Cystic fibrosis mutations and genotype-pulmonary phenotype analysis.
J. Cyst. Fibros. 5: 33-41 (2006).
-
Braun F, Behrend M. Basic immunosuppressive drugs outside solid organ transplantation.
Expert Opin. Investig. Drugs 15: 267-291 (2006).
-
Braun J. In search of desire: mimicry, MAP, and Crohn's disease.
Gastroenterology 131: 312-314 (2006).
*
-
Braun J, Sieper J. Early diagnosis of spondyloarthritis.
Nat. Clin. Pract. Rheumatol. 2: 536-545 (2006).
*
-
Braun J, Sieper J. Spondylarthritides.
Z. Rheumatol. 65: 613-632 (2006).
-
Braun J, Targan SR. Multiparameter analysis of immunogenetic mechanisms in clinical diagnosis and management of inflammatory bowel disease.
Adv. Exp. Med. Biol. 579: 209-218 (2006).
-
Braun J, Zochling J, Baraliakos X, Alten RH, Burmester GR, Grasedyck K, Brandt J, Haibel H, Hammer M, Krause A, Mielke F, Tony HP, Ebner W, Gomor B, Hermann J, Zeidler H, Beck E, Baumgaertner M, Sieper J. Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomized controlled trial.
Ann. Rheum. Dis. 65: 1147-1153 (2006).
*
-
Braun-Moscovici Y, Markovits D, Zinder O, Schapira D, Rozin A, Ehrenburg M, Dain L, Hoffer E, Nahir AM, Balbir-Gurman A. Anti-cyclic citrullinated protein antibodies as a predictor of response to anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis.
J. Rheumatol. 33: 497-500 (2006).
-
Bravo E, Napolitano M, Lopez-Soldado I, Valeri M, Botham KM, Stefanutti C. Hypercholesterolaemia alters the responses of the plasma lipid profile and inflammatory markers to supplementation of the diet with n-3 polyunsaturated fatty acids from fish oil.
Eur. J. Clin. Invest. 36: 788-795 (2006).
*
-
Braybrook C. Are patients with rheumatoid arthritis prone to accelerated atherosclerosis?
Nat. Clin. Pract. Cardiovasc. Med. 3: 296-297 (2006).
-
Brazova J, Sediva A, Pospisilova D, Vavrova V, Pohunek P, Macek M Jr, Bartunkova J, Lauschmann H. Differential cytokine profile in children with cystic fibrosis.
Clin. Immunol. 115: 210-215 (2006).
*
-
Brazova J, Sismova K, Vavrova V, Bartosova J, Macek M Jr, Lauschman H, Sediva A. Polymorphisms of TGF-beta1 in cystic fibrosis patients.
Clin. Immunol. 121: 350-357 (2006).
*
-
Breant B, Gesina E, Blondeau B. Nutrition, glucocorticoids and pancreas development.
Horm. Res. 65 Suppl. 3: 98-104 (2006).
-
Breban M, Miceli-Richard C, Zinovieva E, Monnet D, Said-Nahal R. The genetics of spondyloarthropathies.
Joint Bone Spine 73: 355-362 (2006).
*
-
Bregenzer N, Hartmann A, Strauch U, Scholmerich J, Andus T, Bollheimer LC. Increased insulin resistance and beta cell activity in patients with Crohn's disease.
Inflamm. Bowel Dis. 12: 53-56 (2006).
*
-
Bregenzer N, Schaffler A, Gelbmann CM, Steinkamp M, Reinshagen M, Scholmerich J, Andus T. Lack of correlation between the vitamin D receptor Fokl start codon polymorphism and bone mineral density in patients with Crohn's disease.
Exp. Clin. Endocrinol. Diabetes 114: 1-5 (2006).
-
Breij EC, Heijnen P, van der Goes A, Teunissen CE, Polman CH, Dijkstra CD. Myelin flow cytometry assay detects enhanced levels of antibodies to human whole myelin in a subpopulation of multiple sclerosis patients.
J. Neuroimmunol. 176: 106-114 (2006).
-
Breitwieser GE. Calcium sensing receptors and calcium oscillations: calcium as a first messenger.
Curr. Top. Dev. Biol. 73: 85-114 (2006).
-
Brellou GD, Kleinschmidt S, Meneses F, Nolte I, Hewicker-Trautwein M. Eosinophilic granulomatous gastroenterocolitis and hepatitis in a 1-year-old male Siberian husky.
Vet. Pathol. 43: 1022-1025 (2006).
-
Bremner AR, Griffiths M, Argent JD, Fairhurst JJ, Beattie RM. Sonographic evaluation of inflammatory bowel disease: a prospective, blinded, comparative study.
Pediatr. Radiol. 36: 947-953 (2006).
*
-
Brennan PA, Kendrick KM. Mammalian social odours: attraction and individual recognition.
Philos. Trans. R. Soc. Lond. B. Biol. Sci. 361: 2061-2078 (2006).
*
-
Brenner H, Chang-Claude J, Seiler CM, Sturmer T, Hoffmeister M. Does a negative screening colonoscopy ever need to be repeated?
Gut 55: 1145-1150 (2006).
*
-
Brenner M, Laragione T, Yarlett NC, Li W, Mello A, Gulko PS. Cia27 is a novel non-MHC arthritis severity locus on rat chromosome 10 syntenic to the rheumatoid arthritis 17q22-q25 locus.
Genes Immun. 7: 335-341 (2006).
*
-
Breslow JL. n-3 Fatty acids and cardiovascular disease.
Am. J. Clin. Nutr. 83: 1477S-1482S (2006).
*
-
Bresnihan B. Synovial biomarkers in the spondylarthropathies.
Curr. Opin. Rheumatol. 18: 359-363 (2006).
-
Bressan E, De Queiroz Cunha F, Tonussi CR. Contribution of TNFalpha, IL-1beta and CINC-1 for articular incapacitation, edema and cell migration in a model of LPS-induced reactive arthritis.
Cytokine 36: 83-89 (2006).
-
Bressler B. Another tool in the epidemiologist's toolbox.
Inflamm. Bowel Dis. 12: 245-246 (2006).
*
-
Bressler B. The role of endoscopy in the management of postoperative patients with Crohn's disease.
Can. J. Gastroenterol. 20: 631-632 (2006).
*
-
Bressler B, Sands BE. Review article: medical therapy for fistulizing Crohn's disease.
Aliment. Pharmacol. Ther. 24: 1283-1293 (2006).
*
-
Bresson D, Togher L, Rodrigo E, Chen Y, Bluestone JA, Herold KC, von Herrath M. Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs.
J. Clin. Invest. 116: 1371-1381 (2006).
*
-
Breuer GS, Baer A, Dahan D, Nesher G. Lupus-associated pancreatitis.
Autoimmun. Rev. 5: 314-318 (2006).
-
Breuhahn K, Baeuerle PA, Peters M, Prang N, Tox U, Kohne-Volland R, Dries V, Schirmacher P, Leo E. Expression of epithelial cellular adhesion molecule (Ep-CAM) in chronic (necro-)inflammatory liver diseases and hepatocellular carcinoma.
Hepatol. Res. 34: 50-56 (2006).
-
Brewer GJ, Dick R, Zeng C, Hou G. The use of tetrathiomolybdate in treating fibrotic, inflammatory, and autoimmune diseases, including the non-obese diabetic mouse model.
J. Inorg. Biochem. 100: 927-930 (2006).
*
-
Brewer M, Kirkpatrick ND, Wharton JT, Wang J, Hatch K, Auersperg N, Utzinger U, Gershenson D, Bast R, Zou C. 4-HPR modulates gene expression in ovarian cells.
Int. J. Cancer 119: 1005-1013 (2006).
*
-
Breza TS Jr, Magro CM. Lichenoid and granulomatous dermatitis associated with atypical mycobacterium infections.
J. Cutan. Pathol. 33: 512-515 (2006).
*
-
Brezinschek HP, Brickmann K, Yazdani-Biuki B, Dorner T, Graninger WB, Brezinschek RI. Treatment of rheumatoid arthritis in the 21st century: targeting B-lymphocytes.
Wien. Med. Wochenschr. 156: 61-67 (2006).
-
Briancon N, Weiss MC. In vivo role of the HNF4alpha AF-1 activation domain revealed by exon swapping.
EMBO J. 25: 1253-1262 (2006).
*
-
Briani C, Doria A, Marcolongo R, Tognon S, Ruggero S, Toffanin E, Ermani M, Ghirardello A, Zampieri S, Semenzato G. Increased titres of IgM anti-heparan sulfate antibody in Behcet's disease.
Clin. Exp. Rheumatol. 24: S104-S107 (2006).
-
Brickner AG. Mechanisms of minor histocompatibility antigen immunogenicity: the role of infinitesimal versus structurally profound polymorphisms.
Immunol. Res. 36: 33-42 (2006).
*
-
Bridges CC, Zalups RK. System B0,+ and the transport of thiol-S-conjugates of methylmercury.
J. Pharmacol. Exp. Ther. 319: 948-956 (2006).
*
-
Bridges CC, Zalups RK. Molecular mimicry as a mechanism for the uptake of cysteine S-conjugates of methylmercury and inorganic mercury.
Chem. Res. Toxicol. 19: 1117-1118 (2006).
*
-
Brigman C, Feranchak A. Liver involvement in cystic fibrosis.
Curr. Treat. Options Gastroenterol. 9: 484-496 (2006).
-
Brik R, Livnat G, Pollack S, Catz R, Nagler R. Salivary gland involvement and oxidative stress in juvenile idiopathic arthritis: novel observation in oligoarticular-type patients.
J. Rheumatol. 33: 2532-2537 (2006).
-
Brinar VV, Petelin Z, Brinar M, Djakovic V, Zadro I, Vranjes D. CNS demyelination in autoimmune diseases.
Clin. Neurol. Neurosurg. 108: 318-326 (2006).
-
Bringer MA, Glasser AL, Tung CH, Meresse S, Darfeuille-Michaud A. The Crohn's disease-associated adherent-invasive Escherichia coli strain LF82 replicates in mature phagolysosomes within J774 macrophages.
Cell. Microbiol. 8: 471-484 (2006).
*
-
Brinza D, He J, Zelikovsky A. Combinatorial search methods for multi-SNP disease association.
Conf. Proc. IEEE Eng. Med. Biol. Soc. 1: 5802-5805 (2006).
-
Brisebois M, Zehntner SP, Estrada J, Owens T, Fournier S. A pathogenic role for CD8+ T cells in a spontaneous model of demyelinating disease.
J. Immunol. 177: 2403-2411 (2006).
*
-
Brisslert M, Bokarewa M, Larsson P, Wing K, Collins LV, Tarkowski A. Phenotypic and functional characterization of human CD25 B cells.
Immunology 117: 548-557 (2006).
*
-
Briz O, Macias RI, Perez MJ, Serrano MA, Marin JJ. Excretion of fetal biliverdin by the rat placenta-maternal liver tandem.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 290: R749-R756 (2006).
*
-
Briz O, Romero MR, Martinez-Becerra P, Macias RI, Perez MJ, Jimenez F, San Martin FG, Marin JJ. OATP8/1B3-mediated cotransport of bile acids and glutathione: an export pathway for organic anions from hepatocytes?
J. Biol. Chem. 281: 30326-30335 (2006).
*
-
Broad A, Jones DE, Kirby JA. Toll-like receptor (TLR) response tolerance: a key physiological "damage limitation" effect and an important potential opportunity for therapy.
Curr. Med. Chem. 13: 2487-2502 (2006).
-
Brockhausen I. The role of galactosyltransferases in cell surface functions and in the immune system.
Drug News Perspect. 19: 401-409 (2006).
-
Brockton NT. Localized depletion: the key to colorectal cancer risk mediated by MTHFR genotype and folate?
Cancer Causes Control 17: 1005-1016 (2006).
*
-
Brod SA, Nguyen M, Hood Z, Shipley GL. Ingested (oral) IFN-alpha represses TNF-alpha mRNA in relapsing-remitting multiple sclerosis.
J. Interferon Cytokine Res. 26: 150-155 (2006).
-
Brode S, Raine T, Zaccone P, Cooke A. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.
J. Immunol. 177: 6603-6612 (2006).
*
-
Broderick G, Craddock RC, Whistler T, Taylor R, Klimas N, Unger ER. Identifying illness parameters in fatiguing syndromes using classical projection methods.
Pharmacogenomics 7: 407-419 (2006).
-
Brodtkorb E. Autoimmune epilepsy.
Tidsskr. Nor. Laegeforen. 126: 782 (2006).
-
Broekaert IJ, Walker WA. Probiotics and chronic disease.
J. Clin. Gastroenterol. 40: 270-274 (2006).
-
Broer S. The SLC6 orphans are forming a family of amino acid transporters.
Neurochem. Int. 48: 559-567 (2006).
-
Broersen K, Brink DV, Fraser G, Goedert M, Davletov B. alpha-Synuclein adopts an alpha-helical conformation in the presence of polyunsaturated fatty acids to hinder micelle formation.
Biochemistry 45: 15610-15616 (2006).
*
-
Brogan PA, Malik M, Shah N, Kilday JP, Ramsay A, Shah V, Murch SH, Thomson MA, Walker-Smith JA, Lindley KJ, Milla PJ, Dillon MJ. Systemic vasculitis: a cause of indeterminate intestinal inflammation.
J. Pediatr. Gastroenterol. Nutr. 42: 405-415 (2006).
*
-
Bromberg JS, LeRoith D. Diabetes cure - is the glass half full?
N. Engl. J. Med. 355: 1372-1374 (2006).
*
-
Bromberg ME. Immune thrombocytopenic purpura - the changing therapeutic landscape.
N. Engl. J. Med. 355: 1643-1645 (2006).
*
-
Bronner MP. Biomarkers, surveillance strategies, chromoendoscopy medication-induced malignancies and chemoprevention (present).
Inflamm. Bowel Dis. 12 Suppl. 3: S11-S12 (2006).
-
Brookes KJ, Chen W, Xu X, Taylor E, Asherson P. Association of fatty acid desaturase genes with attention-deficit/hyperactivity disorder.
Biol. Psychiatry 60: 1053-1061 (2006).
*
-
Brookes MJ, Hughes S, Turner FE, Reynolds G, Sharma N, Ismail T, Berx G, McKie AT, Hotchin N, Anderson GJ, Iqbal T, Tselepis C. A modulation of iron transport proteins in human colorectal carcinogenesis.
Gut 55: 1449-1460 (2006).
*
-
Brooklyn TN, Dunnill MG, Shetty A, Bowden JJ, Williams JD, Griffiths CE, Forbes A, Greenwood R, Probert CS. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial.
Gut 55: 505-509 (2006).
*
-
Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, Oldstone MB. Interleukin-10 determines viral clearance or persistence in vivo.
Nat. Med. 12: 1301-1309 (2006).
*
-
Brooks PM. The burden of musculoskeletal disease - a global perspective.
Clin. Rheumatol. 25: 778-781 (2006).
*
-
Broom OJ, Massoumi R, Sjolander A. alpha2beta1 integrin signalling enhances cyclooxygenase-2 expression in intestinal epithelial cells.
J. Cell. Physiol. 209: 950-958 (2006).
*
-
Broome U. Primary sclerosing cholangitis could have been the cause of Beethoven's death.
Lakartidningen 103: 2494-2496 (2006).
-
Broome U, Bergquist A. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer.
Semin. Liver Dis. 26: 31-41 (2006).
*
-
Brophy K, Ryan AW, Thornton JM, Abuzakouk M, Fitzgerald AP, McLoughlin RM, O'Morain C, Kennedy NP, Stevens FM, Feighery C, Kelleher D, McManus R. Haplotypes in the CTLA4 region are associated with coeliac disease in the Irish population.
Genes Immun. 7: 19-26 (2006).
*
-
Brosnan JT, Brosnan ME. The sulfur-containing amino acids: an overview.
J. Nutr. 136: 1636S-1640S (2006).
*
-
Brosnan JT, da Silva R, Brosnan ME. Amino acids and the regulation of methyl balance in humans.
Curr. Opin. Clin. Nutr. Metab. Care 10: 52-57 (2006).
-
Broughman JR, Sun L, Umar S, Sellin JH, Morris AP. Chronic PKCbeta activation in HT-29 Cl.19A colonocytes (2) prevents cAMP-mediated ion secretion by inhibiting apical membrane CFTR targeting.
Am. J. Physiol. Gastrointest. Liver Physiol. 291: G331-G344 (2006).
*
-
Brousil JA, Roberts RJ, Schlein AL. Cladribine: an investigational immunomodulatory agent for multiple sclerosis (CE).
Ann. Pharmacother. 40: 1814-1821 (2006).
-
Brouwer IA, Geelen A, Katan MB. n-3 Fatty acids, cardiac arrhythmia and fatal coronary heart disease.
Prog. Lipid Res. 45: 357-367 (2006).
*
-
Brouwer IA, Heeringa J, Geleijnse JM, Zock PL, Witteman JC. Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam Study.
Am. Heart J. 151: 857-862 (2006).
*
-
Brouwer IA, Zock PL, Camm AJ, Bocker D, Hauer RN, Wever EF, Dullemeijer C, Ronden JE, Katan MB, Lubinski A, Buschler H, Schouten EG; SOFA Study Group. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial.
JAMA 295: 2613-2619 (2006).
*
-
Brown AK, Quinn MA, Karim Z, Conaghan PG, Peterfy CG, Hensor E, Wakefield RJ, O'Connor PJ, Emery P. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression.
Arthritis Rheum. 54: 3761-3773 (2006).
*
-
Brown GD. Macrophage receptors and innate immunity: insights from dectin-1.
Novartis Found. Symp. 279: 114-123 (2006).
-
Brown GD. Dectin-1: a signalling non-TLR pattern-recognition receptor.
Nat. Rev. Immunol. 6: 33-43 (2006).
*
-
Brown HJ, Lock HR, Sacks SH, Robson MG. TLR2 stimulation of intrinsic renal cells in the induction of immune-mediated glomerulonephritis.
J. Immunol. 177: 1925-1931 (2006).
*
-
Brown I, Mino-Kenudson M, Deshpande V, Lauwers GY. Intraepithelial lymphocytosis in architecturally preserved proximal small intestinal mucosa: an increasing diagnostic problem with a wide differential diagnosis.
Arch. Pathol. Lab. Med. 130: 1020-1025 (2006).
-
Brown KK. Chronic cough due to nonbronchiectatic suppurative airway disease (bronchiolitis): ACCP evidence-based clinical practice guidelines.
Chest 129: 132S-137S (2006).
*
-
Brown LC, Majumdar SR, Newman SC, Johnson JA. Type 2 diabetes does not increase risk of depression.
CMAJ 175: 42-46 (2006).
*
-
Brown MA. Non-major-histocompatibility-complex genetics of ankylosing spondylitis.
Best Pract. Res. Clin. Rheumatol. 20: 611-621 (2006).
-
Brown MD, Hart CA, Gazi E, Bagley S, Clarke NW. Promotion of prostatic metastatic migration towards human bone marrow stoma by omega 6 and its inhibition by omega 3 PUFAs.
Br. J. Cancer 94: 842-853 (2006).
*
-
Brown N, Nagarkatti M, Nagarkatti PS. Diethylstilbestrol alters positive and negative selection of T cells in the thymus and modulates T-cell repertoire in the periphery.
Toxicol. Appl. Pharmacol. 212: 119-126 (2006).
*
-
Brown RF, Tennant CC, Sharrock M, Hodgkinson S, Dunn SM, Pollard JD. Relationship between stress and relapse in multiple sclerosis: part I. Important features.
Mult. Scler. 12: 453-464 (2006).
*
-
Brown RF, Tennant CC, Sharrock M, Hodgkinson S, Dunn SM, Pollard JD. Relationship between stress and relapse in multiple sclerosis: part II. Direct and indirect relationships.
Mult. Scler. 12: 465-475 (2006).
*
-
Brown RS Jr. Asymptomatic liver mass.
Gastroenterology 131: 619-623 (2006).
*
-
Brown SJ. The role of vitamin D in multiple sclerosis.
Ann. Pharmacother. 40: 1158-1161 (2006).
-
Brown V, Brown RA, Ozinsky A, Hesselberth JR, Fields S. Binding specificity of Toll-like receptor cytoplasmic domains.
Eur. J. Immunol. 36: 742-753 (2006).
*
-
Brown WM. Anti-CD3 antibody MacroGenics Inc.
Curr. Opin. Investig. Drugs 7: 381-388 (2006).
-
Browning BL, Satsangi J, Noble C, Arnott ID, Russell RK, Nimmo ER. DLG5 variants and susceptibility to inflammatory bowel disease in the Scottish population * Authors' reply.
Gut 55: 1050 (2006).
*
-
Browning JD. Statins and hepatic steatosis: perspectives from the Dallas Heart Study.
Hepatology 44: 466-471 (2006).
*
-
Browning JD, Davis J, Saboorian MH, Burgess SC. A low-carbohydrate diet rapidly and dramatically reduces intrahepatic triglyceride content.
Hepatology 44: 487-488 (2006).
*
-
Browning JL. B cells move to centre stage: novel opportunities for autoimmune disease treatment.
Nat. Rev. Drug Discov. 5: 564-576 (2006).
*
-
Browning SR. Multilocus association mapping using variable-length Markov chains.
Am. J. Hum. Genet. 78: 903-913 (2006).
*
-
Brownlie RJ, Myers LK, Wooley PH, Corrigall VM, Bodman-Smith MD, Panayi GS, Thompson SJ. Treatment of murine collagen-induced arthritis by the stress protein BiP via interleukin-4-producing regulatory T cells: a novel function for an ancient protein.
Arthritis Rheum. 54: 854-863 (2006).
*
-
Brucato A, Brambilla G, Moreo A, Alberti A, Munforti C, Ghirardello A, Doria A, Shinar Y, Livneh A, Adler Y, Shoenfeld Y, Mauri F, Palmieri G, Spodick DH. Long-term outcomes in difficult-to-treat patients with recurrent pericarditis.
Am. J. Cardiol. 98: 267-271 (2006).
*
-
Bruckner HW, Hrehorovich VR, Sawhney HS, Meeus SI, Coopeman AM. Chemotherapeutic management of small bowel adenocarcinoma associated with Crohn's disease.
J. Chemother. 18: 545-548 (2006).
-
Brueck M, Runde T, Rauber K, Kramer W. Portal and mesenteric venous thrombosis in inflammatory bowel disease treated by fibrinogen-guided thrombolysis with urokinase.
Dtsch. Med. Wochenschr. 131: 84-88 (2006).
-
Bruewer M, Samarin S, Nusrat A. Inflammatory bowel disease and the apical junctional complex.
Ann. N. Y. Acad. Sci. 1072: 242-252 (2006).
*
-
Bruining DH, Loftus EV. Evolving diagnostic strategies for inflammatory bowel disease.
Curr. Gastroenterol. Rep. 8: 478-485 (2006).
-
Brulhart L, Ciurea A, Finckh A, Notter A, Waldburger JM, Kyburz D, Gabay C. Efficacy of B-cell depletion in rheumatoid arthritis patients refractory to anti-tumour necrosis factor (TNF)- a agents: an open label observational study.
Ann. Rheum. Dis. 65: 1255-1257 (2006).
*
-
Brumeanu TD, Goldstein R, Casares S. Down-regulation of autoreactive T-cells by HMG CoA reductase inhibitors.
Clin. Immunol. 119: 1-12 (2006).
*
-
Brummel R, Roberts TL, Stacey KJ, Lenert P. Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice.
Eur. J. Immunol. 36: 1951-1962 (2006).
*
-
Brun P, Castagliuolo I, Floreani AR, Buda A, Blasone L, Palu G, Martines D. Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region.
Gut 55: 1212 (2006).
*
-
Brune CW, Kim SJ, Salt J, Leventhal BL, Lord C, Cook EH Jr. 5-HTTLPR genotype-specific phenotype in children and adolescents with autism.
Am. J. Psychiatry 163: 2148-2156 (2006).
*
-
Brunham LR, Kruit JK, Iqbal J, Fievet C, Timmins JM, Pape TD, Coburn BA, Bissada N, Staels B, Groen AK, Hussain MM, Parks JS, Kuipers F, Hayden MR. Intestinal ABCA1 directly contributes to HDL biogenesis in vivo.
J. Clin. Invest. 116: 1052-1062 (2006).
*
-
Brunham LR, Kruit JK, Pape TD, Parks JS, Kuipers F, Hayden MR. Tissue-specific induction of intestinal ABCA1 expression with a liver X receptor agonist raises plasma HDL cholesterol levels.
Circ. Res. 99: 672-674 (2006).
*
-
Bruni R, Serino FM, Galluzzo S, Coppolino G, Cacciapaglia F, Vadacca M, Nilo S, Terminio N, Afeltra A. Alexithymia and neuroendocrine-immune response in patients with autoimmune diseases: preliminary results on relationship between alexithymic construct and TNF-alpha levels.
Ann. N. Y. Acad. Sci. 1069: 208-211 (2006).
*
-
Brunmair B, Staniek K, Dorig J, Szocs Z, Stadlbauer K, Marian V, Gras F, Anderwald C, Nohl H, Waldhausl W, Furnsinn C. Activation of PPAR-delta in isolated rat skeletal muscle switches fuel preference from glucose to fatty acids.
Diabetologia 49: 2713-2722 (2006).
*
-
Brunn GJ, Wijdicks MF, Platt JL. Toward a modern concept of sepsis: new answers to ancient questions.
Discov. Med. 6: 11-17 (2006).
-
Brunner E. Oily fish and omega 3 fat supplements.
BMJ 332: 739-740 (2006).
*
-
Brunner J, Sergi C, Muller T, Gassner I, Prufer F, Zimmerhackl LB. Juvenile sarcoidosis presenting as Crohn's disease.
Eur. J. Pediatr. 165: 398-401 (2006).
*
-
Brunner J, Sitzmann FC. The diagnostic value of anti-cyclic citrullinated peptide (CCP) antibodies in children with Juvenile Idiopathic Arthritis.
Clin. Exp. Rheumatol. 24: 449-451 (2006).
-
Brunner JK, Sitzmann FC. Anticyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.
Mod. Rheumatol. 16: 372-375 (2006).
*
-
Brunner M, Lackner E, Exler PS, Fluiter HC, Kletter K, Tschurlovits M, Dudczak R, Eichler HG, Muller M. 5-Aminosalicylic acid release from a new controlled-release mesalazine formulation during gastrointestinal transit in healthy volunteers.
Aliment. Pharmacol. Ther. 23: 137-144 (2006).
*
-
Brunner R, Schaefer D, Hess K, Parzer P, Resch F, Schwab S. Effect of high-dose cortisol on memory functions.
Ann. N. Y. Acad. Sci. 1071: 434-437 (2006).
*
-
Bruno MA, Cuello AC. Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade.
Proc. Natl. Acad. Sci. U.S.A. 103: 6735-6740 (2006).
*
-
Bruscia EM, Price JE, Cheng EC, Weiner S, Caputo C, Ferreira EC, Egan ME, Krause DS. Assessment of cystic fibrosis transmembrane conductance regulator (CFTR) activity in CFTR-null mice after bone marrow transplantation.
Proc. Natl. Acad. Sci. U.S.A. 103: 2965-2970 (2006).
*
-
Bruscia EM, Ziegler EC, Price JE, Weiner S, Egan ME, Krause DS. Engraftment of donor derived epithelial cells in multiple organs following bone marrow transplantation into newborn mice.
Stem Cells 24: 2299-2308 (2006).
*
-
Brustolim D, Ribeiro-Dos-Santos R, Kast RE, Altschuler EL, Soares MB. A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice.
Int. Immunopharmacol. 6: 903-907 (2006).
-
Brutkiewicz RR. CD1d ligands: the good, the bad, and the ugly.
J. Immunol. 177: 769-775 (2006).
*
-
Bry L, Brigl M, Brenner MB. CD4+-T-cell effector functions and costimulatory requirements essential for surviving mucosal infection with Citrobacter rodentium.
Infect. Immun. 74: 673-681 (2006).
*
-
Bryce AH, Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Inwards DJ, Yasenchak CA, Kumar SK, Gertz MA. Response to rituximab in patients with type II cryoglobulinemia.
Clin. Lymphoma Myeloma 7: 140-144 (2006).
-
Bryceson YT, March ME, Ljunggren HG, Long EO. Activation, coactivation, and costimulation of resting human natural killer cells.
Immunol. Rev. 214: 73-91 (2006).
*
-
Brydges S, Kastner DL. The systemic autoinflammatory diseases: inborn errors of the innate immune system.
Curr. Top. Microbiol. Immunol. 305: 127-160 (2006).
-
Bryhn M, Hansteen H, Schanche T, Aakre SE. The bioavailability and pharmacodynamics of different concentrations of omega-3 acid ethyl esters.
Prostaglandins Leukot. Essent. Fatty Acids 75: 19-24 (2006).
*
-
Bsibsi M, Persoon-Deen C, Verwer RW, Meeuwsen S, Ravid R, Van Noort JM. Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators.
Glia 53: 688-695 (2006).
-
Bu D, Tomlinson G, Lewis CM, Zhang C, Kildebeck E, Euhus DM. An intronic polymorphism associated with increased XRCC1 expression, reduced apoptosis and familial breast cancer.
Breast Cancer Res. Treat. 99: 257-265 (2006).
*
-
Bu HZ. A literature review of enzyme kinetic parameters for CYP3A4-mediated metabolic reactions of 113 drugs in human liver microsomes: structure-kinetics relationship assessment.
Curr. Drug Metab. 7: 231-249 (2006).
-
Buc M, Bucova M, Javor J, Krivosikova M, Stuchlikova M, Shawkatova I, Michalkova D, Barak L, Jancova E, Petrek M. Associations between HLA class II alleles and type 1 diabetes mellitus in the Slovak population.
Endocr. Regul. 40: 1-6 (2006).
*
-
Bucci P, Carile F, Sangianantoni A, D'Angio F, Santarelli A, Lo Muzio L. Oral aphthous ulcers and dental enamel defects in children with coeliac disease.
Acta Paediatr. 95: 203-207 (2006).
-
Bucciarelli S, Cervera R, Espinosa G, Gomez-Puerta JA, Ramos-Casals M, Font J. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors.
Autoimmun. Rev. 6: 72-75 (2006).
-
Bucciarelli S, Espinosa G, Asherson RA, Cervera R, Claver G, Gomez-Puerta JA, Ramos-Casals M, Ingelmo M, Font J. The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients.
Ann. Rheum. Dis. 65: 81-86 (2006).
*
-
Bucciarelli S, Espinosa G, Cervera R, Erkan D, Gomez-Puerta JA, Ramos-Casals M, Font J, Asherson RA. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients.
Arthritis Rheum. 54: 2568-2576 (2006).
*
-
Buch T, Waisman A. Protection from autoimmunity by DNA vaccination against T-cell receptor.
Methods Mol. Med. 127: 269-280 (2006).
-
Buchanan FG, Gorden DL, Matta P, Shi Q, Matrisian LM, DuBois RN. Role of beta-arrestin 1 in the metastatic progression of colorectal cancer.
Proc. Natl. Acad. Sci. U.S.A. 103: 1492-1497 (2006).
*
-
Buchli R, Vangundy RS, Giberson CF, Hildebrand WH. Critical factors in the development of fluorescence polarization-based peptide binding assays: an equilibrium study monitoring specific peptide binding to soluble HLA-A*0201.
J. Immunol. Methods 314: 38-53 (2006).
*
-
Buchman AL. Etiology and initial management of short bowel syndrome.
Gastroenterology 130: S5-S15 (2006).
*
-
Buchman AL, Babbo AM, Gieser RG. Central retinal vein thrombosis in a patient with ulcerative colitis.
Dig. Dis. Sci. 51: 1847-1849 (2006).
*
-
Buchman AL, Iyer K, Fryer J. Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation.
Hepatology 43: 9-19 (2006).
*
-
Buchwald P, Juhasz A, Bell C, Patfalusi M, Kovacs P, Hochhaus G, Howes J, Bodor N. Influence of the N-acetylation polymorphism on the metabolism of talampanel: an investigation in fasted and fed subjects genotyped for NAT2 variants.
Pharmazie 61: 125-134 (2006).
-
Buck D, Kroner A, Rieckmann P, Maurer M, Wiendl H. Analysis of the C/T(-1)) single nucleotide polymorphism in the CD40 gene in multiple sclerosis.
Tissue Antigens 68: 335-338 (2006).
*
-
Buckley JL, Chastain MA, Rietschel RL. Improvement of cystic fibrosis during treatment with isotretinoin.
Skinmed. 5: 252-255 (2006).
-
Buckley RH. Primary immunodeficiency or not? Making the correct diagnosis.
J. Allergy Clin. Immunol. 117: 756-758 (2006).
*
-
Buckova D, Holla LI, Znojil V, Vasku A. Polymorphisms of the CD14 gene and atopic phenotypes in Czech patients with IgE-mediated allergy.
J. Hum. Genet. 51: 977-983 (2006).
*
-
Bucuvalas J, Yazigi N, Squires Jr RH. Acute liver failure in children.
Clin. Liver Dis. 10: 149-168 (2006).
-
Budagian V, Bulanova E, Paus R, Bulfone-Paus S. IL-15/IL-15 receptor biology: a guided tour through an expanding universe.
Cytokine Growth Factor Rev. 17: 259-280 (2006).
-
Budancamanak M, Kanter M, Demirel A, Ocakci A, Uysal H, Karakaya C. Protective effects of thymoquinone and methotrexate on the renal injury in collagen-induced arthritis.
Arch. Toxicol. 80: 768-776 (2006).
*
-
Budd RC, Yeh WC, Tschopp J. cFLIP regulation of lymphocyte activation and development.
Nat. Rev. Immunol. 6: 196-204 (2006).
*
-
Buell JF, Alloway RR, Steve Woodle E. How can donors with a previous malignancy be evaluated?
J. Hepatol. 45: 503-507 (2006).
*
-
Buelta-Gonzalez C, Fernandez-Salazar L, Martin-Merino M, Aller de la Fuente R, Cuello Garcia R. Ulcerative colitis and autoimmune hemolytic anemia.
Gastroenterol. Hepatol. 29: 110 (2006).
-
Buendia MA. Liver cancer.
Falk Symposium 156. XIII Falk Liver Week (Part II). GENETICS IN LIVER DISEASES, Freiburg (Germany), October 8-9, 2006, p. 20-21 (2006). *
-
Bueso MB, Caballero R, Castro HJ, Barakat A, Bellanti JA. Recurrent infections and joint pain.
Allergy Asthma Proc. 27: 164-171 (2006).
-
Buettner R, Parhofer KG, Woenckhaus M, Wrede CE, Kunz-Schughart LA, Scholmerich J, Bollheimer LC. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types.
J. Mol. Endocrinol. 36: 485-501 (2006).
*
-
Bugeja MJ, Booth D, Bennetts B, Heard R, Rubio J, Stewart G. An investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians.
BMC Med. Genet. 7: 64 (2006).
*
-
Bugeja MJ, Booth DR, Bennetts BH, Heard RN, Stewart GJ. An investigation of polymorphisms in the 4q1 3.3-21.1 CXC chemokine gene cluster for association with multiple sclerosis in Australians.
Mult. Scler. 12: 710-722 (2006).
*
-
Buhler OT, Wiedig CA, Schmid Y, Grassl GA, Bohn E, Autenrieth IB. The Yersinia enterocolitica invasin protein promotes major histocompatibility complex class I- and class II-restricted T-cell responses.
Infect. Immun. 74: 4322-4329 (2006).
*
-
Buhner S, Buning C, Genschel J, Kling K, Herrmann D, Dignass A, Kuechler I, Krueger S, Schmidt HH, Lochs H. Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD15 3020insC mutation?
Gut 55: 342-347 (2006).
*
-
Bui HH, Schiewe AJ, von Grafenstein H, Haworth IS. Structural prediction of peptides binding to MHC class I molecules.
Proteins 63: 43-52 (2006).
*
-
Bui HH, Sidney J, Dinh K, Southwood S, Newman MJ, Sette A. Predicting population coverage of T-cell epitope-based diagnostics and vaccines.
BMC Bioinformatics 7: 153 (2006).
*
-
Buis CI, Hoekstra H, Verdonk RC, Porte RJ. Causes and consequences of ischemic-type biliary lesions after liver transplantation.
J. Hepatobiliary Pancreat. Surg. 13: 517-524 (2006).
*
-
Bukharin OV, Gritsenko VA, Tret'iakov AA, Chernikov DA. Taxonomic spectrum and antibiotic resistance of Enterobacteriaceae isolated from bile of patients with cholangitis.
Antibiot. Khimioter. 51: 7-12 (2006).
-
Bukreyev A, Serra ME, Laham FR, Melendi GA, Kleeberger SR, Collins PL, Polack FP. The cysteine-rich region and secreted form of the attachment G glycoprotein of respiratory syncytial virus enhance the cytotoxic T-lymphocyte response despite lacking major histocompatibility complex class I-restricted epitopes.
J. Virol. 80: 5854-5861 (2006).
*
-
Bulbul Baskan E, Baykara M, Ercan I, Tunali S, Yucel A. Vitiligo and ocular findings: a study on possible associations.
J. Eur. Acad. Dermatol. Venereol. 20: 829-833 (2006).
*
-
Bulhak AA, Sjoquist PO, Xu CB, Edvinsson L, Pernow J. Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1.
Basic Res. Cardiol. 101: 244-252 (2006).
-
Bullano MF, McNeeley BJ, Yu YF, Quimbo R, Burawski LP, Yu EB, Woolley JM. Comparison of costs associated with the use of etanercept, infliximab, and adalimumab for the treatment of rheumatoid arthritis.
Manag. Care Interface 19: 47-53 (2006).
-
Bullens DM, Truyen E, Coteur L, Dilissen E, Hellings PW, Dupont LJ, Ceuppens JL. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx?
Respir. Res. 7: 135 (2006).
*
-
Bultink IE, Hamann D, Seelen MA, Hart MH, Dijkmans BA, Daha MR, Voskuyl AE. Deficiency of functional mannose-binding lectin is not associated with infections in patients with systemic lupus erythematosus (SLE).
Arthritis Res. Ther. 8: R183 (2006).
*
-
Bulut K, Pennartz C, Felderbauer P, Ansorge N, Banasch M, Schmitz F, Schmidt WE, Hoffmann P. Vascular endothelial growth factor (VEGF(164)) ameliorates intestinal epithelial injury in vitro in IEC-18 and Caco-2 monolayers via induction of TGF-beta release from epithelial cells.
Scand. J. Gastroenterol. 41: 687-692 (2006).
*
-
Bulut M, Turkmen N, Fedakar R, Aydin SA. A case report of fatal oral ingestion of resorcinol.
Mt. Sinai J. Med. 73: 1049-1051 (2006).
*
-
Bulwin GC, Heinemann T, Bugge V, Winter M, Lohan A, Schlawinsky M, Schulze A, Walter S, Sabat R, Schulein R, Wiesner B, Veh RW, Lohler J, Blumberg RS, Volk HD, Utku N. TIRC7 inhibits T cell proliferation by modulation of CTLA-4 expression.
J. Immunol. 177: 6833-6841 (2006).
*
-
Bunce J, Achila D, Hetrick E, Lesley L, Huffman DL. Copper transfer studies between the N-terminal copper binding domains one and four of human Wilson protein.
Biochim. Biophys. Acta 1760: 907-912 (2006).
*
-
Buning C, Geerdts L, Fiedler T, Gentz E, Pitre G, Reuter W, Luck W, Buhner S, Molnar T, Nagy F, Lonovics J, Dignass A, Landt O, Nickel R, Genschel J, Lochs H, Schmidt HH, Witt H. DLG5 variants in inflammatory bowel disease.
Am. J. Gastroenterol. 101: 786-792 (2006).
*
-
Buning C, Lochs H. Conventional therapy for Crohn's disease.
World J. Gastroenterol. 12: 4794-4806 (2006).
*
-
Buning J, Hundorfean G, Schmitz M, Zimmer KP, Strobel S, Gebert A, Ludwig D. Antigen targeting to MHC class II-enriched late endosomes in colonic epithelial cells: trafficking of luminal antigens studied in vivo in Crohn's colitis patients.
FASEB J. 20: 359-361 (2006).
*
-
Bunk R, Dittrich AM, Schulze I, Horn J, Schmolke K, Volk HD, Wahn V, Hoflich C. Rapid whole blood flow cytometric test to detect ICOS deficiency in patients with common variable immunodeficiency.
Int. Arch. Allergy Immunol. 140: 342-344 (2006).
-
Burakoff R, Barish CF, Riff D, Pruitt R, Chey WY, Farraye FA, Shafran I, Katz S, Krone CL, Vander Vliet M, Stevens C, Sherman ML, Jacobson E, Bleday R. A phase 1/2A trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease.
Inflamm. Bowel Dis. 12: 558-565 (2006).
*
-
Burch LH, Picher M. E-NTPDases in human airways: regulation and relevance for chronic lung diseases.
Purinergic Signal. 2: 399-408 (2006).
*
-
Burczynski ME, Peterson RL, Twine NC, Zuberek KA, Brodeur BJ, Casciotti L, Maganti V, Reddy PS, Strahs A, Immermann F, Spinelli W, Schwertschlag U, Slager AM, Cotreau MM, Dorner AJ. Molecular classification of Crohn's disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells.
J. Mol. Diagn. 8: 51-61 (2006).
*
-
Burd RM. Psoriasis: a general overview.
Br. J. Hosp. Med. (Lond.) 67: 259-262 (2006).
-
Burdge GC. Metabolism of alpha-linolenic acid in humans.
Prostaglandins Leukot. Essent. Fatty Acids 75: 161-168 (2006).
*
-
Burger D, Dayer JM, Palmer G, Gabay C. Is IL-1 a good therapeutic target in the treatment of arthritis?
Best Pract. Res. Clin. Rheumatol. 20: 879-896 (2006).
-
Burgermeister E, Schnoebelen A, Flament A, Benz J, Stihle M, Gsell B, Rufer A, Ruf A, Kuhn B, Marki HP, Mizrahi J, Sebokova E, Niesor E, Meyer M. A novel partial agonist of peroxisome proliferator-activated receptor-gamma (PPARgamma) recruits PPARgamma-coactivator-1 alpha (PGC1alpha), prevents triglyceride accumulation and potentiates insulin signaling in vitro.
Mol. Endocrinol. 20: 809-830 (2006).
*
-
Burgess SJ, Marusina AI, Pathmanathan I, Borrego F, Coligan JE. IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells.
J. Immunol. 176: 1490-1497 (2006).
*
-
Burgmann T, Clara I, Graff L, Walker J, Lix L, Rawsthorne P, McPhail C, Rogala L, Miller N, Bernstein CN. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis - how much is irritable bowel syndrome?
Clin. Gastroenterol. Hepatol. 4: 614-620 (2006).
-
Burgos JS, Serrano-Saiz E, Sastre I, Valdivieso F. ICP47 mediates viral neuroinvasiveness by induction of TAP protein following intravenous inoculation of herpes simplex virus type 1 in mice.
J. Neurovirol. 12: 420-427 (2006).
-
Burja AM, Radianingtyas H, Windust A, Barrow CJ. Isolation and characterization of polyunsaturated fatty acid producing Thraustochytrium species: screening of strains and optimization of omega-3 production.
Appl. Microbiol. Biotechnol. 72: 1161-1169 (2006).
*
-
Burkart KM, Barton SJ, Holloway JW, Yang IA, Cakebread JA, Cruikshank W, Little F, Jin X, Farrer LA, Clough JB, Keith TP, Holgate S, Center DM, O'Connor GT. Association of asthma with a functional promoter polymorphism in the IL16 gene.
J. Allergy Clin. Immunol. 117: 86-91 (2006).
*
-
Burman KD, McKinley-Grant L. Dermatologic aspects of thyroid disease.
Clin. Dermatol. 24: 247-255 (2006).
-
Burnand B, Harris JK, Wietlisbach V, Froehlich F, Vader JP, Gonvers JJ, The Epage Study Group. Use, appropriateness, and diagnostic yield of screening colonoscopy: an international observational study (EPAGE).
Gastrointest. Endosc. 63: 1018-1026 (2006).
-
Burne TH, Johnston AN, McGrath JJ, Mackay-Sim A. Swimming behaviour and post-swimming activity in vitamin D receptor knockout mice.
Brain Res. Bull. 69: 74-78 (2006).
-
Burnett JR, Huff MW. Cholesterol absorption inhibitors as a therapeutic option for hypercholesterolaemia.
Expert Opin. Investig. Drugs 15: 1337-1351 (2006).
-
Burnevich EZ, Lopatkina TN. System manifestations of primary biliary cirrhosis.
Klin. Med. (Mosk.) 84: 42-46 (2006).
-
Burns MP, Vardanian L, Pajoohesh-Ganji A, Wang L, Cooper M, Harris DC, Duff K, Rebeck GW. The effects of ABCA1 on cholesterol efflux and Abeta levels in vitro and in vivo.
J. Neurochem. 98: 792-800 (2006).
*
-
Burra P, Porte RJ. Should donors and recipients be matched in liver transplantation?
J. Hepatol. 45: 488-494 (2006).
*
-
Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases: role in arthritis.
Front. Biosci. 11: 529-543 (2006).
-
Burroughs AK, Sabin CA, Rolles K, Delvart V, Karam V, Buckels J, O'Grady JG, Castaing D, Klempnauer J, Jamieson N, Neuhaus P, Lerut J, de Ville de Goyet J, Pollard S, Salizzoni M, Rogiers X, Muhlbacher F, Garcia Valdecasas JC, Broelsch C, Jaeck D, et al. 3-Month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome.
Lancet 367: 225-232 (2006).
*
-
Burrows SR, Rossjohn J, McCluskey J. Have we cut ourselves too short in mapping CTL epitopes?
Trends Immunol. 27: 11-16 (2006).
*
-
Burt RK, Marmont A, Oyama Y, Slavin S, Arnold R, Hiepe F, Fassas A, Snowden J, Schuening F, Myint H, Patel DD, Collier D, Heslop H, Krance R, Statkute L, Verda L, Traynor A, Kozak T, Hintzen RQ, Rose JW, Voltarelli J, Loh Y, Territo M, Cohen BA, et al. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens.
Arthritis Rheum. 54: 3750-3760 (2006).
*
-
Burt RK, Traynor A, Statkute L, Barr WG, Rosa R, Schroeder J, Verda L, Krosnjar N, Quigley K, Yaung K, Villa Bs M, Takahashi M, Jovanovic B, Oyama Y. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus.
JAMA 295: 527-535 (2006).
*
-
Burton DR, Dwek RA. Immunology. Sugar determines antibody activity.
Science 313: 627-628 (2006).
*
-
Burton S, Lloyd M. An overview of rheumatoid arthritis.
Nurs. Stand. 20: 46-49 (2006).
-
Burwick RM, Ramsay PP, Haines JL, Hauser SL, Oksenberg JR, Pericak-Vance MA, Schmidt S, Compston A, Sawcer S, Cittadella R, Savettieri G, Quattrone A, Polman CH, Uitdehaag BM, Zwemmer JN, Hawkins CP, Ollier WE, Weatherby S, Enzinger C, Fazekas F, et al. APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers.
Neurology 66: 1373-1383 (2006).
-
Busche A, Goldmann T, Naumann U, Steinle A, Brandau S. Natural killer cell-mediated rejection of experimental human lung cancer by genetic overexpression of major histocompatibility complex class I chain-related gene A.
Hum. Gene Ther. 17: 135-146 (2006).
-
Buscher R, Grasemann H. Disease modifying genes in cystic fibrosis: therapeutic option or one-way road?
Naunyn. Schmiedebergs. Arch. Pharmacol. 374: 65-77 (2006).
*
-
Buschhausen L, Kruis W, Aymaz S, Weber M, Krakamp B. Characterization of proteinuria in patients with ulcerative colitis and therapy with aminosalicylates.
Med. Klin. (Munich) 101: 791-795 (2006).
-
Bush WS, Dudek SM, Ritchie MD. Parallel multifactor dimensionality reduction: a tool for the large scale analysis of gene-gene interactions.
Bioinformatics 22: 2173-2174 (2006).
*
-
Bushinsky DA, Laplante K, Asplin JR. Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats.
Kidney Int. 69: 1586-1592 (2006).
*
-
Busquets-Perez N, Narvaez J, Valverde-Garcia J. Interstitial granulomatous dermatitis with arthritis (Ackerman syndrome).
J. Rheumatol. 33: 1207-1209 (2006).
-
Bussel JB, Kuter DJ, George JN, McMillan R, Aledort LM, Conklin GT, Lichtin AE, Lyons RM, Nieva J, Wasser JS, Wiznitzer I, Kelly R, Chen CF, Nichol JL. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP.
N. Engl. J. Med. 355: 1672-1681 (2006).
*
-
Bussey H, Andrews B, Boone C. From worm genetic networks to complex human diseases.
Nat. Genet. 38: 862-863 (2006).
*
-
Busteed S, Bennett MW, Molloy C, Houston A, Stone MA, Shanahan F, Molloy MG, O'Connell J. Bcl-x(L) expression in vivo in rheumatoid synovium.
Clin. Rheumatol. 25: 789-793 (2006).
*
-
Bustos D, Moret A, Tambutti M, Gogorza S, Testa R, Ascione A, Prigoshin N. Autoantibodies in Argentine women with recurrent pregnancy loss.
Am. J. Reprod. Immunol. 55: 201-207 (2006).
*
-
Butchar JP, Parsa KV, Marsh CB, Tridandapani S. Negative regulators of Toll-like receptor 4-mediated macrophage inflammatory response.
Curr. Pharm. Des. 12: 4143-4153 (2006).
-
Butler M, Ng CY, van Heel DA, Lombardi G, Lechler R, Playford RJ, Ghosh S. Modulation of dendritic cell phenotype and function in an in vitro model of the intestinal epithelium.
Eur. J. Immunol. 36: 864-874 (2006).
*
-
Butovich IA, Lukyanova SM, Bachmann C. Dihydroxydocosahexaenoic acids of the neuroprotectin D family: synthesis, structure and inhibition of human 5-lipoxygenase.
J. Lipid Res. 47: 2462-2474 (2006).
*
-
Butovsky O, Landa G, Kunis G, Ziv Y, Avidan H, Greenberg N, Schwartz A, Smirnov I, Pollack A, Jung S, Schwartz M. Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis.
J. Clin. Invest. 116: 905-915 (2006).
*
-
Butrimiene I, Ranceva J, Griskevicius A. Potential triggering infections of reactive arthritis.
Scand. J. Rheumatol. 35: 459-462 (2006).
-
Buts JP, Dekeyser N, Stilmant C, Delem E, Smets F, Sokal E. Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylation.
Pediatr. Res. 60: 24-29 (2006).
*
-
Butt AM. Neurotransmitter-mediated calcium signalling in oligodendrocyte physiology and pathology.
Glia 54: 666-675 (2006).
-
Butt C, Gladman D, Rahman P. PPAR-gamma gene polymorphisms and psoriatic arthritis.
J. Rheumatol. 33: 1631-1633 (2006).
*
-
Butt C, Peddle L, Greenwood C, Hamilton S, Gladman D, Rahman P. Association of functional variants of PTPN22 and tp53 in psoriatic arthritis: a case-control study.
Arthritis Res. Ther. 8: R27-R30 (2006).
*
-
Butterworth JR. Another important function for an old friend! The role of iron in colorectal carcinogenesis.
Gut 55: 1384-1386 (2006).
*
-
Butzkueven H, Chapman J, Cristiano E, Grand'Maison F, Hoffmann M, Izquierdo G, Jolley D, Kappos L, Leist T, Pohlau D, Rivera V, Trojano M, Verheul F, Malkowski JP. MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis.
Mult. Scler. 12: 769-774 (2006).
*
-
Buxbaum J, Qian P, Khuu C, Shneider BL, Daikh DI, Gershwin ME, Allen PM, Peters MG. Novel model of antigen-specific induction of bile duct injury.
Gastroenterology 131: 1899-1906 (2006).
*
-
Buydens-Branchey L, Branchey M. n-3 Polyunsaturated fatty acids decrease anxiety feelings in a population of substance abusers.
J. Clin. Psychopharmacol. 26: 661-665 (2006).
-
Buyse F, Hou YX, Vigano C, Zhao Q, Ruysschaert JM, Chang XB. Substitution of the positive-charged Walker A lysine with a hydrophobic leucine and conformational alterations caused by this mutation in MRP1 impair ATP binding and hydrolysis.
Biochem. J. 397: 121-130 (2006).
*
-
Buzas EI, Gyorgy B, Pasztoi M, Jelinek I, Falus A, Gabius HJ. Carbohydrate recognition systems in autoimmunity.
Autoimmunity 39: 691-704 (2006).
-
Buzkova H, Pechandova K, Slanar O, Perlik F. Genetic polymorphism of cytochrome P450 and methods for its determination.
Prague Med. Rep. 107: 383-393 (2006).
-
Buzoni-Gatel D, Schulthess J, Menard LC, Kasper LH. Mucosal defences against orally acquired protozoan parasites, emphasis on Toxoplasma gondii infections.
Cell. Microbiol. 8: 535-544 (2006).
*
-
Buzza MS, Bird PI. Extracellular granzymes: current perspectives.
Biol. Chem. 387: 827-837 (2006).
-
Bybel B, Brunken RC, Shah SN, Wu G, Turbiner E, Neumann DR. PET and PET/CT imaging: what clinicians need to know.
Cleve. Clin. J. Med. 73: 1075-1087 (2006).
*
-
Bylaite M, Moussali H, Marciukaitiene I, Ruzicka T, Walz M. Expression of cathepsin L and its inhibitor hurpin in inflammatory and neoplastic skin diseases.
Exp. Dermatol. 15: 110-118 (2006).
*
-
Byrn JC, Wang JL, Divino CM, Nguyen SQ, Warner RR. Management of goblet cell carcinoid.
J. Surg. Oncol. 94: 396-402 (2006).
-
Byrne FR, Viney JL. Mouse models of inflammatory bowel disease.
Curr. Opin. Drug Discov. Devel. 9: 207-217 (2006).
-
Byrne JA, Strautnieks SS, Ihrke G, Knisely AS, Jirsa M, Cebecauerova D, Linton KJ, Higgins CF, Mieli-Vergani G, Thompson RJ. Investigation of the disease mechanisms associated with missense mutations in the bile salt export pump, BSEP.
Falk Symposium 155. XIII FALK LIVER WEEK (Part I) XIX International Bile Acid Meeting. Bile Acids: Biological Actions and Clinical Relevance, October 6 - 7, 2006 Freiburg (Germany), p. 61 (2006). *
-
Byrnes V, Afdhal N, Challies T, Greenstein PE. Drug induced liver injury secondary to interferon-beta (IFN-beta) in multiple sclerosis.
Ann. Hepatol. 5: 56-59 (2006).
*
-
Cabana MD, Shane AL, Chao C, Oliva-Hemker M. Probiotics in primary care pediatrics.
Clin. Pediatr. (Phila.) 45: 405-410 (2006).
*
-
Cabanillas M, Perez-Perez L, Sanchez-Aguilar D, Toribio J. Generalized pustular psoriasis and cytolytic hepatitis associated with neutrophilic cholangitis.
Actas. Dermosifiliogr. 97: 330-333 (2006).
-
Cabello GM, Cabello PH, Llerena JC Jr, Fernandes O. Polymorphic markers suggest a gene flow of CFTR gene from sub-Saharan/Arabian and Mediterranean to Brazilian population.
J. Hered. 97: 313-317 (2006).
*
-
Cabranes A, Pryce G, Baker D, Fernandez-Ruiz J. Changes in CB(1) receptors in motor-related brain structures of chronic relapsing experimental allergic encephalomyelitis mice.
Brain Res. 1107: 199-205 (2006).
-
Cabriada J, Domenech E, Gomollon F, Gonzalez-Carro P, Gonzalez-Lara V, Hinojosa J, Jimenez-Lopez C, Nos P, Obrador A, Panes J, Saro C, Varea V, Lafuente R, Guilera M. Consensus document on the use of granulocytapheresis in patients with inflammatory bowel disease.
Gastroenterol. Hepatol. 29: 85-91 (2006).
-
Cadavid D, Sondey M, Garcia E, Lawson CL. Residual brain infection in relapsing-Fever borreliosis.
J. Infect. Dis. 193: 1451-1458 (2006).
*
-
Caddy GR, Ardill JE, Fillmore D, Caldwell CM, McKibben BM, Gardiner KR, Watson PR. Plasma concentrations of glucagon-like peptide-2 in adult patients with treated and untreated coeliac disease.
Eur. J. Gastroenterol. Hepatol. 18: 195-202 (2006).
-
Caddy GR, Tham TC. Gallstone disease: symptoms, diagnosis and endoscopic management of common bile duct stones.
Best Pract. Res. Clin. Gastroenterol. 20: 1085-1101 (2006).
-
Cadle RM, Mansouri MD, Darouiche RO. Vancomycin-induced elevation of liver enzyme levels.
Ann. Pharmacother. 40: 1186-1189 (2006).
-
Cadoni G, Boccia S, Scipione S, Arzani D, Cianfagna F, Ricciardi G, Paludetti G, Agostino S. Glutathione S-transferase gene polymorphisms in Italian patients with sudden sensorineural hearing loss.
Otol. Neurotol. 27: 1166-1169 (2006).
-
Cadoni G, Cianfoni A, Agostino S, Scipione S, Tartaglione T, Galli J, Colosimo C. Magnetic resonance imaging findings in sudden sensorineural hearing loss.
J. Otolaryngol. 35: 310-316 (2006).
-
Cagnin A, Taylor-Robinson SD, Forton DM, Banati RB. In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy.
Gut 55: 547-553 (2006).
*
-
Cahoon Jr WD, Kockler DR. Mycophenolate mofetil treatment of myasthenia gravis.
Ann. Pharmacother. 40: 295-298 (2006).
-
Cai J, Kohanof S, Terasaki PI. HLA-DR antibody epitopes.
Clin. Transpl. 2006: 103-114 (2006).
-
Cai L. Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy.
Free Radic. Biol. Med. 41: 851-861 (2006).
-
Cai SS, Syage JA. Comparison of atmospheric pressure photoionization, atmospheric pressure chemical ionization, and electrospray ionization mass spectrometry for analysis of lipids.
Anal. Chem. 78: 1191-1199 (2006).
*
-
Cai SY, Boyer JL. FXR: a target for cholestatic syndromes?
Expert Opin. Ther. Targets 10: 409-421 (2006).
-
Cai W, Wu J, Hong L, Xu Y, Tang Q, Shi C. Oxidative injury and hepatocyte apoptosis in total parenteral nutrition-associated liver dysfunction.
J. Pediatr. Surg. 41: 1663-1668 (2006).
-
Cai X, Wong YF, Zhou H, Liu ZQ, Xie Y, Jiang ZH, Bian ZX, Xu HX, Liu L. Manipulation of the induction of adjuvant arthritis in Sprague-Dawley rats.
Inflamm. Res. 55: 368-377 (2006).
*
-
Cai X, Wong YF, Zhou H, Xie Y, Liu ZQ, Jiang ZH, Bian ZX, Xu HX, Liu L. The comparative study of Sprague-Dawley and Lewis rats in adjuvant-induced arthritis.
Naunyn. Schmiedebergs. Arch. Pharmacol. 373: 140-147 (2006).
*
-
Cai Z, Taddei A, Sheppard DN. Differential sensitivity of the cystic fibrosis (CF)-associated mutants G551D and G1349D to potentiators of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel.
J. Biol. Chem. 281: 1970-1977 (2006).
*
-
Caillat-Zucman S. How NKG2D ligands trigger autoimmunity?
Hum. Immunol. 67: 204-207 (2006).
-
Cairns B, Maile R, Barnes CM, Frelinger JA, Meyer AA. Increased Toll-like receptor 4 expression on T cells may be a mechanism for enhanced T cell response late after burn injury.
J. Trauma 61: 293-299 (2006).
-
Cakir E, Uyan ZS, Ersu RH, Karadag B, Karakoc F, Dagli E. Mucoid impaction: an unusual form of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis.
Pediatr. Pulmonol. 41: 1103-1107 (2006).
-
Calabrese L. The yin and yang of tumor necrosis factor inhibitors.
Cleve. Clin. J. Med. 73: 251-256 (2006).
*
-
Calander AM, Starckx S, Opdenakker G, Bergin P, Quiding-Jarbrink M, Tarkowski A. Matrix metalloproteinase-9 (gelatinase B) deficiency leads to increased severity of Staphylococcus aureus-triggered septic arthritis.
Microbes Infect. 8: 1434-1439 (2006).
*
-
Calano SJ, Shih PA, Liu CC, Kao AH, Navratil JS, Manzi S, Ahearn JM. Cell-bound complement activation products (CB-CAPs) as a source of lupus biomarkers.
Adv. Exp. Med. Biol. 586: 381-390 (2006).
-
Calcagni E, Elenkov I. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases.
Ann. N. Y. Acad. Sci. 1069: 62-76 (2006).
*
-
Calcagno AM, Ludwig JA, Fostel JM, Gottesman MM, Ambudkar SV. Comparison of drug transporter levels in normal colon, colon cancer, and Caco-2 cells: impact on drug disposition and discovery.
Mol. Pharm. 3: 87-93 (2006).
-
Caldarella MP, Giamberardino MA, Sacco F, Affaitati G, Milano A, Lerza R, Balatsinou C, Laterza F, Pierdomenico SD, Cuccurullo F, Neri M. Sensitivity disturbances in patients with irritable bowel syndrome and fibromyalgia.
Am. J. Gastroenterol. 101: 2782-2789 (2006).
*
-
Caldari-Torres C, Rodriguez-Sallaberry C, Greene ES, Badinga L. Differential effects of n-3 and n-6 fatty acids on prostaglandin F2alpha production by bovine endometrial cells.
J. Dairy Sci. 89: 971-977 (2006).
*
-
Caldas C, Luna E, Spadafora-Ferreira M, Porto G, Iwai LK, Oshiro SE, Monteiro SM, Fonseca JA, Lemos F, Hammer J, Ho PL, Kalil J, Coelho V. Cellular autoreactivity against heat shock protein 60 in renal transplant patients: peripheral and graft-infiltrating responses.
Clin. Exp. Immunol. 146: 66-75 (2006).
*
-
Calder CJ, Nicholson LB, Dick AD. Mechanisms for inducing nasal mucosal tolerance in experimental autoimmune uveoretinitis.
Methods 38: 69-76 (2006).
*
-
Calder PC. Polyunsaturated fatty acids and inflammation.
Prostaglandins Leukot. Essent. Fatty Acids 75: 197-202 (2006).
*
-
Calder PC. Branched-chain amino acids and immunity.
J. Nutr. 136: 288S-293S (2006).
*
-
Calder PC. n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases.
Am. J. Clin. Nutr. 83: 1505S-1519S (2006).
*
-
Calder PC. Use of fish oil in parenteral nutrition: rationale and reality.
Proc. Nutr. Soc. 65: 264-277 (2006).
*
-
Calder PC, Krauss-Etschmann S, de Jong EC, Dupont C, Frick JS, Frokiaer H, Heinrich J, Garn H, Koletzko S, Lack G, Mattelio G, Renz H, Sangild PT, Schrezenmeir J, Stulnig TM, Thymann T, Wold AE, Koletzko B. Early nutrition and immunity - progress and perspectives.
Br. J. Nutr. 96: 774-790 (2006).
*
-
Calderon TM, Eugenin EA, Lopez L, Kumar SS, Hesselgesser J, Raine CS, Berman JW. A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein.
J. Neuroimmunol. 177: 27-39 (2006).
-
Calderoni DR, Andrade Tdos S, Grotto HZ. Haptoglobin phenotype appears to affect the pathogenesis of American trypanosomiasis.
Ann. Trop. Med. Parasitol. 100: 213-221 (2006).
-
Caldwell SH, Argo CK, Al-Osaimi AM. Therapy of NAFLD: insulin sensitizing agents.
J. Clin. Gastroenterol. 40 Suppl. 1: S61-S66 (2006).
-
Caldwell SH, Hoffman M, Lisman T, Macik BG, Northup PG, Reddy KR, Tripodi A, Sanyal AJ. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management.
Hepatology 44: 1039-1046 (2006).
*
-
Calguneri OM, Ozturk MA, Kiraz S, Ertenli I, Onat AM, Ureten K, Ozbalkan Z, Haznedaroglu IC. Lack of association between familial Mediterranean fever and angiotensin converting enzyme gene polymorphism.
Joint Bone Spine 73: 334-336 (2006).
*
-
Calkin AC, Giunti S, Jandeleit-Dahm KA, Allen TJ, Cooper ME, Thomas MC. PPAR-alpha and gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse.
Nephrol. Dial. Transplant. 21: 2399-2405 (2006).
*
-
Callaghan R, Ford RC, Kerr ID. The translocation mechanism of P-glycoprotein.
FEBS Lett. 580: 1056-1063 (2006).
*
-
Callegari PE, Schaible TF, Boscia JA. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
JAMA 296: 2202 (2006).
*
-
Calleja C, Messaddeq N, Chapellier B, Yang H, Krezel W, Li M, Metzger D, Mascrez B, Ohta K, Kagechika H, Endo Y, Mark M, Ghyselinck NB, Chambon P. Genetic and pharmacological evidence that a retinoic acid cannot be the RXR-activating ligand in mouse epidermis keratinocytes.
Genes Dev. 20: 1525-1538 (2006).
*
-
Callejas JL, Sabio JM, Haro MD, Camps M, Ramon ED, Garcia-Hernandez FJ, Koeleman B, Martin J, Gonzalez-Escribano MF. Polymorphisms of the FCRL3 gene in a Spanish population of systemic lupus erythematosus patients.
Rheumatology (Oxford) 45: 1044-1046 (2006).
*
-
Callejas-Rubio JL, Lopez-Nevot MA, Martin-Ibanez J, Ortego-Centeno N. Takayasus's arteritis associated with ulcerative colitis.
Med. Clin. (Barc.) 126: 518 (2006).
-
Calsbeek H, Rijken M, Bekkers MJ, Dekker J, Henegouwen GP. School and leisure activities in adolescents and young adults with chronic digestive disorders: impact of burden of disease.
Int. J. Behav. Med. 13: 121-130 (2006).
-
Calsbeek H, Rijken M, Dekker J, van Berge Henegouwen GP. Disease characteristics as determinants of the labour market position of adolescents and young adults with chronic digestive disorders.
Eur. J. Gastroenterol. Hepatol. 18: 203-209 (2006).
-
Calverley DC, Baldermann LV, Moran K, Chen NN, McFann K. Platelet FcgammaRIIA expression is associated with the alpha(2) integrin C807T gene polymorphism in type 2 diabetes.
Platelets 17: 78-83 (2006).
-
Calvet X, Gallardo O, Coronas R, Casellas F, Montserrat A, Torrejon A, Vergara M, Campo R, Brullet E. Remission on thiopurinic immunomodulators normalizes quality of life and psychological status in patients with Crohn's disease.
Inflamm. Bowel Dis. 12: 692-696 (2006).
*
-
Calvete JJ, Revert F, Blanco M, Cervera J, Tarrega C, Sanz L, Revert-Ros F, Granero F, Perez-Paya E, Hudson BG, Saus J. Conformational diversity of the Goodpasture antigen, the noncollagenous-1 domain of the alpha3 chain of collagen IV.
Proteomics 6 Suppl. 1: S237-S244 (2006).
*
-
Calvisi DF, Ladu S, Gorden A, Farina M, Conner EA, Lee JS, Factor VM, Thorgeirsson SS. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.
Gastroenterology 130: 1117-1128 (2006).
*
-
Calvo N, Iversen E, Munck LK. Intestinal side effects of COX-2 inhibitors.
Ugeskr. Laeger. 168: 1343-1344 (2006).
-
Calvo-Alen J, Alarcon GS, Tew MB, Tan FK, McGwin G Jr, Fessler BJ, Vila LM, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort: XXXIV. Deficient mannose-binding lectin exon 1 polymorphisms are associated with cerebrovascular but not with other arterial thrombotic events.
Arthritis Rheum. 54: 1940-1945 (2006).
*
-
Calvopina M, Barroso PA, Marco JD, Korenaga M, Cooper PJ, Nonaka S, Hashiguchi Y. Efficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis.
Vaccine 24: 5645-5652 (2006).
*
-
Camacho JA, Mardach R, Rioseco-Camacho N, Ruiz-Pesini E, Derbeneva O, Andrade D, Zaldivar F, Qu Y, Cederbaum SD. Clinical and functional characterization of a human ORNT1 mutation (T32R) in the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome.
Pediatr. Res. 60: 423-429 (2006).
*
-
Camateros P, Moisan J, Henault J, De Sanctis J, Skamene E, Radzioch D. Toll-like receptors, cytokines and the immunotherapeutics of asthma.
Curr. Pharm. Des. 12: 2365-2374 (2006).
-
Cambridge G, Stohl W, Leandro MJ, Migone TS, Hilbert DM, Edwards JC. Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse.
Arthritis Rheum. 54: 723-732 (2006).
*
-
Cameron L, Webster RB, Strempel JM, Kiesler P, Kabesch M, Ramachandran H, Yu L, Stern DA, Graves PE, Lohman IC, Wright AL, Halonen M, Klimecki WT, Vercelli D. Th2 cell-selective enhancement of human IL13 transcription by IL13-1112C>T, a polymorphism associated with allergic inflammation.
J. Immunol. 177: 8633-8642 (2006).
*
-
Camilleri M. Probiotics and irritable bowel syndrome: rationale, putative mechanisms, and evidence of clinical efficacy.
J. Clin. Gastroenterol. 40: 264-269 (2006).
-
Camilleri M. Is there a role for probiotics in irritable bowel syndrome?
Dig. Liver Dis. 38 Suppl. 2: S266-S269 (2006).
-
Camilleri M. Gastroenterology and hepatology clinical research update: 2005-2006.
Clin. Gastroenterol. Hepatol. 4: 1428-1433 (2006).
-
Camilli A, Bassler BL. Bacterial small-molecule signaling pathways.
Science 311: 1113-1116 (2006).
*
-
Cammarota G, Cesaro P, Martino A, Zuccala G, Cianci R, Nista E, Larocca LM, Vecchio FM, Gasbarrini A, Gasbarrini G. High accuracy and cost-effectiveness of a biopsy-avoiding endoscopic approach in diagnosing coeliac disease.
Aliment. Pharmacol. Ther. 23: 61-69 (2006).
*
-
Cammelli D. Extra-articular manifestations of seronegative spondyloarthritis.
Recenti Prog. Med. 97: 280-289 (2006).
-
Camp RD. Updates from the Fourth International Congress 'Psoriasis: from Gene to Clinic', The Royal College of Physicians, London, U.K., 1-3 December 2005.
Br. J. Dermatol. 155: 1124-1130 (2006).
*
-
Campagnoli MF, Garbarini L, Quarello P, Garelli E, Carando A, Baravalle V, Doria A, Biava A, Chiocchetti A, Rosolen A, Dufour C, Dianzani U, Ramenghi U. The broad spectrum of autoimmune lymphoproliferative disease: molecular bases, clinical features and long-term follow-up in 31 patients.
Haematologica 91: 538-541 (2006).
*
-
Campagnoli MF, Pucci A, Garelli E, Carando A, Defilippi C, Lala R, Ingrosso G, Dianzani I, Forni M, Ramenghi U. Familial tumoral calcinosis and testicular microlithiasis associated with a new mutation of GALNT3 in a white family.
J. Clin. Pathol. 59: 440-442 (2006).
*
-
Campard D, Vasse M, Rose-John S, Poyer F, Lamacz M, Vannier JP. Multilevel regulation of IL-6R by IL-6-sIL-6R fusion protein according to the primitiveness of peripheral blood-derived CD133+ cells.
Stem Cells 24: 1302-1314 (2006).
*
-
Campbell DB, Sutcliffe JS, Ebert PJ, Militerni R, Bravaccio C, Trillo S, Elia M, Schneider C, Melmed R, Sacco R, Persico AM, Levitt P. A genetic variant that disrupts MET transcription is associated with autism.
Proc. Natl. Acad. Sci. U.S.A. 103: 16834-16839 (2006).
*
-
Campbell JN, Meyer RA. Mechanisms of neuropathic pain.
Neuron 52: 77-92 (2006).
*
-
Campbell MJ, Abedin SA. Vitamin D and cancer.
Expert Rev. Endocrinol. Metab. 1: 219-231 (2006). *
-
Campbell MJ, Adorini L. The vitamin D receptor as a therapeutic target.
Expert Opin. Ther. Targets 10: 735-748 (2006).
-
Campbell PJ, Green AR. The myeloproliferative disorders.
N. Engl. J. Med. 355: 2452-2466 (2006).
*
-
Campbell S, Burkly LC, Gao HX, Berman JW, Su L, Browning B, Zheng T, Schiffer L, Michaelson JS, Putterman C. Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells.
J. Immunol. 176: 1889-1898 (2006).
*
-
Camplejohn RS, Hodgson S, Carter N, Kato BS, Spector TD. Heritability of DNA-damage-induced apoptosis and its relationship with age in lymphocytes from female twins.
Br. J. Cancer 95: 520-524 (2006).
*
-
Campos RA, Szczepanik M, Lisbonne M, Itakura A, Leite-de-Moraes M, Askenase PW. Invariant NKT cells rapidly activated via immunization with diverse contact antigens collaborate in vitro with B-1 cells to initiate contact sensitivity.
J. Immunol. 177: 3686-3694 (2006).
*
-
Camuesco D, Comalada M, Concha A, Nieto A, Sierra S, Xaus J, Zarzuelo A, Galvez J. Intestinal anti-inflammatory activity of combined quercitrin and dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, in rats with DSS-induced colitis.
Clin. Nutr. 25: 466-476 (2006).
-
Canales P, Mery VP, Larrondo FJ, Bravo FL, Godoy J. Epilepsy and celiac disease: favorable outcome with a gluten-free diet in a patient refractory to antiepileptic drugs.
Neurologist 12: 318-321 (2006).
-
Canaple L, Rambaud J, Dkhissi-Benyahya O, Rayet B, Tan NS, Michalik L, Delaunay F, Wahli W, Laudet V. Reciprocal regulation of BMAL1 and PPARalpha defines a novel positive feedback loop in the rodent liver circadian clock.
Mol. Endocrinol. 20: 1715-1727 (2006).
*
-
Canavan C, Abrams KR, Hawthorne B, Drossman D, Mayberry JF. Long-term prognosis in Crohn's disease: factors that affect quality of life.
Aliment. Pharmacol. Ther. 23: 377-385 (2006).
*
-
Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease.
Aliment. Pharmacol. Ther. 23: 1097-1104 (2006).
*
-
Canbay A, Bechmann LP, Best J, Jochum C, Treichel U, Gerken G. Crohn's disease-induced non-alcoholic fatty liver disease (NAFLD) sensitizes for severe acute hepatitis B infection and liver failure.
Z. Gastroenterol. 44: 245-248 (2006).
-
Cancado EL, Medeiros DM, Deguti MM, Dos Santos MS, de Mello ES, Vendramini MB, Carrilho FJ. Celiac disease associated with nodular regenerative hyperplasia, pulmonary abnormalities, and IgA anticardiolipin antibodies.
J. Clin. Gastroenterol. 40: 135-139 (2006).
-
Candia L, Cuellar ML, Marlowe SM, Marquez J, Iglesias A, Espinoza LR. Charcot-like arthropathy: a newly-recognized subset of psoriatic arthritis.
Clin. Exp. Rheumatol. 24: 172-175 (2006).
-
Candia L, Marquez J, Gonzalez C, Santos AM, Londono J, Valle R, Zabaleta J, Yaqub Z, Espinoza LR. Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis.
J. Clin. Rheumatol. 12: 226-229 (2006).
-
Candon S, Mosca A, Ruemmele F, Goulet O, Chatenoud L, Cezard JP. Clinical and biological consequences of immunization to infliximab in pediatric Crohn's disease.
Clin. Immunol. 118: 11-19 (2006).
*
-
Candore G, Aquino A, Balistreri CR, Bulati M, Di Carlo D, Grimaldi MP, Listi F, Orlando V, Vasto S, Caruso M, Colonna-Romano G, Lio D, Caruso C. Inflammation, longevity, and cardiovascular diseases: role of polymorphisms of TLR4.
Ann. N. Y. Acad. Sci. 1067: 282-287 (2006).
*
-
Candore G, Balistreri CR, Campagna AM, Colombo A, Cuppari I, DI-Carlo D, Grimaldi MP, Orlando V, Piazza G, Vasto S, Lio D, Caruso C. Genetic control of immune response in carriers of ancestral haplotype 8.1: the study of chemotaxis.
Ann. N. Y. Acad. Sci. 1089: 509-515 (2006).
*
-
Caniato RN, Alvarenga ME, Garcia-Alcaraz MA. Effect of omega-3 fatty acids on the lipid profile of patients taking clozapine.
Aust. N. Z. J. Psychiatry 40: 691-697 (2006).
*
-
Cankurtaran M, Ulger Z, Dogan S, Balam Yavuz B, Halil M, Gullu I, Gedikoglu G, Aniogul S. Complications due to late diagnosis of celiac disease with co-existing plasma cell dyscrasia in an elderly patient.
Aging Clin. Exp. Res. 18: 75-77 (2006).
-
Canny G, Cario E, Lennartsson A, Gullberg U, Brennan C, Levy O, Colgan SP. Functional and biochemical characterization of epithelial bactericidal/permeability-increasing protein.
Am. J. Physiol. Gastrointest. Liver Physiol. 290: G557-G567 (2006).
*
-
Canny G, Swidsinski A, McCormick BA. Interactions of intestinal epithelial cells with bacteria and immune cells: methods to characterize microflora and functional consequences.
Methods Mol. Biol. 341: 17-35 (2006).
-
Canny GO, Trifonova RT, Kindelberger DW, Colgan SP, Fichorova RN. Expression and function of bactericidal/permeability-increasing protein in human genital tract epithelial cells.
J. Infect. Dis. 194: 498-502 (2006).
*
-
Cano DA, Sekine S, Hebrok M. Primary cilia deletion in pancreatic epithelial cells results in cyst formation and pancreatitis.
Gastroenterology 131: 1856-1869 (2006).
*
-
Cano Vargas-Machuca E, Mondejar-Marin B, Navarro-Munoz S, Perez-Molina I, Garrido-Robres JA, Alvarez-Tejerina A. Recurrent aseptic meningitis secondary to taking ibuprofen and ketorolac.
Rev. Neurol. 42: 217-219 (2006).
-
Canovic P, Gajovic O, Todorovic Z, Mijailovic Z. Epstein-Barr virus hepatitis associated with icterus - a case report.
Med. Pregl. 59: 179-182 (2006).
-
Cantaert T, De Rycke L, Bongartz T, Matteson EL, Tak PP, Nicholas AP, Baeten D. Citrullinated proteins in rheumatoid arthritis: crucial ... but not sufficient!
Arthritis Rheum. 54: 3381-3389 (2006).
*
-
Cantarini MC, de la Monte SM, Pang M, Tong M, D'Errico A, Trevisani F, Wands JR. Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms.
Hepatology 44: 446-457 (2006).
*
-
Cantin AM, Bacon M, Berthiaume Y. Mechanical airway clearance using the frequencer electro-acoustical transducer in cystic fibrosis.
Clin. Invest. Med. 29: 159-165 (2006).
-
Cantin AM, Berthiaume Y, Cloutier D, Martel M. Prolastin aerosol therapy and sputum taurine in cystic fibrosis.
Clin. Invest. Med. 29: 201-207 (2006).
-
Cantin AM, Bilodeau G, Ouellet C, Liao J, Hanrahan JW. Oxidant stress suppresses CFTR expression.
Am. J. Physiol. Cell. Physiol. 290: C262-C270 (2006).
*
-
Cantin AM, Hanrahan JW, Bilodeau G, Ellis L, Dupuis A, Liao J, Zielenski J, Durie P. Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers.
Am. J. Respir. Crit. Care Med. 173: 1139-1144 (2006).
*
-
Canto E, Ricart E, Monfort D, Gonzalez-Juan D, Balanzo J, Rodriguez-Sanchez JL, Vidal S. TNFalpha production to TLR2 ligands in active IBD patients.
Clin. Immunol. 119: 156-165 (2006).
*
-
Cantorna MT. Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease.
Prog. Biophys. Mol. Biol. 92: 60-64 (2006).
*
-
Cantwell MM, Flynn MA, Gibney MJ. Acute postprandial effect of hydrogenated fish oil, palm oil and lard on plasma cholesterol, triacylglycerol and non-esterified fatty acid metabolism in normocholesterolaemic males.
Br. J. Nutr. 95: 787-794 (2006).
*
-
Cao H, Kabaroff LC, You Q, Rodriguez A, Boermans HJ, Karrow NA. Characterization of ovine hepatic gene expression profiles in response to Escherichia coli lipopolysaccharide using a bovine cDNA microarray.
BMC Vet. Res. 2: 34 (2006).
*
-
Cao J, Li JL, Li D, Tobin JF, Gimeno RE. Molecular identification of microsomal acyl-CoA:glycerol-3-phosphate acyltransferase, a key enzyme in de novo triacylglycerol synthesis.
Proc. Natl. Acad. Sci. U.S.A. 103: 19695-19700 (2006).
*
-
Cao J, Schwichtenberg KA, Hanson NQ, Tsai MY. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids.
Clin. Chem. 52: 2265-2272 (2006).
*
-
Cao P, Zhang S, Gong Z, Tang X, Cao M, Hu Y. Development of a compact anti-BAFF antibody in Escherichia coli.
Appl. Microbiol. Biotechnol. 73: 151-157 (2006).
*
-
Cao Q, Shen XL, Zhou W, Wang JG. The relationship of nature killer cell 2D gene polymorphisms and ulcerative colitis in the Chinese.
Zhonghua Nei Ke Za Zhi 45: 824-826 (2006).
-
Cao Q, Zhu Q, Wu ML, Hu WL, Gao M, Si JM. Genetic susceptibility to ulcerative colitis in the Chinese Han ethnic population: association with TNF polymorphisms.
Chin. Med. J. (Engl.) 119: 1198-1203 (2006).
*
-
Cao W, Harnett KM, Pricolo VE. NK2 receptor-mediated spontaneous phasic contractions in normal and ulcerative colitis human sigmoid colon.
J. Pharmacol. Exp. Ther. 317: 1349-1355 (2006).
*
-
Capasso M, Di Muzio A, Comar M, Robuffo I, Gambi A, Crovella S, Pizzigallo E, Campello C, Uncini A. The association of chronic hepatitis B and myopathy.
Neurology 67: 1467-1469 (2006).
-
Caplan JP. All-trans retinoic acid (ATRA) syndrome can mimic panic disorder.
Psychosomatics 47: 450-451 (2006).
*
-
Capoluongo E, Pitocco D, Santonocito C, Concolino P, Santini SA, Manto A, Lulli P, Ghirlanda G, Zuppi C, Ameglio F. Association between serum free IGF-I and IGFBP-3 levels in type-I diabetes patients affected with associated autoimmune diseases or diabetic complications.
Eur. Cytokine Netw. 17: 167-174 (2006).
-
Caporale CM, Papola F, Fioroni MA, Aureli A, Giovannini A, Notturno F, Adorno D, Caporale V, Uncini A. Susceptibility to Guillain-Barre syndrome is associated to polymorphisms of CD1 genes.
J. Neuroimmunol. 177: 112-118 (2006).
-
Capoulade-Metay C, Ayouba A, Kfutwah A, Lole K, Petres S, Dudoit Y, Deterre P, Menu E, Barre-Sinoussi F, Debre P, Theodorou I. A natural CCL5/RANTES variant antagonist for CCR1 and CCR3.
Immunogenetics 58: 533-541 (2006).
*
-
Cappell MS. The effect of Nazism on medical progress in gastroenterology: the inefficiency of evil.
Dig. Dis. Sci. 51: 1137-1158 (2006).
*
-
Caprilli R, Gassull MA, Escher JC, Moser G, Munkholm P, Forbes A, Hommes DW, Lochs H, Angelucci E, Cocco A, Vucelic B, Hildebrand H, Kolacek S, Riis L, Lukas M, de Franchis R, Hamilton M, Jantschek G, Michetti P, O'Morain C, Anwar MM, Freitas JL, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Gut 55 Suppl. 1: i36-i58 (2006).
*
-
Caprioli F, Losco A, Vigano C, Conte D, Biondetti P, Forzenigo LV, Basilisco G. Computer-assisted evaluation of perianal fistula activity by means of anal ultrasound in patients with Crohn's disease.
Am. J. Gastroenterol. 101: 1551-1558 (2006).
*
-
Caproni M, Torchia D, Schincaglia E, Volpi W, Frezzolini A, Schena D, Marzano A, Quaglino P, De Simone C, Parodi A, Barletta E, Fabbri P. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
Br. J. Dermatol. 154: 319-324 (2006).
*
-
Caputo M, Brizzolara R, Schiavo M, Salmaso C, Pesce G, Bagnasco M. Occurrence of overt celiac disease in the elderly following total thyroidectomy.
J. Endocrinol. Invest. 29: 831-833 (2006).
-
Caputo R, Marzano AV, Tourlaki A, Marchini M. Reticular erythematous mucinosis occurring in a brother and sister.
Dermatology 212: 385-387 (2006).
-
Caramaschi P, Biasi D, Colombatti M, Pieropan S, Martinelli N, Carletto A, Volpe A, Pacor LM, Bambara LM. Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity.
Rheumatol. Int. 26: 209-214 (2006).
*
-
Caramori G, Adcock I. Gene-environment interactions in the development of chronic obstructive pulmonary disease.
Curr. Opin. Allergy Clin. Immunol. 6: 323-328 (2006).
-
Carayol N, Chen J, Yang F, Jin T, Jin L, States D, Wang CY. A dominant function of IKK/NF-kappaB signaling in global lipopolysaccharide-induced gene expression.
J. Biol. Chem. 281: 31142-31151 (2006).
*
-
Carbone J, Sarmiento E, Micheloud D, Rodriguez-Mahou M, Rodriguez-Molina JJ, Cobo R, Fernandez-Cruz E. Systemic autoimmune disease in patients with uveitis.
Arch. Soc. Esp. Oftalmol. 81: 193-198 (2006).
-
Carbone J, Sarmiento E, Micheloud D, Rodriguez-Molina J, Fernandez-Cruz E. Elevated levels of activated CD4 T cells in common variable immunodeficiency: association with clinical findings.
Allergol. Immunopathol. (Madr.) 34: 131-135 (2006).
-
Card TR, Solaymani-Dodaran M, Hubbard R, Logan RF, West J. Is an internal comparison better than using national data when estimating mortality in longitudinal studies?
J. Epidemiol. Community Health 60: 819-821 (2006).
-
Cardaba B, Pozo VD, Gallardo S, Palomino P, Posada M, Lahoz C. Genetic approaches in the understanding of toxic oil syndrome.
Toxicol. Lett. 161: 83-88 (2006).
*
-
Cardell SL. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.
Clin. Exp. Immunol. 143: 194-202 (2006).
*
-
Cardenas VM, Mulla ZD, Ortiz M, Graham DY. Iron deficiency and Helicobacter pylori infection in the United States.
Am. J. Epidemiol. 163: 127-134 (2006).
*
-
Cardon LR. Genetics. Delivering new disease genes.
Science 314: 1403-1405 (2006).
*
-
Cardona K, Korbutt GS, Milas Z, Lyon J, Cano J, Jiang W, Bello-Laborn H, Hacquoil B, Strobert E, Gangappa S, Weber CJ, Pearson TC, Rajotte RV, Larsen CP. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways.
Nat. Med. 12: 304-306 (2006).
*
-
Cardoso E, Fukuda T, Pereira J, Seixas J, Miranda R, Rodrigues B, Saback T, Andrade R, Cardoso G, Martinez R, Avena J, Melo A. Clinical and epidemiological profile of multiple sclerosis in a reference center in the State of Bahia, Brazil.
Arq. Neuropsiquiatr. 64: 727-730 (2006).
*
-
Cardoso H, Nunes AC, Carneiro F, Veloso FT. Successful infliximab therapy for oral Crohn's disease.
Inflamm. Bowel Dis. 12: 337-338 (2006).
*
-
Carey AL, Petersen EW, Bruce CR, Southgate RJ, Pilegaard H, Hawley JA, Pedersen BK, Febbraio MA. Discordant gene expression in skeletal muscle and adipose tissue of patients with type 2 diabetes: effect of interleukin-6 infusion.
Diabetologia 49: 1000-1007 (2006).
*
-
Carini R, Alchera E, De Cesaris MG, Splendore R, Piranda D, Baldanzi G, Albano E. Purinergic P2Y2 receptors promote hepatocyte resistance to hypoxia.
J. Hepatol. 45: 236-245 (2006).
*
-
Cario E. Toll-like receptors in IBD.
Falk Symposium 154: INFLAMMATORY BOWEL DISEASE - DIAGNOSTIC AND THERAPEUTIC STRATEGIES, Moscow (Russia), June 9 - 10, 2006, p. 27 (2006). *
-
Cario E, Golenbock DT, Visintin A, Runzi M, Gerken G, Podolsky DK. Trypsin-sensitive modulation of intestinal epithelial MD-2 as mechanism of lipopolysaccharide tolerance.
J. Immunol. 176: 4258-4266 (2006).
*
-
Cario E, Podolsky DK. Toll-like receptor signaling and its relevance to intestinal inflammation.
Ann. N. Y. Acad. Sci. 1072: 332-338 (2006).
*
-
Cariou B, Staels B. The expanding role of the bile acid receptor FXR in the small intestine.
J. Hepatol. 44: 1213-1215 (2006).
*
-
Cariou B, van Harmelen K, Duran-Sandoval D, van Dijk TH, Grefhorst A, Abdelkarim M, Caron S, Torpier G, Fruchart JC, Gonzalez FJ, Kuipers F, Staels B. The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice.
J. Biol. Chem. 281: 11039-11049 (2006).
*
-
Carlberg C, Dunlop TW. The impact of chromatin organization of vitamin D target genes.
Anticancer Res. 26: 2637-2645 (2006).
-
Carlberg C, Dunlop TW. An integrated biological approach to nuclear receptor signaling in physiological control and disease.
Crit. Rev. Eukaryot. Gene Expr. 16: 1-22 (2006).
-
Carlberg C, Molnar F. Detailed molecular understanding of agonistic and antagonistic vitamin D receptor ligands.
Curr. Top. Med. Chem. 6: 1243-1253 (2006).
-
Carlo JT, Demarco D, Smith BA, Livingston S, Wiser K, Kuhn JA, Lamont JP. The utility of capsule endoscopy and its role for diagnosing pathology in the gastrointestinal tract.
Am. J. Surg. 190: 886-890 (2006).
*
-
Carlsen HS, Yamanaka T, Scott H, Rugtveit J, Brandtzaeg P. The proportion of CD40+ mucosal macrophages is increased in inflammatory bowel disease whereas CD40 ligand (CD154)+ T cells are relatively decreased, suggesting differential modulation of these costimulatory molecules in human gut lamina propria.
Inflamm. Bowel Dis. 12: 1013-1024 (2006).
*
-
Carlsen M, Cilio CM. Normal T cell development in the absence of thymic insulin expression.
Ann. N. Y. Acad. Sci. 1079: 205-212 (2006).
*
-
Carlson BA, Kingston JD. Docosahexaenoic acid, the aquatic diet, and hominin encephalization: difficulties in establishing evolutionary links.
Am. J. Hum. Biol. 19: 132-141 (2006).
*
-
Carlson CM, Endrizzi BT, Wu J, Ding X, Weinreich MA, Walsh ER, Wani MA, Lingrel JB, Hogquist KA, Jameson SC. Kruppel-like factor 2 regulates thymocyte and T-cell migration.
Nature 442: 299-302 (2006).
*
-
Carlson EJ, Pitonzo D, Skach WR. p97 functions as an auxiliary factor to facilitate TM domain extraction during CFTR ER-associated degradation.
EMBO J. 25: 4557-4566 (2006).
*
-
Carlsson A, Agardh D, Borulf S, Grodzinsky E, Axelsson I, Ivarsson SA. Prevalence of celiac disease: before and after a national change in feeding recommendations.
Scand. J. Gastroenterol. 41: 553-558 (2006).
*
-
Carlton VE, Ireland JS, Useche F, Faham M. Functional single nucleotide polymorphism-based association studies.
Hum. Genomics 2: 391-402 (2006).
-
Carmel L, Efroni S, White PD, Aslakson E, Vollmer-Conna U, Rajeevan MS. Gene expression profile of empirically delineated classes of unexplained chronic fatigue.
Pharmacogenomics 7: 375-386 (2006).
-
Carmelo E, Zurita AI, Martinez E, Valladares B. The sera from individuals suffering from cutaneous leishmaniasis due to Leishmania brazilensis present antibodies against parasitic conserved proteins, but not their human counterparts.
Parasite 13: 231-236 (2006).
-
Carmichael SL, Shaw GM, Iovannisci DM, Yang W, Finnell RH, Cheng S, Lammer EJ. Risks of human limb deficiency anomalies associated with 29 SNPs of genes involved in homocysteine metabolism, coagulation, cell-cell interactions, inflammatory response, and blood pressure regulation.
Am. J. Med. Genet. A. 140: 2433-2440 (2006).
-
Carol M, Borruel N, Antolin M, Llopis M, Casellas F, Guarner F, Malagelada JR. Modulation of apoptosis in intestinal lymphocytes by a probiotic bacteria in Crohn's disease.
J. Leukoc. Biol. 79: 917-922 (2006).
*
-
Caroli E, Salvati M, Ferrante L. Tumor-like multiple sclerosis: report of four cases and literature review.
Tumori. 92: 559-562 (2006).
-
Caron P, Trottier J, Verreault M, Belanger J, Kaeding J, Barbier O. Enzymatic production of bile acid glucuronides used as analytical standards for liquid chromatography-mass spectrometry analyses.
Mol. Pharm. 3: 293-302 (2006).
*
-
Carotenuto A, D'Ursi AM, Mulinacci B, Paolini I, Lolli F, Papini AM, Novellino E, Rovero P. Conformation-activity relationship of designed glycopeptides as synthetic probes for the detection of autoantibodies, biomarkers of multiple sclerosis.
J. Med. Chem. 49: 5072-5079 (2006).
*
-
Carpenter DO. Polychlorinated biphenyls (PCBs): routes of exposure and effects on human health.
Rev. Environ. Health 21: 1-23 (2006).
-
Carpentier YA, Hacquebard M. Intravenous lipid emulsions to deliver omega 3 fatty acids.
Prostaglandins Leukot. Essent. Fatty Acids 75: 145-148 (2006).
*
-
Carpentier YA, Portois L, Malaisse WJ. n-3 Fatty acids and the metabolic syndrome.
Am. J. Clin. Nutr. 83: 1499S-1504S (2006).
*
-
Carr-Locke DL. Cholelithiasis plus choledocholithiasis: ERCP first, what next?
Gastroenterology 130: 270-272 (2006).
*
-
Carrell DT, De Jonge C, Lamb DJ. The genetics of male infertility: a field of study whose time is now.
Arch. Androl. 52: 269-274 (2006).
-
Carrera D, Domenech A, Mora J, Ballester R, Roca M, Jimenez RI, Verdura B, Baliellas C, Guardiola J, Martin-Comin J. Prognostic utility of scintigraphy with 99mTc-HMPAO labelled leukocytes in inflammatory bowel disease.
Rev. Esp. Med. Nucl. 25: 380-386 (2006).
-
Carrero JJ, Grimble RF. Does nutrition have a role in peripheral vascular disease?
Br. J. Nutr. 95: 217-229 (2006).
*
-
Carrick DM, Chulada P, Donn R, Fabris M, McNicholl J, Whitworth W, Blackshear PJ. Genetic variations in ZFP36 and their possible relationship to autoimmune diseases.
J. Autoimmun. 26: 182-196 (2006).
-
Carrington M, Martin MP. The impact of variation at the KIR gene cluster on human disease.
Curr. Top. Microbiol. Immunol. 298: 225-257 (2006).
-
Carroccio A, Di Prima L, Pirrone G, Ambrosiano G, Noto D, Cefalu AB. Anti-TNF (infliximab) treatment in Crohn disease: safety profile.
Recenti Prog. Med. 97: 108-112 (2006).
-
Carroccio A, Di Prima L, Pirrone G, Scalici C, Florena AM, Gasparin M, Tolazzi G, Gucciardi A, Sciume C, Iacono G. Anti-transglutaminase antibody assay of the culture medium of intestinal biopsy specimens can improve the accuracy of celiac disease diagnosis.
Clin. Chem. 52: 1175-1180 (2006).
*
-
Carroccio A, Di Prima L, Scalici C, Soresi M, Cefalu AB, Noto D, Averna MR, Montalto G, Iacono G. Unexplained elevated serum pancreatic enzymes: a reason to suspect celiac disease.
Clin. Gastroenterol. Hepatol. 4: 455-459 (2006).
-
Carroll L, Hannawi S, Marwick T, Thomas R. Rheumatoid arthritis: links with cardiovascular disease and the receptor for advanced glycation end products.
Wien. Med. Wochenschr. 156: 42-52 (2006).
-
Carson MJ, Doose JM, Melchior B, Schmid CD, Ploix CC. CNS immune privilege: hiding in plain sight.
Immunol. Rev. 213: 48-65 (2006).
*
-
Carta M, Stancampiano R, Tronci E, Collu M, Usiello A, Morelli M, Fadda F. Vitamin A deficiency induces motor impairments and striatal cholinergic dysfunction in rats.
Neuroscience 139: 1163-1172 (2006).
*
-
Carter JD. Tumour necrosis factor inhibition causing psoriasis? A more plausible explanation exists.
Ann. Rheum. Dis. 65: 1680 (2006).
*
-
Carter JD, Valeriano J, Vasey FB. Tumor necrosis factor-alpha inhibition and VATER association: a causal relationship.
J. Rheumatol. 33: 1014-1017 (2006).
-
Carter PJ. Potent antibody therapeutics by design.
Nat. Rev. Immunol. 6: 343-357 (2006).
*
-
Carter RH. B cells in health and disease.
Mayo Clin. Proc. 81: 377-384 (2006).
*
-
Carty M, Goodbody R, Schroder M, Stack J, Moynagh PN, Bowie AG. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling.
Nat. Immunol. 7: 1074-1081 (2006).
*
-
Carulli L, Lonardo A, Lombardini S, Marchesini G, Loria P. Gender, fatty liver and GGT.
Hepatology 44: 278-279 (2006).
*
-
Carvalho RS, Abadom V, Dilworth HP, Thompson R, Oliva-Hemker M, Cuffari C. Indeterminate colitis: a significant subgroup of pediatric IBD.
Inflamm. Bowel Dis. 12: 258-262 (2006).
*
-
Casais P, Meschengieser SS, Gennari LC, Alberto MF, Sanchez-Luceros A, Blanco AN, Lazzari MA. Antiphospholipid antibodies and hyperhomocysteinaemia in patients with vascular occlusive disease.
Thromb. Haemost. 96: 19-23 (2006).
-
Casale TB, Kessler J, Romero FA. Safety of the intranasal Toll-like receptor 4 agonist CRX-675 in allergic rhinitis.
Ann. Allergy Asthma Immunol. 97: 454-456 (2006).
-
Casartelli N, Giolo G, Neri F, Haller C, Potesta M, Rossi P, Fackler OT, Doria M. The Pro78 residue regulates the capacity of the human immunodeficiency virus type 1 Nef protein to inhibit recycling of major histocompatibility complex class I molecules in an SH3-independent manner.
J. Gen. Virol. 87: 2291-2296 (2006).
*
-
Casas JP, Cavalleri GL, Bautista LE, Smeeth L, Humphries S, Hingorani AD. Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review.
Am. J. Epidemiol. 164: 921-935 (2006).
*
-
Case S, Adams PC. Celiac disease - hidden and dangerous.
Can. J. Gastroenterol. 20: 571-573 (2006).
*
-
Casella G, De Marco E, Monti C, Baldini V. The therapeutic role of thalidomide in inflammatory bowel disease.
Minerva Gastroenterol. Dietol. 52: 293-301 (2006).
-
Casellas F, Lopez Vivancos J, Malagelada JR. Current epidemiology and accessibility to diet compliance in adult celiac disease.
Rev. Esp. Enferm. Dig. 98: 408-419 (2006).
-
Casellas I Jorda F. Celiac disease.
Med. Clin. (Barc.) 126: 137-142 (2006).
-
Casey J. Successful treatment of inflammatory bowel disease with budesonide in clinical practice.
Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 185 (2006). *
-
Cash HL, Whitham CV, Behrendt CL, Hooper LV. Symbiotic bacteria direct expression of an intestinal bactericidal lectin.
Science 313: 1126-1130 (2006).
*
-
Cash HL, Whitham CV, Hooper LV. Refolding, purification, and characterization of human and murine RegIII proteins expressed in Escherichia coli.
Protein Expr. Purif. 48: 151-159 (2006).
*
-
Casola S, Rajewsky K. B cell recruitment and selection in mouse GALT germinal centers.
Curr. Top. Microbiol. Immunol. 308: 155-171 (2006).
-
Caspi D, Anouk M, Golan I, Paran D, Kaufman I, Wigler I, Levartovsky D, Litinsky I, Elkayam O. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Arthritis Rheum. 55: 53-56 (2006).
*
-
Caspi RR. Ocular autoimmunity: the price of privilege?
Immunol. Rev. 213: 23-35 (2006).
*
-
Cassan C, Piaggio E, Zappulla JP, Mars LT, Couturier N, Bucciarelli F, Desbois S, Bauer J, Gonzalez-Dunia D, Liblau RS. Pertussis toxin reduces the number of splenic Foxp3+ regulatory T cells.
J. Immunol. 177: 1552-1560 (2006).
*
-
Cassano N, Loconsole F, Coviello C, Vena GA. Infliximab in recalcitrant severe atopic eczema associated with contact allergy.
Int. J. Immunopathol. Pharmacol. 19: 237-240 (2006).
-
Cassano N, Loconsole F, Galluccio A, Miracapillo A, Pezza M, Vena GA. Once-weekly administration of high-dosage Etanercept in patients with plaque psoriasis: results of a pilot experience (power study).
Int. J. Immunopathol. Pharmacol. 19: 225-229 (2006).
-
Cassatella MA. On the production of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2L) by human neutrophils.
J. Leukoc. Biol. 79: 1140-1149 (2006).
*
-
Cassater D, Gambaro G, Fabris A, Cena C, Calabria S, Capelluto S, Lupo A. Henoch-Schonlein purpura and Crohn's disease in a family.
J. Nephrol. 19: 387-390 (2006).
-
Cassell S, Kavanaugh AF. Therapies for psoriatic nail disease. A systematic review.
J. Rheumatol. 33: 1452-1456 (2006).
-
Cassiani-Ingoni R, Cabral ES, Lunemann JD, Garza Z, Magnus T, Gelderblom H, Munson PJ, Marques A, Martin R. Borrelia burgdorferi induces TLR1 and TLR2 in human microglia and peripheral blood monocytes but differentially regulates HLA-class II expression.
J. Neuropathol. Exp. Neurol. 65: 540-548 (2006).
-
Castaldo G, Tomaiuolo R, Vanacore B, Ferrara P, Del Vecchio S, Carnovale V, Abete P, Rengo F, Salvatore F. Phenotypic discordance in three siblings affected by atypical cystic fibrosis with the F508del/D614G genotype.
J. Cyst. Fibros. 5: 193-195 (2006).
-
Castano G, Etchart C, Sookoian S. Vitamin A toxicity in a physical culturist patient: a case report and review of the literature.
Ann. Hepatol. 5: 293-295 (2006).
*
-
Castell JV, Castell M. Allergic hepatitis induced by drugs.
Curr. Opin. Allergy Clin. Immunol. 6: 258-265 (2006).
-
Castellaneta A, Di Leo A, Francavilla R, Margiotta M, Barone M, Amoruso A, Troiani L, Thomson AW, Francavilla A. Functional modification of CD11c(+) liver dendritic cells during liver regeneration after partial hepatectomy in mice.
Hepatology 43: 807-816 (2006).
*
-
Castellani C, Malerba G, Sangalli A, Delmarco A, Petrelli E, Rossini M, Assael BM, Mottes M. The genetic background of osteoporosis in cystic fibrosis: association analysis with polymorphic markers in four candidate genes.
J. Cyst. Fibros. 5: 229-235 (2006).
-
Castellino F, Germain RN. Cooperation between CD4(+) and CD8(+) T cells: when, where, and how.
Annu. Rev. Immunol. 24: 519-540 (2006).
*
-
Castellino F, Huang AY, Altan-Bonnet G, Stoll S, Scheinecker C, Germain RN. Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction.
Nature 440: 890-895 (2006).
*
-
Castera L, Foucher J, Bertet J, Couzigou P, de Ledinghen V. FibroScan and FibroTest to assess liver fibrosis in HCV with normal aminotransferases.
Hepatology 43: 373-374 (2006).
*
-
Castigli E, Geha RS. Molecular basis of common variable immunodeficiency.
J. Allergy Clin. Immunol. 117: 740-746 (2006).
*
-
Castillo AI, Sanchez-Martinez R, Jimenez-Lara AM, Steinmeyer A, Zugel U, Aranda A. Characterization of vitamin D receptor ligands with cell-specific and "dissociated" activity.
Mol. Endocrinol. 20: 3093-3104 (2006).
*
-
Castro E Silva O, Sankarankutty AK, Martinelli AL, Souza FF, Teixeira AC, Feres O, Mente ED, Oliveira GR, Akita R, Muglia V, Elias J Jr, Ramalho LN, Zucoloto S. Therapeutic effect of hyperbaric oxygen in hepatic artery thrombosis and functional cholestasis after orthotopic liver transplantation.
Transplant. Proc. 38: 1913-1917 (2006).
*
-
Castro HK, Cross RK, Finkelstein J. Using a home automated telemanagement (HAT) system: experiences and perceptions of patients with inflammatory bowel disease.
AMIA Annu. Symp. Proc. 2006: 872 (2006).
*
-
Castro M, Knafelz D, Rossi L, Ambrosini MI, Papadatou B, Mambrini G, Magnani M. Periodic treatment with autologous erythrocytes loaded with dexamethasone 21-phosphate for fistulizing pediatric Crohn's disease: case report.
J. Pediatr. Gastroenterol. Nutr. 42: 313-315 (2006).
*
-
Castro P, Rebocho AP, Soares RJ, Magalhaes J, Roque L, Trovisco V, Vieira de Castro I, Cardoso-de-Oliveira M, Fonseca E, Soares P, Sobrinho-Simoes M. PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.
J. Clin. Endocrinol. Metab. 91: 213-220 (2006).
*
-
Castro RC. Impact of the internet on communication flow of scientific health information.
Rev. Saude Publica 40: S57-S63 (2006).
-
Castro-Caldas M. Annexin-1: 2nd messanger of the anti-inflammatory actions of glucocorticoids.
Acta Reumatol. Port. 31: 293-302 (2006).
-
Castro-Santos P, Mozo L, Gutierrez C, Suarez A. TNFalpha genotype influences development of IgA-ASCA antibodies in Crohn's disease patients with CARD15 wild type.
Clin. Immunol. 121: 305-313 (2006).
*
-
Castro-Santos P, Suarez A, Lopez-Rivas L, Mozo L, Gutierrez C. TNFalpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of -1082 AA low producer IL-10 genotype with steroid dependency.
Am. J. Gastroenterol. 101: 1039-1047 (2006).
*
-
Castro-Silva C, Damasceno R, Neto O, Alves A, Bruin V. Clinical and laboratory features of 50 patients with cystic fibrosis from a reference center in Brazil.
Rev. Port. Pneumol. 12: S18-S19 (2006).
-
Catala A. An overview of lipid peroxidation with emphasis in outer segments of photoreceptors and the chemiluminescence assay.
Int. J. Biochem. Cell Biol. 38: 1482-1495 (2006).
*
-
Cataldo F, Accomando S, Fragapane ML, Montaperto D; SIGENP and GLNBI Working Groups on Food Intolerances*. Are food intolerances and allergies increasing in immigrant children coming from developing countries?
Pediatr. Allergy Immunol. 17: 364-369 (2006).
-
Cater MA, La Fontaine S, Shield K, Deal Y, Mercer JF. ATP7B mediates vesicular sequestration of copper: insight into biliary copper excretion.
Gastroenterology 130: 493-506 (2006).
*
-
Caterson B. Notice of retraction: "Pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3 fatty acids" (Arthritis Rheum 2002;46:1544-53).
Arthritis Rheum. 54: 2933 (2006).
*
-
Catta-Preta M, Oliveira DA, Mandarim-de-Lacerda CA, Aguila MB. Adult cardiorenal benefits from postnatal fish oil supplement in rat offspring of low-protein pregnancies.
Life Sci. 80: 219-229 (2006).
*
-
Caughey AB. Cholestasis of pregnancy: in need of a more rapid diagnosis.
J. Perinatol. 26: 525-526 (2006).
*
-
Cauley JA. Osteoporosis in men: prevalence and investigation.
Clin. Cornerstone 8 Suppl. 3: S20-S25 (2006).
-
Cauza E, Dunky A. Psoriatic arthritis.
Wien. Med. Wochenschr. 156: 587-595 (2006).
-
Cavaillon JM, Adib-Conquy M. Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis.
Crit. Care 10: 233 (2006).
*
-
Cavaletti G. Current status and future prospective of immunointervention in multiple sclerosis.
Curr. Med. Chem. 13: 2329-2343 (2006).
-
Cavanaugh J. NOD2: ethnic and geographic differences.
World J. Gastroenterol. 12: 3673-3677 (2006).
*
-
Cavassani KA, Campanelli AP, Moreira AP, Vancim JO, Vitali LH, Mamede RC, Martinez R, Silva JS. Systemic and local characterization of regulatory T cells in a chronic fungal infection in humans.
J. Immunol. 177: 5811-5818 (2006).
*
-
Cavazzana I, Bobbio-Pallavicini F, Bazzani C, Bravi E, Zingarelli S, Ceribelli A, Caporali R, Cattaneo R, Franceschini F, Montecucco C. TNFalpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects.
Reumatismo 58: 275-282 (2006).
-
Cavazzana I, Franceschini F, Quinzanini M, Manera C, Del Papa N, Maglione W, Comina D, Radice A, Sinico RA, Cattaneo R. Anti-Ro/SSA antibodies in rheumatoid arthritis: clinical and immunologic associations.
Clin. Exp. Rheumatol. 24: 59-64 (2006).
-
Cavelier C, Lorenzi I, Rohrer L, von Eckardstein A. Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1.
Biochim. Biophys. Acta 1761: 655-666 (2006).
*
-
Cavill I, Auerbach M, Bailie GR, Barrett-Lee P, Beguin Y, Kaltwasser P, Littlewood T, Macdougall IC, Wilson K. Iron and the anaemia of chronic disease: a review and strategic recommendations.
Curr. Med. Res. Opin. 22: 731-737 (2006).
-
Cawston TE, Wilson AJ. Understanding the role of tissue degrading enzymes and their inhibitors in development and disease.
Best Pract. Res. Clin. Rheumatol. 20: 983-1002 (2006).
-
Cay HF, Gungor HA, Sezer I, Kacar C, Balci N. Adverse effect of TNF-alpha blocker? Demyelination in an ankylosing spondylitis patient: a case report.
J. Clin. Pharm. Ther. 31: 645-648 (2006).
*
-
Cayabyab MJ, Hovav AH, Hsu T, Krivulka GR, Lifton MA, Gorgone DA, Fennelly GJ, Haynes BF, Jacobs WR Jr, Letvin NL. Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env.
J. Virol. 80: 1645-1652 (2006).
*
-
Cazanave C, Rakotondravelo S, Morlat P, Blanco P, Bonnet F, Beylot J. Autoimmune hepatitis in a HIV-HCV co-infected patient: diagnostic and therapeutic difficulties.
Rev. Med. Interne. 27: 414-419 (2006).
-
Cebeci AN, Nuhoglu Y, Arslanoglu I, Erguven M, Agachan N. The role of IL-18 in Th1/Th2 balance in children.
Allergy Asthma Proc. 27: 365-370 (2006).
-
Cecchi R, Bartoli L. Psoriasis and hepatitis C treated with anti-TNF alpha therapy (etanercept).
Dermatol. Online J. 12: 4 (2006).
-
Cecil JE, Watt P, Palmer CN, Hetherington M. Energy balance and food intake: the role of PPARgamma gene polymorphisms.
Physiol. Behav. 88: 227-233 (2006).
*
-
Cekaite L, Hovig E, Sioud M. Protein arrays: a versatile toolbox for target identification and monitoring of patient immune responses.
Methods Mol. Biol. 360: 335-348 (2006).
-
Celik Y, Dagli U, Yalin Kilic M, Toruner M, Ceren Ozen S, Ozkan M, Soykan I, Cetinkaya H, Ulker A, Ozden A, Mithat Bozdayi A. Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease.
Scand. J. Gastroenterol. 41: 559-565 (2006).
*
-
Celio S, Troxler H, Durka SS, Chladek J, Wildhaber JH, Sennhauser FH, Heizmann CW, Moeller A. Free 3-nitrotyrosine in exhaled breath condensates of children fails as a marker for oxidative stress in stable cystic fibrosis and asthma.
Nitric Oxide 15: 226-232 (2006).
-
Cellini L, Grande R, Di Campli E, Di Bartolomeo S, Capodicasa S, Marzio L. Analysis of genetic variability, antimicrobial susceptibility and virulence markers in Helicobacter pylori identified in Central Italy.
Scand. J. Gastroenterol. 41: 280-287 (2006).
*
-
Ceni E, Crabb DW, Foschi M, Mello T, Tarocchi M, Patussi V, Moraldi L, Moretti R, Milani S, Surrenti C, Galli A. Acetaldehyde inhibits PPARgamma via H(2)O(2)-mediated c-Abl activation in human hepatic stellate cells.
Gastroenterology 131: 1235-1252 (2006).
*
-
Centers for Disease Control and Prevention (CDC). Update: Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine - United States, October 2005-February 2006.
MMWR Morb. Mortal. Wkly. Rep. 55: 364-366 (2006).
-
Centers for Disease Control and Prevention (CDC). Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs - worldwide, 2000-2004.
MMWR Morb. Mortal. Wkly. Rep. 55: 301-305 (2006).
-
Centers for Disease Control and Prevention (CDC). Trends in tuberculosis - United States, 2005.
MMWR Morb. Mortal. Wkly. Rep. 55: 305-308 (2006).
-
Centers for Disease Control and Prevention (CDC). Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation - United States, 2003-2005.
MMWR Morb. Mortal. Wkly. Rep. 55: 1089-1092 (2006).
-
Centers for Disease Control and Prevention (CDC). Update: Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine - United States, June 2005-September 2006.
MMWR Morb. Mortal. Wkly. Rep. 55: 1120-1124 (2006).
-
Centola M, Frank MB, Bolstad AI, Alex P, Szanto A, Zeher M, Hjelmervik TO, Jonsson R, Nakken B, Szegedi G, Szodoray P. Genome-scale assessment of molecular pathology in systemic autoimmune diseases using microarray technology: a potential breakthrough diagnostic and individualized therapy-design tool.
Scand. J. Immunol. 64: 236-242 (2006).
*
-
Ceovic R, Pasic A, Lipozencic J, Murat-Susic S, Skerlev M, Husar K, Kostovic K. Treatment of childhood psoriasis.
Acta Dermatovenerol. Croat. 14: 261-264 (2006).
-
Cereda S, Cefalo G, Spreafico F, Catania S, Meazza C, Podda M, Terenziani M. Celiac disease and childhood cancer.
J. Pediatr. Hematol. Oncol. 28: 346-349 (2006).
-
Cervera R, Asherson RA. Primary pulmonary arterial hypertension and the systemic autoimmune diseases.
Isr. Med. Assoc. J. 8: 277-279 (2006).
*
-
Cervilla JA, Rivera M, Molina E, Torres-Gonzalez F, Bellon JA, Moreno B, de Dios Luna J, Lorente JA, de Diego-Otero Y, King M, Nazareth I, Gutierrez B. The 5-HTTLPR s/s genotype at the serotonin transporter gene (SLC6A4) increases the risk for depression in a large cohort of primary care attendees: the PREDICT-gene study.
Am. J. Med. Genet. B. Neuropsychiatr. Genet. 141: 912-917 (2006).
-
Cervino AC, Gosink M, Fallahi M, Pascal B, Mader C, Tsinoremas NF. A comprehensive mouse IBD database for the efficient localization of quantitative trait loci.
Mamm. Genome 17: 565-574 (2006).
*
-
Cesario RM, Stone J, Yen WC, Bissonnette RP, Lamph WW. Differentiation and growth inhibition mediated via the RXR:PPARgamma heterodimer in colon cancer.
Cancer Lett. 240: 225-233 (2006).
*
-
Cesarman-Maus G, Rios-Luna NP, Deora AB, Huang B, Villa R, Del Carmen Cravioto M, Alarcon-Segovia D, Sanchez-Guerrero J, Hajjar KA. Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome.
Blood 107: 4375-4382 (2006).
*
-
Cetinkaya A, Bulbuloglu E, Kantarceken B, Ciralik H, Kurutas EB, Buyukbese MA, Gumusalan Y. Effects of L-carnitine on oxidant/antioxidant status in acetic acid-induced colitis.
Dig. Dis. Sci. 51: 488-494 (2006).
*
-
Ceyhan B. Pulmonary involvement in inflammatory bowel disease.
Tuberk. Toraks. 54: 292-298 (2006).
-
Ceyssens C, Frans JM, Christiaens PS, Van Steenbergen W, Peetermans WE. Recommendations for antibiotic prophylaxis before ERCP: can we come to workable conclusions after review of the literature?
Acta Clin. Belg. 61: 10-18 (2006).
-
Cha S, Singson E, Cornelius J, Yagna JP, Knot HJ, Peck AB. Muscarinic acetylcholine type-3 receptor desensitization due to chronic exposure to Sjogren's syndrome-associated autoantibodies.
J. Rheumatol. 33: 296-306 (2006).
-
Cha SI, Fessler MB, Cool CD, Schwarz MI, Brown KK. Lymphoid interstitial pneumonia: clinical features, associations, and prognosis.
Eur. Respir. J. 28: 364-369 (2006).
-
Chaar V, Keclard L, Etienne-Julan M, Diara JP, Elion J, Krishnamoorthy R, Romana M. UGT1A1 polymorphism outweighs the modest effect of deletional (-3.7 kb) alpha-thalassemia on cholelithogenesis in sickle cell anemia.
Am. J. Hematol. 81: 377-379 (2006).
*
-
Chabas D. Recent advances in the immunology of multiple sclerosis.
Rev. Neurol. (Paris) 162: 162-173 (2006).
-
Chabas D, Green AJ, Waubant E. Pediatric multiple sclerosis.
NeuroRx. 3: 264-275 (2006).
-
Chabchoub G, Maalej A, Petit-Teixeira E, Glikmans E, Rebai A, Farid NR, Cornelis F, Ayadi H. Polymorphisms in the protein tyrosine phosphatase (PTPN22) gene is not associated with autoimmune thyroid in a large affected Tunisian family.
Clin. Immunol. 120: 235-236 (2006).
*
-
Chabchoub G, Mnif M, Maalej A, Charfi N, Ayadi H, Abid M. Epidemiologic study of autoimmune thyroid disease in south Tunisia.
Ann. Endocrinol. (Paris) 67: 591-595 (2006).
-
Chabchoub G, Petit-Teixeira E, Maalej A, Pierlot C, Bahloul Z, Cornelis F, Ayadi H. Lack of association between signaling lymphocytic activation molecule family member 1 gene and rheumatoid arthritis in the French and Tunisian populations.
Ann. Rheum. Dis. 65: 1538-1539 (2006).
*
-
Chackerian AA, Chen SJ, Brodie SJ, Mattson JD, McClanahan TK, Kastelein RA, Bowman EP. Neutralization or absence of the interleukin-23 pathway does not compromise immunity to mycobacterial infection.
Infect. Immun. 74: 6092-6099 (2006).
*
-
Chadha K, Weinstock-Guttman B, Zivadinov R, Bhasi K, Muhitch J, Feichter J, Tamano-Blanco M, Abdelrahman N, Ambrus J Sr, Munschauer F, Ramanathan M. Interferon inhibitory activity in patients with multiple sclerosis.
Arch. Neurol. 63: 1579-1584 (2006).
*
-
Chadha S, Miller K, Farwell L, Sacks S, Daly MJ, Rioux JD, Vyse TJ. Haplotype analysis of tumour necrosis factor receptor genes in 1p36: no evidence for association with systemic lupus erythematosus.
Eur. J. Hum. Genet. 14: 69-78 (2006).
*
-
Chadha T, Hernandez JE. Infliximab-related lupus and associated valvulitis: a case report and review of the literature.
Arthritis Rheum. 55: 163-166 (2006).
*
-
Chae JJ, Wood G, Masters SL, Richard K, Park G, Smith BJ, Kastner DL. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production.
Proc. Natl. Acad. Sci. U.S.A. 103: 9982-9987 (2006).
*
-
Chae SC, Park BL, Park CS, Ryu HJ, Yang YS, Lee SO, Choi YH, Kim EM, Uh ST, Kim YH, Kim KK, Oh B, Chung HT, Kimm K, Shin HD. Putative association of RUNX1 polymorphisms with IgE levels in a Korean population.
Exp. Mol. Med. 38: 583-588 (2006).
*
-
Chae SC, Park YR, Li CS, Lee JH, Yang YS, Zhang Q, Kim KS, Chung HT. Analysis of the variations in IL-28RA gene and their association with allergic rhinitis.
Exp. Mol. Med. 38: 302-309 (2006).
*
-
Chae WJ, Henegariu O, Lee SK, Bothwell AL. The mutant leucine-zipper domain impairs both dimerization and suppressive function of Foxp3 in T cells.
Proc. Natl. Acad. Sci. U.S.A. 103: 9631-9636 (2006).
*
-
Chagnon P, Schneider R, Hebert J, Fortin PR, Provost S, Belisle C, Gingras M, Bolduc V, Perreault C, Silverman E, Busque L. Identification and characterization of an Xp22.33;Yp11.2 translocation causing a triplication of several genes of the pseudoautosomal region 1 in an XX male patient with severe systemic lupus erythematosus.
Arthritis Rheum. 54: 1270-1278 (2006).
*
-
Chaimuangraj S, Thammachoti R, Ongphiphadhanakul B, Thammavit W. Lack of association of VDR polymorphisms with Thai prostate cancer as compared with benign prostate hyperplasia and controls.
Asian Pac. J. Cancer Prev. 7: 136-139 (2006).
-
Chakraborty G, Jain S, Behera R, Ahmed M, Sharma P, Kumar V, Kundu GC. The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis.
Curr. Mol. Med. 6: 819-830 (2006).
-
Chakravarti A. Complex genetic diseases: why are chronic inflammatory diseases so complicated?
Inflamm. Bowel Dis. 12 Suppl. 3: S2 (2006).
-
Chakravarti N, El-Naggar AK, Lotan R, Anderson J, Diwan AH, Saadati HG, Diba R, Prieto VG, Esmaeli B. Expression of retinoid receptors in sebaceous cell carcinoma.
J. Cutan. Pathol. 33: 10-17 (2006).
*
-
Chakravarty EF, Nelson L, Krishnan E. Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis.
Arthritis Rheum. 54: 899-907 (2006).
*
-
Chalbot S, Morfin R. Dehydroepiandrosterone metabolites and their interactions in humans.
Drug Metabol. Drug Interact. 22: 1-23 (2006).
-
Chalon S. Omega-3 fatty acids and monoamine neurotransmission.
Prostaglandins Leukot. Essent. Fatty Acids 75: 259-269 (2006).
*
-
Chamaillard M, Iacob R, Desreumaux P, Colombel JF. Advances and perspectives in the genetics of inflammatory bowel diseases.
Clin. Gastroenterol. Hepatol. 4: 143-151 (2006).
-
Chamberlain G, Wallberg M, Rainbow D, Hunter K, Wicker LS, Green EA. A 20-Mb region of chromosome 4 controls TNF-alpha-mediated CD8+ T cell aggression toward beta cells in type 1 diabetes.
J. Immunol. 177: 5105-5114 (2006).
*
-
Chamberlain MC, Schwarzenberg SJ, Akin EU, Kurth MH. Minocycline-induced autoimmune hepatitis with subsequent cirrhosis.
J. Pediatr. Gastroenterol. Nutr. 42: 232-235 (2006).
*
-
Chamberlin WM, Naser SA. Integrating theories of the etiology of Crohn's disease on the etiology of Crohn's disease: questioning the hypotheses.
Med. Sci. Monit. 12: RA27-RA33 (2006).
*
-
Chamouard P, Richert Z, Meyer N, Rahmi G, Baumann R. Diagnostic value of C-reactive protein for predicting activity level of Crohn's disease.
Clin. Gastroenterol. Hepatol. 4: 882-887 (2006).
-
Champagne E, Martinez LO, Vantourout P, Collet X, Barbaras R. Role of apolipoproteins in gammadelta and NKT cell-mediated innate immunity.
Immunol. Res. 33: 241-256 (2006).
-
Champeil-Potokar G, Chaumontet C, Guesnet P, Lavialle M, Denis I. Docosahexaenoic acid (22:6n-3) enrichment of membrane phospholipids increases gap junction coupling capacity in cultured astrocytes.
Eur. J. Neurosci. 24: 3084-3090 (2006).
*
-
Chan A, Newman DL, Shon AM, Schneider DH, Kuldanek S, Ober C. Variation in the type I interferon gene cluster on 9p21 influences susceptibility to asthma and atopy.
Genes Immun. 7: 169-178 (2006).
*
-
Chan AO, Lai KC. A patient with long-standing iron-deficient anemia.
Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 112-116 (2006).
*
-
Chan AO, Peng JZ, Lam SK, Lai KC, Yuen MF, Cheung HK, Kwong KL, Rashid A, Chan CK, Wong BC. Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation.
Gut 55: 463-468 (2006).
*
-
Chan AO, Rashid A. CpG island methylation in precursors of gastrointestinal malignancies.
Curr. Mol. Med. 6: 401-408 (2006).
-
Chan AY, Liu DT. Methotrexate and chronic uveitis associated with juvenile idiopathic arthritis.
J. Rheumatol. 33: 198 (2006).
-
Chan AY, Westcott JM, Mooney JM, Wakeland EK, Schatzle JD. The role of SAP and the SLAM family in autoimmunity.
Curr. Opin. Immunol. 18: 656-664 (2006).
-
Chan CW, Crafton E, Fan HN, Flook J, Yoshimura K, Skarica M, Brockstedt D, Dubensky TW, Stins MF, Lanier LL, Pardoll DM, Housseau F. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity.
Nat. Med. 12: 207-213 (2006).
*
-
Chan DC, Watts GF, Nguyen MN, Barrett PH. Factorial study of the effect of n-3 fatty acid supplementation and atorvastatin on the kinetics of HDL apolipoproteins A-I and A-II in men with abdominal obesity.
Am. J. Clin. Nutr. 84: 37-43 (2006).
*
-
Chan E, Tan CS, Deurenberg-Yap M, Chia KS, Chew SK, Tai ES. The V227A polymorphism at the PPARA locus is associated with serum lipid concentrations and modulates the association between dietary polyunsaturated fatty acid intake and serum high density lipoprotein concentrations in Chinese women.
Atherosclerosis 187: 309-315 (2006).
-
Chan EP, Lichtenstein GR. Chemoprevention: risk reduction with medical therapy of inflammatory bowel disease.
Gastroenterol. Clin. North Am. 35: 675-712 (2006).
-
Chan HC, Shi QX, Zhou CX, Wang XF, Xu WM, Chen WY, Chen AJ, Ni Y, Yuan YY. Critical role of CFTR in uterine bicarbonate secretion and the fertilizing capacity of sperm.
Mol. Cell. Endocrinol. 250: 106-113 (2006).
-
Chan J, Clements W, Field J, Nasa Z, Lock P, Yap F, Toh BH, Alderuccio F. Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice.
J. Gene Med. 8: 1281-1290 (2006).
-
Chan JC, Trachtman H. Modulating the progression in IgA nephropathy.
Nephron. Clin. Pract. 104: c61-c68 (2006).
-
Chan JL, Matarese G, Shetty GK, Raciti P, Kelesidis I, Aufiero D, De Rosa V, Perna F, Fontana S, Mantzoros CS. Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans.
Proc. Natl. Acad. Sci. U.S.A. 103: 8481-8486 (2006).
*
-
Chan JR, Blumenschein W, Murphy E, Diveu C, Wiekowski M, Abbondanzo S, Lucian L, Geissler R, Brodie S, Kimball AB, Gorman DM, Smith K, de Waal Malefyt R, Kastelein RA, McClanahan TK, Bowman EP. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis.
J. Exp. Med. 203: 2577-2587 (2006).
*
-
Chan MM, Chmura K, Chan ED. Increased NaCl-induced interleukin-8 production by human bronchial epithelial cells is enhanced by the DeltaF508/W1282X mutation of the cystic fibrosis transmembrane conductance regulator gene.
Cytokine 33: 309-316 (2006).
-
Chan RC, Katelaris PH, Stewart P, Lin BP. Small bowel adenocarcinoma with high levels of microsatellite instability in Crohn's disease.
Hum. Pathol. 37: 631-634 (2006).
-
Chan TA. Prostaglandins and the colon cancer connection.
Trends Mol. Med. 12: 240-244 (2006).
*
-
Chan V, Tett SE. Changes in use of disease-modifying anti-rheumatic drugs in Australia over the period 1992-2004.
Pharmacoepidemiol. Drug Saf. 15: 462-468 (2006).
-
Chance SA. Subtle changes in the ageing human brain.
Nutr. Health 18: 217-224 (2006).
-
Chand N, Mihas AA. Celiac disease: current concepts in diagnosis and treatment.
J. Clin. Gastroenterol. 40: 3-14 (2006).
-
Chande N, McDonald J, Macdonald J. Interventions for treating collagenous colitis.
Cochrane Database Syst. Rev. 4: CD003575 (2006).
*
-
Chandran V, Upadhyaya SK, Haroon N, Aggarwal A, Misra R. Lack of clinical association with antibodies to ribosomal p proteins in Indian patients with systemic lupus erythematosus.
J. Rheumatol. 33: 1987-1989 (2006).
-
Chang AJ, Song DH, Wolfe MM. Attenuation of peroxisome proliferator activated receptor gamma (PPARgamma) mediates gastrin-stimulated colorectal cancer cell proliferation.
J. Biol. Chem. 281: 14700-14710 (2006).
*
-
Chang CY, Argo CK, Al-Osaimi AM, Caldwell SH. Therapy of NAFLD: antioxidants and cytoprotective agents.
J. Clin. Gastroenterol. 40 Suppl. 1: S51-S60 (2006).
-
Chang ER, Pineau CA, Bernatsky S, Neville C, Clarke AE, Fortin PR. Risk for incident arterial or venous vascular events varies over the course of systemic lupus erythematosus.
J. Rheumatol. 33: 1780-1784 (2006).
-
Chang H, Hanawa H, Liu H, Yoshida T, Hayashi M, Watanabe R, Abe S, Toba K, Yoshida K, Elnaggar R, Minagawa S, Okura Y, Kato K, Kodama M, Maruyama H, Miyazaki J, Aizawa Y. Hydrodynamic-based delivery of an interleukin-22-Ig fusion gene ameliorates experimental autoimmune myocarditis in rats.
J. Immunol. 177: 3635-3643 (2006).
*
-
Chang HK, Bang KT, Lee BH, Kim JH, Bae KW, Kim MJ, Kim SK. Concurrence of Sjogren's syndrome in a patient with Chlamydia-induced reactive arthritis; an unusual finding.
Korean J. Intern. Med. 21: 116-119 (2006).
-
Chang HW, Yang CH, Chang PL, Cheng YH, Chuang LY. SNP-RFLPing: restriction enzyme mining for SNPs in genomes.
BMC Genomics 7: 30 (2006).
*
-
Chang JH, Lin KH, Shih CH, Chang YJ, Chi HC, Chen SL. Myogenic basic helix-loop-helix proteins regulate the expression of peroxisomal proliferator activated receptor-gamma coactivator-1alpha.
Endocrinology 147: 3093-3106 (2006).
*
-
Chang JH, McCluskey PJ, Wakefield D. Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease.
Br. J. Ophthalmol. 90: 103-108 (2006).
-
Chang JT, Lichtenstein GR. Drug insight: antagonists of tumor-necrosis factor-alpha in the treatment of inflammatory bowel disease.
Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 220-228 (2006).
*
-
Chang KH, Lyu RK, Ro LS, Wu YR, Chen CM. Coexistence of pernicious anemia and myasthenia gravis - a rare combination of autoimmune diseases in Taiwan.
J. Formos. Med. Assoc. 105: 946-949 (2006).
-
Chang L. Neuroendocrine and neuroimmune markers in IBS: pathophysiological role or epiphenomenon?
Gastroenterology 130: 596-600 (2006).
*
-
Chang L, Chey WD, Harris L, Olden K, Surawicz C, Schoenfeld P. Incidence of ischemic colitis and serious complications of constipation among patients using alosetron: systematic review of clinical trials and post-marketing surveillance data.
Am. J. Gastroenterol. 101: 1069-1079 (2006).
*
-
Chang L, Kamata H, Solinas G, Luo JL, Maeda S, Venuprasad K, Liu YC, Karin M. The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover.
Cell 124: 601-613 (2006).
*
-
Chang LT, Sun CK, Wang CY, Youssef AA, Wu CJ, Chua S, Yip HK. Downregulation of peroxisme proliferator activated receptor gamma co-activator 1alpha in diabetic rats.
Int. Heart J. 47: 901-910 (2006).
-
Chang MC, Chang YT, Tien YW, Liang PC, Wei SC, Wong JM. Association of tumour necrosis factor-alpha promoter haplotype with chronic pancreatitis.
Gut 55: 1674-1676 (2006).
*
-
Chang SH, Park H, Dong C. Act1 adaptor protein is an immediate and essential signaling component of IL-17 receptor.
J. Biol. Chem. 281: 35603-35607 (2006).
*
-
Chang SK, Arendt BK, Darce JR, Wu X, Jelinek DF. A role for BLyS in the activation of innate immune cells.
Blood 108: 2687-2694 (2006).
*
-
Chang TK, Waxman DJ. Synthetic drugs and natural products as modulators of constitutive androstane receptor (CAR) and pregnane X receptor (PXR).
Drug Metab. Rev. 38: 51-73 (2006).
*
-
Chang X, Zheng P, Liu Y. FoxP3: a genetic link between immunodeficiency and autoimmune diseases.
Autoimmun. Rev. 5: 399-402 (2006).
-
Chang YC, Chan YH, Jackson DG, Hsieh SL. The glycosaminoglycan-binding domain of decoy receptor 3 is essential for induction of monocyte adhesion.
J. Immunol. 176: 173-180 (2006).
*
-
Chang YH, Lee DS, Jo HS, Cho SI, Yoon HJ, Shin S, Yoon JH, Kim HY, Hong YJ, Hong SI, Cho HI. Tumor necrosis factor alpha promoter polymorphism associated with increased susceptibility to secondary hemophagocytic lymphohistiocytosis in the Korean population.
Cytokine 36: 45-50 (2006).
-
Chang YT, Chou CT, Shiao YM, Lin MW, Yu CW, Chen CC, Huang CH, Lee DD, Liu HN, Wang WJ, Tsai SF. Psoriasis vulgaris in Chinese individuals is associated with PSORS1C3 and CDSN genes.
Br. J. Dermatol. 155: 663-669 (2006).
*
-
Chang YT, Lee WR, Yu CW, Liu HN, Lin MW, Huang CH, Chen CC, Lee DD, Wang WJ, Hu CH, Tsai SF. No association of cytokine gene polymorphisms in Chinese patients with atopic dermatitis.
Clin. Exp. Dermatol. 31: 419-423 (2006).
*
-
Chang YT, Liu HN, Yu CW, Lin MW, Huang CH, Chen CC, Liu MT, Lee DD, Wang WJ, Tsai SF. Cytokine gene polymorphisms in bullous pemphigoid in a Chinese population.
Br. J. Dermatol. 154: 79-84 (2006).
-
Chao C, Zhang ZF, Berthiller J, Boffetta P, Hashibe M. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.
Cancer Epidemiol. Biomarkers Prev. 15: 979-987 (2006).
*
-
Chao YC, Cheng TS, Chou CT. Panniculitis: an unusual cutaneous manifestation of rheumatoid arthritis.
J. Clin. Rheumatol. 12: 190-193 (2006).
-
Chaparro RJ, Konigshofer Y, Beilhack GF, Shizuru JA, McDevitt HO, Chien Yh. Nonobese diabetic mice express aspects of both type 1 and type 2 diabetes.
Proc. Natl. Acad. Sci. U.S.A. 103: 12475-12480 (2006).
*
-
Chapidze G E, Kapanadze SD, Dolidze NK, Latsabidze NE, Bakhutashvili ZV. Combination treatment with coenzyme Q10 and simvastatin in patients with coronary atherosclerosis.
Kardiologiia 46: 11-13 (2006).
-
Chaplin DD. 1. Overview of the human immune response.
J. Allergy Clin. Immunol. 117 (2 Suppl. Mini-Primer): S430-S435 (2006).
*
-
Chapman J. Thrombin in inflammatory brain diseases.
Autoimmun. Rev. 5: 528-531 (2006).
-
Chapman KE, Coutinho A, Gray M, Gilmour JS, Savill JS, Seckl JR. Local amplification of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 and its role in the inflammatory response.
Ann. N. Y. Acad. Sci. 1088: 265-273 (2006).
*
-
Chapman RW. Medical management of PSC: high dose vs low dose UDCA and bile duct dilatation.
Falk Workshop "Primary Sclerosing Cholangitis: Complications and Consequences", Moscow (Russia), June 11, 2006, p. 13-14 (2006). *
-
Chapman RW. High-dose UDCA in the treatment of primary sclerosing cholangitis.
Falk Symposium 155. XIII FALK LIVER WEEK (Part I) XIX International Bile Acid Meeting. Bile Acids: Biological Actions and Clinical Relevance, October 6 - 7, 2006 Freiburg (Germany), p. 88-89 (2006). *
-
Chapman RW. Primary sclerosing cholangitis.
Semin. Liver Dis. 26: 1-2 (2006).
-
Chapman SJ, Khor CC, Vannberg FO, Maskell NA, Davies CW, Hedley EL, Segal S, Moore CE, Knox K, Day NP, Gillespie SH, Crook DW, Davies RJ, Hill AV. PTPN22 and invasive bacterial disease.
Nat. Genet. 38: 499-500 (2006).
*
-
Chapman TM, Plosker GL, Figgitt DP. VSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseases.
Drugs 66: 1371-1387 (2006).
-
Charakida A, Dadzie O, Teixeira F, Charakida M, Evangelou G, Chu AC. Calcipotriol/betamethasone dipropionate for the treatment of psoriasis.
Expert Opin. Pharmacother. 7: 597-606 (2006).
-
Charalabopoulos K, Kotsalos A, Karkabounas S, Vezyraki P, Kalfakakou V, Metsios A, Golias C, Charalabopoulos A, Batistatou A, Evangelou A. Low selenium levels in serum and increased concentration in neoplastic tissues in patients with colorectal cancer: Correlation with serum carcinoembryonic antigen.
Scand. J. Gastroenterol. 41: 359-360 (2006).
*
-
Charalabopoulos K, Mittari E, Peschos D, Golias C, Charalabopoulos A, Tsanou E, Batistatou A. Rare association of chronic lymphocytic thyroiditis with dermatomyositis.
Arch. Med. Res. 37: 563-565 (2006).
-
Charatcharoenwitthaya P, Lindor KD. Primary sclerosing cholangitis: diagnosis and management.
Curr. Gastroenterol. Rep. 8: 75-82 (2006).
-
Charbonnier LM, van Duivenvoorde LM, Apparailly F, Cantos C, Han WG, Noel D, Duperray C, Huizinga TW, Toes RE, Jorgensen C, Louis-Plence P. Immature dendritic cells suppress collagen-induced arthritis by in vivo expansion of CD49b+ regulatory T cells.
J. Immunol. 177: 3806-3813 (2006).
*
-
Chardot C. Biliary atresia.
Orphanet J. Rare Dis. 1: 28 (2006).
*
-
Charerntantanakul W, Roth JA. Biology of porcine T lymphocytes.
Anim. Health Res. Rev. 7: 81-96 (2006).
*
-
Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, Zhang L, Clain JE, Pearson RK, Petersen BT, Vege SS, Farnell MB. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience.
Clin. Gastroenterol. Hepatol. 4: 1010-1016 (2006).
-
Charizopoulou N, Wilke M, Dorsch M, Bot A, Jorna H, Jansen S, Stanke F, Hedrich HJ, de Jonge HR, Tummler B. Spontaneous rescue from cystic fibrosis in a mouse model.
BMC Genet. 7: 18 (2006).
*
-
Charlton M. Branched-chain amino-acid granules: can they improve survival in patients with liver cirrhosis?
Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 72-73 (2006).
*
-
Charng MJ, Wu CH. Transcriptional activation of p21 by Tranilast is mediated via transforming growth factor beta signal pathway.
Br. J. Pharmacol. 147: 117-124 (2006).
*
-
Charniot JC, Genereau T, Mouthon L. Celiprolol-induced lupus-like syndrome.
Acta Cardiol. 61: 661-663 (2006).
-
Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation.
N. Engl. J. Med. 354: 610-621 (2006).
*
-
Charoonpatrapong K, Shah R, Robling AG, Alvarez M, Clapp DW, Chen S, Kopp RP, Pavalko FM, Yu J, Bidwell JP. HMGB1 expression and release by bone cells.
J. Cell Physiol. 207: 480-490 (2006).
*
-
Charrier L, Merlin D. The oligopeptide transporter hPepT1: gateway to the innate immune response.
Lab. Invest. 86: 538-546 (2006).
*
-
Chase K, Sargan D, Miller K, Ostrander EA, Lark KG. Understanding the genetics of autoimmune disease: two loci that regulate late onset Addison's disease in Portuguese water dogs.
Int. J. Immunogenet. 33: 179-184 (2006).
*
-
Chatelain D, Maes C, Yzet T, Brevet M, Bounicaud D, Plachot JP, Verhaeghe P. Primary hepatic lymphoma of MALT-type: a tumor that can simulate a liver metastasis.
Ann. Chir. 131: 121-124 (2006).
-
Chatenoud L. Protection from autoimmunity: immunological indifference versus T-cell mediated suppression?
Eur. J. Immunol. 36: 2296-2298 (2006).
*
-
Chatenoud L. Immune therapies of autoimmune diseases: are we approaching a real cure?
Curr. Opin. Immunol. 18: 710-717 (2006).
-
Chatterjee M, Ionan A, Draghici S, Tainsky MA. Epitomics: global profiling of immune response to disease using protein microarrays.
OMICS 10: 499-506 (2006).
-
Chatterjee M, Mohapatra S, Ionan A, Bawa G, Ali-Fehmi R, Wang X, Nowak J, Ye B, Nahhas FA, Lu K, Witkin SS, Fishman D, Munkarah A, Morris R, Levin NK, Shirley NN, Tromp G, Abrams J, Draghici S, Tainsky MA. Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays.
Cancer Res. 66: 1181-1190 (2006).
*
-
Chattopadhyay K, Bhatia S, Fiser A, Almo SC, Nathenson SG. Structural basis of inducible costimulator ligand costimulatory function: determination of the cell surface oligomeric state and functional mapping of the receptor binding site of the protein.
J. Immunol. 177: 3920-3929 (2006).
*
-
Chattopadhyay N. Effects of calcium-sensing receptor on the secretion of parathyroid hormone-related peptide and its impact on humoral hypercalcemia of malignancy.
Am. J. Physiol. Endocrinol. Metab. 290: E761-E770 (2006).
*
-
Chaturvedi UC, Nagar R, Shrivastava R. Macrophage & dengue virus: friend or foe?
Indian J. Med. Res. 124: 23-40 (2006).
-
Chatzantoni K, Mouzaki A. Anti-TNF-alpha antibody therapies in autoimmune diseases.
Curr. Top. Med. Chem. 6: 1707-1714 (2006).
-
Chatzicostas C, Roussomoustakaki M, Potamianos S, Paspatis G, Mouzas I, Romanos J, Mavrogeni H, Kouroumalis EA. Factors associated with disease evolution in Greek patients with inflammatory bowel disease.
BMC Gastroenterol. 6: 21 (2006).
*
-
Chatzipantelis P, Lazaris AC, Kafiri G, Papadimitriou K, Papathomas TG, Nonni A, Patsouris ES. Cytokeratin-7, cytokeratin-19, and c-Kit: immunoreaction during the evolution stages of primary biliary cirrhosis.
Hepatol. Res. 36: 182-187 (2006).
-
Chaudhuri A. Selective adhesion-molecule therapy and inflammatory bowel disease.
N. Engl. J. Med. 354: 644-645 (2006).
*
-
Chaudhury C, Kim J, Mehnaz S, Wani MA, Oberyszyn TM, Bronson CL, Mohanty S, Hayton WL, Robinson JM, Anderson CL. Accelerated transferrin degradation in HFE-deficient mice is associated with increased transferrin saturation.
J. Nutr. 136: 2993-2998 (2006).
*
-
Chaudry G, Navarro OM, Levine DS, Oudjhane K. Abdominal manifestations of cystic fibrosis in children.
Pediatr. Radiol. 36: 233-240 (2006).
-
Chavez-Tapia NC, Lizardi-Cervera J, Perez-Bautista O, Ramos-Ostos MH, Uribe M. Smoking is not associated with nonalcoholic fatty liver disease.
World J. Gastroenterol. 12: 5196-5200 (2006).
*
-
Chawla PS, Kochar MS. What's new in clinical pharmacology and therapeutics.
WMJ 105: 24-29 (2006).
-
Chazouilleres O, Corpechot C. Is high-dose ursodeoxycholic acid effective for the treatment of patients with primary sclerosing cholangitis?
Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 248-249 (2006).
*
-
Chazouilleres O, Wendum D, Serfaty L, Rosmorduc O, Poupon R. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
J. Hepatol. 44: 400-406 (2006).
*
-
Cheatham CL, Colombo J, Carlson SE. n-3 Fatty acids and cognitive and visual acuity development: methodologic and conceptual considerations.
Am. J. Clin. Nutr. 83: 1458S-1466S (2006).
*
-
Chechi K, Cheema SK. Maternal diet rich in saturated fats has deleterious effects on plasma lipids of mice.
Exp. Clin. Cardol. 11: 129-135 (2006).
*
-
Cheema AA, McNeill AJ. Images in cardiology. Left main coronary artery stenosis associated with aortitis in a patient with Crohn's disease.
Heart 92: 618 (2006).
*
-
Cheetham TC, Wagner RA, Chiu G, Day JM, Yoshinaga MA, Wong L. A risk management program aimed at preventing fetal exposure to isotretinoin: retrospective cohort study.
J. Am. Acad. Dermatol. 55: 442-448 (2006).
-
Cheifetz AS, Kornbluth AA, Legnani P, Schmelkin I, Brown A, Lichtiger S, Lewis BS. The risk of retention of the capsule endoscope in patients with known or suspected Crohn's disease.
Am. J. Gastroenterol. 101: 2218-2222 (2006).
*
-
Cheifetz AS, Lewis BS. Capsule endoscopy retention: is it a complication?
J. Clin. Gastroenterol. 40: 688-691 (2006).
-
Chelly J, Khelfaoui M, Francis F, Cherif B, Bienvenu T. Genetics and pathophysiology of mental retardation.
Eur. J. Hum. Genet. 14: 701-713 (2006).
*
-
Chelvarajan RL, Liu Y, Popa D, Getchell ML, Getchell TV, Stromberg AJ, Bondada S. Molecular basis of age-associated cytokine dysregulation in LPS-stimulated macrophages.
J. Leukoc. Biol. 79: 1314-1327 (2006).
*
-
Chemli J, Braham N, Boughattas S, Harbi A. Graves' disease and celiac disease association in adolescent with Down syndrome.
Rev. Med. Interne. 27: 791-793 (2006).
-
Chemli S, Rym D, Jebali A, Hammami W. Association lichen planus and ulcerative colitis. A case report.
Tunis. Med. 84: 65-67 (2006).
-
Chen AB, D'Amico AV, Neville BA, Earle CC. Patient and treatment factors associated with complications after prostate brachytherapy.
J. Clin. Oncol. 24: 5298-5304 (2006).
*
-
Chen C, Lee WH, Zhong L, Liu CP. Regulatory T cells can mediate their function through the stimulation of APCs to produce immunosuppressive nitric oxide.
J. Immunol. 176: 3449-3460 (2006).
*
-
Chen C, Li H, Tian Q, Beardall M, Xu Y, Casanova N, Weigert M. Selection of anti-double-stranded DNA B cells in autoimmune MRL-lpr/lpr mice.
J. Immunol. 176: 5183-5190 (2006).
*
-
Chen C, Ran ZH, Xiao SD. Therapeutic effects of pravastatin on colitis induced by acetic acid and relevant mechanism: experiment with rats.
Zhonghua Yi Xue Za Zhi 86: 1284-1288 (2006).
-
Chen C, Rowell EA, Thomas RM, Hancock WW, Wells AD. Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation.
J. Biol. Chem. 281: 36828-36834 (2006).
*
-
Chen CH, Chen HA, Wang HP, Liao HT, Chou CT, Huang de F. Pulmonary arterial hypertension in autoimmune diseases: an analysis of 19 cases from a medical center in northern Taiwan.
J. Microbiol. Immunol. Infect. 39: 162-168 (2006).
*
-
Chen CH, Floyd H, Olson NE, Magaletti D, Li C, Draves K, Clark EA. Dendritic cell-associated C-type lectin 2 (DCAL-2) alters dendritic cell maturation and cytokine production.
Blood 107: 1459-1467 (2006).
*
-
Chen CH, Kuo LM, Chang Y, Wu W, Goldbach C, Ross MA, Stolz DB, Chen L, Fung JJ, Lu L, Qian S. In vivo immune modulatory activity of hepatic stellate cells in mice.
Hepatology 44: 1171-1181 (2006).
*
-
Chen CR, Aliesky HA, Guo J, Rapoport B, McLachlan SM. Blockade of costimulation between T cells and antigen-presenting cells: an approach to suppress murine Graves' disease induced using thyrotropin receptor-expressing adenovirus.
Thyroid 16: 427-434 (2006).
-
Chen D, Bromberg JS. T regulatory cells and migration.
Am. J. Transplant. 6: 1518-1523 (2006).
-
Chen H, Hewison M, Adams JS. Functional characterization of heterogeneous nuclear ribonuclear protein C1/C2 in vitamin D resistance: a novel response element binding protein.
J. Biol. Chem. 281: 39114-39120 (2006).
*
-
Chen HL. Sonographic diagnosis in infantile cholestasis.
Acta Paediatr. Taiwan 47: 167-168 (2006).
-
Chen HL, Su HJ, Wang YJ, Guo YL, Liao PC, Lee CC. Interactive effects between CYP1A1 genotypes and environmental polychlorinated dibenzo-p-dioxins and dibenzofurans exposures on liver function profile.
J. Toxicol. Environ. Health A. 69: 269-281 (2006).
-
Chen HY, Wu KD, Chen YM. Vasculitis-related Wunderlich's syndrome treated without surgical intervention.
Clin. Nephrol. 66: 291-296 (2006).
-
Chen J, Carcamo JM, Golde DW. The alpha subunit of the granulocyte-macrophage colony-stimulating factor receptor interacts with c-Kit and inhibits c-Kit signaling.
J. Biol. Chem. 281: 22421-22426 (2006).
*
-
Chen J, Fujimoto C, Vistica BP, Wawrousek EF, Kelsall B, Gery I. Active participation of antigen-nonspecific lymphoid cells in immune-mediated inflammation.
J. Immunol. 177: 3362-3368 (2006).
*
-
Chen J, Liu C. Is sulfasalazine effective in ankylosing spondylitis? A systematic review of randomized controlled trials.
J. Rheumatol. 33: 722-731 (2006).
-
Chen J, Liu C, Lin J. Methotrexate for ankylosing spondylitis.
Cochrane Database Syst. Rev. 4: CD004524 (2006).
*
-
Chen J, Mehta JL. Angiotensin II-mediated oxidative stress and pro-collagen-1 expression in cardiac fibroblasts: blockade by pravastatin and pioglitazone.
Am. J. Physiol. Heart Circ. Physiol. 291: H1738-H1745 (2006).
*
-
Chen J, Raymond K. Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor.
Ann. Clin. Microbiol. Antimicrob. 5: 3 (2006).
*
-
Chen J, Raymond K. Nuclear receptors, bile-acid detoxification, and cholestasis.
Lancet 367: 454-456 (2006).
*
-
Chen J, Raymond K. Treatment effect of rifampicin on cholestasis.
The Internet Journal of Pharmacology Vol. 4 (http://www.ispub.com/ostia/index.php?xmlFilePath=journals/ijpharm/vol4n2/colestasis.xml) (2006). *
-
Chen J, Tan Z, Liu H, Liu Z, Wu Y, Li J. Expression of plasmacytoid dendritic cells, IRF-7, IFN-alpha mRNA in the lesions of psoriasis vulgaris.
J. Huazhong Univ. Sci. Technolog. Med. Sci. 26: 747-749 (2006).
-
Chen JT, Collins DL, Atkins HL, Freedman MS, Galal A, Arnold DL. Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosis.
Neurology 66: 1935-1937 (2006).
-
Chen JY, Wang CM, Lu SC, Chou YH, Luo SF. Association of apoptosis-related microsatellite polymorphisms on chromosome 1q in Taiwanese systemic lupus erythematosus patients.
Clin. Exp. Immunol. 143: 281-287 (2006).
*
-
Chen JY, Wang CM, Ma CC, Luo SF, Edberg JC, Kimberly RP, Wu J. Association of a transmembrane polymorphism of Fcgamma receptor IIb (FCGR2B) with systemic lupus erythematosus in Taiwanese patients.
Arthritis Rheum. 54: 3908-3917 (2006).
*
-
Chen JY, Wang CM, Wu JM, Ho HH, Luo SF. Association of rheumatoid factor production with FcgammaRIIIa polymorphism in Taiwanese rheumatoid arthritis.
Clin. Exp. Immunol. 144: 10-16 (2006).
*
-
Chen L, Ambrosone CB, Lee J, Sellers TA, Pow-Sang J, Park JY. Association between polymorphisms in the DNA repair genes XRCC1 and APE1, and the risk of prostate cancer in white and black Americans.
J. Urol. 175: 108-112 (2006).
-
Chen L, Brosnan CF. Regulation of immune response by P2X7 receptor.
Crit. Rev. Immunol. 26: 499-513 (2006).
-
Chen L, Liu BC, Zhang XL, Zhang JD, Liu H, Li MX. Influence of connective tissue growth factor antisense oligonucleotide on angiotensin II-induced epithelial mesenchymal transition in HK2 cells.
Acta Pharmacol. Sin. 27: 1029-1036 (2006).
*
-
Chen L, Necela BM, Su W, Yanagisawa M, Anastasiadis PZ, Fields AP, Thompson EA. Peroxisome proliferator-activated receptor-gamma promotes epithelial to mesenchymal transformation by Rho GTPase activation of ERK1/2.
J. Biol. Chem. 281: 24575-24587 (2006).
*
-
Chen L, Patel RP, Teng X, Bosworth CA, Lancaster JR Jr, Matalon S. Mechanisms of cystic fibrosis transmembrane conductance regulator activation by S-nitrosoglutathione.
J. Biol. Chem. 281: 9190-9199 (2006).
*
-
Chen L, Wang T, Zhou P, Ma L, Yin D, Shen J, Molinero L, Nozaki T, Phillips T, Uematsu S, Akira S, Wang CR, Fairchild RL, Alegre ML, Chong A. TLR engagement prevents transplantation tolerance.
Am. J. Transplant. 6: 2282-2291 (2006).
*
-
Chen LW, Huang HL, Lee IT, Hsu CM, Lu PJ. Hypertonic saline enhances host defense to bacterial challenge by augmenting Toll-like receptors.
Crit. Care Med. 34: 1758-1768 (2006).
-
Chen M, Lam BK, Kanaoka Y, Nigrovic PA, Audoly LP, Austen KF, Lee DM. Neutrophil-derived leukotriene B4 is required for inflammatory arthritis.
J. Exp. Med. 203: 837-842 (2006).
*
-
Chen M, Wang YH, Wang Y, Huang L, Sandoval H, Liu YJ, Wang J. Dendritic cell apoptosis in the maintenance of immune tolerance.
Science 311: 1160-1164 (2006).
*
-
Chen MC, Mudge CS, Klumpp D. Urothelial lesion formation is mediated by TNFR1 during neurogenic cystitis.
Am. J. Physiol. Renal Physiol. 291: F741-F749 (2006).
*
-
Chen MJ, Lin YC, Wu MS. Optimization of timing of endoscopic variceal ligation of esophageal varices.
Am. J. Gastroenterol. 101: 908 (2006).
*
-
Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, Shin SJ, Lee YJ. ENPP1 K121Q polymorphism is not related to type 2 diabetes mellitus, features of metabolic syndrome, and diabetic cardiovascular complications in a Chinese population.
Rev. Diabet. Stud. 3: 21-30 (2006).
*
-
Chen PJ, Wei CC, Wang C, Chen FW, Hsu YH, Chang MS. Promoter analysis of interleukin 19.
Biochem. Biophys. Res. Commun. 344: 713-720 (2006).
*
-
Chen Q, Carroll HP, Gadina M. The newest interleukins: recent additions to the ever-growing cytokine family.
Vitam. Horm. 74C: 207-228 (2006).
-
Chen Q, Kamboh MI. Complete DNA sequence variation in the apolipoprotein H (beta-glycoprotein I) gene and identification of informative SNPs.
Ann. Hum. Genet. 70: 1-11 (2006).
*
-
Chen Q, Yang Y, Li L, Zhang JT. The amino terminus of the human multidrug resistance transporter ABCC1 has a U-shaped folding with a gating function.
J. Biol. Chem. 281: 31152-31163 (2006).
*
-
Chen RH, Wang TY, Chen WC, Tsai CH, Tsai FJ. Association between the TAP2 gene codon 665 polymorphism and Graves' disease.
J. Clin. Lab. Anal. 20: 93-97 (2006).
-
Chen S, Ding JH, Bekeredjian R, Yang BZ, Shohet RV, Johnston SA, Hohmeier HE, Newgard CB, Grayburn PA. Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology.
Proc. Natl. Acad. Sci. U.S.A. 103: 8469-8474 (2006).
*
-
Chen S, Feng D. Novel parameter estimation methods for 11C-acetate dual-input liver model with dynamic PET.
IEEE Trans. Biomed. Eng. 53: 967-973 (2006).
-
Chen SC, Cummings OW, Hartley MP, Filomena CA, Cho WK. Hepatocellular carcinoma occurring in a patient with Crohn's disease treated with both azathioprine and infliximab.
Dig. Dis. Sci. 51: 952-955 (2006).
*
-
Chen SC, Tsai HJ, Jan CM, Wang YH, Chen LT. Low dose of thalidomide can be effective in advanced hepatocellular carcinoma.
J. Gastroenterol. Hepatol. 21: 1868-1869 (2006).
*
-
Chen SH, Hung CS, Yang CP, Lo FS, Hsu HH. Coexistence of megaloblastic anemia and iron deficiency anemia in a young woman with chronic lymphocytic thyroiditis.
Int. J. Hematol. 84: 238-241 (2006).
-
Chen WH, Lui CC, Chen CJ, Liu JS. An increase of anticardiolipin antibody in association with stroke and chronic chemical exposure.
Clin. Appl. Thromb. Hemost. 12: 231-235 (2006).
-
Chen WH, Wang XX, Lin W, He XW, Wu ZQ, Lin Y, Hu SN, Wang XN. Analysis of 10,000 ESTs from lymphocytes of the cynomolgus monkey to improve our understanding of its immune system.
BMC Genomics 7: 82 (2006).
*
-
Chen WJ, Li H, Jia Y, Zhang L, Lu ML, Li MY, Jiang ZH. Study of the construction and function of an eukaryotic expression plasmid of immunotoxin DT390 gene.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 22: 299-301 (2006).
-
Chen X, Chen F, Liu S, Glaeser H, Dawson PA, Hofmann AF, Kim RB, Shneider BL, Pang KS. Transactivation of rat ASBT and increased bile acid transport by 1alpha,25-dihydroxyvitamin D3 via the vitamin D receptor (VDR).
Mol. Pharmacol. 69: 1913-1923 (2006).
*
-
Chen X, Katoh Y, Nakamura K, Oyama N, Kaneko F, Endo Y, Fujita T, Nishida T, Mizuki N. Single nucleotide polymorphisms of Ficolin 2 gene in Behcet's disease.
J. Dermatol. Sci. 43: 201-205 (2006).
-
Chen X, Maiti S, Zhang J, Chen G. Nuclear receptor interactions in methotrexate induction of human dehydroepiandrosterone sulfotransferase (hSULT2A1).
J. Biochem. Mol. Toxicol. 20: 309-317 (2006).
*
-
Chen X, Oppenheim JJ, Winkler-Pickett RT, Ortaldo JR, Howard OM. Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3(+)CD4(+)CD25(+) T regulatory cells in vivo and enhances their capacity to suppress EAE.
Eur. J. Immunol. 36: 2139-2149 (2006).
*
-
Chen X, Tan Z, Yue Q, Liu H, Liu Z, Li J. The expression of interleukin-23 (p19/p40) and inteleukin-12 (p35/p40) in psoriasis skin.
J. Huazhong Univ. Sci. Technolog. Med. Sci. 26: 750-752 (2006).
-
Chen X, Wang H, Xie W, Liang R, Wei Z, Zhi L, Zhang X, Hao B, Zhong S, Zhou G, Zhang L, Gao X, Zhu Y, He F. Association of CYP1A2 genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a high-risk region of China.
Pharmacogenet. Genomics 16: 219-227 (2006).
-
Chen X, Winkler-Pickett RT, Carbonetti NH, Ortaldo JR, Oppenheim JJ, Howard OM. Pertussis toxin as an adjuvant suppresses the number and function of CD4(+)CD25(+) T regulatory cells.
Eur. J. Immunol. 36: 671-680 (2006).
*
-
Chen XP, Wang Q, Guan J, Huang ZY, Zhang WG, Zhang BX. Reversing multidrug resistance by RNA interference through the suppression of MDR1 gene in human hepatoma cells.
World J. Gastroenterol. 12: 3332-3337 (2006).
*
-
Chen XR, Feng YL, Ma Y, Zhang ZD, Li CY, Wen FQ, Tang XY, Su ZG. Study on the association of two polymorphisms of the vitamin D receptor (VDR) gene with the susceptibility to pulmonary tuberculosis (PTB) in Chinese Tibetans.
Sichuan Da Xue Xue Bao Yi Xue Ban 37: 847-851 (2006).
-
Chen Y, Corriden R, Inoue Y, Yip L, Hashiguchi N, Zinkernagel A, Nizet V, Insel PA, Junger WG. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors.
Science 314: 1792-1795 (2006).
*
-
Chen Y, Langrish CL, McKenzie B, Joyce-Shaikh B, Stumhofer JS, McClanahan T, Blumenschein W, Churakovsa T, Low J, Presta L, Hunter CA, Kastelein RA, Cua DJ. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis.
J. Clin. Invest. 116: 1317-1326 (2006).
*
-
Chen Y, Thelin WR, Yang B, Milgram SL, Jacobson K. Transient anchorage of cross-linked glycosyl-phosphatidylinositol-anchored proteins depends on cholesterol, Src family kinases, caveolin, and phosphoinositides.
J. Cell Biol. 175: 169-178 (2006).
*
-
Chen Y, Yang C, Xie Z, Zou L, Ruan Z, Zhang X, Tang Y, Fei L, Jia Z, Wu Y. Expression of the novel co-stimulatory molecule B7-H4 by renal tubular epithelial cells.
Kidney Int. 70: 2092-2099 (2006).
*
-
Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
Health Technol. Assess. 10: 1-248 (2006).
*
-
Chen YH, Lin SJ, Chen YL, Liu PL, Chen JW. Anti-inflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules.
Cardiovasc. Hematol. Disord. Drug Targets 6: 279-304 (2006).
-
Chen YP, Pfab T, Slowinski T, Richter CM, Godes M, Hocher B. Impact of genetic variation of tumor necrosis factor-alpha on gestational hypertension.
Chin. Med. J. (Engl.) 119: 719-724 (2006).
*
-
Chen YQ, Berquin IM, Daniel LW, Edwards IJ, O'Flaherty JT, Thomas MJ, Tooze JA, Wykle B. Omega-3 fatty acids and cancer risk.
JAMA 296: 282 (2006).
*
-
Chen YQ, Shi HZ. CD28/CTLA-4-CD80/CD86 and ICOS-B7RP-1 costimulatory pathway in bronchial asthma.
Allergy 61: 15-26 (2006).
*
-
Chen YS, Chou PH, Li SN, Tsai WC, Lin KH, Tsai KB, Yen JH, Liu HW. Parvovirus B19 infection in patients with rheumatoid arthritis in Taiwan.
J. Rheumatol. 33: 887-891 (2006).
-
Chen Z, de Kauwe AL, Keech C, Wijburg O, Simpfendorfer K, Alexander WS, McCluskey J. Humanized transgenic mice expressing HLA DR4-DQ3 haplotype: reconstitution of phenotype and HLA-restricted T-cell responses.
Tissue Antigens 68: 210-219 (2006).
*
-
Chen Z, Laurence A, Kanno Y, Pacher-Zavisin M, Zhu BM, Tato C, Yoshimura A, Hennighausen L, O'Shea JJ. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells.
Proc. Natl. Acad. Sci. U.S.A. 103: 8137-8142 (2006).
*
-
Chen Z, Pan XC. Hepatitis C and autoimmune diseases.
Zhonghua Gan Zang Bing Za Zhi 14: 236-237 (2006).
-
Chen Z, Stockton J, Mathis D, Benoist C. Modeling CTLA4-linked autoimmunity with RNA interference in mice.
Proc. Natl. Acad. Sci. U.S.A. 103: 16400-16405 (2006).
*
-
Chen ZL, Wang DM, Duan JF, Wen SQ, Tang YF, Li ZX. Leptin enhances the release of cytokines by peripheral blood mononuclear cells from acute multiple sclerosis patients.
Neurosci. Bull. 22: 115-117 (2006).
-
Chen ZY, Jing D, Bath KG, Ieraci A, Khan T, Siao CJ, Herrera DG, Toth M, Yang C, McEwen BS, Hempstead BL, Lee FS. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior.
Science 314: 140-143 (2006).
*
-
Chenevier-Gobeaux C, Lemarechal H, Bonnefont-Rousselot D, Poiraudeau S, Ekindjian OG, Borderie D. Superoxide production and NADPH oxidase expression in human rheumatoid synovial cells: regulation by interleukin-1beta and tumour necrosis factor-alpha.
Inflamm. Res. 55: 483-490 (2006).
*
-
Cheng AY, Leiter LA. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
Curr. Opin. Cardiol. 21: 400-404 (2006).
-
Cheng CL, Sherman S, Watkins JL, Barnett J, Freeman M, Geenen J, Ryan M, Parker H, Frakes JT, Fogel EL, Silverman WB, Dua KS, Aliperti G, Yakshe P, Uzer M, Jones W, Goff J, Lazzell-Pannell L, Rashdan A, Temkit M, Lehman GA. Risk factors for post-ERCP pancreatitis: a prospective multicenter study.
Am. J. Gastroenterol. 101: 139-147 (2006).
*
-
Cheng HT, Chen JY, Huang YC, Chang HC, Hung WC. Functional role of VDR in the activation of p27(Kip1) by the VDR/Sp1 complex.
J. Cell. Biochem. 98: 1450-1456 (2006).
*
-
Cheng S, Afif H, Martel-Pelletier J, Benderdour M, Pelletier JP, Hilal G, Haraoui P, Raynauld JP, Choquette D, Fahmi H. Association of polymorphisms in the peroxisome proliferator-activated receptor gamma gene and osteoarthritis of the knee.
Ann. Rheum. Dis. 65: 1394-1397 (2006).
*
-
Cheng TF, Brzostek S, Ando O, Van Scoy S, Kumar KP, Reich NC. Differential activation of IFN regulatory factor (IRF)-3 and IRF-5 transcription factors during viral infection.
J. Immunol. 176: 7462-7470 (2006).
*
-
Cheng W, Cheng NS, Xiong XZ, Xia QJ, Chen OY, Yan NH, Jing J. Expression of PPAR-gamma in human hilar bile duct carcinoma cell line QBC939 and the effects of PPAR-Y activated by its ligand on the growth of QBC939.
Sichuan Da Xue Xue Bao Yi Xue Ban 37: 745-749 (2006).
-
Cheng X, Klaassen CD. Regulation of mRNA expression of xenobiotic transporters by the pregnane-X receptor (PXR) in mouse liver, kidney, and intestine.
Drug Metab. Dispos. 34: 1863-1867 (2006).
*
-
Cheng X, Maher JM, Lu H, Klaassen CD. Endocrine regulation of gender-divergent mouse organic anion transporting polypeptide (Oatp) expression.
Mol. Pharmacol. 70: 1291-1297 (2006).
*
-
Cheng YK, Lin CD, Chang WC, Hwang GY, Tsai SW, Wan L, Tsai MH, Tsai JJ, Tsai FJ. Increased prevalence of interleukin-1 receptor antagonist gene polymorphism in patients with chronic rhinosinusitis.
Arch. Otolaryngol. Head Neck Surg. 132: 285-290 (2006).
-
Cheon H, Rho YH, Choi SJ, Lee YH, Song GG, Sohn J, Won NH, Ji JD. Prostaglandin E2 augments IL-10 signaling and function.
J. Immunol. 177: 1092-1100 (2006).
*
-
Cheon JH, Kim JS, Kim JM, Kim N, Jung HC, Song IS. Plant sterol guggulsterone inhibits nuclear factor-kappaB signaling in intestinal epithelial cells by blocking IkappaB kinase and ameliorates acute murine colitis.
Inflamm. Bowel Dis. 12: 1152-1161 (2006).
*
-
Cheong JY, Cho SW, Chung SG, Lee JA, Yeo M, Wang HJ, Lee JE, Hahm KB, Kim JH. Genetic polymorphism of interferon-gamma, interferon-gamma receptor, and interferon regulatory factor-1 genes in patients with hepatitis B virus infection.
Biochem. Genet. 44: 246-255 (2006).
*
-
Chermesh I, Eliakim R. Probiotics and the gastrointestinal tract: where are we in 2005?
World J. Gastroenterol. 12: 853-857 (2006).
*
-
Chermesh I, Tamir A, Suissa A, Eliakim R. Ferrus calcium citrate is absorbed better than iron bisglycinate in patients with Crohn's disease, but not in healthy controls.
Dig. Dis. Sci. 51: 942-945 (2006).
*
-
Cheroki C, Krepischi-Santos AC, Rosenberg C, Jehee FS, Mingroni-Netto RC, Filho IP, Filho SZ, Kim CA, Bagnoli VR, Mendonca BB, Szuhai K, Otto PA. Report of a del22q11 in a patient with Mayer-Rokitansky-Kuster-Hauser (MRKH) anomaly and exclusion of WNT-4, RAR-gamma, and RXR-alpha as major genes determining MRKH anomaly in a study of 25 affected women.
Am. J. Med. Genet. A. 140: 1339-1342 (2006).
-
Cheroutre H. In IBD eight can come before four.
Gastroenterology 131: 667-670 (2006).
*
-
Cherry K. Measuring bone mineral density in celiac disease patients.
Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 6 (2006). *
-
Cherry K. NOD2/CARD15 variants and Crohn's disease.
Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 11 (2006). *
-
Cherry K. Oral nicotine therapy for the treatment of inflammatory bowel disease.
Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 123 (2006). *
-
Cheskis BJ, Freedman LP, Nagpal S. Vitamin D receptor ligands for osteoporosis.
Curr. Opin. Investig. Drugs 7: 906-911 (2006).
-
Chetty VT, Sharma AM. Can PPARgamma agonists have a role in the management of obesity-related hypertension?
Vascul. Pharmacol. 45: 46-53 (2006).
*
-
Cheung C, Yu AM, Chen CS, Krausz KW, Byrd LG, Feigenbaum L, Edwards RJ, Waxman DJ, Gonzalez FJ. Growth hormone determines sexual dimorphism of hepatic cytochrome P450 3A4 expression in transgenic mice.
J. Pharmacol. Exp. Ther. 316: 1328-1334 (2006).
*
-
Cheung PF, Wong CK, Ip WK, Lam CW. IL-25 regulates the expression of adhesion molecules on eosinophils: mechanism of eosinophilia in allergic inflammation.
Allergy 61: 878-885 (2006).
*
-
Chew LJ, Takanohashi A, Bell M. Microglia and inflammation: impact on developmental brain injuries.
Ment. Retard. Dev. Disabil. Res. Rev. 12: 105-112 (2006).
-
Chi H, Barry SP, Roth RJ, Wu JJ, Jones EA, Bennett AM, Flavell RA. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses.
Proc. Natl. Acad. Sci. U.S.A. 103: 2274-2279 (2006).
*
-
Chiang JY, Li T, Song KH, Owsley E. Regulation of CYP7A1 by nuclear receptor signaling in human liver cells.
Falk Symposium 155. XIII FALK LIVER WEEK (Part I) XIX International Bile Acid Meeting. Bile Acids: Biological Actions and Clinical Relevance, October 6 - 7, 2006 Freiburg (Germany), p. 50 (2006). *
-
Chiang N, Hurwitz S, Ridker PM, Serhan CN. Aspirin has a gender-dependent impact on antiinflammatory 15-epi-lipoxin A4 formation: a randomized human trial.
Arterioscler. Thromb. Vasc. Biol. 26: e14-e17 (2006).
-
Chiang N, Serhan CN. New mechanism for an old drug: aspirin triggers anti-inflammatory lipid mediators with gender implications.
Compr. Ther. 32: 150-157 (2006).
-
Chiang N, Serhan CN. Cell-cell interaction in the transcellular biosynthesis of novel omega-3-derived lipid mediators.
Methods Mol. Biol. 341: 227-250 (2006).
-
Chiang N, Serhan CN, Dahlen SE, Drazen JM, Hay DW, Rovati GE, Shimizu T, Yokomizo T, Brink C. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo.
Pharmacol. Rev. 58: 463-487 (2006).
*
-
Chiappelli M, Tumini E, Porcellini E, Licastro F. Impaired regulation of immune responses in cognitive decline and Alzheimer's disease: lessons from genetic association studies.
Expert Rev. Neurother. 6: 1327-1336 (2006).
-
Chiavaroli C, Moore A. An hypothesis to link the opposing immunological effects induced by the bacterial lysate OM-89 in urinary tract infection and rheumatoid arthritis.
BioDrugs 20: 141-149 (2006).
-
Chiba H, Kojima T, Osanai M, Sawada N. The significance of interferon-gamma-triggered internalization of tight-junction proteins in inflammatory bowel disease.
Sci. STKE 316: pe1 (2006).
*
-
Chiba H, Sakai N, Murata M, Osanai M, Ninomiya T, Kojima T, Sawada N. The nuclear receptor hepatocyte nuclear factor 4alpha acts as a morphogen to induce the formation of microvilli.
J. Cell Biol. 175: 971-980 (2006).
*
-
Chiba K, Matsuyuki H, Maeda Y, Sugahara K. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.
Cell. Mol. Immunol. 3: 11-19 (2006).
*
-
Chiba T, Kita K, Zheng YW, Yokosuka O, Saisho H, Iwama A, Nakauchi H, Taniguchi H. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties.
Hepatology 44: 240-251 (2006).
*
-
Chida Y, Sudo N, Kubo C. Does stress exacerbate liver diseases?
J. Gastroenterol. Hepatol. 21: 202-208 (2006).
-
Chidlow JH Jr, Langston W, Greer JJ, Ostanin D, Abdelbaqi M, Houghton J, Senthilkumar A, Shukla D, Mazar AP, Grisham MB, Kevil CG. Differential angiogenic regulation of experimental colitis.
Am. J. Pathol. 169: 2014-2030 (2006).
*
-
Chien JW, Chen WL, Tsui YG, Lee MC, Lin AY, Lin CY. Daily urinary interleukin-11 excretion correlated with proteinuria in IgA nephropathy and lupus nephritis.
Pediatr. Nephrol. 21: 490-496 (2006).
*
-
Chieppa M, Rescigno M, Huang AY, Germain RN. Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement.
J. Exp. Med. 203: 2841-2852 (2006).
*
-
Chikviladze D, Sinjikashvili M, Metreveli D, Mikeladze M, Gachechiladze Kh. Results of serotyping of strains isolated from patients with ulcerative colitis (colitis gravis), adaptive colitis and chronic catarrhal colitis.
Georgian Med. News 130: 122-125 (2006).
-
Child MW, Kennedy A, Walker AW, Bahrami B, Macfarlane S, Macfarlane GT. Studies on the effect of system retention time on bacterial populations colonizing a three-stage continuous culture model of the human large gut using FISH techniques.
FEMS Microbiol. Ecol. 55: 299-310 (2006).
*
-
Childers CP, Newkirk HL, Honeycutt DA, Ramlachan N, Muzney DM, Sodergren E, Gibbs RA, Weinstock GM, Womack JE, Skow LC. Comparative analysis of the bovine MHC class IIb sequence identifies inversion breakpoints and three unexpected genes.
Anim. Genet. 37: 121-129 (2006).
*
-
Childs SG. The pathogenesis of systemic lupus erythematosus.
Orthop. Nurs. 25: 140-145 (2006).
-
Chillingworth NL, Morham SG, Donaldson LF. Sex differences in inflammation and inflammatory pain in cyclooxygenase-deficient mice.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 291: R327-334 (2006).
*
-
Chin AC, Parkos CA. Neutrophil transepithelial migration and epithelial barrier function in IBD: potential targets for inhibiting neutrophil trafficking.
Ann. N. Y. Acad. Sci. 1072: 276-287 (2006).
*
-
Chin D, Boyle GM, Theile DR, Parsons PG, Coman WB. The human genome and gene expression profiling.
J. Plast. Reconstr. Aesthet. Surg. 59: 902-911 (2006).
-
Chin RK, Zhu M, Christiansen PA, Liu W, Ware C, Peltonen L, Zhang X, Guo L, Han S, Zheng B, Fu YX. Lymphotoxin pathway-directed, autoimmune regulator-independent central tolerance to arthritogenic collagen.
J. Immunol. 177: 290-297 (2006).
*
-
Chin RL, Tseng VG, Green PH, Sander HW, Brannagan TH 3rd, Latov N. Multifocal axonal polyneuropathy in celiac disease.
Neurology 66: 1923-1925 (2006).
-
Chindelevitch L, Li Z, Blais E, Blanchette M. On the inference of parsimonious indel evolutionary scenarios.
J. Bioinform. Comput. Biol. 4: 721-744 (2006).
-
Chinen J, Finkelman F, Shearer WT. Advances in basic and clinical immunology.
J. Allergy Clin. Immunol. 118: 489-495 (2006).
*
-
Chinen T, Kobayashi T, Ogata H, Takaesu G, Takaki H, Hashimoto M, Yagita H, Nawata H, Yoshimura A. Suppressor of cytokine signaling-1 regulates inflammatory bowel disease in which both IFN-gamma and IL-4 are involved.
Gastroenterology 130: 373-388 (2006).
*
-
Chinetti G, Fruchart JC, Staels B. Transcriptional regulation of macrophage cholesterol trafficking by PPARalpha and LXR.
Biochem. Soc. Trans. 34: 1128-1131 (2006).
*
-
Chintharlapalli S, Papineni S, Safe S. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through PPARgamma-dependent and PPARgamma-independent pathways.
Mol. Cancer Ther. 5: 1362-1370 (2006).
-
Chiou CF, Sherbourne CD, Cornelio I, Lubeck DP, Paulus HE, Dylan M, Chang CH, Weisman MH. Development and validation of the revised Cedars-Sinai health-related quality of life for rheumatoid arthritis instrument.
Arthritis Rheum. 55: 856-863 (2006).
*
-
Chiovetti A. Bridging the gap between health literacy and patient education for people with multiple sclerosis.
J. Neurosci. Nurs. 38: 374-378 (2006).
-
Chirino YI, Orozco-Lbarra M, Pedraza-Chaverri J. Role of peroxynitrite anion in different diseases.
Rev. Invest. Clin. 58: 350-358 (2006).
-
Chistiakov D, Zotova E, Savost'anov K, Bursa T, Galeev I, Strokov Ia, Nosikov V. The 262T>C promoter polymorphism of the catalase gene is associated with diabetic neuropathy in type 1 diabetic Russian patients.
Diabetes Metab. 32: 63-68 (2006).
-
Chistiakov DA, Savost'anov KV, Turakulov RI, Efremov IA, Demurov LM. Genetic analysis and functional evaluation of the C/T(-318) and A/G(-1661) polymorphisms of the CTLA-4 gene in patients affected with Graves' disease.
Clin. Immunol. 118: 233-242 (2006).
*
-
Chitnis T. Pediatric multiple sclerosis.
Neurologist 12: 299-310 (2006).
-
Chiu A, Chan LM, Fan ST. Molecular adsorbent recirculating system treatment for patients with liver failure: the Hong Kong experience.
Liver Int. 26: 695-702 (2006).
*
-
Chiu A, Fan ST. MARS in the treatment of liver failure: controversies and evidence.
Int. J. Artif. Organs 29: 660-667 (2006).
-
Chiu WA, Caldwell JC, Keshava N, Scott CS. Key scientific issues in the health risk assessment of trichloroethylene.
Environ. Health Perspect. 114: 1445-1449 (2006).
*
-
Chivu RD, Chivu LI, Ion DA, Barbu C, Fica S. Allergic reactions to antithyroid drugs are associated with autoimmunity a retrospective case-control study.
Rev. Med. Chir. Soc. Med. Nat. Iasi. 110: 830-832 (2006).
-
Chizzolini C, Parel Y, Scheja A, Dayer JM. Polarized subsets of human T-helper cells induce distinct patterns of chemokine production by normal and systemic sclerosis dermal fibroblasts.
Arthritis Res. Ther. 8: R10 (2006).
*
-
Chmaisse HN, Fakhoury HA, Salti NN, Makki RF. The ICAM-1 469 T/C gene polymorphism but not 241 G/A is associated with Behcets disease in the Lebanese population.
Saudi Med. J. 27: 604-607 (2006).
-
Chmiela M, Michetti P. Inflammation, immunity, vaccines for Helicobacter infection.
Helicobacter 11 Suppl. 1: 21-26 (2006).
*
-
Cho EK, Tchinda J, Freeman JL, Chung YJ, Cai WW, Lee C. Array-based comparative genomic hybridization and copy number variation in cancer research.
Cytogenet. Genome Res. 115: 262-272 (2006).
-
Cho HH, Bae YC, Jung JS. Role of Toll-like receptors on human adipose-derived stromal cells.
Stem Cells 24: 2744-2752 (2006).
*
-
Cho HJ, Chung JH, Kim IS, Kim HJ, Cho SH, Ki CS, Kim JW. Lack of a genetic association between the CTLA-4 gene and Graves' disease in Koreans.
Thyroid 16: 237-241 (2006).
-
Cho J. Genetic advances in inflammatory bowel disease.
Curr. Treat. Options Gastroenterol. 9: 191-200 (2006).
-
Cho JH. Recent progress in inflammatory bowel disease genetics.
Adv. Exp. Med. Biol. 579: 24-34 (2006).
-
Cho JH. Finding inflammatory bowel disease genes will lead to a cure.
Can. J. Gastroenterol. 20: 641-642 (2006).
*
-
Cho JW, Kim JY, Kim CW, Lee KS. Down-regulation of TGF-beta1-induced type I collagen synthesis by AP-1 transcription factor decoy in scleroderma fibroblasts.
J. Dermatol. Sci. 43: 207-209 (2006).
-
Cho JY, Suh KS, Lee HW, Cho EH, Yang SH, Cho YB, Yi NJ, Kim MA, Jang JJ, Lee KU. Hypoattenuation in unenhanced CT reflects histological graft dysfunction and predicts 1-year mortality after living donor liver transplantation.
Liver Transpl. 12: 1403-1411 (2006).
*
-
Cho JY, Suh KS, Lee HW, Cho EH, Yang SH, Cho YB, Yi NJ, Kim MA, Jang JJ, Lee KU. Hepatic steatosis is associated with intrahepatic cholestasis and transient hyperbilirubinemia during regeneration after living donor liver transplantation.
Transpl. Int. 19: 807-813 (2006).
*
-
Cho MC, Yoon HE, Kang JW, Park SW, Yang Y, Hong JT, Song EY, Paik SG, Kim SH, Yoon DY. A simple method to screen ligands of peroxisome proliferator-activated receptor delta.
Eur. J. Pharm. Sci. 29: 355-360 (2006).
*
-
Cho ML, Kang JW, Moon YM, Nam HJ, Jhun JY, Heo SB, Jin HT, Min SY, Ju JH, Park KS, Cho YG, Yoon CH, Park SH, Sung YC, Kim HY. STAT3 and NF-kappaB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice.
J. Immunol. 176: 5652-5661 (2006).
*
-
Cho ML, Min SY, Chang SH, Kim KW, Heo SB, Lee SH, Park SH, Cho CS, Kim HY. Transforming growth factor beta 1(TGF-beta1) down-regulates TNFalpha-induced RANTES production in rheumatoid synovial fibroblasts through NF-kappaB-mediated transcriptional repression.
Immunol. Lett. 105: 159-166 (2006).
-
Cho SE, Sook Hong K, Shin GJ, Chung WS. The methylenetetrahydrofolate reductase C677T gene mutation is associated with hyperhomocysteinemia, cardiovascular disease and plasma B-type natriuretic peptide levels in Korea.
Clin. Chem. Lab. Med. 44: 1070-1075 (2006).
*
-
Cho SG, Min SY, Park MJ, Lee KW, Cho YG, Cho ML, Chang HS, Park SH, Lee JW, Min WS, Kim CC, Kim HY. Immunoregulatory effects of allogeneic mixed chimerism induced by nonmyeloablative bone marrow transplantation on chronic inflammatory arthritis and autoimmunity in interleukin-1 receptor antagonist-deficient mice.
Arthritis Rheum. 54: 1878-1887 (2006).
*
-
Cho-Rok J, Yoo J, Jang YJ, Kim S, Chu IS, Yeom YI, Choi JY, Im DS. Adenovirus-mediated transfer of siRNA against PTTG1 inhibits liver cancer cell growth in vitro and in vivo.
Hepatology 43: 1042-1052 (2006).
*
-
Choi BG, Vilahur G, Viles-Gonzalez JF, Badimon JJ. The role of high-density lipoprotein cholesterol in atherothrombosis.
Mt. Sinai J. Med. 73: 690-701 (2006).
*
-
Choi BK, Asai T, Vinay DS, Kim YH, Kwon BS. 4-1BB-mediated amelioration of experimental autoimmune uveoretinitis is caused by indoleamine 2,3-dioxygenase-dependent mechanisms.
Cytokine 34: 233-242 (2006).
-
Choi CB, Kang CP, Seong SS, Bae SC, Kang C. The -169C/T polymorphism in FCRL3 is not associated with susceptibility to rheumatoid arthritis or systemic lupus erythematosus in a case-control study of Koreans.
Arthritis Rheum. 54: 3838-3841 (2006).
*
-
Choi CH. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted county, Minnesota.
Korean J. Gastroenterol. 48: 58-61 (2006).
-
Choi EH, Ehrmantraut M, Foster CB, Moss J, Chanock SJ. Association of common haplotypes of surfactant protein A1 and A2 (SFTPA1 and SFTPA2) genes with severity of lung disease in cystic fibrosis.
Pediatr. Pulmonol. 41: 255-262 (2006).
-
Choi EK, Kim MH, Kim JC, Han J, Oh SI, Jeong WJ, Jeong JY, Lee SS, Seo DW, Lee SK. The long-term follow-up results after steroid treatment in patients with autoimmune chronic pancreatitis.
Korean J. Gastroenterol. 47: 440-448 (2006).
-
Choi EW, Shin IS, Bhang DH, Lee DH, Bae BK, Kang MS, Kim DY, Hwang CY, Lee CW, Youn HY. Hormonal change and cytokine mRNA expression in peripheral blood mononuclear cells during the development of canine autoimmune thyroiditis.
Clin. Exp. Immunol. 146: 101-108 (2006).
*
-
Choi HJ, Huber AH, Weis WI. Thermodynamics of beta -catenin-ligand interactions. The roles of the N- and C-terminal tails in modulating binding affinity.
J. Biol. Chem. 281: 1027-1038 (2006).
*
-
Choi JM, Ahn MH, Chae WJ, Jung YG, Park JC, Song HM, Kim YE, Shin JA, Park CS, Park JW, Park TK, Lee JH, Seo BF, Kim KD, Kim ES, Lee DH, Lee SK, Lee SK. Intranasal delivery of the cytoplasmic domain of CTLA-4 using a novel protein transduction domain prevents allergic inflammation.
Nat. Med. 12: 574-579 (2006).
*
-
Choi JY, Gao W, Odegard J, Shiah HS, Kashgarian M, McNiff JM, Baker DC, Cheng YC, Craft J. Abrogation of skin disease in LUPUS-prone MRL/FAS(lpr) mice by means of a novel tylophorine analog.
Arthritis Rheum. 54: 3277-3283 (2006).
*
-
Choi JY, Son EJ, Kim JL, Lee JH, Park HY, Kim SH, Song MH, Yoon JH. ENaC- and CFTR-dependent ion and fluid transport in human middle ear epithelial cells.
Hear. Res. 211: 26-32 (2006).
*
-
Choi M, Inagaki T, Moschetta A, Mangelsdorf DJ, Kliewer S. Regulation of bile acid homeostasis by FXR and FGF15.
Falk Symposium 155. XIII FALK LIVER WEEK (Part I) XIX International Bile Acid Meeting. Bile Acids: Biological Actions and Clinical Relevance, October 6 - 7, 2006 Freiburg (Germany), p. 53 (2006). *
-
Choi M, Moschetta A, Bookout AL, Peng L, Umetani M, Holmstrom SR, Suino-Powell K, Xu HE, Richardson JA, Gerard RD, Mangelsdorf DJ, Kliewer SA. Identification of a hormonal basis for gallbladder filling.
Nat. Med. 12: 1253-1255 (2006).
*
-
Choi SJ, Chung SS, Rho EJ, Lee HW, Lee MH, Choi HS, Seol JH, Baek SH, Bang OS, Chung CH. Negative modulation of RXRalpha transcriptional activity by small ubiquitin-related modifier (SUMO) modification and its reversal by SUMO-specific protease SUSP1.
J. Biol. Chem. 281: 30669-30677 (2006).
*
-
Choi SJ, Rho YH, Ji JD, Song GG, Lee YH. Genome scan meta-analysis of rheumatoid arthritis.
Rheumatology (Oxford) 45: 166-170 (2006).
*
-
Choi SS, Sicklick JK, Ma Q, Yang L, Huang J, Qi Y, Chen W, Li YX, Goldschmidt-Clermont PJ, Diehl AM. Sustained activation of Rac1 in hepatic stellate cells promotes liver injury and fibrosis in mice.
Hepatology 44: 1267-1277 (2006).
*
-
Choi YH, Stamm C, Hammer PE, Kwaku KF, Marler JJ, Friehs I, Jones M, Rader CM, Roy N, Eddy MT, Triedman JK, Walsh EP, McGowan FX Jr, Del Nido PJ, Cowan DB. Cardiac conduction through engineered tissue.
Am. J. Pathol. 169: 72-85 (2006).
*
-
Choi YS, Hong JM, Lim S, Ko KS, Pak YK. Impaired coactivator activity of the Gly(482) variant of peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) on mitochondrial transcription factor A (Tfam) promoter.
Biochem. Biophys. Res. Commun. 344: 708-712 (2006).
*
-
Choileain NN, Macconmara M, Zang Y, Murphy TJ, Mannick JA, Lederer JA. Enhanced regulatory T cell activity is an element of the host response to injury.
J. Immunol. 176: 225-236 (2006).
*
-
Cholongitas E, Quaglia A, Samonakis D, Senzolo M, Triantos C, Patch D, Leandro G, Dhillon A, Burroughs AK. Transjugular liver biopsy: how good it is for accurate histological interpretation?
Gut 55: 1789-1794 (2006).
*
-
Cholongitas E, Samonakis D, Patch D, Senzolo M, Burroughs AK, Quaglia A, Dhillon A. Induction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus.
Transplantation 81: 488-490 (2006).
-
Chon CY, Park JY. Primary biliary cirrhosis.
Korean J. Hepatol. 12: 364-372 (2006).
-
Chong AK, Chin BW, Meredith CG. Clinically significant small-bowel pathology identified by double-balloon enteroscopy but missed by capsule endoscopy.
Gastrointest. Endosc. 64: 445-449 (2006).
-
Chong AS, Shen J, Tao J, Yin D, Kuznetsov A, Hara M, Philipson LH. Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration.
Science 311: 1774-1775 (2006).
*
-
Chong MS, Wolff K, Wise K, Tanton C, Winstock A, Silber E. Cannabis use in patients with multiple sclerosis.
Mult. Scler. 12: 646-651 (2006).
*
-
Chong WP, Ip WE, Tso GH, Ng MW, Wong WH, Law HK, Yung RW, Chow EY, Au K, Chan EY, Lim W, Peiris JM, Lau YL. The interferon gamma gene polymorphism +874 A/T is associated with severe acute respiratory syndrome.
BMC Infect. Dis. 6: 82 (2006).
*
-
Chopra A, Pardi DS, Loftus EV Jr, Tremaine WJ, Egan LJ, Faubion WA, Hanson KA, Johnson TA, Sandborn WJ. Budesonide in the treatment of inflammatory bowel disease: the first year of experience in clinical practice.
Inflamm. Bowel Dis. 12: 29-32 (2006).
*
-
Chorny A, Gonzalez-Rey E, Delgado M. Regulation of dendritic cell differentiation by vasoactive intestinal peptide: therapeutic applications on autoimmunity and transplantation.
Ann. N. Y. Acad. Sci. 1088: 187-194 (2006).
*
-
Chorny A, Gonzalez-Rey E, Fernandez-Martin A, Ganea D, Delgado M. Vasoactive intestinal peptide induces regulatory dendritic cells that prevent acute graft-versus-host disease while maintaining the graft-versus-tumor response.
Blood 107: 3787-3794 (2006).
*
-
Chorny A, Gonzalez-Rey E, Ganea D, Delgado M. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo: therapeutic applications in autoimmunity and transplantation.
Ann. N. Y. Acad. Sci. 1070: 190-195 (2006).
*
-
Chorny A, Gonzalez-Rey E, Varela N, Robledo G, Delgado M. Signaling mechanisms of vasoactive intestinal peptide on inflammatory conditions.
Regul. Pept. 137: 67-74 (2006).
-
Choudhuri S, Klaassen CD. Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters.
Int. J. Toxicol. 25: 231-259 (2006).
*
-
Chouhan S, Gahlot S, Pokharna RK, Mathur KC, Saini K, Pal M. Severity and extent of ulcerative colitis: role of C-reactive protein.
Indian J. Gastroenterol. 25: 46-47 (2006).
*
-
Chow E, Lipton L, Lynch E, D'Souza R, Aragona C, Hodgkin L, Brown G, Winship I, Barker M, Buchanan D, Cowie S, Nasioulas S, du Sart D, Young J, Leggett B, Jass J, Macrae F. Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH.
Gastroenterology 131: 30-39 (2006).
*
-
Chow EK, Castrillo A, Shahangian A, Pei L, O'Connell RM, Modlin RL, Tontonoz P, Cheng G. A role for IRF3-dependent RXRalpha repression in hepatotoxicity associated with viral infections.
J. Exp. Med. 203: 2589-2602 (2006).
*
-
Chowdhury A, Santra A, Bhattacharjee K, Ghatak S, Saha DR, Dhali GK. Mitochondrial oxidative stress and permeability transition in isoniazid and rifampicin induced liver injury in mice.
J. Hepatol. 45: 117-126 (2006).
*
-
Chowdhury P, Gupta P. Pathophysiology of alcoholic pancreatitis: an overview.
World J. Gastroenterol. 12: 7421-7427 (2006).
*
-
Chowdhury P, Sacks SH, Sheerin NS. Toll-like receptors TLR2 and TLR4 initiate the innate immune response of the renal tubular epithelium to bacterial products.
Clin. Exp. Immunol. 145: 346-356 (2006).
*
-
Chowta MN, Chowta NK. Hypothyroidism caused by thalidomide.
Indian J. Med. Sci. 60: 424-426 (2006).
*
-
Christakos S, Dhawan P, Shen Q, Peng X, Benn B, Zhong Y. New insights into the mechanisms involved in the pleiotropic actions of 1,25dihydroxyvitamin D3.
Ann. N. Y. Acad. Sci. 1068: 194-203 (2006).
*
-
Christensen C, Bruden D, Livingston S, Deubner H, Homan C, Smith K, Oh E, Gretch D, Williams J, McMahon B. Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients.
J. Viral Hepat. 13: 652-658 (2006).
*
-
Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.
Immunity 25: 417-428 (2006).
*
-
Christensen T. The role of EBV in MS pathogenesis.
Int. MS J. 13: 52-57 (2006).
*
-
Christodoulou C, Choy EH. Joint inflammation and cytokine inhibition in rheumatoid arthritis.
Clin. Exp. Med. 6: 13-19 (2006).
*
-
Christodoulou J, Craig HJ, Walker DC, Weaving LS, Pearson CE, McInnes RR. Deletion hotspot in the argininosuccinate lyase gene: association with topoisomerase II and DNA polymerase alpha sites.
Hum. Mutat. 27: 1065-1071 (2006).
-
Christofori G. New signals from the invasive front.
Nature 441: 444-450 (2006).
*
-
Christoforidis E, Mantzoros I, Goulimaris I, Kanellos I, Tsorlini H, Vakalis I, Betsis D. Endoscopic management strategies in relation to the severity of acute cholangitis.
Surg. Laparosc. Endosc. Percutan. Tech. 16: 325-329 (2006).
-
Christophers E. Comorbidities in psoriasis.
J. Eur. Acad. Dermatol. Venereol. 20 Suppl. 2: 52-55 (2006). *
-
Chromek M, Slamova Z, Bergman P, Kovacs L, Podracka L, Ehren I, Hokfelt T, Gudmundsson GH, Gallo RL, Agerberth B, Brauner A. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection.
Nat. Med. 12: 636-641 (2006).
*
-
Chrzanowska M, Kurzawski M, Drozdzik M, Mazik M, Oko A, Czekalski S. Thiopurine S-methyltransferase phenotype-genotype correlation in hemodialyzed patients.
Pharmacol. Rep. 58: 973-978 (2006).
*
-
Chu K, Miyazaki M, Man WC, Ntambi JM. Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation.
Mol. Cell. Biol. 26: 6786-6798 (2006).
*
-
Chu KM, Lee YT, Ng EK. EUS could detect ascites missed by CT scan * Author's reply.
Gut 55: 1524 (2006).
*
-
Chu SC, Yang SF, Lue KH, Hsieh YS, Hsiao TY, Lu KH. Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee.
J. Rheumatol. 33: 311-317 (2006).
-
Chu X, Strauss JR, Mariano MA, Li J, Newton DJ, Cai X, Wang RW, Yabut J, Hartley DP, Evans DC, Evers R. Characterization of mice lacking the multidrug resistance protein Mrp2 (Abcc2).
J. Pharmacol. Exp. Ther. 317: 579-589 (2006).
*
-
Chuang CZ, Boyles A, Legardeur B, Su J, Japa S, Lopez SA. Effects of riboflavin and folic acid supplementation on plasma homocysteine levels in healthy subjects.
Am. J. Med. Sci. 331: 65-71 (2006).
-
Chuang JH, Chou MH, Wu CL, Du YY. Implication of innate immunity in the pathogenesis of biliary atresia.
Chang Gung Med. J. 29: 240-250 (2006).
*
-
Chuang YH, Lian ZX, Tsuneyama K, Chiang BL, Ansari AA, Coppel RL, Eric Gershwin M. Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis.
J. Autoimmun. 26: 232-240 (2006).
-
Chubinskaya S, Frank BS, Michalska M, Kumar B, Merrihew CA, Thonar EJ, Lenz ME, Otten L, Rueger DC, Block JA. Osteogenic protein 1 in synovial fluid from patients with rheumatoid arthritis or osteoarthritis: relationship with disease and levels of hyaluronan and antigenic keratan sulfate.
Arthritis Res. Ther. 8: R73 (2006).
*
-
Chuman H. Nitric oxide in optic neuritis and multiple sclerosis.
J. Neuroophthalmol. 26: 85-86 (2006).
-
Chun J, Rosen H. Lysophospholipid receptors as potential drug targets in tissue transplantation and autoimmune diseases.
Curr. Pharm. Des. 12: 161-171 (2006).
-
Chung CP, Oeser A, Avalos I, Gebretsadik T, Shintani A, Raggi P, Sokka T, Pincus T, Stein CM. Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis.
Arthritis Res. Ther. 8: R186 (2006).
*
-
Chung EY, Kim SJ, Ma XJ. Regulation of cytokine production during phagocytosis of apoptotic cells.
Cell Res. 16: 154-161 (2006).
*
-
Chung GE, Cheon JH, Lee JY, Ye BD, Kim SG, Kim JS, Jung HC, Song IS. Efficacy of combination of intravenous cyclosporin A and steroid therapy versus prolonged intravenous steroid therapy alone in patients with severe ulcerative colitis refractory to initial intravenous steroid therapy.
Korean J. Gastroenterol. 48: 263-268 (2006).
-
Chung H, Kudo M, Haji S, Osaki Y, Oka H, Seki T, Kasugai H, Sasaki Y. A proposal of the modified liver damage classification for hepatocellular carcinoma.
Hepatol. Res. 34: 124-129 (2006).
-
Chung HJ, Choi YH, Choi HD, Jang JM, Shim HJ, Yoo M, Kwon JW, Lee MG. Pharmacokinetics of DA-6034, an agent for inflammatory bowel disease, in rats and dogs: contribution of intestinal first-pass effect to low bioavailability in rats.
Eur. J. Pharm. Sci. 27: 363-374 (2006).
-
Chung L, Flyckt RL, Colon I, Shah AA, Druzin M, Chakravarty EF. Outcome of pregnancies complicated by systemic sclerosis and mixed connective tissue disease.
Lupus 15: 595-589 (2006).
-
Chung S, Lapoint K, Martinez K, Kennedy A, Boysen Sandberg M, McIntosh MK. Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes.
Endocrinology 147: 5340-5351 (2006).
*
-
Chung SL, Chiou KR, Charng MJ. 677TT polymorphism of methylenetetrahydrofolate reductase in combination with low serum vitamin B(12) is associated with coronary in-stent restenosis.
Catheter Cardiovasc. Interv. 67: 349-355 (2006).
-
Chung SS, Choi HH, Cho YM, Lee HK, Park KS. Sp1 mediates repression of the resistin gene by PPARgamma agonists in 3T3-L1 adipocytes.
Biochem. Biophys. Res. Commun. 348: 253-258 (2006).
*
-
Chung Y, Yang X, Chang SH, Ma L, Tian Q, Dong C. Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes.
Cell Res. 16: 902-907 (2006).
*
-
Chung YS, Cha HE, Kang IG, Hwang YJ, Kim ST. Polymorphism at the glutathione S-transferase P1 locus in Korean patients with perennial allergic rhinitis.
Am. J. Rhinol. 20: 648-651 (2006).
-
Chung YW, Sohn JH, Baek CH, Kim JP, Jeon YC, Han DS, Lee DH, Kee CS, Park IK. Macro-aspartate aminotransferase in a patient with chronic hepatitis C.
Korean J. Gastroenterol. 47: 229-232 (2006).
-
Church LD, Churchman SM, Hawkins PN, McDermott MF. Hereditary auto-inflammatory disorders and biologics.
Springer Semin. Immunopathol. 27: 494-508 (2006).
*
-
Chute JP, Muramoto GG, Whitesides J, Colvin M, Safi R, Chao NJ, McDonnell DP. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells.
Proc. Natl. Acad. Sci. U.S.A. 103: 11707-11712 (2006).
*
-
Chuu CP, Hiipakka RA, Kokontis JM, Fukuchi J, Chen RY, Liao S. Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist.
Cancer Res. 66: 6482-6486 (2006).
*
-
Ciacci C, Gennarelli D, Esposito G, Tortora R, Salvatore F, Sacchetti L. Hereditary fructose intolerance and celiac disease: a novel genetic association.
Clin. Gastroenterol. Hepatol. 4: 635-638 (2006).
-
Ciccocioppo R, Finamore A, Ara C, Di Sabatino A, Mengheri E, Corazza GR. Altered expression, localization, and phosphorylation of epithelial junctional proteins in celiac disease.
Am. J. Clin. Pathol. 125: 502-511 (2006).
*
-
Cicek MS, Liu X, Schumacher FR, Casey G, Witte JS. Vitamin D receptor genotypes/haplotypes and prostate cancer risk.
Cancer Epidemiol. Biomarkers Prev. 15: 2549-2552 (2006).
*
-
Cichoz-Lach H, Partycka J, Nesina I, Celinski K, Slomka M. The influence of genetic polymorphism of CYP2E1 on the development of alcohol liver cirrhosis.
Wiad. Lek. 59: 757-761 (2006).
-
Cichoz-Lach H, Partycka J, Nesina I, Celinski K, Slomka M, Wojcierowski J. Genetic polymorphism of alcohol dehydrogenase 3 in alcohol liver cirrhosis and in alcohol chronic pancreatitis.
Alcohol Alcohol. 41: 14-17 (2006).
-
Cicinnati VR, Zhang X, Yu Z, Ferencik S, Schmitz KJ, Dworacki G, Kaczmarek E, Oldhafer K, Frilling A, Baba HA, Schmid KW, Grosse-Wilde H, Broelsch CE, Deleo AB, Gerken G, Beckebaum S. Increased frequencies of CD8+ T lymphocytes recognizing wild-type p53-derived epitopes in peripheral blood correlate with presence of epitope loss tumor variants in patients with hepatocellular carcinoma.
Int. J. Cancer 119: 2851-2860 (2006).
*
-
Ciernikova S, Tomka M, Kovac M, Stevurkova V, Zajac V. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
Neoplasma 53: 97-102 (2006).
*
-
Cifelli CJ, Ross AC. All-trans-retinoic acid distribution and metabolism in vitamin A-marginal rats.
Am. J. Physiol. Gastrointest. Liver Physiol. 291: G195-G202 (2006).
*
-
Ciga M, Oteiza F, Marzo J, Armendariz P, De Miguel M, Ortiz H. Treatment of perianal Crohn's disease.
An. Sist. Sanit. Navar. 29: 367-386 (2006).
-
Cignarella A, Bellosta S, Corsini A, Bolego C. Hypolipidemic therapy for the metabolic syndrome.
Pharmacol. Res. 53: 492-500 (2006).
*
-
Cillo U, Vitale A, Grigoletto F, Farinati F, Brolese A, Zanus G, Neri D, Boccagni P, Srsen N, D'Amico F, Antonio Ciarleglio F, Bridda A, Francesco D'Amico D. Prospective validation of the Barcelona Clinic Liver Cancer staging system.
J. Hepatol. 44: 723-731 (2006).
*
-
Cima RR. Is race a real issue in colectomy for ulcerative colitis?
Clin. Gastroenterol. Hepatol. 4: 1426-1427 (2006).
-
Cima RR, Dubach JM, Wieland AM, Walsh BM, Soybel DI. Intracellular Ca2+ and Zn2+ signals during monochloramine induced oxidative stress in isolated rat colon crypts.
Am. J. Physiol. Gastrointest. Liver Physiol. 290: G250-G261 (2006).
*
-
Cimaz R, Duquesne A. Neonatal lupus syndromes.
Arch. Pediatr. 13: 473-478 (2006).
-
Cimaz R, Vijay S, Haase C, Coppa GV, Bruni S, Wraith E, Guffon N. Attenuated type I mucopolysaccharidosis in the differential diagnosis of juvenile idiopathic arthritis: a series of 13 patients with Scheie syndrome.
Clin. Exp. Rheumatol. 24: 196-202 (2006).
-
Cimmino MA. Does magnetic resonance represent the gold-standard of imaging for the follow-up of arthritis?
Reumatismo 58: 245-252 (2006).
-
Cina RA, Wikiel KJ, Lee PW, Cameron AM, Hettiarachy S, Rowland H, Goodrich J, Colby C, Spitzer TR, Neville DM Jr, Huang CA. Stable multilineage chimerism without graft versus host disease following nonmyeloablative haploidentical hematopoietic cell transplantation.
Transplantation 81: 1677-1685 (2006).
-
Cintado A, Sorell L, Galvan JA, Martinez L, Castaneda C, Fragoso T, Camacho H, Ferrer A, Companioni O, Benitez J, Nazabal M, Novoa LI, Duenas M. HLA DQA1*0501 and DQB1*02 in Cuban celiac patients.
Hum. Immunol. 67: 639-642 (2006).
-
Cirillo N, Femiano F, Gombos F, Lanza A. Serum from pemphigus vulgaris reduces desmoglein 3 half-life and perturbs its de novo assembly to desmosomal sites in cultured keratinocytes.
FEBS Lett. 580: 3276-3281 (2006).
*
-
Cirulli V, Zalatan J, McMaster M, Prinsen R, Salomon DR, Ricordi C, Torbett BE, Meda P, Crisa L. The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G.
Diabetes 55: 1214-1222 (2006).
*
-
Claeys V, Wackens G. Sjogren syndrome: a review of the literature and a case report.
Rev. Belge. Med. Dent. 61: 161-172 (2006).
-
Clapp DW. Developmental regulation of the immune system.
Semin. Perinatol. 30: 69-72 (2006).
-
Clarizia AD, Bastos-Rodrigues L, Pena HB, Anacleto C, Rossi B, Soares FA, Lopes A, Rocha JC, Caballero O, Camargo A, Simpson AJ, Pena SD. Relationship of the methylenetetrahydrofolate reductase C677T polymorphism with microsatellite instability and promoter hypermethylation in sporadic colorectal cancer.
Genet. Mol. Res. 5: 315-322 (2006).
*
-
Clark CA, Mehta BH, Pruchnicki MC, Rodis JL. The pharmacist's role in teaching methotrexate injection for patients with Crohn's disease.
Am. J. Health Syst. Pharm. 63: 1792-1794 (2006).
*
-
Clark DW, Harrison-Woolrych M. The role of the New Zealand Intensive Medicines Monitoring Programme in identification of previously unrecognised signals of adverse drug reactions.
Curr. Drug Saf. 1: 169-178 (2006).
-
Clark JF, Doepke A, Filosa JA, Wardle RL, Lu A, Meeker TJ, Pyne-Geithman GJ. N-Acetylaspartate as a reservoir for glutamate.
Med. Hypotheses 67: 506-512 (2006).
-
Clark RA, Chong B, Mirchandani N, Brinster NK, Yamanaka KI, Dowgiert RK, Kupper TS. The vast majority of CLA+ T cells are resident in normal skin.
J. Immunol. 176: 4431-4439 (2006).
*
-
Clark RA, Kupper TS. Misbehaving macrophages in the pathogenesis of psoriasis.
J. Clin. Invest. 116: 2084-2087 (2006).
*
-
Clarke AR, Meniel V. The intestinal stem cell niche studied through conditional transgenesis.
Ernst Schering Found. Symp. Proc. 5: 99-108 (2006).
-
Clarke SL, Betts GJ, Plant A, Wright KL, El-Shanawany TM, Harrop R, Torkington J, Rees BI, Williams GT, Gallimore AM, Godkin AJ. CD4CD25FOXP3 regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer.
PLoS ONE 1: e129 (2006).
*
-
Clatworthy MR, Jayne DR. Acquired hemophilia in association with ANCA-associated vasculitis: response to rituximab.
Am. J. Kidney Dis. 47: 680-682 (2006).
-
Claudepierre P, Wendling D, Cohen JD. Anti-TNF alpha in the treatment of psoriatic arthritis.
Presse. Med. 35: 647-655 (2006).
-
Claus J, Pringot J, Ghijselings L, Landen S. Small bowel obstruction by abricot pit in Crohn's disease.
JBR-BTR 89: 329 (2006).
-
Clavel G, Valvason C, Yamaoka K, Lemeiter D, Laroche L, Boissier MC, Bessis N. Relationship between angiogenesis and inflammation in experimental arthritis.
Eur. Cytokine Netw. 17: 202-210 (2006).
-
Clavien PA. How far can we go with marginal donors?
J. Hepatol. 45: 483-484 (2006).
*
-
Clavien PA. Fifth forum on liver transplantation.
J. Hepatol. 44: 11-12 (2006).
*
-
Clavien PA. Sixth Forum on Liver Transplantation. Center approach to liver diseases. Is it worthwhile?
J. Hepatol. 44: 637-638 (2006).
*
-
Clayton PT. B(6)-responsive disorders: a model of vitamin dependency.
J. Inherit. Metab. Dis. 29: 317-326 (2006).
*
-
Clayton PT. Hereditary liver diseases: screening strategies.
Falk Symposium 156. XIII Falk Liver Week (Part II). GENETICS IN LIVER DISEASES, Freiburg (Germany), October 8-9, 2006, p. 42-43 (2006). *
-
Clayton TA, Lindon JC, Cloarec O, Antti H, Charuel C, Hanton G, Provost JP, Le Net JL, Baker D, Walley RJ, Everett JR, Nicholson JK. Pharmaco-metabonomic phenotyping and personalized drug treatment.
Nature 440: 1073-1077 (2006).
*
-
Clayton TH, Ogden S, Goodfield MD. Treatment of refractory subacute cutaneous lupus erythematosus with efalizumab.
J. Am. Acad. Dermatol. 54: 892-895 (2006).
-
Clayton TH, Walker BP, Stables GI. Treatment of chronic erythema nodosum with infliximab.
Clin. Exp. Dermatol. 31: 823-824 (2006).
*
-
Cleary MA, Feillet F, White FJ, Vidailhet M, Macdonald A, Grimsley A, Maurin N, de Baulny HO, Rutherford PJ. Randomised controlled trial of essential fatty acid supplementation in phenylketonuria.
Eur. J. Clin. Nutr. 60: 915-920 (2006).
*
-
Clee SM, Yandell BS, Schueler KM, Rabaglia ME, Richards OC, Raines SM, Kabara EA, Klass DM, Mui ET, Stapleton DS, Gray-Keller MP, Young MB, Stoehr JP, Lan H, Boronenkov I, Raess PW, Flowers MT, Attie AD. Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locus.
Nat. Genet. 38: 688-693 (2006).
*
-
Cleland JG, Freemantle N, Coletta AP, Clark AL. Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE.
Eur. J. Heart Fail. 8: 105-110 (2006).
-
Cleland LG, Caughey GE, James MJ, Proudman SM. Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis.
J. Rheumatol. 33: 1973-1979 (2006).
-
Cleland LG, James MJ, Proudman SM. Fish oil: what the prescriber needs to know.
Arthritis Res. Ther. 8: 402 (2006).
*
-
Clement MJ, Fortune A, Phalipon A, Marcel-Peyre V, Simenel C, Imberty A, Delepierre M, Mulard LA. Towards a better understanding of the basis of molecular mimicry of polysaccharide antigens by peptides: the example of Shigella flexneri 5a.
J. Biol. Chem. 281: 2317-2332 (2006).
*
-
Clementi M, Gianantonio ED. Genetic susceptibility to infectious diseases.
Reprod. Toxicol. 21: 345-349 (2006).
-
Clements CS, Dunstone MA, Macdonald WA, McCluskey J, Rossjohn J. Specificity on a knife-edge: the alphabeta T cell receptor.
Curr. Opin. Struct. Biol. 16: 787-795 (2006).
*
-
Clements CS, Kjer-Nielsen L, Kostenko L, McCluskey J, Rossjohn J. The production, purification and crystallization of a soluble form of the nonclassical MHC HLA-G: the essential role of cobalt.
Acta Crystallograph. Sect. F. Struct. Biol. Cryst. Commun. 62: 70-73 (2006).
*
-
Clerbaux T, Detry B, Geubel A, Veriter C, Liistro G, Horsmans Y, Frans A. The oxyhemoglobin dissociation curve in liver cirrhosis.
Chest 129: 438-445 (2006).
*
-
Clerici C, Castellani D, Asciutti S, Pellicciari R, Setchell KD, O'Connell NC, Sadeghpour B, Camaioni E, Fiorucci S, Renga B, Nardi E, Sabatino G, Clementi M, Giuliano V, Baldoni M, Orlandi S, Mazzocchi A, Morelli A, Morelli O. 3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.
Toxicol. Appl. Pharmacol. 214: 199-208 (2006).
*
-
Clevers H. Colon cancer - understanding how NSAIDs work.
N. Engl. J. Med. 354: 761-763 (2006).
*
-
Clodfelter KH, Holloway MG, Hodor P, Park SH, Ray WJ, Waxman DJ. Sex-dependent liver gene expression is extensive and largely dependent upon signal transducer and activator of transcription 5b (STAT5b): STAT5b-dependent activation of male genes and repression of female genes revealed by microarray analysis.
Mol. Endocrinol. 20: 1333-1351 (2006).
*
-
Closs EI, Boissel JP, Habermeier A, Rotmann A. Structure and function of cationic amino acid transporters (CATs).
J. Membr. Biol. 213: 67-77 (2006).
*
-
Coates MD, Johnson AC, Greenwood-Van Meerveld B, Mawe GM. Effects of serotonin transporter inhibition on gastrointestinal motility and colonic sensitivity in the mouse.
Neurogastroenterol. Motil. 18: 464-471 (2006).
-
Cobb BS, Hertweck A, Smith J, O'Connor E, Graf D, Cook T, Smale ST, Sakaguchi S, Livesey FJ, Fisher AG, Merkenschlager M. A role for Dicer in immune regulation.
J. Exp. Med. 203: 2519-2527 (2006).
*
-
Cobb CS, Ernst E. Systematic review of a marine nutriceutical supplement in clinical trials for arthritis: the effectiveness of the New Zealand green-lipped mussel Perna canaliculus.
Clin. Rheumatol. 25: 275-284 (2006).
*
-
Cobb LJ, Liu B, Lee KW, Cohen P. Phosphorylation by DNA-dependent protein kinase is critical for apoptosis induction by insulin-like growth factor binding protein-3.
Cancer Res. 66: 10878-10884 (2006).
*
-
Cobbold J, Lim A, Wylezinska M, Cunningham C, Crossey M, Thomas H, Patel N, Cox J, Taylor-Robinson S. Magnetic resonance and ultrasound techniques for the evaluation of hepatic fibrosis.
Hepatology 43: 1401-1402 (2006).
*
-
Cobbold SP. The hidden truth about gene expression in Tregs: is it what you don't see that counts?
Eur. J. Immunol. 36: 1360-1363 (2006).
*
-
Cobbold SP, Adams E, Graca L, Daley S, Yates S, Paterson A, Robertson NJ, Nolan KF, Fairchild PJ, Waldmann H. Immune privilege induced by regulatory T cells in transplantation tolerance.
Immunol. Rev. 213: 239-255 (2006).
*
-
Coburn LA, Wise PE, Schwartz DA. The successful use of adalimumab to treat active Crohn's disease of an ileoanal pouch during pregnancy.
Dig. Dis. Sci. 51: 2045-2047 (2006).
*
-
Coccia EM, Uze G, Pellegrini S. Negative regulation of type I interferon signaling: facts and mechanisms.
Cell. Mol. Biol. (Noisy-le-grand) 52: 77-87 (2006).
-
Cocco E, Marchi P, Mascia MG, Deriu M, Sirca A, Mamusa E, Lai M, Mura M, Mallarini G, Marrosu MG. Effect of dose and frequency of interferon beta-1a administration on clinical and magnetic resonance imaging parameters in relapsing-remitting multiple sclerosis.
Funct. Neurol. 21: 145-149 (2006).
-
Cochery-Nouvellon E, Vitry F, Cornillet-Lefebvre P, Hezard N, Gillot L, Nguyen P. Interleukin-10 promoter polymorphism and venous thrombosis: a case-control study.
Thromb. Haemost. 96: 24-28 (2006).
-
Cochran AJ, Huang RR, Lee J, Itakura E, Leong SP, Essner R. Tumour-induced immune modulation of sentinel lymph nodes.
Nat. Rev. Immunol. 6: 659-670 (2006).
*
-
Coco G, Dal Pra C, Presotto F, Albergoni MP, Canova C, Pedini B, Zanchetta R, Chen S, Furmaniak J, Rees Smith B, Mantero F, Betterle C. Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex autoantibodies.
J. Clin. Endocrinol. Metab. 91: 1637-1645 (2006).
*
-
Codina J, Liu J, Bleyer AJ, Penn RB, Dubose TD Jr. Phosphorylation of S955 at the protein kinase A consensus promotes maturation of the alpha subunit of the colonic H+,K+-ATPase.
J. Am. Soc. Nephrol. 17: 1833-1840 (2006).
*
-
Codner E, Deng L, Perez-Bravo F, Roman R, Lanzano P, Cassorla F, Chung WK. Glucokinase mutations in young children with hyperglycemia.
Diabetes Metab. Res. Rev. 22: 348-355 (2006).
-
Coenen JJ, Koenen HJ, van Rijssen E, Boon L, Joosten I, Hilbrands LB. CTLA-4 engagement and regulatory CD4+CD25+ T cells independently control CD8+-mediated responses under costimulation blockade.
J. Immunol. 176: 5240-5246 (2006).
*
-
Cogan NG. Effects of persister formation on bacterial response to dosing.
J. Theor. Biol. 238: 694-703 (2006).
*
-
Cohen DE, Anania FA, Chalasani N. An assessment of statin safety by hepatologists.
Am. J. Cardiol. 97: S77-S81 (2006).
-
Cohen EI, Wilck EJ, Shapiro RS. Hepatic imaging in the 21st century.
Semin. Liver Dis. 26: 363-372 (2006).
-
Cohen HD, Das KM. The metabolism of mesalamine and its possible use in colonic diverticulitis as an anti-inflammatory agent.
J. Clin. Gastroenterol. 40 Suppl. 3: S150-S154 (2006).
-
Cohen J, Safdi MA, Deal SE, Baron TH, Chak A, Hoffman B, Jacobson BC, Mergener K, Petersen BT, Petrini JL, Rex DK, Faigel DO, Pike IM; ASGE/ACG Taskforce on Quality in Endoscopy. Quality indicators for esophagogastroduodenoscopy.
Am. J. Gastroenterol. 101: 886-891 (2006).
*
-
Cohen JC, Larson JE. Cystic fibrosis transmembrane conductance regulator (CFTR) dependent cytoskeletal tension during lung organogenesis.
Dev. Dyn. 235: 2736-2748 (2006).
-
Cohen Jr MM. The new bone biology: pathologic, molecular, and clinical correlates.
Am. J. Med. Genet. A. 140: 2646-2706 (2006).
-
Cohen LB, Wecsler JS, Gaetano JN, Benson AA, Miller KM, Durkalski V, Aisenberg J. Endoscopic sedation in the United States: results from a nationwide survey.
Am. J. Gastroenterol. 101: 967-974 (2006).
*
-
Cohen PL. Apoptotic cell death and lupus.
Springer Semin. Immunopathol. 28: 145-152 (2006).
*
-
Cohen RD. Review article: evolutionary advances in the delivery of aminosalicylates for the treatment of ulcerative colitis.
Aliment. Pharmacol. Ther. 24: 465-474 (2006).
*
-
Cohen RD. Azathioprine versus mesalamine in steroid-dependent ulcerative colitis: long-awaited results?
Gastroenterology 130: 607-608 (2006).
*
-
Cohen RD, Thomas T. Economics of the use of biologics in the treatment of inflammatory bowel disease.
Gastroenterol. Clin. North Am. 35: 867-882 (2006).
-
Cohen SB. Updates from B cell trials: efficacy.
J. Rheumatol. Suppl. 77: 12-17 (2006).
*
-
Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC, Keystone EC, Loveless JE, Burmester GR, Cravets MW, Hessey EW, Shaw T, Totoritis MC. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.
Arthritis Rheum. 54: 2793-2806 (2006).
*
-
Cojocaru M, Cojocaru IM, Iacob SA. Prevalence of anti-neutrophil cytoplasmic antibodies in patients with chronic hepatitis C infection associated mixed cryoglobulinemia.
Rom. J. Intern. Med. 44: 427-431 (2006).
-
Cojocaru VM, Ciurtin C, Puchianu E, Anothe F. Electroforetic analysis of lacrimal proteins - diagnostic method in secondary Sjogren syndrome.
Oftalmologia 50: 3-5 (2006).
-
Cojocaru VM, Ciurtin C, Puchianu E, Antohe F. Lacrimal proteins electrophoretic analysis - diagnostic method in secondary Sjogren syndrome.
Oftalmologia 50: 60-63 (2006).
-
Colak R, Ozkan Y, Cengiz S, Saral Y, Kandi B, Halifeoglu I. A comparison between the effects of low (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal cortex functions with Behcet's disease.
J. Eur. Acad. Dermatol. Venereol. 20: 721-725 (2006).
*
-
Colas S, Maheo K, Denis F, Goupille C, Hoinard C, Champeroux P, Tranquart F, Bougnoux P. Sensitization by dietary docosahexaenoic acid of rat mammary carcinoma to anthracycline: a role for tumor vascularization.
Clin. Cancer Res. 12: 5879-5886 (2006).
*
-
Colasurdo GN, Fullmer JJ, Elidemir O, Atkins C, Khan AM, Stark JM. Respiratory syncytial virus infection in a murine model of cystic fibrosis.
J. Med. Virol. 78: 651-658 (2006).
*
-
Cole GM, Frautschy SA. Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse model.
Nutr. Health 18: 249-259 (2006).
-
Cole SP, Deeley RG. Transport of glutathione and glutathione conjugates by MRP1.
Trends Pharmacol. Sci. 27: 438-446 (2006).
*
-
Cole TJ. Glucocorticoid action and the development of selective glucocorticoid receptor ligands.
Biotechnol. Annu. Rev. 12: 269-300 (2006).
-
Colecchia A, Mazzella G, Sandri L, Azzaroli F, Magliuolo M, Simoni P, Bacchi-Reggiani ML, Roda E, Festi D. Ursodeoxycholic acid improves gastrointestinal motility defects in gallstone patients.
World J. Gastroenterol. 12: 5336-5343 (2006).
*
-
Colecchia A, Sandri L, Bacchi-Reggiani ML, Portincasa P, Palasciano G, Mazzella G, Roda E, Festi D. Is it possible to predict the clinical course of gallstone disease? Usefulness of gallbladder motility evaluation in a clinical setting.
Am. J. Gastroenterol. 101: 2576-2581 (2006).
*
-
Coleman NS, Foley S, Dunlop SP, Wheatcroft J, Blackshaw E, Perkins AC, Singh G, Marsden CA, Holmes GK, Spiller RC. Abnormalities of serotonin metabolism and its relation to symptoms in untreated celiac disease.
Clin. Gastroenterol. Hepatol. 4: 874-881 (2006).
-
Coleman SH, Madrid R, Van Damme N, Mitchell RS, Bouchet J, Servant C, Pillai S, Benichou S, Guatelli JC. Modulation of cellular protein trafficking by human immunodeficiency virus type 1 Nef: role of the acidic residue in the ExxxLL motif.
J. Virol. 80: 1837-1849 (2006).
*
-
Coles A. The curious incident of disability in multiple sclerosis trials.
Lancet Neurol. 5: 899-900 (2006).
-
Colgan J, Rothman P. All in the family: IL-27 suppression of T(H)-17 cells.
Nat. Immunol. 7: 899-901 (2006).
*
-
Colli A, Fraquelli M, Casazza G, Massironi S, Colucci A, Conte D, Duca P. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review.
Am. J. Gastroenterol. 101: 513-523 (2006).
*
-
Collier S, Bolte A, Manolios N. Discrepancy in CD3-transmembrane peptide activity between in vitro and in vivo T-cell inhibition.
Scand. J. Immunol. 64: 388-391 (2006).
*
-
Collin M, Murch O, Thiemermann C. Peroxisome proliferator-activated receptor-gamma antagonists GW9662 and T0070907 reduce the protective effects of lipopolysaccharide preconditioning against organ failure caused by endotoxemia.
Crit. Care Med. 34: 1131-1138 (2006).
-
Collino M, Aragno M, Mastrocola R, Benetti E, Gallicchio M, Dianzani C, Danni O, Thiemermann C, Fantozzi R. Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-alpha agonist WY14643.
Free Radic. Biol. Med. 41: 579-589 (2006).
-
Collins N, Bastian B, Jones C, Morgan R, Reeves G. Abnormal pulmonary vascular responses in patients registered with a systemic autoimmunity database: pulmonary hypertension assessment and screening evaluation using stress echocardiography (PHASE-I).
Eur. J. Echocardiogr. 7: 439-446 (2006).
-
Collins P, Mpofu C, Watson A, Rhodes J. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.
Cochrane Database Syst. Rev. 2: CD000279 (2006).
*
-
Collins P, Rhodes J. Ulcerative colitis: diagnosis and management.
BMJ 333: 340-343 (2006).
*
-
Collins S, Verma-Gandhu M. The putative role of endogenous and exogenous opiates in inflammatory bowel disease.
Gut 55: 756-757 (2006).
*
-
Collins SM, Dominguez M, Ilmarinen T, Costigan C, Irvine AD. Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome.
Br. J. Dermatol. 154: 1088-1093 (2006).
*
-
Colliver DW, Crawford NP, Eichenberger MR, Zacharius W, Petras RE, Stromberg AJ, Galandiuk S. Molecular profiling of ulcerative colitis-associated neoplastic progression.
Exp. Mol. Pathol. 80: 1-10 (2006).
*
-
Colman RW. Regulation of angiogenesis by the kallikrein-kinin system.
Curr. Pharm. Des. 12: 2599-2607 (2006).
-
Colmegna I, Garry RF. Role of endogenous retroviruses in autoimmune diseases.
Infect. Dis. Clin. North Am. 20: 913-929 (2006).
-
Colmone A, Li S, Wang CR. Activating transcription factor/cAMP response element binding protein family member regulated transcription of CD1A.
J. Immunol. 177: 7024-7032 (2006).
*
-
Colmone A, Wang CR. H2-M3-restricted T cell response to infection.
Microbes Infect. 8: 2277-2283 (2006).
*
-
Colombel JF, Solem CA, Sandborn WJ, Booya F, Loftus EV, Harmsen WS, Zinsmeister AR, Bodily KD, Fletcher JG. Quantitative measurement and visual assessment of ileal Crohn's disease activity by CT enterography: correlation with endoscopic severity and C-reactive protein.
Gut 55: 1561-1567 (2006).
*
-
Colombo C. Liver disease in cystic fibrosis.
Falk Symposium 156. XIII Falk Liver Week (Part II). GENETICS IN LIVER DISEASES, Freiburg (Germany), October 8-9, 2006, p. 31-33 (2006). *
-
Colombo C, Bennato V, Costantini D, Valmarana L, Dacco V, Zazzeron L, Ghisleni D, Bruzzese MG, Scaglioni S, Riva E, Agostoni C. Dietary and circulating polyunsaturated fatty acids in cystic fibrosis: are they related to clinical outcomes?
J. Pediatr. Gastroenterol. Nutr. 43: 660-665 (2006).
*
-
Colombo C, Russo MC, Zazzeron L, Romano G. Liver disease in cystic fibrosis.
J. Pediatr. Gastroenterol. Nutr. 43 Suppl. 1: S49-S55 (2006).
*
-
Colombo PL, Benedetti M, Tinozzi FP, Ticozzelli E, Maroni N, Di Sabatino A, Tinozzi S. Different approaches for medical or surgical management of Crohn's disease: the importance of the classification of Vienna.
Ann. Ital. Chir. 77: 485-496 (2006).
-
Colon-Soto M, Peredo RA, Vila LM. Systemic lupus erythematosus after mesotherapy with acetyl-L-carnitine.
J. Clin. Rheumatol. 12: 261-262 (2006).
-
Colonna L, Dinnall JA, Shivers DK, Frisoni L, Caricchio R, Gallucci S. Abnormal costimulatory phenotype and function of dendritic cells before and after the onset of severe murine lupus.
Arthritis Res. Ther. 8: R49 (2006).
*
-
Colonna M. Toll-like receptors and IFN-alpha: partners in autoimmunity.
J. Clin. Invest. 116: 2319-2322 (2006).
*
-
Columba-Cabezas S, Griguoli M, Rosicarelli B, Magliozzi R, Ria F, Serafini B, Aloisi F. Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein.
J. Neuroimmunol. 179: 76-86 (2006).
-
Comabella M, Romera C, Camina M, Perkal H, Moro MA, Leza JC, Lizasoain I, Castillo M, Montalban X. TNF-alpha converting enzyme (TACE) protein expression in different clinical subtypes of multiple sclerosis.
J. Neurol. 253: 701-706 (2006).
*
-
Comalada M, Peppelenbosch MP. Impaired innate immunity in Crohn's disease.
Trends Mol. Med. 12: 397-399 (2006).
*
-
Combe BG, Codreanu C, Fiocco U, Gaubitz M, Geusens PP, Kvien TK, Pavelka K, Sambrook PN, Smolen J, Wajdula J, Fatenejad S. Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison.
Ann. Rheum. Dis. 65: 1357-1362 (2006).
*
-
Combe CL, Moretto MM, Schwartzman JD, Gigley JP, Bzik DJ, Khan IA. Lack of IL-15 results in the suboptimal priming of CD4+ T cell response against an intracellular parasite.
Proc. Natl. Acad. Sci. U.S.A. 103: 6635-6640 (2006).
*
-
Comby E, Tanaff P, Mariotte D, Costentin-Pignol V, Marcelli C, Ballet JJ. Evolution of antinuclear antibodies and clinical patterns in patients with active rheumatoid arthritis with longterm infliximab therapy.
J. Rheumatol. 33: 24-30 (2006).
-
Comerford I, Milasta S, Morrow V, Milligan G, Nibbs R. The chemokine receptor CCX-CKR mediates effective scavenging of CCL19 in vitro.
Eur. J. Immunol. 36: 1904-1916 (2006).
*
-
Comin-Anduix B, Gualberto A, Glaspy JA, Seja E, Ontiveros M, Reardon DL, Renteria R, Englahner B, Economou JS, Gomez-Navarro J, Ribas A. Definition of an immunologic response using the major histocompatibility complex tetramer and enzyme-linked immunospot assays.
Clin. Cancer Res. 12: 107-116 (2006).
*
-
Compston A. The basis for treatment in multiple sclerosis.
Acta Neurol. Scand. Suppl. 183: 41-47 (2006).
-
Concheiro Cao J, Loureiro Martinez M, Tarrazo Antelo M, Lado Lado FL. Extrapulmonary sarcoidosis as a cause of chronic liver disease. Report of one case.
An. Med. Interna 23: 48-49 (2006).
-
Conchillo A, Valencia I, Puente A, Ansorena D, Astiasaran I. Functional components in fish and algae oils.
Nutr. Hosp. 21: 369-373 (2006).
-
Condomines M, Quittet P, Lu ZY, Nadal L, Latry P, Lopez E, Baudard M, Requirand G, Duperray C, Schved JF, Rossi JF, Tarte K, Klein B. Functional regulatory T cells are collected in stem cell autografts by mobilization with high-dose cyclophosphamide and granulocyte colony-stimulating factor.
J. Immunol. 176: 6631-6639 (2006).
*
-
Conen KL, Jeanneret C, Hecker B, Cathomas G, Biedermann BC. Acute occlusive large vessel disease leading to fatal stroke in a patient with systemic lupus erythematosus: arteritis or atherosclerosis?
Arthritis Rheum. 54: 908-913 (2006).
*
-
Confavreux C, Vukusic S. Accumulation of irreversible disability in multiple sclerosis: from epidemiology to treatment.
Clin. Neurol. Neurosurg. 108: 327-332 (2006).
-
Confavreux C, Vukusic S. Natural history of multiple sclerosis: a unifying concept.
Brain 129: 606-616 (2006).
*
-
Connell L, McInnes IB. New cytokine targets in inflammatory rheumatic diseases.
Best Pract. Res. Clin. Rheumatol. 20: 865-878 (2006).
-
Connelly M, Schanberg L. Opioid therapy for the treatment of refractory pain in children with juvenile rheumatoid arthritis.
Nat. Clin. Pract. Rheumatol. 2: 636-637 (2006).
*
-
Connor EE, Cates EA, Williams JL, Bannerman DD. Cloning and radiation hybrid mapping of bovine Toll-like receptor-4 (TLR-4) signaling molecules.
Vet. Immunol. Immunopathol. 112: 302-308 (2006).
*
-
Connor FL, Di Lorenzo C. Chronic intestinal pseudo-obstruction: assessment and management.
Gastroenterology 130: S29-S36 (2006).
*
-
Conrad C, Nestle FO. Animal models of psoriasis and psoriatic arthritis: an update.
Curr. Rheumatol. Rep. 8: 342-347 (2006).
-
Conrad DF, Andrews TD, Carter NP, Hurles ME, Pritchard JK. A high-resolution survey of deletion polymorphism in the human genome.
Nat. Genet. 38: 75-81 (2006).
*
-
Conscience I, Perceau G, Durlach A, Bernard P. Vulvar involvement in Crohn's disease: efficacy of metronidazole.
Ann. Dermatol. Venereol. 133: 585-587 (2006).
-
Conseil G, Deeley RG, Cole SP. Functional importance of three basic residues clustered at the cytosolic interface of transmembrane helix 15 in the multidrug and organic anion transporter MRP1 (ABCC1).
J. Biol. Chem. 281: 43-50 (2006).
*
-
Consigny Y, Modigliani R, Colombel JF, Dupas JL, Lemann M, Mary JY; Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID). A simple biological score for predicting low risk of short-term relapse in Crohn's disease.
Inflamm. Bowel Dis. 12: 551-557 (2006).
*
-
Consolazio A, Al Ograve PL, Rivera M, Iacopini F, Paoluzi OA, Crispino P, Pica R, Paoluzi P. Overexpression of fatty acid synthase in ulcerative colitis.
Am. J. Clin. Pathol. 126: 1-6 (2006).
*
-
Constable PA, Lawrenson JG, Arden GB. Light and alcohol evoked electro-oculograms in cystic fibrosis.
Doc. Ophthalmol. 113: 133-143 (2006).
*
-
Constable PA, Lawrenson JG, Dolman DE, Arden GB, Abbott NJ. P-Glycoprotein expression in human retinal pigment epithelium cell lines.
Exp. Eye Res. 83: 24-30 (2006).
*
-
Constante M, Jiang W, Wang D, Raymond VA, Bilodeau M, Santos MM. Distinct requirements for Hfe in basal and induced hepcidin levels in iron overload and inflammation.
Am. J. Physiol. Gastrointest. Liver Physiol. 291: G229-G237 (2006).
*
-
Constantin T, Ponyi A, Orban I, Molnar K, Derfalvi B, Dicso F, Kalovics T, Muller J, Garami M, Sallai A, Balogh Z, Szalai Z, Fekete G, Danko K. National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary - clinical characteristics and disease course of 44 patients with juvenile dermatomyositis.
Autoimmunity 39: 223-232 (2006).
-
Conte MP, Schippa S, Zamboni I, Penta M, Chiarini F, Seganti L, Osborn J, Falconieri P, Borrelli O, Cucchiara S. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease.
Gut 55: 1760-1767 (2006).
*
-
Conti B, Sanchez-Alavez M, Winsky-Sommerer R, Morale MC, Lucero J, Brownell S, Fabre V, Huitron-Resendiz S, Henriksen S, Zorrilla EP, de Lecea L, Bartfai T. Transgenic mice with a reduced core body temperature have an increased life span.
Science 314: 825-828 (2006).
*
-
Contreras G, Lenz O, Pardo V, Borja E, Cely C, Iqbal K, Nahar N, de La Cuesta C, Hurtado A, Fornoni A, Beltran-Garcia L, Asif A, Young L, Diego J, Zachariah M, Smith-Norwood B. Outcomes in African Americans and Hispanics with lupus nephritis.
Kidney Int. 69: 1846-1851 (2006).
*
-
Cook CH, Trgovcich J, Zimmerman PD, Zhang Y, Sedmak DD. Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent mice.
J. Virol. 80: 9151-9158 (2006).
*
-
Cook DN, Whitehead GS, Burch LH, Berman KG, Kapadia Z, Wohlford-Lenane C, Schwartz DA. Spontaneous mutations in recombinant inbred mice: mutant Toll-like receptor 4 (Tlr4) in BXD29 mice.
Genetics 172: 1751-1755 (2006).
*
-
Cook HT, Botto M. Mechanisms of disease: the complement system and the pathogenesis of systemic lupus erythematosus.
Nat. Clin. Pract. Rheumatol. 2: 330-337 (2006).
*
-
Cooke A. Th17 cells in inflammatory conditions.
Rev. Diabet. Stud. 3: 72-75 (2006).
*
-
Cooke GS, Campbell SJ, Sillah J, Gustafson P, Bah B, Sirugo G, Bennett S, McAdam KP, Sow O, Lienhardt C, Hill AV. Polymorphism within the interferon-gamma/receptor complex is associated with pulmonary tuberculosis.
Am. J. Respir. Crit. Care Med. 174: 339-343 (2006).
*
-
Cooper EL. Role of Toll-like receptors in adjuvant-augmented immune therapies by T. seya.
Evid. Based Complement. Alternat. Med. 3: 133-137 (2006).
*
-
Cooper GS, Parks CG, Schur PS, Fraser PA. Occupational and environmental associations with antinuclear antibodies in a general population sample.
J. Toxicol. Environ. Health A. 69: 2063-2069 (2006).
-
Cooper JG, Purcell GP. Data mining for correlations between diet and Crohn's disease activity.
AMIA Annu. Symp. Proc. 2006: 897 (2006).
*
-
Cooper L, Ausubel L, Gutierrez M, Stephan S, Shakeley R, Olivares S, Serrano L, Burton L, Jensen M, Forman S, Digiusto D. Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma.
Cytotherapy 8: 105-117 (2006).
-
Cope AP. Harmful waste products as novel immune modulators for treating inflammatory arthritis?
PLoS Med. 3: e385 (2006).
*
-
Cope KA, Solga SF, Hummers LK, Wigley FM, Diehl AM, Risby TH. Abnormal exhaled ethane concentrations in scleroderma.
Biomarkers 11: 70-84 (2006).
-
Copelan EA. Hematopoietic stem-cell transplantation.
N. Engl. J. Med. 354: 1813-1826 (2006).
*
-
Coppo P, Veyradier A, Monge M; , pour le Reseau d'etude des microangiopathies thrombotiques. Acquired idiopathic thrombotic thrombocytopenic purpura: arguments for an autoimmune disease.
Presse. Med. 35: 1876-1886 (2006).
-
Coppola G, Geschwind DH. Technology insight: querying the genome with microarrays-progress and hope for neurological disease.
Nat. Clin. Pract. Neurol. 2: 147-158 (2006).
-
Coppotelli G, Summers A, Chidakel A, Ross JM, Celi FS. Functional characterization of the 258 A/G (D2-ORFa-Gly3Asp) human type-2 deiodinase polymorphism: a naturally occurring variant increases the enzymatic activity by removing a putative repressor site in the 5' UTR of the gene.
Thyroid 16: 625-632 (2006).
-
Corbett ST, Hill O, Nangia AK. Vitamin D receptor found in human sperm.
Urology 68: 1345-1349 (2006).
-
Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Risso M, Gualandi F, Mancardi GL, Pistoia V, Uccelli A. Human mesenchymal stem cells modulate B cell functions.
Blood 107: 367-372 (2006).
*
-
Corder EH, Hefler LA. Multilocus genotypes spanning estrogen metabolism associated with breast cancer and fibroadenoma.
Rejuvenation Res. 9: 56-60 (2006).
-
Cordes T, Diesing D, Becker S, Diedrich K, Reichrath J, Friedrich M. Modulation of MAPK ERK1 and ERK2 in VDR-positive and -negative breast cancer cell lines.
Anticancer Res. 26: 2749-2753 (2006).
-
Cordiali Fei P, Trento E, D'Agosto G, Bordignon V, Mussi A, Ardigo M, Mastroianni A, Vento A, Solivetti F, Berardesca E, Ensoli F. Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha.
J. Autoimmune Dis. 3: 5 (2006).
*
-
Corella D, Qi L, Tai ES, Deurenberg-Yap M, Tan CE, Chew SK, Ordovas JM. Perilipin gene variation determines higher susceptibility to insulin resistance in Asian women when consuming a high-saturated fat, low-carbohydrate diet.
Diabetes Care 29: 1313-1319 (2006).
*
-
Cornillet A, Camus C, Nimubona S, Gandemer V, Tattevin P, Belleguic C, Chevrier S, Meunier C, Lebert C, Aupee M, Caulet-Maugendre S, Faucheux M, Lelong B, Leray E, Guiguen C, Gangneux JP. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey.
Clin. Infect. Dis. 43: 577-584 (2006).
*
-
Corominas H, Figuls R, Riera M, Baiget M. Phenotype of ulcerative colitis, rheumatoid arthritis, and interleukin-10 gene polymorphism.
Rev. Esp. Enferm. Dig. 98: 704-705 (2006).
-
Corpechot C, El Naggar A, Poujol-Robert A, Ziol M, Wendum D, Chazouilleres O, de Ledinghen V, Dhumeaux D, Marcellin P, Beaugrand M, Poupon R. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC.
Hepatology 43: 1118-1124 (2006).
*
-
Corpechot C, El Naggar A, Poupon R. Gender and liver: is the liver stiffness weaker in weaker sex?
Hepatology 44: 513-514 (2006).
*
-
Corpechot C, Ping C, Wendum D, Matsuda F, Barbu V, Poupon R. Identification of a novel 974C-->G nonsense mutation of the MRP2/ABCC2 gene in a patient with Dubin-Johnson syndrome and analysis of the effects of rifampicin and ursodeoxycholic acid on serum bilirubin and bile acids.
Am. J. Gastroenterol. 101: 2427-2432 (2006).
*
-
Corpeleijn E, van der Kallen CJ, Kruijshoop M, Magagnin MG, de Bruin TW, Feskens EJ, Saris WH, Blaak EE. Direct association of a promoter polymorphism in the CD36/FAT fatty acid transporter gene with type 2 diabetes mellitus and insulin resistance.
Diabet. Med. 23: 907-911 (2006).
*
-
Corporeau C, Foll CL, Taouis M, Gouygou JP, Berge JP, Delarue J. Adipose tissue compensates for defect of phosphatidylinositol 3'-kinase induced in liver and muscle by dietary fish oil in fed rats.
Am. J. Physiol. Endocrinol. Metab. 290: E78-E86 (2006).
*
-
Corrales JJ, Almeida M, Burgo R, Mories MT, Miralles JM, Orfao A. Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency.
J. Endocrinol. 189: 595-604 (2006).
*
-
Correale J, Fiol M, Gilmore W. The risk of relapses in multiple sclerosis during systemic infections.
Neurology 67: 652-659 (2006).
-
Correale J, Meli F, Ysrraelit C. Neuronal injury in multiple sclerosis.
Medicina (B. Aires) 66: 472-485 (2006).
-
Cortesini R, Suciu-Foca N. ILT3+ ILT4+ tolerogenic endothelial cells in transplantation.
Transplantation 82 Suppl. 1: S30-S32 (2006).
-
Cortez-Gonzalez X, Pellicciotta I, Gerloni M, Wheeler MC, Castiglioni P, Lenert P, Zanetti M. TLR9-independent activation of B lymphocytes by bacterial DNA.
DNA Cell Biol. 25: 253-261 (2006).
-
Cortez-Pinto H, de Moura MC, Day CP. Non-alcoholic steatohepatitis: from cell biology to clinical practice.
J. Hepatol. 44: 197-208 (2006).
*
-
Corthay A. A three-cell model for activation of naive T helper cells.
Scand. J. Immunol. 64: 93-96 (2006).
*
-
Corvol H, Flamant C, Vallet C, Clement A, Brouard J. Modifier genes and cystic fibrosis.
Arch. Pediatr. 13: 57-63 (2006).
-
Cosen-Binker LI, Binker MG, Cosen R, Negri G, Tiscornia O. Relaxin prevents the development of severe acute pancreatitis.
World J. Gastroenterol. 12: 1558-1568 (2006).
*
-
Cosnes J, Seksik P, Nion-Larmurier I, Beaugerie L, Gendre JP. Prior appendectomy and the phenotype and course of Crohn's disease.
World J. Gastroenterol. 12: 1235-1242 (2006).
*
-
Cossaro M, Noce L, Bonutti A, Pecile P, Di Loreto C, Saro F, Intini S, Terrosu G. An abdominal Burkitt's lymphoma in acute phase. Case report.
Minerva Pediatr. 58: 311-318 (2006).
-
Costa AG, Bressan J, Sabarense CM. Trans fatty acids: foods and effects on health.
Arch. Latinoam. Nutr. 56: 12-21 (2006).
-
Costa DB, Miksad RA, Buff MS, Wang Y, Dezube BJ. Case of fatal sickle cell intrahepatic cholestasis despite use of exchange transfusion in an African-American patient.
J. Natl. Med. Assoc. 98: 1183-1187 (2006).
-
Costabile M, Quach A, Ferrante A. Molecular approaches in the diagnosis of primary immunodeficiency diseases.
Hum. Mutat. 27: 1163-1173 (2006).
*
-
Costal AL, Chaves EC. Stress coping strategies and depressive symptoms among ulcerative colitis patients.
Rev. Esc. Enferm. USP 40: 507-514 (2006).
-
Costas J, Perez-Pampin E, Ferreiros-Vidal I, Torres M, Phillips C, Vicario JL, Pablos JL, Carracedo A, Gomez-Reino JJ, Gonzalez A. SUMO4 and MAP3K7IP2 single nucleotide polymorphisms and susceptibility to rheumatoid arthritis.
J. Rheumatol. 33: 1048-1051 (2006).
-
Coste AT, Turner V, Ischer F, Morschhauser J, Forche A, Semelcki A, Berman J, Bille J, Sanglard D. A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans.
Genetics 172: 2139-2156 (2006).
*
-
Costedoat-Chalumeau N, Amoura Z, Hulot JS, Hammoud HA, Aymard G, Cacoub P, Frances C, Wechsler B, Huong DL, Ghillani P, Musset L, Lechat P, Piette JC. Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus.
Arthritis Rheum. 54: 3284-3290 (2006).
*
-
Costello F. Myasthenia gravis and multiple sclerosis: a review of the ocular manifestations.
Insight 31: 19-22 (2006).
-
Costenbader KH, Feskanich D, Mandl LA, Karlson EW. Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women.
Am. J. Med. 119: 503, e1-9 (2006).
*
-
Costenbader KH, Glass R, Cui J, Shadick N. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
JAMA 296: 2201 (2006).
-
Costenbader KH, Karlson EW. Epstein-Barr virus and rheumatoid arthritis: is there a link?
Arthritis Res. Ther. 8: 204 (2006).
*
-
Costenbader KH, Karlson EW. Cigarette smoking and autoimmune disease: what can we learn from epidemiology?
Lupus 15: 737-745 (2006).
*
-
Costet P, Cariou B, Lambert G, Lalanne F, Lardeux B, Jarnoux AL, Grefhorst A, Staels B, Krempf M. Hepatic PCSK9 expression is regulated by nutritional status via insulin and sterol regulatory-element binding protein 1c.
J. Biol. Chem. 281: 6211-6218 (2006).
*
-
Costner MI, Grau RH. Update on connective tissue diseases in dermatology.
Semin. Cutan. Med. Surg. 25: 207-220 (2006).
-
Coti Bertrand P, O'kusky JR, Innis SM. Maternal dietary (n-3) fatty acid deficiency alters neurogenesis in the embryonic rat brain.
J. Nutr. 136: 1570-1575 (2006).
*
-
Cottone M. Recurrent disease after resection for Crohn's disease: is it preventable?
Inflamm. Bowel Dis. 12 Suppl. 3: S13-S14 (2006).
-
Cottone M, Mocciaro F, Modesto I. Infliximab and ulcerative colitis.
Expert Opin. Biol. Ther. 6: 401-408 (2006).
-
Cottone M, Mocciaro F, Scimeca D. Adalimumab induction for Crohn's disease.
Gastroenterology 130: 1929 (2006).
*
-
Cottone M, Orlando A, Modesto I. Postoperative maintenance therapy for inflammatory bowel disease.
Curr. Opin. Gastroenterol. 22: 377-381 (2006).
-
Cottone M, Renda MC, Mattaliano A, Oliva L, Fries W, Criscuoli V, Modesto I, Scimeca D, Maggio A, Casa A, Maisano S, Mocciaro F, Sferrazza A, Orlando A. Incidence of Crohn's disease and CARD15 mutation in a small township in Sicily.
Eur. J. Epidemiol. 21: 887-892 (2006).
*
-
Couderc AL, Costello R, Bagneres D, Rossi P, Vitton V, Demoux AL, Bonin-Guillaume S, Frances Y, Granel B. Is pure red cell aplasia a new extra digestive manifestation of celiac disease?
Rev. Med. Interne. 27: 336-339 (2006).
-
Couderc LJ, Catherinot E. Sarcoidosis and granulomatous disease: observation.
Rev. Mal. Respir. 23: 5S59-5S67 (2006).
-
Coudevylle N, Rokas D, Sakarellos-Daitsiotis M, Krikorian D, Panou-Pomonis E, Sakarellos C, Boussard G, Cung MT. Phosphorylated and non-phosphorylated epitopes of the La/SSB autoantigen: comparison of their antigenic and conformational characteristics.
Biopolymers 84: 368-382 (2006).
-
Coulouarn C, Gomez-Quiroz LE, Lee JS, Kaposi-Novak P, Conner EA, Goldina TA, Onishchenko GE, Factor VM, Thorgeirsson SS. Oncogene-specific gene expression signatures at preneoplastic stage in mice define distinct mechanisms of hepatocarcinogenesis.
Hepatology 44: 1003-1011 (2006).
*
-
Coulter ID, Hardy ML, Morton SC, Hilton LG, Tu W, Valentine D, Shekelle PG. Antioxidants vitamin C and vitamin E for the prevention and treatment of cancer.
J. Gen. Intern. Med. 21: 735-744 (2006).
*
-
Counts DR, Sierpina VS. Celiac disease/gluten intolerance.
Explore (NY) 2: 43-45 (2006).
-
Courivaud C, Ferrand C, Deschamps M, Tiberghien P, Chalopin JM, Duperrier A, Saas P, Ducloux D. No evidence of association between NOD2/CARD15 gene polymorphism and atherosclerotic events after renal transplantation.
Transplantation 81: 1212-1215 (2006).
-
Courtney JM, Plant BJ, Morgan K, Rendall J, Gallagher C, Ennis M, Kalsheker N, Elborn S, O'Connor CM. Association of improved pulmonary phenotype in Irish cystic fibrosis patients with a 3' enhancer polymorphism in alpha-1-antitrypsin.
Pediatr. Pulmonol. 41: 584-591 (2006).
-
Courtois G, Gilmore TD. Mutations in the NF-kappaB signaling pathway: implications for human disease.
Oncogene 25: 6831-6843 (2006).
*
-
Courville P, Chaloupka R, Cellier MF. Recent progress in structure-function analyses of Nramp proton-dependent metal-ion transporters.
Biochem. Cell. Biol. 84: 960-978 (2006).
*
-
Cousins L, Graham M, Tooze R, Carter C, Miller JR, Powrie FM, Macpherson GG, Butcher GW. Eosinophilic bowel disease controlled by the BB rat-derived lymphopenia/Gimap5 gene.
Gastroenterology 131: 1475-1485 (2006).
*
-
Couvreur P, Vauthier C. Nanotechnology: intelligent design to treat complex disease.
Pharm. Res. 23: 1417-1450 (2006).
*
-
Couzin J. Genomics. Microarray data reproduced, but some concerns remain.
Science 313: 1559 (2006).
*
-
Couzin J. Genomics. The HapMap gold rush: researchers mine a rich deposit.
Science 312: 1131 (2006).
*
-
Couzin J. Biomedical research. Bone disease gene finally found.
Science 312: 514-515 (2006).
*
-
Couzin J. Immunology. Diabetes studies conflict on power of spleen cells.
Science 311: 1694 (2006).
*
-
Couzin J. Cancer. T cells a boon for colon cancer prognosis.
Science 313: 1868-1869 (2006).
*
-
Covelli M, Favia I, Marrone M, Iannone F, Gentile A, Lastilla G, Lapadula G. Cutaneous lesions as presenting symptoms of primary biliary cirrhosis: an undifferentiated connective tissue disease-like onset.
Clin. Rheumatol. 25: 919-922 (2006).
*
-
Cox DW. Wilson disease: practical applications of molecular approaches.
Falk Symposium 156. XIII Falk Liver Week (Part II). GENETICS IN LIVER DISEASES, Freiburg (Germany), October 8-9, 2006, p. 27 (2006). *
-
Cox IJ, Sharif A, Cobbold JF, Thomas HC, Taylor-Robinson SD. Current and future applications of in vitro magnetic resonance spectroscopy in hepatobiliary disease.
World J. Gastroenterol. 12: 4773-4783 (2006).
*
-
Cox SL. Tesaglitazar: a promising approach in type 2 diabetes.
Drugs Today (Barc.) 42: 139-146 (2006).
-
Coyne CB, Bergelson JM. Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions.
Cell 124: 119-131 (2006).
*
-
Coyne JD. Crohn's disease with inflammatory splenic granuloma.
J. Clin. Pathol. 59: 889 (2006).
*
-
Cozzolino M, Gallieni M, Brancaccio D, Arcidiacono T, Bianchi G, Vezzoli G. Vitamin D retains an important role in the pathogenesis and management of secondary hyperparathyroidism in chronic v.
J. Nephrol. 19: 566-577 (2006).
-
Cozzone D, Debard C, Dif N, Ricard N, Disse E, Vouillarmet J, Rabasa-Lhoret R, Laville M, Pruneau D, Rieusset J, Lefai E, Vidal H. Activation of liver X receptors promotes lipid accumulation but does not alter insulin action in human skeletal muscle cells.
Diabetologia 49: 990-999 (2006).
*
-
Crabb DW, Liangpunsakul S. Alcohol and lipid metabolism.
J. Gastroenterol. Hepatol. 21 Suppl. 3: S56-S60 (2006).
*
-
Cracowski JL, Durand T. Cardiovascular pharmacology and physiology of the isoprostanes.
Fundam. Clin. Pharmacol. 20: 417-427 (2006).
-
Craddock N, Forty L. Genetics of affective (mood) disorders.
Eur. J. Hum. Genet. 14: 660-668 (2006).
*
-
Craddock RC, Taylor R, Broderick G, Whistler T, Klimas N, Unger ER. Exploration of statistical dependence between illness parameters using the entropy correlation coefficient.
Pharmacogenomics 7: 421-428 (2006).
-
Crameri R, Weichel M, Glaser AG, Fluckiger S, Rhyner C. Fungal allergies: a yet unsolved problem.
Chem. Immunol. Allergy 91: 121-133 (2006).
-
Crane JK, Choudhari SS, Naeher TM, Duffey ME. Mutual enhancement of virulence by enterotoxigenic and enteropathogenic Escherichia coli.
Infect. Immun. 74: 1505-1515 (2006).
*
-
Cravo AR, Tavares V, Canas Da Silva J. Anti-TNF alfa therapy in ankylosing spondylitis.
Acta Med. Port. 19: 141-150 (2006).
-
Crawford BA, Labio ED, Strasser SI, McCaughan GW. Vitamin D replacement for cirrhosis-related bone disease.
Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 689-699 (2006).
*
-
Crawford CL. No role for thalidomide in the treatment of leprosy.
J. Infect. Dis. 193: 1743-1744 (2006).
*
-
Crawford F, Jordan KR, Stadinski B, Wang Y, Huseby E, Marrack P, Slansky JE, Kappler JW. Use of baculovirus MHC/peptide display libraries to characterize T-cell receptor ligands.
Immunol. Rev. 210: 156-170 (2006).
*
-
Crawford MA. Docosahexaenoic acid in neural signaling systems.
Nutr. Health 18: 263-276 (2006).
-
Crawford RM, Treharne KJ, Best OG, Riemen CE, Muimo R, Gruenert DC, Arnaud-Dabernat S, Daniel JY, Mehta A. NDPK-A (but not NDPK-B) and AMPK alpha1 (but not AMPK alpha2) bind the cystic fibrosis transmembrane conductance regulator in epithelial cell membranes.
Cell. Signal. 18: 1595-1603 (2006).
*
-
Creagh EM, O'neill LA. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity.
Trends Immunol. 27: 352-357 (2006).
*
-
Cree B. Emerging monoclonal antibody therapies for multiple sclerosis.
Neurologist 12: 171-178 (2006).
-
Creed TJ, Probert CS, Norman MN, Moorghen M, Shepherd NA, Hearing SD, Dayan CM; THE BASBUC INVESTIGATORS. Basiliximab for the treatment of steroid-resistant ulcerative colitis: further experience in moderate and severe disease.
Aliment. Pharmacol. Ther. 23: 1435-1442 (2006).
*
-
Crema MD, Richarme D, Azizi L, Hoeffel CC, Tubiana JM, Arrive L. Pouchography, CT, and MRI features of ileal J pouch-anal anastomosis.
AJR Am. J. Roentgenol. 187: W594-W603 (2006).
*
-
Cremers MI, Marques-Vidal P; NGHD (Nucleo de Gastrenterologia dos Hospitais Distritais). Colonoscopies in Portuguese district hospitals: a multicentric transverse study.
Dig. Liver Dis. 38: 912-917 (2006).
-
Cretney E, Shanker A, Yagita H, Smyth MJ, Sayers TJ. TNF-related apoptosis-inducing ligand as a therapeutic agent in autoimmunity and cancer.
Immunol. Cell Biol. 84: 87-98 (2006).
*
-
Crettaz J, Berraondo P, Mauleon I, Ochoa L, Shankar V, Barajas M, van Rooijen N, Kochanek S, Qian C, Prieto J, Hernandez-Alcoceba R, Gonzalez-Aseguinolaza G. Intrahepatic injection of adenovirus reduces inflammation and increases gene transfer and therapeutic effect in mice.
Hepatology 44: 623-632 (2006).
*
-
Cribier B. Urticaria and hepatitis.
Clin. Rev. Allergy Immunol. 30: 25-30 (2006).
-
Cribier B. Psoriasis under the microscope.
J. Eur. Acad. Dermatol. Venereol. 20 Suppl. 2: 3-9 (2006).
-
Criscuoli V, Rizzuto MR, Cottone M. Cytomegalovirus and inflammatory bowel disease: is there a link?
World J. Gastroenterol. 12: 4813-4818 (2006).
*
-
Crispe IN, Giannandrea M, Klein I, John B, Sampson B, Wuensch S. Cellular and molecular mechanisms of liver tolerance.
Immunol. Rev. 213: 101-118 (2006).
*
-
Crispino P, Habib FI, Badiali D, Pica R, Iacopini F, Bella A, Cassieri C, Anzini F, Paoluzi P. Colorectal motor and sensitivity features in patients affected by ulcerative proctitis with constipation: a radiological and manometric controlled study.
Inflamm. Bowel Dis. 12: 712-718 (2006).
*
-
Cristofaro P, Opal SM. Role of Toll-like receptors in infection and immunity: clinical implications.
Drugs 66: 15-29 (2006).
-
Criswell LA, Saag KG, Mikuls TR, Cerhan JR, Merlino LA, Lum RF, Pfeiffer KA, Woehl B, Seldin MF. Smoking interacts with genetic risk factors in the development of rheumatoid arthritis among older Caucasian women.
Ann. Rheum. Dis. 65: 1163-1167 (2006).
*
-
Crivello A, Giacalone A, Vaglica M, Scola L, Forte GI, Macaluso MC, Raimondi C, Noto LD, Bongiovanni A, Accardo A, Candore G, Palmeri L, Verna R, Caruso C, Lio D, Palmeri S. Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma.
Ann. N. Y. Acad. Sci. 1089: 98-103 (2006).
*
-
Crivori P, Reinach B, Pezzetta D, Poggesi I. Computational models for identifying potential P-glycoprotein substrates and inhibitors.
Mol. Pharm. 3: 33-44 (2006).
*
-
Crocenzi FA, Pellegrino JM, Catania VA, Luquita MG, Roma MG, Mottino AD, Sanchez Pozzi E. Galactosamine prevents ethinylestradiol-induced cholestasis.
Drug Metab. Dispos. 34: 993-997 (2006).
*
-
Crocenzi FA, Roma MG. Silymarin as a new hepatoprotective agent in experimental cholestasis: new possibilities for an ancient medication.
Curr. Med. Chem. 13: 1055-1074 (2006).
-
Croese J, Wood MJ, Melrose W, Speare R. Allergy controls the population density of Necator americanus in the small intestine.
Gastroenterology 131: 402-409 (2006).
*
-
Croitoru AG, Hytiroglou P, Schwartz ME, Saxena R. Liver transplantation for liver rupture due to light chain deposition disease: a case report.
Semin. Liver Dis. 26: 298-303 (2006).
-
Cron RQ, Bandyopadhyay R, Genin A, Brunner M, Kersh GJ, Yin J, Finkel TH, Crow MK. Early growth response-1 is required for CD154 transcription.
J. Immunol. 176: 811-818 (2006).
*
-
Cronin EM, Sibartie V, Crosbie OM, Quigley EM. Autoimmune hepatitis in association with lymphocytic colitis.
J. Clin. Gastroenterol. 40: 648-650 (2006).
-
Cronstein BN. Pharmacogenetics in the rheumatic diseases.
Bull. Hosp. Jt. Dis. 64: 16-19 (2006).
-
Cronstein BN, Terkeltaub R. The inflammatory process of gout and its treatment.
Arthritis Res. Ther. 8 Suppl. 1: S3 (2006).
*
-
Cross RK, Arora M, Finkelstein J. Acceptance of telemanagement is high in patients with inflammatory bowel disease.
J. Clin. Gastroenterol. 40: 200-208 (2006).
-
Cross RK, Binion DG. Narcotic use in patients with Crohn's disease: reply from Drs. Cross and Binion.
Am. J. Gastroenterol. 101: 1397-1398 (2006).
*
-
Cross RK, Jung C, Wasan S, Joshi G, Sawyer R, Roghmann MC. Racial differences in disease phenotypes in patients with Crohn's disease.
Inflamm. Bowel Dis. 12: 192-198 (2006).
*
-
Crouthamel MH, Wu D, Yang Z, Ho RJ. A novel MDR1 G1199T variant alters drug resistance and efflux transport activity of P-glycoprotein in recombinant Hek cells.
J. Pharm. Sci. 95: 2767-2777 (2006).
*
-
Crow MK. Modification of accessory molecule signaling.
Springer Semin. Immunopathol. 27: 409-424 (2006).
*
-
Croxford JL, Ercolini AM, Degutes M, Miller SD. Structural requirements for initiation of cross-reactivity and CNS autoimmunity with a PLP(139-151) mimic peptide derived from murine hepatitis virus.
Eur. J. Immunol. 36: 2671-2680 (2006).
*
-
Croxford JL, Miyake S, Huang YY, Shimamura M, Yamamura T. Invariant V(alpha)19i T cells regulate autoimmune inflammation.
Nat. Immunol. 7: 987-994 (2006).
*
-
Cruyssen BV, Van Looy S, Wyns B, Westhovens R, Durez P, Van den Bosch F, Mielants H, De Clerck L, Peretz A, Malaise M, Verbruggen L, Vastesaeger N, Geldhof A, Boullart L, De Keyser F. Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity.
Arthritis Res. Ther. 8: R112 (2006).
*
-
Cruz A, Khader SA, Torrado E, Fraga A, Pearl JE, Pedrosa J, Cooper AM, Castro AG. Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection.
J. Immunol. 177: 1416-1420 (2006).
*
-
Cryer B. A COX-2-specific inhibitor plus a proton-pump inhibitor: is this a reasonable approach to reduction in NSAIDs' GI toxicity?
Am. J. Gastroenterol. 101: 711-713 (2006).
*
-
Csak T, Folhoffer A, Horvath A, Halasz J, Diczhazi C, Schaff Z, Szalay F. Holmes-Adie syndrome, autoimmune hepatitis and celiac disease: a case report.
World J. Gastroenterol. 12: 1485-1487 (2006).
*
-
Csanady L, Nairn AC, Gadsby DC. Thermodynamics of CFTR channel gating: a spreading conformational change initiates an irreversible gating cycle.
J. Gen. Physiol. 128: 523-533 (2006).
*
-
Csaplar M, Juhasz M, Muzes G, Jakab C, Aranyi Z, Rozsa C, Molnar B, Komoly S, Papay J, Zagoni T, Herszenyi L, Tulassay Z. Association of coeliac disease and myasthenia gravis.
Orv. Hetil. 147: 841-844 (2006).
-
Csepregi A, Malfertheiner P. Do we need alternative treatment options for autoimmune hepatitis?
Curr. Gastroenterol. Rep. 8: 177-178 (2006).
-
Csepregi A, Rocken C, Treiber G, Malfertheiner P. Budesonide induces complete remission in autoimmune hepatitis.
World J. Gastroenterol. 12: 1362-1366 (2006).
*
-
Csernok E, Ai M, Gross WL, Wicklein D, Petersen A, Lindner B, Lamprecht P, Holle JU, Hellmich B. Wegener's autoantigen induces maturation of dendritic cells and licences them for TH1 priming via the protease-activated receptor-2 pathway.
Blood 107: 4440-4448 (2006).
*
-
Csiszer E. Cystic fibrosis and celiac disease in a family: adding a fourth reminder.
Respir. Care 51: 768-769 (2006).
*
-
Cua DJ, Kastelein RA. TGF-beta, a 'double agent' in the immune pathology war.
Nat. Immunol. 7: 557-559 (2006).
*
-
Cua IH, Kwan V, Henriquez M, Kench J, George J. Long term suppressive therapy with pegylated interferon for chronic hepatitis C associated membranoproliferative glomerulonephritis.
Gut 55: 1521-1522 (2006).
*
-
Cuarterolo M, Ciocca M, Velasco CC, Ramonet M, Gonzalez T, Lopez S, Garsd A, Alvarez F. Follow-up of children with autoimmune hepatitis treated with cyclosporine.
J. Pediatr. Gastroenterol. Nutr. 43: 635-639 (2006).
*
-
Cuchacovich M, Soto L, Edwardes M, Gutierrez M, Llanos C, Pacheco D, Sabugo F, Alamo M, Fuentealba C, Villanueva L, Gatica H, Schiattino I, Salazaro L, Catalan D, Valenzuela O, Salazar-Onfray F, Aguillon JC. Tumour necrosis factor (TNF)alpha -308 G/G promoter polymorphism and TNFalpha levels correlate with a better response to adalimumab in patients with rheumatoid arthritis.
Scand. J. Rheumatol. 35: 435-440 (2006).
-
Cuenca J, Martin-Sanz P, Alvarez-Barrientos AM, Bosca L, Goren N. Infiltration of inflammatory cells plays an important role in matrix metalloproteinase expression and activation in the heart during sepsis.
Am. J. Pathol. 169: 1567-1576 (2006).
*
-
Cuffari C. Inflammatory bowel disease in children: a pediatrician's perspective.
Minerva Pediatr. 58: 139-157 (2006).
-
Cui G, Olsen T, Christiansen I, Vonen B, Florholmen J, Goll R. Improvement of real-time polymerase chain reaction for quantifying TNF-alpha mRNA expression in inflamed colorectal mucosa: an approach to optimize procedures for clinical use.
Scand. J. Clin. Lab. Invest. 66: 249-259 (2006).
*
-
Cui GM, Liu G, Liu W, Kan B, Mao YQ, Wei YQ. Experimental study of pristane-induced murine lupus model.
Sichuan Da Xue Xue Bao Yi Xue Ban 37: 309-312 (2006).
-
Cui J, Han LY, Lin HH, Tang ZQ, Jiang L, Cao ZW, Chen YZ. MHC-BPS: MHC-binder prediction server for identifying peptides of flexible lengths from sequence-derived physicochemical properties.
Immunogenetics 58: 607-613 (2006).
*
-
Cui J, Wang W, Lai MD, Xu EP, Lv BJ, Lin J, Ruan WJ, Ma Y, Yao C. Identification of a novel VNTR polymorphism in C6orf37 and its association with colorectal cancer risk in Chinese population.
Clin. Chim. Acta 368: 155-159 (2006).
*
-
Cui L, Aleksandrov LA, Hou YX, Gentzsch M, Chen JH, Riordan JR, Aleksandrov AA. The role of cystic fibrosis transmembrane conductance regulator phenylalanine 508 side chain in ion channel gating.
J. Physiol. 572: 347-358 (2006).
*
-
Cui T, Schopfer FJ, Zhang J, Chen K, Ichikawa T, Baker PR, Batthyany C, Chacko BK, Feng X, Patel RP, Agarwal A, Freeman BA, Chen YE. Nitrated fatty acids: endogenous anti-inflammatory signaling mediators.
J. Biol. Chem. 281: 35686-35698 (2006).
*
-
Cui Y, Rohan TE. Vitamin D, calcium, and breast cancer risk: a review.
Cancer Epidemiol. Biomarkers Prev. 15: 1427-1437 (2006).
*
-
Cukovic-Cavka S, Likic R, Francetic I, Rustemovic N, Opacic M, Vucelic B. Lactobacillus acidophilus as a cause of liver abscess in a NOD2/CARD15-positive patient with Crohn's disease.
Digestion 73: 107-110 (2006).
*
-
Cukovic-Cavka S, Vermeire S, Hrstic I, Claessens G, Kolacek S, Jakic-Razumovic J, Krznaric Z, Grubelic K, Radic D, Misak Z, Jadresin O, Rutgeerts P, Vucelic B. NOD2/CARD15 mutations in Croatian patients with Crohn's disease: prevalence and genotype-phenotype relationship.
Eur. J. Gastroenterol. Hepatol. 18: 895-899 (2006).
-
Cullen PT. Ileostomy carcinomas a review: the latent risk after colectomy for ulcerative colitis and familial adenomatous polyposis: H. M. Quah, A. Samad and A. Maw.
Colorectal Dis. 8: 526 (2006).
*
-
Cullen SN, Chapman RW. The medical management of primary sclerosing cholangitis.
Semin. Liver Dis. 26: 52-61 (2006).
*
-
Cumberbatch M, Singh M, Dearman RJ, Young HS, Kimber I, Griffiths CE. Impaired Langerhans cell migration in psoriasis.
J. Exp. Med. 203: 953-960 (2006).
*
-
Cumming A, Grundy P, Keeney S, Lester W, Enayat S, Guilliatt A, Bowen D, Pasi J, Keeling D, Hill F, Bolton-Maggs PH, Hay C, Collins P; on behalf of the UK Haemophilia Centre Doctors' Organisation. An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease.
Thromb. Haemost. 96: 630-641 (2006).
-
Cummings CE, Rosenman KD. Ulcerative colitis reactivation after mercury vapor inhalation.
Am. J. Ind. Med. 49: 499-502 (2006).
*
-
Cummings SA, Rubin DT. The complexity and challenges of genetic counseling and testing for inflammatory bowel disease.
J. Genet. Couns. 15: 465-476 (2006).
*
-
Cummins CL, Mangelsdorf DJ. Liver X receptors and cholesterol homoeostasis: spotlight on the adrenal gland.
Biochem. Soc. Trans. 34: 1110-1113 (2006).
*
-
Cummins CL, Volle DH, Zhang Y, McDonald JG, Sion B, Lefrancois-Martinez AM, Caira F, Veyssiere G, Mangelsdorf DJ, Lobaccaro JM. Liver X receptors regulate adrenal cholesterol balance.
J. Clin. Invest. 116: 1902-1912 (2006).
*
-
Cunha-Neto E, Bilate AM, Hyland KV, Fonseca SG, Kalil J, Engman DM. Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry.
Autoimmunity 39: 41-54 (2006).
-
Cunnane SC. Survival of the fattest: the key to human brain evolution.
Med. Sci. (Paris) 22: 659-663 (2006).
-
Cunningham C, Drotar D, Palermo TM, McGowan K, Arendt R. Health-related quality of life in children and adolescents with inflammatory bowel disease: 57.
Pediatr. Res. 60: 500 (2006).
-
Cunningham-Rundles C, Radigan L, Knight AK, Zhang L, Bauer L, Nakazawa A. TLR9 activation is defective in common variable immune deficiency.
J. Immunol. 176: 1978-1987 (2006).
*
-
Cuoco L, Salvagnini M. Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin.
Minerva Gastroenterol. Dietol. 52: 89-95 (2006).
-
Cuomo R, Vandaele P, Coulie B, Peeters T, Depoortere I, Janssens J, Tack J. Influence of motilin on gastric fundus tone and on meal-induced satiety in man: role of cholinergic pathways.
Am. J. Gastroenterol. 101: 804-811 (2006).
*
-
Curley CR, Monsuur AJ, Wapenaar MC, Rioux JD, Wijmenga C. A functional candidate screen for coeliac disease genes.
Eur. J. Hum. Genet. 14: 1215-1222 (2006).
*
-
Cursiefen C, Jacobi C, Dietrich T, Kruse FE. Current treatment for dry eye syndrome.
Ophthalmologe 103: 18-24 (2006).
-
Cusack C, Buckley C. Etanercept: effective in the management of hidradenitis suppurativa.
Br. J. Dermatol. 154: 726-729 (2006).
*
-
Cusack S, Molgaard C, Michaelsen KF, Jakobsen J, Lamberg-Allardt CJ, Cashman KD. Vitamin D and estrogen receptor-alpha genotype and indices of bone mass and bone turnover in Danish girls.
J. Bone Miner. Metab. 24: 329-336 (2006).
*
-
Cusatis G, Gregorc V, Li J, Spreafico A, Ingersoll RG, Verweij J, Ludovini V, Villa E, Hidalgo M, Sparreboom A, Baker SD. Pharmacogenetics of ABCG2 and adverse reactions to gefitinib.
J. Natl. Cancer Inst. 98: 1739-1742 (2006).
*
-
Cuschieri J, Billgren J, Maier RV. Phosphatidylcholine-specific phospholipase C (PC-PLC) is required for LPS-mediated macrophage activation through CD14.
J. Leukoc. Biol. 80: 407-414 (2006).
*
-
Cuthbert AW. The prospects of pharmacotherapy for cystic fibrosis.
J. R. Soc. Med. 99 Suppl. 46: 30-35 (2006).
-
Cutillo L, Najimi M, Smets F, Janssen M, Reding R, de Goyet Jde V, Sokal EM. Safety of living-related liver transplantation for progressive familial intrahepatic cholestasis.
Pediatr. Transplant. 10: 570-574 (2006).
*
-
Cutolo M, Capellino S, Sulli A, Serioli B, Secchi ME, Villaggio B, Straub RH. Estrogens and autoimmune diseases.
Ann. N. Y. Acad. Sci. 1089: 538-547 (2006).
*
-
Cutolo M, Otsa K, Laas K, Yprus M, Lehtme R, Secchi ME, Sulli A, Paolino S, Seriolo B. Circannual vitamin D serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe.
Clin. Exp. Rheumatol. 24: 702-704 (2006).
-
Cutolo M, Straub RH. Stress as a risk factor in the pathogenesis of rheumatoid arthritis.
Neuroimmunomodulation 13: 277-282 (2006).
-
Cutolo M, Sulli A, Capellino S, Villaggio B, Montagna P, Pizzorni C, Paolino S, Seriolo B, Felli L, Straub RH. Anti-TNF and sex hormones.
Ann. N. Y. Acad. Sci. 1069: 391-400 (2006).
*
-
Cutolo M, Sulli A, Pizzorni C, Secchi ME, Soldano S, Seriolo B, Straub RH, Otsa K, Maestroni GJ. Circadian rhythms: glucocorticoids and arthritis.
Ann. N. Y. Acad. Sci. 1069: 289-299 (2006).
*
-
Cutolo M, Sulli A, Secchi ME, Paolino S, Pizzorni C. Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement?
Rheumatology (Oxford) 45 Suppl. 4: iv43-iv46 (2006).
*
-
Cutting GR. Cystic fibrosis: using genetic association to identify modifiers of disease variability in cystic fibrosis.
Eur. J. Hum. Genet. 14: 890-891 (2006).
*
-
Cuzzocrea S. Role of nitric oxide and reactive oxygen species in arthritis.
Curr. Pharm. Des. 12: 3551-3570 (2006).
-
Cuzzocrea S. Peroxisome proliferator-activated receptors and acute lung injury.
Curr. Opin. Pharmacol. 6: 263-270 (2006).
-
Cuzzocrea S, Mazzon E, Di Paola R, Peli A, Bonato A, Britti D, Genovese T, Mui C, Crisafulli C, Caputi AP. The role of the peroxisome proliferator-activated receptor-alpha (PPAR-alpha) in the regulation of acute inflammation.
J. Leukoc. Biol. 79: 999-1010 (2006).
*
-
Cvetanovic M, Mitchell JE, Patel V, Avner BS, Su Y, van der Saag PT, Witte PL, Fiore S, Levine JS, Ucker DS. Specific recognition of apoptotic cells reveals a ubiquitous and unconventional innate immunity.
J. Biol. Chem. 281: 20055-20567 (2006).
*
-
Cvetkovic I, Stosic-Grujicic S. Neutralization of macrophage migration inhibitory factor-novel approach for the treatment of immunoinflammatory disorders.
Int. Immunopharmacol. 6: 1527-1534 (2006).
-
Cvetkovic RS, Scott LJ. Adalimumab: a review of its use in adult patients with rheumatoid arthritis.
BioDrugs 20: 293-311 (2006).
-
Cyganek K, Mirkiewicz-Sieradzka B, Malecki MT, Wolkow P, Skupien J, Bobrek J, Czogala M, Klupa T, Sieradzki J. Clinical risk factors and the role of VDR gene polymorphisms in diabetic retinopathy in Polish type 2 diabetes patients.
Acta Diabetol. 43: 114-119 (2006).
*
-
Czaja AJ. Autoimmune hepatitis - approach to diagnosis.
MedGenMed. 8: 55 (2006).
*
-
Czaja AJ. Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a foray across diagnostic boundaries.
J. Hepatol. 44: 251-252 (2006).
*
-
Czaja AJ. Autoimmune liver disease.
Curr. Opin. Gastroenterol. 22: 234-240 (2006).
-
Czaja AJ, Carpenter HA. Thiopurine methyltransferase deficiency and azathioprine intolerance in autoimmune hepatitis.
Dig. Dis. Sci. 51: 968-975 (2006).
*
-
Czaja AJ, Carpenter HA. Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly.
Hepatology 43: 532-538 (2006).
*
-
Czaja AJ, Carpenter HA, Moore SB. Clinical and HLA phenotypes of type 1 autoimmune hepatitis in North American patients outside DR3 and DR4.
Liver Int. 26: 552-558 (2006).
*
-
Czauderna P, Zbrzezniak G, Narozanski W, Korzon M, Wyszomirska M, Stoba C. Preliminary experience with arterial chemoembolization for hepatoblastoma and hepatocellular carcinoma in children.
Pediatr. Blood Cancer 46: 825-828 (2006).
-
Czeslick E, Struppert A, Simm A, Sablotzki A. E5564 (Eritoran) inhibits lipopolysaccharide-induced cytokine production in human blood monocytes.
Inflamm. Res. 55: 511-515 (2006).
*
-
Czito BG, Anscher MS, Willett CG. Radiation therapy in the treatment of cholangiocarcinoma.
Oncology (Williston Park) 20: 873-884 (2006).
-
Czlonkowska A, Ciesielska A, Gromadzka G, Kurkowska-Jastrzebska I. Gender differences in neurological disease: role of estrogens and cytokines.
Endocrine 29: 243-256 (2006).
-
Czochra P, Klopcic B, Meyer E, Herkel J, Garcia-Lazaro JF, Thieringer F, Schirmacher P, Biesterfeld S, Galle PR, Lohse AW, Kanzler S. Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice.
J. Hepatol. 45: 419-428 (2006).
*
-
Czogala M, Czogala W, Balwierz W. Hemophagocytic syndrome: diagnostic problems.
Przegl. Lek. 63: 47-52 (2006).
-
Czompoly T, Olasz K, Simon D, Nyarady Z, Palinkas L, Czirjak L, Berki T, Nemeth P. A possible new bridge between innate and adaptive immunity: are the anti-mitochondrial citrate synthase autoantibodies components of the natural antibody network?
Mol. Immunol. 43: 1761-1768 (2006).
*
-
Czopik AK, Bynoe MS, Palm N, Raine CS, Medzhitov R. Semaphorin 7A is a negative regulator of T cell responses.
Immunity 24: 591-600 (2006).
*
-
Czuwara-Ladykowska J, Sicinska J, Olszewska M, Uhrynowska-Tyszkiewicz I, Rudnicka L. Prolactin synthesis by lymphocytes from patients with systemic sclerosis.
Biomed. Pharmacother. 60: 152-155 (2006).
-
Czyzewska-Buczynska A, Lewandowicz-Uszynska A, Jankowski A. IgA, an essential part of the immune system: selected issues.
Postepy. Hig. Med. Dosw. (Online) 61: 38-47 (2006).
-
Czyzyk J. The role of Toll-like receptors in the pathogenesis of renal disease.
Semin. Nephrol. 26: 167-172 (2006).
-
D'Acquisto F, Ianaro A. From willow bark to peptides: the ever widening spectrum of NF-kappaB inhibitors.
Curr. Opin. Pharmacol. 6: 387-392 (2006).
-
D'Agata EM, Cataldo MA, Cauda R, Tacconelli E. The importance of addressing multidrug resistance and not assuming single-drug resistance in case-control studies.
Infect. Control Hosp. Epidemiol. 27: 670-674 (2006).
*
-
D'Alisa S, Miscio G, Baudo S, Simone A, Tesio L, Mauro A. Depression is the main determinant of quality of life in multiple sclerosis: a classification-regression (CART) study.
Disabil. Rehabil. 28: 307-314 (2006).
-
D'Amico G, Garcia-Pagan JC, Luca A, Bosch J. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review.
Gastroenterology 131: 1611-1624 (2006).
*
-
D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.
J. Hepatol. 44: 217-231 (2006).
*
-
D'Argenio G, Calvani M, Casamassimi A, Petillo O, Margarucci S, Rienzo M, Peluso I, Calvani R, Ciccodicola A, Caporaso N, Peluso G. Experimental colitis: decreased Octn2 and Atb0+ expression in rat colonocytes induces carnitine depletion that is reversible by carnitine-loaded liposomes.
FASEB J. 20: 2544-2546 (2006).
*
-
D'Argenio G, Valenti M, Scaglione G, Cosenza V, Sorrentini I, Di Marzo V. Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation.
FASEB J. 20: 568-570 (2006).
*
-
D'Cruz DP. Systemic lupus erythematosus.
BMJ 332: 890-894 (2006).
*
-
D'Eufemia P, Finocchiaro R, Celli M, Tote J, Ferrucci V, Zambrano A, Troiani P, Quattrucci S. Neutrophil glutamine deficiency in relation to genotype in children with cystic fibrosis.
Pediatr. Res. 59: 13-16 (2006).
*
-
D'Haens G. Dysplasia and cancer in ulcerative colitis: too many questions, too few answers.
Digestion 73: 9-10 (2006).
*
-
D'Haens G, Daperno M. Advances in biologic therapy for ulcerative colitis and Crohn's disease.
Curr. Gastroenterol. Rep. 8: 506-512 (2006).
-
D'Haens G, Hommes D, Engels L, Baert F, VAN DER Waaij L, Connor P, Ramage J, Dewit O, Palmen M, Stephenson D, Joseph R. Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study.
Aliment. Pharmacol. Ther. 24: 1087-1097 (2006).
*
-
D'Inca R, Annese V, di Leo V, Latiano A, Quaino V, Abazia C, Vettorato MG, Sturniolo GC. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease.
Aliment. Pharmacol. Ther. 23: 1455-1461 (2006).
*
-
D'Intino G, Perretta G, Taglioni A, Calistri M, Falzone C, Baroni M, Giardino L, Calza L. Endogenous stem and precursor cells for demyelinating diseases: an alternative for transplantation?
Neurol. Res. 28: 513-517 (2006).
-
D'Onofrio F, Miele L, Diaco M, Santoro L, De Socio G, Montalto M, Grieco A, Gasbarrini G, Manna R. Sjogrens syndrome in a celiac patient: searching for environmental triggers.
Int. J. Immunopathol. Pharmacol. 19: 445-448 (2006).
-
D'Osualdo A, Ferlito F, Prigione I, Obici L, Meini A, Zulian F, Pontillo A, Corona F, Barcellona R, Di Duca M, Santamaria G, Traverso F, Picco P, Baldi M, Plebani A, Ravazzolo R, Ceccherini I, Martini A, Gattorno M. Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: pathogenetic and clinical implications.
Arthritis Rheum. 54: 998-1008 (2006).
*
-
D'Ovidio V, Aratari A, Viscido A, Marcheggiano A, Papi C, Capurso L, Caprilli R. Mucosal features and granulocyte-monocyte-apheresis in steroid-dependent/refractory ulcerative colitis.
Dig. Liver Dis. 38: 389-394 (2006).
-
D'Souza CA, Moscarello MA. Differences in susceptibility of MBP charge isomers to digestion by stromelysin-1 (MMP-3) and release of an immunodominant epitope.
Neurochem. Res. 31: 1045-1054 (2006).
*
-
da Rocha FA. Protective role of helminthiasis in the development of autoimmune diseases.
Clin. Dev. Immunol. 13: 159-162 (2006).
*
-
da Silva AP, Pollett A, Rittling SR, Denhardt DT, Sodek J, Zohar R. Exacerbated tissue destruction in DSS-induced acute colitis of OPN-null mice is associated with downregulation of TNF-alpha expression and non-programmed cell death.
J. Cell. Physiol. 208: 629-639 (2006).
*
-
da Silva Correia J, Miranda Y, Austin-Brown N, Hsu J, Mathison J, Xiang R, Zhou H, Li Q, Han J, Ulevitch RJ. Nod1-dependent control of tumor growth.
Proc. Natl. Acad. Sci. U.S.A. 103: 1840-1845 (2006).
*
-
Da Silva JA, Jacobs JW, Bijlsma JW. Revisiting the toxicity of low-dose glucocorticoids: risks and fears.
Ann. N. Y. Acad. Sci. 1069: 275-288 (2006).
*
-
da Silva JG, De Brito T, Cintra Damiao AO, Laudanna AA, Sipahi AM. Histologic study of colonic mucosa in patients with chronic diarrhea and normal colonoscopic findings.
J. Clin. Gastroenterol. 40: 44-48 (2006).
-
da Silva MF, Nobrega A, Ribeiro RC, Levy MS, Ribeiro OG, Tambourgi DV, Sant'anna DA, da Silva AC. Genetic selection for resistance or susceptibility to oral tolerance imparts correlation to both immunoglobulin E level and mast cell number phenotypes with a profound impact on the atopic potential of the individual.
Clin. Exp. Allergy 36: 1399-1407 (2006).
*
-
da Silveira EB. Outcome of cirrhotic patients undergoing cholecystectomy: applying Bayesian analysis in gastroenterology.
J. Gastroenterol. Hepatol. 21: 958-962 (2006).
*
-
Dabrowska E, Blahuszewska K, Minarowska A, Kaczmarski M, Niedzwiecka-Andrzejewicz I, Stokowska W. Assessment of dental status and oral hygiene in the study population of cystic fibrosis patients in the Podlasie province.
Adv. Med. Sci. 51 Suppl. 1: 100-103 (2006).
-
Daddaoua A, Puerta V, Requena P, Martinez-Ferez A, Guadix E, Sanchez de Medina F, Zarzuelo A, Suarez MD, Boza JJ, Martinez-Augustin O. Goat milk oligosaccharides are anti-inflammatory in rats with hapten-induced colitis.
J. Nutr. 136: 672-676 (2006).
*
-
Dagan E, Brik R, Broza Y, Gershoni-Baruch R. Henoch-Schonlein purpura: polymorphisms in thrombophilia genes.
Pediatr. Nephrol. 21: 1117-1121 (2006).
*
-
Dagan E, Laitman Y, Levanon N, Feuer A, Sidi AA, Baniel J, Korach Y, Baruch GB, Friedman E, Gershoni-Baruch R. The 471delAAAG mutation and C353T polymorphism in the RNASEL gene in sporadic and inherited cancer in Israel.
Fam. Cancer 5: 389-395 (2006).
*
-
Dahl L, Bjorkkjaer T, Graff IE, Malde MK, Klementsen B. Fish provide more to the diet than just omega 3.
Tidsskr. Nor. Laegeforen. 126: 309-311 (2006).
-
Dahlman I, Nilsson M, Jiao H, Hoffstedt J, Lindgren CM, Humphreys K, Kere J, Gustafsson JA, Arner P, Dahlman-Wright K. Liver X receptor gene polymorphisms and adipose tissue expression levels in obesity.
Pharmacogenet. Genomics 16: 881-889 (2006).
-
Dai G, He L, Chou N, Wan YJ. Acetaminophen metabolism does not contribute to gender difference in its hepatotoxicity in mouse.
Toxicol. Sci. 92: 33-41 (2006).
*
-
Dai Q, Pruett SB. Ethanol suppresses LPS-induced Toll-like receptor 4 clustering, reorganization of the actin cytoskeleton, and associated TNF-alpha production.
Alcohol Clin. Exp. Res. 30: 1436-1444 (2006).
-
Dai X, Sayama K, Yamasaki K, Tohyama M, Shirakata Y, Hanakawa Y, Tokumaru S, Yahata Y, Yang L, Yoshimura A, Hashimoto K. SOCS1-negative feedback of STAT1 activation is a key pathway in the dsRNA-induced innate immune response of human keratinocytes.
J. Invest. Dermatol. 126: 1574-1581 (2006).
*
-
Dai Y, Hebert MF, Isoherranen N, Davis CL, Marsh C, Shen DD, Thummel KE. Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro.
Drug Metab. Dispos. 34: 836-847 (2006).
*
-
Daigeler A, Lehnhardt M, Helwing M, Steinstraesser L, Homann HH, Steinau HU, Druecke D. Differential diagnosis of "sterile" phlegmonous hand infections.
Chirurg. 77: 1040-1045 (2006).
-
Dain L, Braun-Moscovici Y, Baum E, Nahir AM, Hoffer E. Modification of neutrophil function by plasma of rheumatoid arthritis patients treated with infliximab.
Clin. Exp. Rheumatol. 24: 38-44 (2006).
-
Daire I, Parrod C, Devanlay M, Duquenoy A, Le Roux P, Le Luyer B. Macroamylasemia: one pediatric case.
Arch. Pediatr. 13: 269-272 (2006).
-
Dalakas MC. Mechanisms of disease: signaling pathways and immunobiology of inflammatory myopathies.
Nat. Clin. Pract. Rheumatol. 2: 219-227 (2006).
*
-
Dalakas MC. Sporadic inclusion body myositis-diagnosis, pathogenesis and therapeutic strategies.
Nat. Clin. Pract. Neurol. 2: 437-447 (2006).
*
-
Dalakas MC. B cells in the pathophysiology of autoimmune neurological disorders: a credible therapeutic target.
Pharmacol. Ther. 112: 57-70 (2006).
*
-
Dalakas MC. Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: present and future prospects.
J. Neurol. 253 Suppl. 5: v25-v32 (2006).
-
Dalakas MC. Inflammatory, immune, and viral aspects of inclusion-body myositis.
Neurology 66: S33-S38 (2006).
-
Dalal A, Pradhan M, Tiwari D, Behari S, Singh U, Mallik GK, Das V, Agarwal S. MTHFR 677C-->T and 1298A-->C polymorphisms: evaluation of maternal genotypic risk and association with level of neural tube defect.
Gynecol. Obstet. Invest. 63: 146-150 (2006).
-
Dalal I, Karban A, Wine E, Eliakim R, Shirin H, Fridlender M, Shaoul R, Leshinsky-Silver E, Levine A. Polymorphisms in the TNF-alpha promoter and variability in the granulomatous response in patients with Crohn's disease.
Pediatr. Res. 59: 825-828 (2006).
*
-
Dale DC, Bolyard AA, Schwinzer BG, Pracht G, Bonilla MA, Boxer L, Freedman MH, Donadieu J, Kannourakis G, Alter BP, Cham BP, Winkelstein J, Kinsey SE, Zeidler C, Welte K. The Severe Chronic Neutropenia International Registry: 10-year follow-up report.
Support Cancer Ther. 3: 220-231 (2006).
-
Dale E, Davis M, Faustman DL. A role for transcription factor NF-kappaB in autoimmunity: possible interactions of genes, sex, and the immune response.
Adv. Physiol. Educ. 30: 152-158 (2006).
*
-
Dale RC, Candler PM, Church AJ, Wait R, Pocock JM, Giovannoni G. Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease.
J. Neuroimmunol. 172: 187-197 (2006).
-
Dalgic B, Dursun I, Serdaroglu A, Dursun A. Latent and potential celiac disease in epileptic Turkish children.
J. Child. Neurol. 21: 6-7 (2006).
-
Dalgleish AG, O'Byrne K. Inflammation and cancer: the role of the immune response and angiogenesis.
Cancer Treat. Res. 130: 1-38 (2006).
-
Dall M. Plasmapheresis in the treatment of cholestasis-induced pruritus.
Ugeskr. Laeger. 168: 779-781 (2006).
-
Dall'era M, Wofsy D. Clinical trial design in systemic lupus erythematosus.
Curr. Opin. Rheumatol. 18: 476-480 (2006).
-
Dallapiccola B, Torrente I, Morena A, Dagna-Bricarelli F, Mingarelli R. Genetic testing in Italy, year 2004.
Eur. J. Hum. Genet. 14: 911-916 (2006).
*
-
Dalmasso G, Cottrez F, Imbert V, Lagadec P, Peyron JF, Rampal P, Czerucka D, Groux H. Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes.
Gastroenterology 131: 1812-1825 (2006).
*
-
Dalpke A, Frank J, Peter M, Heeg K. Activation of Toll-like receptor 9 by DNA from different bacterial species.
Infect. Immun. 74: 940-946 (2006).
*
-
Dalton JE, Cruickshank SM, Egan CE, Mears R, Newton DJ, Andrew EM, Lawrence B, Howell G, Else KJ, Gubbels MJ, Striepen B, Smith JE, White SJ, Carding SR. Intraepithelial gammadelta(+) lymphocytes maintain the integrity of intestinal epithelial tight junctions in response to infection.
Gastroenterology 131: 818-829 (2006).
*
-
Dalton WS, Friend SH. Cancer biomarkers - an invitation to the table.
Science 312: 1165-1168 (2006).
*
-
Daly A, Walsh C, Feighery C, O'Shea U, Jackson J, Whelan A. Serum levels of soluble CD163 correlate with the inflammatory process in coeliac disease.
Aliment. Pharmacol. Ther. 24: 553-559 (2006).
*
-
Daly AK. Significance of the minor cytochrome P450 3A isoforms.
Clin. Pharmacokinet. 45: 13-31 (2006).
-
Daly AK, King BP, Leathart JB. Genotyping for cytochrome P450 polymorphisms.
Methods Mol. Biol. 320: 193-207 (2006).
-
Daly M, Ross P, Giblin L, Buckley F. Polymorphisms within the lactoferrin gene promoter in various cattle breeds.
Anim. Biotechnol. 17: 33-42 (2006).
-
Daly MJ, Rioux JD. Reply to Tenesa et al 'Association of DLG5 and inflammatory bowel disease across populations'.
Eur. J. Hum. Genet. 14: 260-261 (2006).
*
-
Dam J, Baber J, Grishaev A, Malchiodi EL, Schuck P, Bax A, Mariuzza RA. Variable dimerization of the Ly49A natural killer cell receptor results in differential engagement of its MHC class I ligand.
J. Mol. Biol. 362: 102-113 (2006).
*
-
Damen GM, Hol J, de Ruiter L, Bouquet J, Sinaasappel M, van der Woude J, Laman JD, Hop WC, Buller HA, Escher JC, Nieuwenhuis EE. Chemokine production by buccal epithelium as a distinctive feature of pediatric Crohn disease.
J. Pediatr. Gastroenterol. Nutr. 42: 142-149 (2006).
*
-
Damoiseaux J. Regulatory T cells: back to the future.
Neth. J. Med. 64: 4-9 (2006).
*
-
Damsgaard CT, Schack-Nielsen L, Michaelsen KF, Fruekilde MB, Hels O, Lauritzen L. Fish oil affects blood pressure and the plasma lipid profile in healthy Danish infants.
J. Nutr. 136: 94-99 (2006).
*
-
Damude HG, Zhang H, Farrall L, Ripp KG, Tomb JF, Hollerbach D, Yadav NS. Identification of bifunctional Delta12/omega3 fatty acid desaturases for improving the ratio of omega-3 to omega-6 fatty acids in microbes and plants.
Proc. Natl. Acad. Sci. U.S.A. 103: 9446-9451 (2006).
*
-
Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden.
Lupus 15: 308-318 (2006).
-
Danese S, Fiocchi C. Etiopathogenesis of inflammatory bowel diseases.
World J. Gastroenterol. 12: 4807-4812 (2006).
*
-
Danese S, Papa A, Scaldaferri F, Graziani C, Bonizzi M, Armuzzi A, Fedeli G, Gasbarrini G, Gasbarrini A. A novel pathogenic role for microvasculature in inflammatory bowel disease.
Eur. Rev. Med. Pharmacol. Sci. 10: 3-5 (2006).
-
Danese S, Sans M, de la Motte C, Graziani C, West G, Phillips MH, Pola R, Rutella S, Willis J, Gasbarrini A, Fiocchi C. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis.
Gastroenterology 130: 2060-2073 (2006).
*
-
Danese S, Sans M, Scaldaferri F, Sgambato A, Rutella S, Cittadini A, Pique JM, Panes J, Katz JA, Gasbarrini A, Fiocchi C. TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease.
J. Immunol. 176: 2617-2624 (2006).
*
-
Danese S, Semeraro S, Armuzzi A, Papa A, Gasbarrini A. Biological therapies for inflammatory bowel disease: research drives clinics.
Mini. Rev. Med. Chem. 6: 771-784 (2006).
-
Daneshtalab N, Lewanczuk RZ, Russell AS, Jamali F. Drug-disease interactions: losartan effect is not downregulated by rheumatoid arthritis.
J. Clin. Pharmacol. 46: 1344-1355 (2006).
*
-
Dangour AD, Clemens F, Elbourne D, Fasey N, Fletcher AE, Hardy P, Holder GE, Huppert FA, Knight R, Letley L, Richards M, Truesdale A, Vickers M, Uauy R. A randomised controlled trial investigating the effect of n-3 long-chain polyunsaturated fatty acid supplementation on cognitive and retinal function in cognitively healthy older people …
Nutr. J. 5: 20 (2006).
*
-
Daniel C, Poiret S, Goudercourt D, Dennin V, Leyer G, Pot B. Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model.
Appl. Environ. Microbiol. 72: 5799-5805 (2006).
*
-
Daniel C, Radeke HH, Sartory NA, Zahn N, Zuegel U, Steinmeyer A, Stein JM. The new low calcemic vitamin D analog 22-ene-25-oxa-vitamin D prominently ameliorates Th1-mediated colitis in mice.
J. Pharmacol. Exp. Ther. 319: 622-631 (2006).
*
-
Daniel F, Damotte D, Moindrot H, Molina T, Berger A, Cellier C. A steroid-refractory ulcerative colitis revealing Epstein-Barr virus/cytomegalovirus-positive colonic lymphoma.
Int. J. Colorectal Dis. 21: 288-290 (2006).
*
-
Daniels MA, Teixeiro E, Gill J, Hausmann B, Roubaty D, Holmberg K, Werlen G, Hollander GA, Gascoigne NR, Palmer E. Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling.
Nature 444: 724-729 (2006).
*
-
Daniels N. Clarifying omega-3 fatty acid recommendations.
Can. Fam. Physician. 52: 1061 (2006).
*
-
Dankof A, Morawietz L, Feist E. Labial salivary gland biopsy in Sjogren's syndrome.
Pathologe 27: 416-421 (2006).
-
Dann AT, Kenyon AP, Wierzbicki AS, Seed PT, Shennan AH, Tribe RM. Plasma lipid profiles of women with intrahepatic cholestasis of pregnancy.
Obstet. Gynecol. 107: 106-114 (2006).
-
Danner S, Sordet C, Terzic J, Donato L, Velten M, Fischbach M, Sibilia J. Epidemiology of juvenile idiopathic arthritis in Alsace, France.
J. Rheumatol. 33: 1377-1381 (2006).
-
Danowski A, Magder L, Petri M. Flares in Lupus: Outcome Assessment Trial (FLOAT), a comparison between oral methylprednisolone and intramuscular triamcinolone.
J. Rheumatol. 33: 57-60 (2006).
-
Dao K, Cush JJ. Acute polyarthritis.
Best Pract. Res. Clin. Rheumatol. 20: 653-672 (2006).
-
Daoud W, El Euch D, Mokni M, Cherif F, Ben Tekaya N, Azaiz MI, Ben Osman-Dhahri A. Linear IgA bullous dermatosis associated with celiac disease.
Ann. Dermatol. Venereol. 133: 588-589 (2006).
-
Daram SR. CA 19-9: not a magic marker for pancreatic cancer.
South. Med. J. 99: 205 (2006).
*
-
Darbari A, Kalloo AN, Cuffari C. Diagnostic yield, safety, and efficacy of push enteroscopy in pediatrics.
Gastrointest. Endosc. 64: 224-228 (2006).
-
Darendeliler F, Bas F. Hyperinsulinism in infancy - genetic aspects.
Pediatr. Endocrinol. Rev. 3 Suppl. 3: 521-526 (2006).
-
Darimont C, Avanti O, Zbinden I, Leone-Vautravers P, Mansourian R, Giusti V, Mace K. Liver X receptor preferentially activates de novo lipogenesis in human preadipocytes.
Biochimie 88: 309-318 (2006).
-
Darios F, Davletov B. Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3.
Nature 440: 813-817 (2006).
*
-
Darmawan J, Nasution AR, Chen SL, Haq SA, Zhao D, Zeng Q, Davatchi F. Excellent endpoints from step-down bridge combination therapy of 5 immunosuppressants in NSAID-refractory ankylosing spondylitis: 6 year international study in Asia - WHO-ILAR COPCORD Stage II Treatment of the Autoimmune Diseases.
J. Rheumatol. 33: 2484-2492 (2006).
-
Darnige L. Laboratory diagnosis of antiphospholipid syndrome.
Rev. Med. Interne. 27: 296-301 (2006).
-
Darragh J, Hunter M, Pohler E, Nelson L, Dillon JF, Nenutil R, Vojtesek B, Ross PE, Kernohan N, Hupp TR. The calcium-binding domain of the stress protein SEP53 is required for survival in response to deoxycholic acid-mediated injury.
FEBS J. 273: 1930-1947 (2006).
*
-
Darwish AA, Debauche C, Clapuyt P, Feruzi Z, de Ville de Goyet J, Reding R. Pyloric obstruction, duodenal dilatation, and extrahepatic cholestasis: a neonatal triad suggesting multiple intestinal atresias.
J. Pediatr. Surg. 41: 1771-1773 (2006).
-
Daryani NE, Bashashati M, Aram S, Hashtroudi AA, Shakiba M, Sayyah A, Nayer-Habibi A. Pattern of relapses in Iranian patients with ulcerative colitis. A prospective study.
J. Gastrointestin. Liver Dis. 15: 355-358 (2006).
*
-
Das A, Fernandez-Zapico ME, Cao S, Yao J, Fiorucci S, Hebbel RP, Urrutia R, Shah VH. Disruption of an SP2/KLF6 repression complex by SHP is required for farnesoid X receptor-induced endothelial cell migration.
J. Biol. Chem. 281: 39105-39113 (2006).
*
-
Das BB, Recto M, Johnsrude C, Klein L, Orman K, Shoemaker L, Mitchell M, Austin EH. Cardiac transplantation for pediatric giant cell myocarditis.
J. Heart Lung Transplant. 25: 474-478 (2006).
-
Das D, Graham I, Rose J. Recurrent acute hepatitis in patient receiving pulsed methylprednisolone for multiple sclerosis.
Indian J. Gastroenterol. 25: 314-316 (2006).
*
-
Das G, Das J, Eynott P, Zhang Y, Bothwell AL, Kaer LV, Shi Y. Pivotal roles of CD8+ T cells restricted by MHC class I-like molecules in autoimmune diseases.
J. Exp. Med. 203: 2603-2611 (2006).
*
-
Das K, Sachdeva S, Misra A, Ghoshal UC. Malabsorption syndrome due to various causes is associated with antroduodenal hypomotility.
Indian J. Gastroenterol. 25: 58-61 (2006).
*
-
Das KM. Response: double blind trial in Crohn's disease of autologous colon extracted proteins (Am J Gastroenterol 2006;101:561-8).
Am. J. Gastroenterol. 101: 2889-2890 (2006).
*
-
Das SK, Chakrabarti R. Role of PPAR in cardiovascular diseases.
Recent Patents Cardiovasc. Drug Discov. 1: 193-209 (2006).
-
Das UN. Essential fatty acids: biochemistry, physiology and pathology.
Biotechnol. J. 1: 420-439 (2006).
*
-
Das UN. Biological significance of essential fatty acids.
J. Assoc. Physicians India 54: 309-319 (2006).
-
Das UN. Essential fatty acids - a review.
Curr. Pharm. Biotechnol. 7: 467-482 (2006).
-
Dash S, Marwaha R, Trehan A. Attenuated form of Evans syndrome among pediatric ITP patients.
Indian Pediatr. 43: 340-343 (2006).
*
-
Dashwood RH. Xenobiotic metabolism relevance to cancer.
J. Nutr. 136: 2681S-2682S (2006).
*
-
Dass S, Vital EM, Emery P. Rituximab: novel B-cell depletion therapy for the treatment of rheumatoid arthritis.
Expert Opin. Pharmacother. 7: 2559-2570 (2006).
-
Dastani Z, Engert JC, Genest J, Marcil M. Genetics of high-density lipoproteins.
Curr. Opin. Cardiol. 21: 329-335 (2006).
-
Datta A, Sinha-Datta U, Kaur Dhillon N, Buch S, Nicot C. The HTLV-I p30 Interferes with TLR4 signaling and modulates the release of pro-and anti-inflammatory cytokines from human macrophages.
J. Biol. Chem. 281: 23414-23424 (2006).
*
-
Daub K, Langer H, Seizer P, Stellos K, May AE, Goyal P, Bigalke B, Schonberger T, Geisler T, Siegel-Axel D, Oostendorp RA, Lindemann S, Gawaz M. Platelets induce differentiation of human CD34+ progenitor cells into foam cells and endothelial cells.
FASEB J. 20: 2559-2561 (2006).
*
-
Daubresse JC, Sternon J. Omega-3 fatty acids and cardiovascular diseases.
Rev. Med. Brux. 27: 43-48 (2006).
-
Daum S, Zeitz M. Native sprue.
Schweiz. Rundsch. Med. Prax. 95: 1983-1986 (2006).
-
Dauphinee SM, Karsan A. Lipopolysaccharide signaling in endothelial cells.
Lab. Invest. 86: 9-22 (2006).
*
-
Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ, Greiner TC, Weisenburger DD, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, Grogan TM, Campo E, Jaffe ES, Dave BJ, Sanger W, Bast M, Vose JM, Armitage JO, et al. Molecular diagnosis of Burkitt's lymphoma.
N. Engl. J. Med. 354: 2431-2442 (2006).
*
-
Davern TJ. Indeterminate acute liver failure: a riddle wrapped in a mystery inside an enigma.
Hepatology 44: 765-768 (2006).
*
-
Davey GM, Heath WR, Starr R. SOCS1: a potent and multifaceted regulator of cytokines and cell-mediated inflammation.
Tissue Antigens 67: 1-9 (2006).
*
-
Davey MP, Martin TM, Planck SR, Lee J, Zamora D, Rosenbaum JT. Human endothelial cells express NOD2/CARD15 and increase IL-6 secretion in response to muramyl dipeptide.
Microvasc. Res. 71: 103-107 (2006).
*
-
David AL, Peebles DM, Gregory L, Waddington SN, Themis M, Weisz B, Ruthe A, Lawrence L, Cook T, Rodeck CH, Coutelle C. Clinically applicable procedure for gene delivery to fetal gut by ultrasound-guided gastric injection: toward prenatal prevention of early-onset intestinal diseases.
Hum. Gene Ther. 17: 767-779 (2006).
-
Davidson A. New immune modulatory drugs for systemic lupus erythematosus - what can we expect?
Nat. Clin. Pract. Rheumatol. 2: 638-639 (2006).
*
-
Davidson A, Aranow C. Pathogenesis and treatment of systemic lupus erythematosus nephritis.
Curr. Opin. Rheumatol. 18: 468-475 (2006).
-
Davidson EH. The sea urchin genome: where will it lead us?
Science 314: 939-940 (2006).
*
-
Davidson H, McLachlan G, Wilson A, Boyd AC, Doherty A, Macgregor G, Davies L, Painter HA, Coles R, Hyde SC, Gill DR, Amaral MD, Collie DD, Porteous DJ, Penque D. Human specific cystic fibrosis transmembrane conductance regulator antibodies detect in vivo gene transfer to ovine airways.
Am. J. Respir. Cell. Mol. Biol. 35: 72-83 (2006).
*
-
Davidson J, Rotondo D. Atherosclerosis; cell biology and lipoproteins: lipid metabolism, eicosanoids, peroxisome proliferator activated receptors and the atherogenic process.
Curr. Opin. Lipidol. 17: 489-491 (2006).
-
Davidson MH. Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids.
Am. J. Cardiol. 98: S27-S33 (2006).
-
Davidson MH. Statin/fibrate combination in patients with metabolic syndrome or diabetes: evaluating the risks of pharmacokinetic drug interactions.
Expert Opin. Drug Saf. 5: 145-156 (2006).
-
Davidson MH, Yannicelli HD. New concepts in dyslipidemia in the metabolic syndrome and diabetes.
Metab. Syndr. Relat. Disord. 4: 299-314 (2006).
-
Davies JC. Novel antipseudomonal treatment approaches.
Arch. Pediatr. 13 Suppl. 1: S51-S54 (2006).
-
Davies JC. New tests for cystic fibrosis.
Paediatr. Respir. Rev. 7 Suppl. 1: S141-S143 (2006).
-
Davies SL, Moral MA. Spotlight on: clinical development of mycophenolate mofetil in multiple sclerosis.
Drug News Perspect. 19: 632-633 (2006).
-
Davila JA, El-Serag HB. Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study.
Clin. Gastroenterol. Hepatol. 4: 104-110 (2006).
*
-
Davis GE Jr, Lowell WE. Solar cycles and their relationship to human disease and adaptability.
Med. Hypotheses 67: 447-461 (2006).
-
Davis GL. Thoughts on nutrition and liver disease.
Nutr. Clin. Pract. 21: 243-244 (2006).
*
-
Davis JM, Thomas VM. Systematic approach to evaluating trade-offs among fuel options: the lessons of MTBE.
Ann. N. Y. Acad. Sci. 1076: 498-515 (2006).
*
-
Davis Jr JC, Dougados M, Braun J, Sieper J, van der Heijde D, van der Linden S. The definition of disease duration in ankylosing spondylitis: reassessing the concept.
Ann. Rheum. Dis. 65: 1518-1520 (2006).
*
-
Davis KA, Cowley EA. Two-pore-domain potassium channels support anion secretion from human airway Calu-3 epithelial cells.
Pflugers Arch. 451: 631-641 (2006).
*
-
Davis L, Chen Y, Sen M. WISP-3 functions as a ligand and promotes superoxide dismutase activity.
Biochem. Biophys. Res. Commun. 342: 259-265 (2006).
*
-
Davis LM, Pei Z, Trush MA, Cheskin LJ, Contoreggi C, McCullough K, Watkins PA, Moran TH. Bromocriptine reduces steatosis in obese rodent models.
J. Hepatol. 45: 439-444 (2006).
*
-
Davis MC, Affleck G, Zautra AJ, Tennen H. Daily interpersonal events in pain patients: applying action theory to chronic illness.
J. Clin. Psychol. 62: 1097-1113 (2006).
*
-
Davis MW, Hammarlund M. Single-nucleotide polymorphism mapping.
Methods Mol. Biol. 351: 75-92 (2006).
-
Davis PB. Cystic fibrosis since 1938.
Am. J. Respir. Crit. Care Med. 173: 475-482 (2006).
*
-
Davis TA, Gao L, Yin H, Morrow JD, Porter NA. In vivo and in vitro lipid peroxidation of arachidonate esters: the effect of fish oil omega-3 lipids on product distribution.
J. Am. Chem. Soc. 128: 14897-14904 (2006).
*
-
Dawson HD, Collins G, Pyle R, Key M, Weeraratna A, Deep-Dixit V, Nadal CN, Taub DD. Direct and indirect effects of retinoic acid on human Th2 cytokine and chemokine expression by human T lymphocytes.
BMC Immunol. 7: 27 (2006).
*
-
Dawson PA, Rao A, Craddock AL, Haywood J. Analysis of the molecular mechanisms responsible for intestinal basolateral bile acid transport.
Falk Symposium 155. XIII FALK LIVER WEEK (Part I) XIX International Bile Acid Meeting. Bile Acids: Biological Actions and Clinical Relevance, October 6 - 7, 2006 Freiburg (Germany), p. 43 (2006). *
-
Dawson RJ, Locher KP. Structure of a bacterial multidrug ABC transporter.
Nature 443: 180-185 (2006).
*
-
Day AS, Whitten KE, Lemberg DA, Clarkson C, Vitug-Sales M, Jackson R, Bohane TD. Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach.
J. Gastroenterol. Hepatol. 21: 1609-1614 (2006).
*
-
Day C, Hewins P, Sheikh L, Kilby M, McPake D, Lipkin G. Cholestasis in pregnancy associated with ciclosporin therapy in renal transplant recipients.
Transpl. Int. 19: 1026-1029 (2006).
*
-
Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S, Mackey EW, Miller JD, Leslie AJ, Depierres C, Mncube Z, Duraiswamy J, Zhu B, Eichbaum Q, Altfeld M, Wherry EJ, Coovadia HM, Goulder PJ, Klenerman P, Ahmed R, Freeman GJ, Walker BD. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.
Nature 443: 350-354 (2006).
*
-
Day CP. Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease.
Liver Int. 26: 1021-1028 (2006).
*
-
Day CP. From fat to inflammation.
Gastroenterology 130: 207-210 (2006).
*
-
Dayer JM, Chicheportiche R, Juge-Aubry C, Meier C. Adipose tissue has anti-inflammatory properties: focus on IL-1 receptor antagonist (IL-1Ra).
Ann. N. Y. Acad. Sci. 1069: 444-453 (2006).
*
-
Dayspring T, Pokrywka G. Fibrate therapy in patients with metabolic syndrome and diabetes mellitus.
Curr. Atheroscler. Rep. 8: 356-364 (2006).
-
Dbouk N, McGuire BM. Hepatic encephalopathy: a review of its pathophysiology and treatment.
Curr. Treat. Options Gastroenterol. 9: 464-474 (2006).
*
-
de Almeida SF, de Sousa LB, Vieira LA, Chiamollera MI, Barros JD. Clinic-cytologic study of conjunctivochalasis and its relation to thyroid autoimmune diseases: prospective cohort study.
Cornea 25: 789-793 (2006).
-
De Angelis M, Rizzello CG, Fasano A, Clemente MG, De Simone C, Silano M, De Vincenzi M, Losito I, Gobbetti M. VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for celiac sprue.
Biochim. Biophys. Acta 1762: 80-93 (2006).
*
-
de Bakker PI, McVean G, Sabeti PC, Miretti MM, Green T, Marchini J, Ke X, Monsuur AJ, Whittaker P, Delgado M, Morrison J, Richardson A, Walsh EC, Gao X, Galver L, Hart J, Hafler DA, Pericak-Vance M, Todd JA, Daly MJ, Trowsdale J, Wijmenga C, et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC.
Nat. Genet. 38: 1166-1172 (2006).
*
-
De Bandt M. Lessons for lupus from tumour necrosis factor blockade.
Lupus 15: 762-767 (2006).
-
De Bem RS, Da Ro Sa Utiyama SR, Nisihara RM, Fortunato JA, Tondo JA, Carmes ER, Souza RA, Pisani JC, Amarante HM. Celiac disease prevalence in Brazilian dilated cardiomyopathy patients.
Dig. Dis. Sci. 51: 1016-1019 (2006).
*
-
De Biasio MB, Periolo N, Avagnina A, Garcia de Davila MT, Ciocca M, Goni JH, De Matteo E, Galoppo C, Canero-Velasco MC, Fainboim H, Munoz AE, Fainboim L, Chernavsky AC. Liver-infiltrating mononuclear cells in children with type 1 autoimmune hepatitis.
J. Clin. Pathol. 59: 417-423 (2006).
*
-
de Bie P, van de Sluis B, Burstein E, Duran KJ, Berger R, Duckett CS, Wijmenga C, Klomp LW. Characterization of COMMD protein-protein interactions in NF-kappaB signalling.
Biochem. J. 398: 63-71 (2006).
*
-
De Boeck K, Wilschanski M, Castellani C, Taylor CJ, Cuppens H, Dodge JA, Sinaasappel M. Cystic fibrosis: terminology and diagnostic algorithms.
Thorax 61: 627-635 (2006).
*
-
de Boer NK, Jarbandhan SV, de Graaf P, Mulder CJ, van Elburg RM, van Bodegraven AA. Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites.
Am. J. Gastroenterol. 101: 1390-1392 (2006).
*
-
De Boer NK, Mulder CJ, Van Bodegraven AA. Impracticalities of thiopurine S-methyltransferase determination in daily inflammatory bowel disease practice.
Aliment. Pharmacol. Ther. 23: 1278-1279 (2006).
*
-
de Boer NK, Reinisch W, Teml A, van Bodegraven AA, Schwab M, Lukas M, Ochsenkuhn T, Petritsch W, Knoflach P, Almer S, van der Merwe SW, Herrlinger KR, Seiderer J, Vogelsang H, Mulder CJ. 6-Thioguanine treatment in inflammatory bowel disease: a critical appraisal by a European 6-TG working party.
Digestion 73: 25-31 (2006).
*
-
De Bona M, Bellumat A, Cian E, Valiante F, Moschini A, De Boni M. Capsule endoscopy findings in patients with suspected Crohn's disease and biochemical markers of inflammation.
Dig. Liver Dis. 38: 331-335 (2006).
-
De Bosscher K, Vanden Berghe W, Haegeman G. Cross-talk between nuclear receptors and nuclear factor kappaB.
Oncogene 25: 6868-6886 (2006).
*
-
De Bruin JH, Ligtenberg MJ, Nagengast FM, Adang EM, Van Krieken JH, Hoogerbrugge N. Optimizing the detection of hereditary non-polyposis colorectal cancer: an update.
Scand. J. Gastroenterol. Suppl. 243: 146-152 (2006).
*
-
De Bruyne R, Portmann B, Samyn M, Bansal S, Knisely A, Mieli-Vergani G, Dhawan A. Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia.
J. Hepatol. 44: 407-410 (2006).
*
-
de Buhr MF, Mahler M, Geffers R, Hansen W, Westendorf AM, Lauber J, Buer J, Schlegelberger B, Hedrich HJ, Bleich A. Cd14, Gbp1, and Pla2g2a: three major candidate genes for experimental IBD identified by combining QTL and microarray analyses.
Physiol. Genomics 25: 426-434 (2006).
*
-
de Cerqueira Lima P, Golbraikh A, Oloff S, Xiao Y, Tropsha A. Combinatorial QSAR modeling of P-glycoprotein substrates.
J. Chem. Inf. Model. 46: 1245-1254 (2006).
-
De Diego C, Alcantara M, Valle J, Repiso A, Carrobles JM, Martinez-Castro P. Influence of smoking habits and CARD15 mutations on the onset of Crohn’s disease.
Scand. J. Gastroenterol. 41: 1209-1211 (2006).
*
-
De Domenico I, McVey Ward D, Nemeth E, Ganz T, Corradini E, Ferrara F, Musci G, Pietrangelo A, Kaplan J. Molecular and clinical correlates in iron overload associated with mutations in ferroportin.
Haematologica 91: 1092-1095 (2006).
*
-
De Felice C, Mazzotta A, Esposito M, Bianchi L, Chimenti S. High-dose initiation of etanercept in psoriatic arthritis and plaque psoriasis: efficacy, safety and impact on patients' quality of life.
J. Dermatolog. Treat. 17: 355-358 (2006).
-
De Filippis L, Caliri A, Anghelone S, Scibilia G, Lo Gullo R, Bagnato G. Improving outcomes in tumour necrosis factor a treatment: comparison of the efficacy of the tumour necrosis factor a blocking agents etanercept and infliximab in patients with active rheumatoid arthritis.
Panminerva Med. 48: 129-135 (2006).
-
de Franchis R. Noninvasive diagnosis of esophageal varices: is it feasible?
Am. J. Gastroenterol. 101: 2520-2522 (2006).
*
-
de Franchis R. Endoscopy critics vs. endoscopy enthusiasts for primary prophylaxis of variceal bleeding.
Hepatology 43: 24-26 (2006).
*
-
De Gobbi M, Viprakasit V, Hughes JR, Fisher C, Buckle VJ, Ayyub H, Gibbons RJ, Vernimmen D, Yoshinaga Y, de Jong P, Cheng JF, Rubin EM, Wood WG, Bowden D, Higgs DR. A regulatory SNP causes a human genetic disease by creating a new transcriptional promoter.
Science 312: 1215-1217 (2006).
*
-
De Gottardi A, Pazienza V, Pugnale P, Bruttin F, Rubbia-Brandt L, Juge-Aubry CE, Meier CA, Hadengue A, Negro F. Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection.
Aliment. Pharmacol.Ther. 23: 107-114 (2006).
*
-
de Graaf R, Kloppenburg G, Kitslaar PJ, Bruggeman CA, Stassen F. Human heat shock protein 60 stimulates vascular smooth muscle cell proliferation through Toll-like receptors 2 and 4.
Microbes Infect. 8: 1859-1865 (2006).
*
-
De Groot AS, Goldberg M, Moise L, Martin W. Evolutionary deimmunization: an ancillary mechanism for self-tolerance?
Cell. Immunol. 244: 148-153 (2006).
*
-
de Groot M, Appelman M, Spuls PI, de Rie MA, Bos JD. Initial experience with routine administration of etanercept in psoriasis.
Br. J. Dermatol. 155: 808-814 (2006).
*
-
De Hertogh G, Aerssens J, de Hoogt R, Peeters P, Verhasselt P, Van Eyken P, Ectors N, Vermeire S, Rutgeerts P, Coulie B, Geboes K. Validation of 16S rDNA sequencing in microdissected bowel biopsies from Crohn's disease patients to assess bacterial flora diversity.
J. Pathol. 209: 532-539 (2006).
*
-
De Jager PL, Graham R, Farwell L, Sawcer S, Richardson A, Behrens TW, Compston A, Hafler DA, Kere J, Vyse TJ, Rioux JD. The role of inflammatory bowel disease susceptibility loci in multiple sclerosis and systemic lupus erythematosus.
Genes Immun. 7: 327-334 (2006).
*
-
De Jager PL, Richardson A, Vyse TJ, Rioux JD. Genetic variation in Toll-like receptor 9 and susceptibility to systemic lupus erythematosus.
Arthritis Rheum. 54: 1279-1282 (2006).
*
-
De Jager PL, Sawcer S, Waliszewska A, Farwell L, Wild G, Cohen A, Langelier D, Bitton A, Compston A, Hafler DA, Rioux JD. Evaluating the role of the 620W allele of protein tyrosine phosphatase PTPN22 in Crohn's disease and multiple sclerosis.
Eur. J. Hum. Genet. 14: 317-321 (2006).
*
-
de Jong NS, Leach ST, Day AS. Fecal S100A12: a novel noninvasive marker in children with Crohn's disease.
Inflamm. Bowel Dis. 12: 566-572 (2006).
*
-
de Kleer I, Vastert B, Klein M, Teklenburg G, Arkesteijn G, Puga Yung G, Albani S, Kuis W, Wulffraat N, Prakken B. Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T-cells and restoring the CD4+CD25+ immune regulatory network.
Blood 107: 1696-1702 (2006).
*
-
de la Barrera S, Aleman M, Sasiain Mdel C. Toll-like receptors in human infectious diseases.
Curr. Pharm. Des. 12: 4173-4184 (2006).
-
de la Fontaine L, Schwarz M, Plischke H, Kleindienst N, Gruber R. Lack of association of the CD14/C-159T polymorphism with susceptibility and serological activity parameters of rheumatoid arthritis.
Scand. J. Rheumatol. 35: 20-22 (2006).
*
-
de la Fontaine L, Schwarz MJ, Riedel M, Dehning S, Douhet A, Spellmann I, Kleindienst N, Zill P, Plischke H, Gruber R, Muller N. Investigating disease susceptibility and the negative correlation of schizophrenia and rheumatoid arthritis focusing on MIF and CD14 gene polymorphisms.
Psychiatry Res. 144: 39-47 (2006).
-
de la Monte SM, Tong M, Lester-Coll N, Plater M Jr, Wands JR. Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease.
J. Alzheimers Dis. 10: 89-109 (2006).
-
De La Rue SA, Bickston SJ. Evidence-based medications for the treatment of the inflammatory bowel diseases.
Curr. Opin. Gastroenterol. 22: 365-369 (2006).
-
de Laat B, Derksen RH, Mackie IJ, Roest M, Schoormans S, Woodhams BJ, de Groot PG, van Heerde WL. Annexin A5 polymorphism (-1C>T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome.
Ann. Rheum. Dis. 65: 1468-1472 (2006).
*
-
de Lange P, Farina P, Moreno M, Ragni M, Lombardi A, Silvestri E, Burrone L, Lanni A, Goglia F. Sequential changes in the signal transduction responses of skeletal muscle following food deprivation.
FASEB J. 20: 2579-2581 (2006).
*
-
de Lange T, Svensen AM, Larsen S, Aabakken L. The functionality and reliability of an Internet interface for assessments of endoscopic still images and video clips: distributed research in gastroenterology.
Gastrointest. Endosc. 63: 445-452 (2006).
-
de Ledinghen V, Ratziu V, Causse X, Le Bail B, Capron D, Renou C, Pilette C, Oules V, Gelsi E, Oberti F, Vallet-Pichard A, Le Provost N, Cadranel JF; Association Francaise pour l'Etude du Foie Groupe Epidemiologie et Evaluation. Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study.
J. Hepatol. 45: 592-599 (2006).
*
-
De Libero G, Mori L. How T lymphocytes recognize lipid antigens.
FEBS Lett. 580: 5580-5587 (2006).
*
-
De Lisle RC, Roach EA, Norkina O. Eradication of small intestinal bacterial overgrowth in the cystic fibrosis mouse reduces mucus accumulation.
J. Pediatr. Gastroenterol. Nutr. 42: 46-52 (2006).
*
-
de Lorgeril M, Salen P. The Mediterranean-style diet for the prevention of cardiovascular diseases.
Public Health Nutr. 9: 118-123 (2006).
-
de Lorgeril M, Salen P. The Mediterranean diet in secondary prevention of coronary heart disease.
Clin. Invest. Med. 29: 154-158 (2006).
-
De Luis D, Aller R, Culebras J. Recommendations in artificial nutritional support in critically ill patients.
Med. Clin. (Barc.) 127: 232-236 (2006).
-
De Luis D, Aller R, Zarzuelo S. Dietary salt in the era of anthypertensive drugs.
Med. Clin. (Barc.) 127: 673-675 (2006).
-
de Luis D, Ballesteros M, Cano I, Fernandez M, Izaola O, de la Lama G, Lopez Guzman A, Maldonado A, Martin MA, Munoz C, Ruiz E. Current status of clinical nutrition at the network of public hospitals from Castilla y Leon.
Nutr. Hosp. 21: 357-361 (2006).
-
de Luis DA, Aller R, Izaola O, Terroba MC, Cabezas G, Cuellar LA. Experience of 6 years with home enteral nutrition in an area of Spain.
Eur. J. Clin. Nutr. 60: 553-557 (2006).
*
-
de Lyra EC, da Silva IA, Katayama ML, Brentani MM, Nonogaki S, Goes JC, Folgueira MA. 25(OH)D(3) and 1,25(OH)(2)D(3) serum concentration and breast tissue expression of 1alpha-hydroxylase, 24-hydroxylase and Vitamin D receptor in women with and without breast cancer.
J. Steroid Biochem. Mol. Biol. 100: 184-192 (2006).
-
De Marco G, Barabino A, Gambarara M, Diamanti A, Martelossi S, Guarino A. Network approach to the child with primary intestinal failure.
J. Pediatr. Gastroenterol. Nutr. 43 Suppl. 1: S61-S67 (2006).
*
-
De Marco G, Sordino D, Bruzzese E, DI Caro S, Mambretti D, Tramontano A, Colombo C, Simoni P, Guarino A. Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure.
Aliment. Pharmacol. Ther. 24: 387-394 (2006).
*
-
De Minicis S, Bataller R, Brenner DA. NADPH oxidase in the liver: defensive, offensive, or fibrogenic?
Gastroenterology 131: 272-275 (2006).
*
-
de Moura CG, de Moura TG, de Souza SP, Testagrossa L. Inflammatory bowel disease, ankylosing spondylitis, and IgA nephropathy.
J. Clin. Rheumatol. 12: 106-107 (2006).
-
de Noo ME, Tollenaar RA, Deelder AM, Bouwman LH. Current status and prospects of clinical proteomics studies on detection of colorectal cancer: hopes and fears.
World J. Gastroenterol. 12: 6594-6601 (2006).
*
-
de Oca EP, Rangel-Villalobos H, Gallegos-Arreola MP, Sandoval L, Figuera LE. SNPs in human beta-defensin 1 gene (DEFB1): frequencies in a Mexican population and new PCR-RFLPs assays.
Int. J. Immunogenet. 33: 339-342 (2006).
*
-
de Oliveira CP, Stefano JT, de Lima VM, de Sa SV, Simplicio FI, de Mello ES, Correa-Giannella ML, Alves VA, Laurindo FR, de Oliveira MG, Giannella-Neto D, Carrilho FJ. Hepatic gene expression profile associated with non-alcoholic steatohepatitis protection by S-nitroso-N-acetylcysteine in ob/ob mice.
J. Hepatol. 45: 725-733 (2006).
*
-
De Palma R, Del Galdo F, Lupoli S, Altucci P, Abbate G, Valentini G. Peripheral T lymphocytes from patients with early systemic sclerosis co-cultured with autologous fibroblasts undergo an oligoclonal expansion similar to that occurring in the skin.
Clin. Exp. Immunol. 144: 169-176 (2006).
*
-
De Pascale A, Garofalo G, Perna M, Priola S, Fava C. Contrast-enhanced ultrasonography in Crohn's disease.
Radiol. Med. (Torino) 111: 539-550 (2006).
*
-
De Pascale MC, Bassi AM, Patrone V, Villacorta L, Azzi A, Zingg JM. Increased expression of transglutaminase-1 and PPARgamma after vitamin E treatment in human keratinocytes.
Arch. Biochem. Biophys. 447: 97-106 (2006).
*
-
De Pascalis B, Bianchi A, Satta MA, Lupascu A, Mentella MC, Leo D, Fiore F, Fedeli P, Pontecorvi A, Pola P, Melina D, Gasbarrini A, De Marinis L, Armuzzi A. Growth hormone in inflammatory bowel disease.
Eur. Rev. Med. Pharmacol. Sci. 10: 13-16 (2006).
-
De Paula JA. Celiac disease and refractory sprue: we had advanced but we are still far from the objective.
Acta Gastroenterol. Latinoam. 36: 63-65 (2006).
-
de Paula Sabino A, Ribeiro DD, Carvalho MD, Cardoso J, Dusse LM, Fernandes AP. Factor V Leiden and increased risk for arterial thrombotic disease in young Brazilian patients.
Blood Coagul. Fibrinolysis 17: 271-275 (2006).
-
de Prost Y. New topical immunological treatments for psoriasis.
J. Eur. Acad. Dermatol. Venereol. 20 Suppl. 2: 80-82 (2006).
-
de Ridder L, Benninga MA, Taminiau JA, Hommes DW. Infliximab as first-line therapy in severe pediatric Crohn disease.
J. Pediatr. Gastroenterol. Nutr. 43: 388-390 (2006).
*
-
de Ridder L, Van Dieren JM, Van Deventer HJ, Stokkers PC, Van der Woude JC, Van Vuuren AJ, Benninga MA, Escher JC, Hommes DW. Pharmacogenetics of thiopurine therapy in paediatric IBD patients.
Aliment. Pharmacol. Ther. 23: 1137-1141 (2006).
*
-
de Rooij SR, Painter RC, Phillips DI, Osmond C, Tanck MW, Defesche JC, Bossuyt PM, Michels RP, Bleker OP, Roseboom TJ. The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on glucose/insulin metabolism interact with prenatal exposure to famine.
Diabetes Care 29: 1052-1057 (2006).
*
-
De Rosa CT, Hicks HE, Ashizawa AE, Pohl HR, Mumtaz MM. A regional approach to assess the impact of living in a chemical world.
Ann. N. Y. Acad. Sci. 1076: 829-838 (2006).
*
-
De Rosa V, Procaccini C, La Cava A, Chieffi P, Nicoletti GF, Fontana S, Zappacosta S, Matarese G. Leptin neutralization interferes with pathogenic T cell autoreactivity in autoimmune encephalomyelitis.
J. Clin. Invest. 11: 447-455 (2006).
*
-
De Rycke L, Kruithof E, Vandooren B, Tak PP, Baeten D. Pathogenesis of spondyloarthritis: insights from synovial membrane studies.
Curr. Rheumatol. Rep. 8: 275-282 (2006).
-
De Sa J, Paulos A, Mendes H, Becho J, Marques J, Roxo J. The prevalence of multiple sclerosis in the District of Santarem, Portugal.
J. Neurol. 253: 914-918 (2006).
*
-
de Santibanes E, Palavecino M, Ardiles V, Pekolj J. Bile duct injuries: management of late complications.
Surg. Endosc. 20: 1648-1653 (2006).
-
De Santis W, Esposito A, Conti V, Fantauzzi A, Guerra A, Mezzaroma I, Aiuti F. Health care and infective aspects in patients affected by common variable immunodeficiency assisted in the Lazio Regional Authority Reference Centre for Primary Immunodeficiencies.
Infez. Med. 14: 13-23 (2006).
-
De Schepper S, Boucneau J, Vander Haeghen Y, Messiaen L, Naeyaert JM, Lambert J. Cafe-au-lait spots in neurofibromatosis type 1 and in healthy control individuals: hyperpigmentation of a different kind?
Arch. Dermatol. Res. 297: 439-449 (2006).
*
-
de Silva A, Rampton DS. Treatment of anaemia in inflammatory bowel disease: authors' reply.
Aliment. Pharmacol. Ther. 23: 1274-1275 (2006).
-
De Silva MG, Hildebrand MS, Christopoulos H, Newman MR, Bell K, Ritchie M, Smyth GK, Dahl HH. Gene expression changes during step-wise differentiation of embryonic stem cells along the inner ear hair cell pathway.
Acta Otolaryngol. 126: 1148-1157 (2006).
*
-
De Silva S, Neuberger J. HLA and autoimmune hepatitis.
Liver Int. 26: 509-511 (2006).
*
-
De Simone M, Cioffi U, Quatrini M, Lemos A, Ciulla M, Botti F, Carrara A, Marconato R, Contessini Avesani E. Crohn's disease and Takayasu's arteritis: is this association difficult to find out?
Minerva Gastroenterol. Dietol. 52: 441-443 (2006).
-
De Sousa EA, Hays AP, Chin RL, Sander HW, Brannagan TH 3rd. Characteristics of patients with sensory neuropathy diagnosed with abnormal small nerve fibres on skin biopsy.
J. Neurol. Neurosurg. Psychiatry 77: 983-985 (2006).
-
De Souza AT, Cornwell PD, Dai X, Caguyong MJ, Ulrich RG. Agonists of the peroxisome proliferator activated receptor alpha induce a fiber-type selective transcriptional response in rat skeletal muscle.
Toxicol. Sci. 92: 578-586 (2006).
*
-
De Souza AT, Dai X, Spencer AG, Reppen T, Menzie A, Roesch PL, He Y, Caguyong MJ, Bloomer S, Herweijer H, Wolff JA, Hagstrom JE, Lewis DL, Linsley PS, Ulrich RG. Transcriptional and phenotypic comparisons of Ppara knockout and siRNA knockdown mice.
Nucleic Acids Res. 34: 4486-4494 (2006).
*
-
de Souza PM, Newson J, Gilroy DW. Targeting lipoxygenases with care.
Chem. Biol. 13: 1121-1122 (2006).
*
-
De Stefano D, Maiuri MC, Iovine B, Ialenti A, Bevilacqua MA, Carnuccio R. The role of NF-kappaB, IRF-1, and STAT-1alpha transcription factors in the iNOS gene induction by gliadin and IFN-gamma in RAW 264.7 macrophages.
J. Mol. Med. 84: 65-74 (2006).
*
-
de Villiers JN, Treurnicht FK, Warnich L, Carr J, van Rensburg SJ, Kotze MJ. Analysis of viral and genetic factors in South African patients with multiple sclerosis.
Metab. Brain Dis. 21: 163-169 (2006).
*
-
De Vita S, Quartuccio L. Treatment of rheumatoid arthritis with rituximab: an update and possible indications.
Autoimmun. Rev. 5: 443-448 (2006).
-
de Vlam K, Lories RJ. Efficacy, effectiveness and safety of etanercept in monotherapy for refractory psoriatic arthritis: a 26-week observational study.
Rheumatology (Oxford) 45: 321-324 (2006).
*
-
de Vries RR, Huizinga TW, Toes RE. HLA and RA revisited: citrullinated food for the SE hypothesis, the DR6 effect, and NIMA.
Hum. Immunol. 67: 454-459 (2006).
-
de Vries TW, Ajubi N, Slomp J, Storm H. Analyzing DNA from buccal cells is a reliable method for the exclusion of cystic fibrosis. Results of a pilot study.
Genet. Med. 8: 175-177 (2006).
-
de Vries-Bouwstra J, Le Cessie S, Allaart C, Breedveld F, Huizinga T. Using predicted disease outcome to provide differentiated treatment of early rheumatoid arthritis.
J. Rheumatol. 33: 1747-1753 (2006).
-
de Waart DR, Paulusma CC, Kunne C, Oude Elferink RP. Multidrug resistance associated protein 2 mediates transport of prostaglandin E.
Liver Int. 26: 362-368 (2006).
*
-
De Wall SL, Painter C, Stone JD, Bandaranayake R, Wiley DC, Mitchison TJ, Stern LJ, Dedecker BS. Noble metals strip peptides from class II MHC proteins.
Nat. Chem. Biol. 2: 197-201 (2006).
*
-
De-Leon-Bojorge B, Zaltzman-Girsevich S, Ortega-Salgado A, Prieto-Patron A, Cordoba-Cordoba R, Yamazaki-Nakashimada M. Thrombotic microangiopathy involving the gallbladder as an unusual manifestation of systemic lupus erythematosus and antiphospholipid syndrome: case report and review of the literature.
World J. Gastroenterol. 12: 7206-7209 (2006).
*
-
Deakin JE, Papenfuss AT, Belov K, Cross JG, Coggill P, Palmer S, Sims S, Speed TP, Beck S, Marshall Graves JA. Evolution and comparative analysis of the MHC class III inflammatory region.
BMC Genomics 7: 281 (2006).
*
-
Deane JA, Bolland S. Nucleic acid-sensing TLRs as modifiers of autoimmunity.
J. Immunol. 177: 6573-6578 (2006).
*
-
DeAngelis MM. Retinitis pigmentosa and common variable immunodeficiency disease: associated or separate?
South. Med. J. 99: 914 (2006).
-
Deary IJ, Spinath FM, Bates TC. Genetics of intelligence.
Eur. J. Hum. Genet. 14: 690-700 (2006).
*
-
Debard C, Cozzone D, Ricard N, Vouillarmet J, Disse E, Husson B, Laville M, Vidal H. Short-term activation of peroxisome proliferator-activated receptor beta/delta increases fatty acid oxidation but does not restore insulin action in muscle cells from type 2 diabetic patients.
J. Mol. Med. 84: 747-752 (2006).
*
-
Debruin LS, Haines JD, Bienzle D, Harauz G. Partitioning of myelin basic protein into membrane microdomains in a spontaneously demyelinating mouse model for multiple sclerosis.
Biochem. Cell. Biol. 84: 993-1005 (2006).
-
Debruyne PR, Witek M, Gong L, Birbe R, Chervoneva I, Jin T, Domon-Cell C, Palazzo JP, Freund JN, Li P, Pitari GM, Schulz S, Waldman SA. Bile acids induce ectopic expression of intestinal guanylyl cyclase C through NF-KB and Cdx2 in human esophageal cells.
Gastroenterology 130: 1191-1206 (2006).
*
-
Deckelbaum RJ, Worgall TS, Seo T. n-3 Fatty acids and gene expression.
Am. J. Clin. Nutr. 83: 1520S-1525S (2006).
*
-
Decker P, Kotter I, Klein R, Berner B, Rammensee HG. Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus.
Rheumatology (Oxford) 45: 1087-1095 (2006).
*
-
Decker WK, Xing D, Shpall EJ. Dendritic cell immunotherapy for the treatment of neoplastic disease.
Biol. Blood Marrow Transplant. 12: 113-125 (2006).
-
Decobert M, Larue H, Bergeron A, Harel F, Pfister C, Rousseau F, Lacombe L, Fradet Y. Polymorphisms of the human NRAMP1 gene are associated with response to Bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.
J. Urol. 175: 1506-1511 (2006).
-
Decochez K, Rippley RK, Miller JL, De Smet M, Yan KX, Matthijs Z, Riffel KA, Song H, Zhu H, Maynor HO, Tanaka W, Johnson-Levonas AO, Davies MJ, Gottesdiener KM, Keymeulen B, Wagner JA. A dual PPAR alpha/gamma agonist increases adiponectin and improves plasma lipid profiles in healthy subjects.
Drugs R. D. 7: 99-110 (2006).
-
Deconinck N, Scaillon M, Segers V, Groswasser JJ, Dan B. Opsoclonus-myoclonus associated with celiac disease.
Pediatr. Neurol. 34: 312-314 (2006).
-
Decorti G, De Iudicibus S, Stocco G, Martelossi S, Drigo I, Bartoli F, Ventura A. Glucocorticoid receptor polymorphisms in inflammatory bowel disease.
Gut 55: 1053-1054 (2006).
*
-
Decramer M, Gosselink R. Physical activity in patients with cystic fibrosis: a new variable in the health-status equation unravelled?
Eur. Respir. J. 28: 678-679 (2006).
*
-
Decuzzi M, Tatulli F, Giampaolo M, Tesse R, Gasparre M, Pepe G, Decuzzi P, Asteriadis I. Sialocintigraphy versus ultrasonography of the salivary glands in patients first diagnosed with Sjogren's syndrome.
Hell. J. Nucl. Med. 9: 103-105 (2006).
-
Dederichs F, Pinciu F, Gerhard H, Eveld K, Stallmach A. Listeria meningitis in a patient with Crohn's disease - a seldom, but clinically relevant adverse event of therapy with infliximab.
Z. Gastroenterol. 44: 657-660 (2006).
-
Dedoussis GV, Maumus S, Choumerianou DM, Skoumas J, Pitsavos C, Stefanadis C, Visvikis-Siest S. Different genes and polymorphisms affecting high-density lipoprotein cholesterol levels in Greek familial hypercholesterolemia patients.
Genet. Test. 10: 192-199 (2006).
-
Dedoussis GV, Maumus S, Skoumas J, Choumerianou DM, Pitsavos C, Stefanadis C, Visvikis-Siest S. Natriuretic peptide Val7Met substitution and risk of coronary artery disease in Greek patients with familial hypercholesterolemia.
J. Clin. Lab. Anal. 20: 98-104 (2006).
-
Deedwania PC, Gupta R. Management issues in the metabolic syndrome.
J. Assoc. Physicians India 54: 797-810 (2006).
-
Deeg CA, Pompetzki D, Raith AJ, Hauck SM, Amann B, Suppmann S, Goebel TW, Olazabal U, Gerhards H, Reese S, Stangassinger M, Kaspers B, Ueffing M. Identification and functional validation of novel autoantigens in equine uveitis.
Mol. Cell. Proteomics 5: 1462-1470 (2006).
*
-
Deeks ED, Lyseng-Williamson KA. Oral paricalcitol.
Treat. Endocrinol. 5: 319-325 (2006).
-
Deeley RG, Cole SP. Substrate recognition and transport by multidrug resistance protein 1 (ABCC1).
FEBS Lett. 580: 1103-1111 (2006).
*
-
Deeley RG, Westlake C, Cole SP. Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins.
Physiol. Rev. 86: 849-899 (2006).
*
-
Deepak N A, Patel ND. Differential diagnosis of acute liver failure in India.
Ann. Hepatol. 5: 150-156 (2006).
*
-
Deering RP, Orange JS. Development of a clinical assay to evaluate Toll-like receptor function.
Clin. Vaccine Immunol. 13: 68-76 (2006).
*
-
Deetz CO, Hebbeler AM, Propp NA, Cairo C, Tikhonov I, Pauza CD. Gamma interferon secretion by human Vgamma2Vdelta2 T cells after stimulation with antibody against the T-cell receptor plus the Toll-like receptor 2 agonist Pam3Cys.
Infect. Immun. 74: 4505-4511 (2006).
*
-
Defilippis AP, Sperling LS. Understanding omega-3's.
Am. Heart J. 151: 564-570 (2006).
*
-
Degenhardt T, Matilainen M, Herzig KH, Dunlop TW, Carlberg C. The insulin-like growth factor binding protein 1 gene is a primary target of peroxisome proliferator-activated receptors.
J. Biol. Chem. 281: 39607-39619 (2006).
*
-
Deger C, Erbil Y, Giris M, Yanik BT, Tunca F, Olgac V, Abbasoglu SD, Oztezcan S, Toker G. The effect of glutamine on pancreatic damage in TNBS-induced colitis.
Dig. Dis. Sci. 51: 1841-1846 (2006).
*
-
Deguchi T, Isozaki K, Yousuke K, Terasaki T, Otagiri M. Involvement of organic anion transporters in the efflux of uremic toxins across the blood-brain barrier.
J. Neurochem. 96: 1051-1059 (2006).
-
Deguchi Y, Yoshimatsu K, Endo S. Natural killer-like T cell lymphoma of the small intestine: report of a case.
Surg. Today 36: 474-477 (2006).
*
-
Dehghani SM, Haghighat M, Imanieh MH, Geramizadeh B. Comparison of different diagnostic methods in infants with cholestasis.
World J. Gastroenterol. 12: 5893-5896 (2006).
*
-
Deighton C, Criswell LA. Recent advances in the genetics of rheumatoid arthritis.
Curr. Rheumatol. Rep. 8: 394-400 (2006).
-
Deighton CM, George E, Kiely PD, Ledingham J, Luqmani RA, Scott DG. Updating the British Society for Rheumatology guidelines for anti-tumour necrosis factor therapy in adult rheumatoid arthritis (again).
Rheumatology (Oxford) 45: 649-652 (2006).
*
-
Dejaco C, Duftner C, Grubeck-Loebenstein B, Schirmer M. Imbalance of regulatory T cells in human autoimmune diseases.
Immunology 117: 289-300 (2006).
*
-
Dejaco C, Duftner C, Schirmer M. Induction of tolerance in autoimmune diseases rather than cure of cancer by interleukin-2 therapy.
J. Clin. Oncol. 24: e34 (2006).
*
-
Dejaco C, Haas T, Kirchgatterer A, Miehsler W, Wenzl H, Knoflach P, Petritsch W, Vogelsang H, Reinisch W, Tilg H. Aminosalicylates and steroids in the treatment ot chronic inflammatory bowel diseases - consensus paper of the Working Group for Chronic Inflammatory Bowel Diseases of the OGGH.
Z. Gastroenterol. 44: 525-538 (2006).
-
Dejaco C, Klotz W, Larcher H, Duftner C, Schirmer M, Herold M. Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis.
Arthritis Res. Ther. 8: R119 (2006).
*
-
Dejardin E. The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development.
Biochem. Pharmacol. 72: 1161-1179 (2006).
*
-
Dejica DI, Manea EM. Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therapeutic perspectives.
Roum. Arch. Microbiol. Immunol. 65: 66-74 (2006).
-
Dejima K, Randell SH, Stutts MJ, Senior BA, Boucher RC. Potential role of abnormal ion transport in the pathogenesis of chronic sinusitis.
Arch. Otolaryngol. Head Neck Surg. 132: 1352-1362 (2006).
-
Del Galdo F, Artlett CM. T cells and B cells in the pathogenesis of systemic sclerosis: recent insights and therapeutic opportunities.
Curr. Rheumatol. Rep. 8: 123-130 (2006).
-
del Pino M, Cervio G, Dip M, Giannivelli S, Buamscha D, Ciocca M, de Davila MTG, Imventarza O, Lejarraga H. Mortality risk score in liver transplantation: changes over time in its predicting power.
Pediatr. Transpl. 10: 466-473 (2006).
*
-
Del Poggio P, Mazzoleni M. Screening in liver disease.
World J. Gastroenterol. 12: 5272-5280 (2006).
*
-
Del Rey A, Roggero E, Kabiersch A, Schafer M, Besedovsky HO. The role of noradrenergic nerves in the development of the lymphoproliferative disease in Fas-deficient, lpr/lpr mice.
J. Immunol. 176: 7079-7086 (2006).
*
-
Del Rosso Do JQ. Combination topical therapy for the treatment of psoriasis.
J. Drugs Dermatol. 5: 232-234 (2006).
-
Del Rosso JQ. Combination topical therapy in the treatment of acne.
Cutis 78: S5-S12 (2006).
-
Del Val Del Amo N, Ibanez Bosch R, Fito Manteca C, Gutierrez Polo R, Loza Cortina E. Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness.
Clin. Exp. Rheumatol. 24: 281-286 (2006).
-
Delarue J, Chang-Hong L, Richard C, Charlotte C, Brigitte S. Interaction of fish oil and a glucocorticoid on metabolic responses to an oral glucose load in healthy human subjects.
Br. J. Nutr. 95: 267-272 (2006).
*
-
Delaunoit T, Limburg PJ, Goldberg RM, Lymp JF, Loftus EV Jr. Colorectal cancer prognosis among patients with inflammatory bowel disease.
Clin. Gastroenterol. Hepatol. 4: 335-342 (2006).
-
Delco F, Mu Llhaupt B. Should we screen for colorectal cancer in liver transplantation?
J. Hepatol. 44: 32-38 (2006).
*
-
Delgado JC, Baena A, Thim S, Goldfeld AE. Aspartic acid homozygosity at codon 57 of HLA-DQ beta is associated with susceptibility to pulmonary tuberculosis in Cambodia.
J. Immunol. 176: 1090-1097 (2006).
*
-
Delgado M, Gonzalez-Rey E, Ganea D. Vasoactive intestinal peptide: the dendritic cell --> regulatory T cell axis.
Ann. N. Y. Acad. Sci. 1070: 233-238 (2006).
*
-
Delgado MA, Poschet JF, Deretic V. Nonclassical pathway of Pseudomonas aeruginosa DNA-induced interleukin-8 secretion in cystic fibrosis airway epithelial cells.
Infect. Immun. 74: 2975-2984 (2006).
*
-
Delgado Plasencia L, Arteaga Gonzalez I, Lopez-Tomassetti Fernandez EM, Martin Malagon A, Diaz Luis H, Carrillo Pallares A. Restorative proctocolectomy with an ileoanal pouch: the role of laparoscopy.
Rev. Esp. Enferm. Dig. 98: 420-428 (2006).
-
Delgado S, Sheremata WA. The role of CD4+ T-cells in the development of MS.
Neurol. Res. 28: 245-249 (2006).
-
Delgado-Vega AM, Martin J, Granados J, Anaya JM. Genetic epidemiology of rheumatoid arthritis: what to expect from Latin America?
Biomedica 26: 562-584 (2006).
-
Delia M, Liso V, Capalbo S, Napoli A, Ricco R, Semenzato G, Liso A. Common variable immunodeficiency patient with large granular lymphocytosis developing extranodal diffuse large B-cell lymphoma: a case report.
Haematologica 91: ECR61 (2006).
*
-
Deligezer U, Akisik EE, Yaman F, Erten N, Dalay N. MTHFR C677 T gene polymorphism in lymphoproliferative diseases.
J. Clin. Lab. Anal. 20: 37-41 (2006).
-
Delikoukos S, Christodoulidis G, Zacharoulis D, Poultsidi A, Hatzitheofilou C. Multiple small bowel ruptures due to ischemic enteritis: a case report.
World J. Gastroenterol. 12: 4262-4263 (2006).
*
-
Dell'uomo N, Tassoni E, Brunetti T, Pessotto P, Sciarroni AF, Milazzo FM, De Angelis F, Peschechera A, Tinti MO, Carminati P, Giannessi F. 2-{3-[2-(4-Chlorophenyl)ethoxy]phenylthio}-2-methylpropanoic acid: a fibrate-like compound with hypolipidemic and antidiabetic activity.
ChemMedChem. 1: 49-53 (2006).
-
Dellinger R, Fang JL, Chen G, Weinberg R, Lazarus P. Importance of UDP-glucuronosyl transferase 1A10 (UGT1A10) in the detoxification of polycyclic aromatic hydrocarbons: decreased glucuronidative activity of the UGT1A10139Lys isoform.
Drug Metab. Dispos. 34: 943-949 (2006).
*
-
Deloire MS, Bonnet MC, Salort E, Arimone Y, Boudineau M, Petry KG, Brochet B. How to detect cognitive dysfunction at early stages of multiple sclerosis?
Mult. Scler. 12: 445-452 (2006).
*
-
Delorenze GN, Munger KL, Lennette ET, Orentreich N, Vogelman JH, Ascherio A. Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up.
Arch. Neurol. 63: 839-844 (2006).
*
-
Delrieu O, Bowman C. Visualizing gene determinants of disease in drug discovery.
Pharmacogenomics 7: 311-329 (2006).
-
Deltenre P, Valla DC. Ischemic cholangiopathy.
J. Hepatol. 44: 806-817 (2006).
*
-
Delunardo F, Conti F, Margutti P, Alessandri C, Priori R, Siracusano A, Rigano R, Profumo E, Valesini G, Sorice M, Ortona E. Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behcet's disease.
Arthritis Res. Ther. 8: R71 (2006).
*
-
Delvaux M, Gerard Gay. Capsule endoscopy in 2005: facts and perspectives.
Best Pract. Res. Clin. Gastroenterol. 20: 23-39 (2006).
-
Demacq C, de Souza AP, Machado AA, Gerlach RF, Tanus-Santos JE. Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma MMP-9 activity in healthy subjects.
Clin. Chim. Acta 365: 183-187 (2006).
*
-
DeMar Jr JC, Ma K, Bell JM, Igarishi M, Greenstein D, Rapoport SI. Dietary n-3 polyunsaturated fatty acid deprivation in rats following weaning increases their behavioral depression and aggression test scores.
J. Lipid Res. 47: 172-180 (2006).
*
-
Demarco P, Singh I, Weinstein A. Management of the antiphospholipid syndrome.
Curr. Rheumatol. Rep. 8: 114-120 (2006).
-
Demars JJ, Riquet JJ, Feve KK, Gautier MM, Morisson MM, Demeure OO, Renard CC, Chardon PP, Milan DD. High resolution physical map of porcine chromosome 7 QTL region and comparative mapping of this region among vertebrate genomes.
BMC Genomics 7: 13 (2006).
*
-
Demay MB. Mechanism of vitamin D receptor action.
Ann. N. Y. Acad. Sci. 1068: 204-213 (2006).
*
-
Demedts IK, Bracke KR, Maes T, Joos GF, Brusselle GG. Different roles for human lung dendritic cell subsets in pulmonary immune defense mechanisms.
Am. J. Respir. Cell. Mol. Biol. 35: 387-393 (2006).
*
-
Demeilliers C, Jacquemin E, Barbu V, Mergey M, Paye F, Fouassier L, Chignard N, Housset C, Lomri NE. Altered hepatobiliary gene expressions in PFIC1: ATP8B1 gene defect is associated with CFTR downregulation.
Hepatology 43: 1125-1134 (2006).
*
-
Demengeot J, Zelenay S, Moraes-Fontes MF, Caramalho I, Coutinho A. Regulatory T cells in microbial infection.
Springer Semin. Immunopathol. 28: 41-50 (2006).
*
-
Demerjian M, Man MQ, Choi EH, Brown BE, Crumrine D, Chang S, Mauro T, Elias PM, Feingold KR. Topical treatment with thiazolidinediones, activators of peroxisome proliferator-activated receptor-gamma, normalizes epidermal homeostasis in a murine hyperproliferative disease model.
Exp. Dermatol. 15: 154-160 (2006).
*
-
Demetris AJ. Liver biopsy interpretation for causes of late liver allograft dysfunction.
Hepatology 44: 489-501 (2006).
*
-
Demetris AJ. Distinguishing between recurrent primary sclerosing cholangitis and chronic rejection.
Liver Transpl. 12: S68-S72 (2006).
*
-
Demetris AJ, Fontes P, Lunz JG 3rd, Specht S, Murase N, Marcos A. Wound healing in the biliary tree of liver allografts.
Cell Transplant. 15 Suppl. 1: S57-S65 (2006).
-
Demetris AJ, Lunz JG 3rd, Specht S, Nozaki I. Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease.
World J. Gastroenterol. 12: 3512-3522 (2006).
*
-
Demirbilek S, Akin M, Gurunluoglu K, Aydin NE, Emre MH, Tas E, Aksoy RT, Ay S. The NF-kappaB inhibitors attenuate hepatic injury in bile duct ligated rats.
Pediatr. Surg. Int. 22: 655-663 (2006).
*
-
Demirjian AN, Callery MP. Environment, genetics, and fish? Answers to the cancer riddle.
Gastroenterology 130: 1000-1001 (2006).
*
-
Demirkiran A, Kok A, Kwekkeboom J, Kusters JG, Metselaar HJ, Tilanus HW, van der Laan LJ. Low circulating regulatory T-cell levels after acute rejection in liver transplantation.
Liver Transpl. 12: 277-284 (2006).
*
-
Demirtas-Ertan G, Rowshani AT, Ten Berge IJ. Azathioprine-induced shock in a patient suffering from undifferentiated erosive oligoarthritis.
Neth. J. Med. 64: 124-126 (2006).
*
-
Demitrack MA. Clinical methodology and its implications for the study of therapeutic interventions for chronic fatigue syndrome: a commentary.
Pharmacogenomics 7: 521-538 (2006).
-
Demoly P, Guglielmi P, Guglielmi L. Drug allergy and hypersensitivity. Risk factors.
Bull. Acad. Natl. Med. 190: 1733-1742 (2006).
-
Demond AL, Starr T, Dustin ML, Groves JT. Control of antigen presentation with a photoreleasable agonist peptide.
J. Am. Chem. Soc. 128: 15354-15355 (2006).
*
-
Demonty I, Chan YM, Pelled D, Jones PJ. Fish-oil esters of plant sterols improve the lipid profile of dyslipidemic subjects more than do fish-oil or sunflower oil esters of plant sterols.
Am. J. Clin. Nutr. 84: 1534-1542 (2006).
*
-
Demory D, Forel JM, Michel F, Guillin-Poujol A, Consentino B, Gainnier M, Papazian L, Sainty JM. Crohn disease and abdominal tuberculosis: complications related to a diagnostic error.
Presse. Med. 35: 51-54 (2006).
-
den Brok MH, Sutmuller RP, Nierkens S, Bennink EJ, Frielink C, Toonen LW, Boerman OC, Figdor CG, Ruers TJ, Adema GJ. Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity.
Br. J. Cancer 95: 896-905 (2006).
*
-
Dendle C, Woolley IJ, Korman TM. Rat-bite fever septic arthritis: illustrative case and literature review.
Eur. J. Clin. Microbiol. Infect. Dis. 25: 791-797 (2006).
*
-
Dendrinos KG, Becker JM, Stucchi AF, Saubermann LJ, Lamorte W, Farraye FA. Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosis.
J. Gastrointest. Surg. 10: 1060-1064 (2006).
-
Deng A, Harvey V, Sina B, Strobel D, Badros A, Junkins-Hopkins JM, Samuels A, Oghilikhan M, Gaspari A. Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors.
Arch. Dermatol. 142: 198-202 (2006).
*
-
Deng CT, Cai J, Tarsitani C, El-Awar N, Lachmann N, Ozawa M. HLA class II DQ epitopes.
Clin. Transpl. 2006: 115-122 (2006).
-
Deng L, Mariuzza RA. Structural basis for recognition of MHC and MHC-like ligands by natural killer cell receptors.
Semin. Immunol. 18: 159-166 (2006).
*
-
Deng R, Yang D, Yang J, Yan B. Oxysterol 22(R)-hydroxycholesterol induces the expression of the bile salt export pump through nuclear receptor FXR but not LXR.
J. Pharmacol. Exp. Ther. 317: 317-325 (2006).
*
-
Deng X, Stachlewitz RF, Liguori MJ, Blomme EA, Waring JF, Luyendyk JP, Maddox JF, Ganey PE, Roth RA. Modest inflammation enhances diclofenac hepatotoxicity in rats: role of neutrophils and bacterial translocation.
J. Pharmacol. Exp. Ther. 319: 1191-1199 (2006).
*
-
Deng YJ, Huang ZX, Zhou CJ, Wang JW, You Y, Song ZQ, Xiang MM, Zhong BY, Hao F. Gene profiling involved in immature CD4+ T lymphocyte responsible for systemic lupus erythematosus.
Mol. Immunol. 43: 1497-1507 (2006).
*
-
Denk GU, Cai SY, Chen WS, Lin A, Soroka CJ, Boyer JL. A comparison of gene expression in mouse liver and kidney in obstructive cholestasis utilizing high-density oligonucleotide microarray technology.
World J. Gastroenterol. 12: 2536-2548 (2006).
*
-
Denke MA. Dietary fats, fatty acids, and their effects on lipoproteins.
Curr. Atheroscler. Rep. 8: 466-471 (2006).
-
Dennehy KM, Elias F, Zeder-Lutz G, Ding X, Altschuh D, Luhder F, Hunig T. Cutting edge: monovalency of CD28 maintains the antigen dependence of T cell costimulatory responses.
J. Immunol. 176: 5725-5729 (2006).
*
-
Dennert G, Aswad F. The role of NKT cells in animal models of autoimmune hepatitis.
Crit. Rev. Immunol. 26: 453-474 (2006).
-
Denning GM, Stoll LL. Peroxisome proliferator-activated receptors: potential therapeutic targets in lung disease?
Pediatr. Pulmonol. 41: 23-34 (2006).
-
Dennis C. Australians back bacterial theory for bowel disease.
Nat. Med. 12: 595 (2006).
*
-
Denson LA. Adding fuel to the fire: STAT3 priming of gastric tumorigenesis.
Gastroenterology 131: 1342-1344 (2006).
*
-
Dentener MA, Wouters EF. Tumor necrosis factor inhibitors for rheumatoid arthritis.
N. Engl. J. Med. 355: 2047-2048 (2006).
-
Denton CP, Black CM, Abraham DJ. Mechanisms and consequences of fibrosis in systemic sclerosis.
Nat. Clin. Pract. Rheumatol. 2: 134-144 (2006).
*
-
Derbel S, Doumaguet C, Hubert D, Mosnier-Pudar H, Grabar S, Chelly J, Bienvenu T. Calpain 10 and development of diabetes mellitus in cystic fibrosis.
J. Cyst. Fibros. 5: 47-51 (2006).
-
Derdak SV, Kueng HJ, Leb VM, Neunkirchner A, Schmetterer KG, Bielek E, Majdic O, Knapp W, Seed B, Pickl WF. Direct stimulation of T lymphocytes by immunosomes: virus-like particles decorated with T cell receptor/CD3 ligands plus costimulatory molecules.
Proc. Natl. Acad. Sci. U.S.A. 103: 13144-13149 (2006).
*
-
Derijk RH, Wust S, Meijer OC, Zennaro MC, Federenko IS, Hellhammer DH, Giacchetti G, Vreugdenhil E, Zitman FG, de Kloet ER. A common polymorphism in the mineralocorticoid receptor modulates stress responsiveness.
J. Clin. Endocrinol. Metab. 91: 5083-5089 (2006).
*
-
Derijks LJ, Gilissen LP, de Boer NK, Mulder CJ. 6-Thioguanine-related hepatotoxicity in patients with inflammatory bowel disease: dose or level dependent?
J. Hepatol. 44: 821-822 (2006).
*
-
Derijks LJ, Gilissen LP, Engels LG, Bos LP, Bus PJ, Lohman JJ, van Deventer SJ, Hommes DW, Hooymans PM. Pharmacokinetics of 6-thioguanine in patients with inflammatory bowel disease.
Ther. Drug Monit. 28: 45-50 (2006).
-
Derijks LJ, Gilissen LP, Hooymans PM, Hommes DW. Review article: thiopurines in inflammatory bowel disease.
Aliment. Pharmacol. Ther. 24: 715-729 (2006).
*
-
Derijks LJ, Hommes DW. Thiopurines in inflammatory bowel disease: new strategies for optimization of pharmacotherapy?
Curr. Gastroenterol. Rep. 8: 89-92 (2006).
-
Deroo BJ, Korach KS. Estrogen receptors and human disease.
J. Clin. Invest. 116: 561-570 (2006).
*
-
Deryck O, Ketelaer P, Dubois B. Clinical characteristics and long term prognosis in early onset multiple sclerosis.
J. Neurol. 253: 720-723 (2006).
*
-
Desai CS, Josh AG, Abraham P, Desai DC, Deshpande RB, Bhaduri A, Shah SR. Hepatic tuberculosis in absence of disseminated abdominal tuberculosis.
Ann. Hepatol. 5: 41-43 (2006).
-
Desai SB, Furst DE. Problems encountered during anti-tumour necrosis factor therapy.
Best Pract. Res. Clin. Rheumatol. 20: 757-790 (2006).
-
Desai SN, White DM, O'Shea KM, Brown ML, Cywin CL, Spero DM, Panzenbeck MJ. An orally active reversible inhibitor of cathepsin S inhibits human trans vivo delayed-type hypersensitivity.
Eur. J. Pharmacol. 538: 168-174 (2006).
*
-
Desar IM, Keuter M, Raemaekers JM, Jansen JB, van Krieken JH, van der Meer JW. Extranodal marginal zone (MALT) lymphoma in common variable immunodeficiency.
Neth. J. Med. 64: 136-140 (2006).
*
-
Descamps D, Vigant F, Esselin S, Connault E, Opolon P, Perricaudet M, Benihoud K. Expression of non-signaling membrane-anchored death receptors protects murine livers in different models of hepatitis.
Hepatology 44: 399-409 (2006).
*
-
Descamps V. Efalizumab.
Ann. Dermatol. Venereol. 133: 666-678 (2006).
-
deSchoolmeester ML, Manku H, Else KJ. The innate immune responses of colonic epithelial cells to Trichuris muris are similar in mouse strains that develop a type 1 or type 2 adaptive immune response.
Infect. Immun. 74: 6280-6286 (2006).
*
-
Deshpande AV, Lahei ER, Shun A, Martin HC, O'loughlin EV. Idiopathic fibrosing pancreatitis in children-a single-center experience.
J. Pediatr. Surg. 41: 1987-1991 (2006).
-
Deshpande R, Heaton N. Can non-heart-beating donors replace cadaveric heart-beating liver donors?
J. Hepatol. 45: 499-503 (2006).
*
-
Deshpande V, Chiocca S, Finkelberg D, Selig MK, Mino-Kenudson M, Brugge WR, Colvin RB, Lauwers GY. Autoimmune pancreatitis: a systemic immune complex mediated disease.
Am. J. Surg. Pathol. 30: 1537-1545 (2006).
-
Desmetz C, Lin YL, Mettling C, Portales P, Rabesandratana H, Clot J, Corbeau P. The strength of the chemotactic response to a CCR5 binding chemokine is determined by the level of cell surface CCR5 density.
Immunology 119: 551-561 (2006).
*
-
Desreumaux P, Ghosh S. Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence.
Aliment. Pharmacol. Ther. 24 Suppl. 1: 2-9 (2006).
*
-
Dessein PH, Joffe BI. Suppression of circulating interleukin-6 concentrations is associated with decreased endothelial activation in rheumatoid arthritis.
Clin. Exp. Rheumatol. 24: 161-167 (2006).
-
Dessein PH, Joffe BI. Insulin resistance and impaired beta cell function in rheumatoid arthritis.
Arthritis Rheum. 54: 2765-2775 (2006).
*
-
Dessein PH, Tobias M, Veller MG. Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis.
J. Rheumatol. 33: 2425-2432 (2006).
-
Deutscher N, Bataille F, Hausmann M, Kiessling S, Muller-Newen G, Leeb SN, Herfarth H, Heinrich PC, Scholmerich J, Rogler G. Functional expression of the interleukin-11 receptor alpha-chain in normal colonic epithelium and colon cancer.
Int. J. Colorectal Dis. 21: 573-581 (2006).
*
-
Deutschman CS, Cereda M, Ochroch EA, Raj NR. Sepsis-induced cholestasis, steatosis, hepatocellular injury, and impaired hepatocellular regeneration are enhanced in interleukin-6 -/- mice.
Crit. Care Med. 34: 2613-2620 (2006).
-
Devaraj S, Kasim-Karakas S, Jialal I. The effect of weight loss and dietary fatty acids on inflammation.
Curr. Atheroscler. Rep. 8: 477-486 (2006).
-
Devauchelle V, Essabbani A, De Pinieux G, Germain S, Tourneur L, Mistou S, Margottin-Goguet F, Anract P, Migaud H, Le Nen D, Lequerre T, Saraux A, Dougados M, Breban M, Fournier C, Chiocchia G. Characterization and functional consequences of underexpression of clusterin in rheumatoid arthritis.
J. Immunol. 177: 6471-6479 (2006).
*
-
Devaux PF, Lopez-Montero I, Bryde S. Proteins involved in lipid translocation in eukaryotic cells.
Chem. Phys. Lipids 141: 119-132 (2006).
-
Devel L, Rogakos V, David A, Makaritis A, Beau F, Cuniasse P, Yiotakis A, Dive V. Development of selective inhibitors and substrate of matrix metalloproteinase-12.
J. Biol. Chem. 281: 11152-11160 (2006).
*
-
Devendra D, Miao D, Nakayama M, Eisenbarth GS, Liu E. Pancreatic autoimmunity induction with insulin B:9-23 peptide and viral mimics in the NZB mouse.
Ann. N. Y. Acad. Sci. 1079: 135-137 (2006).
*
-
Devereux G. The increase in the prevalence of asthma and allergy: food for thought.
Nat. Rev. Immunol. 6: 869-874 (2006).
*
-
Devitt G, Meyer C, Wiedemann N, Eichmuller S, Kopp-Schneider A, Haferkamp A, Hautmann R, Zoller M. Serological analysis of human renal cell carcinoma.
Int. J. Cancer 118: 2210-2219 (2006).
*
-
Devoss J, Hou Y, Johannes K, Lu W, Liou GI, Rinn J, Chang H, Caspi R, Fong L, Anderson MS. Spontaneous autoimmunity prevented by thymic expression of a single self-antigen.
J. Exp. Med. 203: 2727-2735 (2006).
*
-
Dewan A, Liu M, Hartman S, Zhang S, Liu DT, Zhao C, Tam PO, Chan WM, Lam DS, Snyder M, Barnstable C, Pang CP, Hoh J. HTRA1 promoter polymorphism in wet age-related macular degeneration.
Science 314: 989-992 (2006).
*
-
Dewar DH, Amato M, Ellis HJ, Pollock EL, Gonzalez-Cinca N, Wieser H, Ciclitira PJ. The toxicity of high molecular weight glutenin subunits of wheat to patients with coeliac disease.
Eur. J. Gastroenterol. Hepatol. 18: 483-491 (2006).
-
Dewint P, Hoffman IE, Rogge S, Joos R, Union A, Dehoorne J, Delanghe J, Veys EM, De Keyser F, Elewaut D. Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis.
Rheumatology (Oxford) 45: 204-208 (2006).
*
-
Dewitt J, Misra VL, Leblanc JK, McHenry L, Sherman S. EUS-guided FNA of proximal biliary strictures after negative ERCP brush cytology results.
Gastrointest. Endosc. 64: 325-333 (2006).
-
Dey A, Cederbaum AI. Alcohol and oxidative liver injury.
Hepatology 43: S63-S74 (2006).
*
-
Dey I, Lejeune M, Chadee K. Prostaglandin E2 receptor distribution and function in the gastrointestinal tract.
Br. J. Pharmacol. 149: 611-623 (2006).
*
-
Dhalluin-Venier V, Besson C, Dimet S, Thirot-Bibault A, Tchernia G, Buffet C. Imatinib mesylate-induced acute hepatitis with autoimmune features.
Eur. J. Gastroenterol. Hepatol. 18: 1235-1237 (2006).
-
Dhar A, Johnson KS, Novelli MR, Bown SG, Bigio IJ, Lovat LB, Bloom SL. Elastic scattering spectroscopy for the diagnosis of colonic lesions: initial results of a novel optical biopsy technique.
Gastrointest. Endosc. 63: 257-261 (2006).
-
Dhar JP, Sokol RJ. Lupus and pregnancy: complex yet manageable.
Clin. Med. Res. 4: 310-321 (2006).
*
-
Dhawan A, Mitry RR, Hughes RD. Hepatocyte transplantation for liver-based metabolic disorders.
J. Inherit. Metab. Dis. 29: 431-435 (2006).
*
-
Dhuley JN. Effect of picroliv administration on hepatic microsomal mixed function oxidases and glutathione-conjugating enzyme system in cholestatic rats.
Hindustan Antibiot. Bull. 47-48: 13-19 (2006).
-
Di A, Brown ME, Deriy LV, Li C, Szeto FL, Chen Y, Huang P, Tong J, Naren AP, Bindokas V, Palfrey HC, Nelson DJ. CFTR regulates phagosome acidification in macrophages and alters bactericidal activity.
Nat. Cell Biol. 8: 933-944 (2006).
*
-
DI Comite G, Marinosci A, DI Matteo P, Manfredi A, Rovere-Querini P, Baldissera E, Aiello P, Corti A, Sabbadini MG. Neuroendocrine modulation induced by selective blockade of TNF-alpha in rheumatoid arthritis.
Ann. N. Y. Acad. Sci. 1069: 428-437 (2006).
*
-
Di Cristofaro J, Silvy M, Lanteaume A, Marcy M, Carayon P, De Micco C. Expression of tpo mRNA in thyroid tumors: quantitiative PCR analysis and correlation with alterations of ret, Braf, ras and pax8 genes.
Endocr. Relat. Cancer 13: 485-495 (2006).
*
-
Di Girolamo N, Indoh I, Jackson N, Wakefield D, McNeil HP, Yan W, Geczy C, Arm JP, Tedla N. Human mast cell-derived gelatinase B (matrix metalloproteinase-9) is regulated by inflammatory cytokines: role in cell migration.
J. Immunol. 177: 2638-2650 (2006).
*
-
Di Gregorio C, Frattini M, Maffei S, Ponti G, Losi L, Pedroni M, Venesio T, Bertario L, Varesco L, Risio M, de Leon MP. Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis.
Gastroenterology 131: 439-444 (2006).
*
-
Di Lorenzo G, Pacor ML, Mansueto P, Esposito-Pellitteri M, Ditta V, Lo Bianco C, Leto-Barone MS, Di Fede G, Rini GB. Is there a role for antileukotrienes in urticaria?
Clin. Exp. Dermatol. 31: 327-334 (2006).
-
Di Marco P, Pagnotti P, Bellomi F, De Vito G, Sessa E, Bagnato F, Scagnolari C, Bramanti P, Antonelli G. A novel assay to detect low-titred antibodies to interferon beta in multiple sclerosis patients.
New Microbiol. 29: 11-18 (2006).
-
Di Marzo V, Izzo AA. Endocannabinoid overactivity and intestinal inflammation.
Gut 55: 1373-1376 (2006).
*
-
Di Paola R, Esposito E, Mazzon E, Genovese T, Muia C, Crisafulli C, Malleo G, Sessa E, Meli R, Cuzzocrea S. Absence of peroxisome proliferators-activated receptors (PPAR) alpha enhanced the multiple organ failure induced by zymosan.
Shock 26: 477-484 (2006).
*
-
Di Paola R, Mazzon E, Maiere D, Zito D, Britti D, De Majo M, Genovese T, Cuzzocrea S. Rosiglitazone reduces the evolution of experimental periodontitis in the rat.
J. Dent. Res. 85: 156-161 (2006).
-
Di Sabatino A, Ciccocioppo R, Cupelli F, Cinque B, Millimaggi D, Clarkson MM, Paulli M, Cifone MG, Corazza GR. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease.
Gut 55: 469-477 (2006).
*
-
Di Sabatino A, Rosado MM, Cazzola P, Riboni R, Biagi F, Carsetti R, Corazza GR. Splenic hypofunction and the spectrum of autoimmune and malignant complications in celiac disease.
Clin. Gastroenterol. Hepatol. 4: 179-186 (2006).
-
Di ZL, Niu XL, Wei J, Li YQ, Chen GL, Wang NP. Expression of peroxisome proliferator-activated receptors Y changes with age in vascular smooth muscle cells of spontaneously hypertensive rat.
Sichuan Da Xue Xue Bao Yi Xue Ban 37: 204-207 (2006).
-
Diac M, Kenyon A, Nelson-Piercy C, Girling J, Cheng F, Tribe RM, Goodman J, Shennan A, Williamson C. Dexamethasone in the treatment of obstetric cholestasis: a case series.
J. Obstet. Gynaecol. 26: 110-114 (2006).
-
Diaconescu MR, Costea I, Glod M, Ceobanu M, Bulimar V, Ciolpan C. Gastrocolic fistulas. Review of three cases.
Rev. Med. Chir. Soc. Med. Nat. Iasi. 110: 899-904 (2006).
-
Diakos C, Prieschl EE, Saemann MD, Bohmig GA, Csonga R, Sobanov Y, Baumruker T, Zlabinger GJ. n-Butyrate inhibits Jun NH(2)-terminal kinase activation and cytokine transcription in mast cells.
Biochem. Biophys. Res. Commun. 349: 863-868 (2006).
*
-
Dial S, Delaney JA, Schneider V, Suissa S. Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy.
CMAJ 175: 745-748 (2006).
*
-
Diamanti A, Colistro F, Calce A, Devito R, Ferretti F, Minozzi A, Santoni A, Castro M. Clinical value of immunoglobulin A antitransglutaminase assay in the diagnosis of celiac disease.
Pediatrics 118: e1696-e1700 (2006).
*
-
Diamond B. Systemic lupus erythematosus and Sjogren syndrome.
Curr. Opin. Rheumatol. 18: 449-450 (2006).
-
Diamond DL, Proll SC, Jacobs JM, Chan EY, Camp DG 2nd, Smith RD, Katze MG. HepatoProteomics: applying proteomic technologies to the study of liver function and disease.
Hepatology 44: 299-308 (2006).
*
-
Diamond IR, Wales PW, Grant DR, Fecteau A. Isolated liver transplantation in pediatric short bowel syndrome: is there a role?
J. Pediatr. Surg. 41: 955-959 (2006).
-
Dianzani C, Cavalli R, Zara GP, Gallicchio M, Lombardi G, Gasco MR, Panzanelli P, Fantozzi R. Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion of human neutrophils to endothelial cells.
Br. J. Pharmacol. 148: 648-656 (2006).
*
-
Dias Gonzalez F, Pedreira Magalhaes F, Pontes Vilas Boas Freitas A, Castro Lima Filho H, Santiago MB. Lipodermatosclerosis in patients with diffuse connective tissue diseases.
Eur. J. Intern. Med. 17: 288-289 (2006).
-
Diaz F, Rodriguez-Boulan E. Open sesame! Coxsackieviruses conspire to trespass the tight junctional gate.
Dev. Cell. 10: 151-152 (2006).
*
-
Diaz F, Urkijo JC, Mendoza F, De la Viuda JM, Blanco M, Flores M, Berdonces P. Systemic lupus erythematosus associated with acute cytomegalovirus infection.
J. Clin. Rheumatol. 12: 263-264 (2006).
-
Dib SA. Insulin resistance and metabolic syndrome in type 1 diabetes mellitus.
Arq. Bras. Endocrinol. Metabol. 50: 250-263 (2006).
-
Dick M. Cystic fibrosis: hope remains for a 'miracle cure'.
Biotechnol. J. 1: 502-503 (2006).
-
Dickel DE, Veenstra-Vanderweele J, Cox NJ, Wu X, Fischer DJ, Van Etten-Lee M, Himle JA, Leventhal BL, Cook EH Jr, Hanna GL. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder.
Arch. Gen. Psychiatry 63: 778-785 (2006).
*
-
Dickey W. Endoscopic markers for celiac disease.
Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 546-551 (2006).
*
-
Dickey W, Kearney N. Overweight in celiac disease: prevalence, clinical characteristics, and effect of a gluten-free diet.
Am. J. Gastroenterol. 101: 2356-2359 (2006).
*
-
Dickson BC, Streutker CJ, Chetty R. Coeliac disease: an update for pathologists.
J. Clin. Pathol. 59: 1008-1016 (2006).
*
-
Dideberg V, Louis E, Farnir F, Bertoli S, Vermeire S, Rutgeerts P, De Vos M, Van Gossum A, Belaiche J, Bours V. Lymphotoxin alpha gene in Crohn's disease patients: absence of implication in the response to infliximab in a large cohort study.
Pharmacogenet. Genomics 16: 369-373 (2006).
-
Dideberg V, Theatre E, Farnir F, Vermeire S, Rutgeerts P, Vos MD, Belaiche J, Franchimont D, Gossum AV, Louis E, Bours V. The TNF/ADAM 17 system: implication of an ADAM 17 haplotype in the clinical response to infliximab in Crohn's disease.
Pharmacogenet. Genomics 16: 727-734 (2006).
-
Didierlaurent A, Brissoni B, Velin D, Aebi N, Tardivel A, Kaslin E, Sirard JC, Angelov G, Tschopp J, Burns K. Tollip regulates proinflammatory responses to interleukin-1 and lipopolysaccharide.
Mol. Cell. Biol. 26: 735-742 (2006).
*
-
Didierlaurent A, Simonet M, Sirard JC. Innate and acquired plasticity of the intestinal immune system.
Cell. Mol. Life Sci. 62: 1285-1287 (2006).
*
-
Diebold SS, Massacrier C, Akira S, Paturel C, Morel Y, Sousa CR. Nucleic acid agonists for Toll-like receptor 7 are defined by the presence of uridine ribonucleotides.
Eur. J. Immunol. 36: 3256-3267 (2006).
*
-
Dieckgraefe BK, Korzenik JR, Anant S. Growth factors as treatment options for intestinal inflammation.
Ann. N. Y. Acad. Sci. 1072: 300-306 (2006).
*
-
Diefenbach KA, Breuer CK. Pediatric inflammatory bowel disease.
World J. Gastroenterol. 12: 3204-3212 (2006).
*
-
Diego CD, Alcantara M, Valle J, Perez-Grueso MJ, Munoz-Rosas C, Carrobles JM, Martinez-Castro P. Frequency of CARD15 polymorphisms in patients with Crohn's disease from Toledo, Spain: genotype-phenotype correlation.
Genet. Test. 10: 178-185 (2006).
-
Dieker JW, Van Bavel CC, Riemekasten G, Berden JH, Van der Vlag J. The binding of lupus-derived autoantibodies to the C-terminal peptide (83-119) of the major SmD1 autoantigen can be mediated by dsDNA and nucleosomes.
Ann. Rheum. Dis. 65: 1525-1528 (2006).
*
-
Diesing D, Cordes T, Fischer D, Diedrich K, Friedrich M. Vitamin D - metabolism in the human breast cancer cell line MCF-7.
Anticancer Res. 26: 2755-2759 (2006).
-
Dieterich W, Esslinger B, Trapp D, Hahn E, Huff T, Seilmeier W, Wieser H, Schuppan D. Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease.
Gut 55: 478-484 (2006).
*
-
Dieterle C. (Auto)immunological aspects of type 1 diabetes mellitus.
MMW Fortschr. Med. 148: 36-39 (2006).
-
Dietert RR, Piepenbrink MS. Lead and immune function.
Crit. Rev. Toxicol. 36: 359-385 (2006).
*
-
Dif N, Euthine V, Gonnet E, Laville M, Vidal H, Lefai E. Insulin activates human sterol regulatory element-binding protein-1c (SREBP-1c) promoter through SRE motifs.
Biochem. J. 400: 179-188 (2006).
*
-
Digiovanni JJ, Nair P. Spontaneous recovery of sudden sensorineural hearing loss: possible association with autoimmune disorders.
J. Am. Acad. Audiol. 17: 498-505 (2006).
-
Dijkhuis AJ, Klappe K, Kamps W, Sietsma H, Kok JW. Gangliosides do not affect ABC transporter function in human neuroblastoma cells.
J. Lipid Res. 47: 1187-1195 (2006).
*
-
Dijkstra IM, de Haas AH, Brouwer N, Boddeke HW, Biber K. Challenge with innate and protein antigens induces CCR7 expression by microglia in vitro and in vivo.
Glia 54: 861-872 (2006).
-
Dika E, Varotti C, Bardazzi F, Maibach HI. Drug-induced psoriasis: an evidence-based overview and the introduction of psoriatic drug eruption probability score.
Cutan. Ocul. Toxicol. 25: 1-11 (2006).
-
Dikmen M, Gunes HV, Degirmenci I, Ozdemir G, Basaran A. Are the angiotensin-converting enzyme gene and activity risk factors for stroke?
Arq. Neuropsiquiatr. 64: 211-216 (2006).
*
-
Dilger K, Alberer M, Busch A, Enninger A, Behrens R, Koletzko S, Stern M, Beckmann C, Gleiter CH. Pharmacokinetics and pharmacodynamic action of budesonide in children with Crohn's disease.
Aliment. Pharmacol. Ther. 23: 387-396 (2006).
*
-
Dilger K, Cascorbi I, Grunhage F, Hohenester S, Sauerbruch T, Beuers U. Multidrug resistance 1 genotype and disposition of budesonide in early primary biliary cirrhosis.
Liver Int. 26: 285-290 (2006).
*
-
Dillon CF, Rasch EK, Gu Q, Hirsch R. Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991-94.
J. Rheumatol. 33: 2271-2279 (2006).
-
Dillon MJ, Ozen S. A new international classification of childhood vasculitis.
Pediatr. Nephrol. 21: 1219-1222 (2006).
-
Diluvio L, Vollmer S, Besgen P, Ellwart JW, Chimenti S, Prinz JC. Identical TCR beta-chain rearrangements in streptococcal angina and skin lesions of patients with psoriasis vulgaris.
J. Immunol. 176: 7104-7111 (2006).
*
-
Dimagno MJ, Dimagno EP. Chronic pancreatitis.
Curr. Opin. Gastroenterol. 22: 487-497 (2006).
-
Dimarco CS, Dimarco DS, Klingele CJ, Gebhart JB. Vesicouterine fistula: a review of eight cases.
Int. Urogynecol. J. Pelvic Floor Dysfunct. 17: 395-399 (2006).
-
Dimitriadis E, Stoikos C, Tan YL, Salamonsen LA. Interleukin 11 signaling components signal transducer and activator of transcription 3 (STAT3) and suppressor of cytokine signaling 3 (SOCS3) regulate human endometrial stromal cell differentiation.
Endocrinology 147: 3809-3817 (2006).
*
-
Dimitroulia E, Spanakis N, Konstantinidou AE, Legakis NJ, Tsakris A. Frequent detection of cytomegalovirus in the intestine of patients with inflammatory bowel disease.
Inflamm. Bowel Dis. 12: 879-884 (2006).
*
-
Dimitrov S, Lange T, Benedict C, Nowell MA, Jones SA, Scheller J, Rose-John S, Born J. Sleep enhances IL-6 trans-signaling in humans.
FASEB J. 20: 2174-2176 (2006).
*
-
Dimitrova-Sumkovska J, Djosic-Markovska B, Zafirova-Roganovic D, Anastasovska V. Effects of different dietary fatty acid supplements uppon lipoprotein metabolism and lipid peroxides production in hyperlipidemic rats.
Prilozi. 27: 67-86 (2006).
-
Dinan TG, Quigley EM, Ahmed SM, Scully P, O'Brien S, O'Mahony L, O'Mahony S, Shanahan F, Keeling PW. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?
Gastroenterology 130: 304-311 (2006).
*
-
Dinarello CA, Kim SH. IL-32, a novel cytokine with a possible role in disease.
Ann. Rheum. Dis. 65 Suppl. 3: iii61-iii64 (2006).
*
-
Dinato SL, Dinato MC, Lopes MF, Packer E, Romiti N. Localized granuloma annulare in patient with graves hyperthyroidism: case report.
Arq. Bras. Endocrinol. Metabol. 50: 1117-1121 (2006).
-
Dincic E, Zivkovic M, Stankovic A, Obradovic D, Alavantic D, Kostic V, Raicevic R. Association of polymorphisms in CTLA-4, IL-1ra and IL-1beta genes with multiple sclerosis in Serbian population.
J. Neuroimmunol. 177: 146-150 (2006).
-
Ding C, Jones G. Anti-interleukin-6 receptor antibody treatment in inflammatory autoimmune diseases.
Rev. Recent Clin. Trials 1: 193-200 (2006).
-
Ding C, Jones G. Belimumab Human Genome Sciences/Cambridge Antibody Technology/GlaxoSmithKline.
Curr. Opin. Investig. Drugs 7: 464-472 (2006).
-
Ding C, Wang L, Al-Ghawi H, Marroquin J, Mamula M, Yan J. Toll-like receptor engagement stimulates anti-snRNP autoreactive B cells for activation.
Eur. J. Immunol. 36: 2013-2024 (2006).
*
-
Ding D, Mehta H, McCune WJ, Kaplan MJ. Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus.
J. Immunol. 177: 5878-5889 (2006).
*
-
Ding G, Cheng L, Qin Q, Frontin S, Yang Q. PPARdelta modulates lipopolysaccharide-induced TNFalpha inflammation signaling in cultured cardiomyocytes.
J. Mol. Cell. Cardiol. 40: 821-828 (2006).
*
-
Ding WQ, Liu B, Vaught JL, Palmiter RD, Lind SE. Clioquinol and docosahexaenoic acid act synergistically to kill tumor cells.
Mol. Cancer Ther. 5: 1864-1872 (2006).
-
Ding X, Lichti K, Kim I, Gonzalez FJ, Staudinger JL. Regulation of constitutive androstane receptor and its target genes by fasting, cAMP, hepatocyte nuclear factor alpha, and the coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha.
J. Biol. Chem. 281: 26540-26551 (2006).
*
-
Ding X, Lichti K, Staudinger JL. The mycoestrogen zearalenone induces CYP3A through activation of the pregnane X receptor.
Toxicol. Sci. 91: 448-455 (2006).
*
-
Ding X, Saxena NK, Lin S, Gupta N, Anania FA. Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice.
Hepatology 43: 173-181 (2006).
*
-
Ding Y, Zhao L, Mei H, Huang ZH, Zhang SL. Alterations of biliary biochemical constituents and cytokines in infantile hepatitis syndrome.
World J. Gastroenterol. 12: 7038-7041 (2006).
*
-
Ding YJ, Yu JP, Luo HS, Zhou ZY, Liu J. Evaluation and analysis of colonoscopy in the diagnosis of 186 cases of ulcerative colitis patients.
Int. J. Clin. Pract. 60: 1408-1410 (2006).
*
-
Dingli D, Nowak MA. Cancer biology: infectious tumour cells.
Nature 443: 35-36 (2006).
*
-
Diniz-Santos DR, Jambeiro J, Mascarenhas RR, Silva LR. Massive Trichuris trichiura infection as a cause of chronic bloody diarrhea in a child.
J. Trop. Pediatr. 52: 66-68 (2006).
-
Dinnewitzer AJ, Wexner SD, Baig MK, Oberwalder M, Pishori T, Weiss EG, Efron J, Nogueras JJ, Vernava AM 3rd. Timing of restorative proctectomy following subtotal colectomy in patients with inflammatory bowel disease.
Colorectal Dis. 8: 278-182 (2006).
*
-
Dinulos JG, Darmstadt GL, Len MK, Rutledge JC, Murray KF. Infantile Crohn disease presenting with diarrhea and pyoderma gangrenosum.
Pediatr. Dermatol. 23: 43-48 (2006).
*
-
Diosdado B, Monsuur AJ, Mearin ML, Mulder C, Wijmenga C. The downstream modulator of interferon-gamma, STAT1 is not genetically associated to the Dutch coeliac disease population.
Eur. J. Hum. Genet. 14: 1120-1124 (2006).
*
-
Disanti W, Rajapakse RO, Korelitz BI, Panagopoulos G, Bratcher J. Incidence of neoplasms in patients who develop sustained leukopenia during or after treatment with 6-mercaptopurine for inflammatory bowel disease.
Clin. Gastroenterol. Hepatol. 4: 1025-1029 (2006).
-
Dishaw LJ, Herrera ML, Bigger CH. Characterization and phylogenetic analysis of a cnidarian LMP X-like cDNA.
Immunogenetics 58: 454-464 (2006).
*
-
Dissemond J, Grabbe S. Biologics in the treatment of psoriasis.
MMW Fortschr. Med. 148: 42-44 (2006).
-
Distler JH, Huber LC, Gay S, Distler O, Pisetsky DS. Microparticles as mediators of cellular cross-talk in inflammatory disease.
Autoimmunity 39: 683-690 (2006).
-
Divisi D, Di Tommaso S, Salvemini S, Garramone M, Crisci R. Diet and cancer.
Acta Biomed. Ateneo. Parmense. 77: 118-123 (2006).
-
Dixit M, Choudhuri G, Keshri LJ, Mittal B. Association of low density lipoprotein receptor related protein-associated protein (LRPAP1) gene insertion/deletion polymorphism with gallstone disease.
J. Gastroenterol. Hepatol. 21: 847-849 (2006).
*
-
Dixit M, Choudhuri G, Mittal B. Association of APOE-C1 gene cluster polymorphisms with gallstone disease.
Dig. Liver Dis. 38: 397-403 (2006).
-
Dixon A, Wurm P, Hart A, Robinson R. Distal adenomatous polyps are rare in patients with inflammatory bowel disease.
Postgrad. Med. J. 82: 76-78 (2006).
*
-
Dixon AM, Stanley BJ, Matthews EE, Dawson JP, Engelman DM. Invariant chain transmembrane domain trimerization: a step in MHC class II assembly.
Biochemistry 45: 5228-534 (2006).
*
-
Dixon H, Blanchard C, Deschoolmeester ML, Yuill NC, Christie JW, Rothenberg ME, Else KJ. The role of Th2 cytokines, chemokines and parasite products in eosinophil recruitment to the gastrointestinal mucosa during helminth infection.
Eur. J. Immunol. 36: 1753-1763 (2006).
*
-
Dixon W, Silman A. Is there an association between anti-TNF monoclonal antibody therapy in rheumatoid arthritis and risk of malignancy and serious infection? Commentary on the meta-analysis by Bongartz et al.
Arthritis Res. Ther. 8: 111 (2006).
*
-
Dixon WG, Watson K, Lunt M, Hyrich KL, Silman AJ, Symmons DP. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.
Arthritis Rheum. 54: 2368-2376 (2006).
*
-
Djavaheri-Mergny M, Amelotti M, Mathieu J, Besancon F, Bauvy C, Souquere S, Pierron G, Codogno P. NF-kappaB activation represses tumor necrosis factor-alpha-induced autophagy.
J. Biol. Chem. 281: 30373-30382 (2006).
*
-
Djeddi D, Kongolo G, Goissen C, Mounard J, Ribeiro L, Cevallos R, Gottrand F, Pautard JC. Pulmonary involvement with Crohn's disease in an adolescent.
Arch. Pediatr. 13: 202-203 (2006).
-
Djilali-Saiah I, Fakhfakh A, Louafi H, Caillat-Zucman S, Debray D, Alvarez F. HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis.
J. Hepatol. 45: 844-850 (2006).
*
-
Djukic M, Mildner A, Schmidt H, Czesnik D, Bruck W, Priller J, Nau R, Prinz M. Circulating monocytes engraft in the brain, differentiate into microglia and contribute to the pathology following meningitis in mice.
Brain 129: 2394-2403 (2006).
*
-
Djureinovic T, Skoglund J, Vandrovcova J, Zhou XL, Kalushkova A, Iselius L, Lindblom A. A genome wide linkage analysis in Swedish families with hereditary non-familial adenomatous polyposis/non-hereditary non-polyposis colorectal cancer.
Gut 55: 362-366 (2006).
*
-
Dmitriev O, Tsivkovskii R, Abildgaard F, Morgan CT, Markley JL, Lutsenko S. Solution structure of the N-domain of Wilson disease protein: distinct nucleotide-binding environment and effects of disease mutations.
Proc. Natl. Acad. Sci. U.S.A. 103: 5302-5307 (2006).
*
-
Dmitrzak-Weglarz M, Rybakowski JK, Slopien A, Czerski PM, Leszczynska-Rodziewicz A, Kapelski P, Kaczmarkiewicz-Fass M, Hauser J. Dopamine receptor D(1) gene -48A/G polymorphism is associated with bipolar illness but not with schizophrenia in a Polish population.
Neuropsychobiology 53: 46-50 (2006).
-
Do HT, Baars W, Borns K, Windhagen A, Schwinzer R. The 77C->G mutation in the human CD45 (PTPRC) gene leads to increased intensity of TCR signaling in T cell lines from healthy individuals and patients with multiple sclerosis.
J. Immunol. 176: 931-938 (2006).
*
-
do Nascimento AP, Dos Santos Trindade Viana V, de Abreu Testagrossa L, Leon EP, Borba EF, Barros RT, Bonfa E. Antibodies to ribosomal P proteins: a potential serologic marker for lupus membranous glomerulonephritis.
Arthritis Rheum. 54: 1568-1572 (2006).
*
-
do Prado R, D' Almeida VM, Guerra-Shinohara E, Galdieri LC, Terreri MT, Hilario MO. Increased concentration of plasma homocysteine in children with systemic lupus erythematosus.
Clin. Exp. Rheumatol. 24: 594-598 (2006).
-
Dobrovolna M, Vrana M, Brdicka R, Loudova M. Significance of confirmatory testing of HLA system in unrelated haematopoietic stem cell donors.
Cas. Lek. Cesk. 145: 32-35 (2006).
-
Dobrzynski E, Fitzgerald JC, Cao O, Mingozzi F, Wang L, Herzog RW. Prevention of cytotoxic T lymphocyte responses to factor IX-expressing hepatocytes by gene transfer-induced regulatory T cells.
Proc. Natl. Acad. Sci. U.S.A. 103: 4592-4597 (2006).
*
-
Dodd S, Bassi A, Bodger K, Williamson P. A comparison of multivariable regression models to analyse cost data.
J. Eval. Clin. Pract. 12: 76-86 (2006).
-
Dodeller F, Schulze-Koops H. The p38 mitogen-activated protein kinase signaling cascade in CD4 T cells.
Arthritis Res. Ther. 8: 205 (2006).
*
-
Dodge JA, Turck D. Cystic fibrosis: nutritional consequences and management.
Best Pract. Res. Clin. Gastroenterol. 20: 531-546 (2006).
-
Dodick DW. Chronic daily headache.
N. Engl. J. Med. 354: 158-165 (2006).
*
-
Doebis C, Schu S, Ladhoff J, Busch A, Beyer F, Reiser J, Nicosia RF, Broesel S, Volk HD, Seifert M. An anti-major histocompatibility complex class I intrabody protects endothelial cells from an attack by immune mediators.
Cardiovasc. Res. 72: 331-338 (2006).
*
-
Doege H, Baillie RA, Ortegon AM, Tsang B, Wu Q, Punreddy S, Hirsch D, Watson N, Gimeno RE, Stahl A. Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis.
Gastroenterology 130: 1245-1258 (2006).
*
-
Dogan Y, Akarsu S, Ustundag B, Yilmaz E, Gurgoze MK. Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children.
Mediators Inflamm. 2006: 59206 (2006).
*
-
Doganay L, Akinci B, Pekel N, Simsek I, Akpinar H. Mesalazine-induced myopericarditis in a patient with ulcerative colitis.
Int. J. Colorectal Dis. 21: 199-200 (2006).
*
-
Doggrell SA. Muraglitazar: beneficial or detrimental in the treatment of type 2 diabetes?
Expert Opin. Pharmacother. 7: 1229-1233 (2006).
-
Doggrell SA. Phosphoinositide 3-kinase-gamma as a target in rheumatoid arthritis and systemic lupus.
Expert Opin. Ther. Targets 10: 627-630 (2006).
-
Doggrell SA. New targets in and potential treatments for cholesterol gallstone disease.
Curr. Opin. Investig. Drugs 7: 344-348 (2006).
-
Doggrell SA. Bradykinin B2 receptors as a target in diabetic nephropathy.
Curr. Opin. Investig. Drugs 7: 251-255 (2006).
-
Doggrell SA. Inflammation, the key to much pathology. Highlights from the 7th World Congress on Inflammation, held August 20-24, 2005, in Melbourne, Australia.
Timely Top. Med. Cardiovasc. Dis. 10: E4 (2006).
-
Doherty MM, Poon K, Tsang C, Pang KS. Transport is not rate-limiting in morphine glucuronidation in the single pass perfused rat liver preparation.
J. Pharmacol. Exp. Ther. 317: 890-900 (2006).
*
-
Doherty R. Risk of atherosclerosis in patients with inflammatory bowel disease.
Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 6-7 (2006).
-
Doherty R. Is natalizumab effective as induction or maintenance therapy in Crohn's disease?
Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 62-63 (2006). *
-
Doherty R. Genetic and environmental risk factors for primary biliary cirrhosis.
Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 120 (2006). *
-
Doherty SD, Ni X, Doherty CB, Jones D, Zhao X, Owen LB, Duvic M. Abnormal expression of interleukin-23 in mycosis fungoides/Sezary syndrome lesions.
Arch. Dermatol. Res. 298: 353-356 (2006).
*
-
Doherty TM, Fisher EA, Arditi M. TLR signaling and trapped vascular dendritic cells in the development of atherosclerosis.
Trends Immunol. 27: 222-227 (2006).
*
-
Dohi T, Fujihashi K. Type 1 and 2 T helper cell-mediated colitis.
Curr. Opin. Gastroenterol. 22: 651-657 (2006).
-
Dokmanovic L, Urosevic J, Janic D, Jovanovic N, Petrucev B, Tosic N, Pavlovic S. Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia.
Ther. Drug Monit. 28: 800-806 (2006).
-
Dolganiuc A, Bakis G, Kodys K, Mandrekar P, Szabo G. Acute ethanol treatment modulates Toll-like receptor-4 association with lipid rafts.
Alcohol Clin. Exp. Res. 30: 76-85 (2006).
*
-
Domagk D, Fegeler W, Conrad B, Menzel J, Domschke W, Kucharzik T. Biliary tract candidiasis: diagnostic and therapeutic approaches in a case series.
Am. J. Gastroenterol. 101: 2530-2536 (2006).
*
-
Dombrecht EJ, Aerts NE, Schuerwegh AJ, Hagendorens MM, Ebo DG, Van Offel JF, Bridts CH, Stevens WJ, De Clerck LS. Influence of anti-tumor necrosis factor therapy (Adalimumab) on regulatory T cells and dendritic cells in rheumatoid arthritis.
Clin. Exp. Rheumatol. 24: 31-37 (2006).
-
Dombrowski F, Flaschka C, Klotz L, von Netzer B, Schulz C, Lehnert H, Evert M. Hepatocellular neoplasms after intrahepatic transplantation of ovarian fragments into ovariectomized rats.
Hepatology 43: 857-867 (2006).
*
-
Dombrowski F, Stieger B, Beuers U. Tauroursodeoxycholic acid inserts the bile salt export pump into canalicular membranes of cholestatic rat liver.
Lab. Invest. 86: 166-174 (2006).
*
-
Domenech E. Inflammatory bowel disease: current therapeutic options.
Digestion 73 Suppl. 1: 67-76 (2006).
*
-
Domingo-Ribas C, Bosque-Garcia M. Nasal potential difference test to diagnose cystic fibrosis.
Arch. Bronconeumol. 42: 33-38 (2006).
*
-
Dominguez EP, Choi Y, Raijman IL, Sweeney JF. Laparoscopic approach for the retrieval of retained video capsule endoscopy.
JSLS 10: 496-498 (2006).
*
-
Dommett RM, Klein N, Turner MW. Mannose-binding lectin in innate immunity: past, present and future.
Tissue Antigens 68: 193-209 (2006).
*
-
Donadio JV, Bergstralh EJ, Bibus DM, Grande JP. Is body size a biomarker for optimizing dosing of omega-3 polyunsaturated fatty acids in the treatment of patients with IgA nephropathy?
Clin. J. Am. Soc. Nephrol. 1: 933-939 (2006).
*
-
Donaldson PT, Baragiotta A, Heneghan MA, Floreani A, Venturi C, Underhill JA, Jones DE, James OF, Bassendine MF. HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study.
Hepatology 44: 667-674 (2006).
*
-
Donath MY, Ehses JA. Type 1, type 1.5, and type 2 diabetes: NOD the diabetes we thought it was.
Proc. Natl. Acad. Sci. U.S.A. 103: 12217-12218 (2006).
*
-
Dong C. Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells.
Nat. Rev. Immunol. 6: 329-333 (2006).
*
-
Dong HD, Chen XM. Immunoregulatory role of B7-H1 in chronicity of inflammatory responses.
Cell. Mol. Immunol. 3: 179-187 (2006).
*
-
Dong J, Huang ZW, Piao JH, Gong J. Association of bone mineral density with gene polymorphisms and environmental factors in Chinese postmenopausal women.
Wei Sheng Yan Jiu 35: 196-200 (2006).
-
Dong W, Liu Y, Peng J, Chen L, Zou T, Xiao H, Liu Z, Li W, Bu Y, Qi Y. The IRAK-1-BCL10-MALT1-TRAF6-TAK1 cascade mediates signaling to NF-kappa B from Toll-like receptor 4.
J. Biol. Chem. 281: 26029-26040 (2006).
*
-
Dong Y, Denny TN. HLA-A2-restricted human CD8+ cytotoxic T lymphocyte responses to a novel epitope in vaccinia virus that is conserved among orthopox viruses.
J. Infect. Dis. 194: 168-175 (2006).
*
-
Dong Y, Xu Z, Lin P. Association among serous and cerebrospinal fluid TNF-alpha level, gene polymorphisms of TNF-alpha and multiple sclerosis in Han nationality of southern China.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi 23: 677-679 (2006).
-
Doni A, Michela M, Bottazzi B, Peri G, Valentino S, Polentarutti N, Garlanda C, Mantovani A. Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: stimulation by IL-10 and inhibition by IFN-gamma.
J. Leukoc. Biol. 79: 797-802 (2006).
*
-
Donnelly R, Wang B, Qu X. Type 2 diabetes in China: partnerships in education and research to evaluate new antidiabetic treatments.
Br. J. Clin. Pharmacol. 61: 702-705 (2006).
*
-
Donnelly S, Dalton JP, Loukas A. Proteases in helminth- and allergen-induced inflammatory responses.
Chem. Immunol. Allergy 90: 45-64 (2006).
-
Donnelly S, Roake W, Brown S, Young P, Naik H, Wordsworth P, Isenberg DA, Reid KB, Eggleton P. Impaired recognition of apoptotic neutrophils by the C1q/calreticulin and CD91 pathway in systemic lupus erythematosus.
Arthritis Rheum. 54: 1543-1556 (2006).
*
-
Donohue KB, Grant JM, Tewalt EF, Palmer DC, Theoret MR, Restifo NP, Norbury CC. Cross-priming utilizes antigen not available to the direct presentation pathway.
Immunology 119: 63-73 (2006).
*
-
Dooley MA, Ginzler EM. Newer therapeutic approaches for systemic lupus erythematosus: immunosuppressive agents.
Rheum. Dis. Clin. North Am. 32: 91-102 (2006).
-
Dorak MT, Shao W, Machulla HK, Lobashevsky ES, Tang J, Park MH, Kaslow RA. Conserved extended haplotypes of the major histocompatibility complex: further characterization.
Genes Immun. 7: 450-467 (2006).
*
-
Dorer R, Odze RD. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
Am. J. Surg. Pathol. 30: 871-877 (2006).
-
Dorfmeister B, Brandlhofer S, Schaap FG, Hermann M, Furnsinn C, Hagerty BP, Stangl H, Patsch W, Strobl W. Apolipoprotein AV does not contribute to hypertriglyceridaemia or triglyceride lowering by dietary fish oil and rosiglitazone in obese Zucker rats.
Diabetologia 49: 1324-1332 (2006).
*
-
Doria A, Iaccarino L, Arienti S, Ghirardello A, Zampieri S, Rampudda ME, Cutolo M, Tincani A, Todesco S. Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases.
Reprod. Toxicol. 22: 234-241 (2006).
-
Doria A, Iaccarino L, Sarzi-Puttini P, Ghirardello A, Zampieri S, Arienti S, Cutolo M, Todesco S. Estrogens in pregnancy and systemic lupus erythematosus.
Ann. N. Y. Acad. Sci. 1069: 247-256 (2006).
*
-
Doria A, Sarzi-Puttini P, Shoenfeld Y. 2nd Conference on heart, rheumatism and autoimmunity, Pescara, Italy, May 19-20, 2005.
Autoimmun. Rev. 5: 55-63 (2006).
-
Doria AS, Karshafian R, Moineddin R, Mohanta A, Zhong A, Mendes M, Pritzker K, Jong R, Burns P. Contrast-enhanced triggered harmonic sonography for assessment of periarticular hemodynamic changes in experimental arthritis.
Pediatr. Radiol. 36: 1242-1251 (2006).
-
Dorian P. The future of atrial fibrillation therapy.
J. Cardiovasc. Electrophysiol. 17 Suppl. 2: S11-S16 (2006).
-
Dorn SD. Predictors of Crohn's disease.
Gastroenterology 131: 334-335 (2006).
*
-
Dorner T. Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.
J. Rheumatol. Suppl. 77: 3-11 (2006).
*
-
Dorner T, Haas J, Loddenkemper C, von Baehr V, Salama A. Implant-related inflammatory arthritis.
Nat. Clin. Pract. Rheumatol. 2: 53-56 (2006).
*
-
Dorner T, Kaufmann J, Wegener WA, Teoh N, Goldenberg DM, Burmester GR. Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus.
Arthritis Res. Ther. 8: R74 (2006).
*
-
Dorner T, Lipsky PE. Signalling pathways in B cells: implications for autoimmunity.
Curr. Top. Microbiol. Immunol. 305: 213-240 (2006).
-
Doron S, Gorbach SL. Probiotics: their role in the treatment and prevention of disease.
Expert Rev. Anti Infect. Ther. 4: 261-275 (2006).
-
Dorph C, Englund P, Nennesmo I, Lundberg IE. Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis.
Ann. Rheum. Dis. 65: 1565-1571 (2006).
*
-
Dos Santos KG, Canani LH, Gross JL, Tschiedel B, Souto KE, Roisenberg I. The catalase -262C/T promoter polymorphism and diabetic complications in Caucasians with type 2 diabetes.
Dis. Markers 22: 355-359 (2006).
-
Dos Santos KG, Canani LH, Gross JL, Tschiedel B, Souto KE, Roisenberg I. The -106CC genotype of the aldose reductase gene is associated with an increased risk of proliferative diabetic retinopathy in Caucasian-Brazilians with type 2 diabetes.
Mol. Genet. Metab. 88: 280-284 (2006).
*
-
Dosenko VE, Zagoriy VY, Haytovich NV, Gordok OA, Moibenko AA. Allelic polymorphism of endothelial NO-synthase gene and its functional manifestations.
Acta Biochim. Pol. 53: 299-302 (2006).
*
-
Dostal C, Pavelka K, Zvarova J, Hanzlicek P, Olejarova M. Some principles of the development of a clinical database/national register of selected inflammatory rheumatic diseases in the Czech Republic.
Int. J. Med. Inform. 75: 216-223 (2006).
*
-
Dotan I. Inflammatory bowel diseases: in search of novel cytokines and genes.
Harefuah. 145: 817-819, 861 (2006).
-
Dotan I, Chowers Y, Rachmilewitz D, Chermesh I, Lavy A, Israeli E, Karban A, Schwaber MJ, Odes S, Eliakim R. Infliximab in inflammatory bowel diseases - conference summary and suggested guidelines.
Harefuah. 145: 844-849, 860 (2006).
-
Dotan I, Fishman S, Dgani Y, Schwartz M, Karban A, Lerner A, Weishauss O, Spector L, Shtevi A, Altstock RT, Dotan N, Halpern Z. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.
Gastroenterology 131: 366-378 (2006).
*
-
Dotan N, Altstock RT, Schwarz M, Dukler A. Anti-glycan antibodies as biomarkers for diagnosis and prognosis.
Lupus 15: 442-450 (2006).
-
Dotzlaw H, Eggert M, Neeck G, Schulz M. Spots, blots, peaks and chips: proteomic approaches in autoimmune diseases.
Curr. Pharm. Des. 12: 3699-3706 (2006).
-
Douda T, Bures J, Rejchrt S, Kopacova M, Pecka M, Maly J. Mean platelet volume (MPV) in Crohn's disease patients.
Cas. Lek. Cesk. 145: 870-873 (2006).
-
Douet V, Vanwart CM, Heller MB, Reinhard S, Le Saux O. HNF4alpha and NF-E2 are key transcriptional regulators of the murine Abcc6 gene expression.
Biochim. Biophys. Acta 1759: 426-436 (2006).
*
-
Douglas KM, Ladoyanni E, Treharne GJ, Hale ED, Erb N, Kitas GD. Cutaneous abnormalities in rheumatoid arthritis compared to non-inflammatory rheumatic conditions.
Ann. Rheum. Dis. 65: 1341-1345 (2006).
*
-
Dovio A, Perazzolo L, Saba L, Termine A, Capobianco M, Bertolotto A, Angeli A. High-dose glucocorticoids increase serum levels of soluble IL-6 receptor alpha and its ratio to soluble gp130: an additional mechanism for early increased bone resorption.
Eur. J. Endocrinol. 154: 745-751 (2006).
*
-
Dow CT. Paratuberculosis and type I diabetes. Is this the trigger?
Med. Hypotheses 67: 782-785 (2006).
-
Downie-Doyle S, Bayat N, Rischmueller M, Lester S. Influence of CTLA4 haplotypes on susceptibility and some extraglandular manifestations in primary Sjogren's syndrome.
Arthritis Rheum. 54: 2434-2440 (2006).
*
-
Doyle MK, Berggren R, Magnus JH. Interferon-induced sarcoidosis.
J. Clin. Rheumatol. 12: 241-248 (2006).
-
Doyle SE, Schreckhise H, Khuu-Duong K, Henderson K, Rosler R, Storey H, Yao L, Liu H, Barahmand-Pour F, Sivakumar P, Chan C, Birks C, Foster D, Clegg CH, Wietzke-Braun P, Mihm S, Klucher KM. Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes.
Hepatology 44: 896-906 (2006).
*
-
Doyle SL, O'Neill LA. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity.
Biochem. Pharmacol. 72: 1102-1113 (2006).
*
-
Dozois EJ, Wolff BG, Tremaine WJ, Watson WJ, Drelichman ER, Carne PW, Bakken JL. Maternal and fetal outcome after colectomy for fulminant ulcerative colitis during pregnancy: case series and literature review.
Dis. Colon Rectum 49: 64-73 (2006).
*
-
Drago S, El Asmar R, Di Pierro M, Grazia Clemente M, Sapone AT, Thakar M, Iacono G, Carroccio A, D'Agate C, Not T, Zampini L, Catassi C, Fasano A. Gliadin, zonulin and gut permeability: effects on celiac and non-celiac intestinal mucosa and intestinal cell lines.
Scand. J. Gastroenterol. 41: 408-419 (2006).
*
-
Dragon-Durey MA, Fremeaux-Bacchi V. Complement component deficiencies in human disease.
Presse. Med. 35: 861-870 (2006).
-
Dragsted LO, Krath B, Ravn-Haren G, Vogel UB, Vinggaard AM, Bo Jensen P, Loft S, Rasmussen SE, Sandstrom TB, Pedersen A. Biological effects of fruit and vegetables.
Proc. Nutr. Soc. 65: 61-67 (2006).
*
-
Drake TA, Schadt EE, Lusis AJ. Integrating genetic and gene expression data: application to cardiovascular and metabolic traits in mice.
Mamm. Genome 17: 466-479 (2006).
*
-
Drakes ML, Czinn SJ, Blanchard TG. Regulation of murine dendritic cell immune responses by Helicobacter felis antigen.
Infect. Immun. 74: 4624-4633 (2006).
*
-
Dranitzki-Elhalel M, Huang JH, Rachmilewitz J, Pappo O, Parnas M, Schmidt W, Tykocinski ML. CTLA-4.FasL inhibits allogeneic responses in vivo.
Cell. Immunol. 239: 129-135 (2006).
*
-
Drastich P. Capsule endoscopy - the past, presence, and future.
Cas. Lek. Cesk. 145: 432-436 (2006).
-
Dray X, Joly F, Lavergne-Slove A, Treton X, Bouhnik Y, Messing B. A severe but reversible refractory sprue.
Gut 55: 1210-1211 (2006).
*
-
Dray X, Marteau P. Crohn's disease: nutrition should not be forgotten.
Gastroenterol. Clin. Biol. 30: 215-216 (2006).
-
Dray X, Treton X, Mazeron MC, Lavergne-Slove A, Joly F, Mimram D, Attar A, Tobelem G, Bouhnik Y. Herpes simplex virus type 1 colitis in a patient with common variable immunodeficiency syndrome.
Eur. J. Gastroenterol. Hepatol. 18: 541-544 (2006).
-
Drazen JM. Volunteers at risk.
N. Engl. J. Med. 355: 1060-1061 (2006).
*
-
DREAM Trial Investigators; Bosch J, Yusuf S, Gerstein HC, Pogue J, Sheridan P, Dagenais G, Diaz R, Avezum A, Lanas F, Probstfield J, Fodor G, Holman RR. Effect of ramipril on the incidence of diabetes.
N. Engl. J. Med. 355: 1551-1562 (2006).
*
-
Dreno B, Bettoli V, Ochsendorf F, Perez-Lopez M, Mobacken H, Degreef H, Layton A. An expert view on the treatment of acne with systemic antibiotics and/or oral isotretinoin in the light of the new European recommendations.
Eur. J. Dermatol. 16: 565-571 (2006).
-
Drenth JP, van der Meer JW. The inflammasome - a linebacker of innate defense.
N. Engl. J. Med. 355: 730-732 (2006).
*
-
Dressel A, Kolb AK, Elitok E, Bitsch A, Bogumil T, Kitze B, Tumani H, Weber F. Interferon-beta1b treatment modulates cytokines in patients with primary progressive multiple sclerosis.
Acta Neurol. Scand. 114: 368-373 (2006).
-
Drew JE, Padidar S, Horgan G, Duthie GG, Russell WR, Reid M, Duncan G, Rucklidge GJ. Salicylate modulates oxidative stress in the rat colon: a proteomic approach.
Biochem. Pharmacol. 72: 204-216 (2006).
*
-
Drew PD, Xu J, Storer PD, Chavis JA, Racke MK. Peroxisome proliferator-activated receptor agonist regulation of glial activation: relevance to CNS inflammatory disorders.
Neurochem. Int. 49: 183-189 (2006).
-
Drewes AM, Frokjaer JB, Larsen E, Reddy H, Arendt-Nielsen L, Gregersen H. Pain and mechanical properties of the rectum in patients with active ulcerative colitis.
Inflamm. Bowel Dis. 12: 294-303 (2006).
*
-
Drexler C, Wagner T. Blood group chimerism.
Curr. Opin. Hematol. 13: 484-489 (2006).
-
Drigo SA, Cunha-Neto E, Ianni B, Cardoso MR, Braga PE, Fae KC, Nunes VL, Buck P, Mady C, Kalil J, Goldberg AC. TNF gene polymorphisms are associated with reduced survival in severe Chagas' disease cardiomyopathy patients.
Microbes Infect. 8: 598-603 (2006).
*
-
Dring MM, Goulding CA, Trimble VI, Keegan D, Ryan AW, Brophy KM, Smyth CM, Keeling PWN, O’Donoghue D, O’Sullivan M, O’Morain C, Mahmud N, Wikstrom AC, Kelleher D, McManus R. The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease.
Gastroenterology 130: 341-348 (2006).
*
-
Driscoll DF. Lipid injectable emulsions: 2006.
Nutr. Clin. Pract. 21: 381-386 (2006).
-
Drivdal M, Trydal T, Hagve TA, Bergstad I, Aagenaes O. Prognosis, with evaluation of general biochemistry, of liver disease in lymphoedema cholestasis syndrome 1 (LCS1/Aagenaes syndrome).
Scand. J. Gastroenterol. 41: 465-471 (2006).
*
-
Drosera M, Facchetti F, Landolfo S, Mondini M, Nyberg F, Parodi A, Santoro A, Zampieri S, Doria A. Role of soluble and cell surface molecules in the pathogenesis of autoimmune skin diseases.
Clin. Exp. Rheumatol. 24: S7-S13 (2006).
-
Drotar D, Schwartz L, Palermo TM, Burant C. Factor structure of the child health questionnaire-parent form in pediatric populations.
J. Pediatr. Psychol. 31: 127-138 (2006).
-
Drouault-Holowacz S, Foligne B, Dennin V, Goudercourt D, Terpend K, Burckel A, Pot B. Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolerance: in vitro and in vivo considerations.
Clin. Nutr. 25: 994-1003 (2006).
-
Drozdzik A, Kurzawski M, Safronow K, Banach J. Polymorphism in interleukin-1beta gene and the risk of periodontitis in a Polish population.
Adv. Med. Sci. 51 Suppl. 1: 13-17 (2006).
-
Drozdzik M, Rudas T, Pawlik A, Kurzawski M, Czerny B, Gornik W, Herczynska M. The effect of 3435C>T MDR1 gene polymorphism on rheumatoid arthritis treatment with disease-modifying antirheumatic drugs.
Eur. J. Clin. Pharmacol. 62: 933-937 (2006).
*
-
Drumea-Mirancea M, Wessels JT, Muller CA, Essl M, Eble JA, Tolosa E, Koch M, Reinhardt DP, Sixt M, Sorokin L, Stierhof YD, Schwarz H, Klein G. Characterization of a conduit system containing laminin-5 in the human thymus: a potential transport system for small molecules.
J. Cell Sci. 119: 1396-1405 (2006).
*
-
Drummond M. Pharmacoeconomics: friend or foe?
Ann. Rheum. Dis. 65 Suppl. 3: iii44-iii47 (2006).
*
-
Dryden GW, Song M, McClain C. Polyphenols and gastrointestinal diseases.
Curr. Opin. Gastroenterol. 22: 165-170 (2006).
-
Drzewoski J, Gasiorowska A, Malecka-Panas E, Bald E, Czupryniak L. Plasma total homocysteine in the active stage of ulcerative colitis.
J. Gastroenterol. Hepatol. 21: 739-743 (2006).
*
-
du Bois TM, Deng C, Bell W, Huang XF. Fatty acids differentially affect serotonin receptor and transporter binding in the rat brain.
Neuroscience 139: 1397-1403 (2006).
*
-
Du H, Chen M, Zhang Y, Zhao MH. Non-DNA-binding antibodies in patients with lupus nephritis could recognize membrane proteins of glomerular sesangial cells.
J. Clin. Immunol. 26: 138-144 (2006).
*
-
Du M, Keeling KM, Fan L, Liu X, Kovacs T, Sorscher E, Bedwell DM. Clinical doses of amikacin provide more effective suppression of the human CFTR-G542X stop mutation than gentamicin in a transgenic CF mouse model.
J. Mol. Med. 84: 573-582 (2006).
*
-
Du Pasquier RA, Stein MC, Lima MA, Dang X, Jean-Jacques J, Zheng Y, Letvin NL, Koralnik IJ. JC virus induces a vigorous CD8(+) cytotoxic T cell response in multiple sclerosis patients.
J. Neuroimmunol. 176: 181-186 (2006).
-
Du T, Guo XH, Zhu XL, Li JH, Lu LP, Gao JR, Gou CY, Li Z, Liu Y, Li H. Association of TNF-alpha promoter polymorphisms with the outcomes of hepatitis B virus infection in Chinese Han population.
J. Viral Hepat. 13: 618-624 (2006).
*
-
Du W, Wong FS, Li MO, Peng J, Qi H, Flavell RA, Sherwin R, Wen L. TGF-beta signaling is required for the function of insulin-reactive T regulatory cells.
J. Clin. Invest. 116: 1360-1370 (2006).
*
-
Duan B, Morel L. Role of B-1a cells in autoimmunity.
Autoimmun. Rev. 5: 403-408 (2006).
-
Duan RD. Alkaline sphingomyelinase: an old enzyme with novel implications.
Biochim. Biophys. Acta 1761: 281-291 (2006).
*
-
Dubaniewicz A, Dubaniewicz-Wybieralska M, Moszkowska G, Sternau A, Dubaniewicz A. Comparative analysis of DR and DQ alleles occurrence in sarcoidosis and tuberculosis in the same ethnic group: preliminary study.
Sarcoidosis Vasc. Diffuse Lung Dis. 23: 180-189 (2006).
-
Dubcenco E, Jeejeebhoy KN, Streutker CJ, Zalev AH, Garvey MB, Kim YI, Baker JP. A patient with anemia of obscure origin: Crohn's disease in disguise.
Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 229-233 (2006).
*
-
Dubcenco E, Ottaway CA, Chen DL, Baker JP. Neurological symptoms suggestive of demyelination in Crohn's disease after infliximab therapy.
Eur. J. Gastroenterol. Hepatol. 18: 565-566 (2006).
-
Dube PE, Forse CL, Bahrami J, Brubaker PL. The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice.
Gastroenterology 131: 589-605 (2006).
*
-
Dubertret L. Psoriasis: evolution and revolution.
Med. Sci. (Paris) 22: 164-171 (2006).
-
Dubertret L. Patient-based medicine.
J. Eur. Acad. Dermatol. Venereol. 20 Suppl. 2: 73-76 (2006).
-
Dubeykovskiy A, McWhinney C, Robishaw JD. Runx-dependent regulation of G-protein gamma3 expression in T-cells.
Cell. Immunol. 240: 86-95 (2006).
*
-
Dubinsky M. Radiology, serologic markers, wireless capsule endoscopy and optical coherence tomography (past).
Inflamm. Bowel Dis. 12 Suppl. 3: S9 (2006).
-
Dubinsky MC. New patients: should children be treated differently?
Colorectal Dis. 8 Suppl. 1: 15-19 (2006).
-
Dubinsky MC, Lin YC, Dutridge D, Picornell Y, Landers CJ, Farrior S, Wrobel I, Quiros A, Vasiliauskas EA, Grill B, Israel D, Bahar R, Christie D, Wahbeh G, Silber G, Dallazadeh S, Shah P, Thomas D, Kelts D, Hershberg RM, Elson CO, Targan SR, et al. Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression.
Am. J. Gastroenterol. 101: 360-367 (2006).
*
-
Dubinsky MC, Taylor K, Targan SR, Rotter JI. Immunogenetic phenotypes in inflammatory bowel disease.
World J. Gastroenterol. 12: 3645-3650 (2006).
*
-
Dubois C, Hengerer B, Mattes H. Identification of a potent agonist of the orphan nuclear receptor Nurr1.
ChemMedChem. 1: 955-958 (2006).
-
Dubois RN. The COX-2 story: is any drug completely "safe?"
Gastroenterology 130: 6 (2006).
*
-
Dubois SG, Heilbronn LK, Smith SR, Albu JB, Kelley DE, Ravussin E. Decreased expression of adipogenic genes in obese subjects with type 2 diabetes.
Obesity (Silver Spring) 14: 1543-1552 (2006).
*
-
Dubrac S, Schmuth M. (P)PARsing epidermal development.
J. Invest. Dermatol. 126: 241-242 (2006).
*
-
Dubska M, Banga JP, Plochocka D, Hoser G, Kemp EH, Sutton BJ, Gardas A, Gora M. Structural insights into autoreactive determinants in thyroid peroxidase composed of discontinuous and multiple key contact amino acid residues contributing to epitopes recognized by patients' autoantibodies.
Endocrinology 147: 5995-6003 (2006).
*
-
Dubuquoy L, Rousseaux C, Thuru X, Peyrin-Biroulet L, Romano O, Chavatte P, Chamaillard M, Desreumaux P. PPARgamma as a new therapeutic target in inflammatory bowel diseases.
Gut 55: 1341-1349 (2006).
*
-
Duburque C, Lelong J, Iacob R, Seddik M, Desreumaux P, Fournier C, Wallaert B, Cortot A, Colombel JF. Successful induction of tolerance to infliximab in patients with Crohn's disease and prior severe infusion reactions.
Aliment. Pharmacol. Ther. 24: 851-858 (2006).
*
-
Duclos M, Gossec L, Ruyssen-Witrand A, Salliot C, Luc M, Guignard S, Dougados M. Retention rates of tumor necrosis factor blockers in daily practice in 770 rheumatic patients.
J. Rheumatol. 33: 2433-2438 (2006).
-
Ducroq D, Shalev S, Habib A, Munnich A, Kaplan J, Rozet JM. Three different ABCA4 mutations in the same large family with several consanguineous loops affected with autosomal recessive cone-rod dystrophy.
Eur. J. Hum. Genet. 14: 1269-1273 (2006).
*
-
Dudas PL, Mentone S, Greineder CF, Biemesderfer D, Aronson PS. Immunolocalization of anion transporter Slc26a7 in mouse kidney.
Am. J. Physiol. Renal Physiol. 290: F937-F945 (2006).
*
-
Duddy M, Bar-Or A. B-cells in multiple sclerosis.
Int. M.S. J. 13: 84-90 (2006).
*
-
Dudesek A, Zettl UK. Intravenous immunoglobulins as therapeutic option in the treatment of multiple sclerosis.
J. Neurol. 253 Suppl. 5: v50-v58 (2006).
-
Dudler J, Li J, Pagnotta M, Pascual M, von Segesser LK, Vassalli G. Gene transfer of programmed death ligand-1.Ig prolongs cardiac allograft survival.
Transplantation 82: 1733-1737 (2006).
-
Duek A, Shvidel L, Braester A, Berrebi A. Clinical and immunologic aspects of B chronic lymphocytic leukemia associated with autoimmune disorders.
Isr. Med. Assoc. J. 8: 828-831 (2006).
*
-
Duenas AI, Aceves M, Orduna A, Diaz R, Sanchez Crespo M, Garcia-Rodriguez C. Francisella tularensis LPS induces the production of cytokines in human monocytes and signals via Toll-like receptor 4 with much lower potency than E. coli LPS.
Int. Immunol. 18: 785-795 (2006).
*
-
Duerksen DR, Fallows G, Bernstein CN. Vitamin B12 malabsorption in patients with limited ileal resection.
Nutrition 22: 1210-1213 (2006).
*
-
Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW, Kistner EO, Schumm LP, Lee A, Gregersen PK, Barmada MM, Rotter JI, Nicolae DL, Cho JH. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.
Science 315: 1461-1463 (2006).
*
-
Duez C, Gosset P, Tonnel AB. Dendritic cells and Toll-like receptors in allergy and asthma.
Eur. J. Dermatol. 16: 12-16 (2006).
*
-
Dufaitre-Patouraux L, Riveline J, Renard E, Melki V, Belicar-Schaepelynck P, Selam J, Guerci B, Millot L, Brun J, Fermon C, Catargi B, Gin H, Jeandidier N, Lejeune P, Lassmann-Vague V. Continuous intraperitoneal insulin infusion does not increase the risk of organ-specific autoimmune disease in type 1 diabetic patients: results of a multicentric, comparative study.
Diabetes Metab. 32: 427-432 (2006).
*
-
Duff A, Ball R, Wolfe S, Blyth H, Brownlee K. Betterland: an interactive CD-ROM guide for children with cystic fibrosis.
Paediatr. Nurs. 18: 30-33 (2006).
-
Duffield JS, Hong S, Vaidya VS, Lu Y, Fredman G, Serhan CN, Bonventre JV. Resolvin D series and protectin D1 mitigate acute kidney injury.
J. Immunol. 177: 5902-5911 (2006).
*
-
Duffy JE, Zelikoff JT. The relationship between noncoplanar PCB-induced immunotoxicity and hepatic CYP1A induction in a fish model.
J. Immunotoxicol. 3: 39-47 (2006).
-
Dufner A, Pownall S, Mak TW. Caspase recruitment domain protein 6 is a microtubule-interacting protein that positively modulates NF-KB activation.
Proc. Natl. Acad. Sci. U.S.A. 103: 988-993 (2006).
*
-
Dufour JF, Fey MF. What is the current treatment of PTLD after liver transplantation?
J. Hepatol. 44: 23-26 (2006).
*
-
Dufour JF, Oneta CM, Gonvers JJ, Bihl F, Cerny A, Cereda JM, Zala JF, Helbling B, Steuerwald M, Zimmermann A; Swiss Association for the Study of the Liver. Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin E in nonalcoholic steatohepatitis.
Clin. Gastroenterol. Hepatol. 4: 1537-1543 (2006).
*
-
Dukkipati VS, Blair HT, Garrick DJ, Murray A. 'Ovar-Mhc' - ovine major histocompatibility complex: structure and gene polymorphisms.
Genet. Mol. Res. 5: 581-608 (2006).
*
-
Dukkipati VS, Blair HT, Garrick DJ, Murray A. Ovar-Mhc - Ovine major histocompatibility complex: role in genetic resistance to diseases.
N. Z. Vet. J. 54: 153-160 (2006).
-
Dulai GS, Jensen DM. Treatment of watermelon stomach.
Curr. Treat. Options Gastroenterol. 9: 175-180 (2006).
-
Dulic-Sills A, Blunden MJ, Mawdsley J, Bastin AJ, McAuley D, Griffiths M, Rampton DS, Yaqoob MM, Macey MG, Agrawal SG. New flow cytometric technique for the evaluation of circulating endothelial progenitor cell levels in various disease groups.
J. Immunol. Methods 316: 107-115 (2006).
-
Dulos J, Boots AH. DHEA metabolism in arthritis: a role for the p450 enzyme Cyp7b at the immune-endocrine crossroad.
Ann. N. Y. Acad. Sci. 1069: 401-413 (2006).
*
-
Dumas ME, Barton RH, Toye A, Cloarec O, Blancher C, Rothwell A, Fearnside J, Tatoud R, Blanc V, Lindon JC, Mitchell SC, Holmes E, McCarthy MI, Scott J, Gauguier D, Nicholson JK. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice.
Proc. Natl. Acad. Sci. U.S.A. 103: 12511-12516 (2006).
*
-
Dumot JA. ERCP: current uses and less-invasive options.
Cleve. Clin. J. Med. 73: 418, 421, 424-425 (2006).
*
-
Duncan RE, Archer MC. Farnesol induces thyroid hormone receptor (THR) beta1 but inhibits THR-mediated signaling in MCF-7 human breast cancer cells.
Biochem. Biophys. Res. Commun. 343: 239-243 (2006).
*
-
Dunehoo AL, Anderson M, Majumdar S, Kobayashi N, Berkland C, Siahaan TJ. Cell adhesion molecules for targeted drug delivery.
J. Pharm. Sci. 95: 1856-1872 (2006).
*
-
Dunford PJ, O'Donnell N, Riley JP, Williams KN, Karlsson L, Thurmond RL. The histamine H4 receptor mediates allergic airway inflammation by regulating the activation of CD4+ T cells.
J. Immunol. 176: 7062-7070 (2006).
*
-
Dunn AJ. Effects of cytokines and infections on brain neurochemistry.
Clin. Neurosci. Res. 6: 52-68 (2006).
-
Dunn GP, Koebel CM, Schreiber RD. Interferons, immunity and cancer immunoediting.
Nat. Rev. Immunol. 6: 836-848 (2006).
*
-
Dunn SE, Youssef S, Goldstein MJ, Prod'homme T, Weber MS, Zamvil SS, Steinman L. Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin.
J. Exp. Med. 203: 401-412 (2006).
*
-
Dunn W, Angulo P, Sanderson S, Jamil LH, Stadheim L, Rosen C, Malinchoc M, Kamath PS, Shah VH. Utility of a new model to diagnose an alcohol basis for steatohepatitis.
Gastroenterology 131: 1057-1063 (2006).
*
-
Dunne C, McGuigan C, Crowley J, Hagan R, Rooney G, Kelleher J, Hutchinson M, Lawlor E. Human leucocyte antigen class II polymorphism in Irish patients with multiple sclerosis.
Tissue Antigens 68: 257-262 (2006).
*
-
Duong FH, Christen V, Filipowicz M, Heim MH. S-Adenosylmethionine and betaine correct hepatitis C virus induced inhibition of interferon signaling in vitro.
Hepatology 43: 796-806 (2006).
*
-
Duparc A, Staumont-Salle D, Broly F, Piette F, Delaporte E. Treatment of chronic lupus erythematosus with sulfasalazine in 18 patients: reappraisal.
Presse. Med. 35: 1138-1142 (2006).
-
Dupas B, Gournay J, Frampas E, Leaute F, Le Borgne J. Anicteric cholestasis: imaging and diagnostic strategy.
J. Radiol. 87: 441-459 (2006).
-
Duplan V, Foulquier C, Clavel C, Al Badine R, Serre G, Saoudi A, Sebbag M. In the rat, citrullinated autologous fibrinogen is immunogenic but the induced autoimmune response is not arthritogenic.
Clin. Exp. Immunol. 145: 502-512 (2006).
*
-
DuPont HL. Travellers' diarrhoea: contemporary approaches to therapy and prevention.
Drugs 66: 303-314 (2006).
-
Dupuy d'Angeac A, Stefas I, Graafland H, de Lamotte F, Rucheton M, Palais C, Eriksson AK, Bosc P, Rose C, Chicheportiche R. Biotinylation of glycan chains of beta2 glycoprotein I induces dimerisation of the molecule and its detection by the human autoimmune anti-cardiolipin antibody EY2C9.
Biochem. J. 393: 117-127 (2006).
*
-
Dupuy J, Lespine A, Sutra JF, Alvinerie M. The interaction between moxidectin and MDR transporters in primary cultures of rat hepatocytes.
J. Vet. Pharmacol. Ther. 29: 107-111 (2006).
-
Durand F. Risk scores in cirrhotic patients: from non-transplant surgery to transplantation and back.
J. Hepatol. 44: 620-621 (2006).
*
-
Durcan N, Costello RW, McLean WG, Blusztajn J, Madziar B, Fenech AG, Hall IP, Gleich GJ, McGarvey L, Walsh MT. Eosinophil-mediated cholinergic nerve remodeling.
Am. J. Respir. Cell. Mol. Biol. 34: 775-786 (2006).
*
-
Duret C, Daujat-Chavanieu M, Pascussi JM, Pichard-Garcia L, Balaguer P, Fabre JM, Vilarem MJ, Maurel P, Gerbal-Chaloin S. Ketoconazole and miconazole are antagonists of the human glucocorticoid receptor: consequences on the expression and function of the constitutive androstane receptor and the pregnane X receptor.
Mol. Pharmacol. 70: 329-339 (2006).
*
-
Durga J, van Boxtel MP, Schouten EG, Bots ML, Kok FJ, Verhoef P. Folate and the methylenetetrahydrofolate reductase 677C-->T mutation correlate with cognitive performance.
Neurobiol. Aging 27: 334-343 (2006).
-
Duriagin S, Ofori H, Jagodzinski PP. Flow cytometric analysis of CD4+ T cell receptor zeta chain deficiency in patients with systemic lupus erythematosus.
Adv. Med. Sci. 51: 181-183 (2006).
-
Durinovic-Bello I, Rosinger S, Olson JA, Congia M, Ahmad RC, Rickert M, Hampl J, Kalbacher H, Drijfhout JW, Mellins ED, Al Dahouk S, Kamradt T, Maeurer MJ, Nhan C, Roep BO, Boehm BO, Polychronakos C, Nepom GT, Karges W, McDevitt HO, Sonderstrup G. DRB1*0401-restricted human T cell clone specific for the major proinsulin73-90 epitope expresses a down-regulatory T helper 2 phenotype.
Proc. Natl. Acad. Sci. U.S.A. 103: 11683-11688 (2006).
*
-
Dusinska M, Dzupinkova Z, Wsolova L, Harrington V, Collins AR. Possible involvement of XPA in repair of oxidative DNA damage deduced from analysis of damage, repair and genotype in a human population study.
Mutagenesis 21: 205-211 (2006).
*
-
Dustin ML. Immunology. When F-actin becomes too much of a good thing.
Science 313: 767-768 (2006).
*
-
Dustin ML, Zhu C. T cells like a firm molecular handshake.
Proc. Natl. Acad. Sci. U.S.A. 103: 4335-4336 (2006).
*
-
Duthie MS, Kahn SJ. During acute Trypanosoma cruzi infection highly susceptible mice deficient in natural killer cells are protected by a single alpha-galactosylceramide treatment.
Immunology 119: 355-361 (2006).
*
-
Duttala S, Tobi M, Dingell JD. Complementary stimulation of hepatobiliary transport and detoxification by rifampicin and ursodeoxycholic acid in humans.
Gastroenterology 130: 619-620 (2006).
*
-
Dutz JP. The skin as a site of initiation of systemic autoimmune disease: new opportunities for treatment.
J. Invest. Dermatol. 126: 1209-1212 (2006).
*
-
Duvnjak M, Lerotic I, Tomasic V, Pavic T, Virovic L. Inflammatory bowel disease and pregnancy.
Lijec. Vjesn. 128: 48-55 (2006).
-
Dvornyk V, Long JR, Liu PY, Shen H, Recker RR, Deng HW. Polymorphisms of the vitamin D receptor gene predict the onset of surgical menopause in Caucasian females.
Gynecol. Endocrinol. 22: 552-556 (2006).
-
Dwarakanathan A. Diabetes update.
J. Insur. Med. 38: 20-30 (2006).
-
Dyment DA, Yee IM, Ebers GC, Sadovnick AD. Multiple sclerosis in stepsiblings: recurrence risk and ascertainment.
J. Neurol. Neurosurg. Psychiatry 77: 258-259 (2006).
*
-
Dyszkiewicz A, Janik P, Janik M. Preliminary dielectric studies of knee swelling fluid in the case of arthritis, which is hard to diagnose.
Physiol. Meas. 27: 1345-1359 (2006).
-
Dzhambazov B, Nandakumar KS, Kihlberg J, Fugger L, Holmdahl R, Vestberg M. Therapeutic vaccination of active arthritis with a glycosylated collagen type II peptide in complex with MHC class II molecules.
J. Immunol. 176: 1525-1533 (2006).
*
-
Dzierzanowska-Fangrat K, Nilsson I, Wozniak M, Jozwiak P, Rozynek E, Woynarowski M, Socha J, Ljungh A, Wadstrom T. Lack of an association between Helicobacter infection and autoimmune hepatitis in children.
Pol. J. Microbiol. 55: 157-159 (2006).
-
Dzik JM. Molecules released by helminth parasites involved in host colonization.
Acta Biochim. Pol. 53: 33-64 (2006).
-
Eapen C, Roberts-Thomson I. Autoimmune hepatitis.
J. Gastroenterol. Hepatol. 21: 1756-1757 (2006).
*
-
Eapen C, Roberts-Thomson I. Primary sclerosing cholangitis.
J. Gastroenterol. Hepatol. 21: 1862 (2006).
*
-
East JE, Suzuki N, von Herbay A, Saunders BP. Narrow band imaging with magnification for dysplasia detection and pit pattern assessment in ulcerative colitis surveillance: a case with multiple dysplasia associated lesions or masses.
Gut 55: 1432-1435 (2006).
*
-
Eaton KA, Benson LH, Haeger J, Gray BM. Role of transcription factor T-bet expression by CD4+ cells in gastritis due to Helicobacter pylori in mice.
Infect. Immun. 74: 4673-4684 (2006).
*
-
Eaton WW, Byrne M, Ewald H, Mors O, Chen CY, Agerbo E, Mortensen PB. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers.
Am. J. Psychiatry 163: 521-528 (2006).
*
-
Ebers GC. Disease evolution in multiple sclerosis.
J. Neurol. 253: vi3-vi8 (2006).
*
-
Ebert EC, Geng X, Lin J, Das KM. Autoantibodies against human tropomyosin isoform 5 in ulcerative colitis destroys colonic epithelial cells through antibody and complement-mediated lysis.
Cell. Immunol. 244: 43-49 (2006).
*
-
Ebert R, Schutze N, Adamski J, Jakob F. Vitamin D signaling is modulated on multiple levels in health and disease.
Mol. Cell. Endocrinol. 248: 149-159 (2006).
-
Ebrahimkhani MR, Kiani S, Oakley F, Kendall T, Shariftabrizi A, Tavangar SM, Moezi L, Payabvash S, Karoon A, Hoseininik H, Mann DA, Moore KP, Mani AR, Dehpour AR. Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats.
Gut 55: 1606-1616 (2006).
*
-
Ebringer A, Rashid T. Rheumatoid arthritis is an autoimmune disease triggered by Proteus urinary tract infection.
Clin. Dev. Immunol. 13: 41-48 (2006).
*
-
Eccleston A, Dhand R. Signalling in cancer.
Nature 441: 423 (2006).
*
-
Eckert M, Wittmann I, Rollinghoff M, Gessner A, Schnare M. Endotoxin-induced expression of murine bactericidal permeability/increasing protein is mediated exclusively by Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta-dependent pathways.
J. Immunol. 176: 522-528 (2006).
*
-
Eckmann L. Animal models of inflammatory bowel disease: lessons from enteric infections.
Ann. N. Y. Acad. Sci. 1072: 28-38 (2006).
*
-
Eckmann L. Sensor molecules in intestinal innate immunity against bacterial infections.
Curr. Opin. Gastroenterol. 22: 95-101 (2006).
-
Eckstein TM, Chandrasekaran S, Mahapatra S, McNeil MR, Chatterjee D, Rithner CD, Ryan PW, Belisle JT, Inamine JM. A major cell wall lipopeptide of Mycobacterium avium subspecies paratuberculosis.
J. Biol. Chem. 281: 5209-5215 (2006).
*
-
Edelblum KL, Yan F, Yamaoka T, Polk DB. Regulation of apoptosis during homeostasis and disease in the intestinal epithelium.
Inflamm. Bowel Dis. 12: 413-424 (2006).
*
-
Edelman DA, Jiang Y, Tyburski J, Wilson RF, Steffes C. Toll-like receptor-4 message is up-regulated in lipopolysaccharide-exposed rat lung pericytes.
J. Surg. Res. 134: 22-27 (2006).
*
-
Edge V. A lifelong journey.
Nurs. Stand. 20: 20-21 (2006).
-
Edwards CJ, Cooper C. Early environmental factors and rheumatoid arthritis.
Clin. Exp. Immunol. 143: 1-5 (2006).
*
-
Edwards CJ, Cooper C. Early environmental exposure and the development of lupus.
Lupus 15: 814-819 (2006).
-
Edwards CJ, James JA. Making lupus: a complex blend of genes and environmental factors is required to cross the disease threshold.
Lupus 15: 713-714 (2006).
-
Edwards JC. The CLIC1 chloride channel is regulated by the cystic fibrosis transmembrane conductance regulator when expressed in Xenopus oocytes.
J. Membr. Biol. 213: 39-46 (2006).
*
-
Edwards JC, Cambridge G. B-cell targeting in rheumatoid arthritis and other autoimmune diseases.
Nat. Rev. Immunol. 6: 394-403 (2006).
*
-
Edwards JC, Cambridge G, Leandro MJ. B cell depletion therapy in rheumatic disease.
Best Pract. Res. Clin. Rheumatol. 20: 915-928 (2006).
-
Edwards JR, Sun SG, Locklin R, Shipman CM, Adamopoulos IE, Athanasou NA, Sabokbar A. LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis.
Arthritis Rheum. 54: 1451-1462 (2006).
*
-
Edwards RA, Smock AZ. Defective arachidonate release and PGE2 production in Gialpha2-deficient intestinal and colonic subepithelial myofibroblasts.
Inflamm. Bowel Dis. 12: 153-165 (2006).
*
-
Eeckhoute J, Briche I, Kurowska M, Formstecher P, Laine B. Hepatocyte nuclear factor 4 alpha ligand binding and F domains mediate interaction and transcriptional synergy with the pancreatic islet LIM HD transcription factor Isl1.
J. Mol. Biol. 364: 567-581 (2006).
*
-
Eelen G, Verlinden L, De Clercq P, Vandewalle M, Bouillon R, Verstuyf A. Vitamin D analogs and coactivators.
Anticancer Res. 26: 2717-2721 (2006).
-
Efrat B, Iris G, Wang H, Eitan S, Yona K. A subgroup of first-degree relatives of Crohn's disease patients shows a profile of inflammatory markers in the blood which is more typical of Crohn's disease patients than of normal individuals.
Mediators Inflamm. 2006: 74785 (2006).
*
-
Efstratiadis G, Tsiaousis G, Leontsini M, Nikolaidis N, Dimitriadis C, Memmos D. Renal cancer in a patient with Crohn's disease and secondary amyloidosis.
J. Nephrol. 19: 518-520 (2006).
-
Efthimiou P. Tumor necrosis factor-alpha in inflammatory myopathies: pathophysiology and therapeutic implications.
Semin. Arthritis Rheum. 36: 168-172 (2006).
*
-
Efthimiou P, Georgy S. Pathogenesis and management of adult-onset Still's disease.
Semin. Arthritis Rheum. 36: 144-152 (2006).
*
-
Efthimiou P, Paik P, Bielory L. Diagnosis and management of adult onset Still's disease.
Ann. Rheum. Dis. 65: 564-572 (2006).
*
-
Egan LJ, Derijks LJ, Hommes DW. Pharmacogenomics in inflammatory bowel disease.
Clin. Gastroenterol. Hepatol. 4: 21-28 (2006).
*
-
Egan LJ, Toruner M. NF-kappaB signaling: pros and cons of altering NF-kappaB as a therapeutic approach.
Ann. N. Y. Acad. Sci. 1072: 114-122 (2006).
*
-
Eggebeen AT, Wasko MC. Aggressive therapy in patients with stable, long-standing rheumatoid arthritis-does it make a difference?
Nat. Clin. Pract. Rheumatol. 2: 530-531 (2006). *
-
Egger SS, Studer IG, Bravo AE, Krahenbuhl S. Minocycline-induced lupus erythematodes.
Schweiz. Rundsch. Med. Prax. 95: 1297-1303 (2006).
-
Ehlers M, Fukuyama H, McGaha TL, Aderem A, Ravetch JV. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE.
J. Exp. Med. 203: 553-561 (2006).
*
-
Ehlhardt S, Seifert M, Schneider J, Ojak A, Zang KD, Mehraein Y. Human endogenous retrovirus HERV-K(HML-2) Rec expression and transcriptional activities in normal and rheumatoid arthritis synovia.
J. Rheumatol. 33: 16-23 (2006).
-
Ehret MJ, Levin GM, Narasimhan M, Rathinavelu A. Venlafaxine induces P-glycoprotein in human Caco-2 cells.
Hum. Psychopharmacol. 22: 49-53 (2006).
-
Ehrhardt C, Collnot EM, Baldes C, Becker U, Laue M, Kim KJ, Lehr CM. Towards an in vitro model of cystic fibrosis small airway epithelium: characterisation of the human bronchial epithelial cell line CFBE41o-
Cell Tissue Res. 323: 405-415 (2006).
*
-
Ehringer MA, Rhee SH, Young S, Corley R, Hewitt JK. Genetic and environmental contributions to common psychopathologies of childhood and adolescence: a study of twins and their siblings.
J. Abnorm. Child. Psychol. 34: 1-17 (2006).
-
Eid AJ, Brown RA, Razonable RR. Toll-like receptor-2 Arg753Gln polymorphism and herpes virus infections in transplantation.
Transplantation 82: 1383-1385 (2006).
-
Eid HM, Arnesen H, Hjerkinn EM, Lyberg T, Ellingsen I, Seljeflot I. Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine. A randomized controlled trial.
Nutr. Metab. (Lond.) 3: 4 (2006).
*
-
Einstein O, Grigoriadis N, Mizrachi-Kol R, Reinhartz E, Polyzoidou E, Lavon I, Milonas I, Karussis D, Abramsky O, Ben-Hur T. Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis.
Exp. Neurol. 198: 275-284 (2006).
*
-
Eisen GM. The economics of PillCam.
Gastrointest. Endosc. Clin. N. Am. 16: 337-345 (2006).
-
Eisenberg R. Targeting B cells in systemic lupus erythematosus: not just deja vu all over again.
Arthritis Res. Ther. 8: 108 (2006).
*
-
Eisenberg R, Albert D. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
Nat. Clin. Pract. Rheumatol. 2: 20-27 (2006).
*
-
Eisenhut M. Changes in ion transport in inflammatory disease.
J. Inflamm. (Lond.) 3: 5 (2006).
*
-
Eisenlohr LC, Rothstein JL. Oncogenic inflammation and autoimmune disease.
Autoimmun. Rev. 6: 107-114 (2006).
-
Eisinger AL, Nadauld LD, Shelton DN, Peterson PW, Phelps RA, Chidester S, Stafforini DM, Prescott SM, Jones DA. The adenomatous polyposis coli tumor suppressor gene regulates expression of cyclooxygenase-2 by a mechanism that involves retinoic acid.
J. Biol. Chem. 281: 20474-20482 (2006).
*
-
Ejrnaes M, Filippi CM, Martinic MM, Ling EM, Togher LM, Crotty S, von Herrath MG. Resolution of a chronic viral infection after interleukin-10 receptor blockade.
J. Exp. Med. 203: 2461-2472 (2006).
*
-
Ejrnaes M, von Herrath MG, Christen U. Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies.
Clin. Dev. Immunol. 13: 67-77 (2006).
*
-
Ejrnaes M, von Herrath MG, Christen U. Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies.
Clin. Dev. Immunol. 13: 337-347 (2006).
*
-
Ek J, Hansen SP, Lajer M, Nicot C, Boesgaard TW, Pruhova S, Johansen A, Albrechtsen A, Yderstraede K, Lauenborg J, Parrizas M, Boj SF, Jorgensen T, Borch-Johnsen K, Damm P, Ferrer J, Lebl J, Pedersen O, Hansen T. A novel -192c/g mutation in the proximal P2 promoter of the hepatocyte nuclear factor-4alpha gene (HNF4A) associates with late-onset diabetes.
Diabetes 55: 1869-1873 (2006).
*
-
Ekbom A. Can we predict the natural history of IBD?
Falk Symposium 154: INFLAMMATORY BOWEL DISEASE - DIAGNOSTIC AND THERAPEUTIC STRATEGIES, Moscow (Russia), June 9 - 10, 2006, pp. 29-30 (2006). *
-
Eken H, Ozturk H, Ozturk H, Buyukbayram H. Dose-related effects of dexamethasone on liver damage due to bile duct ligation in rats.
World J. Gastroenterol. 12: 5379-5383 (2006).
*
-
Ekins S, Andreyev S, Rybadov A, Kirillov E, Rakhmatulin EA, Sorokina S, Bugrim A, Nikolskaya T. A combined approach to drug metabolism and toxicity assessment.
Drug Metab. Dispos. 34: 495-503 (2006).
*
-
Eklund C, Huttunen R, Syrjanen J, Laine J, Vuento R, Hurme M. Polymorphism of the C-reactive protein gene is associated with mortality in bacteraemia.
Scand. J. Infect. Dis. 38: 1069-1073 (2006).
*
-
Ekroos M, Sjogren T. Structural basis for ligand promiscuity in cytochrome P450 3A4.
Proc. Natl. Acad. Sci. U.S.A. 103: 13682-13687 (2006).
*
-
Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, Kechagias S. Long-term follow-up of patients with NAFLD and elevated liver enzymes.
Hepatology 44: 865-873 (2006).
*
-
Eksteen B, Miles A, Curbishley SM, Tselepis C, Grant AJ, Walker LS, Adams DH. Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10.
J. Immunol. 177: 593-603 (2006).
*
-
El AA, Han Y, Lesniak MS. Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors.
J. Neurosurg. 105: 430-437 (2006).
*
-
El Alaoui S, Gresti C. Development of an immunocapture method for measuring IgA antibodies to tissue transglutaminase in the sera of patients with coeliac disease.
Clin. Exp. Immunol. 144: 101-109 (2006).
*
-
El Andaloussi A, Lesniak MS. An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme.
Neuro-oncol. 8: 234-243 (2006).
-
El Fassi D, Nielsen CH, Hasselbalch HC, Hegedus L. The rationale for B lymphocyte depletion in Graves' disease. Monoclonal anti-CD20 antibody therapy as a novel treatment option.
Eur. J. Endocrinol. 154: 623-632 (2006).
*
-
El Kasmi KC, Holst J, Coffre M, Mielke L, de Pauw A, Lhocine N, Smith AM, Rutschman R, Kaushal D, Shen Y, Suda T, Donnelly RP, Myers MG Jr, Alexander W, Vignali DA, Watowich SS, Ernst M, Hilton DJ, Murray PJ. General nature of the STAT3-activated anti-inflammatory response.
J. Immunol. 177: 7880-7888 (2006).
*
-
El Midaoui A, Wu L, Wang R, de Champlain J. Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats.
Am. J. Hypertens. 19: 407-412 (2006).
-
El Miedany Y, Youssef S, Ahmed I, El Gaafary M. The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases.
Am. J. Gastroenterol. 101: 311-317 (2006).
*
-
El Mokhtari NE, Ott SJ, Nebel A, Simon R, Schreiber S. A functional variant in the CARD4 gene and risk of premature coronary heart disease.
Int. J. Immunogenet. 33: 307-311 (2006).
*
-
El Mouzan MI, Abdullah AM, Al Habbal MT. Epidemiology of juvenile-onset inflammatory bowel disease in Central Saudi Arabia.
J. Trop. Pediatr. 52: 69-71 (2006).
-
El Sayed F, Dhaybi R, Ammoury A, Chababi M, Bazex J. Myasthenia gravis with cutaneous polyarteritis nodosa.
Clin. Exp. Dermatol. 31: 215-217 (2006).
*
-
El-Achkar TM, Dagher PC. Renal Toll-like receptors: recent advances and implications for disease.
Nat. Clin. Pract. Nephrol. 2: 568-581 (2006).
-
El-Andaloussi S, Johansson HJ, Lundberg P, Langel U. Induction of splice correction by cell-penetrating peptide nucleic acids.
J. Gene Med. 8: 1262-1273 (2006).
-
El-Awar N, Cook D, Terasaki PI. HLA class I epitopes: A and B loci.
Clin. Transpl. 2006: 79-94 (2006).
-
El-Chennawi FA, Kamel HA, Mosaad YM, El-Sherbini SM, El-Billey NA. Impact of CD31 mismatches on the outcome of hematopoeitic stem cell transplant of HLA-identical sibling.
Hematology 11: 227-234 (2006).
-
El-Karaksy HM, El-Hawary MI, El-Koofy NM, El-Sayed R, El-Raziky MA, Mansour SA, Taha GM, El-Mougy F. Safety and efficacy of hepatitis A vaccine in children with chronic liver disease.
World J. Gastroenterol. 12: 7337-7340 (2006).
*
-
El-Khayat HA, El-Hodhod MA, Abd El-Basset FZ, Tomoum HY, El-Safory HA, Hamdy AM. Rectal bleeding in Egyptian children.
Ann. Trop. Paediatr. 26: 337-344 (2006).
-
El-Matary W, Jaffray B, Scott J, Hodges S. Portal pyaemia as a presenting feature of paediatric Crohn disease.
J. Pediatr. Gastroenterol. Nutr. 43: 260-262 (2006).
*
-
El-Obeid A, Hassib A, Ponten F, Westermark B. Effect of herbal melanin on IL-8: a possible role of Toll-like receptor 4 (TLR4).
Biochem. Biophys. Res. Commun. 344: 1200-1206 (2006).
*
-
El-Sehemy MS, Al-Saaran AM, Baddour NM, Adam AG, Moez PE. Comparative clinical prospective therapeutic study between cyclophosphamide, cyclosporine and azathioprine in the treatment of lupus nephritis.
Egypt. J. Immunol. 13: 39-52 (2006).
-
El-Shabrawi Y, Wegscheider BJ, Weger M, Renner W, Posch U, Ulrich S, Ardjomand N, Hermann J. Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations.
Ophthalmology 113: 695-700 (2006).
-
El-Shanti H, Majeed HA, El-Khateeb M. Familial Mediterranean fever in Arabs.
Lancet 367: 1016-1024 (2006).
*
-
El-Tanani MK, Campbell FC, Crowe P, Erwin P, Harkin DP, Pharoah P, Ponder B, Rudland PS. BRCA1 suppresses osteopontin-mediated breast cancer.
J. Biol. Chem. 281: 26587-2601 (2006).
*
-
El-Tanani MK, Campbell FC, Kurisetty V, Jin D, McCann M, Rudland PS. The regulation and role of osteopontin in malignant transformation and cancer.
Cytokine Growth Factor Rev. 17: 463-474 (2006).
-
El-Taukhy MA, Salama SM, Abou-Shousha SA, Ismail SS, Saleh M. Effects of chronic ethanol and vitamin C administration on production of tumor necrosis factor-alpha and interleukin-6 in rats.
Egypt. J. Immunol. 13: 1-10 (2006).
-
Elahi E, Khodadad A, Kupershmidt I, Ghasemi F, Alinasab B, Naghizadeh R, Eason RG, Amini M, Esmaili M, Esmaeili Dooki MR, Sanati MH, Davis RW, Ronaghi M, Thorstenson YR. A haplotype framework for cystic fibrosis mutations in Iran.
J. Mol. Diagn. 8: 119-127 (2006).
*
-
Eland IA, Sundstrom A, Velo GP, Andersen M, Sturkenboom MC, Langman MJ, Stricker BH, Wiholm B, For The Edip Study Group Of The European Pharmacovigilance Research Group. Antihypertensive medication and the risk of acute pancreatitis: the European case-control study on drug-induced acute pancreatitis (EDIP).
Scand. J. Gastroenterol. 41: 1484-1490 (2006).
*
-
Elder JT. PSORS1: linking genetics and immunology.
J. Invest. Dermatol. 126: 1205-1206 (2006).
*
-
Eldor R, Yeffet A, Baum K, Doviner V, Amar D, Ben-Neriah Y, Christofori G, Peled A, Carel JC, Boitard C, Klein T, Serup P, Eizirik DL, Melloul D. Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents.
Proc. Natl. Acad. Sci. U.S.A. 103: 5072-5077 (2006).
*
-
Elefteriou F, Benson MD, Sowa H, Starbuck M, Liu X, Ron D, Parada LF, Karsenty G. ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae.
Cell. Metab. 4: 441-451 (2006).
*
-
Eleftheriadis T, Voyatzi S, Antoniadi G, Kartsios C, Liakopoulos V, Paraskevopoulos P, Galaktidou G. Major histocompatibility complex class I restricted T-cell autoreactivity in human peripheral blood mononuclear cells.
Cell. Immunol. 240: 62-67 (2006).
*
-
Eliakim AR. Video capsule endoscopy of the small bowel (PillCam SB).
Curr. Opin. Gastroenterol. 22: 124-127 (2006).
-
Elias D, Avron A, Tamir M, Raz I. DiaPep277(R) preserves endogenous insulin production by immunomodulation in type 1 diabetes.
Ann. N. Y. Acad. Sci. 1079: 340-344 (2006).
*
-
Elias E. Hepatology highlights.
Hepatology 43: 1175-1176 (2006).
*
-
Elias E. Hepatology highlights.
Hepatology 44: 519-520 (2006).
*
-
Elias E. Liver failure and liver disease.
Hepatology 43: S239-S242 (2006).
*
-
Elias E. Hepatology highlights.
Hepatology 44: 1374-1375 (2006).
*
-
Elikowski W, Malek M, Lewandowska M, Kawczynski S, Dobrowolska-Zachwieja A, Psuja P. Massive pulmonary embolism in a patient with ulcerative colitis and hyperhomocysteinemia - a case report.
Kardiol. Pol. 64: 405-409 (2006).
-
Elish D, Silverberg NB. Neonatal lupus erythematosus.
Cutis 77: 82-86 (2006).
-
Elkayam O. Safety and efficacy of vaccination against influenza in patients with rheumatoid arthritis.
Clin. Dev. Immunol. 13: 349-351 (2006).
*
-
Elkord E. Role of regulatory T cells in allergy: implications for therapeutic strategy.
Inflamm. Allergy Drug Targets 5: 211-217 (2006).
-
Ellard S, Colclough K. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.
Hum. Mutat. 27: 854-869 (2006).
-
Elleder M. Glucosylceramide transfer from lysosomes - the missing link in molecular pathology of glucosylceramidase deficiency: a hypothesis based on existing data.
J. Inherit. Metab. Dis. 29: 707-715 (2006).
*
-
Eller E, Vardi P, Babu SR, Bugawan TL, Erlich HA, Yu L, Fain PR. Celiac disease and HLA in a Bedouin kindred.
Hum. Immunol. 67: 940-950 (2006).
-
Ellerby LM, Orr HT. Neurodegenerative disease: cut to the chase.
Nature 442: 641-642 (2006).
*
-
Ellfolk M, Norlin M, Wikvall K. Isolation and properties of the CYP2D25 promoter: transcriptional regulation by vitamin D(3) metabolites.
Biochem. Biophys. Res. Commun. 345: 568-572 (2006).
*
-
Elli L. Coeliac disease: between "pizza" and ethics.
Gut 55: 1672 (2006).
*
-
Elliott DE, Weinstock JV. A new wiggle on worms.
Inflamm. Bowel Dis. 12: 1084-1085 (2006).
*
-
Ellis CN, Clark S. Fibrin glue as an adjunct to flap repair of anal fistulas: a randomized, controlled study.
Dis. Colon Rectum 49: 1736-1740 (2006).
*
-
Ellis E, Wagner M, Lammert F, Nemeth A, Gumhold J, Strassburg CP, Kylander C, Katsika D, Trauner M, Einarsson C, Marschall HU. Successful treatment of severe unconjugated hyperbilirubinemia via induction of UGT1A1 by rifampicin.
J. Hepatol. 44: 243-245 (2006).
*
-
Ellis EC. Suppression of bile acid synthesis by thyroid hormone in primary human hepatocytes.
World J. Gastroenterol. 12: 4640-4645 (2006).
*
-
Ellis SA, Bontrop RE, Antczak DF, Ballingall K, Davies CJ, Kaufman J, Kennedy LJ, Robinson J, Smith DM, Stear MJ, Stet RJ, Waller MJ, Walter L, Marsh SG. ISAG/IUIS-VIC Comparative MHC Nomenclature Committee report, 2005.
Immunogenetics 57: 953-958 (2006).
*
-
Elloumi H, Ben Abdelaziz A, Sfar S, Arfaoui D, Ben Slama A, Ghouma M, Ajmi S. Predictive factors of intestinal stenosis in Crohn's disease.
Tunis. Med. 84: 711-713 (2006).
-
Elloumi H, Ben Slama A, Arfaoui D, Ghouma M, Sfar S, Ajmi S. Renal amyloidosis complicating Crohn's disease: report of two cases and review of literature.
Tunis. Med. 84: 253-255 (2006).
-
Ells LJ, Lang R, Shield JP, Wilkinson JR, Lidstone JS, Coulton S, Summerbell CD. Obesity and disability - a short review.
Obes. Rev. 7: 341-345 (2006).
-
Ellul P, Vassallo M, Ellul C. Clinical characteristics of coeliac disease (CD) in the Maltese islands.
Dig. Liver Dis. 38: 783-784 (2006).
-
Elmaagacli AH, Koldehoff M, Hindahl H, Steckel NK, Trenschel R, Peceny R, Ottinger H, Rath PM, Ross RS, Roggendorf M, Grosse-Wilde H, Beelen DW. Mutations in innate immune system NOD2/CARD15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation.
Transplantation 81: 247-254 (2006).
-
Elsayed S, Zhang K. Isolation and 16S ribosomal RNA gene sequence-based identification of Clostridium scindens from an intra-abdominal abscess.
Anaerobe 12: 13-16 (2006).
*
-
Elsayes KM, Oliveira EP, Narra VR, Abou El Abbass HA, Ahmed MI, Tongdee R, Brown JJ. MR and MRCP in the evaluation of primary sclerosing cholangitis: current applications and imaging findings.
J. Comput. Assist. Tomogr. 30: 398-404 (2006).
-
Elson CO. Animal models of experimental IBD: have they taught enough or do we need more?
Inflamm. Bowel Dis. 12 Suppl. 3: S5 (2006).
-
Elson CO. From cheese to pharma: a designer probiotic for IBD.
Clin. Gastroenterol. Hepatol. 4: 836-837 (2006).
*
-
Elson CO, Cong Y, Qi F, Hershberg RM, Targan SR. Molecular approaches to the role of the microbiota in inflammatory bowel disease.
Ann. N. Y. Acad. Sci. 1072: 39-51 (2006).
*
-
Elson CO, Cong Y, Weaver CT. Alterations of T lymphocytes in inflammatory bowel diseases.
Adv. Exp. Med. Biol. 579: 133-148 (2006).
-
Elston DM. The hygiene hypothesis and atopy: bring back the parasites?
J. Am. Acad. Dermatol. 54: 172-179 (2006).
-
Elvevoll EO, Barstad H, Breimo ES, Brox J, Eilertsen KE, Lund T, Olsen JO, Osterud B. Enhanced incorporation of n-3 fatty acids from fish compared with fish oils.
Lipids 41: 1109-1114 (2006).
-
Elwi AN, Damaraju VL, Baldwin SA, Young JD, Sawyer MB, Cass CE. Renal nucleoside transporters: physiological and clinical implications.
Biochem. Cell. Biol. 84: 844-858 (2006).
*
-
Elwing JE, Gao F, Davidson NO, Early DS. Type 2 diabetes mellitus: the impact on colorectal adenoma risk in women.
Am. J. Gastroenterol. 101: 1866-1871 (2006).
*
-
Ely LK, Beddoe T, Clements CS, Matthews JM, Purcell AW, Kjer-Nielsen L, McCluskey J, Rossjohn J. Disparate thermodynamics governing T cell receptor-MHC-I interactions implicate extrinsic factors in guiding MHC restriction.
Proc. Natl. Acad. Sci. U.S.A. 103: 6641-6646 (2006).
*
-
Emery B, Butzkueven H, Snell C, Binder M, Kilpatrick TJ. Oligodendrocytes exhibit selective expression of suppressor of cytokine signaling genes and signal transducer and activator of transcription 1 independent inhibition of interferon-gamma-induced toxicity in response to leukemia inhibitory factor.
Neuroscience 137: 463-472 (2006).
-
Emery P, Fleischmann R, Filipowicz-Sosnowska A, Schechtman J, Szczepanski L, Kavanaugh A, Racewicz AJ, van Vollenhoven RF, Li NF, Agarwal S, Hessey EW, Shaw TM. The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial.
Arthritis Rheum. 54: 1390-1400 (2006).
*
-
Emery P, Ponchel F. Inhibiting Toll-like receptors in inflammatory disease.
Lancet 368: 821-822 (2006).
*
-
Eming R, Hertl M. Immunoadsorption in pemphigus.
Autoimmunity 39: 609-616 (2006).
-
Emmer BJ, van der Grond J, Steup-Beekman GM, Huizinga TW, van Buchem MA. Selective involvement of the amygdala in systemic lupus erythematosus.
PLoS Med. 3: e499 (2006).
*
-
Emoto C, Murase S, Iwasaki K. Approach to the prediction of the contribution of major cytochrome P450 enzymes to drug metabolism in the early drug-discovery stage.
Xenobiotica 36: 671-683 (2006).
*
-
Enarsson K, Johnsson E, Lindholm C, Lundgren A, Pan-Hammarstrom Q, Stromberg E, Bergin P, Baunge EL, Svennerholm AM, Quiding-Jarbrink M. Differential mechanisms for T lymphocyte recruitment in normal and neoplastic human gastric mucosa.
Clin. Immunol. 118: 24-34 (2006).
*
-
Endo Y, Kamisada S, Fujimoto K, Saito T. Trans fatty acids promote the growth of some Lactobacillus strains.
J. Gen. Appl. Microbiol. 52: 29-35 (2006).
*
-
Endres M. Statins: potential new indications in inflammatory conditions.
Atheroscler. Suppl. 7: 31-35 (2006).
-
Engedal N, Gjevik T, Blomhoff R, Blomhoff HK. All-trans retinoic acid stimulates IL-2-mediated proliferation of human T lymphocytes: early induction of cyclin D3.
J. Immunol. 177: 2851-2861 (2006).
*
-
Engel JJ, Martin TL. Edwardsiella tarda as a cause of postdysenteric ulcerative colitis.
Int. J. Colorectal Dis. 21: 184-185 (2006).
*
-
Engelbrektson AL, Korzenik JR, Sanders ME, Clement BG, Leyer G, Klaenhammer TR, Kitts CL. Analysis of treatment effects on the microbial ecology of the human intestine.
FEMS Microbiol. Ecol. 57: 239-250 (2006).
*
-
Engelhardt B. Molecular mechanisms involved in T cell migration across the blood-brain barrier.
J. Neural. Transm. 113: 477-485 (2006).
*
-
Engelhardt B. Regulation of immune cell entry into the central nervous system.
Results Probl. Cell. Differ. 43: 259-280 (2006).
-
Engelhardt JJ, Sullivan TJ, Allison JP. CTLA-4 overexpression inhibits T cell responses through a CD28-B7-dependent mechanism.
J. Immunol. 177: 1052-1061 (2006).
*
-
Engelhorn ME, Guevara-Patino JA, Noffz G, Hooper AT, Lou O, Gold JS, Kappel BJ, Houghton AN. Autoimmunity and tumor immunity induced by immune responses to mutations in self.
Nat. Med. 12: 198-206 (2006).
*
-
Engelmann G, Meyburg J, Schmidt J, Lenhartz H. Pediatric liver transplantation. Introduction of a program for southern Germany in Heidelberg.
Clin. Transplant. 20 Suppl. 17: 124-130 (2006).
*
-
Engeset D, Alsaker E, Lund E, Welch A, Khaw KT, Clavel-Chapelon F, Thiebaut A, Chajes V, Key TJ, Allen NE, Amiano P, Dorronsoro M, Tjonneland A, Stripp C, Peeters PH, van Gils CH, Chirlaque MD, Nagel G, Linseisen J, Ocke MC, Bueno-de-Mesquita HB, et al. Fish consumption and breast cancer risk. The European Prospective Investigation into Cancer and Nutrition (EPIC).
Int. J. Cancer 119: 175-182 (2006).
*
-
Engi H, Gyemant N, Lorand T, Levai A, Ocsovszki I, Molnar J. Cinnamylidene ketones as potential modulators of multidrug resistance in mouse lymphoma and human colon cancer cell lines.
In Vivo 20: 119-124 (2006).
-
Engkilde K, Menne T, Johansen JD. Inverse relationship between allergic contact dermatitis and type 1 diabetes mellitus: a retrospective clinic-based study.
Diabetologia 49: 644-647 (2006).
*
-
Engler MM, Engler MB. Omega-3 fatty acids: role in cardiovascular health and disease.
J. Cardiovasc. Nurs. 21: 17-24 (2006).
-
English JL, Kassiri Z, Koskivirta I, Atkinson SJ, Di Grappa M, Soloway PD, Nagase H, Vuorio E, Murphy G, Khokha R. Individual Timp deficiencies differentially impact pro-MMP-2 activation.
J. Biol. Chem. 281: 10337-10346 (2006).
*
-
Engwegen JY, Helgason HH, Cats A, Harris N, Bonfrer JM, Schellens JH, Beijnen JH. Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry.
World J. Gastroenterol. 12: 1536-1544 (2006).
*
-
Enk AH. DCs and cytokines cooperate for the induction of Tregs.
Ernst Schering Res. Found. Workshop 56: 97-106 (2006).
-
Eppinger S, Schmitt J, Meurer M. Reiter disease or reactive arthritis?
Hautarzt. 57: 336-339 (2006).
-
Epple HJ, Loddenkemper C, Kunkel D, Troeger H, Maul J, Moos V, Berg E, Ullrich R, Schulzke JD, Stein H, Duchmann R, Zeitz M, Schneider T. Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART.
Blood 108: 3072-3078 (2006).
*
-
Epple R, Azimioara M, Russo R, Bursulaya B, Tian SS, Gerken A, Iskandar M. 1,3,5-Trisubstituted aryls as highly selective PPARdelta agonists.
Bioorg. Med. Chem. Lett. 16: 2969-2973 (2006).
-
Epple R, Russo R, Azimioara M, Cow C, Xie Y, Wang X, Wityak J, Karanewsky D, Gerken A, Iskandar M, Saez E, Martin Seidel H, Tian SS. 3,4,5-Trisubstituted isoxazoles as novel PPARdelta agonists: part 1.
Bioorg. Med. Chem. Lett. 16: 4376-4380 (2006).
-
Epstein CJ. Down's syndrome: critical genes in a critical region.
Nature 441: 582-583 (2006).
*
-
Equi AC, Davies JC, Painter H, Hyde S, Bush A, Geddes DM, Alton EW. Exploring the mechanisms of macrolides in cystic fibrosis.
Respir. Med. 100: 687-697 (2006).
-
Equils O, Naiki Y, Shapiro AM, Michelsen K, Lu D, Adams J, Jordan S. 1,25-Dihydroxyvitamin D inhibits lipopolysaccharide-induced immune activation in human endothelial cells.
Clin. Exp. Immunol. 143: 58-64 (2006).
*
-
Erbagci Z, Erbagci AB, Koyluoglu O, Tuncel AA. Serum adenosine deaminase activity in monitoring disease activity and response to therapy in severe psoriasis.
Acta Medica (Hradec Kralove) 49: 101-104 (2006).
-
Erbay SK, Stewart C, Hassanein A, Fletcher A, Bhattacharyya I, Cohen D, Wesson SK, Weinstein J, Lyons R, Reeves WH. Cutaneous mastocytosis in a patient with primary Sjogren's syndrome.
J. Rheumatol. 33: 1697-1700 (2006).
-
Erber WF, Erber JA. Meta-analysis of the yield of capsule endoscopy in patients with Crohn's disease.
Am. J. Gastroenterol. 101: 2669 (2006).
*
-
Ercan I, Cakir BO, Basak T, Ozbal EA, Sahin A, Balci G, Turgut S. Effects of topical application of methotrexate on nasal mucosa in rats: a preclinical assessment study.
Otolaryngol. Head Neck Surg. 134: 751-755 (2006).
-
Erdelyi DJ, Kamory E, Zalka A, Semsei AF, Csokay B, Andrikovics H, Tordai A, Borgulya G, Magyarosy E, Galantai I, Fekete G, Falus A, Szalai C, Kovacs GT. The role of ABC-transporter gene polymorphisms in chemotherapy induced immunosuppression, a retrospective study in childhood acute lymphoblastic leukaemia.
Cell. Immunol. 244: 121-124 (2006).
*
-
Erdman AR, Mangravite LM, Urban TJ, Lagpacan LL, Castro RA, de la Cruz M, Chan W, Huang CC, Johns SJ, Kawamoto M, Stryke D, Taylor TR, Carlson EJ, Ferrin TE, Brett CM, Burchard EG, Giacomini KM. The human organic anion transporter 3 (OAT3; SLC22A8): genetic variation and functional genomics.
Am. J. Physiol. Renal Physiol. 290: F905-F912 (2006).
*
-
Eren E, Yates J, Cwynarski K, Preston S, Dong R, Germain C, Lechler R, Huby R, Ritter M, Lombardi G. Location of major histocompatibility complex class II molecules in rafts on dendritic cells enhances the efficiency of T-cell activation and proliferation.
Scand. J. Immunol. 63: 7-16 (2006).
*
-
Eren M, Saltik-Temizel IN, Demir H, Kocak N, Ozen H, Gurakan F, Yuce A. Thrombophilic factors in Turkish children with inflammatory bowel disease.
Indian J. Gastroenterol. 25: 318-319 (2006).
*
-
Erfani N, Razmkhah M, Talei AR, Pezeshki AM, Doroudchi M, Monabati A, Ghaderi A. Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer.
Cancer Genet. Cytogenet. 165: 114-120 (2006).
-
Erickson BM, Thompson NL, Hixson DC. Tightly regulated induction of the adhesion molecule necl-5/CD155 during rat liver regeneration and acute liver injury.
Hepatology 43: 325-334 (2006).
*
-
Ericsson CD. Safety and tolerability of the antibacterial rifaximin in the treatment of travellers' diarrhoea.
Drug Saf. 29: 201-207 (2006).
-
Eriksen BB, Kare DL. Open trial of supplements of omega 3 and 6 fatty acids, vitamins and minerals in atopic dermatitis.
J. Dermatolog. Treat. 17: 82-85 (2006).
-
Erkkila AT, Matthan NR, Herrington DM, Lichtenstein AH. Higher plasma docosahexaenoic acid is associated with reduced progression of coronary-artery atherosclerosis in women with established coronary artery disease.
J. Lipid Res. 47: 2814-2819 (2006).
*
-
Erlejman AG, Fraga CG, Oteiza PI. Procyanidins protect Caco-2 cells from bile acid- and oxidant-induced damage.
Free Radic. Biol. Med. 41: 1247-1256 (2006).
-
Ermakov S, Malkin I, Kobyliansky E, Livshits G. Variation in femoral length is associated with polymorphisms in RUNX2 gene.
Bone 38: 199-205 (2006).
-
Ernst PB, Peura DA, Crowe SE. The translation of Helicobacter pylori basic research to patient care.
Gastroenterology 130: 188-206 (2006).
*
-
Ernst R, Koch J, Horn C, Tampe R, Schmitt L. Engineering ATPase activity in the isolated ABC-cassette of human TAP1.
J. Biol. Chem. 281: 27471-27480 (2006).
*
-
Ernstgard L, Iregren A, Sjogren B, Johanson G. Acute effects of exposure to vapours of dioxane in humans.
Hum. Exp. Toxicol. 25: 723-729 (2006).
-
Ersoy O, Sivri B, Arslan S, Batman F, Bayraktar Y. How much helpful is the capsule endoscopy for the diagnosis of small bowel lesions?
World J. Gastroenterol. 12: 3906-3910 (2006).
*
-
Ertam I, Alper S, Unal I. Is it necessary to have routine blood tests in patients treated with isotretinoin?
J. Dermatolog. Treat. 17: 214-216 (2006).
-
Ertekin V, Ayse Selimoglu M, Doneray H, Orbak Z, Ozkan B. Prevalence of celiac disease in a sample of Turkish children and adolescents with type 1 diabetes mellitus.
J. Clin. Gastroenterol. 40: 655-657 (2006).
-
Ertekin V, Orbak Z, Selimoglu MA, Yildiz L. Serum leptin levels in childhood celiac disease.
J. Clin. Gastroenterol. 40: 906-909 (2006).
-
Ertekin V, Selimoglu MA. Prevalence of prolonged prothrombin time in children with coeliac disease.
Eur. J. Gastroenterol. Hepatol. 18: 579-580 (2006).
-
Ertekin V, Selimoglu MA, Altnkaynak S. Prevalence of cyclic vomiting syndrome in a sample of Turkish school children in an urban area.
J. Clin. Gastroenterol. 40: 896-898 (2006).
-
Ertekin V, Selimoglu MA, Gursan N, Ozkan B. Idiopathic pulmonary hemosiderosis in children with celiac disease.
Respir. Med. 100: 568-569 (2006).
-
Ertugrul I, Tunc B, Yuksel I, Yolcu OF, Ulker A. PSOAS abscess: an atypical initial presentation of Crohn's disease.
Dig. Liver Dis. 38: 357-358 (2006).
-
Erwin CR, Jarboe MD, Sartor MA, Medvedovic M, Stringer KF, Warner BW, Bates MD. Developmental characteristics of adapting mouse small intestine crypt cells.
Gastroenterology 130: 1324-1332 (2006).
*
-
Erzin Y, Cosgun S, Dobrucali A, Tasyurekli M, Erdamar S, Tuncer M. Complicated granulomatous colitis in a patient with Hermansky-Pudlak syndrome, successfully treated with infliximab.
Acta Gastroenterol. Belg. 69: 213-216 (2006).
-
Erzurum SC. Inhibition of tumor necrosis factor alpha for refractory asthma.
N. Engl. J. Med. 354: 754-758 (2006).
*
-
Esaki M, Matsumoto T, Nakamura S, Yada S, Fujisawa K, Jo Y, Iida M. Factors affecting recurrence in patients with Crohn's disease under nutritional therapy.
Dis. Colon Rectum 49: S68-S74 (2006).
*
-
Escarcega RO, Garcia-Carrasco M, Fuentes-Alexandro S, Jara LJ, Rojas-Rodriguez J, Escobar-Linares LE, Cervera R. Insulin resistance, chronic inflammatory state and the link with systemic lupus erythematosus-related coronary disease.
Autoimmun. Rev. 6: 48-53 (2006).
-
Escher JC. Nutritional therapy in paediatric Crohn's disease: more food for thought?
Dig. Liver Dis. 38: 387-388 (2006).
-
Escriba PV. Membrane-lipid therapy: a new approach in molecular medicine.
Trends Mol. Med. 12: 34-43 (2006).
*
-
Esen N, Kielian T. Central role for MyD88 in the responses of microglia to pathogen-associated molecular patterns.
J. Immunol. 176: 6802-6811 (2006).
*
-
Eshaque B, Dixon B. Technology platforms for molecular diagnosis of cystic fibrosis.
Biotechnol. Adv. 24: 86-93 (2006).
*
-
Eshima K, Suzuki H, Shinohara N. Cross-positive selection of thymocytes expressing a single TCR by multiple major histocompatibility complex molecules of both classes: implications for CD4+ versus CD8+ lineage commitment.
J. Immunol. 176: 1628-1636 (2006).
*
-
Eskandari HG, Unal M, Ozturk OG, Vayisoglu Y, Muslu N. Leukotriene C4 synthase A-444C gene polymorphism in patients with allergic rhinitis.
Otolaryngol. Head Neck Surg. 134: 997-1000 (2006).
-
Esparza EM, Arch RH. Signaling triggered by glucocorticoid-induced tumor necrosis factor receptor family-related gene: regulation at the interface between regulatory T cells and immune effector cells.
Front. Biosci. 11: 1448-1465 (2006).
-
Espinola-Zavaleta N, Alexanderson-Rosas E, Granados N, Elena Soto M, Amigo MC. Myocardial perfusion defects in patients with autoimmune diseases: a prospective study. Analysis of two diagnostic tests.
Lupus 15: 38-43 (2006).
-
Espinosa A, Zhou W, Ek M, Hedlund M, Brauner S, Popovic K, Horvath L, Wallerskog T, Oukka M, Nyberg F, Kuchroo VK, Wahren-Herlenius M. The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death.
J. Immunol. 176: 6277-6285 (2006).
*
-
Esplin MS. Preterm birth: a review of genetic factors and future directions for genetic study.
Obstet. Gynecol. Surv. 61: 800-806 (2006).
-
Esposito E, Cuzzocrea S, Meli R. Peroxisome proliferator-activated receptors and shock state.
ScientificWorldJournal 6: 1770-1782 (2006).
-
Esposito M, Mazzotta A, de Felice C, Papoutsaki M, Chimenti S. Treatment of erythrodermic psoriasis with etanercept.
Br. J. Dermatol. 155: 156-159 (2006).
*
-
Esposito S, Colombo C, Faelli N, Tagliabue C, Corti F, Costantini D, Principi N, Ravaglia R. Mycoplasma pneumoniae pericarditis and cardiac tamponade in a 7-year-old girl with cystic fibrosis.
Infection 34: 355-356 (2006).
*
-
Estall JL, Drucker DJ. Glucagon and glucagon-like peptide receptors as drug targets.
Curr. Pharm. Des. 12: 1731-1750 (2006).
-
Esteban S, Podder N, Cruciani R. Celiac disease: not all medications are contaminated with gliadin...
J. Pain Symptom Manage. 31: 195-196 (2006).
-
Estebe JP, Legay F, Gentili M, Wodey E, Leduc C, Ecoffey C, Moulinoux JP. An evaluation of a polyamine-deficient diet for the treatment of inflammatory pain.
Anesth. Analg. 102: 1781-1788 (2006).
-
Esteva-Font C, Baccaro ME, Fernandez-Llama P, Sans L, Guevara M, Ars E, Jimenez W, Arroyo V, Ballarin JA, Gines P. Aquaporin-1 and aquaporin-2 urinary excretion in cirrhosis: relationship with ascites and hepatorenal syndrome.
Hepatology 44: 1555-1563 (2006).
*
-
Esteve E, Villuendas G, Mallolas J, Vendrell J, Lopez-Bermejo A, Rodriguez M, Recasens M, Ricart W, San Millan JL, Escobar-Morreale H, Richart C, Fernandez-Real JM. Polymorphisms in the interleukin-6 receptor gene are associated with body mass index and with characteristics of the metabolic syndrome.
Clin. Endocrinol. (Oxf.) 65: 88-91 (2006).
*
-
Esteve M, Rosinach M, Fernandez-Banares F, Farre C, Salas A, Alsina M, Vilar P, Abad-Lacruz A, Forne M, Marine M, Santaolalla R, Espinos JC, Viver JM. Spectrum of gluten sensitive enteropathy in first degree relatives of coeliac patients: clinical relevance of lymphocytic enteritis.
Gut 55: 1739-1745 (2006).
*
-
Esther van de Vosse, Ottenhoff TH. Human host genetic factors in mycobacterial and Salmonella infection: lessons from single gene disorders in IL-12/IL-23-dependent signaling that affect innate and adaptive immunity.
Microbes Infect. 8: 1167-1173 (2006).
*
-
Etemadifar M, Janghorbani M, Shaygannejad V, Ashtari F. Prevalence of multiple sclerosis in Isfahan, Iran.
Neuroepidemiology 27: 39-44 (2006).
-
Etienne M, Weimer LH. Immune-mediated autonomic neuropathies.
Curr. Neurol. Neurosci. Rep. 6: 57-64 (2006).
-
Eto K, Arimura Y, Mizuguchi H, Nishikawa M, Noda M, Ishibashi H. Modulation of ATP-induced inward currents by docosahexaenoic acid and other fatty acids in rat nodose ganglion neurons.
J. Pharmacol. Sci. 102: 343-346 (2006).
*
-
Etzel CJ, Chen WV, Shepard N, Jawaheer D, Cornelis F, Seldin MF, Gregersen PK, Amos CI; for the North American Rheumatoid Arthritis Consortium. Genome-wide meta-analysis for rheumatoid arthritis.
Hum. Genet. 119: 634-641 (2006).
*
-
Eun CS, Han DS, Lee SH, Paik CH, Chung YW, Lee J, Hahm JS. Attenuation of colonic inflammation by PPARgamma in intestinal epithelial cells: effect on Toll-like receptor pathway.
Dig. Dis. Sci. 51: 693-697 (2006).
*
-
Euvrard S, Kanitakis J. Skin cancers after liver transplantation: what to do?
J. Hepatol. 44: 27-32 (2006).
*
-
Evans CH, Ghivizzani SC, Robbins PD. Gene therapy for arthritis: what next?
Arthritis Rheum. 54: 1714-1729 (2006).
*
-
Evans CH, Ghivizzani SC, Robbins PD. Will arthritis gene therapy become a clinical reality?
Nat. Clin. Pract. Rheumatol. 2: 344-345 (2006).
*
-
Evans D, Beil FU. The E670G SNP in the PCSK9 gene is associated with polygenic hypercholesterolemia in men but not in women.
BMC Med. Genet. 7: 66 (2006).
*
-
Evans HM, Kelly DA, McKiernan PJ, Hubscher S. Progressive histological damage in liver allografts following pediatric liver transplantation.
Hepatology 43: 1109-1117 (2006).
*
-
Evans JD, Seeger C. Cardif: a protein central to innate immunity is inactivated by the HCV NS3 serine protease.
Hepatology 43: 615-617 (2006).
*
-
Evans SE, Bonczynski JJ, Broussard JD, Han E, Baer KE. Comparison of endoscopic and full-thickness biopsy specimens for diagnosis of inflammatory bowel disease and alimentary tract lymphoma in cats.
J. Am. Vet. Med. Assoc. 229: 1447-1450 (2006).
-
Evel-Kabler K, Chen SY. Dendritic cell-based tumor vaccines and antigen presentation attenuators.
Mol. Ther. 13: 850-858 (2006).
-
Evenepoel P, Laleman W, Wilmer A, Claes K, Kuypers D, Bammens B, Nevens F, Vanrenterghem Y. Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices.
Artif. Organs 30: 276-284 (2006).
*
-
Evereklioglu C. Diagnostic dilemma between intestinal Behcet disease and inflammatory bowel disease with pyoderma gangrenosum.
World J. Gastroenterol. 12: 5748-5751 (2006).
*
-
Ewaschuk JB, Dieleman LA. Probiotics and prebiotics in chronic inflammatory bowel diseases.
World J. Gastroenterol. 12: 5941-5950 (2006).
*
-
Ewaschuk JB, Tejpar QZ, Soo I, Madsen K, Fedorak RN. The role of antibiotic and probiotic therapies in current and future management of inflammatory bowel disease.
Curr. Gastroenterol. Rep. 8: 486-498 (2006).
-
Ewer K, Cockle P, Gordon S, Mansoor H, Govaerts M, Walravens K, Marche S, Hewinson G, Vordermeier M. Antigen mining with iterative genome screens identifies novel diagnostics for the Mycobacterium tuberculosis complex.
Clin. Vaccine Immunol. 13: 90-97 (2006).
*
-
Eyles JL, Roberts AW, Metcalf D, Wicks IP. Granulocyte colony-stimulating factor and neutrophils-forgotten mediators of inflammatory disease.
Nat. Clin. Pract. Rheumatol. 2: 500-510 (2006).
*
-
Eyre S, Bowes J, Potter C, Worthington J, Barton A. Association of the FCRL3 gene with RA: a further example of population specificity?
Arthritis Res. Ther. 8: R117 (2006).
*
-
Eyre S, Bowes J, Spreckley K, Potter C, Ring S, Strachan D, Worthington J, Barton A. Investigation of the MHC2TA gene, associated with rheumatoid arthritis in a Swedish population, in a UK rheumatoid arthritis cohort.
Arthritis Rheum. 54: 3417-3422 (2006).
*
-
Eyre-Walker A, Woolfit M, Phelps T. The distribution of fitness effects of new deleterious amino acid mutations in humans.
Genetics 173: 891-900 (2006).
*
-
Eysenbach G. The open access advantage.
J. Med. Internet Res. 8: e8 (2006).
-
Ezernitchi AV, Vaknin I, Cohen-Daniel L, Levy O, Manaster E, Halabi A, Pikarsky E, Shapira L, Baniyash M. TCR zeta down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs.
J. Immunol. 177: 4763-4772 (2006).
*
-
Faa V, Bettoli PP, Demurtas M, Zanda M, Ferri V, Cao A, Rosatelli MC. A new insertion/deletion of the cystic fibrosis transmembrane conductance regulator gene accounts for 3.4% of cystic fibrosis mutations in Sardinia: implications for population screening.
J. Mol. Diagn. 8: 499-503 (2006).
*
-
Fabani MM, Turner JJ, Gait MJ. Oligonucleotide analogs as antiviral agents.
Curr. Opin. Mol. Ther. 8: 108-114 (2006).
-
Faber C, Morbach H, Singh SK, Girschick HJ. Differential expression patterns of recombination activating genes in individual mature B cells in juvenile idiopathic arthritis.
Ann. Rheum. Dis. 65: 1351-1356 (2006).
*
-
Faber J, Meyer CU, Gemmer C, Russo A, Finn A, Murdoch C, Zenz W, Mannhalter C, Zabel BU, Schmitt HJ, Habermehl P, Zepp F, Knuf M. Human Toll-like receptor 4 mutations are associated with susceptibility to invasive meningococcal disease in infancy.
Pediatr. Infect. Dis. J. 25: 80-81 (2006).
-
Fabien N, Monier JC. Antireceptor and antichannel autoantibodies.
Pathol. Biol. (Paris) 54: 353-361 (2006).
-
Fabien N, Monier JC. Antireceptor and antichannel autoantibodies.
Pathol. Biol. (Paris) 54: 362-369 (2006).
-
Fabris L, Cadamuro M, Fiorotto R, Roskams T, Spirli C, Melero S, Sonzogni A, Joplin RE, Okolicsanyi L, Strazzabosco M. Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases.
Hepatology 43: 1001-1012 (2006).
*
-
Faddy HM, Robinson JA, Lee WJ, Holman NA, Monteith GR, Roberts-Thomson SJ. Peroxisome proliferator-activated receptor alpha expression is regulated by estrogen receptor alpha and modulates the response of MCF-7 cells to sodium butyrate.
Int. J. Biochem. Cell. Biol. 38: 255-266 (2006).
*
-
Fae KC, da Silva DD, Oshiro SE, Tanaka AC, Pomerantzeff PM, Douay C, Charron D, Toubert A, Cunningham MW, Kalil J, Guilherme L. Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease.
J. Immunol. 176: 5662-5670 (2006).
*
-
Fagarasan S. Intestinal IgA synthesis: a primitive form of adaptive immunity that regulates microbial communities in the gut.
Curr. Top. Microbiol. Immunol. 308: 137-153 (2006).
-
Fagerstam JP, Whiss PA. Higher platelet P-selectin in male patients with inflammatory bowel disease compared to healthy males.
World J. Gastroenterol. 12: 1270-1272 (2006).
*
-
Fagius J, Oberg G. Hematopoietic stem cell transplantation in MS. Justified, and if so, when?
Lakartidningen. 103: 640-642 (2006).
-
Fagoonee S, Di Cunto F, Vozzi D, Volinia S, Pellegrino M, Gasparini P, Silengo L, Altruda F, Tolosano E. Microarray and large-scale in silico-based identification of genes functionally related to haptoglobin and/or hemopexin.
DNA Cell Biol. 25: 323-330 (2006).
-
Fahim NM, Monir E. Functional role of CD4+CD25+ regulatory T cells and transforming growth factor-beta1 in childhood immune thrombocytopenic purpura.
Egypt. J. Immunol. 13: 173-187 (2006).
-
Faigel DO, Pike IM, Baron TH, Chak A, Cohen J, Deal SE, Hoffman B, Jacobson BC, Mergener K, Petersen BT, Petrini JL, Rex DK, Safdi MA; ASGE/ACG Taskforce on Quality in Endoscopy. Quality indicators for gastrointestinal endoscopic procedures: an introduction.
Am. J. Gastroenterol. 101: 866-872 (2006).
*
-
Fain PR, Babu SR, Bennett DC, Spritz RA. HLA class II haplotype DRB1*04-DQB1*0301 contributes to risk of familial generalized vitiligo and early disease onset.
Pigment Cell Res. 19: 51-57 (2006).
*
-
Fairhurst AM, Wandstrat AE, Wakeland EK. Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease.
Adv. Immunol. 92: 1-69 (2006).
-
Fairweather D, Frisancho-Kiss S, Njoku DB, Nyland JF, Kaya Z, Yusung SA, Davis SE, Frisancho JA, Barrett MA, Rose NR. Complement receptor 1 and 2 deficiency increases coxsackievirus B3-induced myocarditis, dilated cardiomyopathy, and heart failure by increasing macrophages, IL-1beta, and immune complex deposition in the heart.
J. Immunol. 176: 3516-3524 (2006).
*
-
Fajans SS, Bell GI. Phenotypic heterogeneity between different mutations of MODY subtypes and within MODY pedigrees.
Diabetologia 49: 1106-2208 (2006).
*
-
Fajardo-Dolci G, Solorio-Abreu J, Romero-Alvarez JC, Zavaleta-Villa B, Cerezo-Camacho O, Jimenez-Lucio R, Olivo-Diaz A. DQA1 and DQB1 association and nasal polyposis.
Otolaryngol. Head Neck Surg. 135: 243-247 (2006).
-
Fakhoury M, Lecordier J, Medard Y, Peuchmaur M, Jacqz-Agrain E. Impact of inflammation on the duodenal mRNA expression of CYP3A and P-glycoprotein in children with Crohn's disease.
Inflamm. Bowel Dis. 12: 745-749 (2006).
*
-
Falcone M, Scalise A, Minisci C, Romito D, Cancelli I, Gigli GL. Spreading of autoimmunity from central to peripheral myelin: two cases of clinical association between multiple sclerosis and chronic inflammatory demyelinating polyneuropathy.
Neurol. Sci. 27: 58-62 (2006).
*
-
Falize L, Guillygomarc'h A, Perrin M, Laine F, Guyader D, Brissot P, Turlin B, Deugnier Y. Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases.
Hepatology 44: 472-477 (2006).
*
-
Fallarino F, Grohmann U, You S, McGrath BC, Cavener DR, Vacca C, Orabona C, Bianchi R, Belladonna ML, Volpi C, Santamaria P, Fioretti MC, Puccetti P. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells.
J. Immunol. 176: 6752-6761 (2006).
*
-
Fallingborg JF. Does 5-ASA prevent development of colon cancer in patients with ulcerative colitis?
Ugeskr. Laeger. 168: 2049-2051 (2006).
-
Fallon MB. Hepatopulmonary syndrome: more than just a matter of tone?
Hepatology 43: 912-914 (2006).
*
-
Familiari L, Strangio G, Consolo P, Luigiano C, Bonica M, Barresi G, Barresi V, Familiari P, D'Arrigo G, Alibrandi A, Zirilli A, Fries W, Scaffidi M. Optical coherence tomography evaluation of ulcerative colitis: the patterns and the comparison with histology.
Am. J. Gastroenterol. 101: 2833-2840 (2006).
*
-
Fan CH, Jin MJ, Zhang Y, Song L, Xu H, Jiang QT, Yu WP, Chen K. Association between genetic polymorphisms of metabolic enzymes and susceptibility of colorectal cancer.
Zhonghua Yu Fang Yi Xue Za Zhi 40: 13-17 (2006).
-
Fan P, Gao T, Li M, Liao W, Fu M, Liu Y, Ikeda S. A case of impetigo herpetiformis associated with intrahepatic cholestasis of pregnancy.
J. Dermatol. 33: 563-566 (2006).
-
Fang H, Xie Q, Boneva R, Fostel J, Perkins R, Tong W. Gene expression profile exploration of a large dataset on chronic fatigue syndrome.
Pharmacogenomics 7: 429-440 (2006).
-
Fang L, Zhang G, Li C, Zheng X, Zhu L, Xiao JJ, Szakacs G, Nadas J, Chan KK, Wang PG, Sun D. Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance.
J. Med. Chem. 49: 932-941 (2006).
*
-
Fang X, Hu S, Xu B, Snyder G, Harmon S, Yao J, Liu Y, Sangras B, Falck J, Weintraub NL, Spector AA. 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator activated receptor alpha.
Am. J. Physiol. Heart Circ. Physiol. 290: H55-H63 (2006).
*
-
Fang X, Song Y, Hirsch J, Galietta LJ, Pedemonte N, Zemans RL, Dolganov G, Verkman AS, Matthay MA. Contribution of CFTR to apical-basolateral fluid transport in cultured human alveolar epithelial type II cells.
Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L242-L249 (2006).
*
-
Fang Y, Rivadeneira F, van Meurs JB, Pols HA, Ioannidis JP, Uitterlinden AG. Vitamin D receptor gene BsmI and TaqI polymorphisms and fracture risk: a meta-analysis.
Bone 39: 938-945 (2006).
-
Fani F, Kamali-Sarvestani E, Yazdanparast R, Monabati A, Rafiei S. T cell tolerance following bacterial glutamic acid decarboxylase (GAD) feeding in streptozotocin-induced diabetes.
Iran. J. Immunol. 3: 169-175 (2006).
-
Fantini MC, Becker C, Tubbe I, Nikolaev A, Lehr HA, Galle PR, Neurath MF. TGF-beta induced Foxp3+ regulatory T cells suppress Th1-mediated experimental colitis.
Gut 55: 671-680 (2006).
*
-
Faour WH, He Q, Mancini A, Jovanovic D, Antoniou J, Di Battista JA. Prostaglandin E2 stimulates p53 transactivational activity through specific serine 15 (ser15) phosphorylation in human synovial fibroblasts (HSF): role in suppression of c/EBP/NF-kappa B mediated Erk kinase kinase (MERKK)1-induced MMP-1 expression.
J. Biol. Chem. 281: 19849-19860 (2006).
*
-
Farah R, Farah R, Makhoul N. Severe hypercalcemia as a presenting sign of systemic lupus erythematosus.
Eur. J. Intern. Med. 17: 206-208 (2006).
-
Farah R, Lisitsin S, Shay M. Bacterial meningitis associated with infliximab.
Pharm. World Sci. 28: 123-125 (2006).
-
Farahani P, Levine M, Gaebel K, Wang EC, Khalidi N. Community-based evaluation of etanercept in patients with rheumatoid arthritis.
J. Rheumatol. 33: 665-670 (2006).
-
Farazi PA, Zeisberg M, Glickman J, Zhang Y, Kalluri R, DePinho RA. Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.
Cancer Res. 66: 6622-6627 (2006).
*
-
Fares C, Libich DS, Harauz G. Solution NMR structure of an immunodominant epitope of myelin basic protein.
FEBS J. 273: 601-614 (2006).
*
-
Farhadi A, Keshavarzian A, Ranjbaran Z, Fields JZ, Banan A. Role of PKC isoforms in modulation of injury and repair of the intestinal barrier.
J. Pharmacol. Exp. Ther. 316: 1-7 (2006).
*
-
Farheen S, Sengupta S, Santra A, Pal S, Dhali GK, Chakravorty M, Majumder PP, Chowdhury A. Gilbert's syndrome: high frequency of the (TA) (7) TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene.
World J. Gastroenterol. 12: 2269-2275 (2006).
*
-
Faria AM, Weiner HL. Oral tolerance: therapeutic implications for autoimmune diseases.
Clin. Dev. Immunol. 13: 143-157 (2006).
*
-
Farias AQ, Goncalves LL, Bittencourt PL, De Melo ES, Abrantes-Lemos CP, Porta G, Nakhle MC, Carrilho FJ, Cancado EL. Applicability of the IAIHG scoring system to the diagnosis of antimitochondrial/anti-M2 seropositive variant form of autoimmune hepatitis.
J. Gastroenterol. Hepatol. 21: 887-893 (2006).
*
-
Farinati F, Marino D, De Giorgio M, Baldan A, Cantarini M, Cursaro C, Rapaccini G, Del Poggio P, Di Nolfo MA, Benvegnu L, Zoli M, Borzio F, Bernardi M, Trevisani F, for the Italian Liver Cancer (ITALICA) group. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?
Am. J. Gastroenterol. 101: 524-532 (2006).
*
-
Farkas S, Hornung M, Sattler C, Edtinger K, Steinbauer M, Anthuber M, Schlitt HJ, Herfarth H, Geissler EK. Blocking MAdCAM-1 in vivo reduces leukocyte extravasation and reverses chronic inflammation in experimental colitis.
Int. J. Colorectal Dis. 21: 71-78 (2006).
*
-
Farkas S, Hornung M, Sattler C, Guba M, Steinbauer M, Anthuber M, Herfarth H, Schlitt HJ, Geissler EK. Rapamycin decreases leukocyte migration in vivo and effectively reduces experimentally induced chronic colitis.
Int. J. Colorectal Dis. 21: 747-753 (2006).
*
-
Farmer LJ, Marron KS, Canan Koch SS, Hwang CK, Kallel EA, Zhi L, Nadzan AM, Robertson DW, Bennani YL. Aza-retinoids as novel retinoid X receptor-specific agonists.
Bioorg. Med. Chem. Lett. 16: 2352-2356 (2006).
*
-
Farnaud S, Patel A, Evans RW. Modelling of a metal-containing hepcidin.
Biometals 19: 527-533 (2006).
*
-
Farooqui AA, Horrocks LA. Phospholipase A2-generated lipid mediators in the brain: the good, the bad, and the ugly.
Neuroscientist 12: 245-260 (2006).
*
-
Farraye FA, Schroy PC 3rd. Chromoendoscopy: a new vision for colonoscopic surveillance in IBD.
Gastroenterology 131: 323-325 (2006).
*
-
Farrell AM, Dean D, Millard PR, Charnock FM, Wojnarowska F. Cytokine alterations in lichen sclerosus: an immunohistochemical study.
Br. J. Dermatol. 155: 931-940 (2006).
*
-
Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis.
Hepatology 43: S99-S112 (2006).
*
-
Farrell RJ. What's the case for case-finding in primary care for coeliac disease?
Dig. Liver Dis. 38: 468-470 (2006).
-
Farrokhyar F, Marshall JK, Easterbrook B, Irvine EJ. Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health.
Inflamm. Bowel Dis. 12: 38-46 (2006).
*
-
Farzaneh-Far A, Roman MJ, Lockshin MD, Devereux RB, Paget SA, Crow MK, Davis A, Sammaritano L, Levine DM, Salmon JE. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus.
Arthritis Rheum. 54: 3918-3925 (2006).
*
-
Fas SC, Fritzsching B, Suri-Payer E, Krammer PH. Death receptor signaling and its function in the immune system.
Curr. Dir. Autoimmun. 9: 1-17 (2006).
-
Fasano A. Systemic autoimmune disorders in celiac disease.
Curr. Opin. Gastroenterol. 22: 674-679 (2006).
*
-
Fasano MB. Dermatologic food allergy.
Pediatr. Ann. 35: 727-731 (2006).
-
Fasciano S, Li L. Intervention of Toll-like receptor-mediated human innate immunity and inflammation by synthetic compounds and naturally occurring products.
Curr. Med. Chem. 13: 1389-1395 (2006).
-
Fathi NA, Hussein MR, Hassan HI, Mosad E, Galal H, Afifi NA. Glomerular expression and elevated serum Bcl-2 and Fas proteins in lupus nephritis: preliminary findings.
Clin. Exp. Immunol. 146: 339-343 (2006).
*
-
Fatourechi MM, el-Azhary RA, Gibson LE. Rituximab: applications in dermatology.
Int. J. Dermatol. 45: 1143-1155 (2006).
*
-
Faubion WA Jr, Bousvaros A. Medical therapy for refractory pediatric Crohn's disease.
Clin. Gastroenterol. Hepatol. 4: 1199-1213 (2006).
-
Faubionmd WA. Step-up versus top-down: application of new biological agents in pediatric inflammatory bowel disease.
Clin. Gastroenterol. Hepatol. 4: 1094-1096 (2006).
-
Faucette SR, Sueyoshi T, Smith CM, Negishi M, Lecluyse EL, Wang H. Differential regulation of hepatic CYP2B6 and CYP3A4 genes by constitutive androstane receptor but not pregnane X receptor.
J. Pharmacol. Exp. Ther. 317: 1200-1209 (2006).
*
-
Faucheron JL, Sani R, Zeid M, Duprez D, Rolachon A. Ileal and right colonic strictures due to prolonged non steroidal anti-inflammatory drug intake.
Gastroenterol. Clin. Biol. 30: 1221-1223 (2006).
-
Faustman DL, Tran SD, Kodama S, Lodde BM, Szalayova I, Key S, Toth ZE, Mezey E. Comment on papers by Chong et al., Nishio et al., and Suri et al. on diabetes reversal in NOD mice.
Science 314: 1243 (2006).
*
-
Fausto N. Involvement of the innate immune system in liver regeneration and injury.
J. Hepatol. 45: 347-349 (2006).
*
-
Fausto N, Campbell JS, Riehle KJ. Liver regeneration.
Hepatology 43: S45-S53 (2006).
*
-
Favia M, Fanelli T, Bagorda A, Di Sole F, Reshkin SJ, Suh PG, Guerra L, Casavola V. NHE3 inhibits PKA-dependent functional expression of CFTR by NHERF2 PDZ interactions.
Biochem. Biophys. Res. Commun. 347: 452-459 (2006).
*
-
Favorova OO, Favorov AV, Boiko AN, Andreewski TV, Sudomoina MA, Alekseenkov AD, Kulakova OG, Gusev EI, Parmigiani G, Ochs MF. Three allele combinations associated with multiple sclerosis.
BMC Med. Genet. 7: 63 (2006).
*
-
Fayad R, Brand MI, Stone D, Keshavarzian A, Qiao L. Apoptosis resistance in ulcerative colitis: high expression of decoy receptors by lamina propria T cells.
Eur. J. Immunol. 36: 2215-2222 (2006).
*
-
Faybik P, Bacher A, Kozek-Langenecker SA, Steltzer H, Krenn CG, Unger S, Hetz H. Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study.
Crit. Care 10: R24 (2006).
*
-
Faybik P, Hetz H. Plasma disappearance rate of indocyanine green in liver dysfunction.
Transplant. Proc. 38: 801-802 (2006).
*
-
Fazekas F, Enzinger C, Ropele S, Schmidt H, Schmidt R, Strasser-Fuchs S. The impact of our genes: Consequences of the apolipoprotein E polymorphism in Alzheimer disease and multiple sclerosis.
J. Neurol. Sci. 245: 35-39 (2006).
-
Fazilleau N, Delarasse C, Sweenie CH, Anderton SM, Fillatreau S, Lemonnier FA, Pham-Dinh D, Kanellopoulos JM. Persistence of autoreactive myelin oligodendrocyte glycoprotein (MOG)-specific T cell repertoires in MOG-expressing mice.
Eur. J. Immunol. 36: 533-543 (2006).
*
-
Fdez-Morera JL, Tunon A, Rodriguez-Rodero S, Rodrigo L, Martinez-Borra J, Gonzalez S, Lopez-Vazquez A, Lahoz CH, Lopez-Larrea C. Clinical behavior of multiple sclerosis is modulated by the MHC class I-chain-related gene A.
Tissue Antigens 67: 409-414 (2006).
*
-
Feagan B. Infliximab, adalimumab and certolizumab: beneficial and adverse effects (past).
Inflamm. Bowel Dis. 12 Suppl. 3: S6 (2006).
-
Feagan BG, Sandborn WJ, Lichtenstein G, Radford-Smith G, Patel J, Innes A. CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, for steroid-dependent Crohn's disease: a randomized, double-blind, placebo-controlled trial.
Aliment. Pharmacol. Ther. 23: 617-628 (2006).
*
-
Fearnhead NS, Chowdhury R, Box B, George BD, Jewell DP, Mortensen NJ. Long-term follow-up of strictureplasty for Crohn's disease.
Br. J. Surg. 93: 475-482 (2006).
*
-
Fearns C, Pan Q, Mathison JC, Chuang TH. Triad3A regulates ubiquitination and proteasomal degradation of RIP1 following disruption of Hsp90 binding.
J. Biol. Chem. 281: 34592-34600 (2006).
*
-
Fearon U, Mullan R, Markham T, Connolly M, Sullivan S, Poole AR, Fitzgerald O, Bresnihan B, Veale DJ. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures.
Arthritis Rheum. 54: 3152-3162 (2006).
*
-
Federici L, Rittore-Domingo C, Kone-Paut I, Jorgensen C, Rodiere M, Le Quellec A, Touitou I. A decision tree for genetic diagnosis of hereditary periodic fever in unselected patients.
Ann. Rheum. Dis. 65: 1427-1432 (2006).
*
-
Fedetz M, Matesanz F, Caro-Maldonado A, Fernandez O, Tamayo JA, Guerrero M, Delgado C, Lopez-Guerrero JA, Alcina A. OAS1 gene haplotype confers susceptibility to multiple sclerosis.
Tissue Antigens 68: 446-449 (2006).
*
-
Fedetz M, Matesanz F, Caro-Maldonado A, Smirnov II, Chvorostinka VN, Moiseenko TA, Alcina A. The 1858T PTPN22 gene variant contributes to a genetic risk of type 1 diabetes in a Ukrainian population.
Tissue Antigens 67: 430-433 (2006).
*
-
Fedorak RN, Penner R, Madsen KL. Probiotics in the treatment of gastrointestinal diseases.
US Gastroenterology Review, p. 28-31 (2006). *
-
Fedorova I, Salem N Jr. Omega-3 fatty acids and rodent behavior.
Prostaglandins Leukot. Essent. Fatty Acids 75: 271-289 (2006).
*
-
Feher J, Lengyel G. Nutrition and cardiovascular mortality.
Orv. Hetil. 147: 1491-1496 (2006).
-
Feige JN, Gelman L, Michalik L, Desvergne B, Wahli W. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions.
Prog. Lipid Res. 45: 120-159 (2006).
*
-
Feigerlova E, Pruhova S, Dittertova L, Lebl J, Pinterova D, Kolostova K, Cerna M, Pedersen O, Hansen T. Aetiological heterogeneity of asymptomatic hyperglycaemia in children and adolescents.
Eur. J. Pediatr. 165: 446-452 (2006).
*
-
Feighery C, Conlon N, Jackson J. Adult population screening for coeliac disease: comparison of tissue-transglutaminase antibody and anti-endomysial antibody tests.
Eur. J. Gastroenterol. Hepatol. 18: 1173-1175 (2006).
*
-
Feist E, Burmester GR. Citrullinated antigens: just diagnostic tools or pathogenic targets in rheumatoid arthritis?
J. Rheumatol. 33: 2103-2134 (2006).
-
Feizy V, Ghobadi A. Atopic dermatitis and systemic autoimmune diseases: a descriptive cross sectional study.
Dermatol. Online J. 12: 3 (2006).
*
-
Fekete A, Viklicky O, Hubacek JA, Rusai K, Erdei G, Treszl A, Vitko S, Tulassay T, Heemann U, Reusz G, Szabo AJ. Association between heat shock protein 70s and Toll-like receptor polymorphisms with long-term renal allograft survival.
Transpl. Int. 19: 190-196 (2006).
*
-
Felberg S, Dantas PE. Sjogren's syndrome: diagnosis and treatment.
Arq. Bras. Oftalmol. 69: 959-963 (2006).
-
Feld JJ, Liang TJ. Hepatitis C - identifying patients with progressive liver injury.
Hepatology 43: S194-S206 (2006).
*
-
Feld JJ, Meddings J, Heathcote EJ. Abnormal intestinal permeability in primary biliary cirrhosis.
Dig. Dis. Sci. 51: 1607-1613 (2006).
*
-
Felderbauer P, Klein W, Bulut K, Ansorge N, Dekomien G, Werner I, Epplen JT, Schmitz F, Schmidt WE. Mutations in the calcium-sensing receptor: a new genetic risk factor for chronic pancreatitis?
Scand. J. Gastroenterol. 41: 343-348 (2006).
*
-
Feldman PA, Regev A, Barkin JS. Hepatobiliary disorders associated with inflammatory bowel disease.
Practical Gastroenterology, August 2006: 52-74 (2006). *
-
Feldmann G. Liver apoptosis.
Gastroenterol. Clin. Biol. 30: 533-545 (2006).
-
Feldmann M, Pusey CD. Is there a role for TNF-alpha in anti-neutrophil cytoplasmic antibody-associated vasculitis? Lessons from other chronic inflammatory diseases.
J. Am. Soc. Nephrol. 17: 1243-1252 (2006).
*
-
Feldmeyer L, Huber M, Fellmann F, Beckmann JS, Frenk E, Hohl D. Confirmation of the origin of NISCH syndrome.
Hum. Mutat. 27: 408-410 (2006).
-
Feldon SE, O'loughlin CW, Ray DM, Landskroner-Eiger S, Seweryniak KE, Phipps RP. Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes.
Am. J. Pathol. 169: 1183-1193 (2006).
*
-
Feleszko W, Jaworska J, Hamelmann E. Toll-like receptors-novel targets in allergic airway disease (probiotics, friends and relatives).
Eur. J. Pharmacol. 533: 308-318 (2006).
*
-
Felipe A, Vicente R, Villalonga N, Roura-Ferrer M, Martinez-Marmol R, Sole L, Ferreres JC, Condom E. Potassium channels: new targets in cancer therapy.
Cancer Detect. Prev. 30: 375-385 (2006).
-
Felix SB, Staudt A. Non-specific immunoadsorption in patients with dilated cardiomyopathy: mechanisms and clinical effects.
Int. J. Cardiol. 112: 30-33 (2006).
-
Fellermann K, Stange DE, Schaeffeler E, Schmalzl H, Wehkamp J, Bevins CL, Reinisch W, Teml A, Schwab M, Lichter P, Radlwimmer B, Stange EF. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon.
Am. J. Hum. Genet. 79: 439-448 (2006).
*
-
Felley C, Guyot J, Hess J, Mottet C, Delarive J, Michetti P. Main therapeutic advance.
Rev. Med. Suisse. 2: 191-1944, 196-198, 201-203 (2006).
-
Felly C, Frei A, Lamy O. Osteoporosis and digestive disease.
Rev. Med. Suisse. 2: 205-209 (2006).
-
Felt-Bersma RJ. Endoanal ultrasound in perianal fistulas and abscesses.
Dig. Liver Dis. 38: 537-543 (2006).
-
Felt-Bersma RJ, Cazemier M. Endosonography in anorectal disease: an overview.
Scand. J. Gastroenterol. Suppl. 243: 165-174 (2006).
*
-
Feng AY, Espat NJ, Sharif S, Glew J, Sullivan C, Kaczor T, Block KI. Integrative Tumor Board: cholangicocarcinoma.
Integr. Cancer Ther. 5: 131-149 (2006).
*
-
Feng CG, Kaviratne M, Rothfuchs AG, Cheever A, Hieny S, Young HA, Wynn TA, Sher A. NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis.
J. Immunol. 177: 7086-7093 (2006).
*
-
Feng N, Jaimes MC, Lazarus NH, Monak D, Zhang C, Butcher EC, Greenberg HB. Redundant role of chemokines CCL25/TECK and CCL28/MEC in IgA+ plasmablast recruitment to the intestinal lamina propria after rotavirus infection.
J. Immunol. 176: 5749-5759 (2006).
*
-
Feng S, Lin L, Wu Q, Zhou W, Shao C. Study on the expression of RXRalpha in patients with psoriasis vulgaris.
Eur. J. Dermatol. 16: 33-38 (2006).
*
-
Feng X, Wu H, Grossman JM, Hanvivadhanakul P, Fitzgerald JD, Park GS, Dong X, Chen W, Kim MH, Weng HH, Furst DE, Gorn A, McMahon M, Taylor M, Brahn E, Hahn BH, Tsao BP. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
Arthritis Rheum. 54: 2951-2962 (2006).
*
-
Fenniche S, Benmously R, Marrak H, Dhaoui A, Ammar FB, Mokhtar I. Neonatal pemphigus vulgaris in an infant born to a mother with pemphigus vulgaris in remission.
Pediatr. Dermatol. 23: 124-127 (2006).
*
-
Feofanova NA, Toporkova LB, Tikhonova MA, Nevinskii GA, Kozlov VA, Orlovskaya IA. Cell cycle of bone marrow CD34+ cells during autoimmune disease development in MRLMpJ/lpr mice.
Bull. Exp. Biol. Med. 142: 137-139 (2006).
-
Fer M, Goulitquer S, Dreano Y, Berthou F, Corcos L, Amet Y. Determination of polyunsatured fatty acid monoepoxides by high performance liquid chromatography-mass spectrometry.
J. Chromatogr. A. 1115: 1-7 (2006).
*
-
Ferdinandusse S, Houten SM. Peroxisomes and bile acid biosynthesis.
Biochim. Biophys. Acta 1763: 1427-1440 (2006).
*
-
Ferec C, Casals T, Chuzhanova N, Macek M, Bienvenu T, Holubova A, King C, McDevitt T, Castellani C, Farrell PM, Sheridan M, Pantaleo SJ, Loumi O, Messaoud T, Cuppens H, Torricelli F, Cutting GR, Williamson R, Ramos MJ, Pignatti PF, Raguenes O, et al. Gross genomic rearrangements involving deletions in the CFTR gene: characterization of six new events from a large cohort of hitherto unidentified cystic fibrosis chromosomes and meta-analysis of the underlying mechanisms.
Eur. J. Hum. Genet. 14: 567-576 (2006).
*
-
Ferguson JW, Dover AR, Chia S, Cruden NL, Hayes PC, Newby DE. Inducible nitric oxide synthase activity contributes to the regulation of peripheral vascular tone in patients with cirrhosis and ascites.
Gut 55: 542-546 (2006).
*
-
Ferguson TA, Griffith TS. A vision of cell death: Fas ligand and immune privilege 10 years later.
Immunol. Rev. 213: 228-238 (2006).
*
-
Ferkolj I, Hocevar A, Golouh R, Dolenc Voljc M. Infliximab for treatment of resistant pyoderma gangrenosum associated with Crohn's disease.
Acta Dermatovenerol. Alp. Panonica Adriat. 15: 173-177 (2006).
-
Ferkolj I, Ihan A, Markovic S, Veceric Z, Pohar M. Infliximab reduces the number of activated mucosal lymphocytes in patients with Crohn's disease.
J. Gastrointestin. Liver Dis. 15: 231-235 (2006).
*
-
Ferlitsch A, Reinisch W, Puspok A, Dejaco C, Schillinger M, Schofl R, Potzi R, Gangl A, Vogelsang H. Safety and efficacy of endoscopic balloon dilation for treatment of Crohn's disease strictures.
Endoscopy 38: 483-487 (2006).
-
Fernandes AR, Rose M, White S, Mortimer DN, Gem M. Dioxins and polychlorinated biphenyls (PCBs) in fish oil dietary supplements: occurrence and human exposure in the UK.
Food Addit. Contam. 23: 939-947 (2006).
-
Fernandes PF, Junior GB, Barros FA, Sousa DC, Franco LM, Patrocinio RM. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
Invest. Clin. 47: 405-411 (2006).
-
Fernandez A, Maddipati S. A priori inference of cross reactivity for drug-targeted kinases.
J. Med. Chem. 49: 3092-3100 (2006).
*
-
Fernandez D, Bonilla E, Mirza N, Niland B, Perl A. Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus.
Arthritis Rheum. 54: 2983-2988 (2006).
*
-
Fernandez D, Bonilla E, Phillips P, Perl A. Signaling abnormalities in systemic lupus erythematosus as potential drug targets.
Endocr. Metab. Immune Disord. Drug Targets 6: 305-311 (2006).
-
Fernandez E, Gallus S, La Vecchia C. Nutrition and cancer risk: an overview.
J. Br. Menopause Soc. 12: 139-142 (2006).
-
Fernandez EB. Monogenic forms of diabetes mellitus.
An. R. Acad. Nac. Med. (Madr.) 123: 211-217 (2006).
-
Fernandez J, Escorsell A, Zabalza M, Felipe V, Navasa M, Mas A, Lacy AM, Gines P, Arroyo V. Adrenal insufficiency in patients with cirrhosis and septic shock: effect of treatment with hydrocortisone on survival.
Hepatology 44: 1288-1295 (2006).
*
-
Fernandez MA, Albor C, Ingelmo-Torres M, Nixon SJ, Ferguson C, Kurzchalia T, Tebar F, Enrich C, Parton RG, Pol A. Caveolin-1 is essential for liver regeneration.
Science 313: 1628-1632 (2006).
*
-
Fernandez PL. Stress and inflammatory bowell disease (I.B.D). Therapeutic strategies.
An. R. Acad. Nac. Med. (Madr.) 123: 219-229 (2006).
-
Fernandez-Fernandez FJ, Rivera-Gallego A, de la Fuente-Aguado J, Perez-Fernandez S, Munoz-Fernandez D. Antiphospholipid syndrome mimicking multiple sclerosis in two patients.
Eur. J. Intern. Med. 17: 500-502 (2006).
-
Fernandez-Martin A, Gonzalez-Rey E, Chorny A, Martin J, Pozo D, Ganea D, Delgado M. VIP prevents experimental multiple sclerosis by downregulating both inflammatory and autoimmune components of the disease.
Ann. N. Y. Acad. Sci. 1070: 276-281 (2006).
*
-
Fernandez-Nebro A, Urena I, Irigoyen MV, Garcia-Vicuna R, Konno S, Iizuka M, Horie Y, Itou H, Shindo K, Watanabe S. Anti-TNF-alpha for treatment of amyloidosis associated with Crohn's disease * author's reply.
Gut 55: 1666-1667 (2006).
*
-
Fernandez-Veledo S, Huber-Ruano I, Aymerich I, Duflot S, Casado FJ, Pastor-Anglada M. Bile acids alter the subcellular localization of CNT2 and increase CNT2-related transport activity in liver parenchymal cells.
Biochem. J. 395: 337-344 (2006).
*
-
Fernandez-Veledo S, Nieto-Vazquez I, Rondinone CM, Lorenzo M. Liver X receptor agonists ameliorate TNFalpha-induced insulin resistance in murine brown adipocytes by downregulating protein tyrosine phosphatase-1B gene expression.
Diabetologia 49: 3038-3048 (2006).
*
-
Fernandezguarino M, Saez EM, Gijon RC, Garcia BP, Olasolo PJ. Linear IgA dermatosis associated with ulcerative colitis.
Eur. J. Dermatol. 16: 692-693 (2006).
*
-
Ferone D, Boschetti M, Resmini E, Giusti M, Albanese V, Goglia U, Albertelli M, Vera L, Bianchi F, Minuto F. Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system.
Ann. N. Y. Acad. Sci. 1069: 129-144 (2006).
*
-
Ferraccioli G, Zoli A, Alivernini S, De Santis M, Verrillo A, Loperfido F. Lupus anticoagulant and ischemic myocardial microangiopathy in rheumatoid arthritis.
Nat. Clin. Pract. Cardiovasc. Med. 3: 339-343 (2006).
*
-
Ferraccioli GF, Gremese E. Biological therapies in autoimmune chronic inflammatory diseases (ACIDs).
Eur. Rev. Med. Pharmacol. Sci. 10: 37-40 (2006).
-
Ferrante M, de Hertogh G, Hlavaty T, D'Haens G, Penninckx F, D'Hoore A, Vermeire S, Rutgeerts P, Geboes K, van Assche G. The value of myenteric plexitis to predict early postoperative Crohn's disease recurrence.
Gastroenterology 130: 1595-1606 (2006).
*
-
Ferrante M, Penninckx F, De Hertogh G, Geboes K, D'Hoore A, Noman M, Vermeire S, Rutgeerts P, Van Assche G. Protein-losing enteropathy in Crohn's disease.
Acta Gastroenterol. Belg. 69: 384-389 (2006).
-
Ferrante M, Pierik M, Henckaerts L, Joossens M, Claes K, Van Schuerbeek N, Vlietinck R, Rutgeerts P, Van Assche G, Vermeire S. The role of vascular endothelial growth factor (VEGF) in inflammatory bowel disease.
Inflamm. Bowel Dis. 12: 870-878 (2006).
*
-
Ferrante P, Masci S, D'Ovidio R, Lafiandra D, Volpi C, Mattei B. A proteomic approach to verify in vivo expression of a novel gamma-gliadin containing an extra cysteine residue.
Proteomics 6: 1908-1914 (2006).
*
-
Ferrari MM, Biondi ML, Rossi G, Grijuela B, Gaita S, Perugino G, Vigano P. Analysis of two polymorphisms in the promoter region of matrix metalloproteinase 1 and 3 genes in women with endometriosis.
Acta Obstet. Gynecol. Scand. 85: 212-217 (2006).
-
Ferrari-Lacraz S, Zheng XX, Fueyo AS, Maslinski W, Moll T, Strom TB. CD8+ T cells resistant to costimulatory blockade are controlled by an antagonist interleukin-15/Fc protein.
Transplantation 82: 1510-1517 (2006).
-
Ferraris A, D'Amato G, Nobili V, Torres B, Marcellini M, Dallapiccola B. Combined test for UGT1A1 -3279T-->G and A(TA)nTAA polymorphisms best predicts Gilbert's syndrome in Italian pediatric patients.
Genet. Test. 10: 121-125 (2006).
-
Ferraris A, Torres B, Knafelz D, Barabino A, Lionetti P, de Angelis GL, Iacono G, Papadatou B, D'Amato G, Di Ciommo V, Dallapiccola B, Castro M. Relationship between CARD15, SLC22A4/5, and DLG5 polymorphisms and early-onset inflammatory bowel diseases: an Italian multicentric study.
Inflamm. Bowel Dis. 12: 355-361 (2006).
-
Ferre N, Claria J. New insights into the regulation of liver inflammation and oxidative stress.
Mini. Rev. Med. Chem. 6: 1321-1330 (2006).
-
Ferre N, Marsillach J, Camps J, Mackness B, Mackness M, Riu F, Coll B, Tous M, Joven J. Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases.
J. Hepatol. 45: 51-59 (2006).
*
-
Ferreira AM, Takagawa S, Fresco R, Zhu X, Varga J, DiPietro LA. Diminished induction of skin fibrosis in mice with MCP-1 deficiency.
J. Invest. Dermatol. 126: 1900-1908 (2006).
*
-
Ferreira CA. Autoimmune diseases: beyond clinical and/or immune parameters to pathogenic process.
Pathol. Biol. (Paris) 54: 119-121 (2006).
-
Ferrer E. Emerging therapeutic strategies for chronic inflammatory diseases.
Drug News Perspect. 19: 353-358 (2006).
-
Ferrer-Francesch X, Caro P, Alcalde L, Armengol MP, Ashhab Y, Lucas-Martin A, Martinez-Caceres EM, Juan M, Pujol-Borrell R. One-tube-PCR technique for CCL2, CCL3, CCL4 and CCL5 applied to fine needle aspiration biopsies shows different profiles in autoimmune and non-autoimmune thyroid disorders.
J. Endocrinol. Invest. 29: 342-349 (2006).
-
Ferrero-Miliani L, Seidelin JB, Nielsen OH. Regulation of cytokine production in inflammatory bowel disease.
Ugeskr. Laeger. 168: 1847-1850 (2006).
-
Ferretti G, Bacchetti T, Diludovico F, Viti B, Angeleri VA, Danni M, Provinciali L. Intracellular oxidative activity and respiratory burst of leukocytes isolated from multiple sclerosis patients.
Neurochem. Int. 48: 87-92 (2006).
-
Ferretti M, Gassner R, Wang Z, Perera P, Deschner J, Sowa G, Salter RB, Agarwal S. Biomechanical signals suppress proinflammatory responses in cartilage: early events in experimental antigen-induced arthritis.
J. Immunol. 177: 8757-8766 (2006).
*
-
Ferroni P, Basili S, Santilli F, Davi G. Low-density lipoprotein-lowering medication and platelet function.
Pathophysiol. Haemost. Thromb. 35: 346-354 (2006).
-
Ferrucci L, Cherubini A, Bandinelli S, Bartali B, Corsi A, Lauretani F, Martin A, Andres-Lacueva C, Senin U, Guralnik JM. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers.
J. Clin. Endocrinol. Metab. 91: 439-446 (2006).
*
-
Feuchtenberger M, Kneitz C, Tony HP. Treatment of rheumatoid arthritis (RA) with anticytokines.
MMW Fortschr. Med. 148: 44-45, 47 (2006).
-
Feuillet V, Medjane S, Mondor I, Demaria O, Pagni PP, Galan JE, Flavell RA, Alexopoulou L. Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria.
Proc. Natl. Acad. Sci. U.S.A. 103: 12487-12492 (2006).
*
-
Feuk L, Marshall CR, Wintle RF, Scherer SW. Structural variants: changing the landscape of chromosomes and design of disease studies.
Hum. Mol. Genet. 15 Suppl. 1: R57-R66 (2006).
*
-
Fiaccavento R, Carotenuto F, Minieri M, Masuelli L, Vecchini A, Bei R, Modesti A, Binaglia L, Fusco A, Bertoli A, Forte G, Carosella L, Di Nardo P. alpha-Linolenic acid-enriched diet prevents myocardial damage and expands longevity in cardiomyopathic hamsters.
Am. J. Pathol. 169: 1913-1924 (2006).
*
-
Fiala Z, Borska L, Pastorkova A, Kremlacek J, Cerna M, Smejkalova J, Hamakova K. Genotoxic effect of Goeckerman regimen of psoriasis.
Arch. Dermatol. Res. 298: 243-251 (2006).
*
-
Fiasse R, Latinne D. Intestinal helminths: a clue explaining the low incidence of inflammatory bowel diseases in Subsaharan Africa? Potential benefits and hazards of helminth therapy.
Acta Gastroenterol. Belg. 69: 418-422 (2006).
-
Fiatte C, Huin C, Bertin I, Lesuffleur T, Pluvinet A, Touche N, Plenat F, Dauca M, Domenjoud L, Schohn H. Genetic analysis of peroxisome proliferator-activated receptor gamma1 splice variants in human colorectal cell lines.
Int. J. Oncol. 29: 1601-1610 (2006).
*
-
Fichera A, Lovadina S, Rubin M, Cimino F, Hurst RD, Michelassi F. Patterns and operative treatment of recurrent Crohn's disease: a prospective longitudinal study.
Surgery 140: 649-654 (2006).
*
-
Fichtner-Feigl S, Strober W, Kawakami K, Puri RK, Kitani A. IL-13 signaling through the IL-13alpha(2) receptor is involved in induction of TGF-beta(1) production and fibrosis.
Nat. Med. 12: 99-106 (2006).
*
-
Fickert P, Fuchsbichler A, Marschall HU, Wagner M, Zollner G, Krause R, Zatloukal K, Jaeschke H, Denk H, Trauner M. Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice.
Am. J. Pathol. 168: 410-422 (2006).
*
-
Fickert P, Fuchsbichler A, Moustafa T, Halilbasic E, Denk H, Trauner M. Bile acids and liver fibrosis - causative agent and therapeutic tool.
Falk Symposium 155. XIII FALK LIVER WEEK (Part I) XIX International Bile Acid Meeting. Bile Acids: Biological Actions and Clinical Relevance, October 6 - 7, 2006 Freiburg (Germany), p. 70-71 (2006). *
-
Fickert P, Wagner M, Marschall HU, Fuchsbichler A, Zollner G, Tsybrovskyy O, Zatloukal K, Liu J, Waalkes MP, Cover C, Denk H, Hofmann AF, Jaeschke H, Trauner M. 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
Gastroenterology 130: 465-481 (2006).
*
-
Fidder HH, Heijmans R, Chowers Y, Bar-Meir S, Avidan B, Pena AS, Crusius JB. TNF-857 polymorphism in Israeli Jewish patients with inflammatory bowel disease.
Int. J. Immunogenet. 33: 81-85 (2006).
*
-
Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, Gale NW, Witzenrath M, Rosseau S, Suttorp N, Sobke A, Herrmann M, Preissner KT, Vajkoczy P, Augustin HG. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation.
Nat. Med. 12: 235-239 (2006).
*
-
Fiedorczyk M, Klimiuk PA, Sierakowski S, Kita K. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathogenesis of rheumatoid arthritis.
Pol. Merkuriusz. Lek. 20: 228-231 (2006).
-
Fields TM, Michel SJ, Butler CL, Kriss VM, Albers SL. Abdominal manifestations of cystic fibrosis in older children and adults.
AJR Am. J. Roentgenol. 187: 1199-1203 (2006).
*
-
Fierer J. MDR-TB and HIV: the perfect storm?
Am. J. Trop. Med. Hyg. 75: 1025-1026 (2006).
-
Fieschi C, Malphettes M, Galicier L, Oksenhendler ER. Adult-onset primary hypogammaglobulinemia.
Presse. Med. 35: 887-894 (2006).
-
Fiester A. Why the omega-3 piggy should not go to market.
Nat. Biotechnol. 24: 1472-1473 (2006).
*
-
Fievet C, Fruchart JC, Staels B. PPARalpha and PPARgamma dual agonists for the treatment of type 2 diabetes and the metabolic syndrome.
Curr. Opin. Pharmacol. 6: 606-614 (2006).
-
Fife BT, Griffin MD, Abbas AK, Locksley RM, Bluestone JA. Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist.
J .Clin. Invest. 116: 2252-2261 (2006).
*
-
Fife BT, Guleria I, Gubbels Bupp M, Eagar TN, Tang Q, Bour-Jordan H, Yagita H, Azuma M, Sayegh MH, Bluestone JA. Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway.
J. Exp. Med. 203: 2737-2747 (2006).
*
-
Fife MS, Gutierrez A, Ogilvie EM, Stock CJ, Samuel JM, Thomson W, Mack LF, Lewis CM, Woo P. Novel IL10 gene family associations with systemic juvenile idiopathic arthritis (sJIA).
Arthritis Res. Ther. 8: R148 (2006).
*
-
Figueira AC, Dias SM, Santos MA, Apriletti JW, Baxter JD, Webb P, Neves FA, Simeoni LA, Ribeiro RC, Polikarpov I. Human thyroid receptor forms tetramers in solution, which dissociate into dimers upon ligand binding.
Cell. Biochem. Biophys. 44: 453-462 (2006).
-
Figueredo MA, Rodriguez A, Ruiz-Yague M, Romero M, Fernandez-Cruz A, Gomez-de la Concha E, Patino R. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
J. Rheumatol. 33: 1980-1986 (2006).
-
Figueroa C, Peralta A, Herrera L, Castro P, Gutierrez A, Valenzuela J, Aguillon JC, Quera R, Hermoso MA. NOD2/CARD15 and Toll-like 4 receptor gene polymorphism in Chilean patients with inflammatory bowel disease.
Eur. Cytokine Netw. 17: 125-130 (2006).
-
Figueroa-Vega N, Galindo-Rodriguez G, Bajana S, Portales-Perez D, Abud-Mendoza C, Sanchez-Torres C, Gonzalez-Amaro R. Phenotypic analysis of IL-10-treated, monocyte-derived dendritic cells in patients with systemic lupus erythematosus.
Scand. J. Immunol. 64: 668-676 (2006).
*
-
Fijak M, Meinhardt A. The testis in immune privilege.
Immunol. Rev. 213: 66-81 (2006).
*
-
Filik L, Dagli U, Ulker A. C-reactive protein and monitoring the activity of Crohn's disease.
Adv. Ther. 23: 655-662 (2006).
-
Filipe-Santos O, Bustamante J, Chapgier A, Vogt G, de Beaucoudrey L, Feinberg J, Jouanguy E, Boisson-Dupuis S, Fieschi C, Picard C, Casanova JL. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features.
Semin. Immunol. 18: 347-361 (2006).
*
-
Filippi J, Al-Jaouni R, Wiroth JB, Hebuterne X, Schneider SM. Nutritional deficiencies in patients with Crohn's disease in remission.
Inflamm. Bowel Dis. 12: 185-191 (2006).
*
-
Filippi L, Biancone L, Petruzziello C, Schillaci O. Tc-99m HMPAO-labeled leukocyte scintigraphy with hybrid SPECT/CT detects perianal fistulas in Crohn disease.
Clin. Nucl. Med. 31: 541-542 (2006).
-
Filippi PD, Badulli C, Cuccia M, De Silvestri A, Dametto E, Pasi A, Garaventa A, Prever AB, Todesco A, Trizzino A, Danesino C, Martinetti M, Arico M. Specific polymorphisms of cytokine genes are associated with different risks to develop single-system or multi-system childhood Langerhans cell histiocytosis.
Br. J. Haematol. 132: 784-787 (2006).
*
-
Filipski E, Li XM, Levi F. Disruption of circadian coordination and malignant growth.
Cancer Causes Control 17: 509-514 (2006).
*
-
Fillatreau S, Manz RA. Tolls for B cells.
Eur. J. Immunol. 36: 798-801 (2006).
*
-
Fillon S, Soulis K, Rajasekaran S, Benedict-Hamilton H, Radin JN, Orihuela CJ, El Kasmi KC, Murti G, Kaushal D, Gaber MW, Weber JR, Murray PJ, Tuomanen EI. Platelet-activating factor receptor and innate immunity: uptake of Gram-positive bacterial cell wall into host cells and cell-specific pathophysiology.
J. Immunol. 177: 6182-6191 (2006).
*
-
Finberg RW, Kurt-Jones EA. CD14: chaperone or matchmaker?
Immunity 24: 127-129 (2006).
*
-
Finck A, Van der Meer JW, Schaffer AA, Pfannstiel J, Fieschi C, Plebani A, Webster AD, Hammarstrom L, Grimbacher B. Linkage of autosomal-dominant common variable immunodeficiency to chromosome 4q.
Eur. J. Hum. Genet. 14: 867-875 (2006).
*
-
Finck BN. Effects of PPARalpha on cardiac glucose metabolism: a transcriptional equivalent of the glucose-fatty acid cycle?
Expert Rev. Cardiovasc. Ther. 4: 161-171 (2006).
-
Finck BN, Gropler MC, Chen Z, Leone TC, Croce MA, Harris TE, Lawrence JC Jr, Kelly DP. Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway.
Cell Metab. 4: 199-210 (2006).
*
-
Finckh A, Cooper GS, Chibnik LB, Costenbader KH, Watts J, Pankey H, Fraser PA, Karlson EW. Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women.
Arthritis Rheum. 54: 3648-3654 (2006).
*
-
Finckh A, Liang MH, van Herckenrode CM, de Pablo P. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: a meta-analysis.
Arthritis Rheum. 55: 864-872 (2006).
*
-
Finis K, Sultmann H, Ruschhaupt M, Buness A, Helmchen B, Kuner R, Gross ML, Fink B, Schirmacher P, Poustka A, Berger I. Analysis of pigmented villonodular synovitis with genome-wide complementary DNA microarray and tissue array technology reveals insight into potential novel therapeutic approaches.
Arthritis Rheum. 54: 1009-1019 (2006).
*
-
Fink E, Oaklander AL. Small-fiber neuropathy: answering the burning questions.
Sci. Aging Knowledge Environ. 6: pe7 (2006).
-
Fink TL, Klepcyk PJ, Oette SM, Gedeon CR, Hyatt SL, Kowalczyk TH, Moen RC, Cooper MJ. Plasmid size up to 20 kbp does not limit effective in vivo lung gene transfer using compacted DNA nanoparticles.
Gene Ther. 13: 1048-1051 (2006).
*
-
Finke D, Meier D. Molecular networks orchestrating GALT development.
Curr. Top. Microbiol. Immunol. 308: 19-57 (2006).
-
Finkelberg DL, Sahani D, Deshpande V, Brugge WR. Autoimmune pancreatitis.
N. Engl. J. Med. 355: 2670-2676 (2006).
*
-
Finkelstein D, Lamba V, Assem M, Rengelshausen J, Yasuda K, Strom S, Schuetz E. ADME transcriptome in Hispanic versus White donor livers: evidence of a globally enhanced NR1I3 (CAR, constitutive androstane receptor) gene signature in Hispanics.
Xenobiotica 36: 989-1012 (2006).
*
-
Finlay DG, Basu D, Sellin JH. Effect of race and ethnicity on perceptions of inflammatory bowel disease.
Inflamm. Bowel Dis. 12: 503-507 (2006).
*
-
Fiocchi C. Probiotics in inflammatory bowel disease: yet another mechanism of action?
Gastroenterology 131: 2009-2012 (2006).
*
-
Fiocchi C. Non-stop progress in inflammatory bowel disease: new players, new understanding, new therapies.
Curr. Opin. Gastroenterol. 22: 347-348 (2006).
-
Fiocchi C. The multifactorial pathogenesis of IBD.
Falk Symposium 154: INFLAMMATORY BOWEL DISEASE - DIAGNOSTIC AND THERAPEUTIC STRATEGIES, Moscow (Russia), June 9 - 10, 2006, pp. 21-22 (2006). *
-
Fiocchi C, Ina K, Danese S, Leite AZ, Vogel JD. Alterations of mesenchymal and endothelial cells in inflammatory bowel diseases.
Adv. Exp. Med. Biol. 579: 168-176 (2006).
-
Fiore CE, Pennisi P, Ferro G, Ximenes B, Privitelli L, Mangiafico RA, Santoro F, Parisi N, Lombardo T. Altered osteoprotegerin/RANKL ratio and low bone mineral density in celiac patients on long-term treatment with gluten-free diet.
Horm. Metab. Res. 38: 417-422 (2006).
-
Fiorucci S. FXR and liver fibrosis.
Falk Symposium 155. XIII FALK LIVER WEEK (Part I) XIX International Bile Acid Meeting. Bile Acids: Biological Actions and Clinical Relevance, October 6 - 7, 2006 Freiburg (Germany), p. 67-69 (2006). *
-
Fiorucci S, Distrutti E, Cirino G, Wallace JL. The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver.
Gastroenterology 131: 259-271 (2006).
*
-
Fiotti N, Altamura N, Fisicaro M, Carraro N, Uxa L, Grassi G, Torelli L, Gobbato R, Guarnieri G, Timothy Baxter B, Giansante C. MMP-9 microsatellite polymorphism and susceptibility to carotid arteries atherosclerosis.
Arterioscler. Thromb. Vasc. Biol. 26: 1330-1336 (2006).
*
-
Fireman Z, Zachlka R, Abu Mouch S, Kopelman Y. The role of endoscopy in the evaluation of iron deficiency anemia in premenopausal women.
Isr. Med. Assoc. J. 8: 88-90 (2006).
*
-
Firestein GS. Inhibiting inflammation in rheumatoid arthritis.
N. Engl. J. Med. 354: 80-82 (2006).
*
-
Firmin CJ, Kruger TF, Davids R. Proximal renal tubular acidosis in pregnancy. A case report and literature review.
Gynecol. Obstet. Invest. 63: 39-44 (2006).
-
Firouzi F, Bahari A, Aghazadeh R, Zali MR. Appendectomy, tonsillectomy, and risk of inflammatory bowel disease: a case control study in Iran.
Int. J. Colorectal Dis. 21: 155-159 (2006).
*
-
Fischer CM, Smith JL, Sanchez LD. Headache in a patient with ulcerative colitis.
Intern. Emerg. Med. 1: 155-159 (2006).
-
Fischer H, Widdicombe JH. Mechanisms of acid and base secretion by the airway epithelium.
J. Membr. Biol. 211: 139-150 (2006).
*
-
Fischer H, Yamamoto M, Akira S, Beutler B, Svanborg C. Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection.
Eur. J. Immunol. 36: 267-277 (2006).
*
-
Fischer K, Brzosko M, Walecka A, Ostanek L, Sawicki M. Antiendothelial cell antibodies as a risk factor of atherosclerosis in systemic lupus erythematosus.
Ann. Acad. Med. Stetin. 52 Suppl. 2: 95-99 (2006).
-
Fischer R, Debbabi H, Dubarry M, Boyaka P, Tome D. Regulation of physiological and pathological Th1 and Th2 responses by lactoferrin.
Biochem. Cell. Biol. 84: 303-311 (2006).
*
-
Fischer SA, Graham MB, Kuehnert MJ, Kotton CN, Srinivasan A, Marty FM, Comer JA, Guarner J, Paddock CD, DeMeo DL, Shieh WJ, Erickson BR, Bandy U, DeMaria A Jr, Davis JP, Delmonico FL, Pavlin B, Likos A, Vincent MJ, Sealy TK, Goldsmith CS, et al. Transmission of lymphocytic choriomeningitis virus by organ transplantation.
N. Engl. J. Med. 354: 2235-2249 (2006).
*
-
Fischer-Betz R, Schneider M. Connective tissue diseases: evaluation of clinical response.
Rheumatology (Oxford) 45 Suppl. 3: iii5-iii7 (2006).
*
-
Fiset PO, Tulic MK, Skrablin PS, Grover SM, Letuve S, Mazer BD, Hamid Q. Signal transducer and activator of transcription 6 down-regulates Toll-like receptor-4 expression of a monocytic cell line.
Clin. Exp. Allergy 36: 158-165 (2006).
*
-
Fishbein TM, Matsumoto CS. Intestinal replacement therapy: timing and indications for referral of patients to an intestinal rehabilitation and transplant program.
Gastroenterology 130: S147-S151 (2006).
*
-
Fisher DA. Watchful waiting after endoscopic removal of common bile duct stones: cheaper and better?
Am. J. Gastroenterol. 101: 753-754 (2006).
*
-
Fisher E, Li Y, Burwinkel B, Kuhr V, Hoffmann K, Mohlig M, Spranger J, Pfeiffer A, Boeing H, Schrezenmeir J, Doring F. Preliminary evidence of FABP2 A54T polymorphism associated with reduced risk of type 2 diabetes and obesity in women from a German cohort.
Horm. Metab. Res. 38: 341-345 (2006).
-
Fisher MR, Mathai SC, Champion HC, Girgis RE, Housten-Harris T, Hummers L, Krishnan JA, Wigley F, Hassoun PM. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension.
Arthritis Rheum. 54: 3043-3050 (2006).
*
-
Fisher RA, Strom SC. Human hepatocyte transplantation: worldwide results.
Transplantation 82: 441-449 (2006).
-
Fisher SA, Hampe J, Onnie CM, Daly MJ, Curley C, Purcell S, Sanderson J, Mansfield J, Annese V, Forbes A, Lewis CM, Schreiber S, Rioux JD, Mathew CG. Direct or indirect association in a complex disease: the role of SLC22A4 and SLC22A5 functional variants in Crohn disease.
Hum. Mutat. 27: 778-785 (2006).
-
Fishman P, Bar-Yehuda S, Madi L, Rath-Wolfson L, Ochaion A, Cohen S, Baharav E. The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis.
Arthritis Res. Ther. 8: R33 (2006).
*
-
Fishman S, Lurie Y, Peretz H, Morad T, Grynberg E, Blendis LM, Leshno M, Brazowski E, Rosner G, Halpern Z, Oren R. Role of CYP2D6 polymorphism in predicting liver fibrosis progression rate in Caucasian patients with chronic hepatitis C.
Liver Int. 26: 279-284 (2006).
*
-
Fisson S, Djelti F, Trenado A, Billiard F, Liblau R, Klatzmann D, Cohen JL, Salomon BL. Therapeutic potential of self-antigen-specific CD4(+)CD25(+) regulatory T cells selected in vitro from a polyclonal repertoire.
Eur. J. Immunol. 36: 817-827 (2006).
*
-
Fite E, Fernandez-Figueras MT, Prats R, Vaquero M, Morera J. High prevalence of Mycobacterium tuberculosis DNA in biopsies from sarcoidosis patients from Catalonia, Spain.
Respiration 73: 20-26 (2006).
*
-
Fitzgerald KA, Chen ZJ. Sorting out Toll signals.
Cell 125: 834-836 (2006).
*
-
Fitzgerald O, Dougados M. Psoriatic arthritis: one or more diseases?
Best Pract. Res. Clin. Rheumatol. 20: 435-450 (2006).
-
Fitzgerald O, McInnes I. Spondyloarthropathy: disease at the crossroads of immunity.
Best Pract. Res. Clin. Rheumatol. 20: 949-967 (2006).
-
Fitzgerald SM, Goyal RK, Osborne WR, Roy JD, Wilson JW, Ferrell RE. Identification of functional single nucleotide polymorphism haplotypes in the cytidine deaminase promoter.
Hum. Genet. 119: 276-283 (2006).
*
-
Fiume I, Napolitano V, del Genio G, Rossetti G, Del Genio A. A mesenteric window to approach a posterior side leak after laparoscopic assisted stapled strictureplasty for Crohn's disease.
Ann. Ital. Chir. 77: 259-262 (2006).
-
Flach CF, Eriksson A, Jennische E, Lange S, Gunnerek C, Lonnroth I. Detection of elafin as a candidate biomarker for ulcerative colitis by whole-genome microarray screening.
Inflamm. Bowel Dis. 12: 837-842 (2006).
*
-
Flachenecker P. Epidemiology of neuroimmunological diseases.
J. Neurol. 253 Suppl. 5: v2-v8 (2006).
*
-
Flachs P, Mohamed-Ali V, Horakova O, Rossmeisl M, Hosseinzadeh-Attar MJ, Hensler M, Ruzickova J, Kopecky J. Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet.
Diabetologia 49: 394-397 (2006).
*
-
Flad T, Mueller L, Dihazi H, Grigorova V, Bogumil R, Beck A, Thedieck C, Mueller GA, Kalbacher H, Mueller CA. T cell epitope definition by differential mass spectrometry: identification of a novel, immunogenic HLA-B8 ligand directly from renal cancer tissue.
Proteomics 6: 364-374 (2006).
*
-
Flamant F, Baxter JD, Forrest D, Refetoff S, Samuels H, Scanlan TS, Vennstrom B, Samarut J. International Union of Pharmacology. LIX. The pharmacology and classification of the nuclear receptor superfamily: thyroid hormone receptors.
Pharmacol. Rev. 58: 705-711 (2006).
*
-
Flato B, Hoffmann-Vold AM, Reiff A, Forre O, Lien G, Vinje O. Long-term outcome and prognostic factors in enthesitis-related arthritis: a case-control study.
Arthritis Rheum. 54: 3573-3582 (2006).
*
-
Fleet JC. Molecular regulation of calcium and bone metabolism through the vitamin D receptor.
J. Musculoskelet. Neuronal Interact. 6: 336-337 (2006).
-
Fleischer A, Ghadiri A, Dessauge F, Duhamel M, Rebollo MP, Alvarez-Franco F, Rebollo A. Modulating apoptosis as a target for effective therapy.
Mol. Immunol. 43: 1065-1079 (2006).
*
-
Fleischer B, Morgenthaler J, Tippel G, Kuhfus A, Gieseler U, Stolte M. Cytomegalovirus-induced colitis in an immunocompetent old patient.
Med. Klin. (Munich) 101: 835-838 (2006).
-
Fleischmann R, Baumgartner SW, Weisman M, Liu T, White B, Peloso PM. Long-term safety of etanercept in elderly subjects with rheumatic diseases.
Ann. Rheum. Dis. 65: 379-384 (2006).
*
-
Fleischmann RM, Tesser J, Schiff M, Schechtman J, Burmester GR, Bennett R, Modafferi D, Zhou L, Bell D, Appleton B. Safety of extended treatment with anakinra in patients with rheumatoid arthritis.
Ann. Rheum. Dis. 65: 1006-1012 (2006).
*
-
Fleming JO, Cook TD. Multiple sclerosis and the hygiene hypothesis.
Neurology 67: 2085-2086 (2006).
-
Fleta Asin B, Gonzalvo Liarte MC, Cia Gomez P. Chimerism: origin and medical implications.
Rev. Clin. Esp. 206: 340-342 (2006).
-
Fletcher CA, Sutherland AP, Groom JR, Batten ML, Ng LG, Gommerman J, Mackay F. Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells.
Eur. J. Immunol. 36: 2504-2514 (2006).
*
-
Fletcher PC, Schneider MA. Is there any food I can eat?: living with inflammatory bowel disease and/or irritable bowel syndrome.
Clin. Nurse Spec. 20: 241-247 (2006).
-
Fletcher S, Steffy K, Averett D. Masked oral prodrugs of Toll-like receptor 7 agonists: a new approach for the treatment of infectious disease.
Curr. Opin. Investig. Drugs 7: 702-708 (2006).
-
Fleurence R, Spackman E. Cost-effectiveness of biologic agents for treatment of autoimmune disorders: structured review of the literature.
J. Rheumatol. 33: 2124-2131 (2006).
-
Floch MH. A hypothesis: is diverticulitis a type of inflammatory bowel disease?
J. Clin. Gastroenterol. 40 Suppl. 3: S121-S125 (2006).
-
Floch MH, Madsen KK, Jenkins DJ, Guandalini S, Katz JA, Onderdonk A, Walker WA, Fedorak RN, Camilleri M. Recommendations for probiotic use.
J. Clin. Gastroenterol. 40: 275-278 (2006).
-
Floreani A, Betterle C, Carderi I, Presotto F, Pedini B, Moscon A, Andrea O, Chiaramonte M; Arsita-one Research Group*. Is hepatitis C virus a risk factor for thyroid autoimmunity?
J. Viral Hepat. 13: 272-277 (2006).
-
Floreani A, Carderi I, Paternoster D, Soardo G, Azzaroli F, Esposito W, Variola A, Tommasi AM, Marchesoni D, Braghin C, Mazzella G. Intrahepatic cholestasis of pregnancy: three novel MDR3 gene mutations.
Aliment. Pharmacol. Ther. 23: 1649-1653 (2006).
*
-
Floreani A, Carderi I, Variola A, Rizzotto ER, Nicol J, Bergasa NV. A novel multidrug-resistance protein 2 gene mutation identifies a subgroup of patients with primary biliary cirrhosis and pruritus.
Hepatology 43: 1152-1154 (2006).
*
-
Floreani A, Niro G, Rosa Rizzotto E, Antoniazzi S, Ferrara F, Carderi I, Baldo V, Premoli A, Olivero F, Morello E, Durazzo M. Type I autoimmune hepatitis: clinical course and outcome in an Italian multicentre study.
Aliment. Pharmacol. Ther. 24: 1051-1057 (2006).
-
Floreani A, Ostuni PA, Ferrara F, Guido M. Primary biliary cirrhosis: when and why does the disease develop?
Dig. Liver Dis. 38: 272-275 (2006).
-
Flores C, Maca-Meyer N, Perez-Mendez L, Sanguesa R, Espinosa E, Muriel A, Blanco J, Villar J. A CXCL2 tandem repeat promoter polymorphism is associated with susceptibility to severe sepsis in the Spanish population.
Genes Immun. 7: 141-149 (2006).
*
-
Flores MV, Lam EY, Crosier P, Crosier K. A hierarchy of Runx transcription factors modulate the onset of chondrogenesis in craniofacial endochondral bones in zebrafish.
Dev. Dyn. 235: 3166-3176 (2006).
-
Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, Shuldiner AR, Knowler WC, Nathan DM, Altshuler D; Diabetes Prevention Program Research Group. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program.
N. Engl. J. Med. 355: 241-250 (2006).
*
-
Florez JC, Saxena R, Winckler W, Burtt NP, Almgren P, Bengtsson Bostrom K, Tuomi T, Gaudet D, Ardlie KG, Daly MJ, Altshuler D, Hirschhorn JN, Groop L. The Kruppel-like factor 11 (KLF11) Q62R polymorphism is not associated with type 2 diabetes in 8,676 people.
Diabetes 55: 3620-3624 (2006).
*
-
Florez O, Zafra G, Morillo C, Martin J, Gonzalez CI. Interleukin-1 gene cluster polymorphism in Chagas disease in a Colombian case-control study.
Hum. Immunol. 67: 741-748 (2006).
-
Florin TH, Paterson EW, Fowler EV, Radford-Smith GL. Clinically active Crohn's disease in the presence of a low C-reactive protein.
Scand. J. Gastroenterol. 41: 306-311 (2006).
*
-
Floto RA, MacAry PA, Boname JM, Mien TS, Kampmann B, Hair JR, Huey OS, Houben EN, Pieters J, Day C, Oehlmann W, Singh M, Smith KG, Lehner PJ. Dendritic cell stimulation by mycobacterial Hsp70 is mediated through CCR5.
Science 314: 454-458 (2006).
*
-
Flower C, Hennis A, Hambleton IR, Nicholson G. Lupus nephritis in an Afro-Caribbean population: renal indices and clinical outcomes.
Lupus 15: 689-694 (2006).
-
Flower DR. Receptor-binding sites: bioinformatic approaches.
Methods Mol. Biol. 316: 291-358 (2006).
-
Flowers MT, Groen AK, Oler AT, Keller MP, Choi Y, Schueler KL, Richhards OC, Lan H, Miyazaki M, Kuipers F, Kendziorski CM, Ntambi JM, Attie AD. Cholestasis and hypercholesterolemia in SCD1-deficient mice fed a low-fat, high-carbohydrate diet.
J. Lipid Res. 47: 2668-2680 (2006).
*
-
Flynn MG, McFarlin BK. Toll-like receptor 4: link to the anti-inflammatory effects of exercise?
Exerc. Sport Sci. Rev. 34: 176-181 (2006).
-
Focareta A, Paton JC, Morona R, Cook J, Paton AW. A recombinant probiotic for treatment and prevention of cholera.
Gastroenterology 130: 1688-1695 (2006).
*
-
Focosi D. Chaperonin 10 for rheumatoid arthritis.
Lancet 368: 1961 (2006).
*
-
Foell J, Mittler RS. Costimulatory molecules as immunotherapeutic targets in systemic lupus erythematosus.
Springer Semin. Immunopathol. 28: 153-162 (2006).
*
-
Foerster J, Wittstock S, Fleischanderl S, Storch A, Riemekasten G, Hochmuth O, Meffert B, Meffert H, Worm M. Infrared-monitored cold response in the assessment of Raynaud's phenomenon.
Clin. Exp. Dermatol. 31: 6-12 (2006).
*
-
Fogarty PF, Seggewiss R, McCloskey DJ, Boss CA, Dunbar CE, Rick ME. Anti-interleukin-2 receptor antibody (daclizumab) treatment of corticosteroid-refractory autoimmune thrombocytopenic purpura.
Haematologica 91: 277-278 (2006).
*
-
Fogel WA, Lewinski A. The effects of diamine oxidase administration on experimental ulcerative colitis in rats.
Inflamm. Res. 55: S63-S64 (2006).
*
-
Foger N, Rangell L, Danilenko DM, Chan AC. Requirement for coronin 1 in T lymphocyte trafficking and cellular homeostasis.
Science 313: 839-842 (2006).
*
-
Fogg DK, Sibon C, Miled C, Jung S, Aucouturier P, Littman DR, Cumano A, Geissmann F. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells.
Science 311: 83-87 (2006).
*
-
| |
